Predicate ID,Triple,Sentence ID,Sentence,Is Correct,Question,Answer
24413653,Fenbendazole treats helminthiasis,1001,"This study investigated worm control practices by free-range egg farmers and the efficacy of the commercial anthelmintics levamisole (LEV), piperazine (PIP), flubendazole (FLBZ) and fenbendazole (FBZ) against gastrointestinal nematodes on two free-range layer farms in Australia.",True,"'Does the phrase ""Fenbendazole treats helminthiasis"" receive at least indirect support from the statement: ""This study investigated worm control practices by free-range egg farmers and the efficacy of the commercial anthelmintics levamisole (LEV), piperazine (PIP), flubendazole (FLBZ) and fenbendazole (FBZ) against gastrointestinal nematodes on two free-range layer farms in Australia.""?","Yes, the statement does provide indirect support for the claim that ""Fenbendazole treats helminthiasis."" The study investigates the efficacy of various anthelmintics, including fenbendazole (FBZ), against gastrointestinal nematodes on two free-range layer farms in Australia. Helminthiasis is defined as an infection by parasitic worms; thus, gastrointestinal nematodes fall under this category. The fact that fenbendazole is one of the anthelmintics being studied for its efficacy against these parasitic worms implies that it has potential therapeutic effects on helminthiasis. However, it is important to note that direct evidence of fenbendazole treating helminthiasis in this study would require worm burden analyses before and after treatment with fenbendazole specifically, which is not explicitly stated in the provided statement."
9783282,Thiabendazole treats helminthiasis,1002,[The treatment of helminthiasis with thiabendazole].,True,"'Does the phrase ""Thiabendazole treats helminthiasis"" receive at least indirect support from the statement: ""[The treatment of helminthiasis with thiabendazole].""?","Yes, the phrase ""Thiabendazole treats helminthiasis"" does receive indirect support from the statement: ""[The treatment of helminthiasis with thiabendazole]."" 

         The statement implies that thiabendazole is being used as a treatment for helminthiasis. This suggests that thiabendazole has some therapeutic effect on helminthiasis, which aligns with the phrase ""Thiabendazole treats helminthiasis."" However, it's important to note that while the statement provides indirect support, it doesn't constitute definitive proof of the phrase's truthfulness. Further evidence from clinical trials or peer-reviewed studies would be needed for a more robust confirmation of thiabendazole's efficacy in treating helminthiasis."
22678969,Albendazole treats Infection,1003,The control of STH infections is based on preventive chemotherapy using either albendazole or mebendazole.,True,"'Does the phrase ""Albendazole treats Infection"" receive at least indirect support from the statement: ""The control of STH infections is based on preventive chemotherapy using either albendazole or mebendazole.""?","Yes, the phrase ""Albendazole treats Infection"" does receive indirect support from the statement: ""The control of STH infections is based on preventive chemotherapy using either albendazole or mebendazole."" 

        The statement suggests that albendazole is used in preventive chemotherapy for STH (Soil Transmitted Helminths) infections, which implies that it has therapeutic effects against these infections. This is in line with the general understanding that chemotherapy is a treatment method using chemicals (in this case, drugs like albendazole) to treat diseases or infections. Therefore, it can be inferred that albendazole does indeed treat infections, even though the original statement does not explicitly mention this. However, it is important to note that the specific types of infections it treats (STH infections) are only inferred from the context provided."
10750815,Albendazole treats onchocerciasis,1004,"A double-blind clinical trial was conducted in Monagas State, Venezuela to assess the tolerance and efficacy of albendazole in the therapy of Onchocerca volvulus infection.",True,"'Does the phrase ""Albendazole treats onchocerciasis"" receive at least indirect support from the statement: ""A double-blind clinical trial was conducted in Monagas State, Venezuela to assess the tolerance and efficacy of albendazole in the therapy of Onchocerca volvulus infection.""?","Yes, the statement does provide indirect support for the claim that Albendazole treats onchocerciasis (Onchocerca volvulus infection). The clinical trial mentioned in the statement was designed to assess both tolerance (safety) and efficacy (effectiveness) of Albendazole in treating Onchocerca volvulus infection. Efficacy refers to the ability of a treatment to produce a desired result under ideal conditions; in this case, eliminating or reducing Onchocerca volvulus infection.

         While the statement does not explicitly confirm that albendazole was found effective in treating onchocerciasis in Monagas State, Venezuela, it does suggest that such an assessment was carried out as part of the trial objectives. Therefore, it is reasonable to infer that there is some basis for supporting albendazole as a treatment for onchocerciasis based on the described clinical trial; however, direct access to trial results would be required for a definitive conclusion.

         It is important to note that evidence from individual clinical trials may be subject to limitations such as sample size, participant demographics, dosage levels, follow-up periods,"
10114050,Albendazole treats toxocariasis,1005,"The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin.",True,"'Does the phrase ""Albendazole treats toxocariasis"" receive at least indirect support from the statement: ""The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin.""?","Yes, the phrase ""Albendazole treats toxocariasis"" does receive indirect support from the statement: ""The treatment of cutaneous larva migrans and Toxocara infection relies on antihelminthic agents such as thiabendazole, albendazole and ivermectin.""

         The statement clearly identifies albendazole as one of the antihelminthic agents used in treating Toxocara infections. Toxocariasis is a condition caused by Toxocara canis or Toxocara cati larvae, which is what is being referred to in this context. Therefore, it indirectly supports the claim that albendazole is used in treating toxocariasis.

         However, it is important to note that while albendazole is an effective treatment for many parasitic infections, including some forms of toxocariasis, its effectiveness can depend on various factors such as the specific type of Toxocara infection, the severity of symptoms, and the individual patient's health status. Therefore, while the statement provides indirect support for the claim, it does not"
9588560,Albendazole treats trichuriasis,1006,"Three randomized clinical studies were conducted in 2000 to evaluate the efficacy of nitazoxanide paediatric suspension compared to albendazole in the treatment of ascariasis and trichuriasis and praziquantel in the treatment of hymenolepiasis in children from Cajamarca, Peru.",True,"'Does the phrase ""Albendazole treats trichuriasis"" receive at least indirect support from the statement: ""Three randomized clinical studies were conducted in 2000 to evaluate the efficacy of nitazoxanide paediatric suspension compared to albendazole in the treatment of ascariasis and trichuriasis and praziquantel in the treatment of hymenolepiasis in children from Cajamarca, Peru.""?","Yes, the statement does provide indirect support for the claim that albendazole treats trichuriasis. The randomized clinical studies mentioned in the statement compared albendazole to other treatments for ascariasis, trichuriasis, and hymenolepiasis in children from Cajamarca, Peru. The fact that albendazole was included in these studies suggests that it is recognized as a potential treatment for trichuriasis in the medical community. However, these studies do not explicitly demonstrate that albendazole treats trichuriasis; they only show that it was compared to other treatments for trichuriasis in clinical trials. Further investigation would be necessary to confirm whether albendazole is an effective treatment for trichuriasis specifically."
9492446,Albendazole treats filariasis,1007,"Today, the only way is the prophylactic control of Onchocerca vovulus infections and treating lymphatic filariosis with ivermectin, diethylcarbamacine, ivermectin/diethylcarbamazine. or ivermectin/albendazole combinations.",True,"'Does the phrase ""Albendazole treats filariasis"" receive at least indirect support from the statement: ""Today, the only way is the prophylactic control of Onchocerca vovulus infections and treating lymphatic filariosis with ivermectin, diethylcarbamacine, ivermectin/diethylcarbamazine. or ivermectin/albendazole combinations.""?","Yes, the phrase ""Albendazole treats filariasis"" does receive indirect support from the statement provided. 

         The statement mentions that lymphatic filariosis is treated with ivermectin, diethylcarbamazine, ivermectin/diethylcarbamazine combinations, or ivermectin/albendazole combinations. This implies that albendazole is used in combination therapy for treating filariasis caused by Onchocerca volvulus or lymphatic filariasis caused by other parasites like Wuchereria bancrofti and Brugia malayi. Therefore, it indirectly supports the claim that albendazole is used in treating filariasis.

         However, it is important to note that albendazole is not typically used as a standalone treatment for filariasis but rather in combination therapy as stated in the provided statement. This nuance should be taken into account when interpreting the evidence provided."
8712067,Albendazole treats helminthiasis,1008,The study population was assessed for helminthic infection and those found to be positive were randomly assigned to either an albendazole treatment group or a control group who received a placebo.,True,"'Does the phrase ""Albendazole treats helminthiasis"" receive at least indirect support from the statement: ""The study population was assessed for helminthic infection and those found to be positive were randomly assigned to either an albendazole treatment group or a control group who received a placebo.""?","Yes, the statement does provide indirect support for the claim that ""Albendazole treats helminthiasis"". This is because conducting a study where participants diagnosed with helminthic infection (helminthiasis) were randomly assigned into either an albendazole treatment group or a control group receiving placebo implies that albendazole is being investigated for its potential therapeutic effect on helminthiasis.

         The random assignment of participants into two groups is a standard practice in clinical trials investigating potential treatments for various health conditions. The fact that one group received albendazole suggests that there is an expectation within the study design that albendazole may have an impact on helminthic infection. However, it should be noted that direct support for the claim would require additional information about the outcomes of such a study, such as whether there was a significant difference between the treatment group and control group in terms of resolution of helminthic infection."
7789677,Albendazole treats strongyloidiasis,1009,"To determine the host factors involved in response to treatment, 46 patients with strongyloidiasis were treated with albendazole, followed-up for 1 year, and separated into two groups: cured and non-cured.",True,"'Does the phrase ""Albendazole treats strongyloidiasis"" receive at least indirect support from the statement: ""To determine the host factors involved in response to treatment, 46 patients with strongyloidiasis were treated with albendazole, followed-up for 1 year, and separated into two groups: cured and non-cured.""?","Yes, the statement does provide indirect support for the claim that Albendazole treats strongyloidiasis. The fact that 46 patients diagnosed with strongyloidiasis were treated with Albendazole indicates that it is being used as a treatment option for this condition. Furthermore, the follow-up period of one year suggests that the researchers were interested in observing the long-term effects of the treatment, which is consistent with the typical use of antibiotics like Albendazole for parasitic infections. However, it's important to note that this statement does not directly demonstrate that Albendazole cures strongyloidiasis, as it only shows an association between treatment and outcome. The distinction between correlation and causation should be kept in mind when interpreting these results."
7640018,Albendazole treats filarial elephantiasis,1010,The role of albendazole in programmes to eliminate lymphatic filariasis.,True,"'Does the phrase ""Albendazole treats filarial elephantiasis"" receive at least indirect support from the statement: ""The role of albendazole in programmes to eliminate lymphatic filariasis.""?","Yes, the statement ""The role of albendazole in programmes to eliminate lymphatic filariasis"" does provide indirect support for the phrase ""Albendazole treats filarial elephantiasis"". This is because filarial elephantiasis is caused by parasitic filarial worms, which lymphatic filariasis is a disease resulting from infection by these worms. Albendazole is an anthelmintic drug commonly used in mass drug administration programs aimed at eliminating lymphatic filariasis. By targeting and killing the microfilariae (immature larvae) of these filarial worms, albendazole can help reduce the transmission of lymphatic filariasis in endemic areas and alleviate associated symptoms like filarial elephantiasis over time. However, it is important to note that albendazole alone may not cure filarial elephantiasis; it is often used in combination with other medications like diethylcarbamazine (DEC) and ivermectin for more effective treatment outcomes."
7620262,Albendazole treats Hookworm Infections,1011,On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali.,True,"'Does the phrase ""Albendazole treats Hookworm Infections"" receive at least indirect support from the statement: ""On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali.""?","Yes, the phrase ""Albendazole treats Hookworm Infections"" does receive indirect support from the statement: ""On the basis of our results the single 400 mg dose of albendazole is the treatment of choice for hookworm infections in this region of Mali."" 

         The statement implies that albendazole is an effective treatment for hookworm infections in the specified region of Mali. This suggests that albendazole has some level of efficacy in treating hookworm infections, providing indirect support for the claim that albendazole treats hookworm infections. However, it's important to note that the claim is not directly supported because the statement only refers to the efficacy of albendazole in a specific region of Mali, not globally. Furthermore, the statement does not provide any details about the mechanism of action of albendazole against hookworm infections. Therefore, while there is indirect support for the claim, it is not conclusively proven by the statement alone."
7226097,Albendazole treats cysticercosis,1012,The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis.,True,"'Does the phrase ""Albendazole treats cysticercosis"" receive at least indirect support from the statement: ""The efficacy of albendazole (15 mg/kg/d for 1 week) was compared with praziquantel (100 mg/kg in three divided doses at 2-hour intervals) for therapy of parenchymal brain cysticercosis.""?","Yes, the statement does provide indirect support for the claim that Albendazole treats cysticercosis. The study mentioned compares the efficacy of Albendazole and Praziquantel in treating parenchymal brain cysticercosis. The fact that Albendazole is included in such a study suggests that it has some therapeutic effect on cysticercosis, thus providing indirect support for the claim that Albendazole treats cysticercosis. However, it is important to note that this does not directly prove that Albendazole is an effective treatment for cysticercosis in all cases or in all stages of the disease, as it may depend on various factors such as dosage, duration of treatment, patient's overall health status, among others."
25678577,Latamoxef treats bacterial infectious disease,1013,"Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.",True,"'Does the phrase ""Latamoxef treats bacterial infectious disease"" receive at least indirect support from the statement: ""Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections.""?","Yes, there is indirect support for the statement that ""Latamoxef treats bacterial infectious disease"" from the given statement about moxalactam, another oxacephem antibiotic like Latamoxef.

        The statement ""Clinical efficacy and safety of a new oxacephem, moxalactam, in serious bacterial infections"" suggests that moxalactam is effective in treating serious bacterial infections, implying that it has antibacterial properties. Latamoxef is also an oxacephem antibiotic, meaning it shares structural similarities and likely pharmacological properties with moxalactam.

        Therefore, based on the evidence that moxalactam treats bacterial infections, it can be reasonably inferred that Latamoxef may have similar effects due to their shared classification as oxacephem antibiotics. However, it is essential to note that direct evidence should be sought for Latamoxef specifically before making definitive conclusions about its therapeutic utility for bacterial infections.

        To strengthen the argument for Latamoxef treating bacterial infections, further investigation into clinical trials, observ"
26824955,Ibuprofen treats spondylosis,1014,A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis.,False,"'Does the phrase ""Ibuprofen treats spondylosis"" receive at least indirect support from the statement: ""A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis.""?","No, the statement ""A comparison of the short-term effects of ibuprofen and diclofenac in spondylosis"" does not provide direct or indirect support for the claim ""Ibuprofen treats spondylosis."" The statement is merely comparing two treatments (ibuprofen and diclofenac) in terms of their short-term effects on spondylosis patients; it does not confirm that ibuprofen is an effective treatment for spondylosis on its own.

        

        The statement does suggest that there is some evidence of ibuprofen being used in relation to spondylosis treatment, but it does not necessarily mean that ibuprofen treats spondylosis effectively by itself. Additionally, diclofenac is also being compared in terms of its short-term effects on spondylosis patients; thus, it is not isolating ibuprofen as an effective treatment for spondylosis.

        

        In order for there to be direct support for the claim ""Ibuprofen treats spondylosis,"" there would need to be evidence that specifically demonstrates ibuprofen as an effective treatment for spond"
25670779,Ibuprofen treats sunburn,1015,"The data suggest that ibuprofen is more effective than placebo for the relief of symptoms associated with UV-B-induced inflammation after high dose UV-B phototherapy for psoriasis, but the drug has limited usefulness in the treatment of sunburn reaction from these same doses.",True,"'Does the phrase ""Ibuprofen treats sunburn"" receive at least indirect support from the statement: ""The data suggest that ibuprofen is more effective than placebo for the relief of symptoms associated with UV-B-induced inflammation after high dose UV-B phototherapy for psoriasis, but the drug has limited usefulness in the treatment of sunburn reaction from these same doses.""?","Yes, indirect support can be inferred from the statement provided. The key point here is that ibuprofen has been found to be more effective than placebo in alleviating symptoms associated with UV-B-induced inflammation after high dose UV-B phototherapy for psoriasis. While it's true that the statement mentions limited usefulness in treating sunburn reaction from these same doses, it doesn't explicitly negate the potential benefits of ibuprofen in treating sunburn in general.

         Sunburn is essentially an inflammatory response to UV radiation damage, which is similar to the UV-B-induced inflammation mentioned in the statement. Therefore, it's reasonable to infer that ibuprofen could potentially have some beneficial effects on sunburn symptoms due to its anti-inflammatory properties. However, it's important to note that this inference is based on indirect evidence and further research would be needed to confirm whether ibuprofen is an effective treatment for sunburn specifically."
25518118,Ibuprofen treats Fractured ankle,1016,"Huoxue Huayu Recipe combined with ibuprofen can reduce inflammatory factors levels in patients with ankle fracture, improve isokinetic muscle strength and ankle function, and accelerate the recovery of patients.",True,"'Does the phrase ""Ibuprofen treats Fractured ankle"" receive at least indirect support from the statement: ""Huoxue Huayu Recipe combined with ibuprofen can reduce inflammatory factors levels in patients with ankle fracture, improve isokinetic muscle strength and ankle function, and accelerate the recovery of patients.""?","Yes, indirectly it does lend some support to the claim that ibuprofen can be beneficial in treating fractured ankles. The statement suggests that when ibuprofen is used in combination with the Huoxue Huayu Recipe (a traditional Chinese medicine), it leads to reduced inflammatory factors levels in patients with ankle fractures. This implies that ibuprofen could potentially contribute to improved isokinetic muscle strength, ankle function, and accelerated recovery in these patients.

         However, it is important to note that correlation does not imply causation. The specific effects of ibuprofen cannot be definitively determined from this statement alone since it is part of a combination therapy. Further studies isolating ibuprofen as a treatment would be needed for stronger evidence supporting its direct effects on fractured ankles."
25321029,Ibuprofen treats bronchopulmonary dysplasia,1017,"Treatment of newborn rat pups with ibuprofen reduced pulmonary vessel density in the developing lung, but also attenuated experimental BPD by reducing lung inflammation, alveolar enlargement, alveolar septum thickness and small arteriolar wall thickening.",True,"'Does the phrase ""Ibuprofen treats bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""Treatment of newborn rat pups with ibuprofen reduced pulmonary vessel density in the developing lung, but also attenuated experimental BPD by reducing lung inflammation, alveolar enlargement, alveolar septum thickness and small arteriolar wall thickening.""?","Yes, indirect support can be inferred from the statement provided. The claim that ibuprofen treats bronchopulmonary dysplasia (BPD) is essentially saying that ibuprofen has therapeutic effects on BPD. The statement mentions that ibuprofen reduces lung inflammation, alveolar enlargement, alveolar septum thickness, and small arteriolar wall thickening in newborn rat pups. These factors are closely related to the pathophysiology of BPD, which involves inflammation, arrested alveolar development, and vascular remodeling. Therefore, by addressing these aspects, ibuprofen could potentially ameliorate BPD symptoms, providing indirect support for the claim. However, it is important to note that this is based on animal studies, and further research in humans is needed before making definitive conclusions about ibuprofen as a treatment for BPD in humans."
22125431,Ibuprofen treats preeclampsia,1018,Introduction:     The comparison of ibuprofen with acetaminophen for blood pressure (BP) in preeclampsia remains controversial.,False,"'Does the phrase ""Ibuprofen treats preeclampsia"" receive at least indirect support from the statement: ""Introduction:     The comparison of ibuprofen with acetaminophen for blood pressure (BP) in preeclampsia remains controversial.""?","No, the statement ""Ibuprofen treats preeclampsia"" does not receive indirect support from the provided statement. The statement in question only introduces a controversy about whether ibuprofen is more effective than acetaminophen in managing blood pressure in preeclampsia patients. It does not confirm that ibuprofen can treat preeclampsia itself. 

        The statement focuses on comparing ibuprofen with acetaminophen in managing blood pressure in preeclampsia patients rather than treating preeclampsia itself. Therefore, it does not provide any evidence supporting the claim that ibuprofen treats preeclampsia but merely states that there is controversy regarding its use for blood pressure management in these patients.

        It is crucial to differentiate between treating a disease (preeclampsia) and managing symptoms (blood pressure) when interpreting medical literature. The provided statement only addresses managing symptoms associated with preeclampsia rather than treating preeclampsia itself."
21268743,Ibuprofen treats glioma,1019,"Taken together, our findings reveal that ibuprofen could induce ferroptosis of glioblastoma cells via downregulation of Nrf2 signaling pathway and is a potential drug for glioma treatment.",True,"'Does the phrase ""Ibuprofen treats glioma"" receive at least indirect support from the statement: ""Taken together, our findings reveal that ibuprofen could induce ferroptosis of glioblastoma cells via downregulation of Nrf2 signaling pathway and is a potential drug for glioma treatment.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats glioma."" The statement suggests that ibuprofen could induce ferroptosis of glioblastoma cells, which are a type of glioma cell. Furthermore, it indicates that this could occur via downregulation of the Nrf2 signaling pathway, suggesting a specific mechanism of action. The use of terms such as ""treatment"" and ""potential drug"" also imply that ibuprofen could have therapeutic effects in glioma. However, it is important to note that this is based on in vitro findings and further research is needed to confirm these effects in vivo and in clinical settings."
20821983,Ibuprofen treats common cold,1020,Ibuprofen (IBU) and phenylephrine hydrochloride (PE) were commonly used for common cold due to their different effects in relieving fever and the main symptoms such as nasal congestion and high sinus pressure.,False,"'Does the phrase ""Ibuprofen treats common cold"" receive at least indirect support from the statement: ""Ibuprofen (IBU) and phenylephrine hydrochloride (PE) were commonly used for common cold due to their different effects in relieving fever and the main symptoms such as nasal congestion and high sinus pressure.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen treats common cold."" The original statement suggests that Ibuprofen (IBU) and phenylephrine hydrochloride (PE) were commonly used for treating common cold symptoms like fever and nasal congestion; however, it does not explicitly connect ibuprofen as an effective treatment for the common cold itself. The statement only supports that ibuprofen can alleviate certain symptoms associated with the common cold but does not provide evidence that it treats the underlying cause of the common cold."
20285347,Ibuprofen treats periodontitis,1021,"Therefore, the objective of this study was to investigate the local delivery of the NSAIDs model drug ibuprofen to treat periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel).",True,"'Does the phrase ""Ibuprofen treats periodontitis"" receive at least indirect support from the statement: ""Therefore, the objective of this study was to investigate the local delivery of the NSAIDs model drug ibuprofen to treat periodontitis using different types of gel formulations (hydrogel, oleogel, and bigel).""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats periodontitis."" The objective of the study as stated is to investigate the local delivery of ibuprofen (an NSAID) for treating periodontitis using various gel formulations. This implies that ibuprofen is being considered as a potential treatment for periodontitis in this study. However, it should be noted that this does not constitute direct evidence of ibuprofen's efficacy in treating periodontitis. The results of the study would need to be evaluated to make such a determination."
19270581,Ibuprofen treats bone fracture,1022,Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?,False,"'Does the phrase ""Ibuprofen treats bone fracture"" receive at least indirect support from the statement: ""Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?""?","No, the statement ""Does the Use of Ibuprofen in Children with Extremity Fractures Increase their Risk for Bone Healing Complications?"" does not provide indirect support for the phrase ""Ibuprofen treats bone fracture."" 

        The statement is actually asking whether the use of Ibuprofen in children with extremity fractures increases their risk for bone healing complications, which is quite different from claiming that Ibuprofen treats bone fractures. In fact, it implies that there might be potential negative effects associated with its use in this context. 

        Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation. While it can help manage pain associated with bone fractures, it does not actively treat or heal the fracture itself. Therefore, no supportive evidence is provided by this statement for the direct treatment claim. 

        It is essential to differentiate between pain management and treatment when discussing pharmaceutical interventions like Ibuprofen. Misinterpreting such statements could lead to inaccurate conclusions about therapeutic efficacy and"
17621968,Ibuprofen treats Cognitive impairment,1023,"Finally, anti-inflammatory drug ibuprofen ameliorated the peripheral surgical wounding-induced cognitive impairment in 18 month-old mice.",True,"'Does the phrase ""Ibuprofen treats Cognitive impairment"" receive at least indirect support from the statement: ""Finally, anti-inflammatory drug ibuprofen ameliorated the peripheral surgical wounding-induced cognitive impairment in 18 month-old mice.""?","Yes, indirectly it does lend some support. The statement suggests that ibuprofen treatment improved cognitive function in mice that had undergone peripheral surgical wounding. However, it's important to note that this is not a direct correlation between ibuprofen and cognitive impairment treatment in general. The cognitive impairment here is specifically related to surgical wounding in mice, which may not translate directly to other forms of cognitive impairment in different organisms, including humans. Therefore, while there is some indirect support for the claim, more extensive research would be needed to fully substantiate it."
17292168,Ibuprofen treats Chronic pain,1024,"In the last several years, several topical NSAIDs including either diclofenac ibuprofen or salicylates for chronic pain have been approved in the United States while similar drugs have been available in Europe for years.",True,"'Does the phrase ""Ibuprofen treats Chronic pain"" receive at least indirect support from the statement: ""In the last several years, several topical NSAIDs including either diclofenac ibuprofen or salicylates for chronic pain have been approved in the United States while similar drugs have been available in Europe for years.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Chronic pain"". The approval of topical NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), including ibuprofen, for chronic pain in the United States suggests that these drugs have been found effective in treating chronic pain. This is further supported by the fact that similar drugs have been available in Europe for years, implying a long-standing recognition of their efficacy in treating chronic pain. However, it is important to note that while this statement supports the efficacy of ibuprofen in treating chronic pain, it does not provide direct evidence of such; further investigation would be required for a more definitive conclusion."
15258520,Ibuprofen treats cardiovascular disorder,1025,Patent ductus arteriosus (PDA) is the most common cardiovascular abnormality of the preterm infant usually treated with ibuprofen (IBU).,True,"'Does the phrase ""Ibuprofen treats cardiovascular disorder"" receive at least indirect support from the statement: ""Patent ductus arteriosus (PDA) is the most common cardiovascular abnormality of the preterm infant usually treated with ibuprofen (IBU).""?","Yes, while the statement does not explicitly say that ibuprofen treats cardiovascular disorders, it implies that ibuprofen is used in the treatment of PDA, which is a cardiovascular abnormality. This suggests that ibuprofen has some therapeutic value in treating cardiovascular conditions, thus providing indirect support for the claim that ibuprofen treats cardiovascular disorders. However, it is important to note that PDA is not a disorder in all contexts but rather a normal fetal circulation pathway that sometimes fails to close after birth in preterm infants. Therefore, the claim should be interpreted in a specific clinical context."
13826476,"Ibuprofen treats osteoarthritis, spine",1026,"In an open three-center pilot study, 17 patients suffering from chronic persistent pain syndrome, due to osteoarthritis of the hip and knee or spondylarthrosis, were treated orally with 1800-2400 mg Ibuprofen per day for 3 weeks.",True,"'Does the phrase ""Ibuprofen treats osteoarthritis, spine"" receive at least indirect support from the statement: ""In an open three-center pilot study, 17 patients suffering from chronic persistent pain syndrome, due to osteoarthritis of the hip and knee or spondylarthrosis, were treated orally with 1800-2400 mg Ibuprofen per day for 3 weeks.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats osteoarthritis, spine"". The study mentions that 17 patients suffering from chronic persistent pain syndrome due to osteoarthritis of the hip and knee or spondylarthrosis were treated with Ibuprofen for 3 weeks. Spondylarthrosis is a type of osteoarthritis that affects the spine. Therefore, this study demonstrates that Ibuprofen was used to treat osteoarthritis in the spine, providing indirect evidence for the claim. However, it is important to note that this is an open three-center pilot study with a small sample size of 17 patients, which limits the generalizability of the results. Additionally, while pain relief is one of the symptoms alleviated by Ibuprofen in osteoarthritis patients, it does not necessarily imply that Ibuprofen treats osteoarthritis as a disease."
13722152,Ibuprofen treats Neck pain,1027,"The patient presented with a 6-month history of neck pain with radiation into the shoulder and arm on the left side, which was relieved by ibuprofen.",True,"'Does the phrase ""Ibuprofen treats Neck pain"" receive at least indirect support from the statement: ""The patient presented with a 6-month history of neck pain with radiation into the shoulder and arm on the left side, which was relieved by ibuprofen.""?","Yes, there is indirect support for the claim that ibuprofen treats neck pain based on the provided statement. The patient's history of neck pain lasting six months, which was subsequently relieved by taking ibuprofen, suggests that ibuprofen had an ameliorative effect on their neck pain symptoms. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that works by reducing hormones that cause inflammation and pain in the body. However, it is important to note that while this statement supports ibuprofen's efficacy in treating neck pain for this particular patient, it does not necessarily imply that ibuprofen will be an effective treatment for all individuals experiencing neck pain. Further studies would be required to establish its general efficacy for treating neck pain conditions."
11790277,Ibuprofen treats hypertensive disorder,1028,"Treatment with nonselective anti-inflammatory drugs ibuprofen, indomethacin, or salicylic acid did not show any effect on angiotensin II-induced superoxide production, hypertension, or cardiac hypertrophy.",False,"'Does the phrase ""Ibuprofen treats hypertensive disorder"" receive at least indirect support from the statement: ""Treatment with nonselective anti-inflammatory drugs ibuprofen, indomethacin, or salicylic acid did not show any effect on angiotensin II-induced superoxide production, hypertension, or cardiac hypertrophy.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen treats hypertensive disorder."" The study mentioned in the statement investigated the effects of nonselective anti-inflammatory drugs (ibuprofen, indomethacin, and salicylic acid) on angiotensin II-induced superoxide production, hypertension, and cardiac hypertrophy but found no significant effects of ibuprofen on these factors.

         The lack of observed effects on hypertension does not necessarily imply that ibuprofen cannot have any impact on hypertensive disorder treatment; however, it does not support such an assertion either. To establish whether ibuprofen treats hypertensive disorders indirectly based on this statement, we would need evidence of its efficacy in treating hypertension or related symptoms under specific conditions.

         It is essential to consider that ibuprofen is primarily an analgesic and anti-inflammatory drug; its potential benefits in treating hypertension might be related to its impact on inflammation rather than blood pressure regulation directly. Therefore, further investigation is required before making conclusions about ibuprofen as a treatment for"
11536369,Ibuprofen treats seasonal allergic rhinitis,1029,Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.,True,"'Does the phrase ""Ibuprofen treats seasonal allergic rhinitis"" receive at least indirect support from the statement: ""Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats seasonal allergic rhinitis"". The statement suggests that ibuprofen is added to pseudoephedrine and chlorpheniramine for the treatment of seasonal allergic rhinitis. This implies that ibuprofen has some therapeutic effect on seasonal allergic rhinitis, otherwise it would not be included in the treatment regimen. However, it's important to note that this is an indirect inference and does not provide direct evidence of ibuprofen's effectiveness in treating seasonal allergic rhinitis. For a more definitive conclusion, clinical trials specifically testing ibuprofen as a treatment for seasonal allergic rhinitis would be needed."
11381904,Ibuprofen treats Premature birth,1030,This should be considered to assess pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates and subsequently to understand and refine the use of ibuprofen in managing PDA either as a prophylactic or curative treatment.,False,"'Does the phrase ""Ibuprofen treats Premature birth"" receive at least indirect support from the statement: ""This should be considered to assess pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates and subsequently to understand and refine the use of ibuprofen in managing PDA either as a prophylactic or curative treatment.""?","No, the statement does not provide direct support for the phrase ""Ibuprofen treats Premature birth."" The statement discusses assessing pharmacokinetic-pharmacodynamic relationships of ibuprofen in premature neonates and refining its use in managing Patent Ductus Arteriosus (PDA), which could be either prophylactic or curative treatment. However, it does not mention or imply that ibuprofen treats premature birth itself but rather focuses on its potential effects on PDA in premature neonates."
11239637,Ibuprofen treats Back pain,1031,"A 57-year-old woman believed that ibuprofen, prescribed for back pain, improved her idiopathic chronic cough that had been resistant to inhaled and oral corticosteroids.",False,"'Does the phrase ""Ibuprofen treats Back pain"" receive at least indirect support from the statement: ""A 57-year-old woman believed that ibuprofen, prescribed for back pain, improved her idiopathic chronic cough that had been resistant to inhaled and oral corticosteroids.""?","No, the statement does not provide direct or indirect support for the claim that ibuprofen treats back pain. The statement describes an observation of a 57-year-old woman who experienced an improvement in her chronic cough after taking ibuprofen prescribed for back pain. However, it does not establish a causal relationship between ibuprofen and back pain relief. The improvement in cough could be coincidental or related to an unknown factor. To support the claim that ibuprofen treats back pain, there should be evidence of its efficacy specifically for back pain symptoms from clinical trials or studies designed to test that hypothesis."
10195210,Ibuprofen treats influenza,1032,"A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.",False,"'Does the phrase ""Ibuprofen treats influenza"" receive at least indirect support from the statement: ""A multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled, parallel-group comparison of diclofenac-K and ibuprofen for the treatment of adults with influenza-like symptoms.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen treats influenza."" The study mentioned in the statement is comparing diclofenac-K and ibuprofen for treating adults with influenza-like symptoms, not proving that ibuprofen can treat influenza itself. The study might show that ibuprofen can help alleviate symptoms associated with influenza-like illnesses; however, it does not demonstrate that ibuprofen has antiviral properties against the influenza virus. Therefore, one cannot infer from this statement that ibuprofen is an effective treatment for influenza."
9950431,Ibuprofen treats rheumatic disorder,1033,"Eight preparations contained synthetic drugs (e.g. benzodiazepines and tricyclic antidepressants in sedative preparations, cyproheptadine in a remedy to gain bodyweight, ibuprofen and dipyrone in herbal capsules used to treat rheumatism).",True,"'Does the phrase ""Ibuprofen treats rheumatic disorder"" receive at least indirect support from the statement: ""Eight preparations contained synthetic drugs (e.g. benzodiazepines and tricyclic antidepressants in sedative preparations, cyproheptadine in a remedy to gain bodyweight, ibuprofen and dipyrone in herbal capsules used to treat rheumatism).""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats rheumatic disorder"". The key information here is that ibuprofen is listed as one of the synthetic drugs found in herbal capsules used to treat rheumatism. This implies that ibuprofen is being used as a therapeutic agent for rheumatic disorders, which aligns with the claim that ibuprofen can treat such conditions. However, it's important to note that this is an indirect inference based on the use of ibuprofen in a therapeutic context for rheumatism, rather than direct evidence of its efficacy in treating rheumatic disorders."
9913360,Ibuprofen treats Myalgia,1034,Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management.,True,"'Does the phrase ""Ibuprofen treats Myalgia"" receive at least indirect support from the statement: ""Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management.""?","Yes, indirect support can be inferred from the statement ""Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management."" This implies that ibuprofen has been studied in relation to muscle soreness management, which includes myalgia (muscle pain). However, it is important to note that while this does provide some support for ibuprofen treating myalgia, it is not a direct claim that ibuprofen is effective for myalgia specifically. The context of the study design, results, and statistical significance would need to be evaluated for a more definitive conclusion about ibuprofen's effectiveness for myalgia."
9550056,Ibuprofen treats Acute Pain,1035,"BACKGROUND: Rofecoxib is a selective cyclooxygenase-2 inhibitor indicated for the treatment of acute pain, with similar analgesic efficacy to ibuprofen and naproxen sodium.",True,"'Does the phrase ""Ibuprofen treats Acute Pain"" receive at least indirect support from the statement: ""BACKGROUND: Rofecoxib is a selective cyclooxygenase-2 inhibitor indicated for the treatment of acute pain, with similar analgesic efficacy to ibuprofen and naproxen sodium.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Acute Pain"". The background information indicates that Rofecoxib is used for treating acute pain and has similar analgesic efficacy to ibuprofen and naproxen sodium. This implies that ibuprofen is also effective in treating acute pain since it has comparable efficacy to Rofecoxib in doing so. However, it is important to note that this is an indirect inference based on the comparative efficacy of Rofecoxib and ibuprofen; direct evidence of ibuprofen's effectiveness in treating acute pain would provide stronger support for the statement in question."
9536612,Ibuprofen treats Low back pain,1036,CONCLUSION: Continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain.,True,"'Does the phrase ""Ibuprofen treats Low back pain"" receive at least indirect support from the statement: ""CONCLUSION: Continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain.""?","Yes, the statement ""Continuous low-level heat wrap therapy was superior to both acetaminophen and ibuprofen for treating low back pain"" does provide indirect support for the claim that ""Ibuprofen treats low back pain."" This is because it suggests that ibuprofen does have some therapeutic effect on low back pain, even though it was found to be less effective than continuous low-level heat wrap therapy in this particular study. However, it is important to note that this does not mean that ibuprofen is the best treatment for low back pain, nor does it necessarily mean that it is superior to other treatments that were not tested in this study. It simply suggests that ibuprofen has some therapeutic benefit in treating low back pain."
9444914,Ibuprofen treats Arthralgia,1037,"To determine the effectiveness of oral glucosamine with ibuprofen for the relief of joint pain in osteoarthritis a mini-review (Griffiths, 2002) of double-blind randomized controlled trials comparing the two was undertaken.",False,"'Does the phrase ""Ibuprofen treats Arthralgia"" receive at least indirect support from the statement: ""To determine the effectiveness of oral glucosamine with ibuprofen for the relief of joint pain in osteoarthritis a mini-review (Griffiths, 2002) of double-blind randomized controlled trials comparing the two was undertaken.""?","No, the statement does not provide direct or indirect support for the claim ""Ibuprofen treats Arthralgia"". The mini-review mentioned in the statement focuses on comparing oral glucosamine and ibuprofen for relieving joint pain in osteoarthritis specifically. Arthralgia refers generally to joint pain, which can be caused by various factors beyond osteoarthritis. Thus, while it is plausible that ibuprofen could help alleviate arthralgia based on other evidence, this particular statement does not offer any relevant information regarding that specific claim."
9436288,Ibuprofen treats Alzheimer disease,1038,"In conclusion, NCX-2216 is more efficacious than ibuprofen or celecoxib in clearing Abeta deposits from the brains of Tg mice, implying potential benefit in the treatment of Alzheimer's dementia.",False,"'Does the phrase ""Ibuprofen treats Alzheimer disease"" receive at least indirect support from the statement: ""In conclusion, NCX-2216 is more efficacious than ibuprofen or celecoxib in clearing Abeta deposits from the brains of Tg mice, implying potential benefit in the treatment of Alzheimer's dementia.""?","No, the statement does not provide indirect support for the claim that ""Ibuprofen treats Alzheimer disease"". The conclusion drawn in the statement is about NCX-2216 being more efficacious than ibuprofen in clearing Abeta deposits from the brains of Tg mice, implying potential benefit in the treatment of Alzheimer's dementia. This suggests that NCX-2216 has better efficacy than ibuprofen in treating Alzheimer's disease-related pathology in mice model but does not indicate that ibuprofen itself is an effective treatment for Alzheimer disease in humans.

        The statement specifically highlights that NCX-2216 is more effective than ibuprofen in treating Alzheimer-like pathology in mice model which does not necessarily translate into ibuprofen being an effective treatment for Alzheimer disease in humans as there might be various factors that could influence its efficacy in humans such as pharmacokinetics, safety profile, bioavailability etc. Therefore, it is not appropriate to infer from this statement that ibuprofen is an effective treatment for Alzheimer disease in humans."
9104501,Ibuprofen treats injury,1039,"Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats.",True,"'Does the phrase ""Ibuprofen treats injury"" receive at least indirect support from the statement: ""Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats.""?","Yes, the statement ""Ibuprofen attenuates early lung injury in endotoxemic, neutropenic rats"" does provide indirect support for the claim that ""Ibuprofen treats injury."" This is because ibuprofen is shown in this study to have a protective effect on lung tissue in rats that have been subjected to an endotoxin challenge under conditions of neutropenia (a state of reduced white blood cell count). This suggests that ibuprofen has therapeutic potential in treating lung injury in certain contexts, such as infections that induce an endotoxin response (a component of Gram-negative bacterial infections).

        

        However, it is important to note that while this finding supports ibuprofen as having beneficial effects on injury in specific contexts (i.e., endotoxin-induced lung injury in neutropenic rats), it does not necessarily mean that ibuprofen is effective in treating all types of injury in all organisms (including humans). Further studies would be needed to establish whether ibuprofen has similar protective effects in other models of injury and in humans before making more generalized"
8748381,Ibuprofen treats Dysmenorrhea,1040,CONCLUSION: Continuous low-level topical heat therapy was as effective as ibuprofen for the treatment of dysmenorrhea.,True,"'Does the phrase ""Ibuprofen treats Dysmenorrhea"" receive at least indirect support from the statement: ""CONCLUSION: Continuous low-level topical heat therapy was as effective as ibuprofen for the treatment of dysmenorrhea.""?","Yes, indirectly it does support the claim that ibuprofen treats dysmenorrhea (menstrual pain). The statement suggests that continuous low-level topical heat therapy is as effective as ibuprofen in treating dysmenorrhea. This implies that ibuprofen has a therapeutic effect on dysmenorrhea, thus supporting the claim that ibuprofen treats dysmenorrhea. However, it's important to note that this is indirect evidence, as it doesn't directly show ibuprofen treating dysmenorrhea, but rather its effectiveness compared to another treatment method."
8698382,Ibuprofen treats Tension-type headache,1041,Is the combination of ibuprofen and caffeine effective for the treatment of a tension-type headache?,True,"'Does the phrase ""Ibuprofen treats Tension-type headache"" receive at least indirect support from the statement: ""Is the combination of ibuprofen and caffeine effective for the treatment of a tension-type headache?""?","Yes, indirectly it does lend support. The statement ""Is the combination of ibuprofen and caffeine effective for the treatment of tension-type headache?"" implies that ibuprofen alone is also potentially effective for treating tension-type headaches, since caffeine is added as an adjuvant for increased efficacy in some formulations. However, it should be noted that while there is evidence supporting the use of ibuprofen for tension-type headaches, individual responses may vary; thus, further investigation is necessary for personalized treatment approaches."
8452594,Ibuprofen treats migraine disorder,1042,"Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.",True,"'Does the phrase ""Ibuprofen treats migraine disorder"" receive at least indirect support from the statement: ""Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats migraine disorder."" The study mentioned is a randomized, double-blind, placebo-controlled, dose-ranging study - all of which are indicative of high-quality clinical research. The fact that ibuprofen was being evaluated specifically for its efficacy in treating migraine headaches suggests that it has some potential therapeutic benefit in managing symptoms of migraine disorder. However, it is important to note that this statement does not equate to a definitive claim that ibuprofen is a definitive treatment for migraine disorder; rather, it supports the notion that ibuprofen could be an effective management strategy for migraine symptoms based on the results of this particular study."
8420965,Ibuprofen treats Hemorrhage,1043,"A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.",False,"'Does the phrase ""Ibuprofen treats Hemorrhage"" receive at least indirect support from the statement: ""A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.""?","No, the statement ""Ibuprofen treats Hemorrhage"" does not receive at least indirect support from the provided statement ""A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.""

         The reason for this is that while the study does involve ibuprofen and measures an outcome that could be related to hemorrhage (fecal blood loss), it does not explicitly test or demonstrate that ibuprofen treats hemorrhage. The study is conducted in healthy subjects, which further limits its applicability to treating hemorrhage, a condition that typically occurs in individuals who are unwell.

         Furthermore, even if the study had found that ibuprofen reduced fecal blood loss in healthy subjects, it would still not necessarily mean that ibuprofen treats hemorrhage. Hemorrhage is a complex condition that can occur in various parts of the body due to different causes, and it would require specific clinical trials to determine whether ibuprofen is effective in treating it in those contexts.

         Therefore, while such a study could potentially provide indirect evidence if it were designed differently (e"
8397426,Ibuprofen treats rheumatoid arthritis,1044,Ibuprofen or aspirin in rheumatoid arthritis therapy.,True,"'Does the phrase ""Ibuprofen treats rheumatoid arthritis"" receive at least indirect support from the statement: ""Ibuprofen or aspirin in rheumatoid arthritis therapy.""?","Yes, indirectly it does lend some support. The statement ""Ibuprofen or aspirin in rheumatoid arthritis therapy"" suggests that ibuprofen is used in the treatment of rheumatoid arthritis. However, it doesn't explicitly state that ibuprofen treats rheumatoid arthritis. It could be interpreted that ibuprofen is used as part of a therapeutic regimen for symptom management rather than as a direct treatment for the disease itself. Therefore, while not providing direct support, it does imply that ibuprofen is utilized in the context of rheumatoid arthritis therapy."
7887942,Ibuprofen treats osteoarthritis,1045,"DESIGN: Ginger extract was compared to placebo and Ibuprofen in patients with osteoarthritis of the hip or knee in a controlled, double blind, double dummy, cross-over study with a wash-out period of one week followed by three treatment periods in a randomized sequence, each of three weeks duration.",True,"'Does the phrase ""Ibuprofen treats osteoarthritis"" receive at least indirect support from the statement: ""DESIGN: Ginger extract was compared to placebo and Ibuprofen in patients with osteoarthritis of the hip or knee in a controlled, double blind, double dummy, cross-over study with a wash-out period of one week followed by three treatment periods in a randomized sequence, each of three weeks duration.""?","Yes, indirectly it does support the claim that ibuprofen treats osteoarthritis. The statement describes a study design where ibuprofen is being compared to placebo in patients with osteoarthritis of the hip or knee. This suggests that ibuprofen is being used as a treatment in this context. However, it doesn't provide direct evidence of ibuprofen's efficacy in treating osteoarthritis as it doesn't mention the outcomes of the study. It would be necessary to review the full study results for more direct support of ibuprofen treating osteoarthritis."
7852264,Ibuprofen treats Headache,1046,"Besides oxygen, acetazolamide, dexamethasone and especially inhibitors of prostaglandin synthesis such as ibuprofen and naproxen are approved for the treatment of HAH.",True,"'Does the phrase ""Ibuprofen treats Headache"" receive at least indirect support from the statement: ""Besides oxygen, acetazolamide, dexamethasone and especially inhibitors of prostaglandin synthesis such as ibuprofen and naproxen are approved for the treatment of HAH.""?","Yes, the phrase ""Ibuprofen treats Headache"" does receive indirect support from the statement provided. The statement mentions that ""inhibitors of prostaglandin synthesis such as ibuprofen and naproxen"" are approved for the treatment of HAH (High Altitude Headache). This implies that ibuprofen is effective in treating at least one type of headache, namely HAH, which is a form of headache. Therefore, it can be inferred that ibuprofen has therapeutic effects on headaches. However, it is important to note that headaches can be caused by various factors, and what works for one type may not work for another. Therefore, while there is indirect support for ibuprofen as a headache treatment, it is not universally applicable to all types of headaches without further investigation."
7851777,Ibuprofen treats patent ductus arteriosus,1047,OBJECTIVE: To evaluate the effect of intravenous ibuprofen and indomethacin for treatment of patent ductus arteriosus (PDA) on mesenteric and renal blood flow velocity in preterm infants.,True,"'Does the phrase ""Ibuprofen treats patent ductus arteriosus"" receive at least indirect support from the statement: ""OBJECTIVE: To evaluate the effect of intravenous ibuprofen and indomethacin for treatment of patent ductus arteriosus (PDA) on mesenteric and renal blood flow velocity in preterm infants.""?","Yes, indirectly it does lend support. The statement is an objective of a study that aims to evaluate the effect of intravenous ibuprofen on treating patent ductus arteriosus (PDA) in preterm infants. This implies that ibuprofen is being considered as a potential treatment for PDA, which aligns with the phrase ""Ibuprofen treats patent ductus arteriosus"". However, it is important to note that the study does not provide direct evidence of ibuprofen's effectiveness in treating PDA, but rather it is an objective of the study. Therefore, any conclusions about ibuprofen's effectiveness would need to be based on the results of the study once it is completed."
7732956,Ibuprofen treats Pain,1048,"The WOMAC detected significant differences between ibuprofen and placebo for pain and physical functioning, whereas the SF-36 detected differences for the bodily pain subscale.",True,"'Does the phrase ""Ibuprofen treats Pain"" receive at least indirect support from the statement: ""The WOMAC detected significant differences between ibuprofen and placebo for pain and physical functioning, whereas the SF-36 detected differences for the bodily pain subscale.""?","Yes, the statement does provide indirect support for the phrase ""Ibuprofen treats Pain"". The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) study found significant differences between ibuprofen and placebo for pain and physical functioning. This indicates that ibuprofen has an impact on pain reduction compared to placebo, providing evidence that it can be used as an effective treatment for pain management. The SF-36 (Short Form Health Survey) study also supports ibuprofen's effect on pain as it detected differences in bodily pain subscale between ibuprofen and placebo groups.

         However, it is important to note that while these studies suggest that ibuprofen can help alleviate pain symptoms in certain contexts (such as osteoarthritis), they do not necessarily imply that ibuprofen treats pain in all cases or conditions. Additionally, ibuprofen use may come with potential side effects such as gastrointestinal issues that should be considered when assessing its overall therapeutic value."
7686895,Ibuprofen treats arthritic joint disease,1049,"I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage.",True,"'Does the phrase ""Ibuprofen treats arthritic joint disease"" receive at least indirect support from the statement: ""I take ibuprofen regularly for my arthritis, but I've heard that it may lead to kidney damage.""?","Yes, indirectly it does. The statement ""I take ibuprofen regularly for my arthritis"" suggests that the individual has found some relief from their arthritic joint disease through taking ibuprofen. This is because ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation in conditions like arthritis. Therefore, it indirectly supports the claim that ibuprofen can help alleviate symptoms of arthritic joint disease.

        
        However, the second part of the statement ""but I've heard that it may lead to kidney damage"" introduces a caveat that needs to be considered when using ibuprofen regularly for arthritis treatment. Long-term use of NSAIDs like ibuprofen has been linked with potential kidney damage due to their effect on renal blood flow and glomerular filtration rate (GFR). This should be taken into account when considering ibuprofen as a treatment option for arthritic joint disease, especially for individuals who have pre-existing kidney issues or other risk factors for kidney"
7258310,Ibuprofen treats Fever,1050,Paracetamol or ibuprofen in febrile children.,True,"'Does the phrase ""Ibuprofen treats Fever"" receive at least indirect support from the statement: ""Paracetamol or ibuprofen in febrile children.""?","Yes, the statement ""Paracetamol or ibuprofen in febrile children"" does provide indirect support for the claim ""Ibuprofen treats fever"". This is because ibuprofen is mentioned alongside paracetamol as an option for treating febrile children, implying that it has some effect on fever reduction. However, it should be noted that this does not constitute direct evidence of ibuprofen's efficacy in treating fever as it could also be inferred that both drugs are used for other symptoms associated with being febrile. To confirm the claim more rigorously, one would need to look at clinical trials or meta-analyses specifically investigating ibuprofen's impact on fever."
7210912,Ibuprofen treats Toothache,1051,"A double-blind, parallel-group study compared the analgesic efficacy of rofecoxib to placebo and ibuprofen in 102 patients with dental pain.",True,"'Does the phrase ""Ibuprofen treats Toothache"" receive at least indirect support from the statement: ""A double-blind, parallel-group study compared the analgesic efficacy of rofecoxib to placebo and ibuprofen in 102 patients with dental pain.""?","Yes, the statement ""Ibuprofen treats Toothache"" does receive indirect support from the provided statement about the double-blind study comparing rofecoxib, placebo, and ibuprofen in patients with dental pain. 

         The reason for my affirmative answer lies in the design of the study itself. It is double-blind and parallel-group, which suggests that it adheres to rigorous standards aimed at minimizing bias in clinical trials. The study compares three interventions for dental pain - rofecoxib (a non-steroidal anti-inflammatory drug), placebo (an inactive treatment), and ibuprofen (another non-steroidal anti-inflammatory drug).

         While the study does not explicitly state that ibuprofen treats toothache, it does so implicitly by including it in a study that is designed to determine which interventions alleviate dental pain more effectively than others. By comparing ibuprofen against both an active treatment (rofecoxib) and placebo (an inactive treatment), it provides an opportunity for ibuprofen's efficacy in treating dental pain to"
25984950,Cefmenoxime treats bacterial infectious disease,1052,Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.,True,"'Does the phrase ""Cefmenoxime treats bacterial infectious disease"" receive at least indirect support from the statement: ""Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections.""?","Yes, the phrase ""Cefmenoxime treats bacterial infectious disease"" does receive indirect support from the statement ""Cefmenoxime versus cefoxitin in the treatment of serious bacterial infections."" This is because the comparison study implies that Cefmenoxime is being used to treat serious bacterial infections, thereby providing evidence that it can be used for treating bacterial infectious diseases. However, it is important to note that direct support would require more specific information about the efficacy and safety of Cefmenoxime in treating bacterial infections compared to other treatments or no treatment at all."
21500374,Ivabradine treats hypotensive disorder,1053,"These are: the association of dobutamine infusion with amiodarone or ivabradine in patients with symptomatic hypotension, and high-dose furosemide associated to hypertonic saline solution, levosimendan, hydralazine/isosorbide dinitrate, sodium nitroprusside or ivabradine in hemodynamically stable patients.",True,"'Does the phrase ""Ivabradine treats hypotensive disorder"" receive at least indirect support from the statement: ""These are: the association of dobutamine infusion with amiodarone or ivabradine in patients with symptomatic hypotension, and high-dose furosemide associated to hypertonic saline solution, levosimendan, hydralazine/isosorbide dinitrate, sodium nitroprusside or ivabradine in hemodynamically stable patients.""?","Yes, the statement does provide indirect support for the phrase ""Ivabradine treats hypotensive disorder."" The statement lists ivabradine as one of the treatments associated with symptomatic hypotension when used in combination with dobutamine infusion. This implies that ivabradine is being used as an intervention for hypotension in this context. However, it is important to note that hypotension in this case may be an adverse effect of dobutamine infusion rather than the primary condition being treated by ivabradine. Additionally, ivabradine is also mentioned in relation to hemodynamically stable patients receiving high-dose furosemide associated with hypertonic saline solution, levosimendan, hydralazine/isosorbide dinitrate, sodium nitroprusside or ivabradine itself. This suggests that ivabradine is being used in these cases as part of a broader treatment strategy for managing hypotensive disorder in certain patient populations. However, without further information on dosage, patient outcomes, and specific clinical scenarios, it is difficult to draw definitive conclusions about ivabradine's efficacy in treating hypotensive"
18841652,Ivabradine treats toxic shock syndrome,1054,If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.,False,"'Does the phrase ""Ivabradine treats toxic shock syndrome"" receive at least indirect support from the statement: ""If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.""?","No, the statement ""If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock"" does not provide indirect support for the claim that ""Ivabradine treats toxic shock syndrome"". The statement is actually negatively framed, suggesting that ivabradine does not have beneficial effects on cardiac and vascular function in experimental septic shock. Septic shock is a severe form of sepsis that can lead to tissue damage, organ failure, and death; it is not equivalent to toxic shock syndrome (TSS), which is a distinct condition typically caused by certain strains of Staphylococcus aureus or Streptococcus pyogenes bacteria that produce exotoxins leading to shock. While both conditions involve dysfunction of the cardiovascular system, they have different underlying causes and may require different treatment approaches. Therefore, evidence of ivabradine's effectiveness in one condition does not necessarily imply its efficacy in another."
18126606,Ivabradine treats mitral valve stenosis,1055,Ivabradine thus can be used effectively and safely in patients with MS in normal sinus rhythm who are intolerant or contraindicated for beta-blocker therapy.,False,"'Does the phrase ""Ivabradine treats mitral valve stenosis"" receive at least indirect support from the statement: ""Ivabradine thus can be used effectively and safely in patients with MS in normal sinus rhythm who are intolerant or contraindicated for beta-blocker therapy.""?","No, the phrase ""Ivabradine treats mitral valve stenosis"" does not receive indirect support from the statement provided. The statement suggests that Ivabradine can be used effectively and safely in patients with mitral valve stenosis (MS) who have normal sinus rhythm and cannot tolerate or are contraindicated for beta-blocker therapy. However, it does not imply that Ivabradine treats mitral valve stenosis itself. Instead, it indicates that Ivabradine is an alternative treatment option for managing heart rate in these specific patients with MS."
17604342,Ivabradine treats atrial fibrillation,1056,Ivabradine is ineffective in atrial fibrillation.,False,"'Does the phrase ""Ivabradine treats atrial fibrillation"" receive at least indirect support from the statement: ""Ivabradine is ineffective in atrial fibrillation.""?","No, the statement ""Ivabradine is ineffective in atrial fibrillation"" does not provide indirect support for the phrase ""Ivabradine treats atrial fibrillation."" In fact, it suggests quite the opposite. The word ""ineffective"" implies that ivabradine does not have a positive impact on atrial fibrillation, which contradicts the claim that ivabradine treats this condition. It is important to note that ""ineffective"" does not mean that ivabradine causes harm in atrial fibrillation; it simply means that it does not provide beneficial effects. Therefore, based on this statement alone, there is no support for the idea that ivabradine is used to treat atrial fibrillation."
17604340,Ivabradine treats diastolic heart failure,1057,The aim of the study was to compare the therapeutic effects of ivabradine in diastolic heart failure with preserved left ventricular systolic function.,True,"'Does the phrase ""Ivabradine treats diastolic heart failure"" receive at least indirect support from the statement: ""The aim of the study was to compare the therapeutic effects of ivabradine in diastolic heart failure with preserved left ventricular systolic function.""?","Yes, based on the provided statement, there is indirect support for the phrase ""Ivabradine treats diastolic heart failure."" The statement indicates that a study was conducted specifically to compare the therapeutic effects of ivabradine in diastolic heart failure with preserved left ventricular systolic function. This implies that ivabradine was being tested as a potential treatment for diastolic heart failure, suggesting that there is some basis for associating ivabradine with the treatment of diastolic heart failure. However, it is important to note that indirect support does not equate to definitive proof of efficacy, as further information about the study outcomes would be necessary to make such a determination."
15681673,Ivabradine treats multiple organ dysfunction syndrome,1058,CONCLUSIONS: The MODI (f)Y trial is the first application of ivabradine as a pure heart rate reducing agent in MODS patients.,True,"'Does the phrase ""Ivabradine treats multiple organ dysfunction syndrome"" receive at least indirect support from the statement: ""CONCLUSIONS: The MODI (f)Y trial is the first application of ivabradine as a pure heart rate reducing agent in MODS patients.""?","Yes, indirectly it does lend some support. The statement ""The MODI (f)Y trial is the first application of ivabradine as a pure heart rate reducing agent in MODS patients"" implies that ivabradine has been used in a trial involving Multiple Organ Dysfunction Syndrome (MODS) patients specifically for its heart rate reducing properties. This suggests that there may be some potential benefit in using ivabradine for treating MODS patients, although it does not explicitly state that ivabradine treats MODS. Therefore, while not direct evidence of treatment efficacy, it does provide some level of indirect support for further investigation into ivabradine's potential therapeutic effects on MODS patients."
15641743,Ivabradine treats systolic heart failure,1059,Ivabradine added to guidelines-based therapy in systolic heart failure patients.,True,"'Does the phrase ""Ivabradine treats systolic heart failure"" receive at least indirect support from the statement: ""Ivabradine added to guidelines-based therapy in systolic heart failure patients.""?","Yes, the statement ""Ivabradine added to guidelines-based therapy in systolic heart failure patients"" does provide indirect support for the claim that ""Ivabradine treats systolic heart failure."" This is because it implies that ivabradine is being used as part of a treatment regimen for systolic heart failure patients who are already receiving guideline-based therapy. However, it does not directly confirm that ivabradine is solely responsible for treating systolic heart failure; it could be part of a larger treatment plan that includes other therapies. Furthermore, while ivabradine may be used in the treatment of systolic heart failure, it does not necessarily mean that it is effective in treating systolic heart failure, as efficacy would need to be demonstrated through clinical trials and subsequent analysis of their results."
13559450,Ivabradine treats Tachycardia,1060,"Clinical studies proved the efficacy of ivabradine in patients with stable angina, while clinical data are awaited to verify its probable value in the treatment of atrial tachyarrhythmias and tachycardia due to ventricular dysfunction.",True,"'Does the phrase ""Ivabradine treats Tachycardia"" receive at least indirect support from the statement: ""Clinical studies proved the efficacy of ivabradine in patients with stable angina, while clinical data are awaited to verify its probable value in the treatment of atrial tachyarrhythmias and tachycardia due to ventricular dysfunction.""?","Yes, there is indirect support for the claim that ""Ivabradine treats Tachycardia"" based on the provided statement.

         The statement mentions that clinical studies have proven the efficacy of Ivabradine in patients with stable angina. While it does not explicitly state that Ivabradine treats tachycardia, it implies that Ivabradine may have value in treating atrial tachyarrhythmias and tachycardia due to ventricular dysfunction, as these conditions are specifically mentioned as areas where clinical data is being awaited. 

         However, it is important to note that while there is indirect support for this claim based on the statement provided, direct evidence of Ivabradine's efficacy in treating tachycardia is not presented in the statement. Therefore, further investigation would be necessary to definitively conclude that Ivabradine treats tachycardia."
12424888,Ivabradine treats coronary artery disorder,1061,"The effective drug, ivabradine, has demonstrated anti-anginal, anti-ischemic efficacy and now is being tested for its effect on survival in patients with coronary artery disease and impaired left ventricular function, as well as for heart failure.",True,"'Does the phrase ""Ivabradine treats coronary artery disorder"" receive at least indirect support from the statement: ""The effective drug, ivabradine, has demonstrated anti-anginal, anti-ischemic efficacy and now is being tested for its effect on survival in patients with coronary artery disease and impaired left ventricular function, as well as for heart failure.""?","Yes, while the statement does not explicitly claim that ivabradine treats coronary artery disorder, it does provide indirect support for that notion. The statement indicates that ivabradine has demonstrated anti-anginal (against chest pain) and anti-ischemic (against insufficient blood supply) efficacy in patients with coronary artery disease (a type of coronary artery disorder). Furthermore, it mentions that ivabradine is being tested for its effect on survival in patients with coronary artery disease and impaired left ventricular function, as well as for heart failure. The broader context of these investigations suggests that ivabradine could have beneficial effects in treating coronary artery disorder by alleviating symptoms (anti-anginal and anti-ischemic efficacy) and potentially improving survival rates in affected patients. However, it is essential to emphasize that further investigation is necessary to establish the precise therapeutic benefits of ivabradine in treating coronary artery disorder since the statement only provides preliminary evidence of its potential efficacy in that regard."
12164130,Ivabradine treats Stable angina,1062,New agent ivabradine (Procoralan) for treatment of chronic stable angina.,True,"'Does the phrase ""Ivabradine treats Stable angina"" receive at least indirect support from the statement: ""New agent ivabradine (Procoralan) for treatment of chronic stable angina.""?","Yes, the phrase ""Ivabradine treats Stable angina"" does receive indirect support from the statement: ""New agent ivabradine (Procoralan) for treatment of chronic stable angina.""

         The statement suggests that Ivabradine is a new agent being used in the treatment of chronic stable angina. This implies that Ivabradine has been found to be effective in treating chronic stable angina, thus providing indirect support for the claim that ""Ivabradine treats Stable angina."" However, it should be noted that this is an indirect inference and the statement does not explicitly state that Ivabradine treats stable angina. For a more direct support, a study or clinical trial report showing the efficacy of Ivabradine in treating stable angina would be required."
11342280,Ivabradine treats cardiovascular disorder,1063,Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.,True,"'Does the phrase ""Ivabradine treats cardiovascular disorder"" receive at least indirect support from the statement: ""Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.""?","Yes, the statement does provide indirect support for the phrase ""Ivabradine treats cardiovascular disorder."" The statement suggests that ivabradine has a specific and selective inhibitory effect on I(f) current, which is associated with heart rate regulation. By doing so, it offers a new therapeutic perspective in cardiovascular disease management. This implies that ivabradine may play a role in treating cardiovascular disorders by targeting heart rate regulation through I(f) current inhibition. However, it is important to note that further investigation would be necessary to establish direct causality and elucidate specific mechanisms of action involved in treating cardiovascular disorders with ivabradine."
26843374,Cefixime treats tonsillitis,1064,These results show that cefixime once daily is at least as effective as penicillin V t.i.d. in pharyngitis and tonsillitis in children.,True,"'Does the phrase ""Cefixime treats tonsillitis"" receive at least indirect support from the statement: ""These results show that cefixime once daily is at least as effective as penicillin V t.i.d. in pharyngitis and tonsillitis in children.""?","Yes, the phrase ""Cefixime treats tonsillitis"" does receive indirect support from the statement provided. The statement indicates that Cefixime is at least as effective as Penicillin V in treating pharyngitis and tonsillitis in children when used once daily. This implies that Cefixime has therapeutic effects on tonsillitis, thus providing indirect support for the claim that Cefixime treats tonsillitis. However, it is important to note that direct causality cannot be inferred from this statement alone; further evidence would be needed for a definitive conclusion about Cefixime's effectiveness in treating tonsillitis specifically."
23970374,Cefixime treats Infection,1065,The aim of this study is to evaluate cefixime for the treatment of osteoarticular infections in pediatric SCD patients by retrospective design.,True,"'Does the phrase ""Cefixime treats Infection"" receive at least indirect support from the statement: ""The aim of this study is to evaluate cefixime for the treatment of osteoarticular infections in pediatric SCD patients by retrospective design.""?","Yes, the phrase ""Cefixime treats infection"" does receive indirect support from the statement provided. The study aims to evaluate cefixime for treating osteoarticular infections in pediatric patients with sickle cell disease (SCD). This implies that cefixime is being considered as a potential treatment for infection in these patients. Therefore, it suggests that cefixime has some theoretical basis for treating infections, even though the statement does not explicitly confirm that cefixime treats infection. However, it is important to note that further evidence from the study itself would be needed to confirm its efficacy in treating infections in pediatric SCD patients specifically."
22544340,Cefixime treats pharyngitis,1066,Purpose: To report a case of Acute bilateral angle closure and Myopia following oral Cefixime therapy for pharyngitis.,False,"'Does the phrase ""Cefixime treats pharyngitis"" receive at least indirect support from the statement: ""Purpose: To report a case of Acute bilateral angle closure and Myopia following oral Cefixime therapy for pharyngitis.""?","No, the statement ""Purpose: To report a case of Acute bilateral angle closure and Myopia following oral Cefixime therapy for pharyngitis"" does not provide direct or indirect support for the claim ""Cefixime treats pharyngitis."" 

        The statement in question is a case report of an adverse reaction following the use of Cefixime for pharyngitis treatment. It does not provide any information about the efficacy of Cefixime in treating pharyngitis. Therefore, it does not support the claim that Cefixime is an effective treatment for pharyngitis. 

        Cefixime is an antibiotic that is often used to treat various bacterial infections, including pharyngitis caused by Group A Streptococcus (GAS). However, the statement does not provide any evidence about the bacterial cause of the pharyngitis case in question, nor does it report on the outcome of the treatment in terms of symptom resolution or bacterial eradication. Therefore, it does not contribute to our understanding of Cefixime's therapeutic effect in treating pharyngitis."
22138225,Cefixime treats syphilis,1067,DISCUSSION: Demonstration of efficacy of cefixime in the treatment of active syphilis in this Phase 2 trial among non-pregnant women will inform a proposed randomized controlled trial to evaluate cefixime as an alternative treatment for pregnant women with active syphilis to evaluate prevention of congenital syphilis.,True,"'Does the phrase ""Cefixime treats syphilis"" receive at least indirect support from the statement: ""DISCUSSION: Demonstration of efficacy of cefixime in the treatment of active syphilis in this Phase 2 trial among non-pregnant women will inform a proposed randomized controlled trial to evaluate cefixime as an alternative treatment for pregnant women with active syphilis to evaluate prevention of congenital syphilis.""?","Yes, the statement does provide indirect support for the phrase ""Cefixime treats syphilis."" The discussion mentions a Phase 2 trial demonstrating the efficacy of cefixime in treating active syphilis in non-pregnant women. This implies that cefixime has shown positive results in treating syphilis, thus lending credence to the idea that cefixime can be used to treat syphilis. However, it is important to note that this is indirect support; a Phase 2 trial typically does not provide definitive evidence of efficacy, and further research in a larger, randomized controlled trial is needed to confirm these findings. Additionally, the trial mentioned is specifically focused on non-pregnant women, so any extrapolation to other populations should be made with caution."
20619094,Cefixime treats bronchitis,1068,"Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin).",False,"'Does the phrase ""Cefixime treats bronchitis"" receive at least indirect support from the statement: ""Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin).""?","No, the statement ""Two weeks following her return to France, the patient presented with an episode of bronchitis and received 5 days of treatment with cefixime (a third-generation cephalosporin)"" does not provide direct or indirect support for the phrase ""Cefixime treats bronchitis."" This is because correlation does not imply causation - even though the patient received cefixime during her bout of bronchitis, it does not necessarily mean that cefixime was responsible for treating her bronchitis. It is possible that her bronchitis resolved on its own or was resolved by other treatments concurrently administered but not mentioned in the statement. To establish that cefixime treats bronchitis, controlled clinical trials would be required that demonstrate both safety and efficacy in treating bronchitis patients compared to placebo groups."
12941415,Cefixime treats otitis media,1069,Efficacy and tolerability of cefixime in otitis media.,True,"'Does the phrase ""Cefixime treats otitis media"" receive at least indirect support from the statement: ""Efficacy and tolerability of cefixime in otitis media.""?","Yes, the statement ""Efficacy and tolerability of cefixime in otitis media"" does provide indirect support for the claim that ""Cefixime treats otitis media."" The term ""efficacy"" implies that cefixime has a positive effect on otitis media, which aligns with the concept of treating the condition. However, it is important to note that direct support would require more specific language indicating causation between cefixime use and improvement in otitis media symptoms. Additionally, ""tolerability"" refers to how well patients can tolerate the drug, not its effectiveness in treating otitis media. Therefore, while there is some level of support for the claim based on this statement, it is not definitive proof of cefixime's ability to treat otitis media."
8827692,Cefixime treats gonorrhea,1070,A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.,True,"'Does the phrase ""Cefixime treats gonorrhea"" receive at least indirect support from the statement: ""A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.""?","Yes, the statement does provide indirect support for the claim that ""Cefixime treats gonorrhea."" The randomized trial mentioned in the statement is comparing two different treatments for gonorrhea - ciprofloxacin and cefixime. The fact that cefixime is being used in a trial for treating gonorrhea suggests that it has some efficacy in treating this infection. However, it's important to note that indirect support does not equate to definitive proof. The effectiveness of cefixime in treating gonorrhea would need to be evaluated in the context of its specific treatment guidelines, potential side effects, and resistance patterns."
7594422,Cefixime treats bacterial infectious disease,1071,A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections.,True,"'Does the phrase ""Cefixime treats bacterial infectious disease"" receive at least indirect support from the statement: ""A randomized controlled clinical study of cefetamet pivoxil (CAT) compared with cefixime (CFX) was conducted to evaluate its safety and efficacy in treating bacterial infections.""?","Yes, indirectly it does lend support. The statement mentions that a randomized controlled clinical study was conducted comparing cefetamet pivoxil (CAT) with cefixime (CFX) for their safety and efficacy in treating bacterial infections. This implies that cefixime (CFX) was used as a treatment for bacterial infections in this study, which suggests that it has potential therapeutic value in treating such conditions. However, it's important to note that this is an indirect inference based on one study. For a more definitive conclusion, a broader review of the literature would be necessary."
26078551,Ceftizoxime treats bacterial infectious disease,1072,"Eighteen children with the following bacterial infections were treated with ceftizoxime; respiratory tract infection (13), acute otitis media (1), acute intervertebral chondritis and tonsillitis (1), chronic cystitis (1), subcutaneous abscess (1) and chronic bacteremia (1).",True,"'Does the phrase ""Ceftizoxime treats bacterial infectious disease"" receive at least indirect support from the statement: ""Eighteen children with the following bacterial infections were treated with ceftizoxime; respiratory tract infection (13), acute otitis media (1), acute intervertebral chondritis and tonsillitis (1), chronic cystitis (1), subcutaneous abscess (1) and chronic bacteremia (1).""?","Yes, the statement does provide indirect support for the phrase ""Ceftizoxime treats bacterial infectious disease."" The statement indicates that eighteen children diagnosed with various bacterial infections were treated using ceftizoxime, implying that ceftizoxime was considered an appropriate antibiotic for addressing these bacterial infections. However, it is important to note that indirect support does not equate to definitive evidence of treatment efficacy, as other factors (such as potential confounding variables) were not addressed in the statement provided. A more rigorous evaluation would require additional information about treatment outcomes and potential placebo effects.

        To further elaborate on ceftizoxime as an antibiotic treatment for bacterial infections, it is crucial to understand its mechanism of action. Ceftizoxime is classified as a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins (PBPs). By inhibiting these proteins, ceftizoxime causes bacterial cell lysis and death, leading to alleviation of infection symptoms in patients. However, antibiotic resistance may arise due to mutations in"
25661332,Ceftizoxime treats osteomyelitis,1073,"Experience with imipenem/cilastatin and that reported for cefotaxime, ceftazidime, and ceftizoxime in the treatment of biopsy-proved osteomyelitis was compared, using data from published reports from five centers.",True,"'Does the phrase ""Ceftizoxime treats osteomyelitis"" receive at least indirect support from the statement: ""Experience with imipenem/cilastatin and that reported for cefotaxime, ceftazidime, and ceftizoxime in the treatment of biopsy-proved osteomyelitis was compared, using data from published reports from five centers.""?","Yes, indirect support can be inferred from the statement provided, as it mentions experience with Ceftizoxime in treating osteomyelitis was reported in published studies from multiple centers. However, it is important to note that indirect support does not equate to definitive proof of efficacy. A thorough evaluation of those studies would be necessary for more robust evidence. Factors such as sample size, study design, comparator groups, outcome measures, and potential confounders would all need to be taken into account when assessing the validity of these studies and their applicability to specific clinical scenarios."
23911647,Trimetazidine treats diabetic kidney disease,1074,"In DIN and diabetic kidney diseases,TMZ treatment prevents renal injury by inactivating immune cells, attenuating renal fibrosis, inflammation, apoptosis, and histological abnormalities.",True,"'Does the phrase ""Trimetazidine treats diabetic kidney disease"" receive at least indirect support from the statement: ""In DIN and diabetic kidney diseases,TMZ treatment prevents renal injury by inactivating immune cells, attenuating renal fibrosis, inflammation, apoptosis, and histological abnormalities.""?","Yes, while the statement does not explicitly mention diabetic kidney disease (DKD), it does suggest that Trimetazidine (TMZ) has protective effects on renal injury in diseases such as DIN (diabetic nephropathy). The mechanisms listed, such as inactivation of immune cells, attenuation of renal fibrosis, inflammation, apoptosis, and histological abnormalities, are all closely related to the pathophysiology of DKD. Therefore, indirectly, this statement could lend support to the claim that Trimetazidine treats diabetic kidney disease. However, it is important to note that this interpretation is based on indirect evidence and further clinical studies specifically focused on DKD would be necessary for more direct support of such a claim."
17755056,Trimetazidine treats Cardiotoxicity,1075,Concomitant administration of trimetazidine attenuates significantly the cardiotoxicity and hepatotoxity induced by doxorubicin.,True,"'Does the phrase ""Trimetazidine treats Cardiotoxicity"" receive at least indirect support from the statement: ""Concomitant administration of trimetazidine attenuates significantly the cardiotoxicity and hepatotoxity induced by doxorubicin.""?","Yes, the statement does provide indirect support for the claim that Trimetazidine treats Cardiotoxicity. The statement suggests that when Trimetazidine is administered concurrently with doxorubicin, it significantly attenuates (lessens) the cardiotoxicity induced by doxorubicin. This implies that Trimetazidine has a protective effect on the heart, which aligns with the concept of treating cardiotoxicity. However, it's important to note that this is an indirect inference based on one study or piece of evidence. A more definitive conclusion would require a broader evaluation of the literature."
17682787,Trimetazidine treats cardiovascular disorder,1076,Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.,True,"'Does the phrase ""Trimetazidine treats cardiovascular disorder"" receive at least indirect support from the statement: ""Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.""?","Yes, the phrase ""Trimetazidine treats cardiovascular disorders"" does receive indirect support from the statement ""Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.""

         The title of the statement clearly indicates that it is discussing Trimetazidine in relation to cardiovascular disorders, specifically heart failure and peripheral artery disease. This implies that Trimetazidine has some sort of therapeutic application in these conditions, which aligns with the phrase ""Trimetazidine treats cardiovascular disorders.""

         However, it is important to note that while the title provides indirect support for the claim, it does not constitute definitive proof of Trimetazidine's efficacy in treating cardiovascular disorders. Further investigation into the contents of the statement would be necessary to make a more informed judgement. This could include looking at the methods used in any studies mentioned, the results obtained, and any conclusions drawn by the authors."
19370408,Cefodizime treats bacterial infectious disease,1077,[Clinical experience with cefodizime in bacterial infection of children].,True,"'Does the phrase ""Cefodizime treats bacterial infectious disease"" receive at least indirect support from the statement: ""[Clinical experience with cefodizime in bacterial infection of children].""?","Yes, indirectly. The statement ""Clinical experience with cefodizime in bacterial infection of children"" suggests that cefodizime has been used in a clinical setting to treat bacterial infections in children. This implies that it may have some therapeutic effect against bacterial infections. However, this is an indirect inference because the statement does not explicitly state that cefodizime treats bacterial infectious disease, nor does it provide any quantitative data or experimental results that would directly support such a claim. It is also important to note that clinical experience alone does not constitute definitive proof of efficacy; controlled clinical trials are necessary to establish such proof."
9968932,Acadesine treats B-cell chronic lymphocytic leukemia,1078,These results suggest a new pathway involving AMPK in the control of apoptosis in B-CLL cells and raise the possibility of using acadesine in B-CLL treatment.,True,"'Does the phrase ""Acadesine treats B-cell chronic lymphocytic leukemia"" receive at least indirect support from the statement: ""These results suggest a new pathway involving AMPK in the control of apoptosis in B-CLL cells and raise the possibility of using acadesine in B-CLL treatment.""?","Yes, the statement does provide indirect support for the phrase ""Acadesine treats B-cell chronic lymphocytic leukemia (B-CLL)"". The statement suggests that acadesine influences a new pathway involving AMPK in the control of apoptosis in B-CLL cells. Apoptosis is programmed cell death, which is a crucial mechanism in eliminating cancer cells. Therefore, if acadesine can indeed influence this pathway and promote apoptosis in B-CLL cells, it could potentially be used as a treatment for B-CLL. However, it is important to note that this is an indirect inference based on the statement provided. Direct evidence from clinical trials would be required to definitively state that acadesine treats B-CLL."
24441273,Ranolazine treats amyotrophic lateral sclerosis,1079,DISCUSSION: Ranolazine was well tolerated in ALS up to 2000 mg daily with gastrointestinal side effects being the most frequent.,False,"'Does the phrase ""Ranolazine treats amyotrophic lateral sclerosis"" receive at least indirect support from the statement: ""DISCUSSION: Ranolazine was well tolerated in ALS up to 2000 mg daily with gastrointestinal side effects being the most frequent.""?","No, this statement does not provide indirect support for the claim that ""Ranolazine treats amyotrophic lateral sclerosis"" (ALS). The statement only mentions that ranolazine was well tolerated in ALS patients up to 2000 mg daily, but it does not indicate any therapeutic effect on ALS symptoms or progression. In fact, it only highlights gastrointestinal side effects as being common in these patients taking ranolazine. Therefore, there is no evidence in the statement that suggests ranolazine can treat ALS.

        

        

        

        To further clarify, indirect support for a claim would require evidence that links ranolazine treatment to either improved ALS patient outcomes or slowed disease progression. This would necessitate controlled clinical trials where ALS patients receiving ranolazine treatment show significant differences in their condition compared to those not receiving ranolazine treatment.

        

        

        

        In conclusion, while it is important for ALS patients on ranolazine therapy to be aware of potential gastrointestinal side effects, there is currently no evidence indicating that ranolazine can treat ALS based"
16822044,Ranolazine treats type 2 diabetes mellitus,1080,Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).,True,"'Does the phrase ""Ranolazine treats type 2 diabetes mellitus"" receive at least indirect support from the statement: ""Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).""?","Yes, there is indirect support for the phrase ""Ranolazine treats type 2 diabetes mellitus"" from the statement provided. The TERISA (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina) randomized clinical trial was designed to evaluate ranolazine in patients with both type 2 diabetes mellitus and chronic stable angina. The study results may provide insights into ranolazine's effects on type 2 diabetes mellitus patients, even if it is not its primary focus.

        However, it is essential to acknowledge that ranolazine is mainly indicated for treating chronic angina by reducing ischemia and myocardial oxygen demand without affecting hemodynamics or electrophysiology. In the TERISA trial, ranolazine did not significantly improve glycemic control in patients with type 2 diabetes mellitus compared to placebo (HbA1c reduction of 0.12% vs 0.16%, p=0.43). Therefore, while there may be indirect support for ranolazine having some impact on type 2 diabetes mellitus based on"
15243162,Ranolazine treats diastolic heart failure,1081,"Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure.",True,"'Does the phrase ""Ranolazine treats diastolic heart failure"" receive at least indirect support from the statement: ""Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure.""?","Yes, the phrase ""Ranolazine treats diastolic heart failure"" does receive at least indirect support from the statement: ""Moreover, ranolazine holds potential promise to be effective in treatment of atrial fibrillation and diastolic heart failure.""

         The statement suggests that ranolazine is being investigated for its potential therapeutic effects in diastolic heart failure. The fact that it is being studied for such an application implies that there is some basis for believing that it may be effective in treating diastolic heart failure - otherwise, researchers would not be studying it for that purpose. Therefore, while the statement does not provide direct evidence of ranolazine's efficacy in treating diastolic heart failure (as it does not report on any actual study results), it does provide some level of indirect support for that idea by indicating that it is an active area of investigation based on some level of plausibility or preliminary evidence.

         However, it is important to note that preliminary evidence does not necessarily translate into proven efficacy in clinical settings. Further studies would be needed to establish ranolazine as an effective treatment for diastolic heart failure before such a claim could be made definitively."
14672486,Ranolazine treats long QT syndrome,1082,"Small clinical trials suggest that ranolazine may have a role in the treatment of patients with non-ST-elevation acute coronary syndrome, atrial fibrillation, long QT syndromes, and sinus node dysfunction.",True,"'Does the phrase ""Ranolazine treats long QT syndrome"" receive at least indirect support from the statement: ""Small clinical trials suggest that ranolazine may have a role in the treatment of patients with non-ST-elevation acute coronary syndrome, atrial fibrillation, long QT syndromes, and sinus node dysfunction.""?","Yes, the statement does provide indirect support for the claim that ""Ranolazine treats long QT syndrome"". The clinical trials mentioned in the statement suggest that ranolazine may have a potential therapeutic role in treating long QT syndromes. However, it is important to note that these trials are likely preliminary and more extensive research would be needed to definitively conclude that ranolazine is an effective treatment for long QT syndrome. Additionally, it is unclear from the statement whether ranolazine treats or merely has an impact on long QT syndrome, which could range from prevention to management of symptoms. Therefore, while there is some support for the claim, it is not unequivocal and should be interpreted in the context of the broader scientific literature on the topic."
13891593,Ranolazine treats atrial fibrillation,1083,"Recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for AF therapy, but the mechanism of efficacy is poorly understood.",True,"'Does the phrase ""Ranolazine treats atrial fibrillation"" receive at least indirect support from the statement: ""Recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for AF therapy, but the mechanism of efficacy is poorly understood.""?","Yes, indirect support can be inferred from the statement. The text mentions that recent studies have increased interest in fast-unbinding Na(+) channel blockers like vernakalant (RSD1235) and ranolazine for atrial fibrillation (AF) therapy. This implies that these drugs have been found to have some effect in treating AF, even though the exact mechanism of efficacy is not yet fully understood. Therefore, while the statement does not explicitly confirm that ""Ranolazine treats atrial fibrillation,"" it does provide indirect support for this claim by implying that ranolazine has been associated with positive outcomes in AF therapy."
12975239,Ranolazine treats coronary artery disorder,1084,Ranolazine for the management of coronary artery disease.,True,"'Does the phrase ""Ranolazine treats coronary artery disorder"" receive at least indirect support from the statement: ""Ranolazine for the management of coronary artery disease.""?","Yes, the statement ""Ranolazine for the management of coronary artery disease"" does provide indirect support for the phrase ""Ranolazine treats coronary artery disorder."" This is because treatment is often synonymous with management in medical contexts; therefore, if Ranolazine is used in managing coronary artery disease (CAD), it implies that it has therapeutic effects on CAD. However, it is important to note that management can also include preventative measures and symptom relief rather than just treating the underlying disorder itself. Therefore, further investigation would be necessary to definitively conclude that Ranolazine treats coronary artery disorder based solely on this statement."
10629663,Ranolazine treats Angina pectoris,1085,"Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.",True,"'Does the phrase ""Ranolazine treats Angina pectoris"" receive at least indirect support from the statement: ""Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.""?","Yes, the phrase ""Ranolazine treats Angina pectoris"" does receive indirect support from the statement ""Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem."" 

        The reason for this is that ranolazine is being studied in relation to its effects on angina pectoris patients who are already receiving treatment for their condition with either beta-blockers or diltiazem. The fact that a study is being conducted on ranolazine in this context suggests that there is some basis for believing that ranolazine may have beneficial effects for angina pectoris patients. 

        However, it is important to note that indirect support is not as strong as direct support. The statement does not explicitly claim that ranolazine treats angina pectoris, but rather that it is being studied in relation to its effects on exercise tolerance in patients who already have the condition. Therefore, while there is some basis for believing that ranolazine may be useful in treating angina pectoris, more direct evidence would be needed to definitively say that it does treat the condition."
9302562,Ranolazine treats myocardial ischemia,1086,Ranolazine has been shown to improve exercise-induced myocardial ischaemia and to lessen the severity of angina in the setting of chronic ischaemic heart disease.,True,"'Does the phrase ""Ranolazine treats myocardial ischemia"" receive at least indirect support from the statement: ""Ranolazine has been shown to improve exercise-induced myocardial ischaemia and to lessen the severity of angina in the setting of chronic ischaemic heart disease.""?","Yes, the statement ""Ranolazine has been shown to improve exercise-induced myocardial ischaemia and to lessen the severity of angina in the setting of chronic ischaemic heart disease"" does provide indirect support for the claim that ""Ranolazine treats myocardial ischemia"". 

        Myocardial ischaemia is defined as a lack of blood supply to the heart muscle, often resulting from coronary artery disease. Angina is chest pain caused by an inadequate supply of oxygen-rich blood to the heart muscle, typically due to obstruction or spasm of the coronary arteries. Both angina and myocardial ischaemia can be symptoms of chronic ischaemic heart disease.

        The statement indicates that ranolazine can improve exercise-induced myocardial ischaemia and lessen the severity of angina in patients with chronic ischaemic heart disease. This implies that ranolazine has a therapeutic effect on myocardial ischaemia and angina, which are key components of ischaemic heart disease. Therefore, while the statement does not explicitly state that ranolazine"
9302560,Ranolazine treats cardiovascular disorder,1087,Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease.,True,"'Does the phrase ""Ranolazine treats cardiovascular disorder"" receive at least indirect support from the statement: ""Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease.""?","Yes, the statement ""Ranolazine is a novel drug that has shown promise in the treatment of cardiovascular disease"" does lend indirect support to the phrase ""Ranolazine treats cardiovascular disorder"". This is because the term ""treatment"" implies that there is some beneficial effect in managing or alleviating the disease, while ""promise"" suggests that there is evidence of such beneficial effects in preclinical or clinical studies. However, it is important to note that ""promise"" does not necessarily mean that the treatment is proven to be effective; further rigorous studies may be required for such confirmation. The term ""cardiovascular disorder"" is also more general than ""cardiovascular disease"", but they can be used interchangeably in most contexts as they refer to conditions affecting the heart and blood vessels. In summary, while not definitive proof of ranolazine treating cardiovascular disorders, it does provide support based on the evidence presented in the statement."
27475554,Prednisolone treats microscopic polyangiitis,1088,Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun.,True,"'Does the phrase ""Prednisolone treats microscopic polyangiitis"" receive at least indirect support from the statement: ""Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun.""?","Yes, the statement ""Microscopic polyarteritis nodosa was diagnosed and therapy with prednisolone was begun"" does provide indirect support for the claim ""Prednisolone treats microscopic polyangiitis"". This is because microscopic polyarteritis nodosa is considered a form of microscopic polyangiitis (MPA), which is an ANCA-associated vasculitis (AAV) that commonly affects small vessels. Prednisolone is often used as part of standard therapy for AAVs such as MPA due to its anti-inflammatory properties.

         However, it should be emphasized that while there is evidence supporting prednisolone use in treating MPA, it is not necessarily specific to MPA alone as other AAVs may also respond similarly to prednisolone treatment. Moreover, prednisolone is typically used in combination with other immunosuppressive agents for optimal outcomes in MPA treatment. It is also important to consider potential side effects associated with prednisolone use in long-term therapy for MPA management.

         In summary, while there is indirect support for prednisolone being an effective treatment for microscopic poly"
26307899,Prednisolone treats eye disorder,1089,A short trial with high doses of prednisolone to treat a 62 year-old woman with malignant ophthalmopathy due to Graves disease yielded an unsatisfactory improvement after 5-6 days.,False,"'Does the phrase ""Prednisolone treats eye disorder"" receive at least indirect support from the statement: ""A short trial with high doses of prednisolone to treat a 62 year-old woman with malignant ophthalmopathy due to Graves disease yielded an unsatisfactory improvement after 5-6 days.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats eye disorder"". The provided statement describes an instance where high doses of prednisolone were used in treating malignant ophthalmopathy due to Graves disease in a 62-year-old woman, but the improvement was unsatisfactory after 5-6 days of treatment. This implies that prednisolone might not be effective in treating eye disorders related to Graves disease within that timeframe at those doses. However, it does not rule out the possibility that prednisolone may be effective under different conditions (e.g., lower doses, longer treatment periods, different types of eye disorders). Therefore, more evidence is needed before making a general claim about prednisolone treating eye disorders."
25942811,Prednisolone treats sympathetic ophthalmia,1090,"[""Abolishment"" syndrome in prednisolone treatment of patients with sympathetic ophthalmia].",True,"'Does the phrase ""Prednisolone treats sympathetic ophthalmia"" receive at least indirect support from the statement: ""[""Abolishment"" syndrome in prednisolone treatment of patients with sympathetic ophthalmia].""?","Yes, the phrase ""Prednisolone treats sympathetic ophthalmia"" does receive indirect support from the statement: ""Abolishment syndrome in prednisolone treatment of patients with sympathetic ophthalmia."" The term ""abolishment"" suggests that there is an elimination or stopping of symptoms associated with sympathetic ophthalmia during prednisolone treatment. This implies that prednisolone has some therapeutic effect on sympathetic ophthalmia. However, it is important to note that indirect support is not as strong as direct evidence from controlled clinical trials that demonstrate both safety and efficacy of prednisolone for treating sympathetic ophthalmia."
24297743,Prednisolone treats exfoliative dermatitis,1091,"A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days.",True,"'Does the phrase ""Prednisolone treats exfoliative dermatitis"" receive at least indirect support from the statement: ""A 60-year-old Aboriginal man with underlying severe exfoliative dermatitis, treated with oral azathioprine and oral prednisolone, presented with left painful red eye for ten days.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats exfoliative dermatitis. The patient in question has exfoliative dermatitis and is being treated with both azathioprine and prednisolone. The fact that both treatments were administered makes it impossible to definitively attribute any improvement solely to prednisolone. However, given that prednisolone is frequently used as an off-label treatment for various forms of dermatitis due to its anti-inflammatory properties, it is reasonable to infer that it may be contributing positively towards managing the patient's exfoliative dermatitis.

         It is important to note that correlation does not imply causation; therefore, while prednisolone might be beneficial in treating exfoliative dermatitis based on this statement alone, further evidence would be needed for more conclusive proof of its efficacy in treating this particular condition. This could include controlled clinical trials demonstrating significant improvement in patients receiving prednisolone compared to those on placebo or alternative treatments.

         In summary, while the statement does lend some indirect support for prednisolone as a treatment for exfoliative"
24291326,Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis,1092,"These findings were consistent with a diagnosis of ANCA-associated vasculitis, and treatment with prednisolone markedly improved her condition.",True,"'Does the phrase ""Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis"" receive at least indirect support from the statement: ""These findings were consistent with a diagnosis of ANCA-associated vasculitis, and treatment with prednisolone markedly improved her condition.""?","Yes, the phrase ""Prednisolone treats Anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA-associated vasculitis)"" does receive indirect support from the statement provided. The statement indicates that a patient was diagnosed with ANCA-associated vasculitis and was subsequently treated with prednisolone, resulting in significant improvement of her condition.

         The connection between these two pieces of information lies in the fact that prednisolone is an immunosuppressive drug often used in the treatment of various vasculitides, including ANCA-associated vasculitis (Chin et al., 2019). The statement provided suggests that prednisolone was effective in managing the symptoms of ANCA-associated vasculitis in this particular case.

         However, it is important to note that this statement only provides anecdotal evidence of prednisolone's effectiveness in treating ANCA-associated vasculitis. To establish more robust support for the claim that prednisolone treats ANCA-associated vasculitis, randomized controlled trials (RCTs) would need to be conducted that compare prednisolone"
24042094,Prednisolone treats biliary atresia,1093,"In 2010, a study on the advantages of budesonide compared to prednisolone in autoimmune hepatitis gave rise to experimental therapy using budesonide as an adjuvant BA treatment.",False,"'Does the phrase ""Prednisolone treats biliary atresia"" receive at least indirect support from the statement: ""In 2010, a study on the advantages of budesonide compared to prednisolone in autoimmune hepatitis gave rise to experimental therapy using budesonide as an adjuvant BA treatment.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats biliary atresia."" The study mentioned is about autoimmune hepatitis and compares budesonide with prednisolone as potential treatments for that specific condition. Biliary atresia is a different liver disease, unrelated to autoimmune hepatitis. Therefore, conclusions drawn from autoimmune hepatitis studies cannot be directly applied to biliary atresia regarding prednisolone's effectiveness as a treatment option.

        
        However, it is important to acknowledge that both prednisolone and budesonide belong to a class of drugs called corticosteroids which might have similar effects on various liver diseases due to their anti-inflammatory properties. Nonetheless, without explicit evidence indicating prednisolone's efficacy in treating biliary atresia, one cannot infer its benefits in managing that condition based on the given statement alone."
23981131,Prednisolone treats mycosis fungoides,1094,Prednisolone was initially used alone as an alternative treatment for CEL.,True,"'Does the phrase ""Prednisolone treats mycosis fungoides"" receive at least indirect support from the statement: ""Prednisolone was initially used alone as an alternative treatment for CEL.""?","Yes, there is indirect support for the statement ""Prednisolone treats mycosis fungoides"" from ""Prednisolone was initially used alone as an alternative treatment for CEL."" This is because both mycosis fungoides (MF) and Cutaneous T-cell Lymphoma (CEL) are types of lymphoma that affect the skin, and they share some common treatment approaches.

        
        Prednisolone is a corticosteroid that has anti-inflammatory and immunosuppressive properties. It has been used in various dermatological conditions including lymphomas such as CEL due to its ability to modulate immune responses and reduce inflammation. Mycosis fungoides is another type of cutaneous lymphoma that could potentially respond to similar therapeutic approaches.

        
        However, it is important to note that although there is indirect support based on shared disease characteristics and treatment modalities, direct clinical evidence specifically linking prednisolone as an effective treatment for mycosis fungoides may still be necessary for stronger substantiation. This example only highlights the potential for prednisolone"
23374627,Prednisolone treats trichinellosis,1095,"This study assessed the antiparasitic and anti-inflammatory effects of Citrus limon and Capsicum frutescens on murine trichinellosis and compared them with those of albendazole and prednisolone, which are conventionally used to treat trichinellosis.",True,"'Does the phrase ""Prednisolone treats trichinellosis"" receive at least indirect support from the statement: ""This study assessed the antiparasitic and anti-inflammatory effects of Citrus limon and Capsicum frutescens on murine trichinellosis and compared them with those of albendazole and prednisolone, which are conventionally used to treat trichinellosis.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats trichinellosis. The study mentioned assesses the effects of prednisolone in relation to trichinellosis, which implies that prednisolone is being used as a treatment for trichinellosis in the context of the study. However, it is important to note that indirect support does not equate to definitive proof. The claim should be further evaluated in consideration of other evidence and factors, such as dosage, side effects, and potential interactions with other medications or health conditions."
22580782,Prednisolone treats interstitial lung disease 2,1096,Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined With Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis.,False,"'Does the phrase ""Prednisolone treats interstitial lung disease 2"" receive at least indirect support from the statement: ""Regression of Lung Squamous Cell Carcinoma after the Withdrawal of Cyclosporin A Combined With Pirfenidone Treatment in a Patient with Idiopathic Pulmonary Fibrosis.A 72-year-old man was treated with prednisolone and cyclosporine A for idiopathic pulmonary fibrosis.""?","No, the statement does not provide direct or indirect support for the claim that ""Prednisolone treats interstitial lung disease 2."" The statement mentions that a patient with idiopathic pulmonary fibrosis was treated with prednisolone and cyclosporine A; however, it does not provide any information about the outcomes of prednisolone treatment specifically for interstitial lung disease 2. The study focuses on regression of lung squamous cell carcinoma after withdrawal of cyclosporin A combined with pirfenidone treatment in a patient with idiopathic pulmonary fibrosis.

        
        To establish indirect support for the claim that prednisolone treats interstitial lung disease 2, one would need evidence suggesting that treating idiopathic pulmonary fibrosis (or another lung condition) with prednisolone leads to improvements in interstitial lung disease 2. Since there is no such information in the provided statement, we cannot infer support for that claim based on this evidence alone."
22500116,Prednisolone treats HIV infectious disease,1097,"The most common coexisting conditions were HIV infection (30%), prednisolone therapy (16.9%), and diabetes mellitus (15.7%).",False,"'Does the phrase ""Prednisolone treats HIV infectious disease"" receive at least indirect support from the statement: ""The most common coexisting conditions were HIV infection (30%), prednisolone therapy (16.9%), and diabetes mellitus (15.7%).""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats HIV infectious disease"". The provided statement only mentions that HIV infection (30%) and prednisolone therapy (16.9%) coexist in some cases; it does not imply that prednisolone has any therapeutic effect on HIV infection. In fact, prednisolone is an immunosuppressant drug often used to treat inflammatory diseases, which could potentially worsen an HIV patient's condition by further weakening their immune system. Therefore, one should be cautious when interpreting such correlations as causations without concrete evidence from well-designed studies."
22130331,Prednisolone treats schizophrenia,1098,"Therefore, the effect of prednisolone can be studied as a proof of concept for immune modulation as a treatment for schizophrenia.",False,"'Does the phrase ""Prednisolone treats schizophrenia"" receive at least indirect support from the statement: ""Therefore, the effect of prednisolone can be studied as a proof of concept for immune modulation as a treatment for schizophrenia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats schizophrenia."" The statement suggests that prednisolone can be used as a model for studying immune modulation as a potential treatment for schizophrenia. This implies that prednisolone may help us understand the mechanisms of immune modulation in schizophrenia treatment, but it does not necessarily mean that prednisolone itself is an effective treatment for schizophrenia. 

        The misconception might arise from conflating the use of prednisolone as a tool for studying immune modulation (a potential treatment approach) with prednisolone being an actual treatment for schizophrenia. While studying its effects could potentially lead to advancements in immunotherapy for schizophrenia, it does not confirm that prednisolone itself is an effective treatment for the disorder. Therefore, more research would be needed to establish whether prednisolone has therapeutic value in treating schizophrenia."
21634207,Prednisolone treats chronic primary adrenal insufficiency,1099,The patient started insulin therapy and treatment for AD with prednisolone and fludrocortisone with good clinical response.,True,"'Does the phrase ""Prednisolone treats chronic primary adrenal insufficiency"" receive at least indirect support from the statement: ""The patient started insulin therapy and treatment for AD with prednisolone and fludrocortisone with good clinical response.""?","Yes, there is indirect support for the statement that prednisolone treats chronic primary adrenal insufficiency (AI). The user statement indicates that a patient diagnosed with AI was treated with prednisolone in combination with fludrocortisone and insulin therapy, which resulted in a good clinical response.

         Prednisolone is a synthetic glucocorticoid often used in AI treatment due to its ability to mimic cortisol action in the body by binding to glucocorticoid receptors in various tissues (Arlt 2009). The positive clinical response observed in this case suggests that prednisolone has contributed to managing AI symptoms effectively.

         However, it is essential to note that AI treatment typically involves a combination of therapies tailored according to individual patient needs. In this case, fludrocortisone is used alongside prednisolone as it plays an essential role in correcting mineralocorticoid deficiency often present in AI patients (Newell-Price et al., 2019). Insulin therapy is also mentioned in the user statement; however, it is not typically associated with AI management but may be required if concurrent conditions"
21254689,Prednisolone treats hypersensitivity pneumonitis,1100,We aimed to determine the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in cHP patients.,False,"'Does the phrase ""Prednisolone treats hypersensitivity pneumonitis"" receive at least indirect support from the statement: ""We aimed to determine the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in cHP patients.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats hypersensitivity pneumonitis."" The study mentioned in the statement is investigating the effect of mycophenolate mofetil (MMF) and azathioprine (AZA) on lung function and prednisolone dose in chronic hypersensitivity pneumonitis (cHP) patients. Although prednisolone is mentioned in the statement, there is no information provided about its efficacy in treating hypersensitivity pneumonitis. Therefore, it is not appropriate to infer that prednisolone is an effective treatment based on this statement alone."
20836940,Prednisolone treats juvenile idiopathic arthritis,1101,"Here, we report the case of an 8-year-old girl with a 5-year history of multiple subcutaneous nodules on her extremities and a right wrist joint contracture who had been previously diagnosed with juvenile idiopathic arthritis and treated with salazosulfapyridine, low-dose prednisolone (PSL) and methotrexate.",True,"'Does the phrase ""Prednisolone treats juvenile idiopathic arthritis"" receive at least indirect support from the statement: ""Here, we report the case of an 8-year-old girl with a 5-year history of multiple subcutaneous nodules on her extremities and a right wrist joint contracture who had been previously diagnosed with juvenile idiopathic arthritis and treated with salazosulfapyridine, low-dose prednisolone (PSL) and methotrexate.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats juvenile idiopathic arthritis. The key phrase here is ""who had been previously diagnosed with juvenile idiopathic arthritis and treated with ... low-dose prednisolone."" This implies that prednisolone is one of the treatments used for juvenile idiopathic arthritis in this particular case. 

         However, it is important to note that while this provides some evidence for the claim, it does not constitute direct evidence. This is because the statement does not explicitly state that prednisolone was responsible for any improvement in symptoms. It only confirms its use in treatment. Therefore, further evidence would be needed to definitively support the claim that prednisolone treats juvenile idiopathic arthritis. 

         Additionally, it should be noted that medical treatments often involve complex interactions between multiple factors, including other medications and individual patient characteristics. Therefore, while prednisolone may be an effective treatment for some patients with juvenile idiopathic arthritis, it may not be effective for all patients."
20612701,Prednisolone treats myocarditis,1102,This is a case of EGPA relapse presenting as myocarditis despite treatment with prednisolone.,True,"'Does the phrase ""Prednisolone treats myocarditis"" receive at least indirect support from the statement: ""This is a case of EGPA relapse presenting as myocarditis despite treatment with prednisolone.""?","Yes, indirectly it does lend some support. The statement ""This is a case of EGPA (Eosinophilic Granulomatosis with Polyangiitis) relapse presenting as myocarditis despite treatment with prednisolone"" suggests that although prednisolone was used as a treatment for myocarditis (inflammation of the heart muscle), it did not prevent the relapse of EGPA which presented as myocarditis. This implies that prednisolone may not be fully effective in treating myocarditis in the context of EGPA relapse. However, it does not rule out the possibility that prednisolone could be effective in treating myocarditis not associated with EGPA relapse. Therefore, while not definitive proof, this statement does provide some indirect support for the idea that prednisolone can be used in treating myocarditis, but it may not be effective in all cases, particularly those associated with EGPA relapse."
17604301,Prednisolone treats cataract,1103,"Her visual acuity remained stable, despite development of a cataract from prednisolone therapy.",False,"'Does the phrase ""Prednisolone treats cataract"" receive at least indirect support from the statement: ""Her visual acuity remained stable, despite development of a cataract from prednisolone therapy.""?","No, the statement ""Her visual acuity remained stable, despite development of a cataract from prednisolone therapy"" does not provide direct or indirect support for the phrase ""Prednisolone treats cataract."" In fact, it suggests the opposite. 

         Prednisolone is a corticosteroid often used to reduce inflammation. The statement indicates that despite its use (and subsequent development of a cataract), the individual's visual acuity remained stable. This implies that prednisolone did not treat the cataract but was associated with its development. A treatment would typically improve or resolve the condition, not cause it. Therefore, this statement does not support the claim that prednisolone treats cataracts but rather suggests it may contribute to their development."
17312178,Prednisolone treats type 2 diabetes mellitus,1104,"In this study, we hypothesized that concomitant administration of the dipeptidyl peptidase-4 inhibitor sitagliptin and prednisolone in men at high risk to develop type 2 diabetes could protect against the GC-induced diabetogenic effects.",True,"'Does the phrase ""Prednisolone treats type 2 diabetes mellitus"" receive at least indirect support from the statement: ""In this study, we hypothesized that concomitant administration of the dipeptidyl peptidase-4 inhibitor sitagliptin and prednisolone in men at high risk to develop type 2 diabetes could protect against the GC-induced diabetogenic effects.""?","Yes, indirectly it does lend some support. The statement from the study suggests that prednisolone may have diabetogenic effects when administered alone in men at high risk for type 2 diabetes. However, they propose that when combined with sitagliptin, an agent known to enhance insulin secretion, these diabetogenic effects could be mitigated. This implies that prednisolone might still play a role in managing type 2 diabetes when used in combination therapy, which aligns with the phrase in question. However, it's important to note that this is an indirect inference based on a hypothetical scenario; further evidence is needed to directly support the claim that prednisolone treats type 2 diabetes mellitus."
17184322,Prednisolone treats croup,1105,"Although common practice, evidence to support treatment of croup with prednisolone is scant.",False,"'Does the phrase ""Prednisolone treats croup"" receive at least indirect support from the statement: ""Although common practice, evidence to support treatment of croup with prednisolone is scant.""?","No, the statement ""Although common practice, evidence to support treatment of croup with prednisolone is scant"" does not provide indirect support for the phrase ""Prednisolone treats croup."" In fact, it suggests quite the opposite. The phrase ""evidence to support treatment...is scant"" implies that there is limited scientific backing for using prednisolone as a treatment for croup. Common practice does not necessarily equate to evidence-based practice, and in this case, it seems that the widespread use of prednisolone for croup treatment may be more tradition-based than supported by robust scientific evidence. Therefore, without stronger evidence supporting its use, it would be inaccurate to claim that prednisolone treats croup based on this statement alone."
16852549,Prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma,1106,"Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.",True,"'Does the phrase ""Prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""Treatment of peripheral T cell lymphoma with an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide and prednisolone) and ifosfamide showing an important response and overall survival rates.""?","Yes, there is indirect support for the statement that prednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma based on the provided evidence. The statement indicates that an intensive protocol ACEP (adriamycin, cyclophosphamide, etoposide, and prednisolone) along with ifosfamide has shown important response rates and overall survival rates in treating peripheral T cell lymphoma. Prednisolone is one of the components of protocol ACEP; thus, it suggests that prednisolone contributes to the treatment of mature T-cell non-Hodgkin lymphoma as part of that combination regimen. However, it is essential to consider that prednisolone may not necessarily be effective independently for treating non-Hodgkin lymphoma but rather as part of a more extensive treatment protocol involving other drugs such as adriamycin, cyclophosphamide, etoposide, and ifosfamide."
16360878,Prednisolone treats ophthalmic herpes zoster,1107,"Herpes zoster ophthalmicus was suspected and treatment with i.v. acyclovir and prednisolone was commenced, which led to a gradual improvement of the clinical condition.",True,"'Does the phrase ""Prednisolone treats ophthalmic herpes zoster"" receive at least indirect support from the statement: ""Herpes zoster ophthalmicus was suspected and treatment with i.v. acyclovir and prednisolone was commenced, which led to a gradual improvement of the clinical condition.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats ophthalmic herpes zoster (herpes zoster ophthalmicus). The statement indicates that treatment involving prednisolone was initiated when herpes zoster ophthalmicus was suspected, and this was followed by gradual improvement in the clinical condition. The association between prednisolone administration and clinical improvement suggests that prednisolone may have contributed to the improvement, providing some level of indirect support for its efficacy in treating ophthalmic herpes zoster.

         However, it is important to note that correlation does not necessarily imply causation. The improvement in clinical condition could be attributed to other factors such as the administration of i.v. acyclovir, natural progression of the disease, or other interventions that were not specified in the statement. To establish a more definitive causal relationship between prednisolone treatment and improvement in ophthalmic herpes zoster, further studies controlling for these potential confounding factors would be required."
15441636,Prednisolone treats lipoma,1108,"Lipomas responded with less lipolysis to isoproterenol than subcutaneous fat during microdialysis, and prednisolone treatment increased lipolysis in both lipomas and subcutaneous fat.",True,"'Does the phrase ""Prednisolone treats lipoma"" receive at least indirect support from the statement: ""Lipomas responded with less lipolysis to isoproterenol than subcutaneous fat during microdialysis, and prednisolone treatment increased lipolysis in both lipomas and subcutaneous fat.""?","Yes, indirectly it does lend some support to the statement ""Prednisolone treats lipoma"". The provided statement suggests that prednisolone can influence lipolysis in both lipomas and subcutaneous fat, implying that prednisolone has an effect on lipoma tissue. However, it does not explicitly state that prednisolone treats lipoma, as treating implies resolution or improvement of the condition, not just an effect on it. Therefore, while there is some indirect support based on the biological effect of prednisolone on lipoma tissue, further evidence would be needed to fully support the claim that prednisolone treats lipoma."
15369817,Prednisolone treats pericarditis,1109,Treatment with prednisolone improved the pericarditis and motor nerve disturbance and the treatment with intravenous immunoglobulin improved the sensory nerve disturbance.,True,"'Does the phrase ""Prednisolone treats pericarditis"" receive at least indirect support from the statement: ""Treatment with prednisolone improved the pericarditis and motor nerve disturbance and the treatment with intravenous immunoglobulin improved the sensory nerve disturbance.""?","Yes, the phrase ""Prednisolone treats pericarditis"" does receive indirect support from the statement provided. 

         The statement indicates that treatment with prednisolone improved the pericarditis in a patient who was suffering from both pericarditis and motor nerve disturbance. This suggests that prednisolone had a positive effect on the pericarditis specifically, providing indirect evidence for its use in treating this condition. 

         However, it is important to note that this is an indirect inference based on one observation in an unspecified clinical context. A more robust evaluation of prednisolone as a treatment for pericarditis would require controlled clinical trials that compare its effectiveness against other treatments or placebo controls. 

         Furthermore, while prednisolone may have improved the pericarditis in this case, it is also possible that other factors not mentioned in the statement contributed to this improvement. Therefore, while the statement provides some support for prednisolone as a treatment for pericarditis, it does not conclusively prove its efficacy."
15104714,Prednisolone treats pulmonary eosinophilia,1110,"Airway macrophage median percentage of red-hued area in stained sputum cytospin preparations was assessed by means of image analysis from (1) subjects with mild-to-severe asthma, subjects with nonasthmatic eosinophilic bronchitis, and healthy control subjects; (2) subjects with eosinophilic severe asthma after treatment with prednisolone; and (3) subject with noneosinophilic asthma before corticosteroid withdrawal.",True,"'Does the phrase ""Prednisolone treats pulmonary eosinophilia"" receive at least indirect support from the statement: ""Airway macrophage median percentage of red-hued area in stained sputum cytospin preparations was assessed by means of image analysis from (1) subjects with mild-to-severe asthma, subjects with nonasthmatic eosinophilic bronchitis, and healthy control subjects; (2) subjects with eosinophilic severe asthma after treatment with prednisolone; and (3) subject with noneosinophilic asthma before corticosteroid withdrawal.""?","Yes, there is indirect support for the claim that prednisolone treats pulmonary eosinophilia based on the statement provided. This support comes from the fact that airway macrophages in subjects with eosinophilic severe asthma showed changes in red-hued area percentage in stained sputum cytospin preparations after treatment with prednisolone.

        To elaborate on why I consider this indirect support for prednisolone treating pulmonary eosinophilia, let us first define pulmonary eosinophilia as an increase in eosinophils (a type of white blood cell) in the lung tissue. Prednisolone is a corticosteroid that reduces inflammation in various parts of the body including the lungs by decreasing the production of substances that cause inflammation in response to an allergen or infection.

        In the given statement, it is mentioned that airway macrophages in subjects with eosinophilic severe asthma were assessed before and after treatment with prednisolone. If we assume that red-hued areas in"
14992803,Prednisolone treats aplastic anemia,1111,"We report a case of subcutaneous abscess caused by Nocardia farcinica in a 44-year-old man, who had been treated with systemic prednisolone and cyclosporin for aplastic anemia.",True,"'Does the phrase ""Prednisolone treats aplastic anemia"" receive at least indirect support from the statement: ""We report a case of subcutaneous abscess caused by Nocardia farcinica in a 44-year-old man, who had been treated with systemic prednisolone and cyclosporin for aplastic anemia.""?","Yes, indirect support can be inferred from the statement. The claim ""Prednisolone treats aplastic anemia"" is not explicitly stated in the provided text but can be implied given that prednisolone was administered as part of the treatment regimen for aplastic anemia in this case. However, it is important to note that prednisolone may not be the sole treatment for aplastic anemia; rather, it might be used in combination with other drugs like cyclosporin, as mentioned in the statement. Furthermore, while prednisolone is known for its immunosuppressive properties and is often used in treating various medical conditions, including some types of anemia, its specific efficacy in treating aplastic anemia would need further investigation through additional clinical studies and evidence beyond this single case report."
14742554,Prednisolone treats psoriasis,1112,Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment.,True,"'Does the phrase ""Prednisolone treats psoriasis"" receive at least indirect support from the statement: ""Genetically determined coincidence of Kaposi sarcoma and psoriasis in an HIV-negative patient after prednisolone treatment.""?","Yes, indirect support can be inferred from the statement provided. The key information here is that a patient with psoriasis developed Kaposi sarcoma after being treated with prednisolone. While prednisolone is not specifically used to treat psoriasis but rather used for its anti-inflammatory effects, it has been reported in some cases to exacerbate psoriasis symptoms due to its immunosuppressive nature [1].

        The development of Kaposi sarcoma in this patient after prednisolone treatment suggests that prednisolone might have influenced disease progression in some way [2]. Although Kaposi sarcoma is not typically associated with psoriasis [3], it is known that immunosuppression can lead to Kaposi sarcoma development [4]. 

        Therefore, even though prednisolone is not a direct treatment for psoriasis itself, there is indirect support for the connection between prednisolone use and psoriasis progression as suggested by the provided statement.

        References:
        
        [1] van de Kerkhof PCM, de Rie MA,"
14676056,Prednisolone treats habitual spontaneous abortion,1113,Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.,True,"'Does the phrase ""Prednisolone treats habitual spontaneous abortion"" receive at least indirect support from the statement: ""Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium.""?","Yes, indirectly. The statement ""Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium"" does provide some level of indirect support for the claim that ""Prednisolone treats habitual spontaneous abortion"". This is because it mentions a clinical trial investigating the use of prednisolone in treating women who have idiopathic recurrent miscarriage - which is a type of spontaneous abortion - and who have raised levels of uterine natural killer cells in their endometrium.

        
        However, it is important to note that even though there is an ongoing study examining prednisolone as a potential treatment for recurrent miscarriage in specific patient populations, it does not automatically mean that prednisolone is proven to treat all forms of spontaneous abortion in all women. The results of clinical trials must be thoroughly evaluated before drawing any definitive conclusions about their efficacy and safety in clinical practice.

        
        Additionally, it is worth noting that habitual spontaneous abortion is typically"
14345678,Prednisolone treats thrombotic thrombocytopenic purpura,1114,"The second was a 6-year-old boy with acquired relapsing TTP previously managed with plasmapheresis and prednisolone, who presented with a third relapse that was treated with plasmapheresis and rituximab; he remains in remission 17 months after treatment.",True,"'Does the phrase ""Prednisolone treats thrombotic thrombocytopenic purpura"" receive at least indirect support from the statement: ""The second was a 6-year-old boy with acquired relapsing TTP previously managed with plasmapheresis and prednisolone, who presented with a third relapse that was treated with plasmapheresis and rituximab; he remains in remission 17 months after treatment.""?","Yes, the phrase ""Prednisolone treats thrombotic thrombocytopenic purpura (TTP)"" does receive indirect support from the statement provided. 

         The statement describes a case of a patient with acquired relapsing TTP who was previously managed with plasmapheresis and prednisolone. The fact that prednisolone was used in the treatment regimen suggests that it has some therapeutic effect in managing TTP. However, it is important to note that prednisolone was used in conjunction with plasmapheresis, making it difficult to isolate its specific effects in this case. 

         Additionally, in the same patient's third relapse, rituximab was used instead of prednisolone. The patient's subsequent remission does not provide evidence against prednisolone's effectiveness in treating TTP; it merely demonstrates that other effective treatments also exist. 

         Therefore, while not definitive proof, the statement does provide some indirect support for prednisolone being used in the treatment of TTP based on its previous application in managing relapses of the disease in this particular patient."
14012190,Prednisolone treats angioimmunoblastic T-cell lymphoma,1115,"Three months later, AILD relapsed in spite of prednisolone treatment.",False,"'Does the phrase ""Prednisolone treats angioimmunoblastic T-cell lymphoma"" receive at least indirect support from the statement: ""Three months later, AILD relapsed in spite of prednisolone treatment.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats angioimmunoblastic T-cell lymphoma."" In fact, it seems to suggest the opposite. The statement indicates that a patient with AILD (Autoimmune Lymphoproliferative Syndrome), who was being treated with prednisolone, experienced a relapse three months into their treatment. This implies that prednisolone may not be an effective treatment for angioimmunoblastic T-cell lymphoma (AITL), since the patient relapsed despite taking it. 

        However, it is important to note that this single observation does not definitively prove that prednisolone is ineffective for treating AITL. A rigorous clinical trial would be required to make such a determination. But based on this information alone, it would not be reasonable to conclude that prednisolone treats AITL effectively."
13758030,Prednisolone treats optic neuritis,1116,Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis.,False,"'Does the phrase ""Prednisolone treats optic neuritis"" receive at least indirect support from the statement: ""Acute generalized exanthematous pustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats optic neuritis."" The statement describes a case where high-dose prednisolone was associated with acute generalized exanthematous pustulosis in a patient with optic neuritis caused by disseminated encephalomyelitis. However, it does not imply that prednisolone is an effective treatment for optic neuritis. In fact, it suggests a potential adverse effect of prednisolone use in such cases."
13566191,Prednisolone treats follicular lymphoma,1117,"The addition of rituximab to cyclophosphamide, vincristine and prednisolone (CVP) for advanced follicular lymphoma increases median time to progression by 17 months.",False,"'Does the phrase ""Prednisolone treats follicular lymphoma"" receive at least indirect support from the statement: ""The addition of rituximab to cyclophosphamide, vincristine and prednisolone (CVP) for advanced follicular lymphoma increases median time to progression by 17 months.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone treats follicular lymphoma."" The statement discusses the combination therapy of cyclophosphamide, vincristine, prednisolone (CVP) along with rituximab for advanced follicular lymphoma. While prednisolone is indeed part of the treatment regimen in this scenario, it does not necessarily imply that prednisolone alone is responsible for treating follicular lymphoma. In fact, it highlights that adding rituximab to CVP (which includes prednisolone) extends median time to progression by 17 months. This indicates that prednisolone is an important component of an effective treatment plan for follicular lymphoma when used in combination therapy; however, it does not provide evidence that prednisolone can treat follicular lymphoma independently."
13327146,Prednisolone treats allergic bronchopulmonary aspergillosis,1118,"Here 2 cases of allergic bronchopulmonary aspergillosis in a family (brother and sister), treated with prednisolone with complete remission are reported.",True,"'Does the phrase ""Prednisolone treats allergic bronchopulmonary aspergillosis"" receive at least indirect support from the statement: ""Here 2 cases of allergic bronchopulmonary aspergillosis in a family (brother and sister), treated with prednisolone with complete remission are reported.""?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats allergic bronchopulmonary aspergillosis"". The case report mentions that two siblings with allergic bronchopulmonary aspergillosis were treated with prednisolone and achieved complete remission. This suggests a positive correlation between prednisolone treatment and resolution of symptoms in allergic bronchopulmonary aspergillosis. However, it is important to note that correlation does not imply causation, so further studies would be needed to definitively conclude that prednisolone is an effective treatment for allergic bronchopulmonary aspergillosis. Additionally, potential side effects, contraindications, and optimal dosage of prednisolone would need to be considered in future investigations."
13311736,Prednisolone treats neoplasm,1119,FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment.,True,"'Does the phrase ""Prednisolone treats neoplasm"" receive at least indirect support from the statement: ""FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment.""?","Yes, indirectly it does support the statement that prednisolone may have some effect on neoplasm (tumors). The statement mentions that FDG-PET was performed in rats bearing BCG granulomas or tumors before and after prednisolone treatment. FDG-PET is a type of imaging that is used in part to observe the metabolic activity of cells, including cancer cells. If there was a change in the FDG-PET results after prednisolone treatment, it could suggest that prednisolone has an effect on these cells, potentially including cancer cells (neoplasm). However, it's important to note that this is an indirect inference and does not provide direct evidence that prednisolone treats neoplasm. Further studies would be needed to confirm this hypothesis."
12767794,Prednisolone treats pneumonia,1120,"After recovering from pneumonia, she was treated initially with prednisolone, 30 mg/day, and remained well until she developed hemoptysis at age 34 years.",True,"'Does the phrase ""Prednisolone treats pneumonia"" receive at least indirect support from the statement: ""After recovering from pneumonia, she was treated initially with prednisolone, 30 mg/day, and remained well until she developed hemoptysis at age 34 years.""?","Yes, while not a direct support, the statement does provide indirect evidence that prednisolone may have contributed to treating pneumonia symptoms effectively in this particular case. Prednisolone is a synthetic glucocorticoid often used in treating inflammatory conditions due to its anti-inflammatory properties. Although it is not typically considered a first-line treatment for pneumonia, it could still play an essential role in managing complications associated with pneumonia or in cases where there is an underlying inflammatory component.

        The statement indicates that after recovering from pneumonia, the patient was treated with prednisolone (30 mg/day) and remained well until developing hemoptysis at 34 years old. This sequence of events could imply that prednisolone helped manage pneumonia symptoms or prevented recurrences effectively in that individual. However, it is crucial to note that correlation does not imply causation; therefore, it would be inappropriate to conclude that prednisolone is solely responsible for treating pneumonia based on this single observation alone.

        It is essential to consider other possible explanations for recovery in conjunction with prednisolone treatment"
12190701,Prednisolone treats castration-resistant prostate carcinoma,1121,Fifteen patients 60 to 80 years old (a mean of 72 years) with hormone-refractory prostate cancer were treated with low dose prednisolone.,True,"'Does the phrase ""Prednisolone treats castration-resistant prostate carcinoma"" receive at least indirect support from the statement: ""Fifteen patients 60 to 80 years old (a mean of 72 years) with hormone-refractory prostate cancer were treated with low dose prednisolone.""?","Yes, while the statement does not explicitly claim that prednisolone treats castration-resistant prostate carcinoma (which is a type of hormone-refractory prostate cancer), it does provide evidence that prednisolone is used in treating hormone-refractory prostate cancer. Castration-resistant prostate carcinoma is a subset of hormone-refractory prostate cancer, meaning that any treatment effective for hormone-refractory prostate cancer could potentially be used for castration-resistant prostate carcinoma. However, it is important to note that the statement does not provide information on the efficacy of prednisolone in treating hormone-refractory prostate cancer, only that it has been used in treatment. Further research would be needed to determine if prednisolone is an effective treatment for castration-resistant prostate carcinoma specifically."
11988157,Prednisolone treats diffuse large B-cell lymphoma,1122,"CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) has been the standard chemotherapy regimen used for diffuse large cell lymphomas for over 30 years.",True,"'Does the phrase ""Prednisolone treats diffuse large B-cell lymphoma"" receive at least indirect support from the statement: ""CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) has been the standard chemotherapy regimen used for diffuse large cell lymphomas for over 30 years.""?","Yes, indirect support can be inferred from the statement provided. The claim that CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) has been the standard chemotherapy regimen used for diffuse large B-cell lymphomas (DLBCL) for over 30 years implies that prednisolone is an effective component of that treatment regimen for DLBCL patients. However, it is essential to note that prednisolone does not act alone in treating DLBCL; it is part of a multi-drug regimen known as CHOP therapy. Therefore, while there is indirect support for prednisolone's efficacy in treating DLBCL as part of CHOP therapy, it would not be accurate to conclude that prednisolone alone treats DLBCL based solely on this information. Further investigation into clinical trial results, mechanistic understanding of prednisolone action in DLBCL treatment, as well as potential side effects and resistance mechanisms would be necessary for a more thorough evaluation of prednisolone’s therapeutic utility in DLBCL treatment."
11889996,Prednisolone treats mucocutaneous lymph node syndrome,1123,"Six patients with Kawasaki disease (KD) were treated with prednisolone (1 to 2 mg/kg/day) for 3 days (from days 10 to 12 after the onset of the illness) after apparently unsuccessful treatment with intravenous immunoglobulin (IVIG, 2 g/kg/dose and additional 1 g/kg/dose).",True,"'Does the phrase ""Prednisolone treats mucocutaneous lymph node syndrome"" receive at least indirect support from the statement: ""Six patients with Kawasaki disease (KD) were treated with prednisolone (1 to 2 mg/kg/day) for 3 days (from days 10 to 12 after the onset of the illness) after apparently unsuccessful treatment with intravenous immunoglobulin (IVIG, 2 g/kg/dose and additional 1 g/kg/dose).""?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats mucocutaneous lymph node syndrome,"" which is another name for Kawasaki disease (KD). The statement describes six patients with KD who were treated with prednisolone after initial treatment with intravenous immunoglobulin (IVIG) was unsuccessful. This suggests that prednisolone was used as a secondary treatment option for KD, implying that it may have some therapeutic effect on the disease. However, it's important to note that this is indirect evidence and does not definitively prove that prednisolone treats KD. A direct causal relationship would require more rigorous clinical trials and experimental evidence."
11813573,Prednisolone treats focal segmental glomerulosclerosis,1124,"RESULTS: Of 136 patients with primary FSGS and nephrotic range proteinuria, 76 (56%) were treated with prednisolone and of this group, 59% were treated with additional immunosuppression.",True,"'Does the phrase ""Prednisolone treats focal segmental glomerulosclerosis"" receive at least indirect support from the statement: ""RESULTS: Of 136 patients with primary FSGS and nephrotic range proteinuria, 76 (56%) were treated with prednisolone and of this group, 59% were treated with additional immunosuppression.""?","Yes, indirect support can be inferred from the statement provided. The excerpt mentions that 56% of patients with primary FSGS (Focal Segmental Glomerulosclerosis) were treated with prednisolone and 59% of those treated experienced additional immunosuppression therapy. This suggests that prednisolone is used as an initial treatment for FSGS patients, which implies that prednisolone may have some therapeutic benefit in treating FSGS. However, it is important to note that direct causality cannot be established based on this statement alone since it does not provide specific information about treatment outcomes (e.g., disease progression or remission rates) in patients treated solely with prednisolone. Comprehensive clinical studies designed specifically to evaluate prednisolone as a treatment for FSGS would be required for more definitive conclusions regarding its efficacy in treating this condition."
11810617,Prednisolone treats congenital adrenal hyperplasia,1125,"METHODS: Growth parameters of twelve children (8 m, 4 f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.",True,"'Does the phrase ""Prednisolone treats congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""METHODS: Growth parameters of twelve children (8 m, 4 f) with congenital adrenal hyperplasia were retrospectively studied while on treatment with prednisolone (PR) earlier and then hydrocortisone (HC) after it became freely available in India.""?","Yes, indirect support can be inferred from the statement provided. The fact that growth parameters of twelve children with congenital adrenal hyperplasia were studied while they were on treatment with prednisolone suggests that prednisolone was being used as a form of treatment for these patients. However, it does not explicitly state that prednisolone treats congenital adrenal hyperplasia. It merely implies that it is being used in the management of the condition, which is not necessarily the same as treating the condition itself. Furthermore, the study also mentions that after prednisolone became freely available in India, these children were treated with hydrocortisone instead. This could imply that prednisolone is not as effective as hydrocortisone in treating congenital adrenal hyperplasia, but again, this is an indirect inference based on limited information. Therefore, while there is some indirect support for the claim that prednisolone treats congenital adrenal hyperplasia based on this statement, it is not direct or definitive evidence."
11808057,Prednisolone treats keratitis,1126,Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.,True,"'Does the phrase ""Prednisolone treats keratitis"" receive at least indirect support from the statement: ""Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis.""?","Yes, the statement ""Ciprofloxacin and prednisolone therapy for experimental Pseudomonas keratitis"" does lend indirect support to the claim that prednisolone treats keratitis (corneal inflammation). The use of prednisolone in combination therapy for experimental Pseudomonas keratitis implies that prednisolone has some efficacy in treating keratitis in that context. However, it should be noted that prednisolone is often used as an anti-inflammatory agent rather than an antibacterial agent for treating keratitis; therefore, its effectiveness is generally observed in combination therapy with antibiotics like ciprofloxacin.

         In summary, while the statement does not directly demonstrate that prednisolone alone treats keratitis, it does provide evidence that prednisolone has been used in therapies for treating keratitis caused by Pseudomonas infections. The nuance here is that prednisolone is often used as an adjunct therapy to antibiotics for treating keratitis rather than as monotherapy due to its anti-inflammatory properties."
11527350,"Prednisolone treats dermatitis, atopic",1127,"Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis.",True,"'Does the phrase ""Prednisolone treats dermatitis, atopic"" receive at least indirect support from the statement: ""Prednicarbate is a non-halogenated, double-ester derivative of prednisolone that has become of interest for the treatment of inflammatory skin diseases, for example atopic dermatitis.""?","Yes, there is indirect support for the claim that prednisolone treats dermatitis, atopic in the provided statement. This support arises from the fact that prednicarbate is derived from prednisolone and is used for treating inflammatory skin diseases such as atopic dermatitis. Prednisolone is a glucocorticoid steroid that is commonly used for its anti-inflammatory properties in treating various skin conditions including atopic dermatitis. Therefore, it is reasonable to infer that since prednicarbate is derived from prednisolone, it shares similar therapeutic properties for treating atopic dermatitis. However, it is important to note that while prednisolone is used topically as well as systemically for treating atopic dermatitis, prednicarbate is primarily used topically due to its lower systemic absorption rate compared to prednisolone."
11526277,Prednisolone treats kidney disorder,1128,"AIM: To evaluate the efficacy of prednisolone, warfarin, and dipyridamole therapy combined with mizoribine (PWDM) in the treatment of diffuse immunoglobulin A (IgA) nephropathy in comparison with prednisolone, warfarin, and dipyridamole therapy without mizoribine (PWD) and with methylprednisolone pulse therapy (PWD pulse).",True,"'Does the phrase ""Prednisolone treats kidney disorder"" receive at least indirect support from the statement: ""AIM: To evaluate the efficacy of prednisolone, warfarin, and dipyridamole therapy combined with mizoribine (PWDM) in the treatment of diffuse immunoglobulin A (IgA) nephropathy in comparison with prednisolone, warfarin, and dipyridamole therapy without mizoribine (PWD) and with methylprednisolone pulse therapy (PWD pulse).""?","Yes, the statement does provide indirect support for the claim that prednisolone treats kidney disorder. The study aims to evaluate the efficacy of prednisolone in treating diffuse immunoglobulin A (IgA) nephropathy, which is a kidney disorder. The fact that a study is being conducted to evaluate its efficacy suggests that there is some basis for believing that prednisolone could have a positive effect on kidney disorder treatment. However, it should be noted that this is an indirect inference, as the statement does not explicitly confirm that prednisolone treats kidney disorder, but rather that it is being studied for its potential efficacy in treating IgA nephropathy, a specific type of kidney disorder."
11497678,Prednisolone treats infertility disorder,1129,"In this double blind cross-over study, 20 infertile men, who had sperm antibodies detected by the mixed antiglobulin reaction (MAR test) in the ejaculate and by the tray agglutination test (TAT) in serum, were treated with 40 mg/day prednisolone or placebo from days 1 to 10 of the partners' menstrual cycle.",True,"'Does the phrase ""Prednisolone treats infertility disorder"" receive at least indirect support from the statement: ""In this double blind cross-over study, 20 infertile men, who had sperm antibodies detected by the mixed antiglobulin reaction (MAR test) in the ejaculate and by the tray agglutination test (TAT) in serum, were treated with 40 mg/day prednisolone or placebo from days 1 to 10 of the partners' menstrual cycle.""?","Yes, while the statement does not explicitly claim that prednisolone treats infertility disorders, it does provide indirect support for such a claim. The study mentioned is investigating the effect of prednisolone on infertile men who have sperm antibodies detected by specific tests (MAR test in ejaculate and TAT in serum). This suggests that prednisolone may have an impact on infertility disorders related to sperm antibodies, which is a step towards treating infertility disorders. However, it is important to note that more extensive studies would be needed to confirm this claim, as this particular study only involves 20 participants in a double-blind cross-over design, which may not be representative of the broader population of infertile men."
11373326,Prednisolone treats prostate cancer,1130,BACKGROUND: We conducted this retrospective study to analyze a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer.,False,"'Does the phrase ""Prednisolone treats prostate cancer"" receive at least indirect support from the statement: ""BACKGROUND: We conducted this retrospective study to analyze a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer.""?","No, the statement does not provide indirect support for the claim that ""Prednisolone treats prostate cancer."" The provided background statement is about a retrospective study analyzing a modified dose schedule of mitoxantrone and prednisolone (MP) in patients with androgen-independent prostate cancer. However, it does not specify that prednisolone has any therapeutic effect on prostate cancer; it only mentions its use in combination with mitoxantrone in a particular dose schedule for patients with androgen-independent prostate cancer.

        To provide indirect support for the claim that ""Prednisolone treats prostate cancer,"" one would need evidence indicating that prednisolone has an impact on prostate cancer independently of other treatments like mitoxantrone. In other words, there should be some demonstration that prednisolone has anticancer properties specific to prostate cancer cells. The background statement given does not provide such evidence; thus, it does not support the claim that prednisolone treats prostate cancer."
11166363,Prednisolone treats canker sore,1131,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"'Does the phrase ""Prednisolone treats canker sore"" receive at least indirect support from the statement: ""It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.""?","Yes, the phrase ""Prednisolone treats canker sore"" does receive indirect support from the statement provided. The statement mentions that prednisolone has been used in combination with other drugs for treating erythema multiforme and aphthous ulcers of the mouth. Aphthous ulcers of the mouth are commonly known as canker sores. Therefore, it can be inferred that prednisolone has been used in treating canker sores, albeit in combination with other drugs. However, it is important to note that this does not directly prove that prednisolone alone is effective in treating canker sores. Further research would be needed to establish this conclusively."
11166362,Prednisolone treats lichen planus,1132,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"'Does the phrase ""Prednisolone treats lichen planus"" receive at least indirect support from the statement: ""It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.""?","Yes, the phrase ""Prednisolone treats lichen planus"" does receive indirect support from the statement provided. The statement mentions that prednisolone is used in combination with other drugs for treating several dermatologic disorders, including lichen planus. This implies that prednisolone has some therapeutic effect on lichen planus, even if it is not used alone in its treatment. However, it is important to note that this is an indirect inference based on a single statement, and further evidence would be needed for a more definitive conclusion."
11166361,Prednisolone treats erythema multiforme,1133,"It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.",True,"'Does the phrase ""Prednisolone treats erythema multiforme"" receive at least indirect support from the statement: ""It has also been used in combination with other drugs for treating a number of dermatologic disorders, e.g. in combination with cimetidine for treating recalcitrant warts, with prednisolone for treating lichen planus, erythema multiforme and aphthous ulcers of the mouth.""?","Yes, the phrase ""Prednisolone treats erythema multiforme"" does receive indirect support from the statement provided. 

        The statement mentions that prednisolone has been used in combination with other drugs for treating a number of dermatologic disorders, including erythema multiforme. This suggests that prednisolone has some therapeutic effect on erythema multiforme, even if it is not used as a standalone treatment. 

        However, it's important to note that the statement does not provide direct evidence of prednisolone's efficacy in treating erythema multiforme in isolation. The treatment could be synergistic with other drugs, meaning that prednisolone may not be effective on its own for treating erythema multiforme. 

        Therefore, while there is some support for the claim, it is indirect and should be interpreted with caution. Further research would be needed to establish whether prednisolone is an effective monotherapy for erythema multiforme."
10782301,Prednisolone treats adrenocortical insufficiency,1134,Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.,True,"'Does the phrase ""Prednisolone treats adrenocortical insufficiency"" receive at least indirect support from the statement: ""Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.""?","Yes, the statement ""Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency"" does provide indirect support for the claim that ""Prednisolone treats adrenocortical insufficiency."" The title of the study suggests that it is investigating the use of Prednisolone in treating adrenal insufficiency, which is another term for adrenocortical insufficiency. Therefore, this study is likely looking at how Prednisolone can be used to manage or treat adrenocortical insufficiency. However, it is important to note that indirect support does not equate to definitive proof. To fully evaluate the validity of the claim, it would be necessary to review the methods, results, and conclusions of the study in detail."
10757066,Prednisolone treats atopic eczema,1135,[Results of prednisolone therapy of eczemas in very young and older infants].,True,"'Does the phrase ""Prednisolone treats atopic eczema"" receive at least indirect support from the statement: ""[Results of prednisolone therapy of eczemas in very young and older infants].""?","Yes, the phrase ""Prednisolone treats atopic eczema"" does receive indirect support from the statement ""[Results of prednisolone therapy of eczemas in very young and older infants]."" This is because the statement suggests that prednisolone has been used in therapy for eczemas in both young and older infants, implying that it may have some effect on treating eczema. However, it is important to note that this is indirect support and does not provide direct evidence of prednisolone's effectiveness in treating atopic eczema. Further research and evidence would be needed to make a definitive conclusion."
10671990,Prednisolone treats Headache,1136,"We report a patient with neuro-Behcet's syndrome presenting with headache and personality change in whom CT and MRI brain imaging was normal, but regional cerebral blood flow imaging using single photon emission tomography with the tracer HMPAO showed extensive perfusion deficits which partially reversed after 3 months of prednisolone therapy.",True,"'Does the phrase ""Prednisolone treats Headache"" receive at least indirect support from the statement: ""We report a patient with neuro-Behcet's syndrome presenting with headache and personality change in whom CT and MRI brain imaging was normal, but regional cerebral blood flow imaging using single photon emission tomography with the tracer HMPAO showed extensive perfusion deficits which partially reversed after 3 months of prednisolone therapy.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats headache. The patient in question was diagnosed with neuro-Behcet's syndrome and was experiencing headaches along with other symptoms. After a treatment period of three months with prednisolone therapy, there was a partial reversal of extensive perfusion deficits in regional cerebral blood flow imaging. Although the statement does not explicitly say that prednisolone treats headaches, it suggests that the drug has had a positive impact on the patient's neurological status, which could reasonably include headache relief given that headaches were part of the patient's initial presentation. However, it is important to note that this is an indirect inference based on one case report; further evidence from controlled clinical trials would be needed to confirm that prednisolone is an effective treatment for headaches associated with neuro-Behcet's syndrome."
10574410,Prednisolone treats synovitis,1137,Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.,True,"'Does the phrase ""Prednisolone treats synovitis"" receive at least indirect support from the statement: ""Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.""?","Yes, the phrase ""Prednisolone treats synovitis"" does receive indirect support from the statement ""Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis."" This is because synovitis is specifically mentioned as one of the conditions treated by Prednisolone in the given statement. 

        However, it is important to note that Prednisolone is mentioned in conjunction with Meticortelone in the original statement. Meticortelone is a different glucocorticoid steroid used in anti-inflammatory therapy, similar to Prednisolone. While it is reasonable to infer that Prednisolone can treat synovitis based on this statement, it would be more accurate to attribute this effect specifically to Prednisolone if it were mentioned alone in a treatment context for synovitis. 

        Additionally, while synovitis is mentioned in relation to radiohumeral synovitis in the original statement, it is possible that Prednisolone may be more effective at treating certain types of synovitis than others due to differences in underlying pathophysiology."
10574409,Prednisolone treats epicondylitis,1138,Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.,True,"'Does the phrase ""Prednisolone treats epicondylitis"" receive at least indirect support from the statement: ""Prednisolone (meticortelone) in treatment of epicondylitis; radiohumeral bursitis and radiohumeral synovitis.""?","Yes, there is indirect support for the claim that prednisolone treats epicondylitis based on the provided statement. The statement mentions prednisolone (meticortelone) in the treatment of epicondylitis, radiohumeral bursitis, and radiohumeral synovitis. This implies that prednisolone could be an effective treatment for epicondylitis, even though it does not explicitly state that prednisolone is used solely for epicondylitis treatment. However, it is important to note that meticortelone is not exactly the same as prednisolone but is instead a prodrug of prednisolone. Therefore, while there is some level of support for prednisolone as an effective treatment for epicondylitis based on this statement, further investigation is necessary for more definitive conclusions."
10565149,Prednisolone treats osteoarthritis,1139,"Intra-articular injections of hydrocortisone prednisolone, and their tertiary-butylacetate derivatives in patients with rheumatoid arthritis and osteoarthritis.",True,"'Does the phrase ""Prednisolone treats osteoarthritis"" receive at least indirect support from the statement: ""Intra-articular injections of hydrocortisone prednisolone, and their tertiary-butylacetate derivatives in patients with rheumatoid arthritis and osteoarthritis.""?","Yes, there is indirect support for the claim that prednisolone treats osteoarthritis based on the provided statement. The statement mentions that intra-articular injections of hydrocortisone prednisolone have been used in patients with rheumatoid arthritis and osteoarthritis. Prednisolone is a glucocorticoid that has anti-inflammatory effects, which is one of its mechanisms of action in treating various conditions including arthritis.

        However, it is important to note that prednisolone is not typically considered as a first-line treatment for osteoarthritis due to its potential side effects when used systemically over long periods of time (e.g., osteoporosis, diabetes mellitus). It is more commonly used in rheumatoid arthritis which is an autoimmune disorder characterized by inflammation in multiple joints. Intra-articular injections of glucocorticoids like prednisolone may be used in osteoarthritis for short-term pain relief in specific cases (e.g., severe pain flare-"
10557390,Prednisolone treats peptic ulcer disease,1140,On the development of peptic ulcers in patients treated with prednisone or prednisolone.,False,"'Does the phrase ""Prednisolone treats peptic ulcer disease"" receive at least indirect support from the statement: ""On the development of peptic ulcers in patients treated with prednisone or prednisolone.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats peptic ulcer disease"". The original statement discusses the development of peptic ulcers in patients treated with prednisone or prednisolone, which implies that these drugs may be associated with an increased risk of developing peptic ulcers, not that they treat the condition. Therefore, based on this information alone, there is no evidence or indirect support suggesting that prednisolone is used as a treatment for peptic ulcer disease.

        To further clarify, prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various medical conditions (1). Prolonged use of glucocorticoids like prednisolone has been associated with an increased risk of developing gastrointestinal side effects such as peptic ulcers (2). Therefore, it is essential to consider alternative sources and additional evidence when making conclusions about therapeutic uses of medications like prednisolone in peptic ulcer disease treatment.

        References:
        
        1. Fardet L, Delarue J, Oberto G, et al. Effect of"
10513879,Prednisolone treats celiac disease,1141,The simultaneous correction of plain-water deficit and extracellular fluid volume loss in non-tropical sprue treated with prednisolone.,False,"'Does the phrase ""Prednisolone treats celiac disease"" receive at least indirect support from the statement: ""The simultaneous correction of plain-water deficit and extracellular fluid volume loss in non-tropical sprue treated with prednisolone.""?","No, the statement does not provide indirect support for the claim that prednisolone treats celiac disease. 

        The statement ""The simultaneous correction of plain-water deficit and extracellular fluid volume loss in non-tropical sprue treated with prednisolone"" refers specifically to the management of symptoms associated with non-tropical sprue (a historical term often used interchangeably with celiac disease) such as dehydration and fluid loss. It does not imply that prednisolone is treating or curing the underlying disease itself but rather alleviates some of its secondary symptoms. Prednisolone is a corticosteroid often used in treating inflammatory conditions; its use in celiac disease is typically aimed at managing severe symptoms of refractory celiac disease rather than as a primary treatment for celiac disease itself."
10509017,Prednisolone treats hepatocellular carcinoma,1142,"One had received four weekly cycles of prednisolone, Adriamycin, vincristine and 5-fluorouracil for an inoperable HCC with a 10-cm diameter, and the other had received localised synchronised hepatic irradiation and Adriamycin.",False,"'Does the phrase ""Prednisolone treats hepatocellular carcinoma"" receive at least indirect support from the statement: ""One had received four weekly cycles of prednisolone, Adriamycin, vincristine and 5-fluorouracil for an inoperable HCC with a 10-cm diameter, and the other had received localised synchronised hepatic irradiation and Adriamycin.""?","No, the statement does not provide indirect support for the claim that prednisolone treats hepatocellular carcinoma (HCC). The statement only mentions that one patient had received prednisolone as part of a treatment regimen for an inoperable HCC, but it does not provide any information about the outcome of that treatment specifically related to prednisolone. Therefore, it is not possible to infer any causal relationship between prednisolone and treatment of HCC from this statement alone."
10502737,Prednisolone treats hemolytic anemia,1143,"[A case of hemolytic anemia with generalized agglutination, treated with ACTH, cortisone, and prednisolone].",True,"'Does the phrase ""Prednisolone treats hemolytic anemia"" receive at least indirect support from the statement: ""[A case of hemolytic anemia with generalized agglutination, treated with ACTH, cortisone, and prednisolone].""?","Yes, indirect support can be inferred from the statement provided. The case description mentions that prednisolone was one of the treatments administered for hemolytic anemia alongside ACTH and cortisone. However, it does not explicitly state that prednisolone was responsible for treating the hemolytic anemia. Therefore, while not definitive proof, it does provide some level of indirect support for the claim that prednisolone can be used to treat hemolytic anemia based on clinical practice in this particular case. It is important to note that further investigation and evidence would be required for more conclusive backing of such a claim in broader clinical contexts."
10335998,Prednisolone treats pemphigus,1144,"OBJECTIVES: The present study describes our experience of the addition of mycophenolate mofetil (MMF) to prednisolone in the management of severe, refractory pemphigus.",True,"'Does the phrase ""Prednisolone treats pemphigus"" receive at least indirect support from the statement: ""OBJECTIVES: The present study describes our experience of the addition of mycophenolate mofetil (MMF) to prednisolone in the management of severe, refractory pemphigus.""?","Yes, indirectly it does lend support. The statement indicates that prednisolone is used in combination with mycophenolate mofetil (MMF) for managing severe, refractory pemphigus. This implies that prednisolone is being utilized as part of the treatment regimen for pemphigus patients in this study. However, it does not provide direct evidence that prednisolone alone treats pemphigus effectively; it only suggests its use as part of a larger treatment plan when combined with MMF."
10020250,Prednisolone treats Hodgkins lymphoma,1145,"Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone.",True,"'Does the phrase ""Prednisolone treats Hodgkins lymphoma"" receive at least indirect support from the statement: ""Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone.""?","Yes, there is indirect support for the statement that ""Prednisolone treats Hodgkin's lymphoma"" in the provided context. The statement ""Under the diagnosis of Hodgkin's disease, she was treated with combination chemotherapy containing pirarubicin, cyclophosphamide, vincristine, and prednisolone"" indicates that prednisolone was one of the drugs used in the treatment regimen for a patient diagnosed with Hodgkin's disease (also known as Hodgkin lymphoma).

         The use of prednisolone in this context suggests that it has therapeutic value in treating Hodgkin lymphoma, even if it is not used as a single-agent treatment. Prednisolone is often used in combination chemotherapy regimens due to its immunosuppressive properties and its ability to enhance the cytotoxicity of certain chemotherapeutic agents. Therefore, while prednisolone may not be solely responsible for treating Hodgkin lymphoma in all cases, its inclusion in a treatment regimen for Hodgkin lymphoma provides indirect evidence for its potential ther"
9848677,Prednisolone treats Inflammation,1146,"Patients who remain high transporters with inflammatory reaction might require pharmacologic intervention, including prednisolone therapy.",True,"'Does the phrase ""Prednisolone treats Inflammation"" receive at least indirect support from the statement: ""Patients who remain high transporters with inflammatory reaction might require pharmacologic intervention, including prednisolone therapy.""?","Yes, the phrase ""Prednisolone treats Inflammation"" does receive indirect support from the statement provided. The statement suggests that prednisolone therapy may be necessary for patients who have an inflammatory reaction and remain high transporters. This implies that prednisolone has an anti-inflammatory effect, which aligns with the phrase ""Prednisolone treats Inflammation"". However, it's important to note that this is an indirect inference based on the statement's mention of prednisolone as a potential treatment for inflammatory conditions. For a more direct support, a statement explicitly stating that prednisolone treats inflammation would be needed."
9729887,Prednisolone treats glomerulonephritis,1147,"[Comparative characteristics of the spectrum of free amino acids of blood serum and urine in children with glomerulonephritis treated with prednisolone, leukeran and anabolic steroids].",True,"'Does the phrase ""Prednisolone treats glomerulonephritis"" receive at least indirect support from the statement: ""[Comparative characteristics of the spectrum of free amino acids of blood serum and urine in children with glomerulonephritis treated with prednisolone, leukeran and anabolic steroids].""?","Yes, the statement does provide indirect support for the claim that Prednisolone treats glomerulonephritis. The title of the paper suggests a comparative study of free amino acids in blood serum and urine of children with glomerulonephritis who were treated with Prednisolone, among other drugs. The fact that Prednisolone is included in such a study implies that it has been considered as a potential treatment for glomerulonephritis. However, it's important to note that indirect support does not equate to definitive proof. The paper would need to be reviewed in its entirety to fully understand the context of Prednisolone's use and its efficacy in treating glomerulonephritis. Additionally, further research including randomized controlled trials would be necessary to make a definitive conclusion about Prednisolone's effectiveness in treating glomerulonephritis."
9717382,Prednisolone treats hemangioma,1148,"Management of hemangioma included observation, prednisolone, flashlamp-pumped pulsed-dye laser, topical therapy and excision in 68 per cent, 8.6 per cent, 10.7 per cent, 9.6 per cent, and 2.5 per cent, respectively.",True,"'Does the phrase ""Prednisolone treats hemangioma"" receive at least indirect support from the statement: ""Management of hemangioma included observation, prednisolone, flashlamp-pumped pulsed-dye laser, topical therapy and excision in 68 per cent, 8.6 per cent, 10.7 per cent, 9.6 per cent, and 2.5 per cent, respectively.""?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats hemangioma"". The text mentions that prednisolone was used in the management of hemangioma in 8.6% of cases, which implies that prednisolone was employed as a treatment for hemangioma. However, it is important to note that correlation does not necessarily imply causation - just because prednisolone was used in some hemangioma cases does not automatically mean it is an effective treatment for hemangioma. Further evidence would be needed to confirm its efficacy as a treatment option for hemangioma."
9668241,Prednisolone treats pure red-cell aplasia,1149,The PRCA and AIHA were successfully treated with prednisolone.,True,"'Does the phrase ""Prednisolone treats pure red-cell aplasia"" receive at least indirect support from the statement: ""The PRCA and AIHA were successfully treated with prednisolone.""?","Yes, the statement ""The PRCA and AIHA were successfully treated with prednisolone"" does provide indirect support for the phrase ""Prednisolone treats pure red-cell aplasia"" (PRCA). 

         The reason is that PRCA is mentioned in the statement as one of the conditions that were successfully treated with prednisolone. However, it is essential to note that PRCA is not explicitly stated as being treated alone; instead, it is part of a conjunction that also includes AIHA (autoimmune hemolytic anemia). This shared treatment course suggests that prednisolone may be an effective treatment for PRCA, but it does not definitively prove it because other factors could influence the treatment outcome. 

         Additionally, while prednisolone has been used in treating PRCA in some cases, it is not universally effective for all patients due to variations in disease presentation, comorbidities, and individual responses to treatment. Therefore, further investigation into prednisolone's specific effects on PRCA would be necessary for more conclusive evidence of its efficacy in treating that condition alone."
9538921,Prednisolone treats Graves disease,1150,"She was diagnosed as having Graves' disease and was treated with propylthiouracil, and prednisolone was given for neck pain.",True,"'Does the phrase ""Prednisolone treats Graves disease"" receive at least indirect support from the statement: ""She was diagnosed as having Graves' disease and was treated with propylthiouracil, and prednisolone was given for neck pain.""?","Yes, there is indirect support for the phrase ""Prednisolone treats Graves disease"" from the statement provided. The individual was diagnosed with Graves disease and treated with propylthiouracil, which is a common antithyroid medication used to manage hyperthyroidism associated with Graves disease. Additionally, prednisolone was given for neck pain. Prednisolone is a glucocorticoid that possesses anti-inflammatory properties and is sometimes prescribed for managing symptoms related to Graves disease, such as eye inflammation (Graves ophthalmopathy). Therefore, although prednisolone was given for neck pain in this case, it does indirectly support the use of prednisolone in treating Graves disease due to its potential therapeutic benefits for certain symptoms of the disease."
9135976,Prednisolone treats sarcoidosis,1151,"Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis.",True,"'Does the phrase ""Prednisolone treats sarcoidosis"" receive at least indirect support from the statement: ""Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis.""?","Yes, the phrase ""Prednisolone treats sarcoidosis"" does receive indirect support from the statement ""Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis."" 

         The statement suggests that prednisolone has been used in the treatment of sarcoidosis in 106 patients, which implies that prednisolone is considered as a treatment option for sarcoidosis. However, it does not provide direct evidence of the efficacy of prednisolone in treating sarcoidosis. To make a definitive conclusion about the effectiveness of prednisolone in treating sarcoidosis, one would need to examine clinical trial results or meta-analyses that report on the efficacy of prednisolone compared to other treatments or placebos. 

         In general, sarcoidosis is a multisystem granulomatous disorder of unknown etiology that can affect virtually any organ system. Corticosteroids such as prednisolone remain the mainstay of therapy for sarcoidosis, although their use is not without risks and side effects. The decision"
9109448,Prednisolone treats psoriatic arthritis,1152,Methotrexate and prednisolone treatment of a child with psoriatic arthritis.,True,"'Does the phrase ""Prednisolone treats psoriatic arthritis"" receive at least indirect support from the statement: ""Methotrexate and prednisolone treatment of a child with psoriatic arthritis.""?","Yes, indirectly it does lend some support to the claim that prednisolone treats psoriatic arthritis. The statement ""Methotrexate and prednisolone treatment of a child with psoriatic arthritis"" implies that both methotrexate and prednisolone were used in the treatment regimen for a patient with psoriatic arthritis. This suggests that prednisolone was considered effective enough for use in treating psoriatic arthritis in this particular case. However, it's important to note that this is not direct evidence of prednisolone's efficacy in treating psoriatic arthritis as it could be confounded by other factors such as the use of methotrexate, patient characteristics, disease severity, etc. Ideally, randomized controlled trials would provide stronger evidence for such a claim."
9077262,Prednisolone treats lymphoma,1153,"This paper presents the results of a prospective study to investigate the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count and average numbers of argyrophilic nucleolar organiser region counts in dogs with multicentric lymphosarcoma treated with a standard chemotherapy protocol comprising vincristine, cyclophosphamide and prednisolone.",True,"'Does the phrase ""Prednisolone treats lymphoma"" receive at least indirect support from the statement: ""This paper presents the results of a prospective study to investigate the prognostic value of clinical staging, histological grading, immunophenotype, mitotic count and average numbers of argyrophilic nucleolar organiser region counts in dogs with multicentric lymphosarcoma treated with a standard chemotherapy protocol comprising vincristine, cyclophosphamide and prednisolone.""?","Yes, while not explicitly stated in the provided text, there is indirect support for the claim that prednisolone treats lymphoma. The statement indicates that dogs with multicentric lymphosarcoma were treated with a standard chemotherapy protocol that includes prednisolone as one of its components. Therefore, it can be inferred that prednisolone is used in treating lymphoma in dogs as part of a broader chemotherapy regimen according to the study presented in this paper. However, it is important to note that prednisolone alone may not be sufficient in treating lymphoma; it is used in combination with other chemotherapy drugs in this specific protocol."
9061500,Prednisolone treats dermatomyositis,1154,"The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM.",True,"'Does the phrase ""Prednisolone treats dermatomyositis"" receive at least indirect support from the statement: ""The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM.""?","Yes, the statement ""The administration of prednisolone (60 mg/day) was initiated, which resulted in improvement of DM"" does lend indirect support to the phrase ""Prednisolone treats dermatomyositis."" Dermatomyositis (DM) is a type of inflammatory myopathy that can be treated with corticosteroids like prednisolone. The improvement of DM symptoms upon prednisolone administration suggests that prednisolone has therapeutic effects on dermatomyositis, providing indirect evidence for its efficacy in treating the condition. However, it is important to note that correlation does not necessarily imply causation, so further investigation would be needed for stronger evidence of prednisolone's direct effects on dermatomyositis."
9046445,Prednisolone treats systemic sclerosis,1155,"METHODS: Resting radionuclide ventriculography with 99mTc was performed before and 20 days after the administration of prednisolone, 20 mg daily, in 32 patients with SSc without clinically evident myocardial dysfunction at rest; 13 and 19 patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), respectively, were studied in parallel as controls.",True,"'Does the phrase ""Prednisolone treats systemic sclerosis"" receive at least indirect support from the statement: ""METHODS: Resting radionuclide ventriculography with 99mTc was performed before and 20 days after the administration of prednisolone, 20 mg daily, in 32 patients with SSc without clinically evident myocardial dysfunction at rest; 13 and 19 patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), respectively, were studied in parallel as controls.""?","Yes, indirect support can be inferred from this statement for the phrase ""Prednisolone treats systemic sclerosis (SSc)"". The study design involves administering prednisolone to patients with SSc for 20 days while monitoring their resting radionuclide ventriculography using 99mTc before and after treatment. This suggests an intentional investigation of the effects of prednisolone on SSc patients. However, it is important to note that direct causality cannot be concluded based solely on this information since the study design does not include a control group without prednisolone treatment for comparison. Additionally, while changes in resting radionuclide ventriculography may indicate improvements in cardiac function associated with prednisolone treatment in SSc patients, it does not necessarily equate to treating systemic sclerosis as a whole. Further information regarding clinical outcomes would be needed for more definitive support of prednisolone treating systemic sclerosis."
9013774,Prednisolone treats ocular pemphigoid,1156,METHODS: Three patients with CP were treated with mycophenolate mofetil and prednisolone.,True,"'Does the phrase ""Prednisolone treats ocular pemphigoid"" receive at least indirect support from the statement: ""METHODS: Three patients with CP were treated with mycophenolate mofetil and prednisolone.""?","Yes, indirectly it does support the claim that prednisolone treats ocular pemphigoid. The statement provided indicates that three patients diagnosed with ocular pemphigoid (CP stands for cicatricial pemphigoid, which is a type of ocular pemphigoid) were treated using mycophenolate mofetil and prednisolone together. This suggests that prednisolone is being used as part of an ocular pemphigoid treatment regimen, providing indirect evidence for its use in managing this condition.

         However, it is important to note that this statement does not offer direct evidence that prednisolone alone treats ocular pemphigoid since it is being used in combination therapy with mycophenolate mofetil in these particular cases. Additionally, it should be emphasized that evidence from clinical trials is necessary for making definitive conclusions about treatment efficacy for medical conditions like ocular pemphigoid."
8939337,Prednisolone treats membranous glomerulonephritis,1157,He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone.,True,"'Does the phrase ""Prednisolone treats membranous glomerulonephritis"" receive at least indirect support from the statement: ""He was diagnosed as having membranous nephropathy by renal biopsy and was treated with prednisolone.""?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats membranous glomerulonephritis."" Membranous glomerulonephritis is another term for membranous nephropathy, which is the condition the individual was diagnosed with in the statement. The fact that this individual was treated with prednisolone suggests that prednisolone may be an effective treatment for membranous glomerulonephritis/nephropathy. However, it is important to note that correlation does not imply causation; while prednisolone may have contributed to improving the patient's condition, it does not necessarily mean that prednisolone was solely responsible for treating the membranous glomerulonephritis/nephropathy. Further studies would be required to establish a direct cause-and-effect relationship between prednisolone treatment and recovery from membranous glomerulonephritis/nephropathy."
8906209,Prednisolone treats allergic disease,1158,"Clinically, both prednisolone and prednisolone sodium succinate are widely used as immunosuppressive agents for the treatment of various allergic disorders.",True,"'Does the phrase ""Prednisolone treats allergic disease"" receive at least indirect support from the statement: ""Clinically, both prednisolone and prednisolone sodium succinate are widely used as immunosuppressive agents for the treatment of various allergic disorders.""?","Yes, the statement ""Clinically, both prednisolone and prednisolone sodium succinate are widely used as immunosuppressive agents for the treatment of various allergic disorders"" does provide indirect support for the claim ""Prednisolone treats allergic disease"". 

        Prednisolone is an immunosuppressive agent, which means it suppresses or reduces the activity of the immune system. In the context of allergic disorders, an overactive immune response is responsible for the symptoms experienced by patients. By suppressing this overactive immune response, prednisolone can help alleviate these symptoms. 

        However, it is important to note that while the statement provides indirect support for the claim, it does not constitute direct evidence. Direct evidence would involve clinical trials or studies demonstrating the efficacy of prednisolone in treating specific allergic disorders. The statement only confirms that prednisolone is used in clinical practice for treating allergic disorders, but it does not provide information about its effectiveness."
8865745,Prednisolone treats subacute thyroiditis,1159,CONCLUSIONS: The recurrence rate of SAT with treated PSL is about 20%.,True,"'Does the phrase ""Prednisolone treats subacute thyroiditis"" receive at least indirect support from the statement: ""CONCLUSIONS: The recurrence rate of SAT with treated PSL is about 20%.""?","Yes, indirectly it does lend some support. The statement ""The recurrence rate of SAT (Subacute Thyroiditis) with treated PSL (Prednisolone) is about 20%"" suggests that Prednisolone has some therapeutic effect on Subacute Thyroiditis as evidenced by the reduced recurrence rate. However, it doesn't explicitly state that Prednisolone treats Subacute Thyroiditis, but rather implies that it can help manage symptoms and potentially prevent recurrences when used as a treatment. It is important to note that while this statement suggests a beneficial effect of Prednisolone on Subacute Thyroiditis, further investigation would be required to fully understand its mechanisms of action, efficacy, dosage, potential side effects, and contraindications in treating Subacute Thyroiditis."
8819323,Prednisolone treats meningeal tuberculosis,1160,"In this case, prednisolone was indispensable for treating tuberculous meningitis in combination with appropriate antituberculosis drugs, though the role of corticosteroids has remained controversial over the years.",True,"'Does the phrase ""Prednisolone treats meningeal tuberculosis"" receive at least indirect support from the statement: ""In this case, prednisolone was indispensable for treating tuberculous meningitis in combination with appropriate antituberculosis drugs, though the role of corticosteroids has remained controversial over the years.""?","Yes, the phrase ""Prednisolone treats meningeal tuberculosis"" does receive indirect support from the statement provided. The statement indicates that prednisolone was used in combination with appropriate antituberculosis drugs to treat tuberculous meningitis (a form of meningeal tuberculosis). The term ""indispensable"" suggests that prednisolone played a crucial role in the treatment process. However, it is important to note that the statement also mentions that the role of corticosteroids like prednisolone in treating tuberculous meningitis has been controversial over the years. This implies that while there is evidence supporting their use, more research is needed to fully understand their mechanism of action and optimal use in treatment regimens."
8755027,Prednisolone treats hypereosinophilic syndrome,1161,"Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities.",True,"'Does the phrase ""Prednisolone treats hypereosinophilic syndrome"" receive at least indirect support from the statement: ""Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities.""?","Yes, the statement ""Prednisolone (PSL) was administered, which improved the anemia, eosinophilia and the cavities"" does lend indirect support to the claim that Prednisolone treats hypereosinophilic syndrome (HES). This is because eosinophilia is one of the key diagnostic features of HES, characterized by an abnormal increase in eosinophil count in peripheral blood and/or bone marrow.

         Prednisolone is a corticosteroid that has been used in managing HES due to its ability to suppress eosinophil production in the bone marrow. By stating that eosinophilia improved following Prednisolone administration in addition to anemia and cavities, it implies that Prednisolone had an impact on HES-related symptoms and thus supports its potential therapeutic value in treating HES.

         However, it is essential to acknowledge that indirect support does not equate to definitive proof of efficacy for HES treatment. More rigorous clinical trials would be required to establish Prednisolone as an evidence-based treatment for HES."
8752241,Prednisolone treats West syndrome,1162,"BACKGROUND: The use of adrenocorticotrophic hormone (ACTH) and prednisolone in the management of infantile spasms has been well established, but is associated with significant morbidity and cannot be used as long-term medication.",True,"'Does the phrase ""Prednisolone treats West syndrome"" receive at least indirect support from the statement: ""BACKGROUND: The use of adrenocorticotrophic hormone (ACTH) and prednisolone in the management of infantile spasms has been well established, but is associated with significant morbidity and cannot be used as long-term medication.""?","Yes, indirectly it does support that prednisolone treats West syndrome (infantile spasms). The statement mentions both ACTH and prednisolone being used in managing infantile spasms (West syndrome), which implies their effectiveness in treating the condition. However, it also highlights significant morbidity associated with their use, suggesting potential side effects that may prevent their long-term usage.

        To further validate this claim, it would be necessary to review additional literature that specifically investigates prednisolone as a treatment for West syndrome, focusing on its efficacy, safety profile, and comparison to other available treatments. In conclusion, while there is some level of support for prednisolone being used as a treatment for West syndrome based on the provided statement, further investigation is warranted for more definitive conclusions."
8647269,Prednisolone treats pulmonary tuberculosis,1163,"However, he died because of lung tuberculosis and acute tuberculous pericarditis during treatment with prednisolone.",False,"'Does the phrase ""Prednisolone treats pulmonary tuberculosis"" receive at least indirect support from the statement: ""However, he died because of lung tuberculosis and acute tuberculous pericarditis during treatment with prednisolone.""?","No, the phrase ""Prednisolone treats pulmonary tuberculosis"" does not receive indirect support from the statement provided. In fact, the statement suggests that prednisolone may not be effective in treating pulmonary tuberculosis since the patient still died from it despite being on prednisolone treatment. 

        Prednisolone is a corticosteroid often used to suppress inflammation in various conditions such as asthma, allergies, and autoimmune diseases. It is not typically used as a primary treatment for pulmonary tuberculosis, which is caused by Mycobacterium tuberculosis infection. Instead, antibiotics like isoniazid, rifampin, ethambutol, and pyrazinamide are commonly used for treating tuberculosis [1].

        The statement indicates that the patient suffered from acute tuberculous pericarditis during prednisolone treatment. Tuberculous pericarditis is an uncommon extrapulmonary manifestation of tuberculosis that can occur due to the hematogenous spread of Mycobacterium tuberculosis [2]. The development"
8583398,Prednisolone treats leprosy,1164,"In untreated reactional leprosy patients, the levels of urinary NO metabolites (1645 +/- 454 microM, n = 9, ENL = 4, RR = 5) decreased significantly 2 weeks after high dose prednisolone treatment (1075 +/- 414 microM, P < 0.05), and remained stable 4 (895 +/- 385 microM, P < 0.02) and 6 weeks following treatment initiation (1048 +/- 452 microM, P < 0.02).",True,"'Does the phrase ""Prednisolone treats leprosy"" receive at least indirect support from the statement: ""In untreated reactional leprosy patients, the levels of urinary NO metabolites (1645 +/- 454 microM, n = 9, ENL = 4, RR = 5) decreased significantly 2 weeks after high dose prednisolone treatment (1075 +/- 414 microM, P < 0.05), and remained stable 4 (895 +/- 385 microM, P < 0.02) and 6 weeks following treatment initiation (1048 +/- 452 microM, P < 0.02).""?","Yes, the statement does provide indirect support for the claim that prednisolone treats leprosy. The study measures urinary nitric oxide (NO) metabolites in reactional leprosy patients before and after prednisolone treatment. The significant decrease in NO metabolites after treatment suggests that prednisolone has an effect on the immune response associated with leprosy reactions. This is relevant because leprosy reactions can cause severe damage to nerves and other tissues if not properly managed. By reducing these reactions, prednisolone could help alleviate symptoms and prevent complications in leprosy patients. However, it is important to note that while prednisolone may help manage leprosy reactions, it does not cure leprosy itself, which is caused by the Mycobacterium leprae bacterium. Therefore, while there is indirect support for prednisolone as a treatment for leprosy-related symptoms, it does not necessarily mean that prednisolone treats leprosy in its entirety."
8573433,Prednisolone treats alcoholic hepatitis,1165,"Prednisolone improves survival in patients with alcoholic hepatitis who have either spontaneous hepatic encephalopathy or a high ""discriminant function.",True,"'Does the phrase ""Prednisolone treats alcoholic hepatitis"" receive at least indirect support from the statement: ""Prednisolone improves survival in patients with alcoholic hepatitis who have either spontaneous hepatic encephalopathy or a high ""discriminant function.""?","Yes, the statement does provide indirect support for the claim that Prednisolone treats alcoholic hepatitis. The provided statement indicates that Prednisolone improves survival in patients with alcoholic hepatitis who have either spontaneous hepatic encephalopathy or a high ""discriminant function."" This suggests that Prednisolone has a positive effect on the condition of alcoholic hepatitis, thus providing support for the claim that it treats the disease. However, it is important to note that the statement does not directly mention that Prednisolone treats alcoholic hepatitis, but rather implies it through its effects on survival in specific patient populations. Therefore, while there is indirect support for the claim, it is not a direct confirmation."
8540122,Prednisolone treats autoimmune hemolytic anemia,1166,She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA).,True,"'Does the phrase ""Prednisolone treats autoimmune hemolytic anemia"" receive at least indirect support from the statement: ""She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA).""?","Yes, the statement ""She had received prednisolone (PSL) therapy for autoimmune hemolytic anemia (AIHA)"" does provide indirect support for the phrase ""Prednisolone treats autoimmune hemolytic anemia."" This is because it indicates that prednisolone was used as a treatment for autoimmune hemolytic anemia in a specific case, implying that prednisolone has some therapeutic effect on this condition. However, it should be noted that this does not constitute direct evidence of treatment efficacy, as it does not include information about the patient's response to treatment or any comparative analysis with other treatments or no treatment at all. Therefore, while it suggests that prednisolone may be useful in treating AIHA, it does not definitively prove that prednisolone treats AIHA."
8499057,Prednisolone treats lupus nephritis,1167,"CONCLUSIONS: For the treatment of diffuse proliferative lupus nephritis, the combination of mycophenolate mofetil and prednisolone is as effective as a regimen of cyclophosphamide and prednisolone followed by azathioprine and prednisolone but is less toxic.",True,"'Does the phrase ""Prednisolone treats lupus nephritis"" receive at least indirect support from the statement: ""CONCLUSIONS: For the treatment of diffuse proliferative lupus nephritis, the combination of mycophenolate mofetil and prednisolone is as effective as a regimen of cyclophosphamide and prednisolone followed by azathioprine and prednisolone but is less toxic.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats lupus nephritis. The conclusion of the study indicates that prednisolone, when used in combination with mycophenolate mofetil, is effective in treating diffuse proliferative lupus nephritis. This implies that prednisolone has therapeutic benefits in treating lupus nephritis, thus supporting the claim. However, it should be noted that prednisolone is not acting alone in this context, but rather in conjunction with other treatments. Therefore, while the statement does provide indirect support for the claim, it does not conclusively prove that prednisolone alone treats lupus nephritis."
8455402,Prednisolone treats chronic obstructive pulmonary disease,1168,Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.,True,"'Does the phrase ""Prednisolone treats chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.""?","Yes, indirectly it does lend some support. The statement suggests that prednisolone, when used in combination with beclomethasone dipropionate, has additive effects in patients with stable chronic obstructive pulmonary disease (COPD). This implies that prednisolone is active in COPD patients, which aligns with the phrase ""Prednisolone treats chronic obstructive pulmonary disease."" However, it's important to note that the original statement does not explicitly state that prednisolone treats COPD on its own, hence the indirect support. Also, the term ""treats"" can be interpreted in different ways, such as improving symptoms, slowing progression, or curing the disease, which may not all be applicable here based on the information provided."
8268574,Prednisolone treats thrombocytopenia,1169,Three out of 8 patients with thrombocytopenia were treated with prednisolone according to the protocol for idiopathic thrombocytopenic purpura.,True,"'Does the phrase ""Prednisolone treats thrombocytopenia"" receive at least indirect support from the statement: ""Three out of 8 patients with thrombocytopenia were treated with prednisolone according to the protocol for idiopathic thrombocytopenic purpura.""?","Yes, the statement does provide indirect support for the phrase ""Prednisolone treats thrombocytopenia."" The fact that three out of eight patients with thrombocytopenia were treated with prednisolone according to a specific protocol for idiopathic thrombocytopenic purpura suggests that prednisolone is being used as a treatment for thrombocytopenia in this context. However, it is important to note that correlation does not imply causation; simply because prednisolone was administered to these patients does not necessarily mean it was responsible for any improvement in their condition. To establish more direct support for the claim that prednisolone treats thrombocytopenia, further evidence such as controlled clinical trials demonstrating the efficacy of prednisolone in treating thrombocytopenia would be needed."
7990669,Prednisolone treats non-Hodgkin lymphoma,1170,"A regimen which incorporates cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) is the standard treatment for patients with non-Hodgkin's lymphoma (NHL), but it has not been effective in patients with aggressive NHL who are at high risk.",True,"'Does the phrase ""Prednisolone treats non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""A regimen which incorporates cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) is the standard treatment for patients with non-Hodgkin's lymphoma (NHL), but it has not been effective in patients with aggressive NHL who are at high risk.""?","Yes, indirect support can be inferred from this statement. The claim specifically mentions prednisolone as part of a standard treatment regimen for non-Hodgkin lymphoma (NHL). Although it is noted that this regimen may not be effective in patients with aggressive NHL who are at high risk, it does not negate the fact that prednisolone is used in treating NHL. Therefore, while prednisolone may not be sufficient on its own or in all cases of NHL treatment, it does form part of an effective treatment regimen for some patients with NHL. However, it is important to note that prednisolone is typically used in combination therapy for NHL treatment, as is indicated in the provided statement."
7986379,Prednisolone treats Crohn disease,1171,"In a stepwise regression that included age, sex, disease duration and cumulative prednisolone dose as independent variables, the femur T score was significantly inversely related to disease duration (r2 = 0.125, F = 6.06) in CD patients.",False,"'Does the phrase ""Prednisolone treats Crohn disease"" receive at least indirect support from the statement: ""In a stepwise regression that included age, sex, disease duration and cumulative prednisolone dose as independent variables, the femur T score was significantly inversely related to disease duration (r2 = 0.125, F = 6.06) in CD patients.""?","No, the statement does not provide direct or indirect support for the claim that Prednisolone treats Crohn disease (CD). The study mentioned in the statement investigates the relationship between various factors including age, sex, disease duration, cumulative prednisolone dose, and femur T score in CD patients. Although it shows an inverse relationship between disease duration and femur T score in CD patients, it does not demonstrate that Prednisolone is responsible for treating Crohn disease.

        The study only establishes an association between cumulative prednisolone dose and femur T score in CD patients but does not prove causation nor does it provide evidence that prednisolone is an effective treatment for Crohn disease specifically. To establish that Prednisolone treats Crohn disease, there should be direct evidence demonstrating its efficacy in treating or alleviating CD symptoms in well-designed clinical trials.

        In summary, while prednisolone may have some impact on bone health in CD patients as suggested by the study, it does not necessarily mean that it can be used as a treatment for Crohn disease itself. Further investigation is required to determine if Prednisolone has any therapeutic"
7985554,Prednisolone treats acute lymphoblastic leukemia,1172,"A regime of treatment of acute non-lymphoblastic leukemia in adult, employing DMCP protocol, especially two step method consisting of daunorubicin, cytosine arabinoside, 6-mercaptopurine and prednisolone is described.",False,"'Does the phrase ""Prednisolone treats acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""A regime of treatment of acute non-lymphoblastic leukemia in adult, employing DMCP protocol, especially two step method consisting of daunorubicin, cytosine arabinoside, 6-mercaptopurine and prednisolone is described.""?","No, the statement does not provide direct or indirect support for the claim that Prednisolone treats acute lymphoblastic leukemia. The statement describes a treatment regimen for acute non-lymphoblastic leukemia in adults using the DMCP protocol, which includes Prednisolone as part of its two-step method. However, it specifically mentions acute non-lymphoblastic leukemia, not acute lymphoblastic leukemia. These two types of leukemia are distinct diseases that may require different treatment approaches. Therefore, it is not valid to infer that Prednisolone is an effective treatment for acute lymphoblastic leukemia based on this statement alone."
7941298,Prednisolone treats granulomatosis with polyangiitis,1173,"Two patients with Wegener's granulomatosis have been treated with chlorambucil and prednisolone continuosly for 3 and 5 years, respectively.",True,"'Does the phrase ""Prednisolone treats granulomatosis with polyangiitis"" receive at least indirect support from the statement: ""Two patients with Wegener's granulomatosis have been treated with chlorambucil and prednisolone continuosly for 3 and 5 years, respectively.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats granulomatosis with polyangiitis (GPA), also known as Wegener's granulomatosis. The statement indicates that two patients diagnosed with Wegener's granulomatosis were treated with prednisolone continuously for 3 and 5 years respectively, which implies that prednisolone was an effective treatment for these patients during that period.

         However, it is important to note that correlation does not imply causation; therefore, while prednisolone may be associated with improved health outcomes in these patients, it does not necessarily mean that prednisolone was solely responsible for treating their GPA. It is possible that other factors, such as chlorambucil (also mentioned in the statement), could have contributed to their improved health outcomes.

         Moreover, since granulomatosis with polyangiitis is a complex disease that can manifest differently in different individuals, it is possible that prednisolone may not be an effective treatment for all patients diagnosed with GPA. Further studies involving larger sample sizes would be needed to establish more definitive evidence for the effectiveness of prednisolone"
7927983,Prednisolone treats nephrotic syndrome,1174,"The second patient, a 73-year-old man receiving prednisolone therapy for nephrotic syndrome, developed right leg cellulitis that evolved to NF.",False,"'Does the phrase ""Prednisolone treats nephrotic syndrome"" receive at least indirect support from the statement: ""The second patient, a 73-year-old man receiving prednisolone therapy for nephrotic syndrome, developed right leg cellulitis that evolved to NF.""?","No, the statement does not provide direct or indirect support for the claim that prednisolone treats nephrotic syndrome. In fact, it suggests that prednisolone may be associated with an adverse effect (cellulitis) in a patient receiving treatment for nephrotic syndrome. This observation does not necessarily imply that prednisolone is ineffective at treating nephrotic syndrome; however, it does not offer any evidence supporting its therapeutic effect in this context either. Therefore, further investigation is required before drawing any conclusions about prednisolone's effectiveness in treating nephrotic syndrome based on this statement alone."
7900660,Prednisolone treats temporal arteritis,1175,"At the time of diagnosis, patients with GCA had an increased median serum level of YKL-40 (256 microg/liter; P<0.01) compared with healthy age-matched controls (median 118 microg/liter), and the serum level of YKL-40 decreased to normal levels during prednisolone treatment (-38% after 1 month; P<0.001).",True,"'Does the phrase ""Prednisolone treats temporal arteritis"" receive at least indirect support from the statement: ""At the time of diagnosis, patients with GCA had an increased median serum level of YKL-40 (256 microg/liter; P<0.01) compared with healthy age-matched controls (median 118 microg/liter), and the serum level of YKL-40 decreased to normal levels during prednisolone treatment (-38% after 1 month; P<0.001).""?","Yes, the statement does provide indirect support for the claim that prednisolone treats temporal arteritis. The study found that patients diagnosed with giant cell arteritis (GCA), a type of temporal arteritis, had elevated levels of YKL-40 at diagnosis compared to healthy controls. Importantly, treatment with prednisolone was associated with a significant decrease in YKL-40 levels after one month (-38%; P<0.001). This finding suggests that prednisolone may have an impact on the biological processes driving GCA, as YKL-40 has been implicated in inflammation and tissue remodeling associated with GCA. However, it is important to note that while this evidence supports prednisolone as an effective treatment for reducing YKL-40 levels in GCA patients, it does not necessarily prove that prednisolone treats temporal arteritis in general, as GCA represents only one form of temporal arteritis. Further studies would be needed to confirm these findings in other forms of temporal arteritis and assess other potential therapeutic options."
7900659,Prednisolone treats polymyalgia rheumatica,1176,Most patients with PMR had normal serum YKL-40 levels (median 158 microg/liter) and had no changes in the serum YKL-40 levels during prednisolone treatment.,False,"'Does the phrase ""Prednisolone treats polymyalgia rheumatica"" receive at least indirect support from the statement: ""Most patients with PMR had normal serum YKL-40 levels (median 158 microg/liter) and had no changes in the serum YKL-40 levels during prednisolone treatment.""?","No, the statement does not provide indirect support for the claim that prednisolone treats polymyalgia rheumatica (PMR). The statement indicates that most patients with PMR have normal serum YKL-40 levels and that these levels do not change during prednisolone treatment. This information does not necessarily imply that prednisolone is an effective treatment for PMR. The effectiveness of prednisolone in treating PMR would need to be evaluated through clinical trials that assess disease activity and patient outcomes in response to prednisolone treatment. Therefore, while prednisolone may be used in the treatment of PMR, the statement provided does not offer evidence of its efficacy in treating the condition."
7866839,Prednisolone treats acute myeloid leukemia,1177,"Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.",True,"'Does the phrase ""Prednisolone treats acute myeloid leukemia"" receive at least indirect support from the statement: ""Treatment of acute myeloid leukemia of childhood with cytosine arabinoside, daunorubicin, prednisolone, and mercaptopurine or thioguanine.""?","Yes, the phrase ""Prednisolone treats acute myeloid leukemia"" does receive indirect support from the statement provided. The statement indicates that prednisolone is used in the treatment of acute myeloid leukemia of childhood in combination with other drugs such as cytosine arabinoside, daunorubicin, mercaptopurine or thioguanine. This suggests that prednisolone has some therapeutic effect against acute myeloid leukemia, thus providing indirect support for the claim. However, it is important to note that prednisolone is rarely used as a single agent in treating acute myeloid leukemia due to its lower efficacy compared to other drugs mentioned in the statement."
7819165,Prednisolone treats systemic lupus erythematosus,1178,Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.,True,"'Does the phrase ""Prednisolone treats systemic lupus erythematosus"" receive at least indirect support from the statement: ""Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.""?","Yes, there is indirect support for the claim that ""Prednisolone treats systemic lupus erythematosus"" based on the statement ""Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis.""

        
        The key word here is ""therapy,"" which implies that prednisolone is being used as a treatment for systemic lupus erythematosus (SLE). The fact that steatohepatitis (a type of liver disease) is occurring during this therapy does not negate the fact that prednisolone is being used as a treatment for SLE. 

        
        Prednisolone is a corticosteroid often used in the treatment of SLE due to its anti-inflammatory effects. However, it is important to note that prednisolone is not a cure for SLE and can have significant side effects, such as steatohepatitis, especially with long-term use. Therefore, while prednisolone can be an effective treatment for SLE, it must be used carefully and often in conjunction with other therapies."
7800931,Prednisolone treats autoimmune thrombocytopenic purpura,1179,"However, after administration of immunoglobulin (IVIG) (0.4 g/kg/day x 5 days), low-dose PSL (20 mg/day) alleviated the LEMS and ITP, and the diseases have remained in remission for 8 months without additional IVIG.",True,"'Does the phrase ""Prednisolone treats autoimmune thrombocytopenic purpura"" receive at least indirect support from the statement: ""However, after administration of immunoglobulin (IVIG) (0.4 g/kg/day x 5 days), low-dose PSL (20 mg/day) alleviated the LEMS and ITP, and the diseases have remained in remission for 8 months without additional IVIG.""?","Yes, the statement does provide indirect support for the claim that Prednisolone (PSL) treats autoimmune thrombocytopenic purpura (ITP). The user statement describes a patient suffering from both Lambert-Eaton myasthenic syndrome (LEMS) and ITP. After treatment with intravenous immunoglobulin (IVIG) and low-dose Prednisolone (PSL), both conditions went into remission for eight months without further IVIG treatment. Since Prednisolone was administered in combination with IVIG and resulted in ITP remission, it suggests that Prednisolone might have contributed to treating ITP in this specific case. However, it is essential to note that controlled clinical trials are necessary for establishing direct causality and efficacy of Prednisolone in treating ITP."
7704078,Prednisolone treats colitis,1180,"On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis.",True,"'Does the phrase ""Prednisolone treats colitis"" receive at least indirect support from the statement: ""On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis.""?","Yes, the phrase ""Prednisolone treats colitis"" does receive indirect support from the statement ""On the other hand, prednisolone and short chain fatty acids seemed to improve only the physiologic changes of colitis."" 

        The statement suggests that prednisolone has an effect on colitis, as evidenced by the improvement in physiologic changes. While it does not explicitly state that prednisolone treats colitis, it implies that prednisolone has some therapeutic effect on the condition. The term ""treats"" generally implies an improvement in symptoms or outcomes, which aligns with the mentioned improvement in physiologic changes. However, it is important to note that the evidence provided is indirect and further research would be needed to confirm the therapeutic effect of prednisolone on colitis."
7676165,Prednisolone treats hypercalcemia disease,1181,"Treatment with extracorporeal shock wave lithotripsy, transurethral lithotomy, saline infusion, and prednisolone (30 mg/day) alleviated the urolithiasis, renal insufficiency, and hypercalcemia.",True,"'Does the phrase ""Prednisolone treats hypercalcemia disease"" receive at least indirect support from the statement: ""Treatment with extracorporeal shock wave lithotripsy, transurethral lithotomy, saline infusion, and prednisolone (30 mg/day) alleviated the urolithiasis, renal insufficiency, and hypercalcemia.""?","Yes, the statement does provide indirect support for the claim that prednisolone treats hypercalcemia disease. The case report mentions that treatment involving prednisolone (30 mg/day) was associated with alleviation of hypercalcemia in addition to urolithiasis and renal insufficiency. Hypercalcemia is an elevated calcium level in the blood that may be caused by several diseases including hyperparathyroidism and cancer. Prednisolone is known to have glucocorticoid properties that can inhibit bone resorption and decrease calcium levels in blood; hence, it could be inferred that prednisolone contributed to improving hypercalcemia in this case. However, it is important to note that prednisolone was used in combination with other treatments such as extracorporeal shock wave lithotripsy, transurethral lithotomy, and saline infusion; therefore, its specific effect on hypercalcemia cannot be definitively separated from these other interventions in this single case report. Further studies would be needed to establish a direct causal relationship between prednisolone use and hypercalce"
7603475,Prednisolone treats Duchenne muscular dystrophy,1182,A special program for long-term application of low-dose prednisolone treatment in Duchenne-Becker muscular dystrophy with complex control of the patients' state was developed.,True,"'Does the phrase ""Prednisolone treats Duchenne muscular dystrophy"" receive at least indirect support from the statement: ""A special program for long-term application of low-dose prednisolone treatment in Duchenne-Becker muscular dystrophy with complex control of the patients' state was developed.""?","Yes, indirect support can be inferred from the statement. The development of a long-term application program for low-dose prednisolone treatment in Duchenne-Becker muscular dystrophy suggests that prednisolone may have therapeutic benefits for these patients. However, it does not explicitly state that prednisolone treats Duchenne muscular dystrophy (DMD). Duchenne-Becker muscular dystrophy is a spectrum of diseases that includes DMD, so any positive effects on Duchenne-Becker patients could potentially extend to DMD patients as well. Nonetheless, further direct evidence would be required for a definitive conclusion about prednisolone's efficacy in treating DMD specifically."
7600829,Prednisolone treats multiple sclerosis,1183,"Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.",True,"'Does the phrase ""Prednisolone treats multiple sclerosis"" receive at least indirect support from the statement: ""Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.""?","Yes, indirect support can be inferred from the statement provided, but it is important to clarify that prednisolone alone does not treat multiple sclerosis (MS). Prednisolone is a corticosteroid often used in conjunction with other medications to manage symptoms of MS due to its anti-inflammatory properties. The study mentioned is an open-trial of mizoribine (an immunosuppressive agent) combined with prednisolone in MS patients. The positive outcomes from this trial suggest that prednisolone might play a beneficial role in treating MS as part of a combination therapy; however, it does not imply that prednisolone is sufficient as monotherapy for treating MS."
7586864,Prednisolone treats ulcerative colitis,1184,A 25-year-old man had been treated with high-dose prednisolone for UC.,True,"'Does the phrase ""Prednisolone treats ulcerative colitis"" receive at least indirect support from the statement: ""A 25-year-old man had been treated with high-dose prednisolone for UC.""?","Yes, the statement ""A 25-year-old man had been treated with high-dose prednisolone for UC"" does provide indirect support for the claim that prednisolone treats ulcerative colitis (UC). 

         The key word here is ""treated."" In medical contexts, treatment refers to therapeutic interventions aimed at alleviating symptoms or managing a condition. Therefore, it can be inferred that prednisolone was administered as a means to manage UC in this case. This does not definitively prove that prednisolone is an effective treatment for UC, but it does suggest that it has been used in such a capacity, providing some level of indirect support for the claim.

          However, it is important to note that this single case does not constitute conclusive evidence. A more robust evaluation would require controlled clinical trials demonstrating consistent positive outcomes in larger patient populations. Additionally, potential side effects, contraindications, and other factors must be taken into account when considering any treatment modality."
7485161,Prednisolone treats uveitis,1185,DISCUSSION: Allopurinol is more effective than prednisolone in treating EAU.,True,"'Does the phrase ""Prednisolone treats uveitis"" receive at least indirect support from the statement: ""DISCUSSION: Allopurinol is more effective than prednisolone in treating EAU.""?","Yes, indirectly it does provide some support for the statement that ""Prednisolone treats uveitis"". The reason being that if Allopurinol were more effective than Prednisolone in treating EAU (Experimental Autoimmune Uveitis), it implies that Prednisolone still has some efficacy in treating uveitis. However, it's important to note that this is an indirect inference based on comparative effectiveness, not a direct claim of Prednisolone's efficacy in treating uveitis. Additionally, uveitis is a symptom of EAU, not equivalent to EAU itself, which may further influence the interpretation of this evidence."
7430895,Prednisolone treats asthma,1186,"Interleukin-5 mRNA was detected in all asthmatics before prednisolone therapy; however, after prednisolone therapy, IL-5 mRNA was only detected in non-GCS-responsive BHR asthmatics.",True,"'Does the phrase ""Prednisolone treats asthma"" receive at least indirect support from the statement: ""Interleukin-5 mRNA was detected in all asthmatics before prednisolone therapy; however, after prednisolone therapy, IL-5 mRNA was only detected in non-GCS-responsive BHR asthmatics.""?","Yes, there is indirect support for the claim that prednisolone treats asthma based on the provided statement. Prednisolone is a type of glucocorticoid steroid (GCS) therapy often used in treating asthma due to its anti-inflammatory properties that can reduce airway inflammation in asthmatics.

         The statement mentions that Interleukin-5 (IL-5) mRNA was detected in all asthmatics before prednisolone therapy but only in non-GCS-responsive BHR (bronchial hyperresponsiveness) asthmatics after prednisolone therapy. This finding suggests that prednisolone has an effect on IL-5 expression in asthmatics who respond well to GCS therapy.

         IL-5 is an important cytokine in asthma pathogenesis as it contributes significantly to eosinophilic airway inflammation, which is characteristic of asthma symptoms such as bronchoconstriction, airway hyperresponsiveness, and mucus production. By reducing IL-5 levels in responsive asthmatics, prednisol"
7417999,Prednisolone treats IgA glomerulonephritis,1187,"Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?",False,"'Does the phrase ""Prednisolone treats IgA glomerulonephritis"" receive at least indirect support from the statement: ""Combined therapy with prednisolone, azathioprine, heparin-warfarin, and dipyridamole for paediatric patients with severe IgA nephropathy--is it relevant for adult patients?""?","No, the statement does not provide indirect support for the phrase ""Prednisolone treats IgA glomerulonephritis."" The original statement discusses combined therapy for severe IgA nephropathy in paediatric patients, which includes prednisolone among other drugs. IgA nephropathy is a type of glomerulonephritis; however, it does not necessarily imply that prednisolone is an effective treatment for IgA glomerulonephritis in general. To establish indirect support for prednisolone as a treatment for IgA glomerulonephritis in adults, we would need additional information linking prednisolone treatment specifically for IgA glomerulonephritis in adults or clinical trials demonstrating its efficacy in that population."
7158230,Prednisolone treats rheumatoid arthritis,1188,Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate.,True,"'Does the phrase ""Prednisolone treats rheumatoid arthritis"" receive at least indirect support from the statement: ""Remission of the nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis treated with prednisolone and methotrexate.""?","Yes, indirectly. The statement provides evidence that prednisolone is an effective treatment for rheumatoid arthritis in a specific context - when it leads to remission of nephrotic syndrome in a patient with renal amyloidosis due to rheumatoid arthritis when used in combination with methotrexate. Therefore, it supports the claim that prednisolone can be used to treat rheumatoid arthritis, although it does not explicitly demonstrate that prednisolone is solely responsible for achieving remission in this case.

        It is important to note that rheumatoid arthritis is a complex disease that often necessitates combination therapy for effective management. In this case, prednisolone was used in combination with methotrexate, making it difficult to attribute remission solely to prednisolone without further investigation into potential synergistic effects between these two medications. However, based on existing knowledge about prednisolone as an immunosuppressive agent commonly used in rheumatoid arthritis treatment regimens, it is reasonable to infer that prednisolone likely"
23769275,Hydrocortisone treats leukemia,1189,"Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.",False,"'Does the phrase ""Hydrocortisone treats leukemia"" receive at least indirect support from the statement: ""Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design.""?","No, the statement does not provide direct or indirect support for the claim that ""hydrocortisone treats leukemia."" The study protocol titled ""DexaDays-2"" is investigating the use of hydrocortisone for treating dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients, not for treating leukemia itself. The misconception might arise from conflating symptom management (in this case, neurobehavioral side effects of dexamethasone treatment) with treating the underlying disease (leukemia). It is essential to differentiate between these two aspects when interpreting such evidence."
22345112,Hydrocortisone treats oral submucous fibrosis,1190,"Aims and Objective: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing mouth opening, burning sensation, and improve the mucosal lining.",True,"'Does the phrase ""Hydrocortisone treats oral submucous fibrosis"" receive at least indirect support from the statement: ""Aims and Objective: To evaluate the efficacy of injection placentrex and injection hydrocortisone in oral submucous fibrosis patients in increasing mouth opening, burning sensation, and improve the mucosal lining.""?","Yes, indirect support can be inferred from the statement provided. The aim of the study includes an evaluation of injection hydrocortisone in oral submucous fibrosis patients in relation to increasing mouth opening, reducing burning sensation, and improving mucosal lining. This suggests that there is an expectation that hydrocortisone may have beneficial effects on oral submucous fibrosis symptoms based on prior evidence or hypotheses in the field of study.

         However, it is important to note that indirect support does not equate to definitive proof of efficacy for hydrocortisone in treating oral submucous fibrosis. A rigorous examination of the study design, methodology, results, and statistical analysis would be required in order to ascertain whether hydrocortisone does indeed have therapeutic value for oral submucous fibrosis patients.

         The statement does not provide information on the control group used in the study, sample size calculation, randomization methods, blinding procedures, or statistical analysis applied which all play crucial roles in determining whether hydrocortisone is an effective treatment for oral submucous fibrosis as compared to placebo/other treatments or if it is"
22282269,Hydrocortisone treats Infection,1191,"The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections.",False,"'Does the phrase ""Hydrocortisone treats Infection"" receive at least indirect support from the statement: ""The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections.""?","No, the phrase ""Hydrocortisone treats Infection"" does not receive at least indirect support from the statement ""The results presented herein imply that the three families of cyanine dyes, in particular compounds 5a-f, show high potential as selective scaffolds to treat C. albicans infections."" 

         The statement specifically mentions cyanine dyes, particularly compounds 5a-f, as having high potential for treating C. albicans infections. Hydrocortisone is not mentioned anywhere in the statement, nor is it implied as a treatment for infections. Hydrocortisone is a corticosteroid often used for its anti-inflammatory effects, not for its antimicrobial properties. Therefore, there is no indirect support for the claim that hydrocortisone treats infections based on this statement."
21368080,Hydrocortisone treats lymphoma,1192,The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l.,False,"'Does the phrase ""Hydrocortisone treats lymphoma"" receive at least indirect support from the statement: ""The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l.""?","No, the statement ""The serum cortisol concentration in the LYMPH patients was 285 +/- 74 nmol/l."" does not provide indirect support for the claim that ""Hydrocortisone treats lymphoma."" 

        The serum cortisol concentration measures the level of cortisol, a hormone produced by the adrenal gland, in lymphoma patients. Hydrocortisone is a synthetic form of cortisol that can be used in treating various conditions where cortisol levels are too low (adrenal insufficiency) or where high cortisol levels can be beneficial (like certain inflammatory diseases). 

        However, stating that hydrocortisone treats lymphoma would require clinical trial evidence demonstrating its efficacy in treating lymphoma specifically. The provided statement only establishes that lymphoma patients have certain cortisol levels; it does not establish any correlation between cortisol/hydrocortisone use and lymphoma treatment outcomes."
19834754,Hydrocortisone treats cardiac arrest,1193,"Compared to controls, glycocalyx was mildly injured by CA, severely disrupted by hyaluronidase (HAase) with CA, and mitigated by hydrocortisone (HC) with CA.",True,"'Does the phrase ""Hydrocortisone treats cardiac arrest"" receive at least indirect support from the statement: ""Compared to controls, glycocalyx was mildly injured by CA, severely disrupted by hyaluronidase (HAase) with CA, and mitigated by hydrocortisone (HC) with CA.""?","Yes, indirect support can be inferred from the statement. The study suggests that hydrocortisone (HC) has a protective effect on glycortex in instances where it is disrupted by hyaluronidase (HAase) during cardiac arrest (CA). This implies that hydrocortisone may have a positive impact on cardiac arrest-related conditions by mitigating glycocalyx damage. However, it is important to note that direct causality between hydrocortisone treatment and improved cardiac arrest outcomes is not explicitly stated in the provided information; further investigation would be required to make such conclusions."
17499762,Hydrocortisone treats dermatitis,1194,"In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption.",True,"'Does the phrase ""Hydrocortisone treats dermatitis"" receive at least indirect support from the statement: ""In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption.""?","Yes, the statement ""In the acute phase of dermatitis, topical hydrocortisone treatment has both a local and a systemic effect, due to percutaneous absorption"" does provide indirect support for the claim that ""Hydrocortisone treats dermatitis"". This is because it suggests that hydrocortisone can be absorbed through the skin (percutaneous absorption) and have an effect both locally (at the site of application) and systemically (throughout the body), which aligns with the general understanding of how treatments for dermatitis work. However, it's important to note that while this statement supports the idea that hydrocortisone can be an effective treatment for dermatitis, it doesn't constitute direct evidence of its efficacy. For a more definitive answer, clinical trials or other forms of empirical evidence would be required."
16946872,Hydrocortisone treats adrenal cortex neoplasm,1195,"The mean (+/- SD) plasma cortisol concentration for the initial 8-hour testing period was highest in 18 dogs with adrenocortical tumor (5.3 +/- 1.6 micrograms/dl), lowest in 15 control dogs (1.3 +/- 0.5 micrograms/dl), and intermediate in 31 dogs with pituitary-dependent hyperadrenocorticism (PDH; 3.4 +/- 1.2 micrograms/dl).",False,"'Does the phrase ""Hydrocortisone treats adrenal cortex neoplasm"" receive at least indirect support from the statement: ""The mean (+/- SD) plasma cortisol concentration for the initial 8-hour testing period was highest in 18 dogs with adrenocortical tumor (5.3 +/- 1.6 micrograms/dl), lowest in 15 control dogs (1.3 +/- 0.5 micrograms/dl), and intermediate in 31 dogs with pituitary-dependent hyperadrenocorticism (PDH; 3.4 +/- 1.2 micrograms/dl).""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone treats adrenal cortex neoplasm"". 

        The statement presents data on plasma cortisol concentrations in dogs with adrenocortical tumor, pituitary-dependent hyperadrenocorticism (PDH), and control dogs. However, it does not mention hydrocortisone or its effects on these conditions. 

        Hydrocortisone is a synthetic glucocorticoid hormone often used in treating various conditions due to its anti-inflammatory and immunosuppressive properties. While it might have some potential benefits in managing symptoms related to adrenal cortex neoplasm (such as reducing inflammation), it does not treat the neoplasm itself. 

        Therefore, even though the statement provides relevant information about cortisol concentrations in different canine conditions, it does not offer any insight into hydrocortisone's effectiveness in treating adrenal cortex neoplasm."
15753359,Hydrocortisone treats dissociative amnesia,1196,Our results suggest that PL may increase the availability of cortisol in chronically stressed men and may attenuate stress-induced memory impairments.,False,"'Does the phrase ""Hydrocortisone treats dissociative amnesia"" receive at least indirect support from the statement: ""Our results suggest that PL may increase the availability of cortisol in chronically stressed men and may attenuate stress-induced memory impairments.""?","No, the phrase ""Hydrocortisone treats dissociative amnesia"" does not receive indirect support from the statement ""Our results suggest that PL may increase the availability of cortisol in chronically stressed men and may attenuate stress-induced memory impairments.""

        The statement in question refers specifically to PL (presumably a specific compound or intervention), its potential effects on cortisol availability in chronically stressed men, and its capacity to mitigate stress-induced memory impairments. Hydrocortisone is not mentioned in the statement, nor does it imply any connection to dissociative amnesia.

        Dissociative amnesia is a condition characterized by an inability to recall important personal information, typically of a traumatic or stressful nature, which is too extensive to be explained by ordinary forgetfulness (American Psychiatric Association, 2013). Hydrocortisone is a synthetic form of cortisol, a hormone that the body produces naturally in response to stress (National Institutes of Health, n.d.). While there is evidence suggesting that cortisol plays a role in memory formation (Lupien"
15602187,Hydrocortisone treats Hypoxemia,1197,All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs.,False,"'Does the phrase ""Hydrocortisone treats Hypoxemia"" receive at least indirect support from the statement: ""All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs.""?","No, the phrase ""Hydrocortisone treats Hypoxemia"" does not receive indirect support from the statement ""All inhibitors prevented the rise in cortisol secretion usually observed in hypoxic dogs."" 

        Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. It is often used to treat conditions such as inflammation, allergies, and adrenal insufficiency. Hypoxemia, on the other hand, is a condition characterized by low oxygen levels in the blood.

        The statement provided relates to the effect of inhibitors on cortisol secretion in hypoxic dogs. While it suggests that these inhibitors can prevent the rise in cortisol levels typically seen in hypoxic conditions, it does not provide any information about the effect of hydrocortisone on hypoxemia. In fact, increasing cortisol levels (which is what hydrocortisone does) could potentially worsen hypoxemia by increasing metabolic demand and oxygen consumption.

        Therefore, based on the information provided, there is no indirect support for the claim"
15325707,Hydrocortisone treats psoriasis,1198,"The expression of StAR and MLN64 was aberrant in two skin disorders, psoriasis and atopic dermatitis, that are commonly treated with cortisol, suggesting dysregulation of epidermal steroid synthesis in these patients.",True,"'Does the phrase ""Hydrocortisone treats psoriasis"" receive at least indirect support from the statement: ""The expression of StAR and MLN64 was aberrant in two skin disorders, psoriasis and atopic dermatitis, that are commonly treated with cortisol, suggesting dysregulation of epidermal steroid synthesis in these patients.""?","Yes, while not explicitly stating that hydrocortisone treats psoriasis, the statement does provide indirect support for the effectiveness of cortisol-based treatments (such as hydrocortisone) for psoriasis. The statement highlights aberrant expression of StAR and MLN64 in psoriasis patients, suggesting dysregulation of epidermal steroid synthesis. Cortisol, including its synthetic forms like hydrocortisone, is a steroid hormone that can help regulate inflammation and immune response in the skin. Therefore, it is reasonable to infer that hydrocortisone could be an effective treatment for psoriasis by addressing the dysregulation of epidermal steroid synthesis suggested by the statement. However, it is essential to consider that further experimental evidence is required to establish a direct causal relationship between hydrocortisone use and improved psoriasis symptoms."
15213238,Hydrocortisone treats herpes labialis,1199,"ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.",True,"'Does the phrase ""Hydrocortisone treats herpes labialis"" receive at least indirect support from the statement: ""ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL.""?","Yes, indirectly it does provide some support for the claim that hydrocortisone can be used in treating herpes labialis (also known as cold sores). The statement indicates that ME-609 (Xerese, Xerclear), which contains 1% hydrocortisone, is developed for topical treatment of herpes labialis. This suggests that hydrocortisone might have some therapeutic effect on herpes labialis, even though it is not the primary active ingredient in ME-609 (acyclovir is). However, it is important to note that indirect support does not equate to definitive proof. Further research would be needed to establish the specific efficacy of hydrocortisone in treating herpes labialis."
14532907,Hydrocortisone treats cirrhosis of liver,1200,The urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C) as a biomarker of CYP3A4 metabolizing activity has been studied in Egyptian patients with chronic liver cirrhosis associated with previous hepatic Schistosomiasis infection to determine any possible alteration in enzyme activity.,False,"'Does the phrase ""Hydrocortisone treats cirrhosis of liver"" receive at least indirect support from the statement: ""The urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C) as a biomarker of CYP3A4 metabolizing activity has been studied in Egyptian patients with chronic liver cirrhosis associated with previous hepatic Schistosomiasis infection to determine any possible alteration in enzyme activity.""?","No, the statement does not provide indirect support for the claim that hydrocortisone treats cirrhosis of the liver. The statement discusses a study on Egyptian patients with chronic liver cirrhosis associated with previous hepatic Schistosomiasis infection. The researchers investigated alterations in CYP3A4 metabolizing activity using the urinary ratio of 6 beta-hydroxycortisol/cortisol (6 beta-OHC/C) as a biomarker. However, there is no mention of hydrocortisone being used as a treatment for cirrhosis in this study.

        The misconception might arise from conflating hydrocortisone (a corticosteroid) with potential therapeutic interventions for liver cirrhosis. While hydrocortisone might have some indirect relevance in studies of liver cirrhosis due to its association with CYP3A4 metabolizing activity, it does not imply that hydrocortisone is used as a treatment for cirrhosis in this particular study.

        In conclusion, it is essential to differentiate between mentions of substances in studies related to diseases (which might not"
14075841,Hydrocortisone treats acute lymphoblastic leukemia,1201,"Here, we report a case of fatal ATLS complicating intrathecal injections of methotrexate, cytarabine and hydrocortisone for acute lymphoblastic leukemia which relapsed with meningeal involvement after allogeneic stem cell transplantation.",False,"'Does the phrase ""Hydrocortisone treats acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Here, we report a case of fatal ATLS complicating intrathecal injections of methotrexate, cytarabine and hydrocortisone for acute lymphoblastic leukemia which relapsed with meningeal involvement after allogeneic stem cell transplantation.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone treats acute lymphoblastic leukemia."" The statement reports a case where hydrocortisone was used in combination with other drugs for treating acute lymphoblastic leukemia that had relapsed with meningeal involvement after allogeneic stem cell transplantation. The patient unfortunately experienced fatal complications from acute traumatic spinal cord injury (ATLS). The use of hydrocortisone in this context is for managing potential side effects from chemotherapy (methotrexate and cytarabine) rather than for treating acute lymphoblastic leukemia itself. Therefore, there is no evidence in this statement suggesting that hydrocortisone has any therapeutic effect on acute lymphoblastic leukemia."
13951019,Hydrocortisone treats HIV infectious disease,1202,"Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.",False,"'Does the phrase ""Hydrocortisone treats HIV infectious disease"" receive at least indirect support from the statement: ""Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.""?","No, the phrase ""Hydrocortisone treats HIV infectious disease"" does not receive at least indirect support from the statement: ""Except in one patient with HIV infection, all the signs and symptoms improved after antituberculous and hydrocortisone treatment.""

         The statement suggests that hydrocortisone may have contributed to the improvement of signs and symptoms in patients undergoing antituberculous treatment for tuberculosis (TB). However, it does not provide evidence that hydrocortisone is responsible for treating HIV infection itself. The improvement of signs and symptoms could be due to hydrocortisone's effect on TB-associated symptoms rather than HIV infection itself. Moreover, there is an explicit mention of one patient who did not improve after hydrocortisone treatment, indicating that hydrocortisone may not be universally effective in treating HIV-related symptoms in all patients receiving antituberculous therapy.

         In summary, while hydrocortisone may potentially have some benefits in managing symptoms in HIV patients undergoing TB treatment, it does not provide conclusive evidence that hydrocortisone treats HIV infectious disease itself. Further studies would be"
13724762,Hydrocortisone treats severe acute respiratory syndrome,1203,"Cortisol levels are elevated in patients with RSV and Ebola, and cortisol was higher in SARS patients with lymphopenia before any steroid therapy.",False,"'Does the phrase ""Hydrocortisone treats severe acute respiratory syndrome"" receive at least indirect support from the statement: ""Cortisol levels are elevated in patients with RSV and Ebola, and cortisol was higher in SARS patients with lymphopenia before any steroid therapy.""?","No, the statement does not provide direct or indirect support for the claim that hydrocortisone treats severe acute respiratory syndrome (SARS). The statement discusses cortisol levels in patients suffering from respiratory syncytial virus (RSV), Ebola, and SARS infections but does not mention hydrocortisone specifically nor does it suggest that hydrocortisone can be used as an effective treatment for SARS.

        Cortisol is a natural hormone produced by our bodies in response to stress, while hydrocortisone is a synthetic version of cortisol that is often used as an anti-inflammatory drug in clinical settings. The fact that cortisol levels may be elevated in certain patients does not necessarily imply that administering exogenous hydrocortisone would be beneficial as it may lead to further complications such as immunosuppression, which could exacerbate viral infections rather than ameliorate them.

        It is essential that any claim about therapeutic interventions is based on rigorous clinical trials demonstrating both safety and efficacy in treating the specific condition in question. In"
13691671,Hydrocortisone treats Insulin resistance,1204,OBJECTIVE: To investigate possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS).,False,"'Does the phrase ""Hydrocortisone treats Insulin resistance"" receive at least indirect support from the statement: ""OBJECTIVE: To investigate possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS).""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone treats Insulin resistance."" The objective of the study is investigating possible effects of insulin-sensitizing treatment on cortisol metabolism in insulin-resistant patients with polycystic ovary syndrome (PCOS). While hydrocortisone is a type of corticosteroid that can affect metabolism, it is not mentioned as a treatment in this objective, nor is it implied as an insulin-sensitizing treatment. Therefore, it does not support the claim that hydrocortisone treats insulin resistance."
12881395,Hydrocortisone treats myocardial infarction,1205,The paper yields the results of the study into the elimination of exogenous cortisol from the blood bed in 26 patients with myocardial infarction.,False,"'Does the phrase ""Hydrocortisone treats myocardial infarction"" receive at least indirect support from the statement: ""The paper yields the results of the study into the elimination of exogenous cortisol from the blood bed in 26 patients with myocardial infarction.""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone treats myocardial infarction."" The study mentioned in the statement investigates the elimination of exogenous cortisol (a synthetic form of corticosteroid) from the bloodstream in patients who have experienced myocardial infarction (heart attack). Hydrocortisone is indeed a corticosteroid; however, it is not explicitly stated in the provided information that hydrocortisone was used in this particular study.

         Additionally, even if hydrocortisone had been used in the study, it would still not necessarily imply that hydrocortisone treats myocardial infarction since the study focuses on cortisol elimination rather than administering hydrocortisone as treatment for heart attack patients. 

         In conclusion, without further information regarding hydrocortisone specifically being used in the study as treatment for myocardial infarction patients, there is no indirect support for the claim that hydrocortisone treats myocardial infarction based on the statement provided."
12524121,Hydrocortisone treats neoplasm,1206,"Retinoic acid treatment controls ACTH and cortisol hyperactivity and tumor size in dogs with ACTH-secreting tumors, leading to resolution of the clinical phenotype.",False,"'Does the phrase ""Hydrocortisone treats neoplasm"" receive at least indirect support from the statement: ""Retinoic acid treatment controls ACTH and cortisol hyperactivity and tumor size in dogs with ACTH-secreting tumors, leading to resolution of the clinical phenotype.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone treats neoplasm."" 

        The statement discusses the effects of retinoic acid treatment on dogs with ACTH-secreting tumors. It mentions that retinoic acid treatment controls ACTH and cortisol hyperactivity and tumor size, leading to resolution of the clinical phenotype. However, hydrocortisone is not mentioned in this statement. 

        Hydrocortisone is a type of corticosteroid that is often used to treat inflammation and allergies, not necessarily neoplasms (tumors). While it is true that hydrocortisone can have immunosuppressive effects, which might potentially influence tumor growth indirectly, the statement provided does not make any mention of hydrocortisone in relation to neoplasm treatment. Therefore, it does not provide any support for the claim that hydrocortisone treats neoplasm."
11965490,Hydrocortisone treats injury,1207,Diurnal cortisol in schizophrenia patients with childhood trauma.,False,"'Does the phrase ""Hydrocortisone treats injury"" receive at least indirect support from the statement: ""Diurnal cortisol in schizophrenia patients with childhood trauma.""?","No, the statement ""Diurnal cortisol in schizophrenia patients with childhood trauma"" does not provide indirect support for the claim that ""Hydrocortisone treats injury"". 

        The statement in question is a research finding about diurnal cortisol levels in schizophrenia patients who have experienced childhood trauma. Cortisol is a hormone that the body produces in response to stress, including physical injury. Hydrocortisone is a synthetic form of cortisol often used in medical treatments. 

        However, even though they are related, the statement about cortisol levels in schizophrenia patients does not directly or indirectly support the claim that hydrocortisone can treat injury. This is because the statement does not provide any information about the therapeutic effects of hydrocortisone, nor does it establish a causal link between cortisol levels and injury treatment. 

        It is also important to note that while cortisol has a role in the body's response to injury, treating an injury involves more than just managing cortisol levels. Therefore, even if the statement were about cortisol levels in relation to"
11029944,Hydrocortisone treats eye disorder,1208,Topical compound F in the treatment of anterior segment eye disease; a preliminary report.,False,"'Does the phrase ""Hydrocortisone treats eye disorder"" receive at least indirect support from the statement: ""Topical compound F in the treatment of anterior segment eye disease; a preliminary report.""?","No, the statement ""Topical compound F in the treatment of anterior segment eye disease; a preliminary report"" does not provide direct or indirect support for the claim that ""Hydrocortisone treats eye disorder."" This is because there is no mention of Hydrocortisone in the provided statement. Compound F could be Hydrocortisone, but without explicit information, it is impossible to make that connection. Additionally, even if Compound F were Hydrocortisone, we would still need further evidence linking it specifically to the treatment of an eye disorder, rather than just anterior segment eye disease in general."
10518308,Hydrocortisone treats ulcerative colitis,1209,Treatment of ulcerative colitis with local hydrocortisone.,True,"'Does the phrase ""Hydrocortisone treats ulcerative colitis"" receive at least indirect support from the statement: ""Treatment of ulcerative colitis with local hydrocortisone.""?","Yes, the statement ""Treatment of ulcerative colitis with local hydrocortisone"" does provide indirect support for the phrase ""Hydrocortisone treats ulcerative colitis."" This is because it suggests that hydrocortisone has been used in a treatment context for ulcerative colitis, implying that it may have some therapeutic effect on the condition. However, it's important to note that this doesn't necessarily mean that hydrocortisone is a primary or optimal treatment for ulcerative colitis in all cases, nor does it specify whether the hydrocortisone is administered locally or systemically. Therefore, while there is some support for the claim, it is not direct or unqualified support."
10516843,Hydrocortisone treats diffuse alopecia areata,1210,"Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone.",True,"'Does the phrase ""Hydrocortisone treats diffuse alopecia areata"" receive at least indirect support from the statement: ""Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone.""?","Yes, the phrase ""Hydrocortisone treats diffuse alopecia areata"" does receive indirect support from the statement ""Alopecia areata, partialis, and totalis; treatment with cortisone, hydrocortisone and their analogs, prednisone and prednisolone."" 

        The statement lists hydrocortisone as one of the treatments for alopecia areata, partialis, and totalis. Diffuse alopecia areata is a subtype of alopecia areata, characterized by hair loss over the entire scalp rather than in patches (as in classic alopecia areata). Therefore, if hydrocortisone is effective for alopecia areata in general, it stands to reason that it may also be effective for diffuse alopecia areata specifically. However, it is important to note that while the statement offers some support for the claim that hydrocortisone can treat diffuse alopecia areata, it does not constitute definitive proof. Clinical trials involving patients with diffuse alopecia areata would be necessary to establish hydrocortisone as an effective treatment"
10492262,Hydrocortisone treats osteoarthritis,1211,Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report.,False,"'Does the phrase ""Hydrocortisone treats osteoarthritis"" receive at least indirect support from the statement: ""Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report.""?","No, the statement ""Phenylbutazone and compound F for osteoarthritis of the hip; a survey and clinical report"" does not provide indirect support for the claim that ""Hydrocortisone treats osteoarthritis.""

        The statement refers to a survey and clinical report on the use of Phenylbutazone (a non-steroidal anti-inflammatory drug) and compound F (a combination of Phenylbutazone and Cortisone acetate) for treating osteoarthritis of the hip. Hydrocortisone is a type of corticosteroid that has anti-inflammatory properties; however, it is distinct from Cortisone acetate used in compound F.

        Although both Hydrocortisone and Cortisone acetate have anti-inflammatory effects that could potentially be used in treating osteoarthritis symptoms, they have not been mentioned specifically in the provided statement. Thus, it does not offer any support for the claim that Hydrocortisone treats osteoarthritis."
10480635,Hydrocortisone treats atopic conjunctivitis,1212,"Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma.",True,"'Does the phrase ""Hydrocortisone treats atopic conjunctivitis"" receive at least indirect support from the statement: ""Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma.""?","Yes, the statement ""Hydrocortisone in treatment of allergic conjunctivitis, allergic rhinitis, and bronchial asthma"" does provide indirect support for the claim that ""Hydrocortisone treats atopic conjunctivitis."" This is because atopic conjunctivitis is a type of allergic conjunctivitis, which is listed in the original statement as being treated by hydrocortisone. However, it's important to note that indirect support does not equate to definitive proof. The specific efficacy of hydrocortisone in treating atopic conjunctivitis would need to be evaluated in controlled clinical trials to establish direct evidence of its therapeutic value for this particular condition."
10280121,Hydrocortisone treats melanoma,1213,"METHOD: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-alpha therapy, both immediately before and 1, 2, and 3 hours after IFN-alpha administration.",False,"'Does the phrase ""Hydrocortisone treats melanoma"" receive at least indirect support from the statement: ""METHOD: Adrenocorticotropic hormone (ACTH), cortisol, and interleukin-6 (IL-6) plasma concentrations were measured in 14 patients with malignant melanoma at regular intervals during the first 12 weeks of IFN-alpha therapy, both immediately before and 1, 2, and 3 hours after IFN-alpha administration.""?","No, the statement does not provide indirect support for the claim that hydrocortisone treats melanoma. The provided method describes a study measuring levels of ACTH, cortisol (a steroid hormone produced in response to ACTH), IL-6 (a cytokine), in patients with melanoma undergoing IFN-alpha therapy at specific time points. Hydrocortisone is also a steroid hormone similar to cortisol but is not explicitly mentioned in the method provided; therefore, there is no connection established between hydrocortisone use and melanoma treatment in this case."
10221382,Hydrocortisone treats atopic eczema,1214,"These data show clobetasone butyrate 0.05% is more effective than 1.0% hydrocortisone in the treatment of eczema and more effective than flurandrenolone 0.0125% (p=0.01%) and a potent topical steroid hydrocortisone butyrate (p<0.05), in the treatment of psoriasis.",True,"'Does the phrase ""Hydrocortisone treats atopic eczema"" receive at least indirect support from the statement: ""These data show clobetasone butyrate 0.05% is more effective than 1.0% hydrocortisone in the treatment of eczema and more effective than flurandrenolone 0.0125% (p=0.01%) and a potent topical steroid hydrocortisone butyrate (p<0.05), in the treatment of psoriasis.""?","Yes, indirect support can be inferred from the statement provided. The excerpt indicates that clobetasone butyrate 0.05% is more effective than 1.0% hydrocortisone in treating eczema. Given that both clobetasone butyrate and hydrocortisone butyrate are synthetic corticosteroids derived from hydrocortisone, it suggests that hydrocortisone is still an effective treatment for atopic eczema, albeit potentially less so than other topical corticosteroids like clobetasone butyrate. However, it should be noted that direct comparisons between clobetasone butyrate and hydrocortisone in treating eczema cannot be made solely based on this statement since it does not provide specifics on their relative effectiveness in treating atopic eczema alone."
9971730,Hydrocortisone treats pneumonia,1215,The use of extracorporeal immunopharmacotherapy with diucifon in 53 patients and the retrosternal injection of isoniazid in combination with hydrocortisone in 43 patients have shown their efficiencies in the treatment of patients with caseous pneumonia.,False,"'Does the phrase ""Hydrocortisone treats pneumonia"" receive at least indirect support from the statement: ""The use of extracorporeal immunopharmacotherapy with diucifon in 53 patients and the retrosternal injection of isoniazid in combination with hydrocortisone in 43 patients have shown their efficiencies in the treatment of patients with caseous pneumonia.""?","No, the phrase ""Hydrocortisone treats pneumonia"" does not receive direct support from the statement provided. The statement mentions that hydrocortisone was used in combination with isoniazid for retrosternal injection in treating patients with caseous pneumonia, but it does not explicitly state that hydrocortisone alone is effective in treating pneumonia. Therefore, any inference of hydrocortisone's efficacy in treating pneumonia would be indirect at best based on this statement alone.

        The statement implies that hydrocortisone may be an effective component in a broader treatment regimen for caseous pneumonia when used in conjunction with other drugs like isoniazid. However, it does not provide sufficient evidence for hydrocortisone as monotherapy for pneumonia treatment, nor does it specify which type of pneumonia it is effective against (e.g., bacterial, viral).

        It is important to note that while hydrocortisone has anti-inflammatory properties that could theoretically benefit some pneumonia patients by reducing lung inflammation, its use in treating pneumonia remains controversial"
9665107,Hydrocortisone treats prostate cancer,1216,"Therefore, a prospective phase II study was conducted to assess the efficacy and safety of a regimen of low dose (200 mg.) oral ketoconazole 3 times daily with replacement doses of hydrocortisone in men with androgen independent prostate cancer.",False,"'Does the phrase ""Hydrocortisone treats prostate cancer"" receive at least indirect support from the statement: ""Therefore, a prospective phase II study was conducted to assess the efficacy and safety of a regimen of low dose (200 mg.) oral ketoconazole 3 times daily with replacement doses of hydrocortisone in men with androgen independent prostate cancer.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone treats prostate cancer."" The passage discusses a study conducted on men with androgen independent prostate cancer using low dose oral ketoconazole three times daily in combination with replacement doses of hydrocortisone. 

         The purpose of administering hydrocortisone in this study is not for treating prostate cancer but rather for replacement therapy due to ketoconazole's ability to suppress adrenal steroid synthesis, which could lead to adrenal insufficiency if not appropriately managed. Therefore, it is inaccurate to infer from this statement that hydrocortisone is used as a treatment for prostate cancer itself."
9535781,Hydrocortisone treats adrenocortical insufficiency,1217,"Long term hydrocortisone therapy for his adrenal insufficiency may have prevented a faster course of the liver disease, whereas the heterozygous alpha1-antitrypsin deficiency and moderate alcohol consumption constituted additional risk factors ultimately leading to the development of cirrhosis.",True,"'Does the phrase ""Hydrocortisone treats adrenocortical insufficiency"" receive at least indirect support from the statement: ""Long term hydrocortisone therapy for his adrenal insufficiency may have prevented a faster course of the liver disease, whereas the heterozygous alpha1-antitrypsin deficiency and moderate alcohol consumption constituted additional risk factors ultimately leading to the development of cirrhosis.""?","Yes, the phrase ""Hydrocortisone treats adrenocortical insufficiency"" does receive indirect support from the statement provided. 

         The statement suggests that long-term hydrocortisone therapy was used for adrenal insufficiency in an individual who also had other risk factors for liver disease progression, including heterozygous alpha1-antitrypsin deficiency and moderate alcohol consumption. The fact that these other risk factors led to cirrhosis development indicates that hydrocortisone therapy did not accelerate liver disease progression in this individual; otherwise, cirrhosis would have developed earlier due to the combined influence of all risk factors.

         Therefore, it can be inferred that hydrocortisone treatment did not worsen adrenocortical insufficiency nor contribute negatively to liver disease progression in this case. Instead, it may have played a protective role in preventing faster progression of liver disease despite the presence of other risk factors. This interpretation indirectly supports the claim that hydrocortisone is used for treating adrenocortical insufficiency since it did not exacerbate the patient's condition in any way."
9459897,Hydrocortisone treats hypotensive disorder,1218,"After 24-h age, a subgroup (n = 8) received up to four doses (0.5-1.0 mg/kg each) of hydrocortisone for refractory hypotension.",True,"'Does the phrase ""Hydrocortisone treats hypotensive disorder"" receive at least indirect support from the statement: ""After 24-h age, a subgroup (n = 8) received up to four doses (0.5-1.0 mg/kg each) of hydrocortisone for refractory hypotension.""?","Yes, the statement does provide indirect support for the phrase ""Hydrocortisone treats hypotensive disorder"". The reason is that it mentions the administration of hydrocortisone to treat refractory hypotension in a subgroup of subjects. However, it's important to note that this is an observational statement and does not constitute definitive proof. A more robust study design would be required to make a definitive claim about the treatment efficacy of hydrocortisone for hypotensive disorder."
9175521,Hydrocortisone treats type 1 diabetes mellitus,1219,"Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus.",False,"'Does the phrase ""Hydrocortisone treats type 1 diabetes mellitus"" receive at least indirect support from the statement: ""Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus.""?","No, the statement ""Interaction of endogenous growth hormone, cortisol, and catecholamines with blood glucose in children with brittle diabetes mellitus"" does not provide indirect support for the claim that ""Hydrocortisone treats type 1 diabetes mellitus."" 

        The statement discusses the interaction of several hormones, including cortisol (a glucocorticoid like hydrocortisone), with blood glucose in children with brittle diabetes mellitus. However, it does not mention hydrocortisone specifically, nor does it suggest that hydrocortisone is used as a treatment for type 1 diabetes mellitus. 

        While it is true that cortisol can affect blood glucose levels, hydrocortisone is not typically used as a primary treatment for type 1 diabetes mellitus. Instead, it might be used in certain situations to manage complications associated with diabetes, such as adrenal insufficiency. Therefore, without additional evidence linking hydrocortisone treatment specifically to type 1 diabetes mellitus, one cannot infer support for"
8776300,Hydrocortisone treats Inflammation,1220,"Acidification with a topical solution of 2 percent acetic acid combined with hydrocortisone for inflammation is effective treatment in most cases and, when used after exposure to moisture, is an excellent prophylactic.",True,"'Does the phrase ""Hydrocortisone treats Inflammation"" receive at least indirect support from the statement: ""Acidification with a topical solution of 2 percent acetic acid combined with hydrocortisone for inflammation is effective treatment in most cases and, when used after exposure to moisture, is an excellent prophylactic.""?","Yes, the statement does provide indirect support for the phrase ""Hydrocortisone treats Inflammation"". The statement suggests that hydrocortisone is used in combination with a topical solution of 2 percent acetic acid as an effective treatment for inflammation (indicated by the term ""acidification"", which is often used in medical contexts to refer to reducing inflammation). This implies that hydrocortisone has anti-inflammatory properties. However, it should be noted that the claim is indirect because it does not explicitly state that hydrocortisone treats inflammation on its own, but rather as part of a combined treatment regimen."
8632826,Hydrocortisone treats bronchopulmonary dysplasia,1221,"To study a possible relation between the use of postnatal glucocorticoids and the incidence and severity of retinopathy of prematurity (ROP), we conducted a retrospective study over a 4-year period that compared data of 161 preterm infants treated with hydrocortisone for bronchopulmonary dysplasia (BPD) with the data of 253 controls.",True,"'Does the phrase ""Hydrocortisone treats bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""To study a possible relation between the use of postnatal glucocorticoids and the incidence and severity of retinopathy of prematurity (ROP), we conducted a retrospective study over a 4-year period that compared data of 161 preterm infants treated with hydrocortisone for bronchopulmonary dysplasia (BPD) with the data of 253 controls.""?","Yes, indirect support can be inferred from the statement provided. The study is investigating the impact of postnatal glucocorticoids (which hydrocortisone is a part of) on retinopathy of prematurity (ROP), while comparing two groups of preterm infants, one treated with hydrocortisone for bronchopulmonary dysplasia (BPD) and another control group. Although the primary outcome of interest in this study is ROP, it does provide some evidence that hydrocortisone is being used to treat BPD in preterm infants. However, it does not offer direct evidence that hydrocortisone specifically treats bronchopulmonary dysplasia as it is possible that other glucocorticoids were used in addition to hydrocortisone for treatment within that group of preterm infants. To draw stronger conclusions about hydrocortisone treating BPD specifically, more detailed information regarding treatment regimens would be required."
8540090,"Hydrocortisone treats dermatitis, atopic",1222,Topical treatment with urea-hydrocortisone in atopic dermatitis.,True,"'Does the phrase ""Hydrocortisone treats dermatitis, atopic"" receive at least indirect support from the statement: ""Topical treatment with urea-hydrocortisone in atopic dermatitis.""?","Yes, the phrase ""Hydrocortisone treats dermatitis, atopic"" does receive indirect support from the statement: ""Topical treatment with urea-hydrocortisone in atopic dermatitis."" 

        The statement suggests that hydrocortisone is used in a topical treatment for atopic dermatitis. This implies that hydrocortisone has some therapeutic effect on atopic dermatitis, which aligns with the claim that hydrocortisone treats dermatitis, atopic. However, it's important to note that the statement mentions urea in conjunction with hydrocortisone, suggesting that they may be used together in a treatment. This does not detract from the fact that hydrocortisone is indicated in the treatment of atopic dermatitis."
8412499,Hydrocortisone treats obesity disorder,1223,"We studied the interactions of leptin, insulin and cortisol in obese children and adolescents at different stages of maturation.",False,"'Does the phrase ""Hydrocortisone treats obesity disorder"" receive at least indirect support from the statement: ""We studied the interactions of leptin, insulin and cortisol in obese children and adolescents at different stages of maturation.""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone treats obesity disorder."" The study investigates the interactions of leptin, insulin, and cortisol in obese children and adolescents at different stages of maturation. Although cortisol is mentioned (which is a hormone secreted by the adrenal gland in response to stress and is also known as hydrocortisone), there is no mention of hydrocortisone as a treatment for obesity disorder in the study population. The study focuses on understanding hormonal interactions in obese individuals rather than providing evidence for an effective treatment for obesity disorder using hydrocortisone."
8248241,Hydrocortisone treats Sepsis,1224,[Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].,True,"'Does the phrase ""Hydrocortisone treats Sepsis"" receive at least indirect support from the statement: ""[Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].""?","Yes, there is indirect support for the statement ""Hydrocortisone treats sepsis"" from the provided reference ""[Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications]."" This is because hydrocortisone is a synthetic glucocorticoid that can be used to supplement cortisol levels in critically ill patients, including those with sepsis.

        The reference provides evidence for the therapeutic implications of cortisol in sepsis patients by discussing its physiologic functions in sepsis pathophysiology. It highlights that cortisol plays an essential role in maintaining vascular tone and cardiac output during sepsis-induced hypotension (1). Moreover, it discusses how cortisol deficiency in sepsis patients can impair immune responses (2). 

        Based on these insights from the reference, hydrocortisone can be used as replacement therapy for critically ill sepsis patients who have relative adrenal insufficiency (RAI) – also known as ""corticotropin insufficiency"" – thereby treating sepsis indirect"
8061437,Hydrocortisone treats congenital adrenal hyperplasia,1225,"We conclude that the regimen of flutamide, testolactone, reduced hydrocortisone dose, and fludrocortisone provides effective control of congenital adrenal hyperplasia with reduced risk of glucocorticoid excess.",True,"'Does the phrase ""Hydrocortisone treats congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""We conclude that the regimen of flutamide, testolactone, reduced hydrocortisone dose, and fludrocortisone provides effective control of congenital adrenal hyperplasia with reduced risk of glucocorticoid excess.""?","Yes, indirect support can be inferred from the statement provided for the phrase ""Hydrocortisone treats congenital adrenal hyperplasia"". The given statement discusses a regimen for managing congenital adrenal hyperplasia (CAH) that includes reduced hydrocortisone doses along with other medications (flutamide, testolactone, and fludrocortisone). This implies that hydrocortisone does have some therapeutic effect in treating CAH; otherwise, it would not be included in the treatment regimen mentioned in the statement. However, it is important to note that reduced doses of hydrocortisone are recommended in combination with other medications in order to mitigate risks associated with glucocorticoid excess.

         In summary, while the statement does not explicitly confirm that hydrocortisone is an effective monotherapy for CAH, it does provide indirect evidence supporting its use in treating CAH as part of a broader treatment regimen aimed at minimizing risks of glucocorticoid excess."
8054429,Hydrocortisone treats borderline personality disorder,1226,RESULTS: The cortisol and prolactin responses to the m-CPP challenge in BPD patients were significantly lower compared to those in controls.,False,"'Does the phrase ""Hydrocortisone treats borderline personality disorder"" receive at least indirect support from the statement: ""RESULTS: The cortisol and prolactin responses to the m-CPP challenge in BPD patients were significantly lower compared to those in controls.""?","No, the statement does not provide indirect support for the claim that hydrocortisone treats borderline personality disorder (BPD). The result presented in the statement is about cortisol and prolactin responses in BPD patients compared to controls when challenged with m-CPP (a compound that stimulates cortisol release). This finding may suggest altered neuroendocrine regulation in BPD patients; however, it does not provide evidence that hydrocortisone can be used as a treatment for BPD. Further studies specifically investigating hydrocortisone as a treatment for BPD would be required to make such a claim."
7996696,Hydrocortisone treats toxic shock syndrome,1227,Two recent small randomized trials evaluating a 5- to 12-day course of low dose hydrocortisone in patients with septic shock have reported a significant clinical improvement and a reduction in mortality.,True,"'Does the phrase ""Hydrocortisone treats toxic shock syndrome"" receive at least indirect support from the statement: ""Two recent small randomized trials evaluating a 5- to 12-day course of low dose hydrocortisone in patients with septic shock have reported a significant clinical improvement and a reduction in mortality.""?","Yes, indirect support can be inferred from the statement provided. Toxic shock syndrome is a severe form of sepsis caused by bacterial infections; hence it falls under the broader category of septic shock. The statement mentions that two recent randomized trials reported significant clinical improvement and reduced mortality in patients with septic shock after administering low-dose hydrocortisone for 5-12 days. This suggests that hydrocortisone may have beneficial effects in treating severe bacterial infections such as toxic shock syndrome by improving clinical outcomes and reducing mortality rates. However, it is important to note that these trials specifically focused on septic shock, not toxic shock syndrome; thus, further studies would be needed before making definitive conclusions about hydrocortisone as an effective treatment for toxic shock syndrome itself."
7882717,Hydrocortisone treats castration-resistant prostate carcinoma,1228,"We have studied intravenous docetaxel 70 mg/m2, oral estramustine, and low-dose daily hydrocortisone in men with HRPC who demonstrated progression after initial hormone therapy.",True,"'Does the phrase ""Hydrocortisone treats castration-resistant prostate carcinoma"" receive at least indirect support from the statement: ""We have studied intravenous docetaxel 70 mg/m2, oral estramustine, and low-dose daily hydrocortisone in men with HRPC who demonstrated progression after initial hormone therapy.""?","Yes, indirect support can be inferred from the statement provided. The study mentions using low-dose daily hydrocortisone in combination with intravenous docetaxel 70 mg/m2 and oral estramustine for men with castration-resistant prostate carcinoma (HRPC) who demonstrated progression after initial hormone therapy.

         Although the statement does not explicitly claim that hydrocortisone treats castration-resistant prostate carcinoma as a single agent, it does show that hydrocortisone is being used in therapeutic interventions for patients with HRPC who have progressed after initial hormone therapy. This usage suggests that hydrocortisone may play a role in managing HRPC symptoms or disease progression in combination therapy regimens.

          However, it is important to note that more extensive clinical trials and direct evidence would be required for definitive proof of hydrocortisone's efficacy as a treatment for castration-resistant prostate carcinoma. The statement provided offers an insight into its use in treating HRPC but does not definitively establish hydrocortisone as a standalone treatment for"
7698304,Hydrocortisone treats otitis externa,1229,"Results of clinical trials indicate that ofloxacin otic solution 0.3% is as effective as topical neomycin/polymixin B/hydrocortisone preparations in the treatment of otitis externa (clinical cure rate >80% in adults and >95% in children for both treatments) and oral amoxicillin/clavulanic acid in the treatment of otitis media in the presence of tympanostomy tubes in children (clinical cure rates 76 and 69% for ofloxacin and amoxicillin/clavulanic acid, respectively).",False,"'Does the phrase ""Hydrocortisone treats otitis externa"" receive at least indirect support from the statement: ""Results of clinical trials indicate that ofloxacin otic solution 0.3% is as effective as topical neomycin/polymixin B/hydrocortisone preparations in the treatment of otitis externa (clinical cure rate >80% in adults and >95% in children for both treatments) and oral amoxicillin/clavulanic acid in the treatment of otitis media in the presence of tympanostomy tubes in children (clinical cure rates 76 and 69% for ofloxacin and amoxicillin/clavulanic acid, respectively).""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone treats otitis externa"". The statement discusses clinical trial results for ofloxacin otic solution 0.3% in treating otitis externa and otitis media in children with tympanostomy tubes. It mentions topical neomycin/polymixin B/hydrocortisone preparations as being effective in treating otitis externa, but it does not specifically attribute the effectiveness of these preparations to hydrocortisone alone. Therefore, it does not provide evidence that hydrocortisone is effective in treating otitis externa when used alone or as a standalone treatment option for otitis externa."
7584436,Hydrocortisone treats Crohn disease,1230,CONCLUSIONS: The observed increase in albumin binding might limit the bioactivity of cortisol in patients with Crohn's disease and contribute to the decreased effectiveness and weaker side effects of glucocorticoid therapy in these patients.,True,"'Does the phrase ""Hydrocortisone treats Crohn disease"" receive at least indirect support from the statement: ""CONCLUSIONS: The observed increase in albumin binding might limit the bioactivity of cortisol in patients with Crohn's disease and contribute to the decreased effectiveness and weaker side effects of glucocorticoid therapy in these patients.""?","Yes, indirectly. The statement does not explicitly mention hydrocortisone by name, but it does discuss glucocorticoid therapy, of which hydrocortisone is a type. The study suggests that in patients with Crohn's disease, there is an increase in albumin binding that might limit the bioactivity of cortisol (a type of glucocorticoid). This could potentially explain why glucocorticoid therapy is less effective in these patients (including hydrocortisone therapy), as less active cortisol would mean less anti-inflammatory effect. However, it's important to note that this is an indirect inference and further research would be needed to confirm this specific hypothesis."
7432481,Hydrocortisone treats pancreatitis,1231,"The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.",False,"'Does the phrase ""Hydrocortisone treats pancreatitis"" receive at least indirect support from the statement: ""The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone treats pancreatitis."" The provided statement discusses the effects of hydrocortisone on N-acetyl D-glucosamine levels in zymogen granule membranes in relation to caerulein-induced acute pancreatitis in rats. It does not provide any information about the therapeutic effects of hydrocortisone on pancreatitis. Therefore, it does not support the claim that hydrocortisone treats pancreatitis."
7402054,Hydrocortisone treats fibromyalgia,1232,Graded ACTH infusion revealed similar increases in cortisol in women with fibromyalgia and healthy controls.,False,"'Does the phrase ""Hydrocortisone treats fibromyalgia"" receive at least indirect support from the statement: ""Graded ACTH infusion revealed similar increases in cortisol in women with fibromyalgia and healthy controls.""?","No, the statement does not provide indirect support for the claim that hydrocortisone treats fibromyalgia. The study mentioned measures cortisol levels in response to ACTH infusion in women with fibromyalgia and healthy controls. While hydrocortisone is a synthetic form of cortisol, the experiment does not demonstrate any direct link between hydrocortisone administration and fibromyalgia treatment.

        To provide indirect support for the claim that hydrocortisone treats fibromyalgia, one would need evidence showing that administering hydrocortisone results in improved fibromyalgia symptoms or related physiological changes specific to fibromyalgia patients. The current statement only demonstrates similar cortisol responses between fibromyalgia patients and healthy controls following ACTH infusion but does not provide information about hydrocortisone treatment for fibromyalgia."
7378370,Hydrocortisone treats chronic primary adrenal insufficiency,1233,The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.,True,"'Does the phrase ""Hydrocortisone treats chronic primary adrenal insufficiency"" receive at least indirect support from the statement: ""The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.""?","Yes, indirectly it does support the statement that hydrocortisone treats chronic primary adrenal insufficiency, also known as Addison's disease. The statement discusses the effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease. Hydrocortisone is a synthetic form of cortisol, which is a hormone that is often deficient in individuals with Addison's disease. Therefore, hydrocortisone is commonly used as a treatment for this condition to replace the missing cortisol. While the statement does not explicitly mention hydrocortisone, it does discuss cortisol in relation to Addison's disease, which implies a connection to treatment options including hydrocortisone. However, it is important to note that this is an indirect inference based on general knowledge about Addison's disease and its treatment, rather than a direct conclusion drawn from the statement itself."
7363431,Hydrocortisone treats asthma,1234,[Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma].,False,"'Does the phrase ""Hydrocortisone treats asthma"" receive at least indirect support from the statement: ""[Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma].""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone treats asthma."" The statement ""Dynamics of the cortisol content in the blood plasma in specific hyposensibilization in children with bronchial asthma"" is discussing the dynamics of cortisol content in children with bronchial asthma undergoing specific hyposensibilization. Cortisol is a natural hormone produced by the adrenal gland that has anti-inflammatory effects, which can help reduce symptoms of asthma. However, hydrocortisone is a synthetic form of cortisol often used in medications. The statement provided does not mention hydrocortisone or any form of treatment, but rather discusses cortisol dynamics in a specific context. Therefore, it does not provide support for the claim that hydrocortisone treats asthma."
27127545,Methylprednisolone treats lymphoproliferative syndrome,1235,Treatment of X-linked lymphoproliferative disease (Duncan disease) with high-dose methylprednisolone and etoposide (VP-16).,True,"'Does the phrase ""Methylprednisolone treats lymphoproliferative syndrome"" receive at least indirect support from the statement: ""Treatment of X-linked lymphoproliferative disease (Duncan disease) with high-dose methylprednisolone and etoposide (VP-16).""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats lymphoproliferative syndrome"". X-linked lymphoproliferative disease (XLP), also known as Duncan disease, is a primary immunodeficiency disorder that can present with lymphoproliferative syndrome as one of its complications. Lymphoproliferative syndrome is characterized by an uncontrolled proliferation of lymphocytes, which can lead to various clinical manifestations such as lymphoma and autoimmune diseases.

         The statement mentions that high-dose methylprednisolone, in combination with etoposide (VP-16), is used in the treatment of XLP. Methylprednisolone is a corticosteroid that possesses anti-inflammatory and immunosuppressive properties. By suppressing the immune system, corticosteroids like methylprednisolone can help control the unchecked proliferation of lymphocytes seen in lymphoproliferative syndrome.

         Therefore, even though the statement does not explicitly state that methylpred"
26450412,Methylprednisolone treats leukemia,1236,"Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.",True,"'Does the phrase ""Methylprednisolone treats leukemia"" receive at least indirect support from the statement: ""Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.""?","Yes, while the statement does not explicitly claim that methylprednisolone treats leukemia on its own, it does imply that methylprednisolone is used in combination with other treatments for L1210 leukemia. This suggests that methylprednisolone may have some therapeutic benefit in treating leukemia, even if it is not effective as a standalone treatment. However, it is important to note that this interpretation is based on indirect evidence and further research would be needed to confirm the specific efficacy of methylprednisolone in treating leukemia. It is also crucial to consider that many cancer treatments involve combinations of drugs to target different aspects of the disease, so finding a drug in such a combination does not necessarily mean it would be effective on its own."
26339812,Methylprednisolone treats alcoholic hepatitis,1237,Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.,True,"'Does the phrase ""Methylprednisolone treats alcoholic hepatitis"" receive at least indirect support from the statement: ""Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.""?","Yes, the statement ""Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis"" does lend indirect support to the claim that methylprednisolone treats alcoholic hepatitis. This is because it suggests that there has been some form of clinical investigation into the effects of methylprednisolone specifically in the context of severe acute alcoholic hepatitis.

         However, it is important to note that a controlled trial does not necessarily equate to a positive outcome or efficacy of treatment. The results of such a trial would need to be examined in order to make a more definitive conclusion about the effectiveness of methylprednisolone for treating alcoholic hepatitis. Additionally, terms like ""severe"" and ""acute"" can influence the interpretation of results, as alcoholic hepatitis can present in various forms and stages of progression.

         Therefore, while the statement does provide some level of support for the claim, it is not definitive proof of methylprednisolone's effectiveness in treating alcoholic hepatitis. Further investigation into the specifics of the trial, including its design, results, and any subsequent publications, would be"
26307075,Methylprednisolone treats psoriatic arthritis,1238,"1 The present study was undertaken to characterize the spectrum of arachidonic acid metabolites present in synovial effusions of patients with rheumatoid or psoriatic arthritis, and to compare changes in their concentration following a short-term treatment with 6alpha-methyl-prednisolone (6-MeP: 4-8 mg/day) or indoprofen (1.2 g/day), a nonsteroidal anti-inflammatory agent with proven synovial prostaglandin inhibitory effect.2 Measurements of prostaglandin E(2) (PGE(2)), thromboxane (TX) B(2), 6-keto-PGF(1alpha) and PGF(2alpha) were performed by radioimmunoassay techniques in synovial effusions obtained from 23 patients, and validated by thin-layer chromatographic analysis of the extracted immunoreactivity.3 PGE(2) and TXB(2) accounted for more than 60% of the total immunoreactivity in untreated patients.",False,"'Does the phrase ""Methylprednisolone treats psoriatic arthritis"" receive at least indirect support from the statement: ""1 The present study was undertaken to characterize the spectrum of arachidonic acid metabolites present in synovial effusions of patients with rheumatoid or psoriatic arthritis, and to compare changes in their concentration following a short-term treatment with 6alpha-methyl-prednisolone (6-MeP: 4-8 mg/day) or indoprofen (1.2 g/day), a nonsteroidal anti-inflammatory agent with proven synovial prostaglandin inhibitory effect.2 Measurements of prostaglandin E(2) (PGE(2)), thromboxane (TX) B(2), 6-keto-PGF(1alpha) and PGF(2alpha) were performed by radioimmunoassay techniques in synovial effusions obtained from 23 patients, and validated by thin-layer chromatographic analysis of the extracted immunoreactivity.3 PGE(2) and TXB(2) accounted for more than 60% of the total immunoreactivity in untreated patients.""?","No, the statement does not provide direct support for the claim that ""Methylprednisolone treats psoriatic arthritis"". The study mentioned primarily focuses on characterizing arachidonic acid metabolites in synovial effusions of patients with rheumatoid or psoriatic arthritis before and after treatment with Methylprednisolone (6-MeP) or indoprofen. The fact that PGE(2) and TXB(2)"
26279366,Methylprednisolone treats angioimmunoblastic T-cell lymphoma,1239,Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy.,True,"'Does the phrase ""Methylprednisolone treats angioimmunoblastic T-cell lymphoma"" receive at least indirect support from the statement: ""Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy.""?","Yes, there is indirect support for the phrase ""Methylprednisolone treats angioimmunoblastic T-cell lymphoma"" from the statement ""Pulse methylprednisolone therapy in angioimmunoblastic lymphadenopathy."" 

        The key term here is ""angioimmunoblastic lymphadenopathy,"" which is a characteristic feature of angioimmunoblastic T-cell lymphoma (AITL). AITL is a type of non-Hodgkin lymphoma that often presents with generalized lymphadenopathy, hepatosplenomegaly, skin rash, polyclonal hypergammaglobulinemia, and autoimmune phenomena. 

        The statement suggests that methylprednisolone is used in pulse therapy for angioimmunoblastic lymphadenopathy. Methylprednisolone is a corticosteroid often used in cancer treatment due to its anti-inflammatory and immunosuppressive properties. Therefore, it can be inferred that methylprednisol"
25738014,Methylprednisolone treats ankylosing spondylitis,1240,Seven patients with active AS and insufficient efficacy of NSAID for three months were treated with one gram methylprednisolone daily given intravenously for three successive days.,True,"'Does the phrase ""Methylprednisolone treats ankylosing spondylitis"" receive at least indirect support from the statement: ""Seven patients with active AS and insufficient efficacy of NSAID for three months were treated with one gram methylprednisolone daily given intravenously for three successive days.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats ankylosing spondylitis (AS). The statement describes seven patients with active AS who were treated with methylprednisolone for three consecutive days due to insufficient efficacy of NSAIDs for three months. The fact that methylprednisolone was administered as a treatment suggests that it has some therapeutic effect on AS, even if it is not explicitly stated in the text provided. However, it is important to note that indirect support does not equate to definitive proof of efficacy; further studies would need to be conducted in order to establish methylprednisolone as an effective treatment for AS."
25734987,Methylprednisolone treats non-Hodgkin lymphoma,1241,"Peptichemio, a new oncolytic drug with alkylating and antimetabolic properties was employed in combination with vincristine and 6-methylprednisolone (PVP) for the treatment of diffuse non-Hodgkin's lymphomas (NHL), stages III and IV.",True,"'Does the phrase ""Methylprednisolone treats non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""Peptichemio, a new oncolytic drug with alkylating and antimetabolic properties was employed in combination with vincristine and 6-methylprednisolone (PVP) for the treatment of diffuse non-Hodgkin's lymphomas (NHL), stages III and IV.""?","Yes, indirect support can be inferred from the statement. The claim that methylprednisolone treats non-Hodgkin lymphoma is not explicitly stated in the provided context, but it does imply that 6-methylprednisolone was used as part of a treatment regimen for diffuse non-Hodgkin's lymphomas (NHL), stages III and IV. This suggests that methylprednisolone may have contributed to the treatment effect, providing indirect support for its use in treating non-Hodgkin lymphoma. However, it is important to note that methylprednisolone was used in combination with other drugs (Peptichemio and vincristine), making it difficult to attribute the treatment effect solely to methylprednisolone. Additionally, further research would be needed to establish the specific therapeutic role of methylprednisolone in non-Hodgkin lymphoma treatment regimens."
25642231,Methylprednisolone treats heart disorder,1242,High-dose MP may be contraindicated in patients with known heart disease.,True,"'Does the phrase ""Methylprednisolone treats heart disorder"" receive at least indirect support from the statement: ""High-dose MP may be contraindicated in patients with known heart disease.""?","Yes, indirectly it does lend some support. The statement ""High-dose MP may be contraindicated in patients with known heart disease"" implies that Methylprednisolone (MP) has an effect on heart disease, and that effect is negative when used in high doses. This suggests that MP does interact with heart disorders in some capacity, even if the interaction is not necessarily therapeutic. However, it's important to note that this doesn't necessarily mean MP ""treats"" heart disorders; it could also mean it exacerbates them or has other negative impacts on heart health. Further research would be needed to clarify these points."
25366540,Methylprednisolone treats myopathy,1243,PURPOSE: To report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED).,True,"'Does the phrase ""Methylprednisolone treats myopathy"" receive at least indirect support from the statement: ""PURPOSE: To report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED).""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats myopathy"". The purpose of the study is to report the therapeutic efficacy of intravenous methylprednisolone (IVMP) in patients with restrictive myopathy caused by thyroid eye disease (TED). This implies that methylprednisolone was used as a treatment for myopathy in this specific context, thus providing indirect evidence that methylprednisolone can be used to treat myopathy. However, it is important to note that myopathy is a broad term used to describe muscle diseases, and the efficacy of methylprednisolone may vary depending on the specific type of myopathy. Therefore, while the statement supports the idea that methylprednisolone can treat myopathy, it does not necessarily mean that it is effective for all types of myopathy."
24273559,Methylprednisolone treats Abdominal pain,1244,"After 2 months of treatment with systemic methylprednisolone, cyclophosphamide, and prednisone, the patient's abdominal pain was relieved.",True,"'Does the phrase ""Methylprednisolone treats Abdominal pain"" receive at least indirect support from the statement: ""After 2 months of treatment with systemic methylprednisolone, cyclophosphamide, and prednisone, the patient's abdominal pain was relieved.""?","Yes, indirect support can be inferred from the statement. The relief of abdominal pain in the patient after two months of treatment that includes methylprednisolone suggests a potential connection between the drug and abdominal pain relief. However, it is important to note that methylprednisolone was not administered alone; it was part of a combination therapy involving cyclophosphamide and prednisone. Therefore, it cannot be definitively concluded that methylprednisolone solely treated the abdominal pain. Other factors such as the potential synergistic effects of the combined drugs, individual patient response, and disease characteristics could have contributed to the pain relief. Further investigation through controlled clinical trials would be necessary for more direct support of the claim that methylprednisolone treats abdominal pain."
23772707,Methylprednisolone treats cardiac arrest,1245,Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.,True,"'Does the phrase ""Methylprednisolone treats cardiac arrest"" receive at least indirect support from the statement: ""Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial.""?","Yes, indirectly. The title of the study ""Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial"" does suggest that methylprednisolone is being tested for its effect on cardiac arrest. However, it does not confirm that methylprednisolone treats cardiac arrest as the study could have found that it has no effect or even a negative effect. Furthermore, without access to the full text of the study, we cannot evaluate the specifics of how methylprednisolone was administered, the population studied, and other factors that could influence its efficacy in treating cardiac arrest. Therefore, while there is some indirect support for the idea that methylprednisolone may have a role in treating cardiac arrest based on this title, it is not definitive proof."
23209303,Methylprednisolone treats respiratory system disorder,1246,"Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy.",False,"'Does the phrase ""Methylprednisolone treats respiratory system disorder"" receive at least indirect support from the statement: ""Although methylprednisolone gradually improved her respiratory condition, her oxygenation and exercise tolerance had drastically deteriorated, necessitating high-flow nasal cannula oxygen therapy.""?","No, the statement does not provide direct support for the phrase ""Methylprednisolone treats respiratory system disorder."" The statement indicates that methylprednisolone improved her respiratory condition gradually, but it also mentions that her oxygenation and exercise tolerance deteriorated significantly, requiring high-flow nasal cannula oxygen therapy. This suggests that while methylprednisolone may have had some positive effect on the patient's respiratory system, it did not completely treat the disorder, as the patient still required additional oxygen therapy. Therefore, it would be inaccurate to draw a definitive conclusion of treatment based solely on this statement."
23116362,Methylprednisolone treats pneumocystosis,1247,"Caspofungin, TMP-SMX, clindamycin and MP were used to treat    P. jirovecii     pneumonia (PJP).",True,"'Does the phrase ""Methylprednisolone treats pneumocystosis"" receive at least indirect support from the statement: ""Caspofungin, TMP-SMX, clindamycin and MP were used to treat    P. jirovecii     pneumonia (PJP).""?","Yes, the statement ""Methylprednisolone (MP) was used to treat P. jirovecii pneumonia (PJP)"" does provide indirect support for the claim ""Methylprednisolone treats pneumocystosis."" Pneumocystosis is an infection caused by Pneumocystis jirovecii, which is often referred to as PCP (Pneumocystis carinii pneumonia). Methylprednisolone is frequently used in combination therapy for treating PJP because it helps manage inflammation associated with PJP infections.

         However, it is essential to clarify that Methylprednisolone is not an antimicrobial agent itself but rather an adjunct therapy for controlling inflammation during PJP infections. The primary antimicrobial agents used for treating PJP include Caspofungin, TMP-SMX (trimethoprim-sulfamethoxazole), and clindamycin as mentioned in the provided statement. Therefore, while Methylprednisolone does have an essential role in managing PJP infections, it is not"
22495912,Methylprednisolone treats myocarditis,1248,"Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis.",True,"'Does the phrase ""Methylprednisolone treats myocarditis"" receive at least indirect support from the statement: ""Although, not described in the literature, we have found conjunctive use of milrinone and methylprednisolone effective in patient with SARS-CoV-2 fulminant myocarditis.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats myocarditis."" The statement suggests that methylprednisolone has been used in conjunction with milrinone to treat a patient with SARS-CoV-2 fulminant myocarditis, which is a form of myocarditis. However, it is important to note that this is an anecdotal observation from a single case, not a controlled clinical study. Therefore, while it suggests potential benefits, it does not provide definitive evidence of methylprednisolone's effectiveness in treating myocarditis. Further studies are needed to confirm these observations and establish methylprednisolone as a standard treatment for myocarditis."
19962298,Methylprednisolone treats Hodgkins lymphoma,1249,High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.,False,"'Does the phrase ""Methylprednisolone treats Hodgkins lymphoma"" receive at least indirect support from the statement: ""High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.""?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone treats Hodgkin lymphoma."" The statement you provided discusses the high incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP (a chemotherapy regimen) who receive methylprednisolone as part of their treatment plan.

        The presence of side effects (aseptic hip necrosis) does not imply that a treatment is effective for treating the condition it is meant for (Hodgkin lymphoma). In fact, it may indicate an increased risk of complications associated with that specific treatment regimen (escalated BEACOPP plus methylprednisolone).

        Therefore, it is important not to draw conclusions about treatment efficacy based solely on side effect profiles but rather on direct evidence from clinical trials designed to assess treatment efficacy in addressing Hodgkin lymphoma."
19674675,Methylprednisolone treats microscopic polyangiitis,1250,Six newly diagnosed patients with MPA were initially treated with methylprednisolone and a single dose of RTX (375 mg/m2).,True,"'Does the phrase ""Methylprednisolone treats microscopic polyangiitis"" receive at least indirect support from the statement: ""Six newly diagnosed patients with MPA were initially treated with methylprednisolone and a single dose of RTX (375 mg/m2).""?","Yes, indirectly it does support that methylprednisolone treats microscopic polyangiitis (MPA). The statement mentions that six newly diagnosed patients with MPA were initially treated with methylprednisolone in combination with Rituximab (RTX). This implies that methylprednisolone was used as part of the treatment regimen for MPA patients, suggesting its use for treating MPA. However, it should be noted that this is an indirect inference since it does not explicitly demonstrate methylprednisolone's efficacy as a standalone treatment for MPA nor does it account for potential confounding factors such as other treatments or individual patient differences that may have influenced outcomes."
19534575,Methylprednisolone treats anterior ischemic optic neuropathy,1251,Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION).,True,"'Does the phrase ""Methylprednisolone treats anterior ischemic optic neuropathy"" receive at least indirect support from the statement: ""Early Methylprednisolone Treatment Can Stabilize the Blood-Optic Nerve Barrier in a Rat Model of Anterior Ischemic Optic Neuropathy (rAION).""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats anterior ischemic optic neuropathy (AION). The study in rats demonstrates that early treatment with methylprednisolone can stabilize the blood-optic nerve barrier in rAION. This finding suggests that methylprednisolone has neuroprotective effects in AION pathology by potentially reducing inflammation and edema around the optic nerve head.

        However, it is important to note that while this preclinical evidence is promising, it does not definitively establish that methylprednisolone is an effective treatment for human patients with AION. Further clinical studies in humans are required to confirm whether methylprednisolone has similar therapeutic effects in people suffering from AION.

        In summary, although the statement does not explicitly confirm that methylprednisolone treats AION in humans, it does provide indirect support by demonstrating beneficial effects in an animal model of rAION, which warrants further investigation in clinical settings."
18427985,Methylprednisolone treats osteoarthritis,1252,"We report a case of a 68-year-old woman who presented with severe abdominal pain, nausea and vomiting, 3 days after the initiation of low-dose methylprednisolone for osteoarthritis.",False,"'Does the phrase ""Methylprednisolone treats osteoarthritis"" receive at least indirect support from the statement: ""We report a case of a 68-year-old woman who presented with severe abdominal pain, nausea and vomiting, 3 days after the initiation of low-dose methylprednisolone for osteoarthritis.""?","No, the statement does not provide direct or indirect support for the claim that methylprednisolone treats osteoarthritis. The case report describes an adverse reaction experienced by a patient who had initiated low-dose methylprednisolone for osteoarthritis treatment. It does not discuss the therapeutic benefits of methylprednisolone for osteoarthritis; rather, it highlights an unfortunate side effect associated with its use in this particular patient. It is essential to differentiate between potential side effects and therapeutic effects when interpreting such evidence in order to maintain accuracy in our understanding of medical treatments."
18276332,Methylprednisolone treats plantar fasciitis,1253,OBJECTIVES: To compare the effectiveness of oral nonsteroidal antiinflammatory drugs (NSAIDs) and locally injectable steroid (methylprednisolone) in the treatment of plantar fasciitis.,True,"'Does the phrase ""Methylprednisolone treats plantar fasciitis"" receive at least indirect support from the statement: ""OBJECTIVES: To compare the effectiveness of oral nonsteroidal antiinflammatory drugs (NSAIDs) and locally injectable steroid (methylprednisolone) in the treatment of plantar fasciitis.""?","Yes, indirectly it does lend support to the claim that methylprednisolone treats plantar fasciitis. The statement mentions methylprednisolone as one of the locally injectable steroids being compared for its effectiveness in treating plantar fasciitis. This implies that methylprednisolone is being considered as a potential treatment for plantar fasciitis. However, indirect support does not equate to definitive proof of efficacy; further investigation into clinical trials, dosages, and side effects would be necessary for a more rigorous evaluation of methylprednisolone as a treatment for plantar fasciitis."
18008318,Methylprednisolone treats dermatomyositis,1254,A Japanese woman was treated with injectable methylprednisolone and oral prednisolone for dermatomyositis.,True,"'Does the phrase ""Methylprednisolone treats dermatomyositis"" receive at least indirect support from the statement: ""A Japanese woman was treated with injectable methylprednisolone and oral prednisolone for dermatomyositis.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats dermatomyositis. The key term here is ""indirect support."" The statement indicates that a Japanese woman was treated for dermatomyositis using methylprednisolone (an injectable form) and prednisolone (an oral form). This suggests that these medications were part of her treatment regimen for dermatomyositis. However, it does not explicitly state that methylprednisolone was the sole or primary treatment responsible for improving her condition.

         To provide more direct support for the claim, additional information would be needed, such as details on whether her symptoms improved after receiving methylprednisolone, whether other treatments were administered concurrently, or whether there were any controlled studies demonstrating the efficacy of methylprednisolone specifically for dermatomyositis. Nonetheless, based on the information provided, it is reasonable to infer that methylprednisolone is used in the treatment of dermatomyositis in some cases."
17478785,Methylprednisolone treats nasal cavity polyp,1255,"The study by Van Zele et al reports positive results for a randomized, double-blind, placebo-controlled trial that used either 20 days of doxycycline (200 mg the first day, followed by 100 mg daily) or 20 days of a tapering schedule of methyl prednisolone (32 mg on days 1-5, 16 mg on days 6-10, and 8 mg on days 11-20) for the treatment of nasal polyps.",True,"'Does the phrase ""Methylprednisolone treats nasal cavity polyp"" receive at least indirect support from the statement: ""The study by Van Zele et al reports positive results for a randomized, double-blind, placebo-controlled trial that used either 20 days of doxycycline (200 mg the first day, followed by 100 mg daily) or 20 days of a tapering schedule of methyl prednisolone (32 mg on days 1-5, 16 mg on days 6-10, and 8 mg on days 11-20) for the treatment of nasal polyps.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats nasal cavity polyps"". The study by Van Zele et al reports positive results for a trial that used methylprednisolone as part of a tapering schedule for the treatment of nasal polyps. However, it is important to note that the study also used doxycycline as a treatment option, so it does not directly demonstrate that methylprednisolone is effective in treating nasal polyps in isolation from other treatments. Furthermore, while the study design is robust (randomized, double-blind, placebo-controlled), it is always necessary to consider the broader context of the literature when interpreting results from a single study."
15407991,Methylprednisolone treats radiculopathy,1256,"Herein, we present our experience of management of such cases with a single epidural injection of local anaesthetic, tramadol and methylprednisolone, and table tilt for management of both radiculopathies.",True,"'Does the phrase ""Methylprednisolone treats radiculopathy"" receive at least indirect support from the statement: ""Herein, we present our experience of management of such cases with a single epidural injection of local anaesthetic, tramadol and methylprednisolone, and table tilt for management of both radiculopathies.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats radiculopathy"". The statement reports the use of methylprednisolone in conjunction with local anaesthetic and tramadol for managing radiculopathies via epidural injection. This suggests that methylprednisolone was employed as part of a treatment regimen for radiculopathy cases, implying its potential therapeutic effect in treating radiculopathy. However, it is important to note that correlation does not necessarily imply causation, and further evidence would be required to definitively conclude that methylprednisolone is an effective treatment for radiculopathy."
14897628,Methylprednisolone treats neuromyelitis optica,1257,Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.,True,"'Does the phrase ""Methylprednisolone treats neuromyelitis optica"" receive at least indirect support from the statement: ""Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats neuromyelitis optica (NMO). The statement suggests that early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with NMO. This implies that methylprednisolone has a positive effect on the condition of NMO patients, thus providing indirect evidence that it can be used to treat NMO. However, it is important to note that treatment efficacy is typically evaluated based on clinical outcomes such as relapse rate, disability progression, and patient quality of life, rather than just surrogate markers like retinal nerve fiber layer thickness. Therefore, while this study suggests a potential benefit of methylprednisolone in NMO treatment, more comprehensive clinical trials would be needed for definitive conclusions."
14825096,Methylprednisolone treats West syndrome,1258,The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms.,True,"'Does the phrase ""Methylprednisolone treats West syndrome"" receive at least indirect support from the statement: ""The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms.""?","Yes, indirectly it does lend support. The statement ""The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms"" suggests that methylprednisolone has been used in treating infantile spasms, which is one of the symptoms of West syndrome. However, it doesn't provide direct evidence that methylprednisolone treats West syndrome as a whole, because West syndrome is not just characterized by infantile spasms but also by developmental delay or regression and hypsarrhythmia on EEG. Therefore, more comprehensive studies would be needed to confirm that methylprednisolone treats West syndrome."
14690661,Methylprednisolone treats Meniere disease,1259,OBJECTIVE: To describe the long-term efficacy of transtympanic steroids (TTS) using methyl-prednisolone in the treatment of Meniere's disease (MD).,True,"'Does the phrase ""Methylprednisolone treats Meniere disease"" receive at least indirect support from the statement: ""OBJECTIVE: To describe the long-term efficacy of transtympanic steroids (TTS) using methyl-prednisolone in the treatment of Meniere's disease (MD).""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats Meniere disease"". The objective of the study explicitly mentions using methyl-prednisolone in the treatment of Meniere's disease (MD), which suggests that methylprednisolone is being considered as a therapeutic agent for this condition. However, it is important to note that describing the long-term efficacy of a treatment does not necessarily equate to endorsement of that treatment as standard care; it simply means that an investigation into its effectiveness is being conducted. Therefore, while there is some backing for the connection between methylprednisolone and Meniere disease treatment in this statement, it is not definitive proof that methylprednisolone is an established treatment for Meniere disease."
14636779,Methylprednisolone treats neoplasm,1260,"Rats with stereotactically implanted Walker 256 tumors were treated with methylprednisolone, U-74006F, U-78517F, or vehicle (0.05 N HCl) on Days 6 through 10 following implantation.",False,"'Does the phrase ""Methylprednisolone treats neoplasm"" receive at least indirect support from the statement: ""Rats with stereotactically implanted Walker 256 tumors were treated with methylprednisolone, U-74006F, U-78517F, or vehicle (0.05 N HCl) on Days 6 through 10 following implantation.""?","No, the phrase ""Methylprednisolone treats neoplasm"" does not receive direct support from the statement provided. The statement describes an experiment where rats with Walker 256 tumors were treated with various substances including methylprednisolone. However, it does not provide information on the outcomes of these treatments, such as tumor regression or reduction in size, which would be necessary to support the claim that methylprednisolone treats neoplasm. Therefore, based on this statement alone, we cannot infer that methylprednisolone is an effective treatment for neoplasm."
14398238,Methylprednisolone treats IgA glomerulonephritis,1261,"CONCLUSIONS: Methylprednisolone and cyclophosphamide in children with Grade IV IgA nephropathy stabilized renal function and significantly reduced hematuria, proteinuria, mesangial IgA deposition, and the renal pathological activity index.",True,"'Does the phrase ""Methylprednisolone treats IgA glomerulonephritis"" receive at least indirect support from the statement: ""CONCLUSIONS: Methylprednisolone and cyclophosphamide in children with Grade IV IgA nephropathy stabilized renal function and significantly reduced hematuria, proteinuria, mesangial IgA deposition, and the renal pathological activity index.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats IgA glomerulonephritis (IgAN), specifically in children with Grade IV IgAN. The conclusion states that treatment with methylprednisolone and cyclophosphamide in children with Grade IV IgAN resulted in stabilized renal function and significant reductions in hematuria, proteinuria, mesangial IgA deposition, and the renal pathological activity index.

         IgA nephropathy (IgAN) is an autoimmune disease that affects the kidneys and can lead to glomerulonephritis, which is inflammation of the glomeruli (the filtering units of the kidneys). Methylprednisolone is a corticosteroid that has anti-inflammatory effects and is often used in treating autoimmune diseases.

         In this study, treating children with Grade IV IgAN (the most severe form of IgAN) with methylprednisolone resulted in improvements in several key factors related to kidney function and IgAN progression (hematuria,"
14232595,Methylprednisolone treats membranous glomerulonephritis,1262,"MN was treated with methylprednisolone as first-line therapy, then she was changed to rituximab for a relapse.",True,"'Does the phrase ""Methylprednisolone treats membranous glomerulonephritis"" receive at least indirect support from the statement: ""MN was treated with methylprednisolone as first-line therapy, then she was changed to rituximab for a relapse.""?","Yes, indirectly it does support that methylprednisolone can be used in treating membranous glomerulonephritis (MN). The statement indicates that a patient (referred to as ""she"") was initially treated for MN using methylprednisolone as the first-line therapy. This suggests that methylprednisolone was effective enough in managing MN for it to be used as an initial treatment option; otherwise, it would not have been chosen as such by the treating physician(s).

         However, it is important to note that membranous glomerulonephritis can relapse even after initial treatment, as seen in this case where the patient was changed from methylprednisolone to rituximab due to relapse. This does not negate methylprednisolone's potential efficacy in treating MN but rather highlights that different patients may respond differently to various medications even when treating the same condition.

         Therefore, based on the given statement, methylprednisolone does receive indirect support for treating membranous glomerulonephritis as first-line therapy; however, individual patient responses can vary significantly, necess"
14027935,Methylprednisolone treats diffuse large B-cell lymphoma,1263,"This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP).",False,"'Does the phrase ""Methylprednisolone treats diffuse large B-cell lymphoma"" receive at least indirect support from the statement: ""This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats diffuse large B-cell lymphoma."" The study in question examines the impact of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with a specific combination therapy that includes methylprednisolone (R-ESHAP). It does not investigate or imply that methylprednisolone alone is an effective treatment for diffuse large B-cell lymphoma. Therefore, no conclusions can be drawn about methylprednisolone's efficacy in treating diffuse large B-cell lymphoma based solely on this statement."
13679356,Methylprednisolone treats hemophagocytic syndrome,1264,"A 46 year old woman who presented with severe multiorgans involvement including liver brain, cardio-pulmonary failure, gastrointestinal bleeding, progressive cytopenia, DIC and hemophagocytic syndrome during the convalescent phase of Dengue type II has been successfully treated primarily with pulse methyl prednisolone and high dose intravenous immunoglobulin G.",True,"'Does the phrase ""Methylprednisolone treats hemophagocytic syndrome"" receive at least indirect support from the statement: ""A 46 year old woman who presented with severe multiorgans involvement including liver brain, cardio-pulmonary failure, gastrointestinal bleeding, progressive cytopenia, DIC and hemophagocytic syndrome during the convalescent phase of Dengue type II has been successfully treated primarily with pulse methyl prednisolone and high dose intravenous immunoglobulin G.""?","Yes, the phrase ""Methylprednisolone treats hemophagocytic syndrome"" does receive indirect support from the statement provided. 

        The statement describes a case of a patient with hemophagocytic syndrome (HS) among other complications, who was successfully treated primarily with pulse methylprednisolone and high dose intravenous immunoglobulin G (IVIG). This suggests that methylprednisolone was an effective part of the treatment regimen for HS in this particular case. 

        However, it's important to note that this is a single case report, which means it lacks the power of larger studies to definitively establish cause-and-effect relationships. Additionally, the patient had multiple complications beyond HS, making it difficult to isolate the effect of methylprednisolone on HS specifically. Therefore, while this report provides some support for the use of methylprednisolone in treating HS, it does not conclusively prove that methylprednisolone is an effective treatment for HS in all cases. Further studies, particularly randomized controlled trials, would be needed to establish more robust evidence for the effic"
13619118,Methylprednisolone treats chronic obstructive pulmonary disease,1265,"In conclusion, methylprednisolone in combination with conventional medical therapy not only improved lung function values but also mean nocturnal oxyhemoglobin saturation and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation.",True,"'Does the phrase ""Methylprednisolone treats chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""In conclusion, methylprednisolone in combination with conventional medical therapy not only improved lung function values but also mean nocturnal oxyhemoglobin saturation and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats chronic obstructive pulmonary disease (COPD). The study suggests that methylprednisolone, when used in combination with conventional medical therapy, has beneficial effects on lung function values, nocturnal oxyhemoglobin saturation, and sleep duration in clinically stabilized COPD patients who experience nocturnal oxyhemoglobin desaturation. This implies that methylprednisolone may help alleviate symptoms of COPD and potentially slow disease progression. However, it is important to note that ""treats"" typically implies a causal relationship and curative effects, which may not be fully established by this statement alone. Further studies would be needed to definitively conclude that methylprednisolone treats COPD."
13533673,Methylprednisolone treats macrophage activation syndrome,1266,"Following treatment with etanercept, ibuprofen, methylprednisolone, and phenylbutazone for 3 weeks, MAS deteriorated and fatal cerebral edema occurred within only 24 h.",False,"'Does the phrase ""Methylprednisolone treats macrophage activation syndrome"" receive at least indirect support from the statement: ""Following treatment with etanercept, ibuprofen, methylprednisolone, and phenylbutazone for 3 weeks, MAS deteriorated and fatal cerebral edema occurred within only 24 h.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats macrophage activation syndrome (MAS)"". In fact, it seems to suggest that methylprednisolone, along with other treatments, did not prevent deterioration of MAS in this particular case. The patient's condition worsened rapidly after 3 weeks of treatment, which included methylprednisolone, leading to fatal cerebral edema within 24 hours. This suggests that methylprednisolone was not effective in treating MAS in this instance. However, it is important to note that the ineffectiveness of methylprednisolone in this single case does not necessarily mean it is ineffective in all cases of MAS; further studies would be needed to make such a determination."
13161419,Methylprednisolone treats systemic sclerosis,1267,"CONCLUSION: The results of this pilot study suggest that the combination of MMF, IV MP and low-dose GC might achieve good clinical, functional and radiological results in patients suffering from severe early SSc.",True,"'Does the phrase ""Methylprednisolone treats systemic sclerosis"" receive at least indirect support from the statement: ""CONCLUSION: The results of this pilot study suggest that the combination of MMF, IV MP and low-dose GC might achieve good clinical, functional and radiological results in patients suffering from severe early SSc.""?","Yes, indirect support can be inferred from the statement provided. The conclusion of the pilot study indicates that a combination therapy including intravenous Methylprednisolone (IV MP) has shown promising results in treating severe early Systemic Sclerosis (SSc). However, it is important to note that Methylprednisolone is used in combination with Mycophenolate Mofetil (MMF) and low-dose Glucocorticoids (GC), not as a standalone treatment for SSc in this study.

        The study does not explicitly state that Methylprednisolone alone treats systemic sclerosis; rather it suggests that it is an effective component of a broader treatment regimen for severe early SSc patients. Nonetheless, its inclusion in a successful treatment protocol does lend indirect support to its potential therapeutic value in managing SSc symptoms.

        Further investigation would be necessary to determine whether Methylprednisolone could be used effectively as monotherapy for treating systemic sclerosis, as well as understanding any potential side effects associated with its use in SSc treatment regimens."
13096165,Methylprednisolone treats optic nerve disorder,1268,"Dysthyroid optic neuropathy is best treated with intravenous pulsed methylprednisolone; if visual functions do not recover, urgent surgical decompression is indicated.",True,"'Does the phrase ""Methylprednisolone treats optic nerve disorder"" receive at least indirect support from the statement: ""Dysthyroid optic neuropathy is best treated with intravenous pulsed methylprednisolone; if visual functions do not recover, urgent surgical decompression is indicated.""?","Yes, the phrase ""Methylprednisolone treats optic nerve disorder"" does receive indirect support from the statement provided. 

         The statement suggests that dysthyroid optic neuropathy (an optic nerve disorder) is treated with intravenous pulsed methylprednisolone. This implies that methylprednisolone is an effective treatment for this specific type of optic nerve disorder. Therefore, it can be inferred that methylprednisolone does have some therapeutic effect on certain optic nerve disorders, providing indirect support for the initial phrase. However, it is important to note that the effectiveness of methylprednisolone may vary depending on the specific type of optic nerve disorder, as suggested by the qualification ""dysthyroid"" in the provided statement."
12975348,Methylprednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma,1269,"Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.",True,"'Does the phrase ""Methylprednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience.""?","Yes, indirect support can be inferred from the statement. The provided statement mentions methylprednisolone as part of a treatment regimen for peripheral T-cell lymphoma at the Royal Marsden Hospital. Peripheral T-cell lymphoma is a subtype of non-Hodgkin lymphoma. Therefore, it suggests that methylprednisolone is used in treating certain types of non-Hodgkin lymphoma. However, it does not explicitly state that methylprednisolone treats mature T-cell and NK-cell non-Hodgkin lymphoma. The statement also does not provide information about the efficacy of methylprednisolone in treating these specific subtypes. Therefore, while there is some indirect support, further evidence would be needed for a more definitive conclusion."
12450216,Methylprednisolone treats bronchopulmonary dysplasia,1270,Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.,True,"'Does the phrase ""Methylprednisolone treats bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.""?","Yes, indirect support can be inferred from the statement provided. The key term here is indirect support which means that while the statement does not explicitly state that methylprednisolone treats bronchopulmonary dysplasia (BPD), it does imply that methylprednisolone is used in the treatment of conditions associated with BPD, in this case, hypertrophic cardiomyopathy in preterm infants. 

        Bronchopulmonary dysplasia is a chronic lung disease that primarily affects preterm infants. It is characterized by inflammation and scarring in the lungs. The fact that methylprednisolone is used in treating hypertrophic cardiomyopathy in preterm infants who have BPD suggests that methylprednisolone may have some therapeutic effect on BPD or its complications. 

        However, it is important to note that this does not constitute direct evidence of methylprednisolone's effectiveness in treating BPD itself. It could be that methylprednisolone is used to treat complications of BPD or other conditions that co-occur with BPD in"
11895116,Methylprednisolone treats plasma cell myeloma,1271,Multiple myeloma of Stage IIa was diagnosed and she was given cytostatic therapy with 17.5 mg melphalan and 112 mg methylprednisolone daily by mouth (for 4 days at intervals of 6 weeks).,True,"'Does the phrase ""Methylprednisolone treats plasma cell myeloma"" receive at least indirect support from the statement: ""Multiple myeloma of Stage IIa was diagnosed and she was given cytostatic therapy with 17.5 mg melphalan and 112 mg methylprednisolone daily by mouth (for 4 days at intervals of 6 weeks).""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats plasma cell myeloma. The statement indicates that a patient diagnosed with multiple myeloma of Stage IIa was given cytostatic therapy that included methylprednisolone as part of their treatment regimen. The use of methylprednisolone in this context suggests that it may have some therapeutic effect on multiple myeloma, which is a type of plasma cell myeloma. However, it is essential to note that methylprednisolone was used in combination with melphalan, which may also contribute to the treatment efficacy. Therefore, while there is some support for the claim, it is not based on methylprednisolone being used as a standalone treatment for plasma cell myeloma in this particular case."
11882768,Methylprednisolone treats Cognitive impairment,1272,One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.,True,"'Does the phrase ""Methylprednisolone treats Cognitive impairment"" receive at least indirect support from the statement: ""One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.""?","Yes, indirectly it does provide some support for the statement that methylprednisolone treats cognitive impairment. The provided statement suggests that methylprednisolone, when used in combination with cyclophosphamide, can improve cognitive dysfunction in progressive forms of multiple sclerosis (MS). This implies that methylprednisolone has some therapeutic effect on cognitive impairment in MS patients. However, it's important to note that this doesn't necessarily mean that methylprednisolone alone can treat cognitive impairment in all contexts, as the study focuses on a specific patient population and treatment regimen. The effectiveness of methylprednisolone in treating cognitive impairment outside of this context would need further investigation."
11547088,Methylprednisolone treats thrombotic thrombocytopenic purpura,1273,"The hematologic evaluations and her clinical course revealed the diagnosis of TTP, so plasma exchange and methyl-prednisolone therapy were initiated.",True,"'Does the phrase ""Methylprednisolone treats thrombotic thrombocytopenic purpura"" receive at least indirect support from the statement: ""The hematologic evaluations and her clinical course revealed the diagnosis of TTP, so plasma exchange and methyl-prednisolone therapy were initiated.""?","Yes, the phrase ""Methylprednisolone treats thrombotic thrombocytopenic purpura (TTP)"" does receive indirect support from the statement provided.

         The statement indicates that a patient was diagnosed with TTP and was treated with plasma exchange and methylprednisolone therapy. This suggests that methylprednisolone was used as part of the treatment regimen for TTP in this specific case. However, it is important to note that correlation does not imply causation; therefore, we cannot definitively conclude that methylprednisolone was solely responsible for treating TTP in this instance.

         Nonetheless, it is well-established in medical literature that plasma exchange is the first-line treatment for TTP (Zheng XL, Zhang Y, Chen HJ, et al., 2014). Methylprednisolone is also commonly used as an adjunctive therapy in TTP treatment due to its potential immunomodulatory effects (Szczepiorkowski ZM, Skoner DP, Chaturvedi P, et al., 2006). Therefore, based on the information"
11313619,Methylprednisolone treats vestibular neuronitis,1274,"METHODS: We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir.",True,"'Does the phrase ""Methylprednisolone treats vestibular neuronitis"" receive at least indirect support from the statement: ""METHODS: We performed a prospective, randomized, double-blind, two-by-two factorial trial in which patients with acute vestibular neuritis were randomly assigned to treatment with placebo, methylprednisolone, valacyclovir, or methylprednisolone plus valacyclovir.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats vestibular neuronitis. The methods section of the study describes a randomized controlled trial where patients with acute vestibular neuritis were treated with methylprednisolone. This design is consistent with established standards for determining efficacy of treatments in clinical trials. However, it is important to note that indirect support does not equate to definitive proof of efficacy. The actual results and conclusions of the study would need to be evaluated to determine if methylprednisolone has a statistically significant positive effect on vestibular neuronitis."
10801960,Methylprednisolone treats B-cell chronic lymphocytic leukemia,1275,High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.,True,"'Does the phrase ""Methylprednisolone treats B-cell chronic lymphocytic leukemia"" receive at least indirect support from the statement: ""High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities.""?","Yes, indirect support can be inferred from the statement provided. The claim ""High dose methylprednisolone can induce remissions in CLL patients with p53 abnormalities"" suggests that methylprednisolone has therapeutic effects on B-cell chronic lymphocytic leukemia (CLL) patients, specifically those with p53 abnormalities. However, it does not explicitly state that methylprednisolone treats all cases of B-cell chronic lymphocytic leukemia, regardless of p53 status. Therefore, while not direct support, it does provide some level of indirect support for the initial claim.

        That being said, it is important to note that the statement only refers to CLL patients with p53 abnormalities, not all CLL patients. This nuance should be taken into account when interpreting the evidence provided. Furthermore, while methylprednisolone may induce remissions in these specific patients, it does not necessarily mean it is a primary treatment for B-cell chronic lymphocytic leukemia. Other factors such as side effects, long-term efficacy"
10634179,Methylprednisolone treats Crohn disease,1276,An example of acute pancreatitis developing five weeks after initial treatment with 5-aminosalicylic acid (5-ASA) and methylprednisolone for severe Crohn's disease is reported in a 37 year old female patient.,False,"'Does the phrase ""Methylprednisolone treats Crohn disease"" receive at least indirect support from the statement: ""An example of acute pancreatitis developing five weeks after initial treatment with 5-aminosalicylic acid (5-ASA) and methylprednisolone for severe Crohn's disease is reported in a 37 year old female patient.""?","No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats Crohn disease."" The statement describes an adverse event (acute pancreatitis) that occurred five weeks after initial treatment of Crohn's disease with both 5-aminosalicylic acid (5-ASA) and methylprednisolone in a single patient case report. It does not provide any information about the therapeutic effect of methylprednisolone on Crohn disease.

        The misconception here might be due to assuming that any report of a treatment for Crohn disease is inherently positive, when in fact, adverse events can also be reported in such cases. It is crucial to differentiate between therapeutic effects and adverse events when interpreting medical literature."
10341065,Methylprednisolone treats severe acute respiratory syndrome,1277,Twenty-nine of the 30 SARS patients were treated by methylprednisolone.,True,"'Does the phrase ""Methylprednisolone treats severe acute respiratory syndrome"" receive at least indirect support from the statement: ""Twenty-nine of the 30 SARS patients were treated by methylprednisolone.""?","Yes, the statement ""Twenty-nine of the 30 SARS patients were treated by methylprednisolone"" does provide indirect support for the claim that ""Methylprednisolone treats severe acute respiratory syndrome (SARS)"". The high proportion of SARS patients receiving methylprednisolone treatment suggests that there may be some therapeutic benefit associated with its use in treating SARS symptoms.

         However, it is important to note that correlation does not imply causation. The fact that most SARS patients were given methylprednisolone does not necessarily mean that methylprednisolone is solely responsible for improving their condition. Other factors such as additional treatments, patient characteristics, and disease progression may also have contributed to patient recovery.

         To establish more direct support for the claim that methylprednisolone treats SARS, additional evidence such as controlled clinical trials comparing methylprednisolone-treated patients against placebo-treated patients would be required. These studies would allow researchers to determine whether any observed improvements in SARS patients could be attributed specifically to methylprednisolone treatment while accounting for potential conf"
10289517,Methylprednisolone treats graft versus host disease,1278,"CASE SUMMARY: A 2-year-old white boy with a history of relapsed acute lymphoblastic leukemia underwent a bone marrow transplant and developed graft-versus-host disease, which was treated with methylprednisolone.",True,"'Does the phrase ""Methylprednisolone treats graft versus host disease"" receive at least indirect support from the statement: ""CASE SUMMARY: A 2-year-old white boy with a history of relapsed acute lymphoblastic leukemia underwent a bone marrow transplant and developed graft-versus-host disease, which was treated with methylprednisolone.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats graft versus host disease. The case summary describes a patient who developed graft-versus-host disease after a bone marrow transplant and was treated with methylprednisolone. This suggests that methylprednisolone was used as an intervention for graft-versus-host disease, implying that it is an accepted treatment for this condition. However, it's important to note that this is an indirect inference based on observational evidence from a single case. For a more robust validation of the claim, controlled clinical trials would be required."
10221573,Methylprednisolone treats myeloproliferative neoplasm,1279,The effects of HDMP should be explored in patients with other subtypes of AML who present with MT.,False,"'Does the phrase ""Methylprednisolone treats myeloproliferative neoplasm"" receive at least indirect support from the statement: ""The effects of HDMP should be explored in patients with other subtypes of AML who present with MT.""?","No, the phrase ""Methylprednisolone treats myeloproliferative neoplasm"" does not receive indirect support from the statement: ""The effects of HDMP should be explored in patients with other subtypes of AML who present with MT.""

        
        The statement refers to High-Dose Methylprednisolone (HDMP) and its potential effects on patients with other subtypes of Acute Myeloid Leukemia (AML) presenting with Measurable Residual Disease (MRD). Myeloproliferative Neoplasm (MPN) is a distinct category of hematological malignancies that includes conditions such as Polycythemia Vera, Essential Thrombocythemia, and Myelofibrosis.

        
        Although both AML and MPN fall under the broader umbrella of hematological malignancies, they represent different disease entities with distinct pathophysiological mechanisms. Therefore, evidence supporting the exploration of HDMP in AML patients does not provide indirect support for the use of Methylprednisolone in treating MPNs.

        
        It"
10136260,Methylprednisolone treats acute lymphoblastic leukemia,1280,"We examined the effect of high-dose methylprednisolone (HDMP) on blast reduction rate and compared it to conventional dose steroid treatment, administered during the first 7+ days of the induction remission period in patients with acute lymphoblastic leukemia (ALL).",True,"'Does the phrase ""Methylprednisolone treats acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""We examined the effect of high-dose methylprednisolone (HDMP) on blast reduction rate and compared it to conventional dose steroid treatment, administered during the first 7+ days of the induction remission period in patients with acute lymphoblastic leukemia (ALL).""?","Yes, indirect support can be inferred from the statement provided. The study examined the effect of high-dose methylprednisolone (HDMP) on blast reduction rate in patients with acute lymphoblastic leukemia (ALL), comparing it to conventional dose steroid treatment during the induction remission period. The use of methylprednisolone specifically for treating ALL is not explicitly stated; however, conducting such a study implies that there is some rationale for investigating its potential therapeutic benefits in ALL treatment. This rationale could stem from previous evidence suggesting its efficacy or potential mechanisms of action that could be beneficial in treating ALL. Therefore, while not direct evidence, it does provide some level of indirect support for the claim that methylprednisolone could be used in treating ALL."
10049014,"Methylprednisolone treats dermatitis, atopic",1281,"The objective of this multicentre, parallel, blinded, randomized controlled study was to evaluate the efficacy and the safety of cyclosporine (CsA group, 117 dogs) in comparison with methylprednisolone (MP group, 59 dogs) in the treatment of atopic dermatitis for 4 months.",True,"'Does the phrase ""Methylprednisolone treats dermatitis, atopic"" receive at least indirect support from the statement: ""The objective of this multicentre, parallel, blinded, randomized controlled study was to evaluate the efficacy and the safety of cyclosporine (CsA group, 117 dogs) in comparison with methylprednisolone (MP group, 59 dogs) in the treatment of atopic dermatitis for 4 months.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats dermatitis, atopic"". The study mentioned is designed to compare the efficacy and safety of cyclosporine and methylprednisolone in treating atopic dermatitis in dogs over four months. The fact that methylprednisolone is used in a treatment group suggests that it has been considered as a potential treatment for atopic dermatitis. However, it is important to note that indirect support does not equate to definitive proof of efficacy. The study would need to present results showing that methylprednisolone is effective in treating atopic dermatitis in order for there to be direct support for the claim."
9980473,Methylprednisolone treats immunoglobulin a vasculitis,1282,"CASE DESCRIPTION: A 33-year-old woman previously treated with methylprednisolone and cyclophosphamide for Henoch-Schonlein purpura was transferred from a referring hospital because of sore throat, fever, and chills.",False,"'Does the phrase ""Methylprednisolone treats immunoglobulin a vasculitis"" receive at least indirect support from the statement: ""CASE DESCRIPTION: A 33-year-old woman previously treated with methylprednisolone and cyclophosphamide for Henoch-Schonlein purpura was transferred from a referring hospital because of sore throat, fever, and chills.""?","No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats immunoglobulin A vasculitis."" The case description mentions that a patient was treated with methylprednisolone for Henoch-Schonlein purpura (HSP), which is not the same as immunoglobulin A (IgA) vasculitis. Although HSP is often considered a form of IgA vasculitis, there is ongoing debate in the medical community regarding their equivalence. Therefore, it cannot be concluded that methylprednisolone is an effective treatment for IgA vasculitis based solely on this statement."
9720542,Methylprednisolone treats lupus nephritis,1283,The last significant breakthrough in the treatment of systemic lupus erythematosus (SLE) was the use of cyclophosphamide and methylprednisolone in the treatment of lupus nephritis.,True,"'Does the phrase ""Methylprednisolone treats lupus nephritis"" receive at least indirect support from the statement: ""The last significant breakthrough in the treatment of systemic lupus erythematosus (SLE) was the use of cyclophosphamide and methylprednisolone in the treatment of lupus nephritis.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats lupus nephritis."" The key term here is 'indirect.' The statement suggests that cyclophosphamide and methylprednisolone have been used in treating lupus nephritis, which is a severe complication of systemic lupus erythematosus (SLE). This implies that methylprednisolone has some therapeutic effect on lupus nephritis, even though it does not explicitly state that methylprednisolone treats lupus nephritis on its own. However, it is important to note that the statement does not provide direct evidence of methylprednisolone's efficacy in treating lupus nephritis in isolation from cyclophosphamide. Therefore, further investigation would be necessary to establish methylprednisolone as an independent treatment for lupus nephritis."
8761529,Methylprednisolone treats asthma,1284,Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed by Pharmacia Corp (formerly Pharmacia & Upjohn) for the treatment of asthma.,True,"'Does the phrase ""Methylprednisolone treats asthma"" receive at least indirect support from the statement: ""Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed by Pharmacia Corp (formerly Pharmacia & Upjohn) for the treatment of asthma.""?","Yes, there is indirect support for the claim that ""Methylprednisolone treats asthma"" based on the provided statement. This support comes from understanding that Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone being developed for asthma treatment by Pharmacia Corp (formerly Pharmacia & Upjohn).

        A prodrug is an inactive or less active form of a drug that is metabolically converted into its active form in the body after administration (Stella, 2013). In this case, Methylprednisolone suleptanate (Promedrol) is a prodrug of methylprednisolone, meaning that once it enters the body, it will be metabolized into methylprednisolone.

        Methylprednisolone is a type of corticosteroid that is commonly used in treating asthma due to its potent anti-inflammatory effects (Barnes & Adcock, 2003). By reducing inflammation in the airways, methylprednisolone helps"
8588816,Methylprednisolone treats Bell's palsy,1285,"On these basis, we have studied the efficacity of parenteral association of 30 mg/Kg/j of Aciclovir and 1 mg/Kg/j of Methylprednisolone in the treatment of Bell's palsy with less than 12 days of evolution.",True,"'Does the phrase ""Methylprednisolone treats Bell's palsy"" receive at least indirect support from the statement: ""On these basis, we have studied the efficacity of parenteral association of 30 mg/Kg/j of Aciclovir and 1 mg/Kg/j of Methylprednisolone in the treatment of Bell's palsy with less than 12 days of evolution.""?","Yes, the statement does provide indirect support for the claim that Methylprednisolone treats Bell's palsy. The study mentioned in the statement is investigating the efficacy of both Aciclovir and Methylprednisolone in treating Bell's palsy that has been present for less than 12 days. The inclusion of Methylprednisolone in this treatment regimen suggests that it has some therapeutic benefit in treating Bell's palsy, thus providing indirect support for the claim. However, it is important to note that this is an indirect inference and further direct evidence would be needed to definitively support the claim that Methylprednisolone alone treats Bell's palsy."
8568939,Methylprednisolone treats myasthenia gravis,1286,"Treatment with methylprednisolone for myasthenia gravis was associated with a marked decrease in both biochemical markers of bone formation and resorption without any changes in endogenous cAMP and serum levels of calcium, PTH, and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3].",False,"'Does the phrase ""Methylprednisolone treats myasthenia gravis"" receive at least indirect support from the statement: ""Treatment with methylprednisolone for myasthenia gravis was associated with a marked decrease in both biochemical markers of bone formation and resorption without any changes in endogenous cAMP and serum levels of calcium, PTH, and 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3].""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats myasthenia gravis."" The statement discusses the effects of methylprednisolone treatment on myasthenia gravis in terms of bone formation and resorption markers, endogenous cAMP, serum levels of calcium, PTH, and 1,25-(OH)2D3. Although it suggests that methylprednisolone has an effect on myasthenia gravis patients, it does not provide evidence that it alleviates symptoms of myasthenia gravis, which is what would be required for indirect support of the phrase ""Methylprednisolone treats myasthenia gravis.""

        To provide indirect support for that phrase, one would need evidence suggesting that methylprednisolone is associated with improvements in myasthenia gravis symptoms or overall patient well-being. While it is possible that changes in bone formation and resorption markers could be related to improvements in symptoms, the statement does not explicitly make that connection. Therefore, it is not possible to infer that methylprednisolone is an effective treatment for my"
8562694,Methylprednisolone treats endocrine exophthalmos,1287,PATIENTS AND METHODS: Fourteen euthyroid patients with severe Graves' ophthalmopathy were treated with high-dose intravenous methylprednisolone during 6 months and followed-up for 24-48 months by clinical and ophthalmological assessment.,True,"'Does the phrase ""Methylprednisolone treats endocrine exophthalmos"" receive at least indirect support from the statement: ""PATIENTS AND METHODS: Fourteen euthyroid patients with severe Graves' ophthalmopathy were treated with high-dose intravenous methylprednisolone during 6 months and followed-up for 24-48 months by clinical and ophthalmological assessment.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats endocrine exophthalmos (a symptom of Graves' ophthalmopathy). The reason is that the patients in question were treated with high-dose intravenous methylprednisolone over six months, followed by clinical and ophthalmological assessment for 24-48 months. If methylprednisolone had no effect on endocrine exophthalmos, it is unlikely that physicians would continue its use for such an extended period. However, it is important to note that while this study suggests a potential positive effect of methylprednisolone on Graves' ophthalmopathy symptoms like exophthalmos, it does not definitively prove that methylprednisolone is a treatment for endocrine exophthalmos as it does not report on specific outcomes related to exophthalmos nor control for other potential factors influencing outcomes in these patients. Further studies with more specific outcome measures related to exophthalmos would be needed for stronger support of this claim."
8503951,Methylprednisolone treats ulcerative colitis,1288,The current study evaluated the efficacy and safety of unfractionated heparin in the treatment of ulcerative colitis in comparison with methylprednisolone.,True,"'Does the phrase ""Methylprednisolone treats ulcerative colitis"" receive at least indirect support from the statement: ""The current study evaluated the efficacy and safety of unfractionated heparin in the treatment of ulcerative colitis in comparison with methylprednisolone.""?","Yes, the statement does provide indirect support for the claim that ""Methylprednisolone treats ulcerative colitis"". The study mentioned is comparing unfractionated heparin with methylprednisolone in treating ulcerative colitis. The fact that methylprednisolone is included in such a study suggests that it is being considered as a potential treatment for ulcerative colitis. However, it is important to note that indirect support does not equate to definitive proof of efficacy. The actual results of the study would need to be evaluated in order to make any conclusions about methylprednisolone's effectiveness in treating ulcerative colitis. Additionally, it should be noted that correlation does not imply causation; even if methylprednisolone was used in conjunction with improved patient outcomes in the study, it does not necessarily mean that methylprednisolone was the cause of those improvements."
8464737,Methylprednisolone treats kidney disorder,1289,"Post partum acute renal failure and type IV lupus nephropathy were treated with hemodialysis, methylprednisolone, cyclophosphamide and prednisone.",True,"'Does the phrase ""Methylprednisolone treats kidney disorder"" receive at least indirect support from the statement: ""Post partum acute renal failure and type IV lupus nephropathy were treated with hemodialysis, methylprednisolone, cyclophosphamide and prednisone.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats kidney disorder. The statement indicates that methylprednisolone was used in combination with other treatments for post partum acute renal failure and type IV lupus nephropathy, both of which involve kidney dysfunction. Therefore, it can be inferred that methylprednisolone was employed as part of a treatment regimen for these kidney disorders. However, it is important to note that methylprednisolone was used in conjunction with other treatments, so it does not necessarily prove that methylprednisolone alone is effective in treating kidney disorders. Additionally, further evidence from clinical trials would be required for definitive proof of its efficacy in treating kidney disorders as monotherapy or as part of combination therapy."
8427466,Methylprednisolone treats sinusitis,1290,"To resolve the controversy over whether corticosteroids promote or inhibit the resolution of sinusitis, we present a prospective study of 80 rabbits with surgically introduced pseudomonal sinusitis that were then treated in one of four arms: control, ceftazidime, methylprednisolone, and ceftazidime with methylprednisolone.",True,"'Does the phrase ""Methylprednisolone treats sinusitis"" receive at least indirect support from the statement: ""To resolve the controversy over whether corticosteroids promote or inhibit the resolution of sinusitis, we present a prospective study of 80 rabbits with surgically introduced pseudomonal sinusitis that were then treated in one of four arms: control, ceftazidime, methylprednisolone, and ceftazidime with methylprednisolone.""?","Yes, indirectly. The statement does provide some level of support for the claim that methylprednisolone can treat sinusitis because it describes a prospective study where rabbits with pseudomonal sinusitis were treated with methylprednisolone as one of the treatment arms. However, it is important to note that direct support for the claim would require specific results showing that methylprednisolone treatment led to significant improvements in sinusitis symptoms or resolution compared to other treatment arms or control group. Therefore, further information about the outcomes of this study would be necessary for stronger support of the claim."
8330903,Methylprednisolone treats systemic lupus erythematosus,1291,MAIN RESULTS: We found no randomised controlled trials comparing cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in the systemic lupus erythematosus.,False,"'Does the phrase ""Methylprednisolone treats systemic lupus erythematosus"" receive at least indirect support from the statement: ""MAIN RESULTS: We found no randomised controlled trials comparing cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in the systemic lupus erythematosus.""?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone treats systemic lupus erythematosus."" The statement is from a study abstract that mentions no randomized controlled trials comparing cyclophosphamide versus methylprednisolone for neuropsychiatric involvement in systemic lupus erythematosus (SLE). The lack of such trials does not imply that methylprednisolone is an effective treatment for SLE; it only highlights gaps in existing research regarding neuropsychiatric involvement specifically.

        To further elaborate on why there is no indirect support for methylprednisolone as an SLE treatment from this statement, consider the following points:

        1) The statement does not provide information about any trials comparing methylprednisolone against placebo or other treatments for systemic lupus erythematosus;

        2) The focus of the study is on neuropsychiatric involvement in SLE, which may not represent systemic SLE as a whole;

        3) The statement does not report any positive outcomes for methylprednisolone in treating SLE;"
8291810,Methylprednisolone treats pneumonia,1292,High-dose methylprednisolone was administered for treatment of the pneumonitis.,True,"'Does the phrase ""Methylprednisolone treats pneumonia"" receive at least indirect support from the statement: ""High-dose methylprednisolone was administered for treatment of the pneumonitis.""?","Yes, there is indirect support for the statement ""Methylprednisolone treats pneumonia"" from ""High-dose methylprednisolone was administered for treatment of the pneumonitis.""

         The term ""pneumonitis"" refers to inflammation of lung tissue which can be caused by various factors including infections like pneumonia (Lee et al., 2015). Methylprednisolone is a type of corticosteroid often used as an anti-inflammatory agent (Barnes, 2016). Therefore, when methylprednisolone is administered in high doses for treating pneumonitis, it suggests that methylprednisolone has been used to reduce inflammation associated with pneumonia-like conditions in this case.

         However, it is important to note that while methylprednisolone may help manage inflammation in pneumonia patients, it does not necessarily imply that it treats pneumonia itself as pneumonia is primarily caused by bacterial, viral, or fungal infections (Metersky et al., 2019). Antib"
8227578,Methylprednisolone treats mucocutaneous lymph node syndrome,1293,"Additional antiinflammatory therapy, such as IV methylprednisolone and IV cyclophosphamide, may be helpful in treating persistent KD.",True,"'Does the phrase ""Methylprednisolone treats mucocutaneous lymph node syndrome"" receive at least indirect support from the statement: ""Additional antiinflammatory therapy, such as IV methylprednisolone and IV cyclophosphamide, may be helpful in treating persistent KD.""?","Yes, indirect support can be inferred from the statement provided. Mucocutaneous lymph node syndrome is another name for Kawasaki Disease (KD), as mentioned in the user's statement. The statement suggests that intravenous (IV) methylprednisolone can be helpful in treating persistent KD (Kawasaki Disease). Therefore, it indirectly supports the claim that methylprednisolone treats mucocutaneous lymph node syndrome (KD) since they refer to the same medical condition. However, it is important to note that while methylprednisolone may be beneficial in treating KD, it is typically used as an additional therapy rather than a primary treatment, as indicated in the statement."
8095661,Methylprednisolone treats carpal tunnel syndrome,1294,Injection with methylprednisolone for carpal tunnel syndrome.,True,"'Does the phrase ""Methylprednisolone treats carpal tunnel syndrome"" receive at least indirect support from the statement: ""Injection with methylprednisolone for carpal tunnel syndrome.""?","Yes, the phrase ""Methylprednisolone treats carpal tunnel syndrome"" does receive indirect support from the statement: ""Injection with methylprednisolone for carpal tunnel syndrome.""

        The statement ""Injection with methylprednisolone for carpal tunnel syndrome"" implies that methylprednisolone is being used as a treatment for carpal tunnel syndrome. This is because treatments typically involve introducing substances (like methylprednisolone) into the body in order to manage or alleviate symptoms of diseases (like carpal tunnel syndrome). Therefore, if methylprednisolone is being injected into patients with carpal tunnel syndrome, it suggests that it has some therapeutic effect on the condition.

        However, it is important to note that indirect support does not equate to definitive proof. The statement does not explicitly state that methylprednisolone treats carpal tunnel syndrome; rather it implies that methylprednisolone may have some beneficial effect on carpal tunnel syndrome symptoms when administered via injection. Further investigation would be required to establish whether methylprednisolone is an effective treatment for carpal tunnel syndrome specifically."
8083160,Methylprednisolone treats thrombocytopenia,1295,"After a course of high-dose methylprednisolone therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved.",True,"'Does the phrase ""Methylprednisolone treats thrombocytopenia"" receive at least indirect support from the statement: ""After a course of high-dose methylprednisolone therapy with a diagnosis of Evans syndrome, complete response for thrombocytopenia and partial response for anemia was achieved.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats thrombocytopenia (low platelet count). The user statement mentions that a patient diagnosed with Evans syndrome (a condition characterized by thrombocytopenia and autoimmune hemolytic anemia) received high-dose methylprednisolone therapy and achieved a complete response for thrombocytopenia. This suggests that methylprednisolone therapy had a positive impact on treating thrombocytopenia in this case. However, it is essential to acknowledge that correlation does not imply causation; therefore, additional studies would be required for more definitive evidence of methylprednisolone as an effective treatment for thrombocytopenia in general."
8063034,Methylprednisolone treats granulomatosis with polyangiitis,1296,We describe a 44-year-old man with Wegener's granulomatosis who was treated with cyclophosphamide and methylprednisolone and who subsequently developed bilateral CMVR.,True,"'Does the phrase ""Methylprednisolone treats granulomatosis with polyangiitis"" receive at least indirect support from the statement: ""We describe a 44-year-old man with Wegener's granulomatosis who was treated with cyclophosphamide and methylprednisolone and who subsequently developed bilateral CMVR.""?","Yes, indirect support can be inferred from the statement ""We describe a 44-year-old man with Wegener’s granulomatosis who was treated with cyclophosphamide and methylprednisolone and who subsequently developed bilateral CMVR.""

         Wegener’s granulomatosis is one form of granulomatosis with polyangiitis (GPA), so the patient in question does indeed have GPA. The statement indicates that methylprednisolone was used in combination with cyclophosphamide as part of the treatment regimen for the patient’s GPA.

         Although it does not explicitly demonstrate that methylprednisolone alone treats GPA, it does provide some evidence that methylprednisolone is used in treating GPA patients as part of an overall treatment plan that includes cyclophosphamide. This is consistent with existing medical literature that supports using corticosteroids like methylprednisolone in combination with other immunosuppressive drugs for treating GPA patients (Jennette et al., 2013).

         Jennette JC, Falk RJ,"
8018847,Methylprednisolone treats Pain,1297,A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.,True,"'Does the phrase ""Methylprednisolone treats Pain"" receive at least indirect support from the statement: ""A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats pain. The study referenced in the statement is comparing two treatments for myofascial pain syndrome and pain from chronic muscle spasm, one of which is methylprednisolone. The fact that it is included in such a study suggests that it has some therapeutic potential for pain relief, even if it is not as effective as the other treatment option in this particular context. However, it is important to note that methylprednisolone may not be effective for all types of pain, and its use should be based on a thorough understanding of its potential benefits and risks in specific clinical situations."
7905007,Methylprednisolone treats chronic progressive multiple sclerosis,1298,OBJECTIVE: To determine if there are variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS).,False,"'Does the phrase ""Methylprednisolone treats chronic progressive multiple sclerosis"" receive at least indirect support from the statement: ""OBJECTIVE: To determine if there are variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS).""?","No, the statement does not provide direct or indirect support for the claim that ""Methylprednisolone treats chronic progressive multiple sclerosis"". The objective of the study only mentions using pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS), but it does not specify which component of the therapy is responsible for any potential positive effects nor does it claim that methylprednisolone treats MS on its own. The statement is focused on determining if there are variables linked to responsiveness to the combined therapy, not on testing the efficacy of methylprednisolone specifically as a treatment for chronic progressive MS."
7853881,Methylprednisolone treats rheumatoid arthritis,1299,Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.,False,"'Does the phrase ""Methylprednisolone treats rheumatoid arthritis"" receive at least indirect support from the statement: ""Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone treats rheumatoid arthritis."" The study referenced in the statement compares oral low-dose glucocorticosteroids (a class of drugs that includes methylprednisolone) with intravenous methylprednisolone pulses in treating rheumatoid arthritis. To provide indirect support for ""Methylprednisolone treats rheumatoid arthritis,"" we would need evidence specifically linking methylprednisolone treatment to improvements in rheumatoid arthritis symptoms or disease progression.

        To clarify, while both forms of glucocorticosteroids may be effective in treating rheumatoid arthritis based on existing knowledge in the field, this specific study does not provide evidence for methylprednisolone as an effective treatment option on its own compared to other glucocorticosteroids or control groups."
7827490,Methylprednisolone treats optic neuritis,1300,CONCLUSIONS: The ONTT has led to a dramatic reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in the treatment of acute optic neuritis.,True,"'Does the phrase ""Methylprednisolone treats optic neuritis"" receive at least indirect support from the statement: ""CONCLUSIONS: The ONTT has led to a dramatic reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in the treatment of acute optic neuritis.""?","Yes, the statement does provide indirect support for the claim that methylprednisolone treats optic neuritis. The ONTT (Optic Neuritis Treatment Trial) led to a reduction in the use of oral prednisone without a preceding course of intravenous methylprednisolone in treating acute optic neuritis. This implies that intravenous methylprednisolone is considered more effective than oral prednisone alone in treating optic neuritis, thus supporting the use of methylprednisolone in treating this condition. However, it is important to note that direct causation cannot be inferred from an observational study such as the ONTT; therefore, further research would be necessary to definitively establish that methylprednisolone treats optic neuritis."
7808987,Methylprednisolone treats autoimmune thrombocytopenic purpura,1301,CONCLUSION: A short intravenous course of high-dose methylprednisolone is effective as initial treatment of adults with ITP.,True,"'Does the phrase ""Methylprednisolone treats autoimmune thrombocytopenic purpura"" receive at least indirect support from the statement: ""CONCLUSION: A short intravenous course of high-dose methylprednisolone is effective as initial treatment of adults with ITP.""?","Yes, the statement does provide indirect support for the phrase ""Methylprednisolone treats autoimmune thrombocytopenic purpura"" (ITP). The conclusion of the study suggests that high-dose methylprednisolone is effective in treating ITP in adults, implying that methylprednisolone has therapeutic benefits for ITP patients. Since autoimmune thrombocytopenic purpura is characterized by low platelet counts due to an immune system malfunction, it can be inferred that methylprednisolone may help manage ITP symptoms by modulating immune system activity. However, it is essential to note that further investigation is required to establish a direct cause-and-effect relationship between methylprednisolone use and ITP symptom improvement."
7700869,Methylprednisolone treats Edema,1302,"Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E.",True,"'Does the phrase ""Methylprednisolone treats Edema"" receive at least indirect support from the statement: ""Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E.""?","Yes, indirectly. The statement ""Lipid peroxidation and oedema in experimental brain injury: comparison of treatment with methylprednisolone, tirilazad mesylate and vitamin E"" does provide some level of support for the claim that methylprednisolone treats edema. This is because it mentions methylprednisolone as one of the treatments compared for edema in experimental brain injury. However, it doesn't explicitly state that methylprednisolone treats edema, hence the indirect support. To confirm this claim more directly, further evidence from clinical trials or studies that specifically test methylprednisolone as a treatment for edema would be required."
7668594,Methylprednisolone treats multiple sclerosis,1303,The same determinations were repeated on plasma and on CSF samples that were collected after the MS patients had ended a six-day treatment with high-dose methylprednisolone (MP).,True,"'Does the phrase ""Methylprednisolone treats multiple sclerosis"" receive at least indirect support from the statement: ""The same determinations were repeated on plasma and on CSF samples that were collected after the MS patients had ended a six-day treatment with high-dose methylprednisolone (MP).""?","Yes, the statement does provide indirect support for the claim that Methylprednisolone treats multiple sclerosis (MS). The key phrase in the statement that allows for this inference is ""after the MS patients had ended a six-day treatment with high-dose methylprednisolone (MP)."" 

        The fact that MS patients had undergone treatment specifically with methylprednisolone suggests that this medication has some therapeutic application in treating MS. Methylprednisolone is a corticosteroid that is commonly used as an anti-inflammatory and immunosuppressive drug in various treatments including MS exacerbations [1]. 

        However, it is important to note that while this statement offers some support for methylprednisolone being used in MS treatment, it does not necessarily prove that methylprednisolone is solely responsible for treating MS nor does it establish its efficacy as a primary therapy for MS management on its own. Further studies would be required to make such conclusions.

        
        References:

        [1]	Sorensen PS, Frederiksen JL."
7649490,Methylprednisolone treats aplastic anemia,1304,"Neutropenic infections are the major cause of morbidity and mortality in the treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG), cyclosporin A (CSA), and methylprednisolone (MP).",True,"'Does the phrase ""Methylprednisolone treats aplastic anemia"" receive at least indirect support from the statement: ""Neutropenic infections are the major cause of morbidity and mortality in the treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG), cyclosporin A (CSA), and methylprednisolone (MP).""?","Yes, indirectly it does provide some support for the statement that methylprednisolone treats aplastic anemia (AA). The provided statement mentions methylprednisolone in conjunction with other treatments for AA, implying its use in treating AA. However, it does not explicitly state that methylprednisolone treats AA, nor does it provide direct evidence of its efficacy in doing so.

         To elaborate, AA is often treated using immunosuppressive therapy (IST), which typically involves ALG, CSA, and sometimes corticosteroids like methylprednisolone. The rationale behind using these drugs is that they can suppress the immune system, potentially reducing immune-mediated destruction of hematopoietic stem cells in AA patients.

         However, it is important to note that while methylprednisolone may be used in treating AA as part of an IST regimen, its specific therapeutic effect in AA has not been definitively established in clinical trials. Furthermore, its use in treating AA is generally considered secondary to ALG and CSA due to their more direct effects on immune function in AA patients.

         Therefore, while"
7552935,Methylprednisolone treats Inflammation,1305,Methylprednisolone treatment resulted in the greatest reduction in the inflammatory cell infiltrate but the numbers of infected neurons did not increase concomitantly.,True,"'Does the phrase ""Methylprednisolone treats Inflammation"" receive at least indirect support from the statement: ""Methylprednisolone treatment resulted in the greatest reduction in the inflammatory cell infiltrate but the numbers of infected neurons did not increase concomitantly.""?","Yes, the statement ""Methylprednisolone treats inflammation"" does receive indirect support from the provided evidence. The statement ""Methylprednisolone treatment resulted in the greatest reduction in the inflammatory cell infiltrate but the numbers of infected neurons did not increase concomitantly"" suggests that Methylprednisolone has an impact on inflammation (inflammatory cell infiltrate), which aligns with the general understanding that Methylprednisolone is used as an anti-inflammatory drug. However, it's important to note that this evidence is specific to the context of infected neurons and doesn't necessarily generalize to all inflammation scenarios. Also, while the statement supports the anti-inflammatory effect of Methylprednisolone, it doesn't explicitly state that Methylprednisolone treats inflammation, as treatment often implies resolution of the condition, not just mitigation of one of its symptoms."
7483648,Methylprednisolone treats adult acute respiratory distress syndrome,1306,Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy.,True,"'Does the phrase ""Methylprednisolone treats adult acute respiratory distress syndrome"" receive at least indirect support from the statement: ""Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy.""?","Yes, indirect support can be inferred from the statement provided. The user statement describes a case of adult respiratory distress syndrome (ARDS) in the context of Still's disease, which was treated successfully using high-dose pulse methylprednisolone therapy. This suggests that methylprednisolone may have therapeutic benefits for ARDS in certain clinical contexts, such as when it is caused by Still's disease. However, it is important to note that this does not provide direct evidence that methylprednisolone is an effective treatment for all cases of adult acute respiratory distress syndrome (ARDS). Further studies would be needed to establish the efficacy of methylprednisolone in different patient populations and under various disease conditions that can lead to ARDS."
7432980,Methylprednisolone treats myelodysplastic syndrome,1307,Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.,True,"'Does the phrase ""Methylprednisolone treats myelodysplastic syndrome"" receive at least indirect support from the statement: ""Eosinophilic fasciitis associated with autoimmune thyroid disease and myelodysplasia treated with pulsed methylprednisolone and antihistamines.""?","Yes, indirectly it does lend some support. The statement mentions that methylprednisolone was used to treat eosinophilic fasciitis associated with myelodysplasia (a type of myelodysplastic syndrome). However, it's important to note that myelodysplastic syndrome is a group of diverse disorders, so this doesn't necessarily mean that methylprednisolone would be effective for all types of myelodysplastic syndrome. Furthermore, the treatment was given in combination with antihistamines, so it's unclear what specific effect methylprednisolone had on the myelodysplasia. Therefore, while there is some indirect support, more specific evidence would be needed to definitively say that methylprednisolone treats myelodysplastic syndrome."
16097513,Cefotaxime treats osteomyelitis,1308,Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.,True,"'Does the phrase ""Cefotaxime treats osteomyelitis"" receive at least indirect support from the statement: ""Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli.""?","Yes, the phrase ""Cefotaxime treats osteomyelitis"" does receive indirect support from the statement ""Cefotaxime in the treatment of chronic osteomyelitis caused by gram-negative bacilli."" This is because osteomyelitis is an inflammation of bone marrow, often caused by bacterial infection [1]. The statement specifically mentions Cefotaxime being used in the treatment of chronic osteomyelitis caused by gram-negative bacilli. Cefotaxime is an antibiotic that works by killing sensitive bacteria [2]. Therefore, it indirectly supports that Cefotaxime can treat osteomyelitis caused by gram-negative bacilli. However, it is important to note that there might be other types of bacteria causing osteomyelitis that Cefotaxime might not be effective against.

        References:
        1. ""Osteomyelitis."" Mayo Clinic, Mayo Foundation for Medical Education and Research, 15 Jan. 2021, www.mayoclinic.org/diseases-conditions/osteomyelitis/symptoms"
15119078,Cefotaxime treats peritonitis,1309,Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis.,True,"'Does the phrase ""Cefotaxime treats peritonitis"" receive at least indirect support from the statement: ""Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis.""?","Yes, indirectly it does. The statement provides evidence that cefotaxime has been used in clinical trials involving patients with peritonitis caused by gram-negative bacteria, which is often associated with cirrhosis. Therefore, one could infer that cefotaxime is a potential treatment for peritonitis based on this study. However, it's important to note that this is an indirect inference because the study is comparing cefotaxime to another antibiotic (aztreonam), not explicitly testing its effectiveness against peritonitis. Furthermore, while cefotaxime may be effective for gram-negative peritonitis, it may not be as effective for other types of peritonitis caused by different bacterial strains. Therefore, while there is some support for the claim, it is not unequivocal evidence that cefotaxime is an effective treatment for peritonitis."
11176033,Cefotaxime treats Sepsis,1310,"Due to the apparent volumes of distribution obtained (ranging from 0.48 to 0.51 L/kg), considering the overall clinical efficacy obtained (90% for the 10 mg/kg dose and 75% for the 20 mg/kg dose), and due to the rapid improvement observed after a few doses of the drug (1.8 to 2.5 doses to 'clinical improvement'), it is safe to postulate such doses of cefotaxime as excellent choices for the treatment of septicaemia in dogs.",True,"'Does the phrase ""Cefotaxime treats Sepsis"" receive at least indirect support from the statement: ""Due to the apparent volumes of distribution obtained (ranging from 0.48 to 0.51 L/kg), considering the overall clinical efficacy obtained (90% for the 10 mg/kg dose and 75% for the 20 mg/kg dose), and due to the rapid improvement observed after a few doses of the drug (1.8 to 2.5 doses to 'clinical improvement'), it is safe to postulate such doses of cefotaxime as excellent choices for the treatment of septicaemia in dogs.""?","Yes, the statement does provide indirect support for the phrase ""Cefotaxime treats Sepsis"" in dogs. The statement discusses a clinical study where cefotaxime was administered to dogs suffering from septicaemia (a severe form of sepsis) at two different doses. The results showed that both doses had high clinical efficacy (90% for 10 mg/kg and 75% for 20 mg/kg), suggesting that cefotaxime can be an effective treatment for septicaemia in dogs.

         Furthermore, the rapid improvement observed after just 1.8 to 2.5 doses indicates that cefotaxime can quickly alleviate symptoms of septicaemia, supporting its use as a treatment option for sepsis in dogs. However, it is essential to note that while the statement provides some evidence for cefotaxime being an effective treatment for sepsis in dogs, it is based on a single study in dogs suffering from septicaemia (a specific type of sepsis). Therefore, further studies would"
8153267,Cefotaxime treats bacterial infectious disease,1311,These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment of bacterial infections in cirrhosis.,False,"'Does the phrase ""Cefotaxime treats bacterial infectious disease"" receive at least indirect support from the statement: ""These results suggest that amoxicillin-clavulanic acid is an effective alternative to cefotaxime for the empirical treatment of bacterial infections in cirrhosis.""?","No, the statement does not provide direct or indirect support for the phrase ""Cefotaxime treats bacterial infectious disease."" The statement discusses an alternative treatment (amoxicillin-clavulanic acid) to cefotaxime for bacterial infections in cirrhosis patients, implying that cefotaxime is indeed effective against bacterial infections. However, it does not offer any new evidence or confirmation that cefotaxime itself treats bacterial infectious disease. The original claim remains unsupported by the provided statement."
26980543,Ceftriaxone treats Lyme disease,1312,"Most children had received prolonged and repeated courses of oral antimicrobials and/or home intravenous infusion of antimicrobials; 79% had been hospitalized for treatment of suspected LD or management of treatment complications, most notably drug-induced symptoms of gallbladder disease occurring in patients receiving ceftriaxone (Rocephin), and bloodstream infections associated with intravenous catheters.",False,"'Does the phrase ""Ceftriaxone treats Lyme disease"" receive at least indirect support from the statement: ""Most children had received prolonged and repeated courses of oral antimicrobials and/or home intravenous infusion of antimicrobials; 79% had been hospitalized for treatment of suspected LD or management of treatment complications, most notably drug-induced symptoms of gallbladder disease occurring in patients receiving ceftriaxone (Rocephin), and bloodstream infections associated with intravenous catheters.""?","No, the statement does not provide indirect support for the claim that Ceftriaxone treats Lyme disease (LD). The passage describes symptoms and complications experienced by children undergoing LD treatment which includes Ceftriaxone (Rocephin), but it does not demonstrate that Ceftriaxone is an effective treatment for Lyme disease itself. Instead, it highlights adverse effects associated with its use in treating LD complications."
26401802,Ceftriaxone treats Sepsis,1313,"Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.",True,"'Does the phrase ""Ceftriaxone treats Sepsis"" receive at least indirect support from the statement: ""Clinical study of Rocephin, a 3d generation cephalosporin, in various septicaemias.""?","Yes, indirectly it does lend some support. The statement mentions Rocephin (ceftriaxone) being used in various septicaemias (a synonym for sepsis) in a clinical study. This suggests that ceftriaxone has been tested for treating sepsis, even if it doesn't provide specific efficacy or outcome details from that study. However, it is crucial to note that indirect support does not equate to definitive proof of effectiveness, as more information is needed about the study design, results, and other contextual factors for a robust evaluation of ceftriaxone's efficacy in treating sepsis."
18413392,Ceftriaxone treats bacterial pneumonia,1314,"The objectives of this open, prospective, randomized and comparative study were to evaluate and compare the efficacy and safety of intravenous ceftriaxone (active ingredient of Rocephin) and cefotaxime in treatment of bacterial pneumoniae.",True,"'Does the phrase ""Ceftriaxone treats bacterial pneumonia"" receive at least indirect support from the statement: ""The objectives of this open, prospective, randomized and comparative study were to evaluate and compare the efficacy and safety of intravenous ceftriaxone (active ingredient of Rocephin) and cefotaxime in treatment of bacterial pneumoniae.""?","Yes, the statement does provide indirect support for the phrase ""Ceftriaxone treats bacterial pneumonia"". The study mentioned in the statement is designed to evaluate and compare the efficacy and safety of intravenous ceftriaxone (the active ingredient in Rocephin) and cefotaxime in treating bacterial pneumonia. This implies that ceftriaxone is being used as a treatment option for bacterial pneumonia in the context of this study. However, it's important to note that indirect support does not equate to definitive proof. The results of the study would need to be analyzed to determine whether ceftriaxone is indeed an effective treatment for bacterial pneumonia."
25810060,Gefarnate treats gastric ulcer,1315,Clinical trial of Gefarnate in the treatment of gastric ulcer disease.,True,"'Does the phrase ""Gefarnate treats gastric ulcer"" receive at least indirect support from the statement: ""Clinical trial of Gefarnate in the treatment of gastric ulcer disease.""?","Yes, the phrase ""Gefarnate treats gastric ulcer"" does receive indirect support from the statement: ""Clinical trial of Gefarnate in the treatment of gastric ulcer disease.""

         The conduct of a clinical trial implies that there is some level of investigation into the potential therapeutic effects of Gefarnate for gastric ulcer disease. While this does not constitute definitive proof of its efficacy, it does suggest that there is some basis for exploring this possibility. In other words, if there were no biological plausibility for Gefarnate treating gastric ulcers, it is unlikely that a clinical trial would be conducted in the first place. Therefore, the statement lends credence to the idea that Gefarnate may have beneficial effects in treating gastric ulcers, even if it does not confirm it outright."
25784688,Gefarnate treats duodenal ulcer,1316,[Clinicobiological evolution of duodenal ulcer treated with gefarnate].,True,"'Does the phrase ""Gefarnate treats duodenal ulcer"" receive at least indirect support from the statement: ""[Clinicobiological evolution of duodenal ulcer treated with gefarnate].""?","Yes, the phrase ""Gefarnate treats duodenal ulcer"" does receive indirect support from the statement: ""[Clinicobiological evolution of duodenal ulcer treated with gefarnate]."" 

        The title of the study suggests that gefarnate was used in the treatment of duodenal ulcers. While it does not explicitly state that gefarnate treats duodenal ulcers, the context implies that gefarnate has some therapeutic effect on duodenal ulcers as it is being used in their treatment within the study. However, it is important to note that a single study title is not sufficient evidence to make definitive conclusions about a treatment's efficacy. A thorough review of the study's methods, results, and conclusions would be necessary to provide more robust support for such a claim."
19702373,Gefarnate treats peptic ulcer disease,1317,"One hundred and thirty-nine patients with endoscopically confirmed peptic ulcers (gastric and duodenal) entered a double blind comparative evaluation of alprazolam (1.2 mg/day), gefarnate (300 mg/day) and their combination in treatment of peptic ulcer.",True,"'Does the phrase ""Gefarnate treats peptic ulcer disease"" receive at least indirect support from the statement: ""One hundred and thirty-nine patients with endoscopically confirmed peptic ulcers (gastric and duodenal) entered a double blind comparative evaluation of alprazolam (1.2 mg/day), gefarnate (300 mg/day) and their combination in treatment of peptic ulcer.""?","Yes, the statement does provide indirect support for the claim that gefarnate treats peptic ulcer disease. The reason is that the statement mentions gefarnate being used in a double-blind comparative evaluation specifically for patients with endoscopically confirmed peptic ulcers (gastric and duodenal). This implies that there is an interest in studying gefarnate as a potential treatment for peptic ulcers, which would not be the case if it did not have some theoretical basis for treating the condition. However, it is important to note that indirect support does not equate to definitive proof of effectiveness; it merely suggests that further investigation is warranted based on some preliminary evidence or rationale."
22023951,Regadenoson treats coronary artery disorder,1318,CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients.,True,"'Does the phrase ""Regadenoson treats coronary artery disorder"" receive at least indirect support from the statement: ""CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients.""?","Yes, there is indirect support for the phrase ""Regadenoson treats coronary artery disorder"" in the statement ""CONCLUSIONS: Regadenoson may be a safe vasodilator for CTP and MR MPI in CAD patients."" 

        The term ""CAD"" in the conclusion stands for Coronary Artery Disease, which is a type of coronary artery disorder. The statement suggests that Regadenoson may be safe for use in CAD patients during Cardiac Magnetic Resonance (MR) Myocardial Perfusion Imaging (MPI) and Coronary Computed Tomography (CT) Perfusion (CTP). This implies that Regadenoson could potentially have a therapeutic effect in treating coronary artery disorders by improving diagnostic imaging and thus guiding treatment decisions. However, it's important to note that this is an indirect inference, as the statement does not explicitly claim that Regadenoson treats coronary artery disorder, but rather that it may be safe for use in diagnostic procedures for such patients."
13297277,Meldonium treats Ischemic stroke,1319,A study is presented of the clinico-hemodynamic efficacy of mildronate in 38 patients with ischemic stroke.,False,"'Does the phrase ""Meldonium treats Ischemic stroke"" receive at least indirect support from the statement: ""A study is presented of the clinico-hemodynamic efficacy of mildronate in 38 patients with ischemic stroke.""?","No, the statement does not provide indirect support for the phrase ""Meldonium treats Ischemic stroke."" The study investigates the clinico-hemodynamic efficacy of mildronate in patients with ischemic stroke; however, it does not establish that meldonium treats ischemic stroke. Meldonium is also known as mildronate, but demonstrating clinico-hemodynamic efficacy is not equivalent to proving that it treats ischemic stroke as treating implies causality in curing or alleviating symptoms of the disease, which is not explicitly shown in the statement.

        To provide indirect support for ""Meldonium treats Ischemic stroke,"" one would need additional evidence demonstrating improved patient outcomes in terms of reduced stroke recurrence, decreased disability, or enhanced neurological recovery following meldonium administration – none of which is mentioned in the statement provided."
25624167,Neobiotic treats pneumonia,1320,Use of neomycin for treatment of Rhodococcus equi pneumonia in foals.,True,"'Does the phrase ""Neobiotic treats pneumonia"" receive at least indirect support from the statement: ""Use of neomycin for treatment of Rhodococcus equi pneumonia in foals.""?","Yes, indirectly it does. The statement ""Use of neomycin for treatment of Rhodococcus equi pneumonia in foals"" suggests that neomycin, which is a type of neobiotic (an antibiotic derived from non-pathogenic bacteria or fungi), has been used effectively in treating pneumonia caused by Rhodococcus equi in foals. However, this does not necessarily mean that all types of neobiotic will be effective in treating all forms of pneumonia. It is a specific example of neobiotic use in one context. Therefore, while not providing direct support for the broad claim ""Neobiotic treats pneumonia"", it does offer indirect support by demonstrating that at least one type of neobiotic has been used successfully in treating pneumonia under certain conditions."
11022701,Neobiotic treats bacterial infectious disease with sepsis,1321,Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin.,True,"'Does the phrase ""Neobiotic treats bacterial infectious disease with sepsis"" receive at least indirect support from the statement: ""Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin.""?","Yes, there is indirect support for the phrase ""Neobiotic treats bacterial infectious disease with sepsis"" from the statement ""Osteomyelitis of the cervical vertebras as a complication of urinary tract disease; Proteus bacteremia treated with neomycin."" 

         The statement indicates that Proteus bacteremia, which is a type of bacterial infection that leads to sepsis, was treated with neomycin, which is a type of neobiotic (an antibiotic that has not been used in clinical practice for many years). This suggests that neomycin can be used to treat bacterial infectious diseases that lead to sepsis, thus providing indirect support for the claim. However, it is important to note that this is based on a single case study and further research would be needed to make more generalizable conclusions."
24398401,BLINATUMOMAB treats B-cell chronic lymphocytic leukemia,1322,Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.,True,"'Does the phrase ""BLINATUMOMAB treats B-cell chronic lymphocytic leukemia"" receive at least indirect support from the statement: ""Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.""?","Yes, there is indirect support for the statement that ""BLINATUMOMAB treats B-cell chronic lymphocytic leukemia"" based on the provided reference ""Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy.""

        
        Blinatumomab is an FDA-approved bispecific T-cell engager (BiTE) antibody construct that binds both CD3 on T-cells and CD19 on B-cells, thereby facilitating T-cell-mediated killing of CD19-expressing malignant B-cells (B-cell lymphoblastic leukemia/lymphoma). The study in question investigates Blinatumomab's effect on pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

        
        Although B-cell chronic lymphocytic leukemia (B-CLL) is not explicitly mentioned in the title, B-CLL is indeed a type of B-"
23073290,BLINATUMOMAB treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,1323,"We report on the Australian experience of blinatumomab for treatment of 24 children with relapsed/refractory precursor B-cell acute lymphoblastic leukaemia (B-ALL) and high-risk genetics, resulting in a minimal residual disease (MRD) response rate of 58%, 2-year progression-free survival (PFS) of 39% and 2-year overall survival of 63%.",True,"'Does the phrase ""BLINATUMOMAB treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma"" receive at least indirect support from the statement: ""We report on the Australian experience of blinatumomab for treatment of 24 children with relapsed/refractory precursor B-cell acute lymphoblastic leukaemia (B-ALL) and high-risk genetics, resulting in a minimal residual disease (MRD) response rate of 58%, 2-year progression-free survival (PFS) of 39% and 2-year overall survival of 63%.""?","Yes, the statement does provide indirect support for the phrase ""BLINATUMOMAB treats Precursor B-Cell Lymphoblastic Leukemia-Lymphoma"". The statement reports on a study where blinatumomab was used to treat 24 children with relapsed/refractory precursor B-cell acute lymphoblastic leukemia (B-ALL) and high-risk genetics. The results showed that 58% of these children had a minimal residual disease (MRD) response rate, and the 2-year progression-free survival (PFS) and overall survival were 39% and 63%, respectively. These positive outcomes suggest that blinatumomab has therapeutic efficacy in treating precursor B-cell lymphoblastic leukemia-lymphoma, thus lending support to the claim. However, it is important to note that while these results are promising, they come from a single study with a relatively small sample size, so further research is needed to confirm these findings"
21932754,BLINATUMOMAB treats acute lymphoblastic leukemia,1324,"Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.On November 15, 2018, the Committee for Medicinal Products for Human Use (CHMP) recommended the extension of indication for blinatumomab to include the treatment of adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL).",True,"'Does the phrase ""BLINATUMOMAB treats acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.On November 15, 2018, the Committee for Medicinal Products for Human Use (CHMP) recommended the extension of indication for blinatumomab to include the treatment of adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL).""?","Yes, the statement does provide indirect support for the phrase ""BLINATUMOMAB treats acute lymphoblastic leukemia"". The Committee for Medicinal Products for Human Use (CHMP) recommending the extension of indication for blinatumomab to include treatment of adults with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL) implies that blinatumomab is an effective treatment for ALL patients who have minimal residual disease. This suggests that blinatumomab can help treat ALL by targeting residual leukemia cells that remain in the body after initial treatment, thereby reducing the risk of relapse. However, it is important to note that ""treats"" in this context refers specifically to its use in treating ALL in patients with minimal residual disease rather than ALL in general."
21720587,BLINATUMOMAB treats lymphoma,1325,"Cytokine storm was reported in four patients (19%).In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.",True,"'Does the phrase ""BLINATUMOMAB treats lymphoma"" receive at least indirect support from the statement: ""Cytokine storm was reported in four patients (19%).In conclusion, treatment with blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial stetting.""?","Yes, indirect support can be inferred from the statement provided. The conclusion that blinatumomab is effective and tolerable in adult patients with relapsed/refractory B-ALL outside of a clinical trial setting suggests that it has positive effects on treating lymphoma (B-ALL is a type of lymphoma). However, direct support for the phrase ""BLINATUMOMAB treats lymphoma"" would require a specific statement linking blinatumomab directly to treating lymphoma rather than just mentioning its effectiveness in treating B-ALL. The cytokine storm incident mentioned in four patients does not negate the effectiveness of blinatumomab but indicates a potential side effect that needs to be managed."
9387116,Ciprofloxacin physically interacts with DNA Gyrase,1326,"UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.",True,"'Does the phrase ""Ciprofloxacin physically interacts with DNA Gyrase"" receive at least indirect support from the statement: ""UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.""?","Yes, the phrase ""Ciprofloxacin physically interacts with DNA Gyrase"" does receive indirect support from the statement: ""UNLABELLED: Ciprofloxacin, a quinolone antibiotic drug, binds to DNA topoisomerase IV and DNA gyrase of various bacteria.""

         The key term here is ""binds."" In molecular biology terms, binding refers to physical interaction between two molecules. Therefore, when it is stated that Ciprofloxacin binds to DNA topoisomerase IV and DNA gyrase of various bacteria, it implies that there is a physical interaction between Ciprofloxacin and these enzymes (DNA gyrase being one of them). This physical interaction can alter the function of DNA gyrase, leading to bacterial cell death - which is the desired effect of Ciprofloxacin as an antibiotic drug."
8212496,Ciprofloxacin physically interacts with DNA Gyrase,1327,Topoisomerase IV and DNA gyrase were purified from a ciprofloxacin-sensitive Streptococcus pneumoniae strain and from two clinical isolates of S. pneumoniae with high-level resistance to ciprofloxacin by means of a gene cloning method in Escherichia coli.,True,"'Does the phrase ""Ciprofloxacin physically interacts with DNA Gyrase"" receive at least indirect support from the statement: ""Topoisomerase IV and DNA gyrase were purified from a ciprofloxacin-sensitive Streptococcus pneumoniae strain and from two clinical isolates of S. pneumoniae with high-level resistance to ciprofloxacin by means of a gene cloning method in Escherichia coli.""?","Yes, indirect support can be inferred from the statement provided for the phrase ""Ciprofloxacin physically interacts with DNA Gyrase."" The statement reveals that both topoisomerase IV and DNA gyrase were purified from ciprofloxacin-sensitive as well as ciprofloxacin-resistant strains of Streptococcus pneumoniae using gene cloning methods in Escherichia coli. 

        
        Ciprofloxacin is an antibiotic from the class of fluoroquinolones that inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, thereby inhibiting DNA replication and transcription. The fact that ciprofloxacin exhibits different effects on sensitive versus resistant strains of S. pneumoniae implies that these enzymes interact physically with ciprofloxacin in some capacity. 

        
        However, it is important to note that while indirect support can be inferred from this statement, direct experimental evidence demonstrating physical interaction between ciprofloxac"
7781719,Ciprofloxacin affects DNA Gyrase,1328,"The concentrations of ciprofloxacin, sparfloxacin, levofloxacin, or ofloxacin required to inhibit wild-type topoisomerase IV were 8 to 16 times lower than those required to inhibit wild-type DNA gyrase.",True,"'Does the phrase ""Ciprofloxacin affects DNA Gyrase"" receive at least indirect support from the statement: ""The concentrations of ciprofloxacin, sparfloxacin, levofloxacin, or ofloxacin required to inhibit wild-type topoisomerase IV were 8 to 16 times lower than those required to inhibit wild-type DNA gyrase.""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin affects DNA Gyrase"". The statement suggests that ciprofloxacin, along with other fluoroquinolones, inhibits wild-type topoisomerase IV at lower concentrations than those required to inhibit wild-type DNA gyrase. This implies that DNA gyrase is more resistant to inhibition by ciprofloxacin than topoisomerase IV. This resistance could be due to structural differences between these two enzymes that affect how they interact with ciprofloxacin. The fact that ciprofloxacin does inhibit DNA gyrase, albeit at higher concentrations, supports the assertion that it affects DNA gyrase.

         However, it is important to note that indirect evidence does not provide as strong of support as direct evidence would. Direct evidence would involve experiments specifically designed to observe the effects of ciprofloxacin on DNA gyrase in isolation from other targets like topoisomerase IV. Nonetheless, in combination with other evidence, this indirect support can contribute to a more robust understanding of c"
18400322,Ciprofloxacin affects DNA Gyrase,1329,Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition.,True,"'Does the phrase ""Ciprofloxacin affects DNA Gyrase"" receive at least indirect support from the statement: ""Plasmid-encoded protein QnrB1 protects DNA gyrase from ciprofloxacin inhibition.""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin affects DNA Gyrase."" The statement implies that Ciprofloxacin inhibits DNA gyrase because it mentions that plasmid-encoded protein QnrB1 protects DNA gyrase from Ciprofloxacin inhibition. This suggests that Ciprofloxacin has an effect on DNA gyrase, otherwise there would be no need for protection.

        DNA gyrase is an essential enzyme for bacterial DNA replication, transcription, and repair. Fluoroquinolones like Ciprofloxacin work by inhibiting DNA gyrase, which leads to bacterial cell death. The QnrB1 protein is known to provide protection against fluoroquinolones by binding to DNA gyrase and preventing the antibiotic from interacting with its target. This mechanism of resistance further supports the notion that Ciprofloxacin indeed affects DNA gyrase."
24010235,Ciprofloxacin treats chronic bronchitis,1330,"Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days.",True,"'Does the phrase ""Ciprofloxacin treats chronic bronchitis"" receive at least indirect support from the statement: ""Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days.""?","Yes, indirectly it does lend some support. The statement suggests that patients suffering from acute purulent exacerbations of chronic bronchitis were treated with Ciprofloxacin. The fact that they were treated implies that it was considered potentially beneficial for these patients, which includes those suffering from chronic bronchitis. However, it's important to note that this doesn't constitute direct evidence that Ciprofloxacin treats chronic bronchitis, as it doesn't specify whether the patients' chronic bronchitis improved as a result of the treatment. It also doesn't rule out other possible factors contributing to any potential improvement. Therefore, while suggestive, further evidence would be needed for a definitive conclusion."
22484062,Ciprofloxacin treats amyotrophic lateral sclerosis,1331,"OBJECTIVE: To evaluate the efficacy of a fixed-dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS).",False,"'Does the phrase ""Ciprofloxacin treats amyotrophic lateral sclerosis"" receive at least indirect support from the statement: ""OBJECTIVE: To evaluate the efficacy of a fixed-dose combination of two approved drugs, Ciprofloxacin and Celecoxib, as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS).""?","No, the statement ""Ciprofloxacin treats amyotrophic lateral sclerosis"" does not receive direct or indirect support from the provided statement. The objective of the study mentioned only aims to evaluate the efficacy of a fixed-dose combination of Ciprofloxacin and Celecoxib as a potential therapeutic treatment for amyotrophic lateral sclerosis (ALS). It does not confirm that Ciprofloxacin alone treats ALS; it only indicates that further investigation is being conducted on its potential therapeutic use for that condition in combination with Celecoxib."
21488232,Ciprofloxacin treats Infection,1332,Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against    Mycobacterium tuberculosis    .The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR)    Mycobacterium tuberculosis     is an urgent priority.,True,"'Does the phrase ""Ciprofloxacin treats Infection"" receive at least indirect support from the statement: ""Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against    Mycobacterium tuberculosis    .The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR)    Mycobacterium tuberculosis     is an urgent priority.""?","Yes, there is indirect support for the phrase ""Ciprofloxacin treats Infection"" from the statement provided. The statement mentions a ""Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate"" that has activity against Mycobacterium tuberculosis. Ciprofloxacin is an antibiotic that belongs to the class of fluoroquinolones, which are known for their antibacterial properties. Therefore, it can be inferred that Ciprofloxacin is being used as part of a treatment for an infection caused by Mycobacterium tuberculosis in this context. However, it is important to note that direct evidence of Ciprofloxacin treating an infection is not provided in the statement; rather, it is implied by its use in conjunction with a pyrrolobenzodiazepine in an antitubercular agent."
20040173,Ciprofloxacin treats lymphoma,1333,Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.,False,"'Does the phrase ""Ciprofloxacin treats lymphoma"" receive at least indirect support from the statement: ""Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.""?","No, the phrase ""Ciprofloxacin treats lymphoma"" does not receive indirect support from the statement provided. The study mentioned is about antibacterial prophylaxis using Ciprofloxacin for patients undergoing autologous haematopoietic cell transplantation, which includes patients with multiple myeloma and lymphoma. This does not imply that Ciprofloxacin treats lymphoma; rather, it suggests that Ciprofloxacin may help prevent infections in immunocompromised lymphoma patients during transplantation procedures. The distinction is crucial as treatment refers to combatting the disease itself while prophylaxis indicates prevention of complications (in this case infections) associated with the disease or treatment thereof."
19067853,Ciprofloxacin treats B-cell chronic lymphocytic leukemia,1334,A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia.,False,"'Does the phrase ""Ciprofloxacin treats B-cell chronic lymphocytic leukemia"" receive at least indirect support from the statement: ""A case of septic arthritis caused by a Mycoplasma salivarium strain resistant towards Ciprofloxacin and Clarithromycin in a patient with chronic lymphatic leukemia.""?","No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats B-cell chronic lymphocytic leukemia."" The statement discusses a case of septic arthritis in a patient with chronic lymphatic leukemia (B-cell chronic lymphocytic leukemia is a type of chronic lymphatic leukemia) caused by a Mycoplasma salivarium strain resistant to Ciprofloxacin and Clarithromycin. This implies that Ciprofloxacin was ineffective against the Mycoplasma salivarium strain in this case, not that it has therapeutic effects on B-cell chronic lymphocytic leukemia."
14572951,Ciprofloxacin treats hearing loss disorder,1335,Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly.,False,"'Does the phrase ""Ciprofloxacin treats hearing loss disorder"" receive at least indirect support from the statement: ""Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly.""?","No, the phrase ""Ciprofloxacin treats hearing loss disorder"" does not receive direct support from the statement ""Treatment with ciprofloxacin and ceftazidime improved the hearing loss significantly.""

        The statement provides evidence that a combination of ciprofloxacin and ceftazidime has been successful in treating hearing loss in a specific context, but it does not necessarily indicate that ciprofloxacin alone is responsible for treating hearing loss disorders. It is possible that both drugs contribute equally to improving hearing loss, that ceftazidime is the more significant factor, or that another unmentioned factor is responsible for the improvement in hearing loss symptoms.

        To establish whether ciprofloxacin treats hearing loss disorder specifically would require further evidence isolating ciprofloxacin as an active ingredient in treating hearing loss disorders in controlled studies where confounding factors have been accounted for and minimized."
14398199,Ciprofloxacin treats sinusitis,1336,"CASE SUMMARY: A 24-year-old woman was admitted to the hospital because of convulsions, severe myopathy, and acute renal failure after taking ciprofloxacin for sinusitis, and urinary tract infections.",False,"'Does the phrase ""Ciprofloxacin treats sinusitis"" receive at least indirect support from the statement: ""CASE SUMMARY: A 24-year-old woman was admitted to the hospital because of convulsions, severe myopathy, and acute renal failure after taking ciprofloxacin for sinusitis, and urinary tract infections.""?","No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats sinusitis."" In fact, it suggests quite the opposite. The case summary describes adverse effects experienced by a patient who took Ciprofloxacin for sinusitis and urinary tract infections. This indicates that while Ciprofloxacin may be used to treat these conditions, it can also have serious side effects. The statement does not provide any evidence that Ciprofloxacin was effective in treating sinusitis in this case; on the contrary, it suggests that the patient suffered significant harm as a result of taking the drug. Therefore, it does not support the claim that Ciprofloxacin treats sinusitis."
14311974,Ciprofloxacin treats liver abscess (disease),1337,Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.,True,"'Does the phrase ""Ciprofloxacin treats liver abscess (disease)"" receive at least indirect support from the statement: ""Chromobacterium violaceum endocarditis and hepatic abscesses treated successfully with meropenem and ciprofloxacin.""?","Yes, indirectly it does lend some support. The statement mentions that Ciprofloxacin was used in conjunction with Meropenem to successfully treat endocarditis (inflammation of the heart valve) and hepatic abscesses (liver abscesses) caused by Chromobacterium violaceum. This suggests that Ciprofloxacin could potentially be effective in treating liver abscesses, although it's important to note that it was used as part of a combination therapy in this case. However, it's crucial to remember that each case is unique and treatment should be individualized based on the patient's specific condition, allergies, potential drug interactions, and other factors. Therefore, while this evidence suggests a potential benefit, it does not conclusively prove that Ciprofloxacin alone is an effective treatment for liver abscesses."
14284683,Ciprofloxacin treats gastroenteritis,1338,"A patient is reported who had previously maintained a stable prothrombin time on Coumadin for 5 years, and who exhibited a marked prolongation of prothrombin time when placed on ciprofloxacin for gastroenteritis.",False,"'Does the phrase ""Ciprofloxacin treats gastroenteritis"" receive at least indirect support from the statement: ""A patient is reported who had previously maintained a stable prothrombin time on Coumadin for 5 years, and who exhibited a marked prolongation of prothrombin time when placed on ciprofloxacin for gastroenteritis.""?","No, the statement does not provide indirect support for the phrase ""Ciprofloxacin treats gastroenteritis."" The statement describes an adverse effect of Ciprofloxacin on prothrombin time in a patient being treated for gastroenteritis, but it does not imply that Ciprofloxacin is an effective treatment for gastroenteritis.

         The statement focuses on the patient's response to Ciprofloxacin therapy in terms of prothrombin time alterations while on Coumadin, which is an anticoagulant drug unrelated to gastroenteritis treatment. The potential side effects of Ciprofloxacin, including its influence on prothrombin time in patients taking Coumadin, have been documented in previous studies (e.g., Weisbord SD et al., 2011). However, there is no evidence in the statement suggesting that Ciprofloxacin has any therapeutic effect on gastroenteritis.

         In fact, gastroenteritis is typically treated through supportive care (e.g., hydration) and antibiotics only"
14141218,Ciprofloxacin treats castration-resistant prostate carcinoma,1339,"Doxorubicin and docetaxel, two standard antineoplastic agents in hormone-refractory prostate cancer (HRPC) therapy and ciprofloxacin were evaluated singly and in several simultaneous and sequential drug combination schemes, against PC-3 and LNCaP cell lines.",False,"'Does the phrase ""Ciprofloxacin treats castration-resistant prostate carcinoma"" receive at least indirect support from the statement: ""Doxorubicin and docetaxel, two standard antineoplastic agents in hormone-refractory prostate cancer (HRPC) therapy and ciprofloxacin were evaluated singly and in several simultaneous and sequential drug combination schemes, against PC-3 and LNCaP cell lines.""?","No, the statement does not provide direct or indirect support for the claim that ""Ciprofloxacin treats castration-resistant prostate carcinoma."" The statement only mentions that ciprofloxacin was evaluated along with other drugs against PC-3 and LNCaP cell lines, which are common models used in prostate cancer research. However, it does not provide any information about the results of these experiments, whether ciprofloxacin had any effect on prostate cancer cells, or if it has been used in any clinical setting for treating castration-resistant prostate carcinoma. Therefore, it is not possible to make any conclusions about the effectiveness of ciprofloxacin for treating castration-resistant prostate carcinoma based on this statement alone."
14005051,Ciprofloxacin treats acute myeloid leukemia,1340,"Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.",False,"'Does the phrase ""Ciprofloxacin treats acute myeloid leukemia"" receive at least indirect support from the statement: ""Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.""?","No, the phrase ""Ciprofloxacin treats acute myeloid leukemia"" does not receive indirect support from the statement provided. The statement mentions that ciprofloxacin is used in combination therapy for myelodysplastic syndrome and acute myeloid leukemia patients, but it does not specify that ciprofloxacin treats acute myeloid leukemia on its own. In fact, it suggests that ciprofloxacin is used in combination with other drugs (amifostine, pentoxifylline, and dexamethasone), which implies that its effect may be dependent on these other treatments. Therefore, we cannot infer from this statement that ciprofloxacin is an effective treatment for acute myeloid leukemia when used alone."
13846017,Ciprofloxacin treats lung disorder,1341,High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacolinetics of 400 and 200 mg intravenous.,False,"'Does the phrase ""Ciprofloxacin treats lung disorder"" receive at least indirect support from the statement: ""High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacolinetics of 400 and 200 mg intravenous.""?","No, the statement ""High dose parenteral ciprofloxacin in pleuro-pulmonary disease: a comparative pharmacokinetics of 400 and 200 mg intravenous."" does not provide indirect support for the phrase ""Ciprofloxacin treats lung disorder.""

         The statement in question is a comparative pharmacokinetics study on ciprofloxacin in pleuro-pulmonary disease, focusing on different dosages administered intravenously. While it does discuss ciprofloxacin's use in lung-related diseases (pleuro-pulmonary), it does not provide evidence that ciprofloxacin treats these disorders. The study is concerned with how ciprofloxacin is absorbed, distributed, metabolized, and excreted in the body at different dosages, not its therapeutic effects on lung disorders. Therefore, it does not offer support for the claim that ciprofloxacin treats lung disorders."
13663890,Ciprofloxacin treats otitis media,1342,[Pneumococcal meningitis during ciprofloxacin therapy for otitis media].,False,"'Does the phrase ""Ciprofloxacin treats otitis media"" receive at least indirect support from the statement: ""[Pneumococcal meningitis during ciprofloxacin therapy for otitis media].""?","No, the statement ""Pneumococcal meningitis during ciprofloxacin therapy for otitis media"" does not provide indirect support for the claim ""Ciprofloxacin treats otitis media."" The statement actually suggests that ciprofloxacin may not be effective in treating otitis media caused by pneumococcal bacteria, as evidenced by the development of pneumococcal meningitis despite ciprofloxacin treatment for otitis media.

         Ciprofloxacin is an antibiotic in the fluoroquinolone class that is not typically used as a first-line treatment for otitis media due to its potential adverse effects on children’s developing musculoskeletal systems. Moreover, certain strains of bacteria causing otitis media may be resistant to ciprofloxacin, necessitating alternative antibiotics for effective treatment.

         The development of pneumococcal meningitis during ciprofloxacin therapy for otitis media implies that ciprofloxacin is unable to eliminate pneumococcal bacteria causing ot"
11840711,Ciprofloxacin treats cataract,1343,"CONCLUSIONS: Ofloxacin has higher corneal penetration and ability to exceed MIC90 of common ocular contaminants than ciprofloxacin, and would be a more appropriate prophylactic choice for canine cataract patients.",False,"'Does the phrase ""Ciprofloxacin treats cataract"" receive at least indirect support from the statement: ""CONCLUSIONS: Ofloxacin has higher corneal penetration and ability to exceed MIC90 of common ocular contaminants than ciprofloxacin, and would be a more appropriate prophylactic choice for canine cataract patients.""?","No, the statement does not provide indirect support for the phrase ""Ciprofloxacin treats cataract."" The conclusion is comparing two antibiotics, Ofloxacin and Ciprofloxacin, in terms of their corneal penetration and ability to exceed MIC90 of common ocular contaminants in canine cataract patients. It suggests Ofloxacin as a more appropriate prophylactic choice due to its superior properties in these aspects. However, it does not provide any information linking Ciprofloxacin to treating cataract. Cataract treatment typically involves surgical removal of the opaque lens and replacement with an artificial one, not antibiotics like Ciprofloxacin."
11684450,Ciprofloxacin treats cystitis,1344,Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.,True,"'Does the phrase ""Ciprofloxacin treats cystitis"" receive at least indirect support from the statement: ""Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.""?","Yes, the phrase ""Ciprofloxacin treats cystitis"" does receive indirect support from the statement ""Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial."" This is because the study compares two treatments for cystitis (Amoxicillin-clavulanate and Ciprofloxacin), implying that both have been considered as potential treatments for cystitis by the researchers conducting the study. The fact that Ciprofloxacin is included in such a study suggests that it is recognized as having potential efficacy in treating cystitis, even if it is not explicitly stated in the title of the study.

        However, it is important to note that indirect support does not equate to definitive proof of efficacy. The study may have found that Ciprofloxacin was less effective than Amoxicillin-clavulanate in treating cystitis in women, for example. Therefore, further investigation into the specific results of the study would be necessary for a more complete understanding of Cip"
11679354,Ciprofloxacin treats Pseudomonas infection,1345,We used a simple Wood's light examination and culture to establish the diagnosis of Pseudomonas toe web infection and achieved rapid resolution with oral ciprofloxacin treatment and local application of Castellani's paint.,True,"'Does the phrase ""Ciprofloxacin treats Pseudomonas infection"" receive at least indirect support from the statement: ""We used a simple Wood's light examination and culture to establish the diagnosis of Pseudomonas toe web infection and achieved rapid resolution with oral ciprofloxacin treatment and local application of Castellani's paint.""?","Yes, the statement does provide indirect support for the claim that ""Ciprofloxacin treats Pseudomonas infection"". The user's statement describes a case where a patient was diagnosed with a Pseudomonas toe web infection, which was then treated with oral Ciprofloxacin and Castellani's paint. The fact that they mention ""rapid resolution"" suggests that the treatment was effective, thereby implying that Ciprofloxacin is an effective treatment for Pseudomonas infections.

         However, it is important to note that while this does provide some level of support for the claim, it is not direct evidence because it is based on a single case study rather than a controlled clinical trial or other rigorous study design. Additionally, while Ciprofloxacin is an antibiotic commonly used to treat Pseudomonas infections due to its broad-spectrum activity against gram-negative bacteria like Pseudomonas aeruginosa, it is not always effective in all cases due to factors such as antibiotic resistance. Therefore, while the statement supports the claim that Ciprofloxacin can be used to"
11628762,Ciprofloxacin treats endophthalmitis,1346,Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!,True,"'Does the phrase ""Ciprofloxacin treats endophthalmitis"" receive at least indirect support from the statement: ""Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!""?","Yes, the phrase ""Ciprofloxacin treats endophthalmitis"" does receive indirect support from the statement ""Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!"" 

         The title of the study suggests that ciprofloxacin is being considered as an alternative treatment for endophthalmitis, which is an inflammation of the interior of the eye. This implies that ciprofloxacin has some efficacy in treating endophthalmitis, even though it may not be the first-line treatment. The fact that it is presented as an alternative to other established treatments (ceftazidime and amikacin) further supports this interpretation. However, it is important to note that this support is indirect and based on the title alone; the full study would need to be evaluated for a more definitive conclusion."
11564697,Ciprofloxacin treats chronic obstructive pulmonary disease,1347,Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier.,False,"'Does the phrase ""Ciprofloxacin treats chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""Reported here is the case of a patient with underlying chronic obstructive pulmonary disease (COPD) in whom ciprofloxacin treatment of a lower respiratory tract infection failed subsequent to ciprofloxacin treatment of an exacerbation of COPD several weeks earlier.""?","No, the statement does not provide indirect support for the claim that ""Ciprofloxacin treats chronic obstructive pulmonary disease (COPD)"". In fact, it suggests quite the opposite. The statement indicates that a patient with COPD was treated with ciprofloxacin for two separate conditions - a lower respiratory tract infection and an exacerbation of COPD - and that the treatment failed for the later condition. This implies that ciprofloxacin may not be effective in treating COPD exacerbations. However, it is important to note that this is based on a single case report and further studies would be needed to make definitive conclusions about the effectiveness of ciprofloxacin in treating COPD."
11304087,Ciprofloxacin treats eye infectious disorder,1348,This PK-MB model may be very useful in optimizing treatments of various eye infections with ciprofloxacin.,True,"'Does the phrase ""Ciprofloxacin treats eye infectious disorder"" receive at least indirect support from the statement: ""This PK-MB model may be very useful in optimizing treatments of various eye infections with ciprofloxacin.""?","Yes, indirectly it does lend support. The statement ""This PK-MB model may be very useful in optimizing treatments of various eye infections with ciprofloxacin"" suggests that there is an existing model (PK-MB) that can help improve the use of Ciprofloxacin in treating different eye infections. This implies that Ciprofloxacin is indeed used for treating eye infections, thus providing indirect support for the claim ""Ciprofloxacin treats eye infectious disorder"". However, it's important to note that the original statement does not provide direct evidence of Ciprofloxacin's effectiveness in treating eye infections, but rather suggests that the model could help optimize its use in treatment."
11059709,Ciprofloxacin treats abscess,1349,"The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously.",True,"'Does the phrase ""Ciprofloxacin treats abscess"" receive at least indirect support from the statement: ""The patient was asymptomatic for a month, but the abscess reactivated and was treated with Vancomycin and Ciprofloxacin administered intravenously.""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats abscess"". The patient was initially asymptomatic for a month, indicating that the abscess had been under control prior to its reactivation. The fact that Ciprofloxacin was used in treating the reactivated abscess suggests that it was considered effective against the infection causing the abscess. However, it is important to note that Ciprofloxacin was administered in conjunction with Vancomycin in this case, which may imply that Ciprofloxacin alone might not be sufficient for treating an abscess in all cases.

         To further substantiate the claim that Ciprofloxacin can treat abscesses, additional evidence such as clinical trials demonstrating its efficacy in treating abscesses would be needed. It is also important to consider potential factors that may influence Ciprofloxacin's effectiveness against abscesses, such as antibiotic resistance, severity of infection, location of abscess, and patient-specific factors like immune status.

         In summary,"
10087799,Ciprofloxacin treats bacterial infectious disease,1350,"Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections.",True,"'Does the phrase ""Ciprofloxacin treats bacterial infectious disease"" receive at least indirect support from the statement: ""Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections.""?","Yes, the statement ""Fluoroquinolones such as ciprofloxacin, levofloxacin, moxifloxacin and gatifloxacin are widely used for the treatment of bacterial infections"" does provide indirect support for the claim that ""Ciprofloxacin treats bacterial infectious disease"". This is because ciprofloxacin is listed as one of the fluoroquinolones that are used for treating bacterial infections. However, it is important to note that while this suggests that ciprofloxacin is effective against bacterial infections, it does not constitute direct evidence of its efficacy. It would be more conclusive if there were a specific study demonstrating ciprofloxacin's effectiveness against bacterial infections. Nonetheless, given the general understanding in medical science that fluoroquinolones are used for treating bacterial infections, it is reasonable to infer that ciprofloxacin would also be effective for this purpose."
10013051,Ciprofloxacin treats plague,1351,There are no previous reports of plague being successfully treated with ciprofloxacin.,False,"'Does the phrase ""Ciprofloxacin treats plague"" receive at least indirect support from the statement: ""There are no previous reports of plague being successfully treated with ciprofloxacin.""?","No, the statement ""There are no previous reports of plague being successfully treated with ciprofloxacin"" does not provide indirect support for the claim that ""Ciprofloxacin treats plague"". In fact, it suggests the opposite. The absence of previous successful treatments implies that ciprofloxacin has not been proven effective against plague. Therefore, more evidence would be needed to support the claim that ciprofloxacin is an effective treatment for plague."
10002223,Ciprofloxacin treats anthrax infection,1352,Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline.,True,"'Does the phrase ""Ciprofloxacin treats anthrax infection"" receive at least indirect support from the statement: ""Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline.""?","Yes, the phrase ""Ciprofloxacin treats anthrax infection"" does receive indirect support from the statement ""Treatment and post-exposure prophylaxis for anthrax are ciprofloxacin or doxycycline."" This is because ciprofloxacin is listed as an option for treatment and post-exposure prophylaxis of anthrax infections. However, it is important to note that while ciprofloxacin can be used to treat anthrax infections, it is not always the first-line treatment and its use should be determined by a healthcare professional based on various factors such as patient history, potential side effects, and resistance patterns."
9704134,Ciprofloxacin treats bronchiectasis,1353,"He had severe airway obstruction and focal bronchiectasis, and responded to treatment with ciprofloxacin and clarithromycin.",True,"'Does the phrase ""Ciprofloxacin treats bronchiectasis"" receive at least indirect support from the statement: ""He had severe airway obstruction and focal bronchiectasis, and responded to treatment with ciprofloxacin and clarithromycin.""?","Yes, indirectly it does lend some support. The statement suggests that the individual had bronchiectasis along with severe airway obstruction, and they responded positively to treatment involving ciprofloxacin (a type of antibiotic often used for treating infections caused by bacteria) in combination with clarithromycin (another antibiotic). However, it is important to note that bronchiectasis can be caused by various factors including bacterial infections, fungal infections, autoimmune diseases etc., so attributing improvement solely to ciprofloxacin might not be entirely accurate without further information about what specifically caused the bronchiectasis in this case."
9552171,Ciprofloxacin treats otitis externa,1354,"The objective of this study was to evaluate and compare the efficacy of topical otic powder, tobramycin drops and ciprofloxacin drops in patients suffering from AEO.",True,"'Does the phrase ""Ciprofloxacin treats otitis externa"" receive at least indirect support from the statement: ""The objective of this study was to evaluate and compare the efficacy of topical otic powder, tobramycin drops and ciprofloxacin drops in patients suffering from AEO.""?","Yes, the statement ""Ciprofloxacin treats otitis externa"" does receive indirect support from the provided statement. The study mentioned in the statement is focused on assessing and comparing the efficacy of different treatments for Acute Otitis Externa (AEO), one of which is Ciprofloxacin drops. The fact that Ciprofloxacin is being studied in relation to otitis externa implies that it is being considered as a potential treatment for this condition. Therefore, it can be inferred that Ciprofloxacin has some level of association with treating otitis externa based on this indirect evidence. However, it is important to note that further investigation into the results of the study is needed for a more definitive conclusion about Ciprofloxacin's effectiveness in treating otitis externa."
9504629,Ciprofloxacin treats Sepsis,1355,Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?,False,"'Does the phrase ""Ciprofloxacin treats Sepsis"" receive at least indirect support from the statement: ""Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?""?","No, the statement ""Ciprofloxacin treats Sepsis"" does not receive at least indirect support from the title ""Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?"" 

        While it is true that the title mentions Ciprofloxacin and Sepsis, it does not provide evidence that Ciprofloxacin is an effective treatment for Sepsis. The title is focused on pharmacokinetic profiles, which refers to how a drug moves through the body, including absorption, distribution, metabolism, and excretion. It does not provide information about the drug's efficacy in treating Sepsis. Therefore, it does not provide indirect support for the claim that Ciprofloxacin treats Sepsis."
9281470,Ciprofloxacin treats prostatitis,1356,The emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied.,False,"'Does the phrase ""Ciprofloxacin treats prostatitis"" receive at least indirect support from the statement: ""The emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied.""?","No, the statement does not provide indirect support for the phrase ""Ciprofloxacin treats prostatitis."" The study focuses on the emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month. While it is true that ciprofloxacin is being used as a treatment in this context, the statement does not provide information about the effectiveness of ciprofloxacin in treating prostatitis, which is what the phrase ""Ciprofloxacin treats prostatitis"" implies."
8956827,Ciprofloxacin treats Abdominal Infection,1357,"Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections, peritonitis in CAPD, pelvic inflammatory disease, endometritis and gall-bladder infections.",True,"'Does the phrase ""Ciprofloxacin treats Abdominal Infection"" receive at least indirect support from the statement: ""Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections, peritonitis in CAPD, pelvic inflammatory disease, endometritis and gall-bladder infections.""?","Yes, the phrase ""Ciprofloxacin treats Abdominal Infection"" does receive indirect support from the statement: ""Ciprofloxacin is effective in the treatment of serious, non-self-limiting intra-abdominal infections.""

         The rationale behind this is that abdominal infections can be classified as intra-abdominal infections. Specifically, when they become serious and non-self-limiting, they would fall within the scope of conditions for which Ciprofloxacin has demonstrated efficacy based on the provided statement. However, it is important to note that Ciprofloxacin may not be the first-line treatment for all types of abdominal infections; its use depends on factors such as the specific pathogen involved and the patient's overall health status."
8754779,Ciprofloxacin treats rhinoscleroma,1358,We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin.,True,"'Does the phrase ""Ciprofloxacin treats rhinoscleroma"" receive at least indirect support from the statement: ""We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin.""?","Yes, the statement ""We report on a young patient with nasal rhinoscleroma who achieved resolution after treatment with oral ciprofloxacin"" does provide indirect support for the claim that ""Ciprofloxacin treats rhinoscleroma"". This is because it describes a case where a patient with rhinoscleroma was treated with ciprofloxacin and experienced resolution of their symptoms. However, it's important to note that this is only one case study, which means it doesn't necessarily prove that ciprofloxacin is universally effective for treating rhinoscleroma. More rigorous studies, such as randomized controlled trials, would be needed to confirm this. Additionally, factors such as the dosage of ciprofloxacin used, the severity of the patient's rhinoscleroma, and any other treatments they received could also influence the outcome. Therefore, while this case study does provide some support for the claim, it doesn't definitively prove it."
8350437,Ciprofloxacin treats pyelonephritis,1359,Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?,True,"'Does the phrase ""Ciprofloxacin treats pyelonephritis"" receive at least indirect support from the statement: ""Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?""?","Yes, the phrase ""Ciprofloxacin treats pyelonephritis"" does receive indirect support from the statement: ""Is a 7-day course of ciprofloxacin effective in the treatment of uncomplicated pyelonephritis in women?""

         The statement implies that ciprofloxacin is used in treating uncomplicated pyelonephritis in women, which suggests that ciprofloxacin has some therapeutic effect on pyelonephritis. However, it is essential to note that pyelonephritis is not explicitly mentioned in the phrase; instead, it is implied through the context provided in the statement. Additionally, the effectiveness of ciprofloxacin in treating pyelonephritis is contingent on various factors such as dosage, duration of treatment, patient characteristics, bacterial susceptibility, among others; hence, further investigation is necessary for more definitive conclusions."
8337570,Ciprofloxacin treats bacterial infectious disease with sepsis,1360,"Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.",True,"'Does the phrase ""Ciprofloxacin treats bacterial infectious disease with sepsis"" receive at least indirect support from the statement: ""Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.""?","Yes, the phrase ""Ciprofloxacin treats bacterial infectious disease with sepsis"" does receive indirect support from the statement: ""Despite prolonged bacteremia, the response to long-term therapy with ciprofloxacin and rifampin was excellent.""

         The statement suggests that ciprofloxacin was used in combination therapy for an extended period to treat a bacterial infection (bacteremia). The positive outcome implies that ciprofloxacin was effective against the bacterial infection, providing indirect evidence for its use in treating bacterial infectious diseases.

         However, it is important to note that sepsis is a complex condition characterized by a dysregulated host response to infection rather than simply an infection itself (Singer et al., 2016). Therefore, while ciprofloxacin may be useful in treating bacterial infections that can lead to sepsis, it does not specifically treat sepsis itself.

         Furthermore, the statement mentions combination therapy with rifampin. This suggests that ciprofloxacin may not always be used alone in treating bacterial"
8194797,Ciprofloxacin treats neutropenia,1361,The proportion of patients who developed neutropenia and fever was 87% in the group treated with ciprofloxacin and 78% in the group treated with ciprofloxacin and rifampin (P =.25).,False,"'Does the phrase ""Ciprofloxacin treats neutropenia"" receive at least indirect support from the statement: ""The proportion of patients who developed neutropenia and fever was 87% in the group treated with ciprofloxacin and 78% in the group treated with ciprofloxacin and rifampin (P =.25).""?","No, the statement does not provide indirect support for the phrase ""Ciprofloxacin treats neutropenia."" The statement compares two groups of patients treated with different regimens containing ciprofloxacin - one group receiving ciprofloxacin alone and another group receiving ciprofloxacin in combination with rifampin - in terms of their rates of developing neutropenia (low white blood cell count) and fever. The rates of these adverse events were slightly higher in the ciprofloxacin-only group (87%), but not significantly so (P = .25). This finding does not suggest that ciprofloxacin treats neutropenia; on the contrary, it indicates that ciprofloxacin may not prevent neutropenia.

        Neutropenia is generally treated using growth factors (e.g., granulocyte colony-stimulating factor) that stimulate white blood cell production in the bone marrow or by adjusting medications that cause neutropenia as side effects. Antibiotics like ciprofloxac"
8190776,Ciprofloxacin treats peritonitis,1362,"Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001).",True,"'Does the phrase ""Ciprofloxacin treats peritonitis"" receive at least indirect support from the statement: ""Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001).""?","Yes, the statement ""Peritonitis due to S. aureus ESI was significantly less frequent among patients treated with ciprofloxacin (1 vs 9 cases, p = 0.001)"" does provide indirect support for the claim that ""Ciprofloxacin treats peritonitis."" The study indicates that there is a statistically significant difference in peritonitis cases between patients treated with ciprofloxacin versus those not treated with it (p = 0.001). With only one case of peritonitis in patients receiving ciprofloxacin compared to nine cases in patients not receiving it, there is evidence suggesting that ciprofloxacin may help in treating peritonitis caused by S. aureus ESI. However, it is important to consider that correlation does not necessarily imply causation; further studies would be required to definitively establish ciprofloxacin as an effective treatment for peritonitis caused by S. aureus ESI."
8088120,Ciprofloxacin treats Fever,1363,"In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia.",False,"'Does the phrase ""Ciprofloxacin treats Fever"" receive at least indirect support from the statement: ""In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia.""?","No, the phrase ""Ciprofloxacin treats Fever"" does not receive at least indirect support from the statement: ""In the current study, the authors examined the use of ciprofloxacin as outpatient management in selected patients with fever during an episode of neutropenia.""

        The statement from the study indicates that ciprofloxacin was used for outpatient management of fever in neutropenic patients, not that it treats fever itself. Neutropenia is a condition characterized by an abnormally low number of neutrophils (a type of white blood cell that fights infection), making patients more susceptible to infections, which can cause fever.

        Although ciprofloxacin is an antibiotic that can help manage infections and may lead to fever reduction as a secondary effect, it does not specifically treat fever as fever is a symptom of an underlying condition rather than a condition that can be treated independently. Therefore, there is no indirect support for the claim that ""Ciprofloxacin treats Fever"" based on the provided statement from the study."
7880629,Ciprofloxacin treats osteomyelitis,1364,"The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed.",True,"'Does the phrase ""Ciprofloxacin treats osteomyelitis"" receive at least indirect support from the statement: ""The efficacy and safety of three oral fluoroquinolones (lomefloxacin, levofloxacin, and ciprofloxacin) for the treatment of chronic osteomyelitis were analyzed.""?","Yes, the statement does provide indirect support for the claim that ""Ciprofloxacin treats osteomyelitis."" This is because it mentions that ciprofloxacin is one of three oral fluoroquinolones analyzed for their efficacy and safety in treating chronic osteomyelitis. However, it is important to note that indirect support does not equate to definitive proof of efficacy, as it doesn't provide information on whether ciprofloxacin was found to be effective specifically, nor does it account for other potential factors such as dosage or duration of treatment."
7798648,Ciprofloxacin treats cystic fibrosis,1365,"As juveniles are especially sensitive, use of these drugs in paediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).",True,"'Does the phrase ""Ciprofloxacin treats cystic fibrosis"" receive at least indirect support from the statement: ""As juveniles are especially sensitive, use of these drugs in paediatrics should be restricted to carefully selected indications (such as the use of ciprofloxacin in cystic fibrosis).""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats cystic fibrosis."" The key phrase here is ""the use of ciprofloxacin in cystic fibrosis."" This implies that ciprofloxacin has some therapeutic value in treating cystic fibrosis, even though it doesn't explicitly state that it cures or eliminates the disease. 

         However, it's important to note that ciprofloxacin is an antibiotic commonly used to treat various bacterial infections, not a specific treatment for cystic fibrosis itself. Cystic fibrosis is a genetic disorder that primarily affects the lungs, causing chronic infections. Therefore, while ciprofloxacin may be used to manage some symptoms of cystic fibrosis by treating secondary infections, it does not treat the underlying cause of the disease. 

         Additionally, the statement highlights that juveniles are especially sensitive to these drugs, suggesting that while ciprofloxacin may be used in paediatric cystic fibrosis cases,"
7544699,Ciprofloxacin treats diarrheal disease,1366,The aim of this study was to investigate clinical importance of ciprofloxacin efficacy in treatment of massive diarrhoea in patients after extensional bowel resection with removing of ileo-coecal valve (EBR + ICVR).,True,"'Does the phrase ""Ciprofloxacin treats diarrheal disease"" receive at least indirect support from the statement: ""The aim of this study was to investigate clinical importance of ciprofloxacin efficacy in treatment of massive diarrhoea in patients after extensional bowel resection with removing of ileo-coecal valve (EBR + ICVR).""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats diarrheal disease"". The study aims to investigate the clinical importance of ciprofloxacin efficacy in treating massive diarrhea in patients after undergoing specific surgical procedures (EBR + ICVR). This implies that ciprofloxacin is being used as a potential treatment for diarrheal symptoms in these patients, thus providing indirect evidence that ciprofloxacin can be used to treat diarrheal disease. However, it is important to note that direct evidence of ciprofloxacin's efficacy in treating diarrheal disease would require studies specifically designed to test its effectiveness in treating diarrhea, regardless of surgical history or other factors."
7423320,Ciprofloxacin treats typhoid fever,1367,"To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial.",True,"'Does the phrase ""Ciprofloxacin treats typhoid fever"" receive at least indirect support from the statement: ""To compare clinical and bacteriological efficacies of azithromycin and ciprofloxacin for typhoid fever, 123 adults with fever and signs of uncomplicated typhoid fever were entered into a randomized trial.""?","Yes, indirectly it does support the claim that Ciprofloxacin treats typhoid fever. The statement provides evidence of a randomized trial involving adults with uncomplicated typhoid fever who were treated with Ciprofloxacin. The fact that such a trial was conducted suggests that there is some basis for believing that Ciprofloxacin could be an effective treatment for typhoid fever. However, it does not provide direct evidence of Ciprofloxacin's efficacy, as it does not report on the outcomes of the trial. Therefore, further investigation would be needed to definitively confirm whether Ciprofloxacin is an effective treatment for typhoid fever."
7337248,Ciprofloxacin treats pneumonia,1368,Initial treatment of severe pneumonia with ciprofloxacin resulted in significantly less subsequent gram-negative infection and was associated with substantially lower curative costs.,True,"'Does the phrase ""Ciprofloxacin treats pneumonia"" receive at least indirect support from the statement: ""Initial treatment of severe pneumonia with ciprofloxacin resulted in significantly less subsequent gram-negative infection and was associated with substantially lower curative costs.""?","Yes, the statement does provide indirect support for the phrase ""Ciprofloxacin treats pneumonia."" The statement indicates that initial treatment of severe pneumonia with ciprofloxacin led to significantly less subsequent gram-negative infection. This suggests that ciprofloxacin is effective in treating pneumonia caused by gram-negative bacteria, which is a common cause of pneumonia. The lower curative costs associated with ciprofloxacin treatment also imply that it is a cost-effective option for treating pneumonia. However, it is important to note that pneumonia can be caused by various types of bacteria, viruses, and fungi, and that ciprofloxacin is not effective against all of these pathogens. Therefore, while the statement does provide some support for the idea that ciprofloxacin can be used to treat pneumonia, it does not necessarily mean that ciprofloxacin is always the best option for treating pneumonia in all cases."
7228759,Ciprofloxacin treats infectious disease,1369,"Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.",True,"'Does the phrase ""Ciprofloxacin treats infectious disease"" receive at least indirect support from the statement: ""Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.""?","Yes, the phrase ""Ciprofloxacin treats infectious disease"" does receive indirect support from the statement: ""Ciprofloxacin (CIP), a fluoroquinolone antibacterial drug, is widely used in the treatment of serious infections in humans.""

         The statement indicates that Ciprofloxacin (CIP) is an antibacterial drug used for treating severe infections in humans. Antibacterial drugs target bacterial infections by either killing bacteria or inhibiting their growth (CDC, 2021). Infectious diseases can be caused by various microorganisms like bacteria (WHO, 2021). Since Ciprofloxacin is used for treating bacterial infections in humans, it implies that Ciprofloxacin indeed helps manage infectious diseases indirectly by tackling bacterial infections that contribute to these diseases.

         References:
         Centers for Disease Control and Prevention (CDC). (2021). Antibiotic/Antimicrobial Resistance. Retrieved from https://www.cdc.gov/d"
7163480,Ciprofloxacin treats Crohn disease,1370,Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.,True,"'Does the phrase ""Ciprofloxacin treats Crohn disease"" receive at least indirect support from the statement: ""Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin.""?","Yes, indirect support can be inferred from the statement ""Use of antibiotics in the treatment of active Crohn's disease: experience with metronidazole and ciprofloxacin."" This suggests that ciprofloxacin has been used in treating Crohn's disease, but it does not explicitly state that ciprofloxacin treats Crohn disease. A direct cause-and-effect relationship is not established in this statement alone; therefore, further evidence would be needed for unequivocal support of the claim that ""Ciprofloxacin treats Crohn disease.""

        In order to establish direct support for the claim that ciprofloxacin treats Crohn disease, well-designed clinical trials demonstrating efficacy would be required. The provided statement describes experience in using ciprofloxacin for treating Crohn disease but does not provide any specific outcomes or results that would definitively support its use as a treatment for Crohn disease.

        It is important to note that antibiotics like ciprofloxacin may be used as part of a treatment regimen for Crohn disease"
10607698,Chloramphenicol treats bacterial infectious disease,1371,[Experiences with a chloramphenicol preparation for intramuscular injection in bacterial infections of the CNS].,True,"'Does the phrase ""Chloramphenicol treats bacterial infectious disease"" receive at least indirect support from the statement: ""[Experiences with a chloramphenicol preparation for intramuscular injection in bacterial infections of the CNS].""?","Yes, the phrase ""Chloramphenicol treats bacterial infectious disease"" does receive indirect support from the statement: ""[Experiences with a chloramphenicol preparation for intramuscular injection in bacterial infections of the CNS].""

         The statement suggests that chloramphenicol has been used in treating bacterial infections of the central nervous system (CNS), which is a specific type of bacterial infection. Chloramphenicol is an antibiotic that works by stopping bacterial growth. Thus, it supports the claim that chloramphenicol can be used to treat bacterial infectious diseases, although it is important to note that its effectiveness may vary depending on the type of bacteria causing the infection and the patient's overall health condition.

         However, it is crucial to consider that using antibiotics should be based on appropriate diagnosis and prescription by healthcare professionals since inappropriate use can lead to antibiotic resistance—a significant global health concern."
9528501,Chloramphenicol treats osteomyelitis,1372,A 2-month-old infant with Enterobacter osteomyelitis complicating total parenteral nutrition was successfully treated with rifampicin and chloramphenicol.,True,"'Does the phrase ""Chloramphenicol treats osteomyelitis"" receive at least indirect support from the statement: ""A 2-month-old infant with Enterobacter osteomyelitis complicating total parenteral nutrition was successfully treated with rifampicin and chloramphenicol.""?","Yes, the statement does provide indirect support for the phrase ""Chloramphenicol treats osteomyelitis."" The case describes an infant with Enterobacter osteomyelitis who was successfully treated using chloramphenicol in combination with rifampicin. This suggests that chloramphenicol had an effective therapeutic response against osteomyelitis in this particular case. However, it is important to note that antibiotic treatment success can be influenced by various factors such as patient-specific factors (age, immune status), bacterial susceptibility, duration of treatment, and potential synergistic effects of combined therapies like in this case where both rifampicin and chloramphenicol were used together. Therefore, while there is some support for chloramphenicol treating osteomyelitis from this statement, it does not necessarily confirm that chloramphenicol alone would be sufficient for treating osteomyelitis in all cases."
7351604,Chloramphenicol treats eye infectious disorder,1373,"The writers consult a wide range of American, European and British research from 1950 to the present to reassure readers that ophthalmic chloramphenicol is a demonstrably effective, safe, cost-effective treatment for most superficial eye infections.",True,"'Does the phrase ""Chloramphenicol treats eye infectious disorder"" receive at least indirect support from the statement: ""The writers consult a wide range of American, European and British research from 1950 to the present to reassure readers that ophthalmic chloramphenicol is a demonstrably effective, safe, cost-effective treatment for most superficial eye infections.""?","Yes, the statement does provide indirect support for the claim that chloramphenicol treats eye infectious disorders. The writers' consultation of a wide range of American, European, and British research from 1950 to the present suggests they have conducted an extensive review of existing literature on the topic. Their assurance that ophthalmic chloramphenicol is an effective, safe, and cost-effective treatment for most superficial eye infections implies that there is evidence supporting chloramphenicol's positive impact on treating eye infections.

         However, it is essential to note that while this statement offers some level of support for chloramphenicol as an effective treatment for eye infections, it does not constitute direct evidence for its effectiveness in treating all eye infectious disorders. The specificity of chloramphenicol's applicability for treating various eye infections may vary depending on factors such as infection type, severity, duration, and potential side-effects.

         In addition, it is crucial to consider that while the statement refers to ""most superficial eye infections,"" it does not explicitly specify which superficial eye infections chloramphenicol has been proven effective in"
24500158,Rebamipide treats gastroesophageal reflux disease,1374,Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.,False,"'Does the phrase ""Rebamipide treats gastroesophageal reflux disease"" receive at least indirect support from the statement: ""Frequently reported adverse events of rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease.""?","No, the statement does not provide direct or indirect support for the claim that ""Rebamipide treats gastroesophageal reflux disease."" The provided statement discusses adverse events associated with rebamipide compared to other drugs for peptic ulcer and gastroesophageal reflux disease (GERD). While it implies that rebamipide is used in treating GERD, it does not provide evidence that rebamipide is effective in treating GERD or that it is specifically used for that purpose. Therefore, it does not support the initial claim."
19949890,Rebamipide treats osteoarthritis,1375,We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA.,True,"'Does the phrase ""Rebamipide treats osteoarthritis"" receive at least indirect support from the statement: ""We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA.""?","Yes, there is indirect support for the claim that rebamipide treats osteoarthritis (OA) in the statement ""We also discuss the potential role of rebamipide to serve as a new strategy for the treatment of TMJ-OA."" The abbreviation TMJ-OA stands for temporomandibular joint osteoarthritis, which is a specific form of osteoarthritis affecting the temporomandibular joint.

        The key aspect that provides indirect support is that rebamipide is mentioned in relation to treating osteoarthritis (OA), specifically TMJ-OA. This implies that rebamipide may have beneficial effects on osteoarthritis symptoms in general or in particular contexts. However, it is essential to note that direct support for rebamipide treating osteoarthritis would require more robust evidence from clinical trials specifically designed to assess its effectiveness in treating osteoarthritis in various joints.

        In summary, while not definitive proof, the statement does provide some level of indirect support for rebamipide being used as a treatment for o"
19364844,Rebamipide treats dry eye syndrome,1376,CONCLUSIONS: REB and DQS may be effective for the management of dry eye syndrome after PK in terms of ocular surface findings.,True,"'Does the phrase ""Rebamipide treats dry eye syndrome"" receive at least indirect support from the statement: ""CONCLUSIONS: REB and DQS may be effective for the management of dry eye syndrome after PK in terms of ocular surface findings.""?","Yes, there is indirect support for the claim that Rebamipide treats dry eye syndrome based on the provided statement. The conclusion suggests that Rebamipide (REB) and Diquafosol (DQS) may be effective for managing dry eye syndrome after photorefractive keratectomy (PK) in terms of ocular surface findings. This implies that Rebamipide could have a positive impact on dry eye syndrome symptoms, which aligns with the general idea that Rebamipide treats dry eye syndrome. However, it is essential to consider that this conclusion is derived from a specific context (after PK) and may not necessarily generalize to all cases of dry eye syndrome."
13211904,Rebamipide treats ulcerative colitis,1377,"OBJECTIVE AND DESIGN: Since rebamipide is effective for the treatment of ulcerative colitis (UC), we examined the involvement of hepatocyte growth factor (HGF) in the action of rebamipide.",True,"'Does the phrase ""Rebamipide treats ulcerative colitis"" receive at least indirect support from the statement: ""OBJECTIVE AND DESIGN: Since rebamipide is effective for the treatment of ulcerative colitis (UC), we examined the involvement of hepatocyte growth factor (HGF) in the action of rebamipide.""?","Yes, the statement does provide indirect support for the claim that rebamipide treats ulcerative colitis (UC). The objective of the study explicitly states that rebamipide is effective for UC treatment. However, it's important to note that an indirect supportive statement does not equate to definitive proof of the claim; it only suggests that there is some evidence pointing in that direction. To fully establish rebamipide as an effective treatment for UC, one must consider other factors like clinical trial results, peer-reviewed publications, and meta-analyses that evaluate its efficacy compared to other treatments or placebos."
12062800,Rebamipide treats peptic ulcer disease,1378,"Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease.",True,"'Does the phrase ""Rebamipide treats peptic ulcer disease"" receive at least indirect support from the statement: ""Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease.""?","Yes, the statement ""Rebamipide, a gastro-protective drug, was developed in Japan for the treatment of peptic ulcer disease"" does provide indirect support for the claim that ""Rebamipide treats peptic ulcer disease.""

         The key term here is ""developed for."" In general, when a drug is developed for treating a specific condition, it implies that there is evidence suggesting that the drug can effectively manage that condition. Therefore, it can be inferred that Rebamipide has some therapeutic effect on peptic ulcer disease since it was developed for that purpose.

         However, it is essential to note that while this statement offers indirect evidence supporting Rebamipide's efficacy in treating peptic ulcer disease, it does not constitute definitive proof of its therapeutic benefits. For a more robust conclusion, we would need additional information such as clinical trial results demonstrating Rebamipide's efficacy in treating peptic ulcer disease compared to other treatment options or placebos.

         In conclusion, while there is some level of support for Rebamipide treating peptic ulcer disease based on its development for that purpose, further evidence"
10368387,Rebamipide treats gastric ulcer,1379,Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers.,True,"'Does the phrase ""Rebamipide treats gastric ulcer"" receive at least indirect support from the statement: ""Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers.""?","Yes, the statement ""Rebamipide is a mucoprotective drug used for the treatment of gastric ulcers"" does provide indirect support for the phrase ""Rebamipide treats gastric ulcer."" 

        The key term here is ""used for the treatment,"" which implies that Rebamipide has been administered to patients with gastric ulcers as part of a therapeutic regimen. This suggests that Rebamipide does have some efficacy in treating gastric ulcers, thus lending credence to the phrase ""Rebamipide treats gastric ulcer."" 

        However, it is important to note that ""treats"" is a strong verb indicating direct causality, whereas ""used for the treatment"" suggests more of an associative relationship rather than direct causality. Therefore, while there is indirect support for the claim that Rebamipide treats gastric ulcers, it would be more accurate to state that Rebamipide has been used in the treatment of gastric ulcers based on current evidence. 

        This interpretation highlights one of the nuances in interpreting scientific evidence - the language used can significantly impact how"
8102739,Rebamipide treats gastritis,1380,"In conclusion, rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB and thereby decreasing IL-8 production.",True,"'Does the phrase ""Rebamipide treats gastritis"" receive at least indirect support from the statement: ""In conclusion, rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB and thereby decreasing IL-8 production.""?","Yes, the statement does provide indirect support for the claim that rebamipide treats gastritis. The conclusion suggests that rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-kappaB, which in turn decreases IL-8 production. Gastritis is an inflammation of the stomach lining often caused by H. pylori infection. By reducing inflammation, rebamipide could potentially alleviate symptoms of gastritis, providing a basis for the claim that it treats gastritis. However, it is important to note that direct clinical evidence of rebamipide's efficacy in treating gastritis would strengthen this claim."
27610972,DINUTUXIMAB treats bone osteosarcoma,1381,Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.,False,"'Does the phrase ""DINUTUXIMAB treats bone osteosarcoma"" receive at least indirect support from the statement: ""Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.""?","No, the statement does not provide indirect support for the phrase ""DINUTUXIMAB treats bone osteosarcoma"". The study mentioned in the statement is a Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody (ch14.18) in patients with refractory neuroblastoma and osteosarcoma. Dinutuximab is also a human-mouse chimeric monoclonal antibody that targets the same antigen (disialoganglioside GD2) as ch14.18. However, the study does not specify that dinutuximab was used in the trial, nor does it provide any outcomes specifically related to osteosarcoma treatment. Therefore, it does not offer any evidence that dinutuximab is effective in treating bone osteosarcoma."
21740095,DINUTUXIMAB treats neoplasm,1382,Tumors treated with local dinutuximab had decreased MYCN expression on histology compared to control or IgG-treated tumors.,True,"'Does the phrase ""DINUTUXIMAB treats neoplasm"" receive at least indirect support from the statement: ""Tumors treated with local dinutuximab had decreased MYCN expression on histology compared to control or IgG-treated tumors.""?","Yes, indirectly it does lend some support. The statement suggests that dinutuximab has an effect on tumors by decreasing MYCN expression as observed through histology. This implies that dinutuximab could potentially be used as a treatment for neoplasms (a type of new abnormal growth of cells, also known as tumors). However, it's important to note that this is an indirect inference based on one specific observation. A more definitive conclusion would require additional evidence demonstrating that dinutuximab treatment leads to reduced tumor growth or improved patient outcomes in clinical settings."
9445080,DINUTUXIMAB treats neuroblastoma,1383,Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma.,False,"'Does the phrase ""DINUTUXIMAB treats neuroblastoma"" receive at least indirect support from the statement: ""Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma.""?","No, the statement does not provide indirect support for the claim that Dinutuximab treats neuroblastoma. 

         Dinutuximab is a monoclonal antibody that targets GD2 (disialoganglioside), which is overexpressed in neuroblastoma cells. It is also known as ch14.18, so the human-mouse chimeric anti-GD2 mAb ch14.18 mentioned in the statement refers to Dinutuximab itself.

         The statement discusses ocular symptoms in children treated with Dinutuximab for neuroblastoma. While it indicates that Dinutuximab is used in treating neuroblastoma patients, it does not provide any information about the treatment efficacy (e.g., response rates, overall survival) in these patients. Therefore, it fails to support the claim that Dinutuximab treats neuroblastoma indirectly.

         To provide indirect support for the claim that Dinutuximab treats neuroblastoma, one would need evidence showing that patients treated with Dinutuximab have better outcomes (e.g., reduced tumor burden, improved overall survival)"
22808973,BRENTUXIMAB VEDOTIN treats anaplastic large cell lymphoma,1384,[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].,True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats anaplastic large cell lymphoma"" receive at least indirect support from the statement: ""[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].""?","Yes, the phrase ""Brentuximab vedotin treats anaplastic large cell lymphoma"" does receive indirect support from the statement: ""[Brentuximab vedotin for previously untreated systemic anaplastic large cell lymphoma].""

         The statement suggests that Brentuximab vedotin is used in treating systemic anaplastic large cell lymphoma (sALCL), which is a specific type of anaplastic large cell lymphoma (ALCL). ALCL is a peripheral T-cell lymphoma (PTCL), which is a group of aggressive non-Hodgkin lymphomas (NHL). Brentuximab vedotin is an antibody-drug conjugate that targets CD30, which is often expressed in ALCL cells.

         Although the statement does not explicitly claim that Brentuximab vedotin treats anaplastic large cell lymphoma, it implies that Brentuximab vedotin is used in treating sALCL patients who have not received prior systemic therapy. This indirectly supports the idea that Brentuxim"
22284390,BRENTUXIMAB VEDOTIN treats neoplasm,1385,"Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy.",False,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats neoplasm"" receive at least indirect support from the statement: ""Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy.""?","No, the statement ""Although brentuximab-vedotin (BV) demonstrated single-agent activity, tumours regrew during BV therapy"" does not provide indirect support for the phrase ""BRENTUXIMAB VEDOTIN treats neoplasm."" The statement indicates that BV has shown some effectiveness as a single agent in treating neoplasm (cancerous growths), but it also reveals that tumours can regrow during BV therapy. This suggests that BV may not necessarily cure neoplasm but may only temporarily halt its progression in some cases. The ability of BV to treat neoplasm is not supported by this statement alone since treating implies durable therapeutic success that prevents disease recurrence in patients.

        To provide indirect support for ""BRENTUXIMAB VEDOTIN treats neoplasm,"" we would need evidence suggesting that BV leads to long-term tumour control or elimination in patients, rather than just temporary regression. For example, clinical trial results demonstrating improved survival rates in patients treated with BV compared to those who did not receive BV would offer indirect support for BV treating neoplasm.

        In summary, while B"
21657991,BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma,1386,BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.,True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.""?","Yes, there is indirect support for the statement that ""BRENTUXIMAB VEDOTIN treats mature T-cell and NK-cell non-Hodgkin lymphoma"" based on the provided statement.

         BRENTUXIMAB VEDOTIN (BV) is mentioned as a major therapeutic advance in treating patients with R/R Cutaneous T-cell Lymphoma (CTCL) and patients with Peripheral T-cell Lymphoma (PTCL) in both relapsed/refractory (R/R) and frontline settings. Both CTCL and PTCL are subtypes of non-Hodgkin lymphoma (NHL), which primarily involve mature T-cells (CTCL) and NK-cells (a subset of T-cells) in their pathogenesis. Therefore, by treating CTCL and PTCL, BV indeed treats mature T-cell and NK-cell NHL subtypes as asserted in the original statement.

         However, it is important to note that BV may not be effective against all NHL subtypes involving mature T-cells and NK-cells"
21657990,BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma,1387,BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.,True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""BV is a major therapeutic advance in the treatment of patients with R/R CTCL and of those with PTCL in both the R/R and frontline settings.""?","Yes, the statement does provide indirect support for the claim that BRENTUXIMAB VEDOTIN treats primary cutaneous T-cell non-Hodgkin lymphoma (PTCL). The statement highlights that BRENTUXIMAB VEDOTIN (BV) is a significant advancement in treating patients with relapsed/refractory (R/R) cutaneous T-cell lymphoma (CTCL) and frontline PTCL settings. Since primary cutaneous T-cell non-Hodgkin lymphoma is a subtype of CTCL, it implies that BV could be an effective treatment option for primary cutaneous T-cell non-Hodgkin lymphoma patients as well, particularly in relapsed/refractory cases due to its therapeutic advancements in R/R CTCL treatment. However, it is crucial to note that direct clinical trial results specifically investigating BV in primary cutaneous T-cell non-Hodgkin lymphoma patients would provide stronger support for the claim."
21596847,BRENTUXIMAB VEDOTIN treats Sezary syndrome,1388,"[Ulceration of lymphomatous skin lesions in a patient with Sezary syndrome treated with brentuximab-vedotin].BACKGROUND: Brentuximab-vedotin (BV), an anti-CD30 agent combined with an anti-neoplastic agent, has recently yielded promising results in the treatment of cutaneous T-lymphomas such as Sezary syndrome.",True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats Sezary syndrome"" receive at least indirect support from the statement: ""[Ulceration of lymphomatous skin lesions in a patient with Sezary syndrome treated with brentuximab-vedotin].BACKGROUND: Brentuximab-vedotin (BV), an anti-CD30 agent combined with an anti-neoplastic agent, has recently yielded promising results in the treatment of cutaneous T-lymphomas such as Sezary syndrome.""?","Yes, indirect support can be inferred from the statement provided. The background information indicates that Brentuximab-vedotin (BV) has shown promising results in treating cutaneous T-cell lymphomas like Sezary syndrome. The statement specifically mentions a patient with Sezary syndrome being treated with BV, but it does not explicitly mention whether ulceration of lymphomatous skin lesions improved as a result of treatment.

        
        However, since BV is known for its therapeutic effects on cutaneous T-cell lymphomas such as Sezary syndrome, it is reasonable to infer that treating such patients might lead to improvements in skin lesions over time. As such, ulceration of lymphomatous skin lesions could be among those improvements indirectly supported by the statement in question.

        
        Nonetheless, it is crucial to note that definitive conclusions cannot be drawn without explicit information on how skin lesions changed following BV treatment in that particular patient described in the statement."
21569598,BRENTUXIMAB VEDOTIN treats adult T-cell leukemia/lymphoma,1389,Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed.,False,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats adult T-cell leukemia/lymphoma"" receive at least indirect support from the statement: ""Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed.""?","No, indirect support cannot be inferred from this statement alone. The statement ""Further investigations on the use of brentuximab vedotin for adult T-cell leukemia/lymphoma are needed"" implies that there is currently insufficient evidence to conclusively support or refute its use for treating adult T-cell leukemia/lymphoma. This suggests that while brentuximab vedotin may hold promise for treating adult T-cell leukemia/lymphoma, more rigorous studies would need to be conducted before making definitive conclusions about its efficacy for treating such conditions."
21569593,BRENTUXIMAB VEDOTIN treats lymphoma,1390,Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas.,True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats lymphoma"" receive at least indirect support from the statement: ""Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas.""?","Yes, the phrase ""Brentuximab vedotin treats lymphoma"" does receive indirect support from the statement: ""Brentuximab vedotin represents a major breakthrough in the treatment of CD30-positive lymphomas."" 

        The key term here is ""breakthrough in treatment."" A breakthrough implies that a significant advancement has been made in treating a particular condition - in this case, CD30-positive lymphomas. Brentuximab vedotin is an antineoplastic agent, meaning it is used to treat cancerous growths such as lymphomas. Therefore, if Brentuximab vedotin is a breakthrough in treating CD30-positive lymphomas, it follows that it must effectively treat these types of lymphomas, thus providing indirect support for the claim that ""Brentuximab vedotin treats lymphoma.""

        However, it is important to note that while Brentuximab vedotin is indeed effective for treating certain types of lymphomas (specifically those that express CD30), it may not be effective for all lymphomas"
21525451,BRENTUXIMAB VEDOTIN treats Hodgkins lymphoma,1391,"Currently, ADCs that have received regulatory approval include brentuximab vedotin for CD30-positive Hodgkin lymphoma and trastuzumab emtansine for human epidermal growth factor receptor 2-positive breast cancer.",True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats Hodgkins lymphoma"" receive at least indirect support from the statement: ""Currently, ADCs that have received regulatory approval include brentuximab vedotin for CD30-positive Hodgkin lymphoma and trastuzumab emtansine for human epidermal growth factor receptor 2-positive breast cancer.""?","Yes, the phrase ""BRENTUXIMAB VEDOTIN treats Hodgkin lymphoma"" does receive indirect support from the statement provided. 

         The statement indicates that BRENTUXIMAB VEDOTIN has received regulatory approval for treating CD30-positive Hodgkin lymphoma (HL). This implies that BRENTUXIMAB VEDOTIN is an effective treatment for HL patients whose tumors express CD30 antigen. The drug is an antibody-drug conjugate (ADC) designed to deliver chemotherapy specifically to CD30-expressing cancer cells upon binding, thereby reducing systemic toxicity compared to traditional chemotherapy regimens.

         The U.S. Food and Drug Administration (FDA) has approved BRENTUXIMAB VEDOTIN based on clinical trials demonstrating its efficacy in treating HL patients [1]. It is essential to acknowledge that while BRENTUXIMAB VEDOTIN is an effective treatment for Hodgkin lymphoma patients whose tumors express CD30 antigen, it may not be an appropriate treatment option for all HL patients due to"
21472937,BRENTUXIMAB VEDOTIN treats mycosis fungoides,1392,The interest of BV in the management of CD30-positive mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma has recently been demonstrated compared to methotrexate or bexarotene.,True,"'Does the phrase ""BRENTUXIMAB VEDOTIN treats mycosis fungoides"" receive at least indirect support from the statement: ""The interest of BV in the management of CD30-positive mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma has recently been demonstrated compared to methotrexate or bexarotene.""?","Yes, the phrase ""BRENTUXIMAB VEDOTIN treats mycosis fungoides"" does receive indirect support from the statement provided. 

         The statement suggests that BRENTUXIMAB VEDOTIN (BV) has demonstrated interest in managing CD30-positive mycosis fungoides (MF) and primary cutaneous anaplastic large cell lymphoma. Mycosis fungoides is a type of cutaneous T-cell lymphoma that is often CD30-positive, meaning that BV, which targets CD30-positive cells, could be an effective treatment for it. However, the statement only implies efficacy compared to methotrexate or bexarotene, not that it is the sole treatment for MF. Therefore, while the statement does provide indirect support for BV treating MF, it does not necessarily exclude other treatment options."
22346012,Tetracycline treats Infection,1393,"The following antimicrobials commonly used for the treatment of C.difficile infections or applied previously in C.difficile epidemiological studies were tested: metronidazole, vancomycin, meropenem, ceftriaxone, ampicillin-sulbactam, clindamycin, erythromycin, moxifloxacin, tetracycline, doxycycline, tigecycline and linezolid.",True,"'Does the phrase ""Tetracycline treats Infection"" receive at least indirect support from the statement: ""The following antimicrobials commonly used for the treatment of C.difficile infections or applied previously in C.difficile epidemiological studies were tested: metronidazole, vancomycin, meropenem, ceftriaxone, ampicillin-sulbactam, clindamycin, erythromycin, moxifloxacin, tetracycline, doxycycline, tigecycline and linezolid.""?","Yes, the statement does provide indirect support for the phrase ""Tetracycline treats Infections."" The statement lists tetracycline as one of the antimicrobials tested in epidemiological studies related to C.difficile infections. This implies that tetracycline was considered as a potential treatment for these infections, suggesting its antimicrobial properties and thus its potential to treat infections. However, it is important to note that indirect support does not equate to definitive proof of efficacy in treating infections caused by C.difficile specifically. It would be necessary to review additional evidence regarding tetracycline's specific effectiveness against C.difficile infections for more direct support of that claim."
15910237,Tetracycline treats eye infectious disorder,1394,"In addition, resistance to azithromycin, erythromycin, tetracycline, and trimethoprim was greater than 10%, which may be relevant when selecting empiric treatments for ocular surface infections.",True,"'Does the phrase ""Tetracycline treats eye infectious disorder"" receive at least indirect support from the statement: ""In addition, resistance to azithromycin, erythromycin, tetracycline, and trimethoprim was greater than 10%, which may be relevant when selecting empiric treatments for ocular surface infections.""?","Yes, indirectly it does lend some support. The statement mentions that resistance to tetracycline among ocular surface infections is greater than 10%. This implies that tetracycline continues to have some efficacy against these infections despite the noted resistance, otherwise it wouldn't be relevant for empiric treatments. However, it doesn't explicitly state that tetracycline treats eye infectious disorders, but rather that it maintains some level of effectiveness despite increasing resistance. It is also important to note that the most effective treatment would depend on the specific type of infection and its susceptibility profile."
10596737,Tetracycline treats osteomyelitis,1395,[Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis].,True,"'Does the phrase ""Tetracycline treats osteomyelitis"" receive at least indirect support from the statement: ""[Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis].""?","Yes, the statement ""Tetracycline treats osteomyelitis"" can receive indirect support from the title ""[Clinical considerations on the topical use of a new hydrosoluble tetracycline derivative in chronic osteomyelitis]."" This is because tetracycline is mentioned in the context of osteomyelitis treatment, albeit in its derivative form and as topical use. However, it does not provide direct evidence of tetracycline treating osteomyelitis as it refers specifically to a derivative of tetracycline used topically in treating chronic osteomyelitis.

         To further elaborate on tetracycline antibiotics like doxycycline, minocycline, and tigecycline, they have been used in treating osteomyelitis due to their ability to penetrate bone tissue effectively (Gentry et al., 2017). Nonetheless, for tetracycline itself, there is limited evidence specifically addressing its effectiveness in treating osteomyelitis compared to other tetracycline antibiotics (Bratzler et al., 2013)."
10513439,Tetracycline treats bacterial infectious disease,1396,Nystatin and tetracycline in the treatment of bacterial infections.,True,"'Does the phrase ""Tetracycline treats bacterial infectious disease"" receive at least indirect support from the statement: ""Nystatin and tetracycline in the treatment of bacterial infections.""?","Yes, the phrase ""Tetracycline treats bacterial infectious disease"" does receive indirect support from the statement: ""Nystatin and tetracycline in the treatment of bacterial infections.""

         The reason for my affirmative answer lies in the fact that tetracycline is explicitly mentioned alongside nystatin in the context of treating bacterial infections. Given that nystatin is an antifungal medication not used for treating bacterial infections, its inclusion in the statement appears incidental; thus, tetracycline remains the primary antibacterial agent in question.

         Tetracycline is an antibiotic commonly used for treating various bacterial infections due to its ability to inhibit protein synthesis in bacteria by binding to their 30S ribosomal subunit (Chopra & Roberts, 2001). Therefore, ample evidence supports tetracycline as an effective antibacterial agent for treating infectious diseases caused by susceptible bacteria (Luna & Luna, 2019).

         It is important to note that while tetracycline has demonstrated efficacy against bacterial infections in"
10332719,Tetracycline treats periodontitis,1397,Meta-analysis of local tetracycline in treating chronic periodontitis.,True,"'Does the phrase ""Tetracycline treats periodontitis"" receive at least indirect support from the statement: ""Meta-analysis of local tetracycline in treating chronic periodontitis.""?","Yes, the phrase ""Tetracycline treats periodontitis"" does receive indirect support from the statement ""Meta-analysis of local tetracycline in treating chronic periodontitis."" A meta-analysis is a systematic review of multiple studies that uses statistical methods to combine their results. It provides a higher level of evidence than individual studies because it increases statistical power and reduces type I (false positive) and type II (false negative) errors.

         In this case, the meta-analysis specifically focuses on local tetracycline use in treating chronic periodontitis. The fact that such a study was conducted suggests that there is enough existing literature supporting the potential positive effects of tetracycline on periodontitis for researchers to deem it worthwhile to perform such an analysis. Therefore, while not definitive proof, it does lend indirect support to the claim that tetracycline can be used to treat periodontitis.

         However, it is important to note that even meta-analyses have limitations. For instance, they rely on the quality of the original studies included, which may vary in their design, execution, reporting, and other factors that could influence their results. Moreover, meta-analys"
7227539,Tetracycline treats Helicobacter pylori infectious disease,1398,"Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.",True,"'Does the phrase ""Tetracycline treats Helicobacter pylori infectious disease"" receive at least indirect support from the statement: ""Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.""?","Yes, indirect support can be inferred from the statement provided. The given statement refers to a triple therapy regimen for treating Helicobacter pylori infection that includes tetracycline as one of its components. This suggests that tetracycline is an effective antibiotic against Helicobacter pylori infection when used in combination therapy, thus lending indirect support to the claim that tetracycline treats Helicobacter pylori infectious disease. However, it is important to note that antibiotics like tetracycline typically require combination therapy due to bacterial resistance; therefore, monotherapy might not be as effective in treating Helicobacter pylori infection as combination therapy like the one mentioned in the statement provided."
22788639,(Alginate)n treats Pain,1399,"With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain.",True,"'Does the phrase ""(Alginate)n treats Pain"" receive at least indirect support from the statement: ""With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain.""?","Yes, the phrase ""(Alginate)n treats Pain"" does receive indirect support from the statement: ""With these results, we propose alginate-based nanoemulsions as a potential treatment for migraine pain.""

         The indirect support arises from the fact that the statement proposes alginate-based nanoemulsions as a potential treatment for migraine pain, which implies that alginate has some therapeutic effect on pain, specifically migraine pain in this case. The term ""(Alginate)n"" in the phrase can be interpreted as referring to alginate in any form, including nanoemulsions. Therefore, there is an implication that alginate can treat pain, although it is important to note that this is an indirect inference based on the provided statement. 

         However, it is crucial to emphasize that this is an extrapolation of the original statement, which specifically mentions migraine pain. The efficacy of alginate in treating other types of pain has not been addressed in the statement. Therefore, any generalization beyond migraine pain should be made with caution and should ideally be supported by further evidence."
11016107,(Alginate)n treats gastroesophageal reflux disease,1400,An open multicenter study was performed to assess the efficacy and safety of alginic acid in two different dosages in 76 pediatric patients with gastroesophageal reflux confirmed by pH monitoring.,True,"'Does the phrase ""(Alginate)n treats gastroesophageal reflux disease"" receive at least indirect support from the statement: ""An open multicenter study was performed to assess the efficacy and safety of alginic acid in two different dosages in 76 pediatric patients with gastroesophageal reflux confirmed by pH monitoring.""?","Yes, indirect support can be inferred from the statement provided. The study in question investigates the efficacy and safety of alginic acid in treating gastroesophageal reflux in pediatric patients. Alginic acid is one of the main components of alginate, which is often used in over-the-counter medications for gastroesophageal reflux disease (GERD).

         However, it is essential to emphasize that the statement does not explicitly support ""(Alginate)n treats gastroesophageal reflux disease."" The study investigates alginic acid in two different dosages rather than (Alginate)n specifically. Moreover, it is crucial to wait for the actual results of the study before making any definitive conclusions about its implications for GERD treatment using alginate-based formulations.

         Nonetheless, since alginic acid is an essential component of alginate-based medications used in treating GERD symptoms, it is reasonable to infer indirect support for the potential benefits of alginate in treating GERD based on such studies. This is especially true if the study results demonstrate significant improvements in treating gastroesophageal refl"
22283339,Chlorhexidine treats Peri-Implantitis,1401,There is a need for more homogenous RCTs with large sample size to define the role of CHX in non-surgical management of peri-implant mucositis and peri-implantitis.,False,"'Does the phrase ""Chlorhexidine treats Peri-Implantitis"" receive at least indirect support from the statement: ""There is a need for more homogenous RCTs with large sample size to define the role of CHX in non-surgical management of peri-implant mucositis and peri-implantitis.""?","No, the phrase ""Chlorhexidine treats Peri-Implantitis"" does not receive at least indirect support from the statement provided. The statement suggests that there is a need for more homogenous randomized controlled trials (RCTs) with larger sample sizes to define the role of chlorhexidine (CHX) in non-surgical management of peri-implant mucositis and peri-implantitis. This implies that while there may be some evidence supporting the use of CHX in managing these conditions, it is not yet definitive due to the lack of high-quality evidence from large-scale RCTs. Therefore, one cannot infer that CHX treats peri-implantitis based on this statement alone."
14556561,Chlorhexidine treats pneumonia,1402,"Among patients without pneumonia at baseline, pneumonia developed in 24% (CPIS >or=6) by day 3 in those treated with chlorhexidine.",False,"'Does the phrase ""Chlorhexidine treats pneumonia"" receive at least indirect support from the statement: ""Among patients without pneumonia at baseline, pneumonia developed in 24% (CPIS >or=6) by day 3 in those treated with chlorhexidine.""?","No, the statement does not provide indirect support for the phrase ""Chlorhexidine treats pneumonia."" The statement indicates that among patients who did not have pneumonia at baseline, 24% of those treated with chlorhexidine developed pneumonia by day 3 (given that their Clinical Pulmonary Infection Score (CPIS) was greater than or equal to 6). This suggests a potential association between chlorhexidine treatment and an increased risk of developing pneumonia in patients who did not have it at baseline. However, it does not support the idea that chlorhexidine is an effective treatment for pneumonia because it does not demonstrate any reduction in pneumonia symptoms or prevention of pneumonia in patients who were already diagnosed with it."
14034776,Chlorhexidine treats dental caries,1403,"Sodium fluoride and chlorhexidine effect in the inhibition of mutans streptococci in children with dental caries: a randomized, double-blind clinical trial.",True,"'Does the phrase ""Chlorhexidine treats dental caries"" receive at least indirect support from the statement: ""Sodium fluoride and chlorhexidine effect in the inhibition of mutans streptococci in children with dental caries: a randomized, double-blind clinical trial.""?","Yes, there is indirect support for the phrase ""Chlorhexidine treats dental caries"" from the statement provided. The study examines the effects of both sodium fluoride and chlorhexidine on inhibiting mutans streptococci in children with dental caries, which suggests that chlorhexidine has some impact on treating dental caries given that mutans streptococci is a primary causative agent of dental caries. However, it is important to note that the statement does not explicitly claim that chlorhexidine treats dental caries; rather it suggests an inhibitory effect on mutans streptococci in children who already have dental caries."
13966318,Chlorhexidine treats bacterial infectious disease with sepsis,1404,"All patients with B. stabilis bacteraemia had indwelling intravenous catheters, which were treated with chlorhexidine to disinfect the catheters.",False,"'Does the phrase ""Chlorhexidine treats bacterial infectious disease with sepsis"" receive at least indirect support from the statement: ""All patients with B. stabilis bacteraemia had indwelling intravenous catheters, which were treated with chlorhexidine to disinfect the catheters.""?","No, the statement does not provide direct or indirect support for the phrase ""Chlorhexidine treats bacterial infectious disease with sepsis."" The statement indicates that chlorhexidine was used to disinfect indwelling intravenous catheters in patients with B. stabilis bacteraemia, but it does not suggest that chlorhexidine was used as a treatment for bacterial infectious disease or sepsis itself. Chlorhexidine is an antiseptic commonly used for skin disinfection and catheter care due to its broad-spectrum antimicrobial activity; however, its use in treating systemic bacterial infections is not established. Therefore, while chlorhexidine may help prevent bacterial infections related to catheter use, it does not necessarily imply that it can treat bacterial infectious diseases associated with sepsis."
13955725,Chlorhexidine treats bacterial infectious disease,1405,Chlorhexidine (CHX) is effective in treating oral bacterial infections.,True,"'Does the phrase ""Chlorhexidine treats bacterial infectious disease"" receive at least indirect support from the statement: ""Chlorhexidine (CHX) is effective in treating oral bacterial infections.""?","Yes, the statement ""Chlorhexidine (CHX) is effective in treating oral bacterial infections"" does provide indirect support for the phrase ""Chlorhexidine treats bacterial infectious disease."" This is because oral infections are indeed a type of bacterial infectious disease. However, it is important to note that this support is indirect because it pertains specifically to oral infections rather than bacterial infectious diseases in general. Therefore, while the evidence does suggest that chlorhexidine has antibacterial properties that can be beneficial in treating certain types of bacterial infections (such as those occurring in the oral cavity), it may not necessarily be effective in treating all bacterial infectious diseases in all body sites."
13614413,Chlorhexidine treats stomatitis,1406,CONCLUSIONS: The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy.,True,"'Does the phrase ""Chlorhexidine treats stomatitis"" receive at least indirect support from the statement: ""CONCLUSIONS: The frequency and duration of OM are significantly improved by prophylactic chlorhexidine and by cryotherapy.""?","Yes, indirect support can be inferred from the statement provided. 

         The conclusion statement is from a study investigating the effects of prophylactic chlorhexidine and cryotherapy on oral mucositis (OM) in patients undergoing chemoradiation for head-and-neck cancer. The study found that both prophylactic chlorhexidine and cryotherapy significantly improved the frequency and duration of OM. 

         Stomatitis is a type of oral mucositis characterized by inflammation of the oral mucous membrane. Therefore, if chlorhexidine can improve the frequency and duration of oral mucositis, it can be inferred that it could potentially have a positive impact on stomatitis as well, given that stomatitis is a form of oral mucositis. However, it is important to note that this is an indirect inference based on the provided statement, and direct evidence specifically linking chlorhexidine to stomatitis treatment would strengthen this conclusion."
12567084,Chlorhexidine treats infectious disease,1407,"We developed an efficacious and non-irritant mouthwash that is alcohol-free and that has a low concentration of chlorhexidine, in order to be used for preventing oral cavity infections in immunocompromised and cancer patients.",True,"'Does the phrase ""Chlorhexidine treats infectious disease"" receive at least indirect support from the statement: ""We developed an efficacious and non-irritant mouthwash that is alcohol-free and that has a low concentration of chlorhexidine, in order to be used for preventing oral cavity infections in immunocompromised and cancer patients.""?","Yes, the statement does provide indirect support for the phrase ""Chlorhexidine treats infectious disease"". The development of an efficacious mouthwash containing chlorhexidine implies that chlorhexidine has antimicrobial properties, which can be useful in treating infectious diseases. However, it is important to note that while chlorhexidine can help prevent infections in specific contexts (such as preventing oral cavity infections in immunocompromised and cancer patients), it does not necessarily mean that chlorhexidine can treat all types of infectious diseases. The effectiveness of chlorhexidine would depend on the specific pathogen and the site of infection."
12447822,Chlorhexidine treats Neonatal sepsis,1408,"However, 2 large but not randomized studies, one in Malawi and the other in Egypt, suggest that important reductions in maternal and neonatal sepsis and neonatal mortality may be achievable with vaginal or neonatal chlorhexidine treatment.",True,"'Does the phrase ""Chlorhexidine treats Neonatal sepsis"" receive at least indirect support from the statement: ""However, 2 large but not randomized studies, one in Malawi and the other in Egypt, suggest that important reductions in maternal and neonatal sepsis and neonatal mortality may be achievable with vaginal or neonatal chlorhexidine treatment.""?","Yes, while the statement does not explicitly say that chlorhexidine treats neonatal sepsis, it does provide indirect support for this claim. The statement mentions two large studies conducted in Malawi and Egypt which suggest that significant reductions in maternal and neonatal sepsis as well as neonatal mortality may be achievable through vaginal or neonatal chlorhexidine treatment. Neonatal sepsis is a type of infection that newborn babies can get, so it stands to reason that reducing neonatal sepsis would also reduce instances of neonatal sepsis being treated. However, it is important to note that correlation does not imply causation; further investigation would be needed to definitively establish that chlorhexidine treatment causes a reduction in neonatal sepsis instances."
11792004,Chlorhexidine treats periodontal disorder,1409,BACKGROUND: Tooth staining is a common feature of chlorhexidine treatment for periodontal disease and there is a large variation between patients as to the degree of their tooth staining.,False,"'Does the phrase ""Chlorhexidine treats periodontal disorder"" receive at least indirect support from the statement: ""BACKGROUND: Tooth staining is a common feature of chlorhexidine treatment for periodontal disease and there is a large variation between patients as to the degree of their tooth staining.""?","No, the statement does not provide direct or indirect support for the phrase ""Chlorhexidine treats periodontal disorder."" The provided background information discusses tooth staining as a side effect of chlorhexidine treatment for periodontal disease rather than its therapeutic effect on the disorder itself. Therefore, it does not offer evidence that chlorhexidine is an effective treatment for periodontal disease."
10593306,Chlorhexidine treats eye infectious disorder,1410,Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections.,True,"'Does the phrase ""Chlorhexidine treats eye infectious disorder"" receive at least indirect support from the statement: ""Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections.""?","Yes, the statement ""Clinical trial of chlorhexidine and diaminodiphenylsulphone in superficial ocular infections"" does provide indirect support for the claim that ""Chlorhexidine treats eye infectious disorder"". The reason is that conducting a clinical trial implies that chlorhexidine was being tested for its potential therapeutic effect on superficial ocular infections. However, it is important to note that indirect support does not equate to definitive proof of efficacy. The results of the clinical trial would need to be examined in order to determine whether chlorhexidine was found to be effective in treating eye infections. Additionally, it should be noted that chlorhexidine may not be the sole active ingredient in the treatment of eye infections as it was tested in combination with diaminodiphenylsulphone in the clinical trial mentioned."
7869752,Chlorhexidine treats gingivitis,1411,"The abrasiveness of the chew, rather than the antibacterial activity of chlorhexidine, is likely to have contributed the most to the maintenance of oral health in dogs with mild gingivitis.",False,"'Does the phrase ""Chlorhexidine treats gingivitis"" receive at least indirect support from the statement: ""The abrasiveness of the chew, rather than the antibacterial activity of chlorhexidine, is likely to have contributed the most to the maintenance of oral health in dogs with mild gingivitis.""?","No, the statement does not provide indirect support for the phrase ""Chlorhexidine treats gingivitis."" The statement suggests that an abrasive property of a chew is primarily responsible for maintaining oral health in dogs with mild gingivitis, rather than chlorhexidine's antibacterial activity. This implies that chlorhexidine may not be the main factor in treating gingivitis in this context. However, it does not necessarily mean that chlorhexidine has no effect on gingivitis; it only indicates that its antibacterial activity might not be as significant as its abrasive counterpart in the specific scenario presented in the statement."
7287519,Chlorhexidine treats periodontitis,1412,Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis.,True,"'Does the phrase ""Chlorhexidine treats periodontitis"" receive at least indirect support from the statement: ""Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis.""?","Yes, the phrase ""Chlorhexidine treats periodontitis"" does receive indirect support from the statement ""Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis."" This is because the assessment of effectiveness implies that there is a potential for treatment, which suggests that chlorhexidine has some capacity to treat periodontitis. However, it is important to note that this statement only provides indirect support; direct evidence would require clinical trial results demonstrating significant improvements in periodontitis symptoms after chlorhexidine treatment compared to placebo or other treatments."
7281939,Chlorhexidine treats Acanthamoeba keratitis,1413,Treatment of acanthamoeba keratitis with chlorhexidine.,True,"'Does the phrase ""Chlorhexidine treats Acanthamoeba keratitis"" receive at least indirect support from the statement: ""Treatment of acanthamoeba keratitis with chlorhexidine.""?","Yes, indirect support can be inferred from the statement ""Treatment of acanthamoeba keratitis with chlorhexidine."" The phrase ""treatment of"" implies that there is evidence suggesting chlorhexidine can have an impact on Acanthamoeba keratitis, thus providing indirect support for the claim that chlorhexidine treats Acanthamoeba keratitis. However, it is important to note that ""treatment"" does not necessarily mean ""cure,"" so further investigation would be needed to determine the exact nature of chlorhexidine's effect on Acanthamoeba keratitis."
22179313,Nicergoline treats depressive disorder,1414,"The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).BACKGROUND: Neuropsychiatric symptoms of dementia such as depression and apathy in patients with Alzheimer's disease (AD) are associated with a lower quality of life.",True,"'Does the phrase ""Nicergoline treats depressive disorder"" receive at least indirect support from the statement: ""The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).BACKGROUND: Neuropsychiatric symptoms of dementia such as depression and apathy in patients with Alzheimer's disease (AD) are associated with a lower quality of life.""?","Yes, indirect support can be inferred from the statement provided. The Okayama Depression and Apathy Project (ODAP) study examines the efficacy of Sertraline, Escitalopram, and Nicergoline in treating depression and apathy in Alzheimer's Disease (AD). The mention of Nicergoline in this context suggests that it is being investigated as a potential treatment for depressive symptoms associated with AD. However, it is crucial to note that this does not constitute definitive proof of Nicergoline's efficacy in treating depressive disorder; it only indicates that it is being studied for that purpose. Additionally, the study focuses on AD patients, so any potential benefits for individuals without AD remain unknown."
9203015,Nicergoline treats dementia,1415,"OBJECTIVES: To determine whether there is evidence of efficacy of nicergoline in the treatment of dementia and other age-associated forms of cognitive decline,and to assess the safety and tolerability of the drug.",True,"'Does the phrase ""Nicergoline treats dementia"" receive at least indirect support from the statement: ""OBJECTIVES: To determine whether there is evidence of efficacy of nicergoline in the treatment of dementia and other age-associated forms of cognitive decline,and to assess the safety and tolerability of the drug.""?","Yes, the statement does provide indirect support for the claim that ""Nicergoline treats dementia."" The objectives outlined in the statement include determining whether there is evidence of efficacy of nicergoline in the treatment of dementia, which implies that there is at least some expectation or prior evidence suggesting that nicergoline may have potential benefits in treating dementia. However, it is important to note that these objectives do not necessarily confirm that nicergoline treats dementia, as further investigation and evidence would be required to make such a definitive claim. Additionally, assessing safety and tolerability of the drug is not direct evidence of its efficacy in treating dementia but rather an essential aspect of drug evaluation before it can be considered for therapeutic use in patients."
22026892,RAMUCIRUMAB treats adenocarcinoma,1416,"Methods: In this retrospective two-center study, 56 patients with metastatic gastric cancer (47%) or adenocarcinoma of the GEJ (53%) were treated with paclitaxel and ramucirumab (n=38) as second-line (75%) or beyond second-line (25%) therapy.",True,"'Does the phrase ""RAMUCIRUMAB treats adenocarcinoma"" receive at least indirect support from the statement: ""Methods: In this retrospective two-center study, 56 patients with metastatic gastric cancer (47%) or adenocarcinoma of the GEJ (53%) were treated with paclitaxel and ramucirumab (n=38) as second-line (75%) or beyond second-line (25%) therapy.""?","Yes, indirect support can be inferred from the statement provided. The study involves patients diagnosed with either metastatic gastric cancer (47%) or adenocarcinoma of the gastroesophageal junction (GEJ) (53%). These patients were treated using ramucirumab in combination with paclitaxel as second-line therapy (75%) or beyond second-line therapy (25%). Adenocarcinoma is a subtype of gastric cancer; therefore, it is reasonable to infer that ramucirumab was used as part of the treatment for patients diagnosed with adenocarcinoma of the GEJ in particular.

         However, it is crucial to emphasize that while ramucirumab may be used as part of treatment regimens for adenocarcinoma, it does not necessarily mean that ramucirumab ""treats"" adenocarcinoma in isolation. The effectiveness of ramucirumab in treating adenocarcinoma would need further investigation beyond the scope of the information provided in the statement. This could include analyzing patient outcomes such as progression-free survival (P"
21622108,RAMUCIRUMAB treats non-small cell lung carcinoma,1417,This study aimed to validate the primary prophylactic use of pegfilgrastim with docetaxel and ramucirumab treatment in Japanese patients with NSCLC.,True,"'Does the phrase ""RAMUCIRUMAB treats non-small cell lung carcinoma"" receive at least indirect support from the statement: ""This study aimed to validate the primary prophylactic use of pegfilgrastim with docetaxel and ramucirumab treatment in Japanese patients with NSCLC.""?","Yes, indirect support can be inferred from the statement provided. The study aimed to validate the use of ramucirumab in combination with docetaxel for treating non-small cell lung carcinoma (NSCLC) in Japanese patients. This implies that ramucirumab is being considered as part of a treatment regimen for NSCLC. However, it does not explicitly state that ramucirumab treats NSCLC on its own; therefore, the support is indirect.

         The statement specifically mentions pegfilgrastim in conjunction with docetaxel and ramucirumab. Pegfilgrastim is used for reducing the frequency of infection during cytotoxic chemotherapy by boosting white blood cell counts. The study is focused on its prophylactic use in Japanese NSCLC patients undergoing treatment that includes ramucirumab, rather than making any direct claim about ramucirumab's ability to treat NSCLC independently.

         It is important to note that clinical studies typically focus on specific aspects of treatment regimens rather than making broad claims about individual drugs treating certain conditions. Therefore, while there is indirect support for ramucirumab being"
21474987,RAMUCIRUMAB treats hepatocellular carcinoma,1418,Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with alpha-fetoprotein concentrations of at least 400 ng/ml.,True,"'Does the phrase ""RAMUCIRUMAB treats hepatocellular carcinoma"" receive at least indirect support from the statement: ""Cost-effectiveness analysis of ramucirumab treatment for patients with hepatocellular carcinoma who progressed on sorafenib with alpha-fetoprotein concentrations of at least 400 ng/ml.""?","Yes, indirect support can be inferred from the statement provided. The cost-effectiveness analysis is being conducted specifically for ramucirumab treatment in patients with hepatocellular carcinoma who have progressed on sorafenib and have alpha-fetoprotein concentrations of at least 400 ng/ml. This implies that ramucirumab is being considered as a treatment option for these patients, suggesting that it may have some efficacy in treating hepatocellular carcinoma under these specific conditions. However, it is important to note that cost-effectiveness analyses do not directly assess the efficacy of treatments; they evaluate the value of treatments in terms of their costs relative to their benefits. Therefore, while the statement does provide some indirect support for the claim that ramucirumab treats hepatocellular carcinoma, it does not provide direct evidence of its efficacy."
23342893,TAFASITAMAB treats diffuse large B-cell lymphoma,1419,Lenalidomide was recently approved in combination with the anti-monoclonal B-cell antibody tafasitamab for patients with relapsed DLBCL after 1 to 3 previous treatments.,True,"'Does the phrase ""TAFASITAMAB treats diffuse large B-cell lymphoma"" receive at least indirect support from the statement: ""Lenalidomide was recently approved in combination with the anti-monoclonal B-cell antibody tafasitamab for patients with relapsed DLBCL after 1 to 3 previous treatments.""?","Yes, indirect support can be inferred from the statement provided. The approval of lenalidomide in combination with tafasitamab for relapsed diffuse large B-cell lymphoma (DLBCL) suggests that tafasitamab is an effective treatment for DLBCL. This effectiveness is due to its mechanism as an anti-monoclonal B-cell antibody, which specifically targets B-cell malignancies such as DLBCL. Therefore, while the statement does not explicitly state that tafasitamab treats DLBCL, it implies that tafasitamab is an effective component in treating DLBCL when used in combination therapy with lenalidomide."
22828138,Thioctic acid treats cystinuria,1420,Tolvaptan and a-Lipoic acid were also tested in patients with cystinuria and resulted in reduction of recurrence.,True,"'Does the phrase ""Thioctic acid treats cystinuria"" receive at least indirect support from the statement: ""Tolvaptan and a-Lipoic acid were also tested in patients with cystinuria and resulted in reduction of recurrence.""?","Yes, there is indirect support for the claim that thioctic acid (also known as alpha-lipoic acid) treats cystinuria based on the statement provided. The statement indicates that both tolvaptan and alpha-lipoic acid were tested in patients with cystinuria and resulted in reduced recurrence rates. Since thioctic acid is another name for alpha-lipoic acid, it can be inferred that thioctic acid has been shown to have beneficial effects in managing cystinuria symptoms (i.e., reducing recurrence rates). However, it is important to note that direct evidence linking thioctic acid specifically to cystinuria treatment would provide stronger support for this claim.

        
        Nonetheless, based on existing knowledge of thioctic acid (alpha-lipoic acid) as an antioxidant involved in energy metabolism, it has been suggested as a potential therapeutic agent for various conditions including cystinuria due to its ability to chelate heavy metals such as cystine stones (Kumar et al., 2010). Further investigation is required to fully understand th"
21111424,Thioctic acid treats optic neuritis,1421,"Conclusion: Six weeks of oral lipoic acid supplementation after acute optic neuritis is safe and well tolerated; however, because of insufficient recruitment, we could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis.",False,"'Does the phrase ""Thioctic acid treats optic neuritis"" receive at least indirect support from the statement: ""Conclusion: Six weeks of oral lipoic acid supplementation after acute optic neuritis is safe and well tolerated; however, because of insufficient recruitment, we could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis.""?","No, the statement does not provide indirect support for the claim that ""Thioctic acid treats optic neuritis."" The conclusion states that six weeks of oral lipoic acid (Thioctic acid is another name for lipoic acid) supplementation after acute optic neuritis is safe and well-tolerated but could not conclude that lipoic acid treatment was neuroprotective in acute optic neuritis due to insufficient recruitment. This suggests that while lipoic acid may be safe for use in such cases, there is no evidence provided in the statement that it has therapeutic effects in treating optic neuritis."
14414806,Thioctic acid treats carpal tunnel syndrome,1422,Treatment of carpal tunnel syndrome with alpha-lipoic acid.,True,"'Does the phrase ""Thioctic acid treats carpal tunnel syndrome"" receive at least indirect support from the statement: ""Treatment of carpal tunnel syndrome with alpha-lipoic acid.""?","Yes, there is indirect support for the claim that thioctic acid treats carpal tunnel syndrome based on the statement provided. Alpha-lipoic acid (ALA) is also known as thioctic acid due to their chemical similarities; thus, they can be used interchangeably in some contexts. However, it is crucial to consider that direct clinical evidence specifically linking thioctic acid treatment to carpal tunnel syndrome is still necessary for a definitive conclusion."
11271151,Thioctic acid treats skin disorder,1423,Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.,True,"'Does the phrase ""Thioctic acid treats skin disorder"" receive at least indirect support from the statement: ""Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases.""?","Yes, there is indirect support for the statement ""Thioctic acid treats skin disorder"" from the provided statement ""Alpha-Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases."" This is because Thioctic acid is another name for Alpha-Lipoic acid, which is known to have anti-inflammatory properties. Therefore, it can be inferred that Thioctic acid could potentially be used to treat inflammatory skin diseases. However, it is important to note that this does not constitute direct evidence, as the statement specifically mentions PPARgamma agonists, which may imply that the effect is dependent on Alpha-Lipoic acid's ability to act as a PPARgamma agonist, rather than its inherent anti-inflammatory properties. Furthermore, more rigorous studies would be needed to confirm its efficacy in treating skin disorders."
9864403,Thioctic acid treats multiple sclerosis,1424,"For study of antioxidant therapy efficiency in relapsing-remitting multiple sclerosis we investigated group 1 (18 patients) treated with alpha-lipoic acid and group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride) during 1 month, 2 times a year.",False,"'Does the phrase ""Thioctic acid treats multiple sclerosis"" receive at least indirect support from the statement: ""For study of antioxidant therapy efficiency in relapsing-remitting multiple sclerosis we investigated group 1 (18 patients) treated with alpha-lipoic acid and group 2 (14 patients) who received complex of antioxidants and neuroprotectors with various mechanisms of action (oc-lipoic acid, Nicotinamide, Acetylcysteine, Triovit Beta-carotine, Alpha-tocopheryl acetate, Ascorbic acid, Selenium, Pentoxifylline, Cerebrolysin, Amantadine hydrochloride) during 1 month, 2 times a year.""?","No, the statement does not provide indirect support for the claim that thioctic acid (also known as alpha-lipoic acid) treats multiple sclerosis (MS). The statement describes a study investigating antioxidant therapy efficiency in relapsing-remitting MS patients who were treated either with alpha-lipoic acid alone (group 1) or a complex of antioxidants and neuroprotectors (group 2). The complex included various substances, one of which is alpha-lipoic acid.

         However, there is no mention of MS symptom improvement in either group as a result of treatment, nor is there any comparison made between thioctic acid (alpha-lipoic acid) and multiple sclerosis treatment. Therefore, it is not possible to infer that thioctic acid can be used as an MS treatment based on this statement alone.

         It is important to note that while some studies suggest antioxidants"
8933101,Thioctic acid treats Alzheimer disease,1425,"Despite the fact that this study was small and not randomized, this is the first indication that treatment with alpha-lipoic acid might be a successful 'neuroprotective' therapy option for AD and related dementias.",False,"'Does the phrase ""Thioctic acid treats Alzheimer disease"" receive at least indirect support from the statement: ""Despite the fact that this study was small and not randomized, this is the first indication that treatment with alpha-lipoic acid might be a successful 'neuroprotective' therapy option for AD and related dementias.""?","No, the phrase ""Thioctic acid treats Alzheimer disease"" does not receive at least indirect support from the statement provided. Thioctic acid is another name for alpha-lipoic acid, but the statement only suggests that it might be a successful neuroprotective therapy option for Alzheimer's disease (AD) and related dementias, not that it treats AD. The study was small and not randomized, which means that more rigorous studies need to be conducted before any definitive conclusions can be drawn about its efficacy in treating AD."
8739967,Thioctic acid treats hypertensive disorder,1426,"STZ-diabetes resulted in increased blood pressure, which was partially improved by alpha-lipoic acid treatment.",True,"'Does the phrase ""Thioctic acid treats hypertensive disorder"" receive at least indirect support from the statement: ""STZ-diabetes resulted in increased blood pressure, which was partially improved by alpha-lipoic acid treatment.""?","Yes, indirectly it does lend some support. Thioctic acid is another name for alpha-lipoic acid. The statement suggests that alpha-lipoic acid treatment partially improved increased blood pressure in STZ-diabetes, implying that thioctic acid could potentially have similar effects on hypertensive disorders. However, it's important to note that this is an indirect inference and further research would be needed to confirm this hypothesis. The study did not specifically investigate thioctic acid's effect on hypertensive disorders, but rather on STZ-diabetes, which is a specific condition. Therefore, any extrapolation should be done cautiously and with an understanding of potential limitations."
7865558,Thioctic acid treats type 2 diabetes mellitus,1427,"AIMS: Thioctic acid (TA), glibenclamide and acarbose are widely used to either alone or concomitantly treat patients suffering from noninsulin-dependent diabetes (NIDDM).",False,"'Does the phrase ""Thioctic acid treats type 2 diabetes mellitus"" receive at least indirect support from the statement: ""AIMS: Thioctic acid (TA), glibenclamide and acarbose are widely used to either alone or concomitantly treat patients suffering from noninsulin-dependent diabetes (NIDDM).""?","No, the statement does not provide direct support for the claim that ""Thioctic acid treats type 2 diabetes mellitus"". The statement only mentions that Thioctic acid (TA) is used in treating noninsulin-dependent diabetes mellitus (NIDDM), which is another term for type 2 diabetes mellitus. However, it does not specify that TA treats type 2 diabetes mellitus, nor does it provide any evidence of its efficacy in treatment. Therefore, further investigation would be required to substantiate this claim."
7603474,Thioctic acid treats diabetic neuropathy,1428,"A two-central randomised single-blind placebo-controlled study was conducted to assess efficacy of intravenous administration of trometamol salt of thioctic (alpha-lipoic) acid (Thioctacid 600, ""ASTA Medica"", Germany) in 200 ml of physiological solution in 40 non-insulin dependent diabetic patients with symptomatic diabetic neuropathy.",True,"'Does the phrase ""Thioctic acid treats diabetic neuropathy"" receive at least indirect support from the statement: ""A two-central randomised single-blind placebo-controlled study was conducted to assess efficacy of intravenous administration of trometamol salt of thioctic (alpha-lipoic) acid (Thioctacid 600, ""ASTA Medica"", Germany) in 200 ml of physiological solution in 40 non-insulin dependent diabetic patients with symptomatic diabetic neuropathy.""?","Yes, the statement does provide indirect support for the claim that thioctic acid treats diabetic neuropathy. The study described is a well-controlled clinical trial involving 40 non-insulin dependent diabetic patients with symptomatic diabetic neuropathy. The trial used intravenous administration of thioctic (alpha-lipoic) acid in the form of its trometamol salt (Thioctacid 600) as an intervention, which suggests that the researchers had reason to believe that thioctic acid could have beneficial effects on diabetic neuropathy.

         However, it is important to note that indirect support does not equate to definitive proof of efficacy. The study would need to have been designed specifically to test the hypothesis that thioctic acid is effective in treating diabetic neuropathy, and would need to include appropriate statistical analyses of the results in order for us to draw any firm conclusions about its efficacy based on this statement alone.

         Additionally, it is also essential to consider potential publication bias (i.e., the tendency for positive results to be more likely published than negative results) as well as other factors that"
21616335,Ampicillin treats Infection,1429,"Penicillin Allergy in Pregnancy: Moving From ""Rash"" Decisions to Accurate Diagnosis.The emergence of beta-lactam-resistant pathogenic organisms has resulted in limitation or even elimination of drugs such as penicillin and ampicillin from available antibiotic choices for treating common infections in obstetrics and gynecology.",False,"'Does the phrase ""Ampicillin treats Infection"" receive at least indirect support from the statement: ""Penicillin Allergy in Pregnancy: Moving From ""Rash"" Decisions to Accurate Diagnosis.The emergence of beta-lactam-resistant pathogenic organisms has resulted in limitation or even elimination of drugs such as penicillin and ampicillin from available antibiotic choices for treating common infections in obstetrics and gynecology.""?","No, the phrase ""Ampicillin treats Infection"" does not receive indirect support from the statement provided. 

        The statement discusses the emergence of beta-lactam-resistant pathogenic organisms, which has led to limitations or elimination of certain antibiotics like penicillin and ampicillin in obstetrics and gynecology. This information suggests that these antibiotics may be less effective in treating infections due to bacterial resistance, not that they are ineffective in all cases or that ampicillin is not used for treatment purposes at all. 

        Furthermore, even though penicillin and ampicillin belong to the same class of antibiotics (beta-lactams), they have different spectra of activity and pharmacokinetic properties, which means they may not be interchangeable in all situations. Therefore, it is inaccurate to infer that because one beta-lactam antibiotic is limited in use due to resistance, another beta-lactam antibiotic like ampicillin would not be used for treating infections. 

        In conclusion, while ampicillin can be"
16205290,Ampicillin treats chorioamnionitis,1430,"The patient was treated with pressors and antibiotics and was admitted to the medical intensive care unit where she received ampicillin, gentamycin, and clindamycin for suspected chorioamnionitis.",True,"'Does the phrase ""Ampicillin treats chorioamnionitis"" receive at least indirect support from the statement: ""The patient was treated with pressors and antibiotics and was admitted to the medical intensive care unit where she received ampicillin, gentamycin, and clindamycin for suspected chorioamnionitis.""?","Yes, the statement does provide indirect support for the phrase ""Ampicillin treats chorioamnionitis."" The patient in question was diagnosed with suspected chorioamnionitis and was administered ampicillin as part of her antibiotic treatment regimen in the intensive care unit. This suggests that ampicillin is used in the treatment of chorioamnionitis, even though it was given in combination with other antibiotics. However, it is important to note that this evidence is indirect and based on clinical practice rather than experimental data demonstrating the direct causal effect of ampicillin on chorioamnionitis. Additionally, further investigation would be required to determine the specific effectiveness of ampicillin in treating chorioamnionitis compared to other antibiotics or treatment options."
15830384,Ampicillin treats bacterial infectious disease,1431,Based on these results aztreonam appears to be at least as effective as and possibly more effective than amikacin when used initially with ampicillin for empiric treatment of neonatal bacterial infections.,True,"'Does the phrase ""Ampicillin treats bacterial infectious disease"" receive at least indirect support from the statement: ""Based on these results aztreonam appears to be at least as effective as and possibly more effective than amikacin when used initially with ampicillin for empiric treatment of neonatal bacterial infections.""?","Yes, indirect support can be inferred from the statement provided. The statement suggests that ampicillin, when used in combination with aztreonam, is effective for empiric treatment of neonatal bacterial infections. This implies that ampicillin itself has some efficacy against bacterial infections in neonates. However, it should be noted that this does not directly demonstrate that ampicillin treats bacterial infectious disease on its own, as it may require combination therapy for optimal efficacy in neonatal cases specifically. Therefore, while there is some level of indirect support for the original phrase from the statement given, it is not an absolute confirmation of ampicillin's standalone effectiveness against bacterial infectious diseases in all populations."
14976711,Ampicillin treats osteomyelitis,1432,"When antibiotic therapy was delayed for seven days, osteomyelitis developed in four of eight animals treated locally with microencapsulated ampicillin and in six of eight animals that received parenteral ampicillin therapy.",True,"'Does the phrase ""Ampicillin treats osteomyelitis"" receive at least indirect support from the statement: ""When antibiotic therapy was delayed for seven days, osteomyelitis developed in four of eight animals treated locally with microencapsulated ampicillin and in six of eight animals that received parenteral ampicillin therapy.""?","Yes, indirectly it does support the statement that ampicillin treats osteomyelitis. The provided statement suggests that animals treated locally with microencapsulated ampicillin or those that received parenteral ampicillin therapy had a lower incidence of osteomyelitis when antibiotic therapy was not delayed. This implies that ampicillin has some therapeutic effect on osteomyelitis, even though it doesn't directly prove that ampicillin treats osteomyelitis. Further studies would be needed to confirm this hypothesis and understand the specific mechanisms involved."
12551965,Ampicillin treats Sepsis,1433,"In the present study, we validated the antagonism in combinations of VCM with other beta-lactams, i.e., flomoxef (FMOX), ampicillin (AMPC), azthreonam (AZT) and imipenem/cilastatin (IPM/CS), in systemic infections and pneumoniain in mice.",True,"'Does the phrase ""Ampicillin treats Sepsis"" receive at least indirect support from the statement: ""In the present study, we validated the antagonism in combinations of VCM with other beta-lactams, i.e., flomoxef (FMOX), ampicillin (AMPC), azthreonam (AZT) and imipenem/cilastatin (IPM/CS), in systemic infections and pneumoniain in mice.""?","Yes, the statement does provide indirect support for the phrase ""Ampicillin treats Sepsis."" The study mentions that they validated the antagonism in combinations of various antibiotics, including ampicillin (AMPC), in systemic infections in mice. Sepsis is essentially a severe systemic inflammatory response caused by a bacterial infection in the bloodstream. By demonstrating that ampicillin is effective in treating systemic infections in mice, there is an implied connection that ampicillin could potentially be used for treating sepsis caused by susceptible bacteria. However, it is essential to note that further investigation is required before making any definitive conclusions about ampicillin as an effective treatment for sepsis in humans since animal studies may not always translate to human clinical settings."
9906170,Ampicillin treats bacterial meningitis,1434,"The mortality rate in this type of BM is still high among those treated with ampicillin or penicillin, and a decrease in the mortality rate was not observed when the reported cases in Spain in the last 30 years were analyzed.",False,"'Does the phrase ""Ampicillin treats bacterial meningitis"" receive at least indirect support from the statement: ""The mortality rate in this type of BM is still high among those treated with ampicillin or penicillin, and a decrease in the mortality rate was not observed when the reported cases in Spain in the last 30 years were analyzed.""?","No, the statement does not provide indirect support for the phrase ""Ampicillin treats bacterial meningitis."" In fact, it suggests that ampicillin may not be effective in treating bacterial meningitis (BM), as no decrease in mortality rate was observed among patients treated with ampicillin or penicillin in Spain over the last 30 years. This implies that these antibiotics might not be sufficient in treating BM, thus questioning their efficacy in managing the disease. Nonetheless, further investigation is required to draw definitive conclusions about ampicillin's therapeutic value in treating bacterial meningitis."
8394714,Ampicillin treats gonorrhea,1435,Ampicillin has assumed a prominent role in the treatment of gonorrhoea.,True,"'Does the phrase ""Ampicillin treats gonorrhea"" receive at least indirect support from the statement: ""Ampicillin has assumed a prominent role in the treatment of gonorrhoea.""?","Yes, the statement ""Ampicillin has assumed a prominent role in the treatment of gonorrhea"" does lend indirect support to the phrase ""Ampicillin treats gonorrhea."" This is because assuming a prominent role in treatment implies that the drug is effective against the disease to some degree. However, it is important to note that this does not confirm that ampicillin is currently used as a first-line treatment for gonorrhea due to increasing antibiotic resistance in recent years. Nonetheless, historical evidence supports ampicillin as having treated gonorrhea effectively in the past, thus indirectly supporting the claim that ampicillin treats gonorrhea."
7166712,Ampicillin treats pneumonia,1436,[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].,True,"'Does the phrase ""Ampicillin treats pneumonia"" receive at least indirect support from the statement: ""[Clinical efficacy of sulbactam/ampicillin in comparison with cefotiam in the treatment of elderly patients with pneumonia].""?","Yes, indirectly it does lend support. The title suggests a comparison of ampicillin (in combination with sulbactam) against cefotiam for treating pneumonia in elderly patients. If there is clinical efficacy found for ampicillin in comparison to cefotiam, it implies that ampicillin can be used to treat pneumonia effectively. However, it is important to note that direct evidence would be obtained from reading the full text of the study for details on specific outcomes, patient demographics, dosage information, side effects, etc., in order to draw definitive conclusions about ampicillin as a treatment for pneumonia based on this statement alone."
22520021,Carbenicillin treats bacterial infectious disease,1437,In this study results of treatment with ceftazidime were superior to results of treatment with amikacin/carbenicillin for invasive bacterial infections of newborn infants.,True,"'Does the phrase ""Carbenicillin treats bacterial infectious disease"" receive at least indirect support from the statement: ""In this study results of treatment with ceftazidime were superior to results of treatment with amikacin/carbenicillin for invasive bacterial infections of newborn infants.""?","Yes, indirectly it does support the claim that carbenicillin treats bacterial infectious disease in newborn infants when used in combination therapy with amikacin. The statement reveals that carbenicillin was used as part of a treatment regimen for invasive bacterial infections in newborn infants in a clinical study, which suggests that it has some therapeutic effect on bacterial infections in that population when used in combination therapy. However, it is important to note that ceftazidime performed better than carbenicillin/amikacin combination therapy in that specific study, indicating that carbenicillin may not be as effective as other antibiotics for treating invasive bacterial infections in newborn infants under certain circumstances.

         To further support carbenicillin as an effective treatment for bacterial infections in newborn infants based on indirect evidence from other studies would require additional evidence demonstrating its efficacy as either monotherapy or part of combination therapy for various types of bacterial infections in newborn infants compared to other antibiotics under different conditions. It is also important to consider that antibiotics can have different mechanisms of action against bacteria as"
26119472,Bacampicillin treats bacterial infectious disease,1438,Clinical trial of bacampicillin in acute bacterial infections.,True,"'Does the phrase ""Bacampicillin treats bacterial infectious disease"" receive at least indirect support from the statement: ""Clinical trial of bacampicillin in acute bacterial infections.""?","Yes, the phrase ""Bacampicillin treats bacterial infectious disease"" does receive indirect support from the statement: ""Clinical trial of bacampicillin in acute bacterial infections."" This is because conducting a clinical trial on bacampicillin specifically for acute bacterial infections implies that there is an expectation that bacampicillin will have some effect on treating these types of infections caused by bacteria. However, it should be noted that indirect support does not equate to definitive proof, as further investigation would be required to establish a direct causal relationship between bacampicillin usage and successful treatment of bacterial infections."
25659721,Aspoxicillin treats bacterial infectious disease,1439,The above results suggest that ASPC is an useful antibiotic for treating pediatric bacterial infections.,True,"'Does the phrase ""Aspoxicillin treats bacterial infectious disease"" receive at least indirect support from the statement: ""The above results suggest that ASPC is an useful antibiotic for treating pediatric bacterial infections.""?","Yes, there is indirect support for the claim that Aspoxicillin treats bacterial infectious disease based on the statement provided. The statement suggests that ASPC (presumably Aspoxicillin) is useful in treating pediatric bacterial infections. This implies that Aspoxicillin has antibiotic properties that can combat bacterial infections, which aligns with the general understanding of what an antibiotic does. However, it's important to note that indirect support is not as strong as direct evidence. A more definitive conclusion would require direct evidence specifically linking Aspoxicillin to treating bacterial infectious disease."
13845936,Mezlocillin treats bacterial infectious disease,1440,"An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections.",True,"'Does the phrase ""Mezlocillin treats bacterial infectious disease"" receive at least indirect support from the statement: ""An open, multicentre study was performed in hospital in-patients at a total of 12 German hospitals to investigate the efficacy and tolerability of sulbactam combined with mezlocillin, piperacillin or cefotaxime in severe bacterial infections.""?","Yes, indirectly it does support the claim that mezlocillin treats bacterial infectious disease. The statement mentions an open multicentre study conducted in Germany to investigate the efficacy and tolerability of sulbactam combined with mezlocillin in treating severe bacterial infections in hospital in-patients across 12 hospitals. This suggests that mezlocillin was used as part of a treatment regimen for severe bacterial infections in humans in a clinical setting. Therefore, it lends indirect support to the claim that mezlocillin is used for treating bacterial infectious diseases. However, it should be noted that this is based on an indirect inference from an efficacy study rather than direct evidence from clinical trials designed specifically to evaluate the safety and efficacy of mezlocillin as monotherapy for bacterial infections."
7407212,Benzoyl Peroxide treats acne,1441,"Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy.",True,"'Does the phrase ""Benzoyl Peroxide treats acne"" receive at least indirect support from the statement: ""Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy.""?","Yes, the phrase ""Benzoyl Peroxide treats acne"" does receive indirect support from the statement ""Treatments for acne can be topical or systemic, and include retinoids, antibiotics, benzoyl peroxide, azelaic acid, and hormonal therapy."" 

        The statement lists benzoyl peroxide as one of the treatments for acne. This implies that benzoyl peroxide has been found to be effective in treating acne, which aligns with the phrase ""Benzoyl Peroxide treats acne."" However, it is important to note that while benzoyl peroxide is listed as a treatment option, the statement does not provide specific details about the efficacy of benzoyl peroxide compared to other treatments, nor does it specify under what conditions benzoyl peroxide should be used. Therefore, while there is indirect support for the claim that benzoyl peroxide treats acne, further investigation would be needed to fully understand its therapeutic role in acne treatment."
26328908,Proglumide treats peptic ulcer disease,1442,[Controlled and double-blind study of the treatment of peptic ulcer with cimetidine and proglumide].,True,"'Does the phrase ""Proglumide treats peptic ulcer disease"" receive at least indirect support from the statement: ""[Controlled and double-blind study of the treatment of peptic ulcer with cimetidine and proglumide].""?","Yes, the statement does provide indirect support for the claim that proglumide treats peptic ulcer disease. The key term here is 'indirect'. The statement indicates that there has been a controlled and double-blind study involving the treatment of peptic ulcer with proglumide. The fact that such a study was conducted implies that there was sufficient scientific interest in investigating proglumide as a potential treatment for peptic ulcer disease. This alone does not prove that proglumide is effective for treating peptic ulcers, but it does suggest that there is some basis for further investigation into its potential therapeutic benefits for this condition. However, it is crucial to note that definitive conclusions about its efficacy would require a thorough review of the actual study results, including details about the study design, participant characteristics, dosage regimens, outcome measures, adverse effects, and statistical analyses."
13022426,Pirenzepine treats gastroesophageal reflux disease,1443,Pirenzepine may provide a unique alternative for some GERD patients who may be refractory to other therapies of GERD.,True,"'Does the phrase ""Pirenzepine treats gastroesophageal reflux disease"" receive at least indirect support from the statement: ""Pirenzepine may provide a unique alternative for some GERD patients who may be refractory to other therapies of GERD.""?","Yes, the statement does provide indirect support for the phrase ""Pirenzepine treats gastroesophageal reflux disease (GERD)"". The key word here is ""alternative"", which implies that Pirenzepine can be used in treating GERD, although it may not be the first line of therapy. However, it is important to note that this does not mean Pirenzepine is a primary treatment for all GERD patients, but rather an option for those who have not responded well to other treatments (i.e., refractory patients). This interpretation should be considered in light of the broader medical context, including the patient's overall health status, potential side effects of Pirenzepine, and other relevant factors."
10839963,Pirenzepine treats peptic ulcer disease,1444,Four hundred and two patients with peptic ulcer were selected for acute therapy with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) using the envelope method.,False,"'Does the phrase ""Pirenzepine treats peptic ulcer disease"" receive at least indirect support from the statement: ""Four hundred and two patients with peptic ulcer were selected for acute therapy with either pirenzepine (100 mg/day) or cimetidine (800 mg/day) using the envelope method.""?","No, the statement does not provide direct or indirect support for the claim that ""Pirenzepine treats peptic ulcer disease."" The statement simply describes a study design where 402 patients with peptic ulcer were selected for acute therapy using either pirenzepine (100 mg/day) or cimetidine (800 mg/day). It does not provide any information about the outcomes of the therapy or whether pirenzepine was effective in treating peptic ulcer disease. Therefore, it is not possible to draw conclusions about treatment efficacy based solely on this information."
16332442,Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum,1445,"In that context, magnesium oxide significantly reduced CIMT in PXE mice, and may be useful for disease prevention in PXE patients.",False,"'Does the phrase ""Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum"" receive at least indirect support from the statement: ""In that context, magnesium oxide significantly reduced CIMT in PXE mice, and may be useful for disease prevention in PXE patients.""?","No, the phrase ""Magnesium Oxide treats autosomal recessive inherited pseudoxanthoma elasticum"" does not receive direct support from the statement provided. The statement suggests that magnesium oxide reduced CIMT (carotid intima-media thickness) in PXE (pseudoxanthoma elasticum) mice, which might imply potential benefits for disease prevention in PXE patients. However, it does not explicitly state that magnesium oxide treats autosomal recessive inherited pseudoxanthoma elasticum. Furthermore, even if magnesium oxide were shown to reduce CIMT in humans with PXE, it would not necessarily mean it treats the autosomal recessive inherited form of the disease specifically, as CIMT could be affected in other forms of PXE as well."
15225864,Magnesium Oxide treats constipation disorder,1446,"This report presents the rare case of a 75-year-old woman who developed a rectal obstruction caused by a pharmacobezoar, following the long-term ingestion of magnesium oxide cathartics for constipation.",True,"'Does the phrase ""Magnesium Oxide treats constipation disorder"" receive at least indirect support from the statement: ""This report presents the rare case of a 75-year-old woman who developed a rectal obstruction caused by a pharmacobezoar, following the long-term ingestion of magnesium oxide cathartics for constipation.""?","Yes, indirect support can be inferred from the statement provided. The case report describes an elderly woman who experienced a rectal obstruction due to long-term ingestion of magnesium oxide cathartics, which are used for treating constipation. This suggests that magnesium oxide may have an impact on bowel movements, potentially alleviating constipation symptoms in some individuals. However, it is important to note that this observation does not equate to magnesium oxide being an approved treatment for constipation disorder, nor does it provide direct evidence of its efficacy in treating constipation symptoms in general. It merely highlights a potential correlation that may warrant further investigation in controlled clinical trials.

         Additionally, it is crucial to consider potential side effects of long-term magnesium oxide use as observed in this case report. The woman experienced a rectal obstruction caused by magnesium oxide cathartics, which could be potentially harmful if not detected and treated promptly. Therefore, any use of magnesium oxide for constipation relief should be done under medical supervision to mitigate potential risks associated with its long-term usage."
26045826,Ticarcillin treats Sepsis,1447,Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.,True,"'Does the phrase ""Ticarcillin treats Sepsis"" receive at least indirect support from the statement: ""Mezlocillin and ticarcillin in the treatment of patients with serious systemic infections.""?","Yes, indirectly it does provide some support for the statement that ""Ticarcillin treats Sepsis"". The provided statement mentions Ticarcillin in conjunction with Mezlocillin in treating patients with serious systemic infections, which can include Sepsis. However, it is important to note that while Ticarcillin may be used as part of treatment regimens for Sepsis due to its antibiotic properties, it is not a definitive cure for Sepsis on its own. Sepsis is a complex condition that often requires intensive care and multifaceted treatments involving antibiotics, intravenous fluids, vasopressors, corticosteroids, insulin therapy, and other supportive measures depending on individual patient circumstances (Singer et al., 2016). 

        Furthermore, while Ticarcillin has been used in treating certain bacterial infections that can lead to Sepsis (such as Pseudomonas aeruginosa), its effectiveness in treating Sepsis specifically is not well-established compared to other antibiotics (Bratzler et al., 2013). Therefore,"
9410149,Ticarcillin treats osteomyelitis,1448,Obviously unbalanced comparative studies showed some benefit of ticarcillin for bone infections caused by Pseudomonas species.,True,"'Does the phrase ""Ticarcillin treats osteomyelitis"" receive at least indirect support from the statement: ""Obviously unbalanced comparative studies showed some benefit of ticarcillin for bone infections caused by Pseudomonas species.""?","Yes, there is indirect support for the claim that ""Ticarcillin treats osteomyelitis"" based on the provided statement. The reason for my affirmative answer lies in the fact that osteomyelitis is an infection of the bone, often caused by bacteria such as Pseudomonas species (as mentioned in the statement). Ticarcillin is an antibiotic that has demonstrated some benefit in treating bone infections caused by these bacteria in unbalanced comparative studies.

        However, it is essential to acknowledge that while there is indirect support for ticarcillin treating osteomyelitis based on this statement alone, it does not definitively prove that ticarcillin is an effective treatment for osteomyelitis caused by Pseudomonas species. A more robust body of evidence would be required for such a conclusion.

        Additionally, it is important to consider potential limitations of unbalanced comparative studies, such as confounding factors that could affect outcomes and potentially bias results in favor of ticarcillin without it being solely responsible for any observed benefits. Therefore, while there is some support for ticarcillin treating osteomyelitis caused by"
26823243,Urea treats citrullinemia,1449,"The precursors of urea (ammonia, glutamate, glutamine and alpha-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.",False,"'Does the phrase ""Urea treats citrullinemia"" receive at least indirect support from the statement: ""The precursors of urea (ammonia, glutamate, glutamine and alpha-amino nitrogen) did not increase after the benzoate administration in the 6 normal subjects as well as in the 2 patients with citrullinaemia.""?","No, the statement does not provide indirect support for the phrase ""Urea treats citrullinemia."" The statement discusses the lack of increase in precursors of urea after benzoate administration in both normal subjects and patients with citrullinemia. However, it does not mention anything about urea treating citrullinemia, which is an inborn error of urea cycle metabolism characterized by an accumulation of citrulline in the body due to deficiency of argininosuccinate synthetase enzyme. Urea itself is not a treatment for citrullinemia; rather, management typically involves dietary restrictions, supplementation of necessary amino acids, and in some cases, liver transplantation."
25855602,Urea treats argininosuccinic aciduria,1450,The relationship between the formation of urea and argininosuccinate in a patient with argininosuccinic aciduria studied with labelled precursors.,True,"'Does the phrase ""Urea treats argininosuccinic aciduria"" receive at least indirect support from the statement: ""The relationship between the formation of urea and argininosuccinate in a patient with argininosuccinic aciduria studied with labelled precursors.""?","Yes, the statement does provide indirect support for the phrase ""Urea treats argininosuccinic aciduria."" Argininosuccinic aciduria is a genetic disorder characterized by an accumulation of argininosuccinic acid in the body due to deficiency of the enzyme argininosuccinate lyase (ASL). This enzyme is crucial for urea synthesis, which helps eliminate ammonia from the body by converting it into urea that can be excreted through urine.

        The statement mentions that labelled precursors were used in studying a patient with argininosuccinic aciduria. In metabolic studies like this one, labelled precursors (substrates) can help trace metabolic pathways in vivo and observe how they are affected in specific genetic disorders like argininosuccinic aciduria.

        Although the statement does not explicitly mention urea being used as treatment for argininosuccinic aciduria, it does imply that understanding urea formation is essential for managing argininosuccinic aciduria by addressing its underlying metabolic dysfunction. Therefore, while it"
19420190,Urea treats psoriasis,1451,"In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured.",False,"'Does the phrase ""Urea treats psoriasis"" receive at least indirect support from the statement: ""In the treatment of psoriasis with urea and urea-combined preparations, the individual sequence should be so clearly prescribed such that acceptance is assured.""?","No, the statement does not provide indirect support for the phrase ""Urea treats psoriasis."" The statement provides information on how urea should be administered in psoriasis treatment but does not confirm that urea effectively treats psoriasis. To establish indirect support for the efficacy of urea in treating psoriasis, additional evidence would be needed to demonstrate that urea application results in improvements in psoriasis symptoms."
17323203,Urea treats radiodermatitis,1452,"RESULTS: Effective treatment with urea has been reported for the following conditions: ichthyosis, xerosis, atopic dermatitis/eczema, contact dermatitis, radiation induced dermatitis, psoriasis/seborrheic dermatitis, onychomycosis, tinea pedis, keratosis, pruritus, and dystrophic nails.",True,"'Does the phrase ""Urea treats radiodermatitis"" receive at least indirect support from the statement: ""RESULTS: Effective treatment with urea has been reported for the following conditions: ichthyosis, xerosis, atopic dermatitis/eczema, contact dermatitis, radiation induced dermatitis, psoriasis/seborrheic dermatitis, onychomycosis, tinea pedis, keratosis, pruritus, and dystrophic nails.""?","Yes, the phrase ""Urea treats radiodermatitis"" does receive indirect support from the statement provided. The list of conditions includes ""radiation induced dermatitis,"" which is another term for radiodermatitis. The fact that urea has been reported as an effective treatment for radiation induced dermatitis suggests that it could potentially be useful in treating radiodermatitis more generally. However, it is important to note that indirect support does not equate to definitive proof. The effectiveness of urea for treating radiodermatitis would need to be confirmed through further controlled clinical trials before it could be considered a proven treatment."
15413374,Urea treats hepatocellular carcinoma,1453,"INTRODUCTION: Sorafenib is a novel oral bis-aryl urea compound that has proven survival benefit in patients with advanced hepatocellular carcinoma (HCC), for which several therapies are currently available with unsatisfactory results.",False,"'Does the phrase ""Urea treats hepatocellular carcinoma"" receive at least indirect support from the statement: ""INTRODUCTION: Sorafenib is a novel oral bis-aryl urea compound that has proven survival benefit in patients with advanced hepatocellular carcinoma (HCC), for which several therapies are currently available with unsatisfactory results.""?","No, the phrase ""Urea treats hepatocellular carcinoma"" does not receive indirect support from the statement provided. The statement mentions Sorafenib, which is indeed an oral bis-aryl urea compound, but it does not imply that urea itself has any therapeutic effect on hepatocellular carcinoma. Sorafenib is a complex molecule that contains urea as part of its structure, but it cannot be concluded that urea is responsible for its therapeutic effects in HCC treatment. Therefore, there is no indirect support for the claim that urea can treat hepatocellular carcinoma based on the provided statement."
12068406,Urea treats type 2 diabetes mellitus,1454,These findings are consistent with the inhibition of hepatic glycogenolysis and support the use of acyl ureas for the treatment of type 2 diabetes.,False,"'Does the phrase ""Urea treats type 2 diabetes mellitus"" receive at least indirect support from the statement: ""These findings are consistent with the inhibition of hepatic glycogenolysis and support the use of acyl ureas for the treatment of type 2 diabetes.""?","No, the phrase ""Urea treats type 2 diabetes mellitus"" does not receive indirect support from the statement provided. The statement discusses acyl ureas in relation to treating type 2 diabetes mellitus by inhibiting hepatic glycogenolysis; urea is not an acyl urea but rather an organic compound containing nitrogen atoms from ammonia (NH3). The structure of urea is CH4N2O, while acyl ureas have more complex structures involving amides (R-CO-NR2) derived from carboxylic acids (R-COOH) linked to urea via an amide bond.

        The misinterpretation might arise because urea is sometimes confused with acyl ureas due to their similar names; however, they represent distinct chemical entities. As such, there is no implicit connection between urea and acyl ureas in terms of biological activity in relation to type 2 diabetes mellitus based on the statement provided.

        To further support this conclusion, let us consider potential mechanisms through which urea could influence glucose metabolism in type 2 diabetes mellit"
11649881,Urea treats Pain,1455,"Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.",True,"'Does the phrase ""Urea treats Pain"" receive at least indirect support from the statement: ""Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.""?","Yes, indirectly. The statement provides evidence that ureas can function as transient receptor potential vanilloid 1 (TRPV1) receptor antagonists, which have been shown to have analgesic properties. Therefore, it supports the idea that ureas could potentially be used in pain treatment. However, it does not explicitly state that urea itself treats pain; rather, it suggests that certain urea-containing compounds may have analgesic effects."
10679439,Urea treats skin disorder,1456,[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES].,True,"'Does the phrase ""Urea treats skin disorder"" receive at least indirect support from the statement: ""[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES].""?","Yes, the phrase ""Urea treats skin disorder"" does receive indirect support from the statement ""[TROPHIC ACTION OF UREA AND ITS USE IN THE TREATMENT OF NEUROTROPHIC SKIN DISEASES]."" 

        The statement suggests that urea has therapeutic applications in treating certain types of skin diseases, specifically neurotrophic ones. Neurotrophic skin diseases refer to conditions where there is damage to nerves that supply the skin, leading to changes in skin integrity and function. Urea is known for its moisturizing properties and its ability to enhance skin permeability, which can be beneficial in managing dryness, scaling, and other symptoms associated with various skin disorders. Therefore, while the statement does not explicitly mention all skin disorders, it does provide evidence for urea's use in treating certain skin conditions, lending indirect support to the claim that urea can be used to treat skin disorders in general."
10511987,Urea treats diabetes mellitus,1457,"[Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].",False,"'Does the phrase ""Urea treats diabetes mellitus"" receive at least indirect support from the statement: ""[Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].""?","No, the statement does not provide indirect support for the phrase ""Urea treats diabetes mellitus."" The statement discusses a preliminary note on the oral treatment of diabetes using N-sulfonyl-p-methylbenzene-N'-n-butyl urea (D 860), which is a specific chemical compound different from urea. Urea is a waste product of protein metabolism in mammals, not an antibacterial agent nor a treatment for diabetes mellitus as per current medical knowledge and research."
8678587,"Urea treats dermatitis, atopic",1458,"In the present report, we compared two creams, identical with the exception that one contained both urea and sodium chloride and the other urea alone, in 22 patients with atopic dermatitis.",True,"'Does the phrase ""Urea treats dermatitis, atopic"" receive at least indirect support from the statement: ""In the present report, we compared two creams, identical with the exception that one contained both urea and sodium chloride and the other urea alone, in 22 patients with atopic dermatitis.""?","Yes, the statement does provide indirect support for the phrase ""Urea treats dermatitis, atopic"". The study mentioned compares two creams, one containing urea alone and the other containing both urea and sodium chloride, in patients with atopic dermatitis. This suggests that urea is being tested as a treatment for dermatitis, specifically atopic dermatitis. However, it should be noted that the statement does not provide direct evidence of urea's efficacy in treating atopic dermatitis. A more definitive conclusion would require data on the clinical outcomes of the study, such as symptoms improvement or reduction in inflammation."
27251301,Mannitol treats brain cancer,1459,"Hyperosmolar blood-brain barrier disruption (HBBBD), produced by infusion of mannitol into the cerebral arteries, has been used in the treatment of brain tumors to increase drug delivery to tumor and adjacent brain.",True,"'Does the phrase ""Mannitol treats brain cancer"" receive at least indirect support from the statement: ""Hyperosmolar blood-brain barrier disruption (HBBBD), produced by infusion of mannitol into the cerebral arteries, has been used in the treatment of brain tumors to increase drug delivery to tumor and adjacent brain.""?","Yes, indirectly it does lend support. The statement suggests that mannitol is used in treating brain tumors by inducing hyperosmolar blood-brain barrier disruption (HBBBD). This process increases drug delivery to both the tumor and adjacent brain tissue. While the statement does not explicitly say that mannitol treats brain cancer on its own, it does imply that mannitol plays a crucial role in brain cancer treatment by facilitating drug delivery to the tumor site. However, it is important to note that mannitol itself is not a treatment for brain cancer but rather a tool used in conjunction with other therapies."
21059003,Mannitol treats hearing loss disorder,1460,[Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness].,True,"'Does the phrase ""Mannitol treats hearing loss disorder"" receive at least indirect support from the statement: ""[Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness].""?","Yes, the statement ""Effects of mannitol on the fluids of the internal ear. Use in the treatment of deafness"" does lend indirect support to the phrase ""Mannitol treats hearing loss disorder"". The use of mannitol in treating deafness suggests that it has some effect on the internal ear fluids which contributes positively towards addressing hearing loss disorders. However, it is important to note that direct support would require more specific information linking mannitol use directly to treating hearing loss disorders rather than just being used in their treatment generally."
20425957,Mannitol treats osteoarthritis,1461,Objective: To assess efficacy and safety of a single intra-articular injection of 2% sodium hyaluronate plus 0.5% mannitol in patients with symptomatic osteoarthritis of the knee.,True,"'Does the phrase ""Mannitol treats osteoarthritis"" receive at least indirect support from the statement: ""Objective: To assess efficacy and safety of a single intra-articular injection of 2% sodium hyaluronate plus 0.5% mannitol in patients with symptomatic osteoarthritis of the knee.""?","Yes, indirectly it does lend some support. The statement mentions that they are assessing the efficacy and safety of a solution that includes mannitol in patients with osteoarthritis of the knee. This implies that mannitol is being considered as part of a treatment for osteoarthritis in this study. However, it's important to note that mannitol is not being studied in isolation; it is being combined with sodium hyaluronate. Therefore, any positive effects observed cannot be solely attributed to mannitol. Furthermore, the results of this particular study would also need to be taken into account when making a definitive conclusion about the efficacy of mannitol in treating osteoarthritis."
16945033,Mannitol treats hypotensive disorder,1462,"These values were correlated with expected risk factors for lactatemia including length of surgery, Body Mass Index (BMI), hypotension, hemoglobin and mannitol therapy.",True,"'Does the phrase ""Mannitol treats hypotensive disorder"" receive at least indirect support from the statement: ""These values were correlated with expected risk factors for lactatemia including length of surgery, Body Mass Index (BMI), hypotension, hemoglobin and mannitol therapy.""?","Yes, while the statement does not explicitly confirm that mannitol treats hypotensive disorder, it does provide indirect support for mannitol therapy being associated with hypotension. The phrase ""mannitol therapy"" is listed as one of the risk factors for lactatemia along with hypotension. This suggests that mannitol may have an influence on hypotension levels, which aligns with the concept of treating hypotensive disorder - although it doesn't necessarily mean that mannitol is used as a treatment for hypotensive disorder in all cases. However, further investigation would be required to establish a direct causal relationship between mannitol therapy and hypotension improvement."
12644644,Mannitol treats Pain,1463,"Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing pain and IOP elevation.",False,"'Does the phrase ""Mannitol treats Pain"" receive at least indirect support from the statement: ""Further treatments with intravenous mannitol, oral carbonic anhydrase inhibitor, topical antiglaumatic agents and subconjunctival 5-fluorouracil (5-FU) injections all failed to control relapsing pain and IOP elevation.""?","No, the statement does not provide indirect support for the phrase ""Mannitol treats Pain"". On the contrary, it suggests that mannitol was ineffective in treating pain and intraocular pressure (IOP) elevation when used intravenously as one of several treatments tried on a patient experiencing relapsing symptoms. The failure of mannitol in this context does not imply that it has no analgesic properties under different circumstances; however, based on the information given, it does not support the claim that mannitol treats pain effectively."
11774217,Mannitol treats brain injury,1464,CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage.,True,"'Does the phrase ""Mannitol treats brain injury"" receive at least indirect support from the statement: ""CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage.""?","Yes, the statement ""CONCLUSIONS: The results suggested that mannitol could improve cerebral perfusion in patients with mild brain damage"" does provide indirect support for the claim ""Mannitol treats brain injury"". This is because improved cerebral perfusion can potentially aid in the recovery of brain tissue after an injury. However, it is important to note that ""treats brain injury"" is a broad claim that may encompass various aspects of brain injury treatment beyond just improving cerebral perfusion. Therefore, while this study suggests a potential beneficial effect of mannitol on brain injury recovery, it does not necessarily confirm that mannitol ""treats"" brain injury in its entirety."
11660589,Mannitol treats malaria,1465,"A possibly indulgent wish list of outcome (mortality) studies using currently known treatment modalities, however, includes the loading dose of quinine, vigorous fluid replacement, ET, the artemisinins, mannitol, and N-acetylcysteine in the treatment of severe malaria.",True,"'Does the phrase ""Mannitol treats malaria"" receive at least indirect support from the statement: ""A possibly indulgent wish list of outcome (mortality) studies using currently known treatment modalities, however, includes the loading dose of quinine, vigorous fluid replacement, ET, the artemisinins, mannitol, and N-acetylcysteine in the treatment of severe malaria.""?","Yes, while indirect, the statement does lend some support to the claim that mannitol treats malaria. The sentence mentions mannitol as part of a list of treatment modalities for severe malaria, suggesting its use in treating the disease. However, it is important to note that this statement alone does not constitute definitive proof of mannitol's efficacy in treating malaria. Further investigation, including controlled clinical trials and meta-analyses of existing studies, would be required to establish mannitol as an evidence-based treatment for malaria. Additionally, it is crucial to consider potential side effects, contraindications, and cost-effectiveness when assessing any treatment modality."
11613595,Mannitol treats chronic obstructive pulmonary disease,1466,CONCLUSION: We propose that AHR to mannitol could predict ICS-responsiveness in mild to moderately severe COPD patients.,False,"'Does the phrase ""Mannitol treats chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""CONCLUSION: We propose that AHR to mannitol could predict ICS-responsiveness in mild to moderately severe COPD patients.""?","No, the phrase ""Mannitol treats chronic obstructive pulmonary disease"" does not receive indirect support from the statement provided. The conclusion of the study suggests that mannitol may be useful as a predictor for ICS (Inhaled Corticosteroid) responsiveness in mild to moderately severe COPD patients based on AHR (Airway Hyperresponsiveness) results. However, it does not imply that mannitol is a treatment for COPD. The study only investigates mannitol's potential predictive value for ICS responsiveness in certain COPD patients."
10724016,Mannitol treats acute kidney failure,1467,MANNITOL THERAPY IN ACUTE RENAL FAILURE.,True,"'Does the phrase ""Mannitol treats acute kidney failure"" receive at least indirect support from the statement: ""MANNITOL THERAPY IN ACUTE RENAL FAILURE.""?","Yes, the phrase ""Mannitol treats acute kidney failure"" does receive indirect support from the statement ""MANNITOL THERAPY IN ACUTE RENAL FAILURE."" This is because mannitol is mentioned in conjunction with acute renal failure (also known as acute kidney injury), implying that it may have some therapeutic effect in treating this condition.

         However, it is essential to note that indirect support does not equate to definitive evidence of treatment efficacy. A more thorough examination of the study design, sample size, statistical analysis, and results would be necessary for a rigorous evaluation of mannitol's therapeutic potential in acute kidney failure.

         Furthermore, it is crucial to consider potential side effects and contraindications associated with mannitol use, as well as any alternative treatment options available for acute kidney failure. A holistic approach should be taken when interpreting such statements, considering both their explicit content and any implicit implications that may be drawn from them."
10707564,Mannitol treats injury,1468,Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats.,True,"'Does the phrase ""Mannitol treats injury"" receive at least indirect support from the statement: ""Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats.""?","Yes, the phrase ""Mannitol treats injury"" does receive indirect support from the statement ""Mannitol has a beneficial effect on ischemic injury following a short-duration forebrain ischemic insult in rats."" This is because mannitol is being shown to have a positive impact on an injury model (ischemic injury), which aligns conceptually with treating injury. However, it is crucial to note that this evidence is derived from animal studies and is specific to ischemic injury in rats; thus, further investigation is required before generalizing these results to other types of injury in different species, including humans."
9454905,Mannitol treats ciguatera fish poisoning,1469,IV mannitol is considered the treatment of choice for CP but has not been evaluated in a double-blind randomized trial.,True,"'Does the phrase ""Mannitol treats ciguatera fish poisoning"" receive at least indirect support from the statement: ""IV mannitol is considered the treatment of choice for CP but has not been evaluated in a double-blind randomized trial.""?","Yes, indirectly it does support the statement that Mannitol treats ciguatera fish poisoning (CP). The given statement mentions IV Mannitol being considered as the treatment of choice for CP but hasn't undergone evaluation in a double-blind randomized trial. This implies that while there is a general consensus among medical professionals about Mannitol being an effective treatment for CP, there is a lack of high-level evidence from randomized controlled trials (RCTs) to confirm its efficacy conclusively.

        The initial statement does not explicitly refute Mannitol's effectiveness in treating CP; instead, it points out the need for further investigation through rigorous clinical trials. Therefore, based on current knowledge and consensus within the medical community, one could infer that Mannitol does indeed have some level of support as a treatment for ciguatera fish poisoning. However, it is crucial to note that more rigorous studies need to be conducted to establish its efficacy conclusively."
9438138,Mannitol treats stroke disorder,1470,Effects of intravenous mannitol on EEG recordings in stroke patients.,False,"'Does the phrase ""Mannitol treats stroke disorder"" receive at least indirect support from the statement: ""Effects of intravenous mannitol on EEG recordings in stroke patients.""?","No, the statement ""Effects of intravenous mannitol on EEG recordings in stroke patients"" does not provide direct or indirect support for the claim that ""Mannitol treats stroke disorder."" 

        The statement only suggests that mannitol has an effect on EEG recordings in stroke patients. It does not specify whether this effect is beneficial (i.e., it treats stroke disorder) or detrimental. Therefore, it is not appropriate to infer a treatment effect based on this statement alone. 

        Furthermore, even if the EEG recordings improved after mannitol administration, this would not necessarily mean that stroke disorder is being treated. EEG recordings reflect electrical activity in the brain, but they do not directly measure stroke severity or outcomes. Therefore, improvements in EEG recordings may not translate into clinical benefits for stroke patients. 

        In order to establish that mannitol treats stroke disorder, well-designed clinical trials would be needed, which evaluate clinically relevant outcomes such as stroke severity, disability, and mortality."
8850005,Mannitol treats coronary artery disorder,1471,"The data suggest the need to further evaluate the physiological importance of the increase in coronary blood flow produced by mannitol in patients with coronary artery disease and indicate the possibility that mannitol might be of value in treating certain problems in patients with coronary artery disease,",True,"'Does the phrase ""Mannitol treats coronary artery disorder"" receive at least indirect support from the statement: ""The data suggest the need to further evaluate the physiological importance of the increase in coronary blood flow produced by mannitol in patients with coronary artery disease and indicate the possibility that mannitol might be of value in treating certain problems in patients with coronary artery disease,""?","Yes, the statement does provide indirect support for the claim that mannitol treats coronary artery disorder. The passage suggests that mannitol increases coronary blood flow in patients with coronary artery disease, which aligns with the general concept of treatment - addressing the disease condition by improving blood flow. However, it is important to note that the language used in the statement is cautious and does not definitively establish mannitol as an effective treatment. Further evaluation is recommended, indicating that more conclusive evidence is needed before making a firm assertion about mannitol's therapeutic value in treating coronary artery disease."
8674974,Mannitol treats bronchiectasis,1472,The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.,True,"'Does the phrase ""Mannitol treats bronchiectasis"" receive at least indirect support from the statement: ""The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis.""?","Yes, the statement ""The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis"" can be interpreted as providing indirect support for the claim that ""Mannitol treats bronchiectasis."" This is because improved mucus clearance is generally associated with better disease outcomes in bronchiectasis patients, suggesting that mannitol may have therapeutic effects. However, it is important to note that demonstrating that mannitol treats bronchiectasis would typically require more extensive clinical trials and evidence of symptom improvement or reduced exacerbations over time. The provided statement only addresses one aspect of bronchiectasis management - mucus clearance - thus offering indirect support for the claim at best."
8007841,"Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive",1473,Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol).,False,"'Does the phrase ""Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive"" receive at least indirect support from the statement: ""Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol).""?","No, the statement ""Treatment of chronic myelocytic leukaemia with dibromo-mannitol (myelobromol)"" does not provide indirect support for the claim that ""Mannitol treats chronic myelogenous leukemia, BCR-ABL1 positive.""

        

        The reason behind my decision is based on several factors. Firstly, dibromo-mannitol (myelobromol) is not the same as mannitol; they have different chemical structures due to the presence of bromine atoms in dibromo-mannitol. Secondly, even if we overlook the structural differences between these two compounds, there is no mention of BCR-ABL1 in the statement provided. BCR-ABL1 is a genetic marker specific for chronic myelogenous leukemia (CML), which implies that targeting BCR-ABL1 is crucial for treating CML effectively. Therefore, without evidence showing that mannitol can target BCR-ABL1 in CML cells, we cannot infer that mannitol can treat chronic myelogenous leukemia, BCR-"
7780960,Mannitol treats cystic fibrosis,1474,Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients.,True,"'Does the phrase ""Mannitol treats cystic fibrosis"" receive at least indirect support from the statement: ""Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients.""?","Yes, the statement ""Inhaled mannitol is a potential mucoactive agent in cystic fibrosis patients"" does provide indirect support for the phrase ""Mannitol treats cystic fibrosis."" 

        The term ""mucoactive agent"" refers to a substance that can alter mucus properties, which is often abnormal in cystic fibrosis patients. The fact that mannitol is mentioned as a potential mucoactive agent in this population suggests that it could have therapeutic benefits for these patients. However, it is important to note that ""treats"" is a strong term that implies direct causality and clinical efficacy, which may not be fully supported by this statement alone. More rigorous clinical trials would be needed to establish whether mannitol is indeed an effective treatment for cystic fibrosis. Nonetheless, this statement does provide some level of indirect support for the potential therapeutic use of mannitol in cystic fibrosis."
7352141,Mannitol treats intracranial hypertension,1475,"CONCLUSION: Hypertonic saline, in both 3 and 23.4% concentrations, is as effective as mannitol in the treatment of intracranial hypertension observed in association with ICH.",True,"'Does the phrase ""Mannitol treats intracranial hypertension"" receive at least indirect support from the statement: ""CONCLUSION: Hypertonic saline, in both 3 and 23.4% concentrations, is as effective as mannitol in the treatment of intracranial hypertension observed in association with ICH.""?","Yes, indirectly it does support the phrase ""Mannitol treats intracranial hypertension"". The conclusion states that hypertonic saline is as effective as mannitol in treating intracranial hypertension associated with ICH (Intracerebral Hemorrhage). This implies that mannitol is indeed effective in treating intracranial hypertension, as it is being compared to another effective treatment (hypertonic saline) in the same context. However, it doesn't necessarily suggest that mannitol is superior to other treatments or that it is the only treatment for intracranial hypertension. It is crucial to consider that indirect support does not equate to definitive proof, but rather it contributes to building a case for the claim in question."
7084538,Mannitol treats brain edema,1476,CONCLUSIONS: Acute mannitol used in patients with cerebral edema after a large hemispheric infarction does not alter midline tissue shifts or worsen neurologic status.,False,"'Does the phrase ""Mannitol treats brain edema"" receive at least indirect support from the statement: ""CONCLUSIONS: Acute mannitol used in patients with cerebral edema after a large hemispheric infarction does not alter midline tissue shifts or worsen neurologic status.""?","No, the statement does not provide indirect support for the phrase ""Mannitol treats brain edema"". The conclusion is derived from a study where mannitol was administered to patients with cerebral edema after a large hemispheric infarction. However, the study found that mannitol did not alter midline tissue shifts or worsen neurologic status. This suggests that mannitol may not be effective in treating brain edema in this specific context, which contradicts the claim that mannitol treats brain edema. It is important to note that medical treatments can have different effects depending on the context and the specific condition of the patient, so further research would be needed to definitively determine mannitol's effectiveness in treating brain edema in other scenarios."
23769437,Temocillin treats bacterial infectious disease with sepsis,1477,The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due to 3GCR-E.,True,"'Does the phrase ""Temocillin treats bacterial infectious disease with sepsis"" receive at least indirect support from the statement: ""The objective is to investigate if temocillin is non-inferior to carbapenems in the targeted treatment of bacteraemia due to 3GCR-E.""?","Yes, indirectly it does provide some support for the statement that ""Temocillin treats bacterial infectious disease with sepsis"". The investigation mentioned in the statement aims to compare Temocillin against carbapenems in treating bacteraemia due to 3GCR-E (extended-spectrum beta-lactamase producing Enterobacteriaceae). Bacteraemia is essentially bacterial infection in the bloodstream that can lead to sepsis if not treated promptly and effectively.

        
        Therefore, if Temocillin is found non-inferior (or even superior) to carbapenems in treating bacteraemia due to 3GCR-E in this investigation, it would imply that Temocillin is indeed effective in treating bacterial infectious diseases associated with sepsis in specific cases (3GCR-E infections). However, it is important to note that this conclusion would be based on an indirect interpretation of the statement as it does not explicitly mention sepsis but rather an infection that can lead to sepsis when not treated appropriately.

        
        Additionally, it should be emphasized that any"
17734631,Artesunic acid treats hepatocellular carcinoma,1478,CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma.,True,"'Does the phrase ""Artesunic acid treats hepatocellular carcinoma"" receive at least indirect support from the statement: ""CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma.""?","Yes, the statement ""CONCLUSION: These findings indicate that artesunate could offer a new approach to the therapy of hepatocellular carcinoma"" does provide indirect support for the phrase ""Artesunic acid treats hepatocellular carcinoma"". The conclusion suggests that artesunate (which is derived from artesunic acid) has potential therapeutic benefits for hepatocellular carcinoma. However, it is important to note that ""could offer a new approach to therapy"" is not the same as ""treats"". The conclusion is based on certain findings from a study, which may not be conclusive and could require further investigation before making definitive statements about its treatment capabilities."
16415826,Artesunic acid treats Crohn disease,1479,Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease.,True,"'Does the phrase ""Artesunic acid treats Crohn disease"" receive at least indirect support from the statement: ""Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease.""?","Yes, the phrase ""Artesunic acid treats Crohn disease"" does receive indirect support from the statement: ""Our data suggest a novel clinical application of artesunate as a potential therapy for Crohn's disease."" 

        The statement implies that artesunate has shown potential in treating Crohn's disease in a clinical context based on their data. While it does not definitively prove that artesunic acid (a close relative of artesunate) treats Crohn disease, it does lend credence to the idea that compounds in this family may have therapeutic effects for this condition. This is because artesunic acid and artesunate share similar chemical structures and mechanisms of action. However, it is important to note that further research is needed to confirm these effects in humans and to understand the specific mechanisms involved before making definitive conclusions about treatment efficacy."
15681287,Artesunic acid treats breast neoplasm,1480,Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.,False,"'Does the phrase ""Artesunic acid treats breast neoplasm"" receive at least indirect support from the statement: ""Taken together our in vitro and in vivo results correlate well showing for the first time that artesunate induces resistance in highly metastatic breast tumors.""?","No, the statement does not provide indirect support for the phrase ""Artesunic acid treats breast neoplasm."" In fact, it suggests quite the opposite - that artesunic acid (artesunate) may induce resistance in highly metastatic breast tumors. This could imply that artesunic acid might not be an effective treatment for breast neoplasm (breast cancer), as it may lead to drug resistance in aggressive breast tumors. However, more research is needed to confirm these findings and fully understand the implications of artesunic acid on breast cancer progression."
13704055,Artesunic acid treats cytomegalovirus infection,1481,"This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation.",True,"'Does the phrase ""Artesunic acid treats cytomegalovirus infection"" receive at least indirect support from the statement: ""This is the first report of treatment of cytomegalovirus infection with artesunate, for a stem cell transplant recipient with a newly identified foscarnet-resistant and ganciclovir-resistant DNA polymerase L776M mutation.""?","Yes, indirectly it does support that statement. The quote mentions artesunate being used for the first time in treating cytomegalovirus (CMV) infection for a patient resistant to both foscarnet and ganciclovir due to an L776M mutation in DNA polymerase. Artesunic acid is a salt of artesunate, meaning they share similar biological properties as they derive from artemisinin. While there isn't direct evidence of artesunic acid treating CMV infection in this quote, it does imply that artemisinin derivatives like artesunate could potentially be effective against CMV infections where conventional treatments have failed due to resistance mutations like L776M. However, further experimental validation would be necessary before making any definitive conclusions about artesunic acid as an antiviral agent against CMV infections."
13022850,Artesunic acid treats neoplasm,1482,The anticancer activity of artesunate has also been shown in human xenograft tumors in mice.,True,"'Does the phrase ""Artesunic acid treats neoplasm"" receive at least indirect support from the statement: ""The anticancer activity of artesunate has also been shown in human xenograft tumors in mice.""?","Yes, indirect support can be inferred from the statement ""The anticancer activity of artesunate has also been shown in human xenograft tumors in mice."" This is because artesunic acid is a form of artesunate, an artemisinin derivative that has demonstrated anticancer properties in preclinical studies using animal models (in this case, mice). However, it is important to note that while these findings suggest potential therapeutic effects of artesunate on neoplastic growths in humans, they do not definitively establish that artesunic acid treats neoplasm in humans. Further research is needed to confirm these preclinical results in clinical settings involving human patients."
10539481,Artesunic acid treats Fever,1483,The 2 groups that received artesunate experienced considerably more rapid reduction in parasitemia and in fever than the group that received only mefloquine (p.002).,True,"'Does the phrase ""Artesunic acid treats Fever"" receive at least indirect support from the statement: ""The 2 groups that received artesunate experienced considerably more rapid reduction in parasitemia and in fever than the group that received only mefloquine (p.002).""?","Yes, the statement does provide indirect support for the claim that artesunic acid treats fever. The study found that groups who received artesunate experienced a more rapid reduction in fever compared to the group that received only mefloquine (p=0.002). Artesunate is a derivative of artesunic acid, which suggests that artesunic acid may have similar fever-reducing properties. However, it is important to note that this is an indirect inference as the study did not explicitly test artesunic acid for fever reduction. Further investigation would be necessary to confirm artesunic acid's direct effect on fever reduction in clinical settings."
10009785,Artesunic acid treats schistosomiasis,1484,CONCLUSION: A mass chemotherapy in conjunction with health education and oral artesunate for preventing reinfection in transmission season is effective for the control of schistosomiasis in lake regions.,True,"'Does the phrase ""Artesunic acid treats schistosomiasis"" receive at least indirect support from the statement: ""CONCLUSION: A mass chemotherapy in conjunction with health education and oral artesunate for preventing reinfection in transmission season is effective for the control of schistosomiasis in lake regions.""?","Yes, there is indirect support for the claim that ""Artesunic acid treats schistosomiasis"" based on the provided conclusion statement.

         The conclusion suggests that mass chemotherapy involving oral artesunate is effective in controlling schistosomiasis in lake regions when combined with health education and efforts to prevent reinfection during transmission season. Artesunic acid is one of the forms of artesunate, which is a derivative of artemisinin - an active component of the traditional Chinese herbal medicine Artemisia annua (sweet wormwood).

         While the conclusion does not explicitly mention Artesunic acid treating schistosomiasis, it does imply that artesunate (which includes Artesunic acid) is an effective component of controlling schistosomiasis in affected populations when used in mass chemotherapy programs alongside other measures. This suggests that Artesunic acid could play an active role in treating schistosomiasis as part of such a program.

         However, it is important to note that further investigation would be required for direct evidence of Artesunic acid treating schistosomiasis in individuals rather than its effectiveness in mass chemotherapy programs for controlling schist"
9194607,Artesunic acid treats urinary schistosomiasis,1485,"Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.",True,"'Does the phrase ""Artesunic acid treats urinary schistosomiasis"" receive at least indirect support from the statement: ""Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.""?","Yes, indirect support can be inferred from the statement provided. The study mentions Artesunate as one of its treatments for Schistosoma haematobium infections, which is closely related to urinary schistosomiasis as it is caused by Schistosoma haematobium species as well. The study being double-blind, randomized, and placebo-controlled adds credibility to its findings; however, it is essential to review the complete study for specific results related to Artesunic acid since there may be differences in efficacy compared to Artesunate.

        
        Artesunic acid is an artemisinin derivative like Artesunate; both have antimalarial properties. However, there is limited direct evidence specifically on Artesunic acid treating urinary schistosomiasis in published literature. Further investigation into specific studies on Artesunic acid for urinary schistosomiasis treatment is recommended for more conclusive support."
7990355,Artesunic acid treats Plasmodium vivax malaria,1486,"To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland) (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria, we conducted a comparative clinical trial of these 3 drugs in an open-label study.",True,"'Does the phrase ""Artesunic acid treats Plasmodium vivax malaria"" receive at least indirect support from the statement: ""To define the current efficacy of Fansidar (F. Hoffmann-La Roche Ltd., Basel Switzerland) (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria, we conducted a comparative clinical trial of these 3 drugs in an open-label study.""?","Yes, indirect support can be inferred from the statement provided for the phrase ""Artesunic acid treats Plasmodium vivax malaria"". The reason behind this is that although artesunic acid is not explicitly mentioned in the clinical trial comparing Fansidar (pyrimethamine and sulfadoxine), primaquine in a high dose, and artesunate for treating acute Plasmodium vivax malaria; artesunate is indeed included in the trial. Artesunate is one of the artemisinin derivatives that shares similar antimalarial properties as artesunic acid against Plasmodium vivax species due to their shared mode of action in inhibiting parasite growth by generating free radicals that damage parasite proteins (White NJ. Antimalarial drug resistance. J Clin Invest. 2004;113(12):1705-1716). Therefore, if artesunate is found effective in treating Plasmodium vivax malaria in the clinical trial, it can be inferred that artesunic acid may also have similar efficacy against Plasmodium vivax species due to their related mechanisms of"
7595063,Artesunic acid treats malaria,1487,Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria.,True,"'Does the phrase ""Artesunic acid treats malaria"" receive at least indirect support from the statement: ""Artemether and artesunate have also been administered by the rectal route with highly promising results for treatment of severe malaria.""?","Yes, there is indirect support for the claim that artesunic acid treats malaria from the provided statement. Artemether and artesunate are derivatives of artemisinin, which is also the primary component of artesunic acid. These compounds share similar mechanisms of action against Plasmodium falciparum, the parasite responsible for malaria infections (WHO Model List of Essential Medicines, 2021).

         The statement highlights that artemether and artesunate have shown promising results in treating severe malaria when administered by the rectal route. While it does not explicitly mention artesunic acid, their shared origin from artemisinin suggests that artesunic acid could also have efficacy in treating malaria. However, it is essential to note that direct evidence confirming artesunic acid's effectiveness in treating malaria should be consulted for definitive conclusions (Bhattarai et al., 2017).

         In summary, while not definitive proof of artesunic acid's effectiveness against malaria, there is an indirect supportive relationship between artemether/artesunate's proven efficacy in treating severe"
7113713,Artesunic acid treats Plasmodium falciparum malaria,1488,Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.,True,"'Does the phrase ""Artesunic acid treats Plasmodium falciparum malaria"" receive at least indirect support from the statement: ""Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.""?","Yes, there is indirect support for the claim that ""Artesunic acid treats Plasmodium falciparum malaria"" based on the statement provided. The statement suggests that during a 5-day oral treatment of artesunate for Falciparum malaria (a species of Plasmodium that causes malaria), there is a decline in dihydroartemisinin concentrations in plasma. Artesunate is a derivative of artemisinin, which is extracted from Artemisia annua (sweet wormwood), and artesunic acid is another derivative of artemisinin. All three compounds have antimalarial properties due to their ability to generate free radicals that can kill malaria parasites.

        
        The decline in dihydroartemisinin concentrations during treatment could be attributed to its conversion from artesunate in vivo, which would indicate that artesunate (and by extension artesunic acid) is actively being metabolized and exerting its effects on Plasmodium falciparum parasites in the body during treatment. This metabolic process is consistent with therapeutic interventions intended for treating mal"
7264251,Artemether treats malaria,1489,These data demonstrate the equality of artemether and quinine for severe malaria and indicate a trend toward greater effectiveness of artemether in regions where there is recognized quinine resistance.,True,"'Does the phrase ""Artemether treats malaria"" receive at least indirect support from the statement: ""These data demonstrate the equality of artemether and quinine for severe malaria and indicate a trend toward greater effectiveness of artemether in regions where there is recognized quinine resistance.""?","Yes, the statement does provide indirect support for the claim that Artemether treats malaria. The statement indicates that Artemether has been tested against Quinine for severe malaria and found to be equally effective, if not more so in regions where Quinine resistance is recognized. This suggests that Artemether can indeed treat malaria, at least on par with Quinine, which is a well-established antimalarial drug. However, it's important to note that this is an indirect inference based on one study. For a more definitive conclusion, a broader evaluation of multiple studies would be necessary."
7168046,Artemether treats Plasmodium falciparum malaria,1490,"The spectrum of falciparum malaria treatment has recently broadened to include new drugs such as artemisinin, artemether or atovaquone/proguanil, the latter being as yet unauthorized in France.",True,"'Does the phrase ""Artemether treats Plasmodium falciparum malaria"" receive at least indirect support from the statement: ""The spectrum of falciparum malaria treatment has recently broadened to include new drugs such as artemisinin, artemether or atovaquone/proguanil, the latter being as yet unauthorized in France.""?","Yes, the statement does provide indirect support for the claim that Artemether treats Plasmodium falciparum malaria. The statement explicitly mentions Artemether as one of the new drugs in the expanded spectrum of falciparum malaria treatment. This implies that Artemether is indeed used for treating Plasmodium falciparum malaria, even though it doesn't provide direct clinical evidence of its efficacy. However, it is important to note that for a definitive conclusion about Artemether's therapeutic effect on Plasmodium falciparum malaria, more detailed clinical studies would be required."
25827221,Isoproterenol treats obstructive lung disease,1491,Investigation into isoprenaline resistance in patients with obstructive lung disease.,True,"'Does the phrase ""Isoproterenol treats obstructive lung disease"" receive at least indirect support from the statement: ""Investigation into isoprenaline resistance in patients with obstructive lung disease.""?","Yes, indirect support can be inferred from this statement. The investigation into isoprenaline resistance in patients with obstructive lung disease suggests that isoprenaline (also known as isoproterenol) is being studied in relation to obstructive lung disease. This implies that there is an interest in understanding how isoproterenol might be used for treating or managing obstructive lung disease, even if resistance is observed in some patients.

        
        However, it is important to note that indirect support does not equate to definitive evidence of efficacy. The statement does not provide information about whether isoproterenol has been found to be effective in treating obstructive lung disease, nor does it specify what form of treatment (e.g., prevention, mitigation of symptoms) is being considered. Therefore, further investigation would be necessary to draw firmer conclusions about the potential therapeutic use of isoproterenol in obstructive lung disease."
15441635,Isoproterenol treats lipoma,1492,AIM: The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas.,True,"'Does the phrase ""Isoproterenol treats lipoma"" receive at least indirect support from the statement: ""AIM: The aim of this study was to evaluate the efficacy of isoproterenol and prednisolone in the treatment of subcutaneous lipomas.""?","Yes, the phrase ""Isoproterenol treats lipoma"" does receive indirect support from the statement provided. The statement indicates that a study aimed to evaluate the efficacy of Isoproterenol (alongside prednisolone) in the treatment of subcutaneous lipomas. This implies that Isoproterenol was used as a treatment for lipomas in the study, providing indirect support for the claim that Isoproterenol treats lipoma. However, it is important to note that efficacy was being evaluated in this study, so further investigation would be needed to determine if Isoproterenol was found to be effective in treating lipomas."
13881275,Isoproterenol treats orthostatic hypotension,1493,"Microdialysate concentrations of the main neuronal metabolite of norepinephrine (NE) and dihydroxyphenylglycol (DHPG) were measured in skeletal muscle, and plasma concentrations of NE and DHPG were measured in response to i.v. tyramine, yohimbine, and isoproterenol, in patients with PD+NOH, patients with pure autonomic failure (PAF), which is characterized by generalized catecholaminergic denervation, and control subjects.",True,"'Does the phrase ""Isoproterenol treats orthostatic hypotension"" receive at least indirect support from the statement: ""Microdialysate concentrations of the main neuronal metabolite of norepinephrine (NE) and dihydroxyphenylglycol (DHPG) were measured in skeletal muscle, and plasma concentrations of NE and DHPG were measured in response to i.v. tyramine, yohimbine, and isoproterenol, in patients with PD+NOH, patients with pure autonomic failure (PAF), which is characterized by generalized catecholaminergic denervation, and control subjects.""?","Yes, the statement does provide indirect support for the claim that isoproterenol treats orthostatic hypotension (OH). The study measures plasma concentrations of NE and DHPG in response to isoproterenol in patients with PD+NOH (Parkinson’s disease with neurogenic orthostatic hypotension) as well as in patients with pure autonomic failure (PAF) and control subjects. The fact that isoproterenol is being tested in patients with PD+NOH suggests that it may have some therapeutic potential for treating OH in these patients.

         However, it is important to note that measuring neuronal metabolite concentrations in skeletal muscle microdialysate and plasma in response to isoproterenol does not provide direct evidence that isoproterenol treats OH. To establish such causality would require additional evidence from clinical trials demonstrating that isoproterenol administration improves OH symptoms in patients. Nonetheless, the fact that isoproterenol is being investigated in patients with PD"
11481186,Isoproterenol treats atrial fibrillation,1494,"RESULTS: LAP series analysis shows a reduction of both LP and R index during isoproterenol infusion in SR and AF (RSR = 0.75 +/- 0.07 RSRISO = 0.69 +/- 0.10, p < 0.0001; RAF = 0.31 +/- 0.08 RAFISO = 0.26 +/- 0.09, p < 0.0001; LPSR = 99.99 +/- 0.001 LPSRISO = 99.97 +/- 0.03, p < 0.0001; LPAF = 69.46 +/- 21.55 LPAFISO = 55 +/- 24.75; p < 0.0001).",True,"'Does the phrase ""Isoproterenol treats atrial fibrillation"" receive at least indirect support from the statement: ""RESULTS: LAP series analysis shows a reduction of both LP and R index during isoproterenol infusion in SR and AF (RSR = 0.75 +/- 0.07 RSRISO = 0.69 +/- 0.10, p < 0.0001; RAF = 0.31 +/- 0.08 RAFISO = 0.26 +/- 0.09, p < 0.0001; LPSR = 99.99 +/- 0.001 LPSRISO = 99.97 +/- 0.03, p < 0.0001; LPAF = 69.46 +/- 21.55 LPAFISO = 55 +/- 24.75; p < 0.0001).""?","Yes, the statement does provide indirect support for the claim that isoproterenol treats atrial fibrillation (AF). The results show that during isoproterenol infusion in both sinus rhythm (SR) and AF, there is a significant reduction in both LP and R index (p < 0.0001). Furthermore, there is also a reduction in LPSR (p < 0.0001) and LPAF (p < 0.0001) during isoproterenol infusion.

         Isoproterenol is a non-selective beta-adrenergic receptor agon"
9565866,Isoproterenol treats obesity disorder,1495,Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP.,False,"'Does the phrase ""Isoproterenol treats obesity disorder"" receive at least indirect support from the statement: ""Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP.""?","No, the statement does not provide indirect support for the phrase ""Isoproterenol treats obesity disorder"". In fact, it suggests the opposite. The statement indicates that obese individuals have decreased responsiveness to isoproterenol due to defects downstream of adenylyl cyclase activation of cyclic AMP. This implies that isoproterenol may not be an effective treatment for obesity disorder as it does not properly stimulate the necessary downstream signaling pathways in obese individuals.

        Justification for my answer is based on understanding how G protein-coupled receptor (GPCR) signaling works in cells. Isoproterenol is an agonist of β-adrenergic receptors (β-ARs), which are GPCRs that activate adenylyl cyclase upon binding, leading to increased levels of intracellular cyclic AMP (cAMP). The statement suggests that obese individuals have impaired signaling downstream of cAMP accumulation due to defects in their system. Therefore, even if isoproterenol successfully binds β-ARs in obese individuals (which"
8710440,Isoproterenol treats postural orthostatic tachycardia syndrome,1496,the responses of heart rate and the plasma cyclic AMP (cAMP) level to isoproterenol infusion in the supine position were evaluated in 10 POTS patients and 10 age-matched controls.,True,"'Does the phrase ""Isoproterenol treats postural orthostatic tachycardia syndrome"" receive at least indirect support from the statement: ""the responses of heart rate and the plasma cyclic AMP (cAMP) level to isoproterenol infusion in the supine position were evaluated in 10 POTS patients and 10 age-matched controls.""?","Yes, the statement does provide indirect support for the phrase ""Isoproterenol treats postural orthostatic tachycardia syndrome (POTS)"". The study mentioned in the statement evaluated the responses of heart rate and plasma cyclic AMP (cAMP) level to isoproterenol infusion in both POTS patients and age-matched controls while in the supine position. This suggests that isoproterenol was administered to these POTS patients as part of the experimental procedure.

        However, it is important to note that while administering isoproterenol may have influenced heart rate and cAMP levels in these patients during the study, it does not necessarily imply that isoproterenol is an effective long-term treatment for POTS. Treatment efficacy would require further investigation in clinical trials designed specifically for determining treatment outcomes over time.

        In summary, while there is some indirect support for isoproterenol potentially having an effect on POTS symptoms based on this statement alone, more rigorous studies would be needed before definitively stating that isoproterenol treats POTS."
10687311,Metaproterenol treats obstructive lung disease,1497,ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS.,True,"'Does the phrase ""Metaproterenol treats obstructive lung disease"" receive at least indirect support from the statement: ""ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS.""?","Yes, there is indirect support for the statement ""Metaproterenol treats obstructive lung disease"" from the provided statement ""ORCIPRENALINE IN TREATMENT OF AIRWAYS OBSTRUCTION IN CHRONIC BRONCHITIS."" The reason behind this is that Orciprenaline (also known as Metaproterenol) is a medication used primarily for treating obstructive lung diseases such as asthma, bronchitis, and emphysema by relaxing muscles in the airways and increasing airflow to the lungs (DrugBank, n.d.).

         However, it is essential to acknowledge some nuances in interpreting these statements. Firstly, Orciprenaline is not only used for chronic bronchitis but also other obstructive lung diseases; thus, its application is broader than just chronic bronchitis. Secondly, while both statements suggest that Metaproterenol is used for treating obstructive lung disease (or airways obstruction in chronic bronchitis), they do not provide direct evidence of its efficacy in treating these conditions. Therefore, further investigation into clinical trials and empirical evidence would be necessary for"
21781034,Bacitracin A treats Infection,1498,"Based on these observations, the combination of CBD and BAC is suggested to be a putative novel treatment in clinical settings for treatment of infections with antibiotic resistant Gram-positive bacteria.",True,"'Does the phrase ""Bacitracin A treats Infection"" receive at least indirect support from the statement: ""Based on these observations, the combination of CBD and BAC is suggested to be a putative novel treatment in clinical settings for treatment of infections with antibiotic resistant Gram-positive bacteria.""?","Yes, indirectly it does lend some support. The statement suggests that BAC (Bacitracin A) could potentially be an effective treatment in conjunction with CBD for infections caused by antibiotic-resistant Gram-positive bacteria. This implies that Bacitracin A has antibacterial properties that could contribute to treating infections. However, the claim does not explicitly state that Bacitracin A treats infections on its own, so the support is indirect.

        
        It is important to note that while Bacitracin A has been used historically as an antibiotic for topical infections, its systemic use is limited due to side effects such as nephrotoxicity (kidney damage) when administered intravenously (IV). Therefore, while there is some support for Bacitracin A having antibacterial properties that could aid in treating infections, its application should be considered in light of potential side effects and limitations.

        
        Additionally, further studies would need to be conducted in order to establish Bacitracin A as an effective treatment for infections caused by antibiotic-resistant Gram-positive"
17678351,Bacitracin A treats bacterial infectious disease,1499,"Thus, the bacitracin and gramicidin S-based self-assembled nanopeptide ribbon may be a successful ointment formulation for bacterial infection control.",True,"'Does the phrase ""Bacitracin A treats bacterial infectious disease"" receive at least indirect support from the statement: ""Thus, the bacitracin and gramicidin S-based self-assembled nanopeptide ribbon may be a successful ointment formulation for bacterial infection control.""?","Yes, there is indirect support for the claim that ""Bacitracin A treats bacterial infectious disease"" from the statement ""Thus, the bacitracin and gramicidin S-based self-assembled nanopeptide ribbon may be a successful ointment formulation for bacterial infection control.""

        The reason for my affirmative response is that bacitracin is explicitly mentioned in the statement as an integral component of a potential treatment for bacterial infections. Bacitracin A is one of several forms of bacitracin, all of which have antibacterial properties. Therefore, if a formulation containing bacitracin can control bacterial infections effectively, it stands to reason that bacitracin itself contributes to treating bacterial infections.

        However, it is essential to acknowledge that this support is indirect because we cannot infer that Bacitracin A alone can treat bacterial infections from the given statement. The statement refers to a combination of bacitracin and gramicidin S in nanopeptide ribbon formulation for bacterial infection control. Thus, further investigation would be necessary to isol"
11891842,Bacitracin A treats burn,1500,"Consensus was found regarding most local (topical) wound care, (SSD for clean non-facial burns, Sulfamylon (mafenide-acetate) for contaminated non-facial burns, Threolone (chloramphenicol 3% and prednisolone 0.5%) or Bacitracin for facial burns, Paraffin gauzes with or without Sulfamylon for donor and graft sites).",True,"'Does the phrase ""Bacitracin A treats burn"" receive at least indirect support from the statement: ""Consensus was found regarding most local (topical) wound care, (SSD for clean non-facial burns, Sulfamylon (mafenide-acetate) for contaminated non-facial burns, Threolone (chloramphenicol 3% and prednisolone 0.5%) or Bacitracin for facial burns, Paraffin gauzes with or without Sulfamylon for donor and graft sites).""?","Yes, the statement does provide indirect support for the claim that ""Bacitracin A treats burns."" The statement lists Bacitracin as one of the recommended treatments for facial burns, which suggests that it has some efficacy in treating burns. However, it's important to note that the statement does not provide direct evidence of Bacitracin's effectiveness in treating burns, as it only mentions its use in specific cases (facial burns). Furthermore, while Bacitracin may be an appropriate treatment in certain circumstances, it's not necessarily the best or only treatment for burns. Therefore, while the statement does lend some support to the claim, it doesn't definitively prove it."
26452786,Fenbendazole causes helminthiasis,101,The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.,False,"'Does the phrase ""Fenbendazole causes helminthiasis"" receive at least indirect support from the statement: ""The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.""?","No, the statement ""The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease"" does not provide any direct or indirect support for the phrase ""Fenbendazole causes helminthiasis."" These two statements discuss entirely different subjects - one is about the anti-ischemic mechanism of ranolazine in treating stable ischemic heart disease while the other is about Fenbendazole potentially causing helminthiasis (a parasitic infection caused by helminths). To establish support for a claim, there needs to be some logical connection between the evidence presented and the claim being made; in this case, no such connection exists."
22762728,Fenbendazole prevents helminthiasis,102,Atrial-selective/predominant sodium channel blockers such as ranolazine effectively suppress AF in experimental models of AF involving canine isolated right atrial preparations at concentrations that produce little to no effect on ventricular electrophysiologic parameters.,False,"'Does the phrase ""Fenbendazole prevents helminthiasis"" receive at least indirect support from the statement: ""Atrial-selective/predominant sodium channel blockers such as ranolazine effectively suppress AF in experimental models of AF involving canine isolated right atrial preparations at concentrations that produce little to no effect on ventricular electrophysiologic parameters.""?","No, the statement does not provide indirect support for the phrase ""Fenbendazole prevents helminthiasis."" The statement discusses the effects of atrial-selective/predominant sodium channel blockers, specifically ranolazine, on atrial fibrillation (AF) in canine models without making any connection to fenbendazole or helminthiasis. Helminthiasis is a condition caused by parasitic worms, which is unrelated to the electrophysiological effects discussed in the statement about AF in canine models. Therefore, there is no reasonable basis for inferring that fenbendazole prevents helminthiasis based on this statement alone."
21848143,Albendazole causes helminthiasis,103,Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption.,False,"'Does the phrase ""Albendazole causes helminthiasis"" receive at least indirect support from the statement: ""Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption.""?","No, the statement ""Ranolazine has been shown to decrease angina pectoris frequency and nitroglycerin consumption"" does not provide any indirect support for the claim ""Albendazole causes helminthiasis."" 

         The two statements discuss different drugs (Albendazole and Ranolazine) and their effects on completely unrelated conditions (helminthiasis and angina pectoris frequency/nitroglycerin consumption). Helminthiasis is a condition caused by parasitic worms (helminths), while ranolazine is used for treating chronic angina (chest pain). Albendazole is actually an anthelmintic drug used for treating various parasitic worm infestations (helminthiasis).

         Thus, there is no connection between these two statements that would allow for one to indirectly support the other. The effect of ranolazine on angina pectoris frequency is unrelated to any potential effects of albendazole on helminthiasis."
25735916,Albendazole affects trichuriasis,104,BACKGROUND: Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina.,False,"'Does the phrase ""Albendazole affects trichuriasis"" receive at least indirect support from the statement: ""BACKGROUND: Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina.""?","No, the statement does not provide indirect support for the phrase ""Albendazole affects trichuriasis."" The background statement refers specifically to Ranolazine, its effects on myocardial ischemia, and its impact on symptom severity in certain patients with chronic angina. It does not mention Albendazole or trichuriasis at all. Therefore, there is no connection or supporting evidence that can be inferred from one statement to the other."
24685635,Albendazole affects filarial elephantiasis,105,"Dominant frequency (DF) of AF was reduced by ranolazine in left atrium from 11.7 (10.7-20.5) Hz to 7.6 (2.9-8.8) Hz (P = 0.02, n = 6).",False,"'Does the phrase ""Albendazole affects filarial elephantiasis"" receive at least indirect support from the statement: ""Dominant frequency (DF) of AF was reduced by ranolazine in left atrium from 11.7 (10.7-20.5) Hz to 7.6 (2.9-8.8) Hz (P = 0.02, n = 6).""?","No, the statement does not provide indirect support for the phrase ""Albendazole affects filarial elephantiasis."" The statement discusses the effect of ranolazine on altering dominant frequency (DF) of atrial fibrillation (AF) in left atrium; it is unrelated to albendazole or filarial elephantiasis.

        Filarial elephantiasis is caused by parasitic filarial worms like Wuchereria bancrofti and Brugia timori; albendazole is an anthelmintic drug used in treating these infections (World Health Organization). The statement in question, however, does not mention albendazole nor filarial elephantiasis; it only refers to ranolazine affecting AF frequency in left atrium in six patients (P < 0.05).

        Therefore, without any connection between ranolazine/AF frequency reduction in left atrium and albendazole/filarial elephantiasis treatment, there is no indirect support for the statement in question based on the provided evidence."
18452252,Albendazole affects toxocariasis,106,"After adjusting for potential sources of bias through propensity-score matched-pair analysis and conditional logistic regression, ranolazine was an independent predictor of preventing POAF (p < 0.0001).",False,"'Does the phrase ""Albendazole affects toxocariasis"" receive at least indirect support from the statement: ""After adjusting for potential sources of bias through propensity-score matched-pair analysis and conditional logistic regression, ranolazine was an independent predictor of preventing POAF (p < 0.0001).""?","No, the statement does not provide any direct or indirect support for the phrase ""Albendazole affects toxocariasis."" The statement discusses the relationship between ranolazine and preventing postoperative atrial fibrillation (POAF), not albendazole and its effects on toxocariasis. Toxocariasis is an infection caused by roundworm parasites that can affect humans; it is unrelated to ranolazine or POAF. Therefore, there is no connection between the two pieces of information provided in the statement and the claim about albendazole affecting toxocariasis."
16658505,Albendazole affects malaria,107,Prednisolone furthers T-cell immunodeficiency and also reduces the intensity of autoimmune reactions in multiple sclerosis.,False,"'Does the phrase ""Albendazole affects malaria"" receive at least indirect support from the statement: ""Prednisolone furthers T-cell immunodeficiency and also reduces the intensity of autoimmune reactions in multiple sclerosis.""?","No, the statement does not provide indirect support for the phrase ""Albendazole affects malaria."" 

        The statement discusses the effects of Prednisolone on T-cell immunodeficiency and autoimmune reactions in multiple sclerosis. It does not mention Albendazole or malaria. Albendazole is an anthelmintic drug used to treat parasitic worm infestations, while malaria is caused by Plasmodium parasites. There is no connection implied or stated between Prednisolone, T-cell immunodeficiency, autoimmune reactions, and malaria in this statement. Therefore, it does not provide any indirect support for the claim that Albendazole affects malaria."
13946207,Albendazole affects helminthiasis,108,[Pharmacokinetics of prednisolone in adrenal insufficiency ].,False,"'Does the phrase ""Albendazole affects helminthiasis"" receive at least indirect support from the statement: ""[Pharmacokinetics of prednisolone in adrenal insufficiency ].""?","No, the statement ""Pharmacokinetics of prednisolone in adrenal insufficiency"" does not provide any direct or indirect support for the phrase ""Albendazole affects helminthiasis."" This is because they discuss different topics entirely; one focuses on pharmacokinetics of prednisolone in adrenal insufficiency, while the other refers to albendazole's effect on helminthiasis.

        To provide further context on these terms for clarity:

        - Pharmacokinetics refers to what the body does to a drug after it is administered; it includes absorption, distribution, metabolism, and excretion of that drug. Prednisolone is a synthetic glucocorticoid used in various conditions such as adrenal insufficiency.

        - Helminthiasis is an infection by parasitic worms (helminths), such as roundworms (nematodes), tapeworms (cestodes), and flukes (trematodes). Albendazole is an anthelmintic drug used in treating such infections as it inhibits"
11239060,Albendazole affects filariasis,109,It is concluded that VAP is effective therapy in AIL.,False,"'Does the phrase ""Albendazole affects filariasis"" receive at least indirect support from the statement: ""It is concluded that VAP is effective therapy in AIL.""?","No, the statement ""It is concluded that VAP is effective therapy in AIL"" does not provide direct or indirect support for the phrase ""Albendazole affects filariasis."" 

        The conclusion that VAP (presumably referring to some form of treatment) is effective therapy in AIL (Assistant Investigator Led trials) does not make any reference to Albendazole, filariasis, or their relationship. Filariasis is a parasitic disease caused by roundworms of the Filarioidea type, whereas Albendazole is an anthelmintic medication used to treat various parasitic worm infestations. 

        The lack of connection between the two statements means that one cannot be inferred from the other without additional information linking Albendazole, filariasis, and VAP/AIL."
24729219,Albendazole disrupts helminthiasis,110,A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis.,False,"'Does the phrase ""Albendazole disrupts helminthiasis"" receive at least indirect support from the statement: ""A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis.""?","No, the statement ""A thermographic assessment of three intra-articular prednisolone analogues given in rheumatoid synovitis"" does not provide indirect support for the phrase ""Albendazole disrupts helminthiasis.""

        The statement is about a thermographic assessment of three intra-articular prednisolone analogues used in rheumatoid synovitis, which is unrelated to albendazole or helminthiasis. Helminthiasis refers to diseases caused by parasitic worms, while albendazole is an antiparasitic drug used primarily for treating these types of infections.

        The lack of connection between these two concepts makes it impossible for one statement to indirectly support the other. It is essential to evaluate each claim based on its specific context and evidence rather than drawing unsupported conclusions from unrelated studies or statements."
16658503,Albendazole disrupts malaria,111,The effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice.,False,"'Does the phrase ""Albendazole disrupts malaria"" receive at least indirect support from the statement: ""The effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice.""?","No, the statement does not provide any direct or indirect support for the phrase ""Albendazole disrupts malaria."" 

        The statement discusses the effect of small doses of prednisolone on the incidence of subcutaneous sarcomas induced by 3-methylcholanthrene in virgin female Swiss mice. This study focuses on cancer incidence in mice treated with prednisolone and 3-methylcholanthrene, which is far removed from the topic of malaria disruption by Albendazole. 

        To establish indirect support, there should be some common ground between the two pieces of information that allows one to inform the other. However, in this case, there is no overlap in terms of subject matter (malaria vs. sarcomas in mice), substances involved (Albendazole vs. prednisolone and 3-methylcholanthrene), or study outcomes (disruption of malaria vs. cancer incidence). Therefore, it is not possible to infer any meaningful relationship between these two statements that would lend credence to the claim ""Albendazole disrupts mal"
13637338,Albendazole disrupts Hookworm Infections,112,[Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits].,False,"'Does the phrase ""Albendazole disrupts Hookworm Infections"" receive at least indirect support from the statement: ""[Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits].""?","No, the statement ""Effects of chromocarb diethylamine and prednisolone in experimental uveitis induced by clove oil in rabbits"" does not provide indirect support for the phrase ""Albendazole disrupts Hookworm Infections.""

        The statement in question is an experimental study on uveitis (inflammation of the uvea) in rabbits induced by clove oil, investigating the effects of two different drugs - chromocarb diethylamine and prednisolone. This study does not involve Albendazole nor does it investigate hookworm infections in any capacity. Therefore, it does not provide any relevant information or indirect support for the claim that Albendazole disrupts hookworm infections.

        It is essential to evaluate scientific literature in context, considering both the specific subject matter of the study as well as its methodology. Only then can one draw valid conclusions or identify potential connections between different pieces of research."
15248433,Albendazole prevents filariasis,113,[Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].,False,"'Does the phrase ""Albendazole prevents filariasis"" receive at least indirect support from the statement: ""[Effect of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus].""?","No, the statement does not provide any direct or indirect support for the claim that ""Albendazole prevents filariasis."" The statement focuses on the effects of prednisolone and heparin on circulating T- and B-lymphocytes in glomerulonephritis and systemic lupus erythematosus. It does not mention Albendazole or filariasis at all. Therefore, it does not contribute any evidence for or against the claim in question.

        To further elaborate, filariasis is a parasitic disease caused by microscopic, thread-like worms. Albendazole is an anthelmintic drug often used in the treatment of filariasis because it kills the parasitic worms in the lymphatic system and reduces the number of microfilariae (immature worms) in the blood. However, preventing filariasis would typically involve preventative measures such as mass drug administration programs in endemic areas or personal protective measures against mosquito bites, as filariasis is transmitted by mosquitoes. The statement provided does not discuss any of these topics."
13732336,Albendazole prevents helminthiasis,114,[Effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis].,False,"'Does the phrase ""Albendazole prevents helminthiasis"" receive at least indirect support from the statement: ""[Effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis].""?","No, the statement does not provide any direct or indirect support for the claim that Albendazole prevents helminthiasis. The statement in question discusses the effects of prednisolone on thyroidal-123I uptake in subacute thyroiditis, which is unrelated to the pharmacological effects of Albendazole on helminthiasis (parasitic worm infections)."
15316470,Ibuprofen subclass of 2-Hydroxyibuprofen,115,"Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma.",False,"'Does the phrase ""Ibuprofen subclass of 2-Hydroxyibuprofen"" receive at least indirect support from the statement: ""Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma.""?","No, the statement ""Blood Eosinophil Depletion with Mepolizumab, Benralizumab and Prednisolone in Eosinophilic Asthma"" does not provide indirect support for the phrase ""Ibuprofen subclass of 2-Hydroxyibuprofen"". The statement discusses the use of certain medications (Mepolizumab, Benralizumab, and Prednisolone) in depleting blood eosinophils in individuals with eosinophilic asthma. Ibuprofen and 2-Hydroxyibuprofen are both nonsteroidal anti-inflammatory drugs (NSAIDs), but there is no mention of either in the provided statement, nor is there any connection made between these drugs and eosinophil depletion in asthma patients. The two concepts remain unrelated in this context."
16265626,Ibuprofen related to Arthralgia,116,[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].,False,"'Does the phrase ""Ibuprofen related to Arthralgia"" receive at least indirect support from the statement: ""[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies].""?","No, the phrase ""Ibuprofen related to Arthralgia"" does not receive indirect support from the statement ""[Prednisolone and aspirin combination therapy in habitual abortion with autoantibodies]."" 

         The statement discusses a combination therapy of prednisolone and aspirin for habitual abortion in patients with autoantibodies. It does not mention ibuprofen at all, let alone its relation to arthralgia (joint pain). Therefore, there is no indirect support for the claim that ibuprofen is related to arthralgia in this statement. 

         Arthralgia can be a side effect of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, but this statement does not provide evidence for that relationship in this context. It is important to base our understanding on direct evidence rather than assuming indirect associations without explicit mention in the text."
14582794,Ibuprofen related to Pain,117,"To illustrate this, we used an example of cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer.",False,"'Does the phrase ""Ibuprofen related to Pain"" receive at least indirect support from the statement: ""To illustrate this, we used an example of cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer.""?","No, the phrase ""Ibuprofen related to Pain"" does not receive indirect support from the statement provided. The statement discusses a cost-effectiveness analysis for docetaxel in combination with prednisolone in metastatic hormone-refractory prostate cancer. This topic is unrelated to ibuprofen, which is a non-prescription nonsteroidal anti-inflammatory drug (NSAID) commonly used for relieving pain, fever, and inflammation. The lack of connection between the two statements makes it impossible for the first statement to receive indirect support from the second statement."
11440746,Ibuprofen related to Toothache,118,Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency.,False,"'Does the phrase ""Ibuprofen related to Toothache"" receive at least indirect support from the statement: ""Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency.""?","No, the statement ""Prednisolone is associated with worse bone mineral density in primary adrenal insufficiency"" does not provide indirect support for the phrase ""Ibuprofen related to toothache."" The two statements discuss different medications (Ibuprofen vs Prednisolone) and different health conditions (toothache vs primary adrenal insufficiency and bone mineral density). Therefore, there is no logical connection between them that would allow for indirect support."
9106384,Ibuprofen related to osteoarthritis,119,CONCLUSIONS: Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA.,False,"'Does the phrase ""Ibuprofen related to osteoarthritis"" receive at least indirect support from the statement: ""CONCLUSIONS: Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA.""?","No, there is no indirect support for the phrase ""Ibuprofen related to osteoarthritis"" from the statement ""CONCLUSIONS: Prednisolone was more effective in inducing response than itraconazole in acute-stage ABPA.""

         The conclusion is about a study comparing the effectiveness of prednisolone versus itraconazole in treating acute-stage allergic bronchopulmonary aspergillosis (ABPA). It does not mention ibuprofen or osteoarthritis at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief, while osteoarthritis is a degenerative joint disease. Therefore, there is no connection between the two statements."
8106985,Ibuprofen related to burn,120,"Purpose: The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL).",False,"'Does the phrase ""Ibuprofen related to burn"" receive at least indirect support from the statement: ""Purpose: The aim of this study was to compare asparaginase-related toxicities in two asparaginase preparations, namely native Escherichia coli L-asparaginase (L-ASP) and pegylated asparaginase (PEG-ASP) in combination with ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) in natural killer (NK)/T-cell lymphoma (NTCL).""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen related to burn"". The purpose of the study mentioned in the statement is focused on comparing asparaginase-related toxicities in two asparaginase preparations when used in combination with specific chemotherapy agents for treating natural killer (NK)/T-cell lymphoma (NTCL). Ibuprofen is not mentioned in the statement, nor is there any connection made between ibuprofen use and burns. Therefore, there is no implied or indirect relationship between ibuprofen use and burns in this context."
13726345,Ibuprofen causes patent ductus arteriosus,121,Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.,False,"'Does the phrase ""Ibuprofen causes patent ductus arteriosus"" receive at least indirect support from the statement: ""Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen causes patent ductus arteriosus."" The meta-analysis focuses on comparing the efficacy and safety of prednisolone combined with adjunctive immunosuppression versus prednisolone alone in treating giant cell arteritis. Ibuprofen is not mentioned in the statement, nor is there any reference made to patent ductus arteriosus (PDA), which is a congenital heart defect unrelated to giant cell arteritis or treatments for it.

        Patent ductus arteriosus is caused by incomplete closure of the ductus arteriosus after birth, which is influenced by various genetic and environmental factors; it is not known to be linked to ibuprofen use in any direct way. While ibuprofen is part of a class of nonsteroidal anti-inflammatory drugs (NSAIDs) that can affect platelet function and potentially contribute to cardiovascular issues in some contexts, there is no evidence supporting its direct causation of PDA in newborns or any population.

        In summary, as there is no"
13653982,Ibuprofen causes Alzheimer disease,122,CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL.,False,"'Does the phrase ""Ibuprofen causes Alzheimer disease"" receive at least indirect support from the statement: ""CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL.""?","No, the phrase ""Ibuprofen causes Alzheimer disease"" does not receive any direct or indirect support from the statement ""CONCLUSION: GVP is well-tolerated regimen with high response rate and needs to be tested in late relapsed HL.""

         The statement in question is related to a treatment regimen called GVP (Gemcitabine + Vinorelbine + Prednisone) in patients with late relapsed Hodgkin Lymphoma (HL). There is no mention of Ibuprofen nor any reference made to Alzheimer disease in the statement provided. Thus, it does not lend any support - direct or indirect - to the claim that Ibuprofen causes Alzheimer disease.

         To further clarify, Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for its analgesic (pain-relieving) and antipyretic (fever-reducing) effects. Alzheimer disease is a neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. While there have been some studies suggesting that chronic"
13133316,Ibuprofen causes peptic ulcer disease,123,Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis.,False,"'Does the phrase ""Ibuprofen causes peptic ulcer disease"" receive at least indirect support from the statement: ""Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis.""?","No, the statement ""Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis"" does not provide indirect support for the claim that ""Ibuprofen causes peptic ulcer disease.""

        The two statements discuss different subjects and therapeutic interventions. The first statement refers to a treatment regimen for psoriatic arthritis involving methotrexate and low-dose prednisolone, while the second statement refers to ibuprofen causing peptic ulcer disease.

        While ibuprofen is an NSAID (nonsteroidal anti-inflammatory drug) that can increase the risk of developing peptic ulcers as a side effect, especially when taken in high doses or over an extended period of time (Nikfar et al., 2002), it does not imply that ibuprofen is the sole cause of peptic ulcer disease.

        The misconception may arise because ibuprofen is one of many factors that can contribute to peptic ulcer disease; however, it is not accurate to"
12641386,Ibuprofen causes Fever,124,"CONCLUSION: Flu/Cy/ATG conditioning regimen, bone marrow as stem cell source and CSA, prednisolone and short methotrexate regimen were associated with better survival in AA.",False,"'Does the phrase ""Ibuprofen causes Fever"" receive at least indirect support from the statement: ""CONCLUSION: Flu/Cy/ATG conditioning regimen, bone marrow as stem cell source and CSA, prednisolone and short methotrexate regimen were associated with better survival in AA.""?","No, the statement ""Ibuprofen causes Fever"" does not receive at least indirect support from the conclusion provided in the study about hematopoietic stem cell transplantation in acute myeloid leukemia (AML) patients. The conclusion mentions various factors associated with better survival in acute myeloid leukemia patients but does not make any reference to ibuprofen nor fever, making it irrelevant in supporting or contradicting the claim that ibuprofen causes fever.

         Ibuprofen is actually an antipyretic agent used for reducing fever; therefore, it is not likely that it would cause fever as suggested in your question. If there is any evidence linking ibuprofen use to fever, it would require separate investigation and cannot be inferred from the given study conclusion related to hematopoietic stem cell transplantation in AML patients."
12482174,Ibuprofen causes pancreatitis,125,Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial.,False,"'Does the phrase ""Ibuprofen causes pancreatitis"" receive at least indirect support from the statement: ""Effect of addition of short course of prednisolone to gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease: a pilot randomized controlled trial.""?","No, the statement does not provide any indirect support for the phrase ""Ibuprofen causes pancreatitis."" The study mentioned is focused on the effects of adding a short course of prednisolone to a gluten-free diet on mucosal epithelial cell regeneration and apoptosis in celiac disease. It does not involve Ibuprofen or discuss its potential side effects or relationship to pancreatitis. Therefore, it does not contribute any evidence, direct or indirect, to the claim about Ibuprofen causing pancreatitis."
12438812,Ibuprofen causes Toothache,126,Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.,False,"'Does the phrase ""Ibuprofen causes Toothache"" receive at least indirect support from the statement: ""Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.""?","No, the phrase ""Ibuprofen causes Toothache"" does not receive any direct or indirect support from the statement ""Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.""

         The reason for this is that neither ibuprofen nor toothache is mentioned in the provided statement. Furthermore, there is no mechanistic link or plausible biological reasoning that could connect coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis to ibuprofen causing toothache."
12079834,Ibuprofen causes adult acute respiratory distress syndrome,127,"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.",False,"'Does the phrase ""Ibuprofen causes adult acute respiratory distress syndrome"" receive at least indirect support from the statement: ""Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.""?","No, the statement does not provide any indirect support for the phrase ""Ibuprofen causes adult acute respiratory distress syndrome."" The RAISE study is focused on evaluating the efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease. Ibuprofen is not mentioned in the study, nor is there any discussion of acute respiratory distress syndrome (ARDS) in adults or its potential causes. Therefore, there is no connection that can be drawn between these two statements based on the provided evidence."
11157616,Ibuprofen causes Pain,128,"Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.",False,"'Does the phrase ""Ibuprofen causes Pain"" receive at least indirect support from the statement: ""Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma.""?","No, the statement ""Response of vincristine, melphalan, cyclophosphamide and prednisolone in refractory multiple myeloma"" does not provide indirect support for the phrase ""Ibuprofen causes Pain."" 

        The statement in question is about the response of certain drugs (vincristine, melphalan, cyclophosphamide, and prednisolone) in treating refractory multiple myeloma, a type of cancer. Ibuprofen is not mentioned in this statement, nor is there any connection made between these drugs and pain cause or relief. Ibuprofen is an analgesic and anti-inflammatory drug commonly used for relieving pain, fever, and inflammation, which is unrelated to the context of the provided statement."
10429873,Ibuprofen causes Hemorrhage,129,Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.,False,"'Does the phrase ""Ibuprofen causes Hemorrhage"" receive at least indirect support from the statement: ""Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia.""?","No, the phrase ""Ibuprofen causes Hemorrhage"" does not receive any direct or indirect support from the statement ""Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia."" 

        The statement in question discusses two specific biological concepts related to acute lymphoblastic leukemia - pyruvate kinase M2 (PKM2) and prednisolone resistance. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief and reducing inflammation, while hemorrhage refers to excessive bleeding. There is no mention of ibuprofen or its potential side effects in the provided statement; hence it does not offer any support for the claim that ibuprofen causes hemorrhage."
9800201,Ibuprofen causes arthritic joint disease,130,"Stimulation with prednisolone and TNFalpha reduced GDF-5 expression in OA and RA fibroblasts, whereas MTX and IL-1beta revealed minor or no relevant change.",False,"'Does the phrase ""Ibuprofen causes arthritic joint disease"" receive at least indirect support from the statement: ""Stimulation with prednisolone and TNFalpha reduced GDF-5 expression in OA and RA fibroblasts, whereas MTX and IL-1beta revealed minor or no relevant change.""?","No, the statement does not provide any indirect support for the phrase ""Ibuprofen causes arthritic joint disease."" The statement discusses the effects of various substances (prednisolone, TNFalpha, MTX, IL-1beta) on GDF-5 expression in osteoarthritis (OA) and rheumatoid arthritis (RA) fibroblasts, but it does not mention ibuprofen at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation, but it is not mentioned in the provided statement. Therefore, it is not possible to draw any conclusions about ibuprofen's effects on arthritic joint disease based on this statement alone."
8163776,Ibuprofen causes injury,131,"A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.",False,"'Does the phrase ""Ibuprofen causes injury"" receive at least indirect support from the statement: ""A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.""?","No, the statement does not provide indirect support for ""Ibuprofen causes injury."" The statement discusses the efficacy of a specific chemotherapy regimen (R-CHOP) in treating certain types of lymphoma (diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)). Ibuprofen is an over-the-counter nonsteroidal anti-inflammatory drug (NSAID) used for pain relief, fever reduction, and inflammation. There is no connection between these two statements in terms of causality or implications for injury."
26701175,Ibuprofen affects rheumatoid arthritis,132,"A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.",False,"'Does the phrase ""Ibuprofen affects rheumatoid arthritis"" receive at least indirect support from the statement: ""A combination of rituximab plus chemotherapy, rituximab+cyclophosphamide+doxorubicin+vincristine+prednisolone (R-CHOP), has the highest efficacy ever described with any chemotherapy in DLBCL and FL.""?","No, there is no direct or indirect support for the phrase ""Ibuprofen affects rheumatoid arthritis"" in the given statement about R-CHOP therapy for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). The statement discusses the efficacy of R-CHOP therapy for specific types of lymphoma but does not mention ibuprofen or rheumatoid arthritis at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and fever reduction, while rheumatoid arthritis is an autoimmune disorder that causes inflammation in joints; they do not have any direct relationship with R-CHOP therapy for lymphoma treatment."
24384432,Ibuprofen affects migraine disorder,133,Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.,False,"'Does the phrase ""Ibuprofen affects migraine disorder"" receive at least indirect support from the statement: ""Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study.""?","No, the statement ""Weekly docetaxel and prednisolone versus prednisolone alone in androgen-independent prostate cancer: a randomized phase II study"" does not provide indirect support for the phrase ""Ibuprofen affects migraine disorder."" 

         The statement is a title of a study about treating prostate cancer with docetaxel and prednisolone, either alone or in combination. Ibuprofen is not mentioned in the title, nor does it have any clear connection to migraines or the treatment of prostate cancer. Therefore, there is no reasonable basis for inferring that this study provides any support for the claim about Ibuprofen's effect on migraines."
23500890,Ibuprofen affects adult acute respiratory distress syndrome,134,Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.,False,"'Does the phrase ""Ibuprofen affects adult acute respiratory distress syndrome"" receive at least indirect support from the statement: ""Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.""?","No, the statement ""Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study"" does not provide indirect support for the phrase ""Ibuprofen affects adult acute respiratory distress syndrome."" The study in question focuses on the effects of prednisolone and azathioprine on membranous nephropathy over a 10-year period. Ibuprofen is not mentioned in the study, nor is there any discussion of acute respiratory distress syndrome (ARDS) or related conditions. Therefore, there is no connection that can be drawn between these two pieces of information.

        It is important to note that while these drugs (prednisolone and azathioprine) may have implications for inflammation and immune response, they are not equivalent to ibuprofen in terms of their mechanisms of action or their potential effects on various diseases. Similarly, membranous nephropathy is a kidney disease, unrelated to ARDS which is a severe lung condition. Therefore, even if ibuprofen were discussed in relation to ARDS in another study, it"
21214366,Ibuprofen affects bronchopulmonary dysplasia,135,"Taken together, the present study points to a strong inhibitory effect of liposomal PLP on tumor angiogenesis by reduction of the intratumoral production of the majority of pro-angiogenic factors studied and direct inhibition of endothelial cell proliferation, which is the result of high prolonged levels of prednisolone in the tumor by liposomal delivery.",False,"'Does the phrase ""Ibuprofen affects bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""Taken together, the present study points to a strong inhibitory effect of liposomal PLP on tumor angiogenesis by reduction of the intratumoral production of the majority of pro-angiogenic factors studied and direct inhibition of endothelial cell proliferation, which is the result of high prolonged levels of prednisolone in the tumor by liposomal delivery.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects bronchopulmonary dysplasia."" The statement discusses the inhibitory effect of liposomal PLP on tumor angiogenesis through prednisolone delivery, which is unrelated to ibuprofen or bronchopulmonary dysplasia. Bronchopulmonary dysplasia is a chronic lung disease in premature infants, while the statement focuses on tumor angiogenesis in adults. Ibuprofen is mentioned in some studies as potentially having beneficial effects on bronchopulmonary dysplasia; however, it is not linked to liposomal PLP or prednisolone in any direct or indirect way in the provided statement."
20886939,Ibuprofen affects Cognitive impairment,136,Prednisolone versus dexamethasone in croup: a randomised equivalence trial.,False,"'Does the phrase ""Ibuprofen affects Cognitive impairment"" receive at least indirect support from the statement: ""Prednisolone versus dexamethasone in croup: a randomised equivalence trial.""?","No, the statement ""Prednisolone versus dexamethasone in croup: a randomised equivalence trial"" does not provide indirect support for the phrase ""Ibuprofen affects cognitive impairment."" 

         The study mentioned is an equivalence trial comparing the efficacy of prednisolone and dexamethasone in treating croup, a viral infection in children that causes inflammation of the upper airways. Ibuprofen is not mentioned in the study at all; therefore, there is no basis for drawing any conclusions about its effect on cognitive impairment from this study.

         To provide indirect support for the claim about ibuprofen and cognitive impairment, one would need evidence from studies that either investigate ibuprofen use in relation to cognitive impairment specifically or explore non-steroidal anti-inflammatory drugs (NSAIDs), of which ibuprofen is one, in relation to cognitive impairment. As of now, there is no evidence in this study that can help support such a claim about ibuprofen."
18977843,Ibuprofen affects Headache,137,Use of ACTH and prednisolone in infantile spasms: experience from a developing country.,False,"'Does the phrase ""Ibuprofen affects Headache"" receive at least indirect support from the statement: ""Use of ACTH and prednisolone in infantile spasms: experience from a developing country.""?","No, the statement ""Use of ACTH and prednisolone in infantile spasms: experience from a developing country"" does not provide any direct or indirect support for the phrase ""Ibuprofen affects Headache."" 

        The reason is that the statement discusses the use of ACTH (Adrenocorticotropic hormone) and prednisolone in treating infantile spasms in a developing country setting. It does not mention, discuss, or provide any evidence about ibuprofen or its effects on headaches. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used as an analgesic (pain reliever) and antipyretic (fever reducer). The statement provided is focused on different substances used for treating specific medical conditions in infants, which is unrelated to ibuprofen's potential impact on headaches."
15746938,Ibuprofen affects injury,138,Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.,False,"'Does the phrase ""Ibuprofen affects injury"" receive at least indirect support from the statement: ""Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.""?","No, the statement ""Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease"" does not provide indirect support for the phrase ""Ibuprofen affects injury."" The statement is about the relationship between bone mineral density, efficacy, and side effects of two specific medications used in treating Crohn's disease, budesonide and prednisolone. Ibuprofen is not mentioned in the statement, nor is there any reference made to its potential effects on injury. Therefore, there is no basis for inferring any relationship between ibuprofen use and injury based on this statement alone."
13826486,Ibuprofen affects osteoarthritis,139,OBJECTIVE: To examine the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses and for remission maintenance in Churg-Strauss syndrome (CSS).,False,"'Does the phrase ""Ibuprofen affects osteoarthritis"" receive at least indirect support from the statement: ""OBJECTIVE: To examine the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses and for remission maintenance in Churg-Strauss syndrome (CSS).""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects osteoarthritis"". The objective of the study mentioned is focused on examining the safety and efficacy of methotrexate (MTX) plus low-dose prednisolone for induction of remission in non life- or organ-threatening courses of Churg-Strauss syndrome (CSS) and for remission maintenance in CSS. Ibuprofen is not mentioned in the statement nor is there any implicit connection that could be inferred."
13584223,Ibuprofen affects Cognitive impairment,140,OBJECTIVE: To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy.,False,"'Does the phrase ""Ibuprofen affects Cognitive impairment"" receive at least indirect support from the statement: ""OBJECTIVE: To determine whether addition of low dose prednisolone to multidrug treatment can prevent reaction and nerve function impairment in leprosy.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects Cognitive impairment."" 

        The objective of the study mentioned is to determine whether low dose prednisolone can prevent reaction and nerve function impairment in leprosy when added to multidrug treatment. This study does not involve ibuprofen or cognitive impairment; therefore, it does not provide any relevant information or support for the claim about ibuprofen's effect on cognitive impairment.

        To establish indirect support for ""Ibuprofen affects Cognitive impairment,"" one would need evidence from related studies that either demonstrate a connection between ibuprofen and cognitive impairment or involve ibuprofen in a way that implies potential effects on cognition. In this case, since neither condition is addressed in the study objective provided, we cannot infer any support for the claim about ibuprofen affecting cognitive impairment."
12659717,Ibuprofen affects Fever,141,A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.,False,"'Does the phrase ""Ibuprofen affects Fever"" receive at least indirect support from the statement: ""A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.""?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen affects Fever."" The study mentioned is focused on infliximab and prednisolone in acute alcoholic hepatitis, not on ibuprofen or fever."
11207850,Ibuprofen affects peptic ulcer disease,142,EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.,False,"'Does the phrase ""Ibuprofen affects peptic ulcer disease"" receive at least indirect support from the statement: ""EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects peptic ulcer disease."" The EULAR randomized controlled trial mentioned in the statement is focused on comparing two different treatment regimens for lupus nephritis, which is a type of kidney inflammation associated with systemic lupus erythematosus (SLE). Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation; however, it is not mentioned nor involved in any way in the trial described in the statement.

        Peptic ulcer disease is an inflammatory condition affecting the stomach lining and duodenum, which can be exacerbated by long-term NSAID use, including ibuprofen. However, since there is no mention of NSAIDs or ibuprofen in the statement provided, it does not offer any support for the connection between ibuprofen use and peptic ulcer disease."
11159990,Ibuprofen affects Hemorrhage,143,OBJECTIVE: To investigate the safety and efficacy of leflunomide plus low-dose prednisolone for the maintenance of remission in Wegener's granulomatosis (WG).,False,"'Does the phrase ""Ibuprofen affects Hemorrhage"" receive at least indirect support from the statement: ""OBJECTIVE: To investigate the safety and efficacy of leflunomide plus low-dose prednisolone for the maintenance of remission in Wegener's granulomatosis (WG).""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Hemorrhage"". The objective of the study is to investigate the safety and efficacy of leflunomide plus low-dose prednisolone for the maintenance of remission in Wegener’s granulomatosis (WG). This study does not involve Ibuprofen or hemorrhage, so it does not provide any relevant information to support the claim that Ibuprofen affects Hemorrhage."
10170540,Ibuprofen affects patent ductus arteriosus,144,"Treatment with combined therapy of adriamycin, vincristine and prednisolone produced a remission in the leukaemia with complete resolution of the breast mass.",False,"'Does the phrase ""Ibuprofen affects patent ductus arteriosus"" receive at least indirect support from the statement: ""Treatment with combined therapy of adriamycin, vincristine and prednisolone produced a remission in the leukaemia with complete resolution of the breast mass.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects patent ductus arteriosus."" The statement discusses the effects of a combined therapy of adriamycin, vincristine, and prednisolone on leukaemia and breast mass resolution. Ibuprofen is not mentioned in the statement; hence, there is no connection between the two statements that would allow for indirect support.

        To further elaborate on why there is no indirect support, let us consider some contextual aspects of both statements. Patent ductus arteriosus (PDA) is a congenital heart condition where a blood vessel called ductus arteriosus fails to close after birth as it should normally do. Ibuprofen is one of several medications used in treating PDA due to its ability to promote vasoconstriction in the ductus arteriosus.

        On the other hand, adriamycin (doxorubicin), vincristine, and prednisolone are chemotherapeutic agents commonly used in treating various types of cancer, including leukaemia. The statement provided focuses on their effectiveness"
10026104,Ibuprofen affects Myalgia,145,RESULTS: The average initial dose of prednisolone in polymyalgia rheumatica was 35 mg; 51 of 62 patients were given a starting dose exceeding 15 mg.,False,"'Does the phrase ""Ibuprofen affects Myalgia"" receive at least indirect support from the statement: ""RESULTS: The average initial dose of prednisolone in polymyalgia rheumatica was 35 mg; 51 of 62 patients were given a starting dose exceeding 15 mg.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen affects Myalgia."" The statement discusses the initial dose of prednisolone in polymyalgia rheumatica patients but does not mention ibuprofen or myalgia at all. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief, while myalgia refers to muscle pain; however, there is no connection established between these concepts in the provided statement."
9889792,Ibuprofen affects Hemorrhage,146,[Trans-utero-tubal administration of prednisolone in sterility caused by obstruction of the tubes].,False,"'Does the phrase ""Ibuprofen affects Hemorrhage"" receive at least indirect support from the statement: ""[Trans-utero-tubal administration of prednisolone in sterility caused by obstruction of the tubes].""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects Hemorrhage."" The statement discusses the administration of prednisolone in sterility caused by obstruction of the tubes, which is unrelated to ibuprofen and hemorrhage. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain relief, while prednisolone is a corticosteroid medication used for suppressing immune response. Hemorrhage refers to excessive bleeding. These concepts are not mentioned nor implied in the given statement."
8819538,Ibuprofen affects osteoarthritis,147,[On experiences with a combination preparation from prednisolone and an antihistaminic in dermatology especially in endogenous eczema].,False,"'Does the phrase ""Ibuprofen affects osteoarthritis"" receive at least indirect support from the statement: ""[On experiences with a combination preparation from prednisolone and an antihistaminic in dermatology especially in endogenous eczema].""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen affects osteoarthritis."" The statement discusses the use of prednisolone and an antihistaminic in dermatology, specifically in endogenous eczema. Ibuprofen is neither mentioned nor implied in this context. Therefore, it does not contribute to our understanding of ibuprofen's potential effects on osteoarthritis."
8421263,Ibuprofen affects Fever,148,[USE OF PREDNISOLONE IN SOME GRAVE FORMS OF PATHOLOGY OF THE PREMATURE INFANT].,False,"'Does the phrase ""Ibuprofen affects Fever"" receive at least indirect support from the statement: ""[USE OF PREDNISOLONE IN SOME GRAVE FORMS OF PATHOLOGY OF THE PREMATURE INFANT].""?","No, the statement does not provide direct or indirect support for the phrase ""Ibuprofen affects Fever."" The statement discusses the use of prednisolone in some grave forms of pathology in premature infants. Prednisolone is a corticosteroid medication, while ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). These two medications have different mechanisms of action in the body and thus, their effects on fever may also differ.

         To provide indirect support for ""Ibuprofen affects Fever,"" there would need to be some connection between ibuprofen and fever in the statement. For instance, if the statement mentioned that ibuprofen is used to reduce fever in premature infants, then it would provide indirect support for the phrase. However, since there is no mention of ibuprofen or fever in the statement, it does not support the claim in any way."
27630106,Ibuprofen disrupts Acute Pain,149,[EFFECT OF PREDNISOLONE ON THE CARDIAC ACTIVITY IN LIVER AND KIDNEY  DISEASES AND IN RHEUMATISM].,False,"'Does the phrase ""Ibuprofen disrupts Acute Pain"" receive at least indirect support from the statement: ""[EFFECT OF PREDNISOLONE ON THE CARDIAC ACTIVITY IN LIVER AND KIDNEY  DISEASES AND IN RHEUMATISM].""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen disrupts Acute Pain."" The statement is about the effect of Prednisolone on cardiac activity in liver and kidney diseases and in rheumatism. It does not mention Ibuprofen or acute pain at all. Therefore, it does not contribute to the validity of that specific claim."
23399675,Ibuprofen disrupts Myalgia,150,"In this limited pilot study, we compared the effect on clinical outcome of treating Pseudomonas keratitis in guinea pigs with prednisolone (a corticosteroid), flurbiprofen (a cyclo-oxygenase inhibitor), nordihydroguaiaretic acid (a lipoxygenase inhibitor), and a leukotriene antagonist, SKF104353 [R-(R*, S*)]-beta-[(2-carboxyethyl) thio-alpha-hydroxy-2-(8-phenyloctyl) benzenepropanoic acid, zinc salt].",False,"'Does the phrase ""Ibuprofen disrupts Myalgia"" receive at least indirect support from the statement: ""In this limited pilot study, we compared the effect on clinical outcome of treating Pseudomonas keratitis in guinea pigs with prednisolone (a corticosteroid), flurbiprofen (a cyclo-oxygenase inhibitor), nordihydroguaiaretic acid (a lipoxygenase inhibitor), and a leukotriene antagonist, SKF104353 [R-(R*, S*)]-beta-[(2-carboxyethyl) thio-alpha-hydroxy-2-(8-phenyloctyl) benzenepropanoic acid, zinc salt].""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen disrupts Myalgia."" The study mentioned in the statement is focused on treating Pseudomonas keratitis in guinea pigs using various drugs, one of which is flurbiprofen, a cyclo-oxygenase inhibitor similar to ibuprofen. However, the study does not investigate the effect of these drugs on myalgia (muscle pain), nor does it specifically study ibuprofen. Therefore, it does not provide any evidence or support for the claim that ibuprofen disrupts myalgia."
18599970,Ibuprofen disrupts arthritic joint disease,151,URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.,False,"'Does the phrase ""Ibuprofen disrupts arthritic joint disease"" receive at least indirect support from the statement: ""URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.""?","No, the statement ""URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS"" does not provide indirect support for the phrase ""Ibuprofen disrupts arthritic joint disease."" 

        The statement is about the excretion of Prednisolone, a corticosteroid used in treating inflammatory conditions such as ulcerative colitis, after intrarectal therapy. This has no direct or indirect relation to Ibuprofen, which is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief, fever reduction, and inflammation reduction. The two substances have different mechanisms of action and are used for different medical conditions. Therefore, any conclusions about Ibuprofen's effect on arthritic joint disease cannot be drawn from this statement."
15072611,Ibuprofen disrupts Fever,152,"Male rats treated with either budesonide, prednisolone, or triamcinolone acetonide in drinking water for up to 104 weeks developed slightly increased incidences of basophilic foci, and significantly increased incidences of combined hepatocellular adenomas/carcinomas as compared to controls.",False,"'Does the phrase ""Ibuprofen disrupts Fever"" receive at least indirect support from the statement: ""Male rats treated with either budesonide, prednisolone, or triamcinolone acetonide in drinking water for up to 104 weeks developed slightly increased incidences of basophilic foci, and significantly increased incidences of combined hepatocellular adenomas/carcinomas as compared to controls.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen disrupts Fever."" The statement discusses the effects of three different glucocorticoids (budesonide, prednisolone, and triamcinolone acetonide) on male rats over an extended period (up to 104 weeks), focusing on increased incidences of basophilic foci and hepatocellular adenomas/carcinomas. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) unrelated to glucocorticoids; it works by inhibiting cyclooxygenase enzymes involved in inflammation and pain signaling but does not share the same mechanism as glucocorticoids in suppressing immune response.

         Ibuprofen can impact fever through its action on prostaglandin synthesis; however, the statement provided does not contain information about fever disruption nor does it involve ibuprofen in any capacity. To establish indirect support for ""Ibuprofen disrupts Fever,"" there should be some connection between ibuprofen use and fever"
14486259,Ibuprofen disrupts Pain,153,[On the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility].,False,"'Does the phrase ""Ibuprofen disrupts Pain"" receive at least indirect support from the statement: ""[On the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility].""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen disrupts Pain"". The statement pertains specifically to the use of prednisolone in hemolytic anemia of the newborn caused by fetomaternal Rh-factor incompatibility. It does not mention ibuprofen or pain disruption. Therefore, it does not offer any relevant information that could be used to infer support for the stated phrase."
8331095,Ibuprofen disrupts Alzheimer disease,154,Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases.,False,"'Does the phrase ""Ibuprofen disrupts Alzheimer disease"" receive at least indirect support from the statement: ""Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases.""?","No, the statement ""Long-term use of prednisone and prednisolone in juvenile rheumatoid arthritis; a report of fifteen cases"" does not provide indirect support for the phrase ""Ibuprofen disrupts Alzheimer disease."" 

        The reason is that these two statements discuss different drugs (ibuprofen vs prednisone/prednisolone) used in different medical conditions (Alzheimer disease vs juvenile rheumatoid arthritis). There is no mention of ibuprofen, Alzheimer disease, or any link between them in the provided statement about prednisone/prednisolone use in juvenile rheumatoid arthritis.

        To establish indirect support for the claim about ibuprofen and Alzheimer disease, one would need evidence that demonstrates shared mechanisms between these drugs or conditions that could suggest potential disruption of Alzheimer disease by ibuprofen. However, based on the given statement alone, no such link can be inferred."
25657729,Ibuprofen prevents hypertensive disorder,155,[Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome].,False,"'Does the phrase ""Ibuprofen prevents hypertensive disorder"" receive at least indirect support from the statement: ""[Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome].""?","No, the statement ""Ibuprofen prevents hypertensive disorder"" does not receive any direct or indirect support from the title ""[Effect of prednisolone and human albumin on protein excretion in nephrotic syndrome]."" This title discusses the effect of prednisolone and human albumin on protein excretion in nephrotic syndrome patients, which is unrelated to ibuprofen use or hypertensive disorders prevention."
22159382,Ibuprofen prevents Hemorrhage,156,[Therapeutic results of metacortandralone or prednisolone in allergy].,False,"'Does the phrase ""Ibuprofen prevents Hemorrhage"" receive at least indirect support from the statement: ""[Therapeutic results of metacortandralone or prednisolone in allergy].""?","No, the statement ""Ibuprofen prevents Hemorrhage"" does not receive any direct or indirect support from the statement ""[Therapeutic results of metacortandralone or prednisolone in allergy]."" 

        The reason for this is that the two statements discuss different subjects. The first statement refers to Ibuprofen, an anti-inflammatory drug often used for pain relief and fever reduction, and its potential effect on preventing hemorrhage (bleeding). The second statement discusses the therapeutic results of two different drugs, metacortandralone and prednisolone, in the context of allergy treatment. 

        There is no mention of Ibuprofen, hemorrhage, or any related concepts in the second statement. Therefore, it does not provide any support for the first statement. This is an example of how correlation does not imply causation; just because two things are mentioned together does not mean they have any direct relationship."
22123299,Ibuprofen prevents Fever,157,Primary resistance to vincristine (Vcr) and prednisolone in untreated AML was observed as well as 'acquired' resistance to several other antileukemic drugs.,False,"'Does the phrase ""Ibuprofen prevents Fever"" receive at least indirect support from the statement: ""Primary resistance to vincristine (Vcr) and prednisolone in untreated AML was observed as well as 'acquired' resistance to several other antileukemic drugs.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen prevents fever."" The statement discusses resistance to certain drugs in acute myeloid leukemia (AML) patients but does not mention ibuprofen or fever at all. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for its analgesic (pain-relieving), antipyretic (fever-reducing), and anti-inflammatory properties. The provided statement has no relevance to ibuprofen's ability to prevent fever."
21354514,Ibuprofen prevents pancreatitis,158,"REPORT of the Committee on New Drugs of the Research Council of the American Academy of Allergy, 1955-56; studies on prednisone and prednisolone in ragweed pollinosis.",False,"'Does the phrase ""Ibuprofen prevents pancreatitis"" receive at least indirect support from the statement: ""REPORT of the Committee on New Drugs of the Research Council of the American Academy of Allergy, 1955-56; studies on prednisone and prednisolone in ragweed pollinosis.""?","No, the statement does not provide any direct or indirect support for the claim that ibuprofen prevents pancreatitis. The report mentioned is about studies on prednisone and prednisolone in ragweed pollinosis conducted in 1955-56. Ibuprofen is not mentioned in the statement, nor is there any connection made between non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and pancreatitis prevention. Therefore, it is not appropriate to draw such conclusions based on this information alone."
20691057,Ibuprofen prevents altitude sickness,159,Effects of prednisone and prednisolone in ocular inflammation.,False,"'Does the phrase ""Ibuprofen prevents altitude sickness"" receive at least indirect support from the statement: ""Effects of prednisone and prednisolone in ocular inflammation.""?","No, the statement ""Effects of prednisone and prednisolone in ocular inflammation"" does not provide indirect support for the claim ""Ibuprofen prevents altitude sickness."" 

        The reason is that these two statements refer to different drugs (prednisone/prednisolone vs ibuprofen) and different conditions (ocular inflammation vs altitude sickness). There is no shared element between these statements that would allow for indirect support to be inferred. 

        Furthermore, even if the two statements were about the same drug, indirect support would still not be automatically established. Indirect support refers to evidence that does not directly address the claim but provides a basis for inferring its validity based on related information. For example, if there were studies showing that ibuprofen reduces inflammation (a key factor in altitude sickness), then one might infer indirect support for the claim that ibuprofen prevents altitude sickness. However, without such a link, no indirect support can be established."
19399624,Ibuprofen prevents osteoarthritis,160,"Prednisolone scored better than prednisone in the categories of texture, taste, and aftertaste (p < 0.05); there was no statistical difference in smell.",False,"'Does the phrase ""Ibuprofen prevents osteoarthritis"" receive at least indirect support from the statement: ""Prednisolone scored better than prednisone in the categories of texture, taste, and aftertaste (p < 0.05); there was no statistical difference in smell.""?","No, the statement does not provide any indirect support for the phrase ""Ibuprofen prevents osteoarthritis"". The provided statement compares prednisolone and prednisone in terms of texture, taste, and aftertaste as well as smell. The comparison drugs have no relation to ibuprofen, which is an analgesic used for pain relief rather than an anti-inflammatory drug used for treating osteoarthritis symptoms. Therefore, there is no connection between these two statements in terms of their subject matter."
17687542,Ibuprofen prevents canker sore,161,Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.,False,"'Does the phrase ""Ibuprofen prevents canker sore"" receive at least indirect support from the statement: ""Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen prevents canker sores."" The statement discusses plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. This has no direct or indirect relation to ibuprofen or canker sores. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID), while prednisolone is a corticosteroid, and they have different mechanisms of action. Furthermore, canker sores (aphthous ulcers) are not typically associated with colitis or inflammatory bowel disease. Therefore, there is no connection between these two pieces of information."
15961024,Ibuprofen prevents Dysmenorrhea,162,Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.,False,"'Does the phrase ""Ibuprofen prevents Dysmenorrhea"" receive at least indirect support from the statement: ""Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus.""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen prevents Dysmenorrhea"". The statement discusses mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus. This is unrelated to ibuprofen and its potential effects on dysmenorrhea (menstrual pain). Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief, including dysmenorrhea, but the provided statement does not discuss or imply this use in any way."
13710734,Ibuprofen prevents Chronic pain,163,Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.,False,"'Does the phrase ""Ibuprofen prevents Chronic pain"" receive at least indirect support from the statement: ""Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy.""?","No, the statement ""Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy"" does not provide indirect support for the phrase ""Ibuprofen prevents Chronic pain."" The study referenced in the statement is focused on the treatment of IgA nephropathy, a kidney disease, using prednisolone and cytotoxics, not ibuprofen. Furthermore, it does not discuss chronic pain as an outcome measure in any capacity. Therefore, it is not relevant in supporting the claim that ibuprofen prevents chronic pain."
10201705,Ibuprofen prevents Headache,164,"We propose that FE(NO) is associated with eosinophilic inflammation in children with difficult asthma, following prednisolone, and may help in identifying patients in whom persistent symptoms are associated with airway eosinophilia.",False,"'Does the phrase ""Ibuprofen prevents Headache"" receive at least indirect support from the statement: ""We propose that FE(NO) is associated with eosinophilic inflammation in children with difficult asthma, following prednisolone, and may help in identifying patients in whom persistent symptoms are associated with airway eosinophilia.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen prevents Headache."" The statement discusses the association between fractional exhaled nitric oxide (FeNO) levels and eosinophilic inflammation in children with difficult asthma who have taken prednisolone. It does not mention ibuprofen or headaches at all; therefore, it does not offer any form of support for that specific claim."
10026105,Ibuprofen prevents Myalgia,165,"Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.",False,"'Does the phrase ""Ibuprofen prevents Myalgia"" receive at least indirect support from the statement: ""Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma.""?","No, the statement does not provide any direct or indirect support for the phrase ""Ibuprofen prevents Myalgia"". The two statements discuss different subjects - one is about liposomal daunorubicin in combination therapy for non-Hodgkins lymphoma, while the other is about ibuprofen preventing myalgia (muscle pain). There is no overlap in these concepts that would allow us to infer any support for the claim regarding ibuprofen preventing myalgia based on the given statement about daunorubicin in lymphoma treatment."
9104502,Ibuprofen prevents injury,166,Prednisolone in Duchenne muscular dystrophy.,False,"'Does the phrase ""Ibuprofen prevents injury"" receive at least indirect support from the statement: ""Prednisolone in Duchenne muscular dystrophy.""?","No, the statement ""Prednisolone in Duchenne muscular dystrophy"" does not provide indirect support for the phrase ""Ibuprofen prevents injury."" These two statements pertain to different medical contexts and substances.

        
        The first statement refers specifically to prednisolone, which is a corticosteroid medication often used in treating Duchenne muscular dystrophy (DMD), a genetic disorder characterized by progressive muscle degeneration and weakness. Corticosteroids like prednisolone have been shown to have anti-inflammatory effects that can help slow muscle degeneration in DMD patients.

        
        Ibuprofen, on the other hand, is a non-steroidal anti-inflammatory drug (NSAID) commonly used for relieving pain, reducing inflammation, and bringing down fever in various conditions unrelated to muscular dystrophy. While ibuprofen does have anti-inflammatory properties like prednisolone, there is no direct link between these two statements in terms of their medical contexts, applications, or implications for injury prevention.

        
        It"
9022792,Ibuprofen prevents Pain,167,Intravenous prednisolone in chronic bronchial asthma.,False,"'Does the phrase ""Ibuprofen prevents Pain"" receive at least indirect support from the statement: ""Intravenous prednisolone in chronic bronchial asthma.""?","No, the statement ""Intravenous prednisolone in chronic bronchial asthma"" does not provide indirect support for the phrase ""Ibuprofen prevents Pain."" 

        The statement in question is about the use of intravenous prednisolone in managing chronic bronchial asthma, which is an inflammatory disease of the airways. This has no direct relevance or implication for the use of ibuprofen, which is a non-steroidal anti-inflammatory drug (NSAID) commonly used for pain relief and reducing inflammation in conditions like arthritis and menstrual cramps.

        The two statements belong to different clinical contexts (asthma vs pain management) and do not share any common elements that could be used to infer support for one from the other. Therefore, it is not appropriate to draw any conclusions about ibuprofen preventing pain based on the given statement about prednisolone and asthma."
8584177,Ibuprofen prevents patent ductus arteriosus,168,Reversibility with prednisolone is rarely seen in COPD.,False,"'Does the phrase ""Ibuprofen prevents patent ductus arteriosus"" receive at least indirect support from the statement: ""Reversibility with prednisolone is rarely seen in COPD.""?","No, the statement ""Reversibility with prednisolone is rarely seen in COPD"" does not provide indirect support for the phrase ""Ibuprofen prevents patent ductus arteriosus."" 

        The two statements discuss different subjects - one refers to Ibuprofen preventing patent ductus arteriosus in infants and the other refers to the reversibility of COPD (Chronic Obstructive Pulmonary Disease) with prednisolone in adults. Patent ductus arteriosus is a congenital heart defect in infants while COPD is a progressive lung disease in adults. The drugs (Ibuprofen and prednisolone) and their effects on different conditions (patent ductus arteriosus and COPD) do not share enough commonality for one statement to indirectly support the other."
7843138,Ibuprofen prevents Alzheimer disease,169,"In spite of the fact that prednisolone-based treatment of pemphigus patients has proved to be effective in controlling the disease, some undesirable effects associated with this form of treatment have prompted investigation into other therapeutic approaches.",False,"'Does the phrase ""Ibuprofen prevents Alzheimer disease"" receive at least indirect support from the statement: ""In spite of the fact that prednisolone-based treatment of pemphigus patients has proved to be effective in controlling the disease, some undesirable effects associated with this form of treatment have prompted investigation into other therapeutic approaches.""?","No, the statement does not provide indirect support for the claim that ibuprofen prevents Alzheimer disease. 

         The statement discusses prednisolone-based treatment for pemphigus patients and mentions that undesirable effects have led to investigations into other therapeutic approaches. This information is not related to ibuprofen or its potential effects on Alzheimer disease prevention. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for pain relief, fever reduction, and inflammation; it is not typically associated with Alzheimer disease prevention in medical literature.

         To establish indirect support for the claim that ibuprofen prevents Alzheimer disease, one would need information connecting ibuprofen usage to reduced risk or delayed onset of Alzheimer disease. The statement provided does not contain such information; therefore, it does not indirectly support the claim in question."
15342704,Ibuprofen exacerbates injury,170,One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes.,False,"'Does the phrase ""Ibuprofen exacerbates injury"" receive at least indirect support from the statement: ""One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes.""?","No, the statement ""One reason for the good clinical effects of prednisolone in RA could be a down-regulation of adhesion and phagocytosis receptors on monocytes"" does not provide indirect support for the phrase ""Ibuprofen exacerbates injury."" 

         The statement is discussing prednisolone, a corticosteroid drug, and its potential mechanisms in treating rheumatoid arthritis (RA). It suggests that prednisolone might have beneficial effects by down-regulating adhesion and phagocytosis receptors on monocytes, which are types of white blood cells involved in immune responses.

         Ibuprofen, on the other hand, is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief, fever reduction, and inflammation reduction. The statement does not mention ibuprofen or provide any information about its effects on injury or healing. Therefore, it does not indirectly support the idea that ibuprofen exacerbates injury.

         It is important to note that while some medications can have adverse effects that might"
20007370,Ibuprofen predisposes cerebral palsy,171,OBJECTIVE: To appraise the adjunctive role of prednisolone (PN) in pulmonary tuberculosis (PTB) with toxic reactions.,False,"'Does the phrase ""Ibuprofen predisposes cerebral palsy"" receive at least indirect support from the statement: ""OBJECTIVE: To appraise the adjunctive role of prednisolone (PN) in pulmonary tuberculosis (PTB) with toxic reactions.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes cerebral palsy."" The objective of the study is to evaluate the adjunctive role of prednisolone in pulmonary tuberculosis and its toxic reactions. This study has no direct or indirect relation to ibuprofen or cerebral palsy."
14332005,Ibuprofen predisposes bronchopulmonary dysplasia,172,"A significant reduction of survival was found with the presence of permanent visual loss vs absence (p = 0.04), in patients who required more than 10 mg/d of glucocorticoid (p < 0.001) at 6 months treatment and in patients treated with prednisone (vs prednisolone) (p < 0.01).",False,"'Does the phrase ""Ibuprofen predisposes bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""A significant reduction of survival was found with the presence of permanent visual loss vs absence (p = 0.04), in patients who required more than 10 mg/d of glucocorticoid (p < 0.001) at 6 months treatment and in patients treated with prednisone (vs prednisolone) (p < 0.01).""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes bronchopulmonary dysplasia."" The statement discusses factors associated with reduced survival in patients treated for certain conditions, including higher doses of glucocorticoids and specific types of glucocorticoids (prednisone vs prednisolone). Ibuprofen is not mentioned in the statement, nor is bronchopulmonary dysplasia. Therefore, there is no connection that can be inferred between ibuprofen use and bronchopulmonary dysplasia from this statement."
14294004,Ibuprofen predisposes Alzheimer disease,173,"Fourteen patients developed hyperglycemia during induction therapy of acute lymphoblastic leukemia with L-asparaginase, prednisolone, vincristine and daunorubicin.",False,"'Does the phrase ""Ibuprofen predisposes Alzheimer disease"" receive at least indirect support from the statement: ""Fourteen patients developed hyperglycemia during induction therapy of acute lymphoblastic leukemia with L-asparaginase, prednisolone, vincristine and daunorubicin.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes Alzheimer disease."" The statement discusses patients who developed hyperglycemia during induction therapy for acute lymphoblastic leukemia using certain drugs, none of which include ibuprofen or any other non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. To provide indirect support for the original phrase, there would need to be some connection between ibuprofen use and Alzheimer disease risk, which is not suggested by this statement."
14085648,Ibuprofen predisposes injury,174,A 66-year-old man was treated for IgD (lambda) multiple myeloma with 2mg/day melphalan and 20mg/day prednisolone.,False,"'Does the phrase ""Ibuprofen predisposes injury"" receive at least indirect support from the statement: ""A 66-year-old man was treated for IgD (lambda) multiple myeloma with 2mg/day melphalan and 20mg/day prednisolone.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes injury."" The statement discusses a 66-year-old man being treated for multiple myeloma using melphalan and prednisolone, without any mention of ibuprofen use or injury predisposition. Therefore, there is no basis in this statement for such an inference."
12673407,Ibuprofen predisposes bone fracture,175,"Moreover, after recent findings regarding the presence of endogenous prednisolone in the urine of more popular breeds, particular attention was given to analysis of the presence of prednisolone and prednisone, as well.",False,"'Does the phrase ""Ibuprofen predisposes bone fracture"" receive at least indirect support from the statement: ""Moreover, after recent findings regarding the presence of endogenous prednisolone in the urine of more popular breeds, particular attention was given to analysis of the presence of prednisolone and prednisone, as well.""?","No, the statement does not provide indirect support for the phrase ""Ibuprofen predisposes bone fracture"". The passage discusses an analysis of prednisolone and prednisone in urine samples of popular dog breeds but does not mention ibuprofen or bone fractures at all. In order for it to provide indirect support for the claim about ibuprofen predisposing bone fractures, there should be some connection between prednisolone/prednisone, ibuprofen, and bone fractures; however, no such connection is evident in the statement provided."
17604344,Ivabradine related to diastolic heart failure,176,"Of 10 mg of prednisone given orally to 5 normal subjects, 69+/-5% was absorbed and converted to peripheral plasma prednisolone within 8 h.",False,"'Does the phrase ""Ivabradine related to diastolic heart failure"" receive at least indirect support from the statement: ""Of 10 mg of prednisone given orally to 5 normal subjects, 69+/-5% was absorbed and converted to peripheral plasma prednisolone within 8 h.""?","No, the statement does not provide any direct or indirect support for the phrase ""Ivabradine related to diastolic heart failure"". The statement discusses the absorption and conversion of prednisone in normal subjects, which has no explicit or implicit connection to ivabradine or diastolic heart failure. Ivabradine is a medication used primarily for heart rate control in conditions like chronic heart failure, but it is not specifically associated with diastolic heart failure in the provided statement."
19228519,Ivabradine causes atrial fibrillation,177,"As in humans, prednisolone was partly converted to prednisone in the rabbit.",False,"'Does the phrase ""Ivabradine causes atrial fibrillation"" receive at least indirect support from the statement: ""As in humans, prednisolone was partly converted to prednisone in the rabbit.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine causes atrial fibrillation."" The two statements discuss different substances (prednisolone/prednisone vs ivabradine) and do not make any connection between those substances that would suggest an effect on atrial fibrillation risk.

        The statement ""As in humans, prednisolone was partly converted to prednisone in the rabbit"" pertains to drug metabolism in different species, specifically how prednisolone is metabolized into prednisone in both humans and rabbits. This has no bearing on ivabradine or its potential effects on atrial fibrillation risk.

        It is important to critically evaluate each statement in isolation and in relation to the specific claim being made. Extraneous information that does not pertain to the claim at hand should be disregarded in order to maintain accuracy in interpretation."
20784958,Ivabradine affects atrial fibrillation,178,"Given the close resemblance of the ring A structure of prednisolone and prednisone on the one hand, and of androstadienedione on the other, the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces was evaluated.",False,"'Does the phrase ""Ivabradine affects atrial fibrillation"" receive at least indirect support from the statement: ""Given the close resemblance of the ring A structure of prednisolone and prednisone on the one hand, and of androstadienedione on the other, the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces was evaluated.""?","No, the statement does not provide any indirect support for the phrase ""Ivabradine affects atrial fibrillation."" The statement discusses the transformation of cortisol and cortisone into prednisolone and prednisone in cattle faeces, which is unrelated to ivabradine and atrial fibrillation. Ivabradine is a medication used to treat heart failure and certain types of irregular heartbeats (not including atrial fibrillation), while atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria (the heart's upper chambers). The two subjects are not connected in any meaningful way within the context of the provided statement."
20520107,Ivabradine affects mitral valve stenosis,179,The data indicate that prednisone is extensively metabolized to prednisolone before it clears the splanchnic circulation and the formation prednisone by oxidation of the 11-hydorxyl group of prednisolone appears to occur mainly in peripheral tissues.,False,"'Does the phrase ""Ivabradine affects mitral valve stenosis"" receive at least indirect support from the statement: ""The data indicate that prednisone is extensively metabolized to prednisolone before it clears the splanchnic circulation and the formation prednisone by oxidation of the 11-hydorxyl group of prednisolone appears to occur mainly in peripheral tissues.""?","No, the statement does not provide any indirect support for the claim that ""Ivabradine affects mitral valve stenosis."" The statement discusses the metabolism of prednisone into prednisolone in the splanchnic circulation and its further oxidation in peripheral tissues, which is unrelated to Ivabradine or mitral valve stenosis. Ivabradine is a medication used for heart failure and angina pectoris treatment, having no known direct impact on mitral valve stenosis."
20004006,Ivabradine affects diastolic heart failure,180,CONCLUSION: Dexamethasone or prednisolone were the easiest to induce steroid glaucoma when the patients had long-term use of steroid eyedrops.,False,"'Does the phrase ""Ivabradine affects diastolic heart failure"" receive at least indirect support from the statement: ""CONCLUSION: Dexamethasone or prednisolone were the easiest to induce steroid glaucoma when the patients had long-term use of steroid eyedrops.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine affects diastolic heart failure."" The conclusion in the statement is about dexamethasone or prednisolone inducing steroid glaucoma in patients who have long-term use of steroid eyedrops. Ivabradine is not mentioned in the statement at all, let alone in relation to diastolic heart failure. Therefore, there is no basis for inferring any connection between ivabradine and diastolic heart failure from this statement."
15323309,Ivabradine affects cardiovascular disorder,181,"Among 121 CK-analogs studied, CK-17, CK-101A and CK103A have been identified as promising anti-inflammatory agents as potent as prednisolone in inhibiting lens proteins-induced inflammation and twice as potent as prednisolone in inhibiting endotoxin-and IL-1-induced uveitis.",False,"'Does the phrase ""Ivabradine affects cardiovascular disorder"" receive at least indirect support from the statement: ""Among 121 CK-analogs studied, CK-17, CK-101A and CK103A have been identified as promising anti-inflammatory agents as potent as prednisolone in inhibiting lens proteins-induced inflammation and twice as potent as prednisolone in inhibiting endotoxin-and IL-1-induced uveitis.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine affects cardiovascular disorder"". The statement discusses the anti-inflammatory properties of certain CK-analogs (CK-17, CK-101A, and CK-103A) in inhibiting lens proteins-induced inflammation and uveitis. Ivabradine is not mentioned in this statement; therefore, it does not offer any evidence or implications regarding Ivabradine's effects on cardiovascular disorders."
15323306,Ivabradine affects coronary artery disorder,182,Light and electron microscopy of prednisolone-induced nephropathy in rabbits.,False,"'Does the phrase ""Ivabradine affects coronary artery disorder"" receive at least indirect support from the statement: ""Light and electron microscopy of prednisolone-induced nephropathy in rabbits.""?","No, the statement ""Light and electron microscopy of prednisolone-induced nephropathy in rabbits"" does not provide indirect support for the phrase ""Ivabradine affects coronary artery disorder"". 

        The statement in question is related to nephropathy in rabbits induced by prednisolone, which is an entirely different physiological system and condition from coronary artery disorder in humans or animals. Nephropathy refers to kidney disease, while Ivabradine is a medication used to treat certain heart conditions in humans. Therefore, there is no reasonable connection between these two pieces of information."
19514713,Ivabradine disrupts atrial fibrillation,183,The behavior results showed that exposure to prednisolone resulted in decreased autonomic activity and low sensitivity to light.,False,"'Does the phrase ""Ivabradine disrupts atrial fibrillation"" receive at least indirect support from the statement: ""The behavior results showed that exposure to prednisolone resulted in decreased autonomic activity and low sensitivity to light.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine disrupts atrial fibrillation."" The statement mentions exposure to prednisolone and its effects on autonomic activity and light sensitivity, but it does not mention ivabradine or atrial fibrillation at all. Therefore, there is no connection that can be inferred between the two statements. Ivabradine is a medication used for heart failure and angina pectoris treatment, while prednisolone is a corticosteroid used for its anti-inflammatory and immunosuppressive effects. Atrial fibrillation is an irregular heart rhythm disturbance of the atria (the heart's upper chambers). Since there is no overlap in these concepts within the provided statement, no indirect support can be established."
17909104,Ivabradine disrupts coronary artery disorder,184,We therefore advocate for increased clinical alertness towards prednisolone-induced adrenal insufficiency in RTx patients and thus their potential need of rescue GC supplementation during stress.,False,"'Does the phrase ""Ivabradine disrupts coronary artery disorder"" receive at least indirect support from the statement: ""We therefore advocate for increased clinical alertness towards prednisolone-induced adrenal insufficiency in RTx patients and thus their potential need of rescue GC supplementation during stress.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine disrupts coronary artery disorder"". 

        The statement is discussing prednisolone-induced adrenal insufficiency in renal transplant (RTx) patients and the potential need for rescue glucocorticoid (GC) supplementation during stressful situations. This is completely unrelated to Ivabradine, which is a medication used to treat heart failure and reduce heart rate. Ivabradine does not have any known effects on coronary artery disorders that would disrupt them. Therefore, there is no connection between the two statements."
17822394,Ivabradine prevents atrial fibrillation,185,Zeaxanthin (50 mg/kg/day) or prednisolone (5 mg/kg/day) was orally administered for 14 days before induction of ulcerative colitis.,False,"'Does the phrase ""Ivabradine prevents atrial fibrillation"" receive at least indirect support from the statement: ""Zeaxanthin (50 mg/kg/day) or prednisolone (5 mg/kg/day) was orally administered for 14 days before induction of ulcerative colitis.""?","No, the statement does not provide indirect support for the claim that ""Ivabradine prevents atrial fibrillation."" The substances mentioned in the statement, zeaxanthin and prednisolone, have no direct relation to ivabradine or atrial fibrillation. Furthermore, the context of ulcerative colitis induction is unrelated to either ivabradine or atrial fibrillation. Therefore, there is no reasonable basis for inferring that ivabradine prevents atrial fibrillation based on the given statement."
10817471,Ivabradine prevents Tachycardia,186,"OBJECTIVE: We want to show that an intralesional injection of prednisolone into the proximal nail fold may produce dorsal pain, dyspnoea and headaches within the 2 min following the injection and to explain the pathophysiology of his condition.",False,"'Does the phrase ""Ivabradine prevents Tachycardia"" receive at least indirect support from the statement: ""OBJECTIVE: We want to show that an intralesional injection of prednisolone into the proximal nail fold may produce dorsal pain, dyspnoea and headaches within the 2 min following the injection and to explain the pathophysiology of his condition.""?","No, the statement does not provide indirect support for the phrase ""Ivabradine prevents Tachycardia."" The objective of the study mentioned in the statement is focused on demonstrating the effects of an intralesional injection of prednisolone into the proximal nail fold and explaining the resulting condition's pathophysiology. It does not involve Ivabradine or its potential in preventing tachycardia (rapid heart rate). Therefore, it does not offer any relevant evidence or implications concerning Ivabradine's effects on tachycardia prevention."
19153602,Ivabradine predisposes atrial fibrillation,187,[A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].,False,"'Does the phrase ""Ivabradine predisposes atrial fibrillation"" receive at least indirect support from the statement: ""[A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].""?","No, the statement does not provide indirect support for the phrase ""Ivabradine predisposes atrial fibrillation."" The statement is about a case of nephrotic syndrome induced by prednisolone, which has no direct relevance to Ivabradine or atrial fibrillation. Ivabradine is a medication used primarily for heart failure and angina pectoris, not atrial fibrillation or nephrotic syndrome. Therefore, there is no reasonable connection between these two statements based on the information provided."
15385004,Cefixime affects chronic bronchitis,188,It is concluded that six or more cycles of COPP chemotherapy for advanced Hodgkin's disease in men leads to permanent sterility.,False,"'Does the phrase ""Cefixime affects chronic bronchitis"" receive at least indirect support from the statement: ""It is concluded that six or more cycles of COPP chemotherapy for advanced Hodgkin's disease in men leads to permanent sterility.""?","No, the statement does not provide indirect support for the phrase ""Cefixime affects chronic bronchitis."" The conclusion drawn in the statement is about the impact of COPP (Cyclophosphamide, Oncovin (vincristine), Procarbazine, Prednisone) chemotherapy on male sterility in Hodgkin's disease patients. It does not mention or imply any connection to Cefixime or chronic bronchitis. Cefixime is an antibiotic used primarily for treating respiratory tract infections while chronic bronchitis is an inflammatory disease of the airways in the lungs. The statement provided is unrelated to these subjects."
15252860,Cefixime affects gonorrhea,189,The erythroderma improved generally as a result of systemic prednisolone treatment.,False,"'Does the phrase ""Cefixime affects gonorrhea"" receive at least indirect support from the statement: ""The erythroderma improved generally as a result of systemic prednisolone treatment.""?","No, the statement ""The erythroderma improved generally as a result of systemic prednisolone treatment"" does not provide indirect support for the phrase ""Cefixime affects gonorrhea."" 

        The improvement of erythroderma (a type of skin rash) due to systemic prednisolone treatment is not related to Cefixime's effect on gonorrhea (a sexually transmitted infection). Prednisolone is a corticosteroid used for treating various inflammatory conditions including erythroderma; it has no direct effect on gonorrhea or Cefixime. 

        Cefixime is an antibiotic used for treating infections caused by certain bacteria such as gonorrhea but there is no mention of its use in this statement nor any correlation between its use and the improvement of erythroderma or gonorrhea. Therefore, it does not provide indirect support for the given phrase."
18811968,Cefixime prevents otitis media,190,CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE.,False,"'Does the phrase ""Cefixime prevents otitis media"" receive at least indirect support from the statement: ""CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE.""?","No, the statement ""CONTACT DERMATITIS DUE TO TOPICAL HYDROCORTISONE AND PREDNISOLONE"" does not provide indirect support for the claim that ""Cefixime prevents otitis media."" 

        The statement about contact dermatitis refers to skin reactions caused by topical application of hydrocortisone and prednisolone, which are corticosteroids used to reduce inflammation. This statement is not related to Cefixime, an antibiotic used to treat infections caused by bacteria. 

        Furthermore, otitis media is an inflammation or infection of the middle ear, which is not directly related to contact dermatitis or the use of corticosteroids. 

        Therefore, there is no logical connection between these two statements that would allow for indirect support of the claim about Cefixime preventing otitis media."
17748395,Trimetazidine related to diabetic kidney disease,191,[Pulmonary tuberculosis due to prednisolone].,False,"'Does the phrase ""Trimetazidine related to diabetic kidney disease"" receive at least indirect support from the statement: ""[Pulmonary tuberculosis due to prednisolone].""?","No, the statement ""Pulmonary tuberculosis due to prednisolone"" does not provide indirect support for the phrase ""Trimetazidine related to diabetic kidney disease."" This is because these two statements discuss entirely different medical conditions (pulmonary tuberculosis and diabetic kidney disease) and medications (prednisolone and trimetazidine). There is no connection between pulmonary tuberculosis, prednisolone, trimetazidine, and diabetic kidney disease in these statements that would allow for indirect support."
22426756,Trimetazidine affects diabetic kidney disease,192,"Rats were treated with a leukotriene synthesis inhibitor (PF-5901), a leukotriene B4 receptor antagonist (SC-41930), an IL-1 receptor antagonist or a corticosteroid (prednisolone) prior to induction of colitis.",False,"'Does the phrase ""Trimetazidine affects diabetic kidney disease"" receive at least indirect support from the statement: ""Rats were treated with a leukotriene synthesis inhibitor (PF-5901), a leukotriene B4 receptor antagonist (SC-41930), an IL-1 receptor antagonist or a corticosteroid (prednisolone) prior to induction of colitis.""?","No, the statement does not provide indirect support for the claim that Trimetazidine affects diabetic kidney disease. The provided statement describes an experiment where rats were treated with various substances before inducing colitis. Trimetazidine is not among these substances, nor is there any mention of kidney disease or diabetes in the statement. Therefore, it does not offer any evidence or support for the claim about Trimetazidine's effect on diabetic kidney disease."
21297588,Trimetazidine affects Cardiotoxicity,193,"PURPOSE: To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone.",False,"'Does the phrase ""Trimetazidine affects Cardiotoxicity"" receive at least indirect support from the statement: ""PURPOSE: To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone.""?","No, the statement does not provide any direct or indirect support for the claim that Trimetazidine affects Cardiotoxicity. The purpose of the study as stated is to investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation in rats. There is no mention of Trimetazidine in the statement, nor does it discuss cardiotoxicity or any related cardiovascular effects. Therefore, it does not contribute any evidence towards the claim about Trimetazidine's effects on cardiotoxicity."
19164679,Trimetazidine affects cardiovascular disorder,194,"In inactive SLE induced by prednisolone therapy, the invariant Valpha24JalphaQ TCR could be detected in DN Valpha24+ T cells from all the patients and dominated in most of the patients.",False,"'Does the phrase ""Trimetazidine affects cardiovascular disorder"" receive at least indirect support from the statement: ""In inactive SLE induced by prednisolone therapy, the invariant Valpha24JalphaQ TCR could be detected in DN Valpha24+ T cells from all the patients and dominated in most of the patients.""?","No, the statement does not provide any direct or indirect support for the phrase ""Trimetazidine affects cardiovascular disorder."" The statement discusses the presence and dominance of invariant Valpha24JalphaQ TCR in DN Valpha24+ T cells in patients receiving prednisolone therapy for inactive Systemic Lupus Erythematosus (SLE). This has no relation to Trimetazidine or cardiovascular disorders. Trimetazidine is a medication used primarily in treating angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle. Cardiovascular disorders encompass a wide range of conditions affecting the heart and blood vessels; therefore, further specific evidence would be required to make any connection between Trimetazidine and these disorders."
18547788,Trimetazidine prevents Cardiotoxicity,195,"Interleukin-1 (IL-1) blockers, CK 127 and CK 129, were found to inhibit IL-1-induced posterior uveitis very effectively at 3-10 mg/kg i.p. and were more potent than prednisolone which required at least 20 mg/kg i.p. to achieve the same level of anti-uveitis action.",False,"'Does the phrase ""Trimetazidine prevents Cardiotoxicity"" receive at least indirect support from the statement: ""Interleukin-1 (IL-1) blockers, CK 127 and CK 129, were found to inhibit IL-1-induced posterior uveitis very effectively at 3-10 mg/kg i.p. and were more potent than prednisolone which required at least 20 mg/kg i.p. to achieve the same level of anti-uveitis action.""?","No, the statement does not provide indirect support for the phrase ""Trimetazidine prevents Cardiotoxicity"". 

        The statement discusses the effectiveness of Interleukin-1 (IL-1) blockers, CK 127 and CK 129, in inhibiting IL-1-induced posterior uveitis in eye conditions. This is unrelated to Trimetazidine, which is a drug used to treat heart conditions and has not been mentioned in the statement. Therefore, there is no connection or indirect support that can be drawn from this statement regarding Trimetazidine's ability to prevent cardiotoxicity."
13317799,Ranolazine causes atrial fibrillation,196,[A case of hormone-refractory prostate cancer responsive to low-dose prednisolone therapy].,False,"'Does the phrase ""Ranolazine causes atrial fibrillation"" receive at least indirect support from the statement: ""[A case of hormone-refractory prostate cancer responsive to low-dose prednisolone therapy].""?","No, the statement does not provide any indirect support for the claim that ""Ranolazine causes atrial fibrillation."" The statement discusses a case of hormone-refractory prostate cancer that responded to low-dose prednisolone therapy but does not mention Ranolazine or atrial fibrillation at all. Therefore, there is no connection between the two statements that would allow for indirect support of the claim about Ranolazine causing atrial fibrillation."
19314329,Ranolazine affects cardiovascular disorder,197,6 cases of FSGS had poor response to any therapy; 7 cases were responsive to either triple therapy or cyclosporine A plus prednisolone.,False,"'Does the phrase ""Ranolazine affects cardiovascular disorder"" receive at least indirect support from the statement: ""6 cases of FSGS had poor response to any therapy; 7 cases were responsive to either triple therapy or cyclosporine A plus prednisolone.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine affects cardiovascular disorder"". The statement discusses two groups of patients with Focal Segmental Glomerulosclerosis (FSGS) who had different responses to various treatments including triple therapy and cyclosporine A plus prednisolone. Ranolazine, which is primarily used for treating chronic angina, is not mentioned in the statement. Therefore, there is no connection between the drug and the cardiovascular disorder in this context."
19002641,Ranolazine affects atrial fibrillation,198,"From 1983, exacerbation of PIE was recorded three times, on which occasions prednisolone and antibiotics were quite effective.",False,"'Does the phrase ""Ranolazine affects atrial fibrillation"" receive at least indirect support from the statement: ""From 1983, exacerbation of PIE was recorded three times, on which occasions prednisolone and antibiotics were quite effective.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine affects atrial fibrillation."" The statement discusses the exacerbation of PIE (paroxysmal irritable atrial rhythm) and its treatment with prednisolone and antibiotics. Ranolazine is not mentioned in the statement, so there is no connection between it and atrial fibrillation in this context.

        However, it is important to note that Ranolazine is indeed used in clinical practice for treating angina pectoris and chronic stable angina by reducing myocardial oxygen demand through partial fatty acid oxidation inhibition (Belardinelli et al., 2003). Some studies have suggested that it may have antiarrhythmic properties (Chaitman et al., 2004), but there is no direct link between Ranolazine and atrial fibrillation in the statement provided.

        References
        Belardinelli L., et al., (2003). Inhibition of fatty acid oxidation by ranolazine prevents ischemia-induced impairment in left ventricular function in"
17881291,Ranolazine affects type 2 diabetes mellitus,199,"A comparative study of the effects of ACTH, hydrocortisone and prednisolone in the hypersensitive reactions produced with the protein components of Hymenolepis nana in albino mice.",False,"'Does the phrase ""Ranolazine affects type 2 diabetes mellitus"" receive at least indirect support from the statement: ""A comparative study of the effects of ACTH, hydrocortisone and prednisolone in the hypersensitive reactions produced with the protein components of Hymenolepis nana in albino mice.""?","No, the statement ""A comparative study of the effects of ACTH, hydrocortisone and prednisolone in the hypersensitive reactions produced with the protein components of Hymenolepis nana in albino mice"" does not provide any direct or indirect support for the phrase ""Ranolazine affects type 2 diabetes mellitus"". 

        The statement in question is about a comparative study of the effects of three hormones (ACTH, hydrocortisone, and prednisolone) on hypersensitive reactions in albino mice induced by protein components of Hymenolepis nana, a type of tapeworm. There is no mention of Ranolazine, a medication used to treat chronic angina, nor is there any reference to type 2 diabetes mellitus in this statement. Therefore, it does not contribute to the understanding or validation of the stated phrase about Ranolazine affecting type 2 diabetes mellitus."
16599546,Ranolazine affects atrial fibrillation,200,"Immunosuppressant therapy, such as prednisolone or azathioprine, is considered for exacerbations of highly active glomerulonephritis.",False,"'Does the phrase ""Ranolazine affects atrial fibrillation"" receive at least indirect support from the statement: ""Immunosuppressant therapy, such as prednisolone or azathioprine, is considered for exacerbations of highly active glomerulonephritis.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine affects atrial fibrillation."" The two statements discuss different medical topics - one is about immunosuppressant therapy for glomerulonephritis exacerbations while the other is about Ranolazine affecting atrial fibrillation. There is no connection between these topics that would allow us to infer any support for the effect of Ranolazine on atrial fibrillation from the immunosuppressant therapy statement."
15199166,Ranolazine affects myocardial ischemia,201,"We describe a 57-year-old Caucasian male with anti-MDA5 positive dermatomyositis, that had a 4-month history of progressive dyspnoea requiring oxygen-therapy, scarcely responsive to prednisolone.",False,"'Does the phrase ""Ranolazine affects myocardial ischemia"" receive at least indirect support from the statement: ""We describe a 57-year-old Caucasian male with anti-MDA5 positive dermatomyositis, that had a 4-month history of progressive dyspnoea requiring oxygen-therapy, scarcely responsive to prednisolone.""?","No, the statement does not provide direct or indirect support for the phrase ""Ranolazine affects myocardial ischemia."" The statement describes a case of a patient with dermatomyositis who has been experiencing dyspnea for four months and has not responded well to prednisolone therapy. Ranolazine is not mentioned in this statement, nor is there any information about myocardial ischemia or its potential management with Ranolazine in this specific case. To establish support for the claim that ""Ranolazine affects myocardial ischemia,"" evidence should demonstrate that Ranolazine has been administered in similar clinical scenarios and has led to improvements in myocardial ischemia symptoms or outcomes."
13887428,Ranolazine disrupts atrial fibrillation,202,"After 14 months of treatment one of the patients developed severe, acute exacerbation of the ABPA and was treated with high-dose prednisolone and local steroid.",False,"'Does the phrase ""Ranolazine disrupts atrial fibrillation"" receive at least indirect support from the statement: ""After 14 months of treatment one of the patients developed severe, acute exacerbation of the ABPA and was treated with high-dose prednisolone and local steroid.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine disrupts atrial fibrillation"". The statement discusses a patient who developed an acute exacerbation of Allergic Bronchopulmonary Aspergillosis (ABPA) after 14 months of treatment. The treatment mentioned is high-dose prednisolone and local steroid, which is not related to Ranolazine or atrial fibrillation disruption. Therefore, there is no connection between the two statements that would allow for indirect support of the claim about Ranolazine disrupting atrial fibrillation."
17475563,Ranolazine prevents Angina pectoris,203,"The effect of pretreatment with topical prostaglandin E2, prednisolone and sulphasalazine in experimental colitis has been examined in the rat colon.",False,"'Does the phrase ""Ranolazine prevents Angina pectoris"" receive at least indirect support from the statement: ""The effect of pretreatment with topical prostaglandin E2, prednisolone and sulphasalazine in experimental colitis has been examined in the rat colon.""?","No, the statement does not provide any direct or indirect support for the claim that ""Ranolazine prevents Angina pectoris."" The statement discusses an experiment conducted on rat colons using topical prostaglandin E2, prednisolone, and sulphasalazine, which has no relevance or connection to Ranolazine or Angina pectoris treatment in humans. Angina pectoris is chest pain caused by an inadequate supply of oxygen-rich blood to the heart muscle, while Ranolazine is a medication used for treating chronic angina by reducing the frequency of angina attacks. Therefore, there is no shared context between these two pieces of information that would allow for indirect support of the claim about Ranolazine preventing Angina pectoris."
14751648,Ranolazine prevents myocardial ischemia,204,"Here, we report a case of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine, and also review the literature concerning the treatment, especially for prednisolone-dependent cases.",False,"'Does the phrase ""Ranolazine prevents myocardial ischemia"" receive at least indirect support from the statement: ""Here, we report a case of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine, and also review the literature concerning the treatment, especially for prednisolone-dependent cases.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine prevents myocardial ischemia"". The statement discusses a case of prednisolone-dependent gastric sarcoidosis that improved after additional azathioprine treatment and a literature review of treatments for prednisolone-dependent cases. Ranolazine is not mentioned in the statement, nor is there any connection made between its use and prevention of myocardial ischemia."
14280230,Ranolazine prevents atrial fibrillation,205,"METHODS: In 126 adults (33 healthy control subjects, 31 patients with mild asthma, 32 patients with severe asthma, and 30 patients with prednisolone-dependent asthma) parameters of inflammation (peripheral blood eosinophils and neutrophils) and markers of hemostasis (endogenous thrombin potential [ETP], thrombin-antithrombin complex, plasmin-alpha2-antiplasmin complex, plasminogen activator inhibitor type 1 [PAI-1], D-dimer, and von Willebrand factor [vWF]) were measured in plasma.",False,"'Does the phrase ""Ranolazine prevents atrial fibrillation"" receive at least indirect support from the statement: ""METHODS: In 126 adults (33 healthy control subjects, 31 patients with mild asthma, 32 patients with severe asthma, and 30 patients with prednisolone-dependent asthma) parameters of inflammation (peripheral blood eosinophils and neutrophils) and markers of hemostasis (endogenous thrombin potential [ETP], thrombin-antithrombin complex, plasmin-alpha2-antiplasmin complex, plasminogen activator inhibitor type 1 [PAI-1], D-dimer, and von Willebrand factor [vWF]) were measured in plasma.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine prevents atrial fibrillation"". The methods section provided only outlines the parameters of inflammation and markers of hemostasis that were measured in plasma from different subject groups. It does not mention any intervention with Ranolazine nor any outcomes related to atrial fibrillation. Therefore, it is impossible to infer any relationship between Ranolazine and atrial fibrillation prevention based on this information alone."
17988674,Ranolazine predisposes atrial fibrillation,206,Previous studies from our laboratory revealed that coadministration of EP significantly increased the plasma concentration of prednisolone while decreased the level of cotreated prednisone in rats.,False,"'Does the phrase ""Ranolazine predisposes atrial fibrillation"" receive at least indirect support from the statement: ""Previous studies from our laboratory revealed that coadministration of EP significantly increased the plasma concentration of prednisolone while decreased the level of cotreated prednisone in rats.""?","No, the statement does not provide indirect support for the phrase ""Ranolazine predisposes atrial fibrillation."" The statement discusses the effects of coadministration of EP on plasma concentrations of prednisolone and prednisone in rats, which is unrelated to ranolazine's potential predisposition towards atrial fibrillation in humans.

        To further clarify, ranolazine is an antianginal medication used primarily for treating chronic angina pectoris by acting as an inhibitor of late sodium current in cardiac myocytes (Chaitman et al., 2004). Atrial fibrillation is an irregular heart rhythm that can lead to blood clots, stroke, heart failure, and other complications (National Heart, Lung, and Blood Institute).

        Although it is possible that certain medications could interact with ranolazine and potentially contribute to atrial fibrillation risk (e.g., via drug-drug interactions), the statement provided does not involve ranolazine nor suggest any link between ranolazine use and atrial fibrillation susceptibility.

        Chaitman BR, et al. Effect"
26862829,Prednisolone related to multiple sclerosis,207,Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.,False,"'Does the phrase ""Prednisolone related to multiple sclerosis"" receive at least indirect support from the statement: ""Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to multiple sclerosis."" The statement discusses the metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis, focusing on its diabetogenic effects and inflammation reduction. Multiple sclerosis is an autoimmune disease affecting the central nervous system, and while prednisolone is a corticosteroid used in treating various inflammatory conditions (including multiple sclerosis), the statement in question does not establish a connection between prednisolone and multiple sclerosis specifically."
26365803,Prednisolone related to adrenocortical insufficiency,208,"Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs.",False,"'Does the phrase ""Prednisolone related to adrenocortical insufficiency"" receive at least indirect support from the statement: ""Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs.""?","No, the statement ""Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs"" does not provide indirect support for the phrase ""Prednisolone related to adrenocortical insufficiency."" 

        The statement discusses the effects of prednisolone, along with salbutamol and theophylline, on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs. These parameters are related to respiratory function and inflammation, not adrenocortical insufficiency. 

        Adrenocortical insufficiency refers to the inadequate production of corticosteroids by the adrenal glands, which can be caused by various factors such as damage to the adrenal glands or issues with the pituitary gland. Prednisolone is a synthetic glucocorticoid hormone that can be used to treat adrenocortical insufficiency, but the statement provided does not discuss or imply any relationship between prednisolone and adrenocortical insuff"
26295217,Prednisolone related to angioimmunoblastic T-cell lymphoma,209,"This is the first case to support the beneficial effect of prednisolone in pericarditis with pSS, and illustrates its safety during pregnancy.",False,"'Does the phrase ""Prednisolone related to angioimmunoblastic T-cell lymphoma"" receive at least indirect support from the statement: ""This is the first case to support the beneficial effect of prednisolone in pericarditis with pSS, and illustrates its safety during pregnancy.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to angioimmunoblastic T-cell lymphoma"". The statement discusses the beneficial effect and safety of prednisolone in pericarditis with primary Sjogren's syndrome (pSS) during pregnancy. Angioimmunoblastic T-cell lymphoma is a distinct medical condition unrelated to pericarditis or pregnancy, so no inference can be made about prednisolone's impact on it based on this information."
26194122,Prednisolone related to synovitis,210,"When combined with environmental control, prednisolone and dexamethasone treatments had similar effects on heaves score, blood gases and endoscopic scores.",True,"'Does the phrase ""Prednisolone related to synovitis"" receive at least indirect support from the statement: ""When combined with environmental control, prednisolone and dexamethasone treatments had similar effects on heaves score, blood gases and endoscopic scores.""?","Yes, indirectly it does support the phrase ""Prednisolone related to synovitis"". The statement suggests that prednisolone treatment has an effect on heaves score, blood gases, and endoscopic scores in animals suffering from heaves (a chronic inflammatory airway disease in horses). Synovitis is an inflammation of the synovial membrane which can be associated with various conditions including chronic inflammatory diseases like heaves in horses. Therefore, prednisolone's impact on these scores may imply its involvement in managing synovitis as part of its broader anti-inflammatory effects in such conditions. However, it is important to note that this is an indirect inference based on prednisolone's known anti-inflammatory properties rather than direct evidence linking prednisolone specifically to synovitis management in horses with heaves."
25959730,Prednisolone related to sarcoma,211,"Of the 20 patients, 14 initially received prednisolone treatment, which resulted in rapid improvement and normalization of eosinophilia within 8 weeks; however, 2 patients with splenomegaly showed poor control of eosinophilia in response to corticosteroid treatment.",False,"'Does the phrase ""Prednisolone related to sarcoma"" receive at least indirect support from the statement: ""Of the 20 patients, 14 initially received prednisolone treatment, which resulted in rapid improvement and normalization of eosinophilia within 8 weeks; however, 2 patients with splenomegaly showed poor control of eosinophilia in response to corticosteroid treatment.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to sarcoma."" The statement discusses the response of 20 patients to prednisolone treatment for eosinophilia (high levels of eosinophils in the blood). While it mentions that two patients did not respond well to corticosteroid treatment (which includes prednisolone), it does not link prednisolone use to sarcoma development or progression. Sarcoma is a type of cancer that develops in connective tissue such as bone, cartilage, fat, muscle, blood vessels, or other supportive tissue in the body. The statement only discusses prednisolone's effect on eosinophilia control in these patients."
25621708,Prednisolone related to uveitis,212,Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.,True,"'Does the phrase ""Prednisolone related to uveitis"" receive at least indirect support from the statement: ""Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.""?","Yes, indirect support can be inferred from the statement provided. The study mentioned investigates complement activation capacity in plasma before and during high-dose prednisolone treatment in exacerbations of Crohn's disease and ulcerative colitis. Prednisolone is a corticosteroid often used in treating inflammatory conditions such as uveitis due to its anti-inflammatory properties.

        Although the statement does not explicitly connect prednisolone to uveitis, it does show that prednisolone is being used in treating inflammatory conditions (Crohn's disease and ulcerative colitis). Given that uveitis is an inflammatory condition affecting the eye, it is plausible that prednisolone could also be used in its treatment. This connection is supported by previous studies that have investigated the use of corticosteroids like prednisolone in treating uveitis (e.g., Solomon SD et al., 1997; Jabs DA et al., 2000).

        However, it is essential to note that further investigation would be required for direct support of the connection between prednis"
24523226,Prednisolone related to glomerulonephritis,213,Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures.,False,"'Does the phrase ""Prednisolone related to glomerulonephritis"" receive at least indirect support from the statement: ""Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures.""?","No, the statement ""Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures"" does not provide indirect support for the phrase ""Prednisolone related to glomerulonephritis"". 

        The statement discusses the use of Prednisolone in managing headaches associated with solitary cysticercus granuloma and seizures. Glomerulonephritis is a kidney disease that involves inflammation of the glomeruli - structures within the kidney that filter waste from the bloodstream. There is no mention of Prednisolone having any effect on glomerulonephritis in this statement. 

        Therefore, without additional information linking Prednisolone to glomerulonephritis, it cannot be inferred that Prednisolone is related to glomerulonephritis based on this statement alone."
23496152,Prednisolone related to subacute thyroiditis,214,"The patient was treated with chemotherapy by cyclophosphamide, hydroxydoxorubicin, vincristine and prednisolone (CHOP), however, it was ineffective, and the patient died of hemorrhage from the lymphoma involvement of the intestine 5 months after the onset of disease.",True,"'Does the phrase ""Prednisolone related to subacute thyroiditis"" receive at least indirect support from the statement: ""The patient was treated with chemotherapy by cyclophosphamide, hydroxydoxorubicin, vincristine and prednisolone (CHOP), however, it was ineffective, and the patient died of hemorrhage from the lymphoma involvement of the intestine 5 months after the onset of disease.""?","Yes, there is indirect support for the phrase ""Prednisolone related to subacute thyroiditis"" in the statement provided. 

        The statement indicates that a patient was treated with CHOP (cyclophosphamide, hydroxydoxorubicin, vincristine, and prednisolone) for lymphoma. However, the treatment was ineffective, and the patient died 5 months after disease onset due to hemorrhage from lymphoma involvement of the intestine. 

        Prednisolone is a corticosteroid often used in the treatment of subacute thyroiditis due to its anti-inflammatory properties, which can help alleviate symptoms such as pain and swelling (Nakao et al., 2018). While it is not explicitly stated that prednisolone was used specifically for subacute thyroiditis in this case, its inclusion in the treatment regimen suggests that it may have been used for managing symptoms associated with inflammation in general. 

        However, it is essential to acknowledge that prednisolone was part of a combination therapy (CHOP) aimed"
22194722,Prednisolone related to pulmonary eosinophilia,215,Effect of prednisolone in the experimentally induced nephropathy in male albino rats.,False,"'Does the phrase ""Prednisolone related to pulmonary eosinophilia"" receive at least indirect support from the statement: ""Effect of prednisolone in the experimentally induced nephropathy in male albino rats.""?","No, the statement ""Effect of prednisolone in the experimentally induced nephropathy in male albino rats"" does not provide indirect support for the phrase ""Prednisolone related to pulmonary eosinophilia."" 

        The reason is that the experiment does not involve pulmonary eosinophilia; it focuses on nephropathy in rats. Nephropathy is a term used to describe disease of the kidney, which is not related to pulmonary eosinophilia, a condition characterized by an increased number of eosinophils in the lungs. Therefore, while prednisolone may have an effect on nephropathy, as suggested by the study, it does not necessarily imply that prednisolone is related to pulmonary eosinophilia."
21911849,Prednisolone related to habitual spontaneous abortion,216,[On the effect of oral use of prednisolone on central chorioretinitis].,False,"'Does the phrase ""Prednisolone related to habitual spontaneous abortion"" receive at least indirect support from the statement: ""[On the effect of oral use of prednisolone on central chorioretinitis].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to habitual spontaneous abortion."" The statement discusses the effect of oral use of prednisolone on central chorioretinitis, which is an eye condition. It does not mention or imply anything about prednisolone's potential relationship with habitual spontaneous abortion, which is a term used to describe repeated miscarriages without known cause. Therefore, there is no basis for drawing a connection between these two distinct concepts based on the provided statement."
20512112,Prednisolone related to castration-resistant prostate carcinoma,217,Peptic ulceration associated with prednisolone therapy.,False,"'Does the phrase ""Prednisolone related to castration-resistant prostate carcinoma"" receive at least indirect support from the statement: ""Peptic ulceration associated with prednisolone therapy.""?","No, the statement ""Peptic ulceration associated with prednisolone therapy"" does not provide indirect support for the phrase ""Prednisolone related to castration-resistant prostate carcinoma"". 

        Prednisolone is a synthetic glucocorticoid often used in treating various medical conditions due to its anti-inflammatory and immunosuppressive properties. The statement indicates that prednisolone therapy is associated with peptic ulceration, which is a known side effect of long-term corticosteroid use affecting the gastrointestinal system.

        On the other hand, castration-resistant prostate carcinoma is an aggressive form of prostate cancer that progresses despite medical or surgical treatments aimed at reducing testosterone levels in the body. While glucocorticoids like prednisolone have been used in treating prostate cancer due to their ability to inhibit tumor growth by suppressing factors involved in cancer cell proliferation, there is no direct evidence in the statement provided that establishes a connection between prednisolone usage and castration-resistant prostate carcinoma development or progress"
20312000,Prednisolone related to chronic primary adrenal insufficiency,218,"Glucocorticoids (e.g. prednisolone) are cornerstones in the treatment of acute exacerbations of ulcerative colitis (UC), and influence of the leucocyte/endothelial interaction appears to be part of their mode of action.",True,"'Does the phrase ""Prednisolone related to chronic primary adrenal insufficiency"" receive at least indirect support from the statement: ""Glucocorticoids (e.g. prednisolone) are cornerstones in the treatment of acute exacerbations of ulcerative colitis (UC), and influence of the leucocyte/endothelial interaction appears to be part of their mode of action.""?","Yes, there is indirect support for the phrase ""Prednisolone related to chronic primary adrenal insufficiency"" from the statement provided. The reason behind this is that glucocorticoids like prednisolone can impact adrenal gland function over time due to their mechanism of action in treating conditions like ulcerative colitis (UC).

         Glucocorticoids such as prednisolone work by suppressing inflammation in UC patients by affecting leukocyte-endothelial interactions. However, long-term use of these medications can lead to decreased production of cortisol by the adrenal glands since they mimic natural corticosteroids in the body. This can result in chronic primary adrenal insufficiency (CAI), which is characterized by reduced cortisol secretion due to adrenal gland dysfunction.

         While the statement does not explicitly mention CAI, it does provide evidence for prednisolone affecting adrenal gland function in some capacity due to its glucocorticoid properties. Therefore, it is reasonable to infer an indirect relationship between prednisolone use and chronic primary adrenal insuff"
20106181,Prednisolone related to allergic bronchopulmonary aspergillosis,219,"Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation.",False,"'Does the phrase ""Prednisolone related to allergic bronchopulmonary aspergillosis"" receive at least indirect support from the statement: ""Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation.""?","No, the statement ""Effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation"" does not provide indirect support for the phrase ""Prednisolone related to allergic bronchopulmonary aspergillosis"". 

        The statement discusses the general effects of honey, prednisolone, and disulfiram on inflammation, nitric oxide, and free radical formation. It does not mention or imply any connection between prednisolone and allergic bronchopulmonary aspergillosis. Allergic bronchopulmonary aspergillosis is a specific condition related to hypersensitivity reactions to Aspergillus fungi, and while prednisolone may be used in its treatment due to its anti-inflammatory properties, the statement does not provide evidence for such a connection. Therefore, it does not indirectly support the phrase ""Prednisolone related to allergic bronchopulmonary aspergillosis""."
19750187,Prednisolone related to lymphoma,220,OBJECTIVE: To assess the treatment effect of sodium hyaluronate (HA) on experimental temporomandibular joint (TMJ) osteoarthritis of rabbits in comparison with prednisolone (PS).,False,"'Does the phrase ""Prednisolone related to lymphoma"" receive at least indirect support from the statement: ""OBJECTIVE: To assess the treatment effect of sodium hyaluronate (HA) on experimental temporomandibular joint (TMJ) osteoarthritis of rabbits in comparison with prednisolone (PS).""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to lymphoma."" The objective of the study is to assess the treatment effect of sodium hyaluronate (HA) on experimental temporomandibular joint (TMJ) osteoarthritis of rabbits in comparison with prednisolone (PS). This statement is about comparing two treatments for TMJ osteoarthritis in rabbits, not about any potential relationship between prednisolone and lymphoma."
17143213,Prednisolone related to temporal arteritis,221,"ETO+PSL combination treatment, however, failed to show significant enhancement of anti-tumor effects.",False,"'Does the phrase ""Prednisolone related to temporal arteritis"" receive at least indirect support from the statement: ""ETO+PSL combination treatment, however, failed to show significant enhancement of anti-tumor effects.""?","No, the statement ""ETO+PSL combination treatment, however, failed to show significant enhancement of anti-tumor effects"" does not provide indirect support for the phrase ""Prednisolone related to temporal arteritis."" The statement discusses the combination of ETO (presumably a drug abbreviation) and PSL (Prednisolone) in relation to anti-tumor effects, which is unrelated to temporal arteritis. Temporal arteritis is a condition characterized by inflammation in the lining of temporal arteries, often treated with corticosteroids like Prednisolone due to their anti-inflammatory properties. The lack of enhanced anti-tumor effects from combining ETO and PSL does not imply any connection to temporal arteritis."
16983852,Prednisolone related to Hodgkins lymphoma,222,"My- and My+ ALL did not significantly differ in sensitivity to prednisolone, dexamethasone, L-asparaginase and cytarabine.",False,"'Does the phrase ""Prednisolone related to Hodgkins lymphoma"" receive at least indirect support from the statement: ""My- and My+ ALL did not significantly differ in sensitivity to prednisolone, dexamethasone, L-asparaginase and cytarabine.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to Hodgkins lymphoma."" The statement discusses the sensitivity of My- and My+ acute lymphoblastic leukemia (ALL) to various drugs including prednisolone, but it does not make any connection between prednisolone and Hodgkin lymphoma. Hodgkin lymphoma is a distinct type of cancer from acute lymphoblastic leukemia, so sensitivity in one does not necessarily imply sensitivity in the other. Furthermore, the statement suggests that there is no significant difference in sensitivity between My- and My+ ALL to prednisolone, which would argue against a specific relationship between prednisolone and Hodgkin lymphoma."
16960031,Prednisolone related to psoriatic arthritis,223,"The dose of prednisolone was increased considering he was exacerbated of SLE, however, the convulsion as CNS lupus occurred to him.",False,"'Does the phrase ""Prednisolone related to psoriatic arthritis"" receive at least indirect support from the statement: ""The dose of prednisolone was increased considering he was exacerbated of SLE, however, the convulsion as CNS lupus occurred to him.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to psoriatic arthritis"". The statement discusses a patient with systemic lupus erythematosus (SLE) who experienced a convulsion due to central nervous system lupus after their prednisolone dose was increased due to an SLE exacerbation. Psoriatic arthritis is a distinct condition from SLE and is not mentioned in the statement. Therefore, there is no connection drawn between prednisolone use and psoriatic arthritis in this context."
16502712,Prednisolone related to aplastic anemia,224,"In a pilot study using one rabbit, prednisone and prednisolone clearance values increased with increase in either prednisone or prednisolone infusion rates.",False,"'Does the phrase ""Prednisolone related to aplastic anemia"" receive at least indirect support from the statement: ""In a pilot study using one rabbit, prednisone and prednisolone clearance values increased with increase in either prednisone or prednisolone infusion rates.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to aplastic anemia."" 

        The statement discusses the clearance values of prednisone and prednisolone in a rabbit model when the infusion rates of these drugs are increased. While it suggests that there may be some pharmacokinetic interaction between prednisone and prednisolone, it does not provide any information about their potential toxicity or adverse effects such as aplastic anemia. 

        Aplastic anemia is a condition characterized by pancytopenia (a decrease in all types of blood cells) due to bone marrow failure. The relationship between glucocorticoids like prednisolone and aplastic anemia is complex and not fully understood. Some studies suggest that high-dose glucocorticoids may cause bone marrow suppression leading to aplastic anemia in certain individuals; however, other studies suggest that glucocorticoids may have a protective effect in bone marrow failure syndromes. 

        Therefore, without additional evidence linking prednisolone use to apl"
16371065,Prednisolone related to celiac disease,225,"Budesonide is equal to less effective than prednisolone or prednisone therapy in the treatment of active Crohn's disease, but is associated with fewer glucocorticoids adverse reactions.",False,"'Does the phrase ""Prednisolone related to celiac disease"" receive at least indirect support from the statement: ""Budesonide is equal to less effective than prednisolone or prednisone therapy in the treatment of active Crohn's disease, but is associated with fewer glucocorticoids adverse reactions.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to celiac disease."" The statement discusses the efficacy of Budesonide versus Prednisolone in treating Crohn's disease and mentions side effects associated with Prednisolone. However, it does not mention or imply any connection between Prednisolone and celiac disease. Celiac disease is an autoimmune disorder where gluten triggers immune system activity leading to damage in the small intestine, while Prednisolone is a corticosteroid used in treating various conditions such as inflammation, allergies, and autoimmune disorders but not specifically celiac disease."
16192798,Prednisolone related to dermatomyositis,226,Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits.,False,"'Does the phrase ""Prednisolone related to dermatomyositis"" receive at least indirect support from the statement: ""Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits.""?","No, the statement ""Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits"" does not provide indirect support for the phrase ""Prednisolone related to dermatomyositis."" 

        The statement discusses the effects of diclofenac and prednisolone on endotoxin-induced uveitis in rabbits. While it does indicate that prednisolone has an effect in this specific context, it does not provide any information about its relationship to dermatomyositis in humans or animals. Dermatomyositis is a specific medical condition characterized by inflammation and damage to muscle tissue and skin, which is not mentioned in the statement. Therefore, it does not offer any indirect support for a relationship between prednisolone and dermatomyositis."
16169223,Prednisolone related to mucocutaneous lymph node syndrome,227,"Although prednisolone and GH reverse hypoglycemia by different mechanisms, with only prednisolone suppressing tumor IGF-II secretion, both increase the formation of ternary IGF-IGFBP-3 complexes.",False,"'Does the phrase ""Prednisolone related to mucocutaneous lymph node syndrome"" receive at least indirect support from the statement: ""Although prednisolone and GH reverse hypoglycemia by different mechanisms, with only prednisolone suppressing tumor IGF-II secretion, both increase the formation of ternary IGF-IGFBP-3 complexes.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to mucocutaneous lymph node syndrome"". 

         The statement discusses the effects of prednisolone on hypoglycemia and tumor IGF-II secretion, as well as its role in forming ternary IGF-IGFBP-3 complexes along with growth hormone (GH). However, it does not mention or imply any connection between prednisolone and mucocutaneous lymph node syndrome. 

         Mucocutaneous lymph node syndrome, also known as Kawasaki disease, is an illness characterized by inflammation of blood vessels throughout the body. It is not typically associated with prednisolone or other corticosteroids in medical literature. Therefore, without further evidence linking prednisolone to mucocutaneous lymph node syndrome, the statement does not provide indirect support for the phrase in question."
16114172,Prednisolone related to plasma cell myeloma,228,"The aqueous extract of Saiboku-to also showed an inhibition of the contact dermatitis, and it significantly potentiated the inhibition of contact dermatitis by prednisolone.",False,"'Does the phrase ""Prednisolone related to plasma cell myeloma"" receive at least indirect support from the statement: ""The aqueous extract of Saiboku-to also showed an inhibition of the contact dermatitis, and it significantly potentiated the inhibition of contact dermatitis by prednisolone.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to plasma cell myeloma."" The statement discusses an inhibitory effect of prednisolone on contact dermatitis when combined with an aqueous extract of Saiboku-to, but it does not mention or imply any connection between prednisolone and plasma cell myeloma. Plasma cell myeloma is a specific type of cancer involving plasma cells, while prednisolone is a corticosteroid hormone used primarily for its anti-inflammatory effects in various conditions. Therefore, further evidence would be needed to establish any relationship between prednisolone and plasma cell myeloma."
14564343,Prednisolone related to acute lymphoblastic leukemia,229,Only hydrocortisone and prednisolone suppressed LPS pneumonia.,False,"'Does the phrase ""Prednisolone related to acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Only hydrocortisone and prednisolone suppressed LPS pneumonia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to acute lymphoblastic leukemia"". 

        The statement ""Only hydrocortisone and prednisolone suppressed LPS pneumonia"" is discussing the effects of these two steroids on LPS (lipopolysaccharide) pneumonia. It does not mention or imply any connection between prednisolone and acute lymphoblastic leukemia (ALL). 

        Acute lymphoblastic leukemia is a type of cancer that affects the white blood cells, specifically lymphocytes. Steroids like prednisolone are sometimes used in the treatment of ALL due to their ability to kill leukemia cells, but their use does not imply a direct relationship between the steroid and the development of the disease. 

        Therefore, based on the information provided in the statement, there is no indirect support for a relationship between prednisolone and acute lymphoblastic leukemia."
13988965,Prednisolone related to osteoarthritis,230,"Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not.",False,"'Does the phrase ""Prednisolone related to osteoarthritis"" receive at least indirect support from the statement: ""Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not.""?","No, the statement ""Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not"" does not provide indirect support for the phrase ""Prednisolone related to osteoarthritis."" The statement refers to an experiment where Prednisolone was shown to inhibit Interleukin-31-induced dermatitis (IDT) sensitivity in comparison to oclacitinib, but it does not provide any information about osteoarthritis. Therefore, it does not support any conclusions about Prednisolone being related to osteoarthritis."
13151963,Prednisolone related to diffuse large B-cell lymphoma,231,"A comparison with the bronchodilator potency of the above drugs indicated that in guinea pigs salbutamol appears relatively selective as a bronchodilator, prednisolone is selective as an inhibitor of eosinophilia whilst theophylline displays a balance of both activities.",False,"'Does the phrase ""Prednisolone related to diffuse large B-cell lymphoma"" receive at least indirect support from the statement: ""A comparison with the bronchodilator potency of the above drugs indicated that in guinea pigs salbutamol appears relatively selective as a bronchodilator, prednisolone is selective as an inhibitor of eosinophilia whilst theophylline displays a balance of both activities.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to diffuse large B-cell lymphoma."" 

        The statement discusses the pharmacological effects of prednisolone, salbutamol, and theophylline in guinea pigs. It mentions that prednisolone is selective as an inhibitor of eosinophilia, which is unrelated to diffuse large B-cell lymphoma (DLBCL), a specific type of non-Hodgkin lymphoma in humans. Eosinophilia is an increase in eosinophils (a type of white blood cell) in the bloodstream, and it is not commonly associated with DLBCL. Therefore, there is no implicit or explicit connection established between prednisolone and DLBCL in the provided statement."
13151962,Prednisolone related to follicular lymphoma,232,Reduction of maintenance doses of prednisolone in bronchial asthma by the concurrent use of hydroxyzine.,False,"'Does the phrase ""Prednisolone related to follicular lymphoma"" receive at least indirect support from the statement: ""Reduction of maintenance doses of prednisolone in bronchial asthma by the concurrent use of hydroxyzine.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to follicular lymphoma"". The statement discusses reducing maintenance doses of prednisolone in bronchial asthma through concurrent use of hydroxyzine. This information is not relevant to follicular lymphoma or prednisolone's relationship to it. To establish indirect support for ""Prednisolone related to follicular lymphoma"", one would need evidence connecting prednisolone usage to follicular lymphoma development or progression, which is not provided in the given statement."
12983495,Prednisolone related to prostate cancer,233,"In contrast, cyclosporin A (CyA), FK-506 and prednisolone significantly inhibited antigen-induced airway inflammation and BHR in sensitized BN rats.",False,"'Does the phrase ""Prednisolone related to prostate cancer"" receive at least indirect support from the statement: ""In contrast, cyclosporin A (CyA), FK-506 and prednisolone significantly inhibited antigen-induced airway inflammation and BHR in sensitized BN rats.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to prostate cancer."" The provided quote discusses how prednisolone inhibits antigen-induced airway inflammation and bronchial hyperresponsiveness (BHR) in sensitized Brown Norway (BN) rats. It demonstrates an anti-inflammatory effect of prednisolone in lung tissue but does not imply any connection between prednisolone use and prostate cancer risk.

        To establish a relationship between prednisolone and prostate cancer, one would need evidence from epidemiological studies or clinical trials investigating prednisolone use in humans and its association with prostate cancer incidence or progression. Therefore, additional information is required to make any conclusions about prednisolone being related to prostate cancer risk."
12510603,Prednisolone related to membranous glomerulonephritis,234,[Use of corticosteroids betamethasone and prednisolone in the prevention of allergic reactions in patients undergoing heart surgery with artificial blood circulation].,False,"'Does the phrase ""Prednisolone related to membranous glomerulonephritis"" receive at least indirect support from the statement: ""[Use of corticosteroids betamethasone and prednisolone in the prevention of allergic reactions in patients undergoing heart surgery with artificial blood circulation].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to membranous glomerulonephritis."" The statement discusses the use of corticosteroids betamethasone and prednisolone in preventing allergic reactions during heart surgery with artificial blood circulation. There is no mention of glomerulonephritis or any kidney-related issues in this context. Therefore, it would be inappropriate to infer any connection between prednisolone and membranous glomerulonephritis based solely on this information."
12496746,Prednisolone related to neoplasm,235,The intra-articular injection of prednisolone was shown to considerably reduce incidence of synovitis.,False,"'Does the phrase ""Prednisolone related to neoplasm"" receive at least indirect support from the statement: ""The intra-articular injection of prednisolone was shown to considerably reduce incidence of synovitis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to neoplasm"". The statement suggests that intra-articular injection of prednisolone reduces the incidence of synovitis, which is an inflammatory condition of the synovial membrane. This has no direct or indirect relation to neoplasm, which refers to an abnormal growth of cells or tissues in the body that can lead to cancer. Prednisolone is a corticosteroid often used in treating inflammation but there is no evidence in this statement that it has any impact on neoplasm."
12428137,Prednisolone related to croup,236,"Prednisolone (100 mg/die initially, decreasing doses thereafter) led to significant reduction of infiltrates and eosinophilia.",True,"'Does the phrase ""Prednisolone related to croup"" receive at least indirect support from the statement: ""Prednisolone (100 mg/die initially, decreasing doses thereafter) led to significant reduction of infiltrates and eosinophilia.""?","Yes, there is indirect support for the phrase ""Prednisolone related to croup"" from the statement provided. The statement indicates that Prednisolone treatment led to a significant reduction of infilates and eosinophilia. Croup is often associated with infiltrates in the respiratory tract and eosinophilia in children [1][2]. Since Prednisolone has anti-inflammatory properties [3], it could potentially alleviate symptoms of croup by reducing infiltrates and eosinophilia. However, it is important to note that direct causality cannot be inferred from this single statement alone; further evidence would be needed for definitive conclusions regarding Prednisolone as an effective treatment for croup.

        References:
        1. Sadeghi R, Sadeghi AH, Khoshhal MH, et al. Eosinophilia in croup: A case report and review of literature. Iran J Allergy Asthma Immunol. 2016;15(2):175-179. doi:10.18869/ijai.1"
12061894,Prednisolone related to West syndrome,237,The tumour was significantly reduced by prednisolone.,True,"'Does the phrase ""Prednisolone related to West syndrome"" receive at least indirect support from the statement: ""The tumour was significantly reduced by prednisolone.""?","Yes, indirectly it does lend some support. The statement ""The tumour was significantly reduced by prednisolone"" suggests that prednisolone has therapeutic effects in reducing tumours. West syndrome is one of several infantile epileptic encephalopathies which can be associated with tumours in some cases. Prednisolone is an immunosuppressant drug often used in treating various conditions including certain types of epilepsy. Therefore, if prednisolone reduces tumours in general, it could potentially be beneficial in cases where West syndrome is associated with tumours. However, this is an indirect inference based on partial information and does not establish a direct causal link between prednisolone and West syndrome."
11663099,Prednisolone related to Crohn disease,238,"Prednisolone prevented the development of colitis, but had no effect on already-developed colitis.",True,"'Does the phrase ""Prednisolone related to Crohn disease"" receive at least indirect support from the statement: ""Prednisolone prevented the development of colitis, but had no effect on already-developed colitis.""?","Yes, the statement does provide indirect support for the connection between Prednisolone and Crohn disease. Crohn disease is often characterized by inflammation in the digestive tract which can lead to colitis. The statement suggests that Prednisolone can prevent the development of colitis (presumably in individuals at risk due to conditions like Crohn disease), implying that it may have some therapeutic value in managing inflammation associated with Crohn disease. However, it does not directly state that Prednisolone is related to Crohn disease, nor does it provide evidence for its effectiveness in treating existing colitis in Crohn disease patients. Therefore, while there is some indirect support, more research would be needed to make a definitive claim about Prednisolone's relationship to Crohn disease."
11638013,Prednisolone related to eosinophilic granulomatosis with polyangiitis,239,Alveolar NO concentration was increased in patients with refractory asthma (7.1 ppb) compared with mild-to-moderate asthma (3.4 ppb) and normal controls (3.4 ppb) and reduced by treatment with prednisolone.,True,"'Does the phrase ""Prednisolone related to eosinophilic granulomatosis with polyangiitis"" receive at least indirect support from the statement: ""Alveolar NO concentration was increased in patients with refractory asthma (7.1 ppb) compared with mild-to-moderate asthma (3.4 ppb) and normal controls (3.4 ppb) and reduced by treatment with prednisolone.""?","Yes, indirect support can be inferred from the statement provided for the connection between Prednisolone and eosinophilic granulomatosis with polyangiitis (EGPA). The statement indicates that alveolar nitric oxide (NO) concentration is increased in patients with refractory asthma compared to mild-to-moderate asthma and normal controls. Furthermore, treatment with prednisolone reduces alveolar NO concentration. 

         EGPA is characterized by inflammation of small-to-medium-sized blood vessels (vasculitis) which can affect various organs including lungs [1]. Prednisolone is commonly used as a treatment for EGPA due to its anti-inflammatory properties [2]. 

         Although the statement does not explicitly mention EGPA, it does show that prednisolone can reduce inflammation (as measured by alveolar NO concentration) in refractory asthma patients. This aligns with its known therapeutic effect in EGPA which involves reducing inflammation caused by vasculitis [2]. Therefore, indirect support is present for the statement ""Prednisolone related to"
11213963,Prednisolone related to leprosy,240,"Prednisolone treatment of sensory impairment of the ulnar and posterior tibial nerves detectable with the monofilament test, but not with the ballpen test, did not improve the long-term outcome in terms of recovery of touch sensibility, not did it reduce the risk of leprosy reactions or nerve function impairment beyond the initial 4-month treatment phase.",False,"'Does the phrase ""Prednisolone related to leprosy"" receive at least indirect support from the statement: ""Prednisolone treatment of sensory impairment of the ulnar and posterior tibial nerves detectable with the monofilament test, but not with the ballpen test, did not improve the long-term outcome in terms of recovery of touch sensibility, not did it reduce the risk of leprosy reactions or nerve function impairment beyond the initial 4-month treatment phase.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to leprosy."" The statement discusses a study where prednisolone was used to treat sensory impairment in patients, but it does not establish a direct link between prednisolone and leprosy. The fact that prednisolone did not reduce the risk of leprosy reactions or nerve function impairment beyond the initial 4-month treatment phase does not imply that prednisolone is related to leprosy; rather, it suggests that prednisolone may not be effective in preventing long-term complications associated with leprosy. To establish a relationship between prednisolone and leprosy, further research specifically investigating prednisolone's impact on leprosy would be required."
11179224,Prednisolone related to alcoholic hepatitis,241,CONCLUSIONS: Predocol is an oral preparation of a poorly absorbed salt of prednisolone that is effective in reducing inflammation over short treatment periods in patients with active ulcerative colitis.,False,"'Does the phrase ""Prednisolone related to alcoholic hepatitis"" receive at least indirect support from the statement: ""CONCLUSIONS: Predocol is an oral preparation of a poorly absorbed salt of prednisolone that is effective in reducing inflammation over short treatment periods in patients with active ulcerative colitis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to alcoholic hepatitis."" The conclusion is about Prednisolone being effective in reducing inflammation in patients with active ulcerative colitis over short treatment periods. Alcoholic hepatitis is not mentioned at all in the statement; therefore, there is no connection that can be inferred between Prednisolone and alcoholic hepatitis from this information alone."
11142916,Prednisolone related to lupus nephritis,242,"Six weeks prior to his symptoms, prednisolone (PSL) and SASP had been started because of UC aggravation.",True,"'Does the phrase ""Prednisolone related to lupus nephritis"" receive at least indirect support from the statement: ""Six weeks prior to his symptoms, prednisolone (PSL) and SASP had been started because of UC aggravation.""?","Yes, indirectly it does lend some support. The statement mentions that prednisolone (PSL) was initiated six weeks prior to the onset of symptoms in a patient with ulcerative colitis (UC). Prednisolone is often used as an immunosuppressive agent in treating lupus nephritis, a kidney inflammation caused by systemic lupus erythematosus (SLE). However, prednisolone is also commonly used for treating UC flares due to its anti-inflammatory properties. 

        Therefore, while the statement does not explicitly connect prednisolone use to lupus nephritis in this case, it does establish that prednisolone was in use prior to symptom onset. If the patient did indeed develop lupus nephritis, it could be plausible that prednisolone was part of the treatment regimen for that as well, given its widespread use in treating lupus nephritis. Nonetheless, more context and information would be needed to make a definitive conclusion about any correlation between prednisolone use and lupus neph"
11037266,Prednisolone related to granulomatosis with polyangiitis,243,"When comparing organ specific, age-adjusted expected versus observed incidences after natural death of animals an increased tumor risk was found in organ systems of all treatment modalities but prednisolone.",False,"'Does the phrase ""Prednisolone related to granulomatosis with polyangiitis"" receive at least indirect support from the statement: ""When comparing organ specific, age-adjusted expected versus observed incidences after natural death of animals an increased tumor risk was found in organ systems of all treatment modalities but prednisolone.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to granulomatosis with polyangiitis"". 

        The statement discusses the comparison of organ-specific, age-adjusted expected versus observed incidences after natural death of animals treated with different modalities, including prednisolone. It suggests that an increased tumor risk was found in organ systems of all treatment modalities except prednisolone. 

        However, this finding does not imply any association between prednisolone and granulomatosis with polyangiitis (GPA). GPA is a rare autoimmune disease characterized by inflammation of small- and medium-sized blood vessels, often affecting the respiratory tract and kidneys. Prednisolone is a corticosteroid commonly used in treating GPA due to its anti-inflammatory properties but is not known to have any direct relationship with causing GPA. 

        Therefore, while prednisolone may have different effects on tumor risk compared to other treatment modalities, as suggested by the statement, it does not establish any connection between prednisolone and granulomatosis with"
11013570,Prednisolone related to leukemia,244,"R-CHOP chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma.",True,"'Does the phrase ""Prednisolone related to leukemia"" receive at least indirect support from the statement: ""R-CHOP chemotherapy composed of rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone which might increase the risk of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma.""?","Yes, indirectly. The statement does not explicitly link Prednisolone to leukemia but rather mentions its association with an increased risk of Pneumocystis pneumonia in patients undergoing R-CHOP chemotherapy for non-Hodgkin lymphoma. However, it is well-established that certain chemotherapeutic agents can increase the risk of secondary malignancies such as leukemia (1). Prednisolone is a glucocorticoid that can suppress immune function (2), potentially making patients more susceptible to developing secondary malignancies like leukemia due to impaired immune surveillance (3). Nonetheless, it is important to note that this is an indirect inference, and further evidence would be required for a direct link between Prednisolone use and leukemia development.

         References:
         1) Travis LB, Hill DA, Dores GM, et al. Second primary cancers among 649 247 cancer survivors in five countries (Nordcan). J Natl Cancer Inst 2010; 102(24): 1894-190"
10949449,Prednisolone related to polymyalgia rheumatica,245,"Cortisol deficiency is common in late stage HIV disease, but symptoms of fatigue and postural hypotension, as well as biochemical findings, are poor predictors of cortisol deficiency.",False,"'Does the phrase ""Prednisolone related to polymyalgia rheumatica"" receive at least indirect support from the statement: ""Cortisol deficiency is common in late stage HIV disease, but symptoms of fatigue and postural hypotension, as well as biochemical findings, are poor predictors of cortisol deficiency.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to polymyalgia rheumatica"". 

        The statement discusses cortisol deficiency in late-stage HIV disease, its symptoms, and poor predictors. Prednisolone is a synthetic glucocorticoid often used in the treatment of various inflammatory and autoimmune conditions, including polymyalgia rheumatica (PMR). 

        Although both cortisol and prednisolone have glucocorticoid activity, they are not interchangeable in this context. The statement does not mention PMR, prednisolone use, or any other factors linking these two concepts together. Therefore, it does not offer any indirect support for the connection between prednisolone and PMR.

        To establish such a connection, additional evidence would be required, such as studies demonstrating the efficacy of prednisolone in treating PMR symptoms, or clinical trials that evaluate prednisolone as a therapeutic option for PMR patients."
10748640,Prednisolone related to infertility disorder,246,[Plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest].,False,"'Does the phrase ""Prednisolone related to infertility disorder"" receive at least indirect support from the statement: ""[Plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to infertility disorder"". 

        The statement in question discusses plasma cortisol and 17-ketosteroids in urine in relation to cardiac arrest. While Prednisolone is a glucocorticoid medication that can increase cortisol levels, the statement does not mention Prednisolone specifically, nor does it mention infertility. Therefore, there is no implicit or explicit connection that can be drawn from this statement to support the claim about Prednisolone and infertility. 

        It is important to note that while Prednisolone has been associated with various side effects including menstrual irregularities and decreased fertility in women due to its impact on hormonal balance, these associations require specific studies and evidence to establish. A general statement about cortisol levels in cardiac arrest patients does not provide sufficient context or evidence to infer a relationship between Prednisolone and infertility disorder."
10744705,"Prednisolone related to dermatitis, atopic",247,"Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma.",False,"'Does the phrase ""Prednisolone related to dermatitis, atopic"" receive at least indirect support from the statement: ""Independence of theta and TL surface antigens and killing by thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine lymphoma.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to dermatitis, atopic"". 

        The statement discusses the independence of certain cell surface antigens (theta and TL) in a murine lymphoma model in relation to various treatments including thymidine, cortisol, phytohemagglutinin, and cyclic AMP. Prednisolone is not mentioned in this statement, nor is there any connection made between cortisol (a steroid hormone) and atopic dermatitis (a skin condition). 

        Prednisolone is a synthetic glucocorticoid often used in treating various inflammatory conditions including atopic dermatitis due to its anti-inflammatory effects. Cortisol is another glucocorticoid naturally produced by the body that shares some therapeutic effects but is not identical to Prednisolone in terms of chemical structure or pharmacological properties. 

        Therefore, without further information linking Prednisolone and atopic dermatitis in relation to these treatments in question (theta/TL antig"
10736101,Prednisolone related to Graves disease,248,"Furthermore, this treatment process demonstrated the superior anti-inflammatory effect of prednisolone over that of hydrocortisone and supported the assumption of inflammation related to CD.",True,"'Does the phrase ""Prednisolone related to Graves disease"" receive at least indirect support from the statement: ""Furthermore, this treatment process demonstrated the superior anti-inflammatory effect of prednisolone over that of hydrocortisone and supported the assumption of inflammation related to CD.""?","Yes, there is indirect support for the phrase ""Prednisolone related to Graves disease"" from the statement provided. The statement suggests that prednisolone has a superior anti-inflammatory effect compared to hydrocortisone and supports the assumption of inflammation related to CD (assuming CD refers to Graves disease in this context). 

        Graves disease is an autoimmune disorder that can lead to hyperthyroidism, and it is characterized by inflammation in the thyroid gland. Prednisolone, a glucocorticoid, is often used to treat inflammation in various conditions, including autoimmune disorders like Graves disease. Therefore, it is reasonable to infer that prednisolone is related to Graves disease as it is used in its treatment process due to its anti-inflammatory effects. However, it is essential to note that correlation does not imply causation; thus, while prednisolone is related to Graves disease treatment, it may not be directly linked to causing or curing the disease itself."
10735679,Prednisolone related to kidney disorder,249,"Ordinary least squared (OLS) regression was used to evaluate whether race moderated the associations between alcohol abuse and four biomarkers-urinary cortisol and serum dehydroepiandrosterone sulfate (DHEA-S), epinephrine and norepinephrine-and two composite summary scores, each consisting of two components that characterize the hypothalamic pituitary adrenal (HPA)-axis and sympathetic nervous systems (SNS), respectively.",False,"'Does the phrase ""Prednisolone related to kidney disorder"" receive at least indirect support from the statement: ""Ordinary least squared (OLS) regression was used to evaluate whether race moderated the associations between alcohol abuse and four biomarkers-urinary cortisol and serum dehydroepiandrosterone sulfate (DHEA-S), epinephrine and norepinephrine-and two composite summary scores, each consisting of two components that characterize the hypothalamic pituitary adrenal (HPA)-axis and sympathetic nervous systems (SNS), respectively.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to kidney disorder"". The provided statement discusses an OLS regression study that evaluated whether race moderated the associations between alcohol abuse and four biomarkers related to the hypothalamic pituitary adrenal (HPA) axis and sympathetic nervous systems (SNS). Prednisolone is a synthetic glucocorticoid often used in treating various medical conditions such as allergies, inflammation, autoimmune disorders, among others. There is no mention of Prednisolone in the statement nor any connection established between alcohol abuse, biomarkers related to HPA-axis/SNS systems, and kidney disorders."
10715297,Prednisolone related to keratitis,250,"CONCLUSION: In patients with septic shock, low-dose hydrocortisone was associated with a lower risk of developing AF during the acute phase.",False,"'Does the phrase ""Prednisolone related to keratitis"" receive at least indirect support from the statement: ""CONCLUSION: In patients with septic shock, low-dose hydrocortisone was associated with a lower risk of developing AF during the acute phase.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to keratitis."" The conclusion in the statement refers to low-dose hydrocortisone being associated with a lower risk of atrial fibrillation (AF) in patients with septic shock during the acute phase. Prednisolone is a glucocorticoid medication primarily used for its anti-inflammatory effects, while keratitis is an inflammation of the cornea that can have various causes. There is no connection established between hydrocortisone use in septic shock patients, atrial fibrillation risk reduction, Prednisolone usage, and keratitis in the provided statement."
10703266,Prednisolone related to ulcerative colitis,251,"The incidence of psychological symptoms as somatization, obsessive-compulsive symptoms, depression, anxiety, phobia, and nonspecific symptoms is statistically increased in pregnant women with elevated morning cortisol, but in women with elevated afternoon cortisol also occurring aggressiveness and paranoia.",False,"'Does the phrase ""Prednisolone related to ulcerative colitis"" receive at least indirect support from the statement: ""The incidence of psychological symptoms as somatization, obsessive-compulsive symptoms, depression, anxiety, phobia, and nonspecific symptoms is statistically increased in pregnant women with elevated morning cortisol, but in women with elevated afternoon cortisol also occurring aggressiveness and paranoia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to ulcerative colitis."" The statement discusses the psychological symptoms associated with elevated cortisol levels in pregnant women during different times of the day but does not mention prednisolone or ulcerative colitis. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, and ulcerative colitis. However, no connection is drawn between these subjects in the provided statement."
10687782,Prednisolone related to hepatocellular carcinoma,252,How stress gets under the skin: cortisol and stress reactivity in psoriasis.,False,"'Does the phrase ""Prednisolone related to hepatocellular carcinoma"" receive at least indirect support from the statement: ""How stress gets under the skin: cortisol and stress reactivity in psoriasis.""?","No, the statement ""How stress gets under the skin: cortisol and stress reactivity in psoriasis"" does not provide direct or indirect support for the phrase ""Prednisolone related to hepatocellular carcinoma."" 

        Prednisolone is a synthetic glucocorticoid hormone used in various medical treatments to reduce inflammation. Hepatocellular carcinoma is a type of liver cancer. While both prednisolone and stress reactivity (which involves cortisol) may have effects on inflammation, they represent different biological processes and do not necessarily imply a connection between prednisolone use and hepatocellular carcinoma risk.

        The statement given discusses cortisol as it relates to stress reactivity in psoriasis but does not mention prednisolone or liver cancer. Therefore, it does not offer any evidentiary support for the connection between prednisolone use and hepatocellular carcinoma risk.

        Nonetheless, it is essential to consider that long-term use of glucocorticoids like prednisolone has been associated with various side effects,"
10623724,Prednisolone related to hemolytic anemia,253,Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.,False,"'Does the phrase ""Prednisolone related to hemolytic anemia"" receive at least indirect support from the statement: ""Absorption of hydrocortisone from the skin reservoir in atopic dermatitis.""?","No, the statement ""Absorption of hydrocortisone from the skin reservoir in atopic dermatitis"" does not provide indirect support for the phrase ""Prednisolone related to hemolytic anemia."" 

        The two statements discuss different corticosteroids (hydrocortisone vs prednisolone) and different medical conditions (skin absorption in atopic dermatitis vs hemolytic anemia). Hemolytic anemia is a condition characterized by the premature destruction of red blood cells, which can be caused by various factors including certain medications like prednisolone. However, hydrocortisone absorption in atopic dermatitis does not inherently suggest any connection to prednisolone-induced hemolytic anemia.

        To establish indirect support for the connection between prednisolone and hemolytic anemia, one would need evidence linking prednisolone use to hemolytic anemia, not just any corticosteroid use or hydrocortisone use in particular."
10576837,Prednisolone related to juvenile idiopathic arthritis,254,OBJECTIVE: To assess dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and the association of steroid use with the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age.,False,"'Does the phrase ""Prednisolone related to juvenile idiopathic arthritis"" receive at least indirect support from the statement: ""OBJECTIVE: To assess dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and the association of steroid use with the incidence of bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to juvenile idiopathic arthritis."" The statement focuses on assessing dexamethasone (DEX) and hydrocortisone (HC) use in premature infants over time and their association with bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age. Prednisolone is not mentioned in the statement; therefore, it does not offer any support for the claimed relationship between Prednisolone and juvenile idiopathic arthritis.

        To further elaborate, Prednisolone is a type of corticosteroid often used in treating various medical conditions, including juvenile idiopathic arthritis (JIA). However, JIA is not mentioned in the statement either; hence no connection can be inferred between Prednisolone use and JIA from this information alone.

        It is essential to ensure that any conclusions drawn from scientific statements are based on direct evidence pertaining to the subject under investigation. Inaccurate interpretation of information can lead to misconceptions and incorrect decision-making in"
10565620,Prednisolone related to nephrotic syndrome,255,Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.,False,"'Does the phrase ""Prednisolone related to nephrotic syndrome"" receive at least indirect support from the statement: ""Increased ratio of mRNA expression of the genes CYP17 and CYP11B1 indicates autonomous cortisol production in adrenocortical tumors.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to nephrotic syndrome."" 

         Prednisolone is a synthetic glucocorticoid often used in treating nephrotic syndrome, but it is not explicitly mentioned in the provided statement. The statement discusses an increased ratio of mRNA expression of the genes CYP17 and CYP11B1 as an indicator of autonomous cortisol production in adrenocortical tumors. While these genes play a role in cortisol production in the adrenal gland, there is no mention of Prednisolone nor its relation to nephrotic syndrome in any capacity within the statement.

         To establish support for such a phrase, one would need evidence linking Prednisolone usage to nephrotic syndrome occurrence or progression, as well as any potential association between autonomous cortisol production in adrenocortical tumors (indicated by CYP17 and CYP11B1 gene expression) and Prednisolone use in nephrotic syndrome patients."
10531966,Prednisolone related to allergic disease,256,"It is concluded that bile acids are potent endogenous inhibitors of 11 beta-HSD and, therefore, could participate in abnormalities of cortisol metabolism observed in liver cirrhosis and extrahepatic biliary obstruction and, possibly, after ingestion of bile acids.",False,"'Does the phrase ""Prednisolone related to allergic disease"" receive at least indirect support from the statement: ""It is concluded that bile acids are potent endogenous inhibitors of 11 beta-HSD and, therefore, could participate in abnormalities of cortisol metabolism observed in liver cirrhosis and extrahepatic biliary obstruction and, possibly, after ingestion of bile acids.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone related to allergic disease."" 

        The statement discusses the role of bile acids as inhibitors of 11 beta-HSD, an enzyme involved in cortisol metabolism. This could potentially explain abnormalities in cortisol metabolism observed in liver cirrhosis, biliary obstruction, and possibly after ingestion of bile acids. 

        Prednisolone is a synthetic glucocorticoid often used in the treatment of allergic diseases due to its anti-inflammatory effects. The statement does not mention Prednisolone or allergic diseases, nor does it establish any connection between bile acids, cortisol metabolism, and Prednisolone use in allergic diseases. Therefore, it does not provide any support for the phrase ""Prednisolone related to allergic disease."""
10527508,Prednisolone related to acute myeloid leukemia,257,"The plasma cortisol concentration was significantly higher in both DD groups before treatment than in the control group, and it decreased significantly after hoof trimming in the trimmed group.",False,"'Does the phrase ""Prednisolone related to acute myeloid leukemia"" receive at least indirect support from the statement: ""The plasma cortisol concentration was significantly higher in both DD groups before treatment than in the control group, and it decreased significantly after hoof trimming in the trimmed group.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to acute myeloid leukemia."" 

        The statement discusses changes in plasma cortisol concentration in response to hoof trimming in different groups, but it does not mention Prednisolone or acute myeloid leukemia at all. Prednisolone is a synthetic glucocorticoid often used in medical treatments for various conditions such as inflammation and allergies (Haverkos et al., 2017). Acute myeloid leukemia is a type of cancer affecting blood-forming cells in bone marrow (De Kouchkovsky et al., 2016). 

        Although both cortisol (a hormone similar to Prednisolone) and Prednisolone can influence immune responses (Haverkos et al., 2017; De Kouchkovsky et al., 2016), there is no direct or indirect connection established between Prednisolone and acute myeloid leukemia in the statement provided. 

        References:
        
        De"
10503828,Prednisolone related to seasonal allergic rhinitis,258,Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.,False,"'Does the phrase ""Prednisolone related to seasonal allergic rhinitis"" receive at least indirect support from the statement: ""Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to seasonal allergic rhinitis."" 

        The statement discusses the protective effects of Hydrocortisone on blast cells in acute myeloblastic leukemia when exposed to cytosine arabinoside. This finding is related to leukemia treatment and has no direct or indirect implications for seasonal allergic rhinitis or Prednisolone use. Prednisolone is a synthetic glucocorticoid often used in treating inflammatory conditions like asthma and allergies; however, its specific relationship to seasonal allergic rhinitis is not mentioned in either statement. To establish any connection between Prednisolone and seasonal allergic rhinitis, direct evidence supporting such a relationship would be required."
10496403,Prednisolone related to Inflammation,259,Continuous subcutaneous hydrocortisone infusion in Addison's disease.,False,"'Does the phrase ""Prednisolone related to Inflammation"" receive at least indirect support from the statement: ""Continuous subcutaneous hydrocortisone infusion in Addison's disease.""?","No, the statement ""Continuous subcutaneous hydrocortisone infusion in Addison's disease"" does not provide direct or indirect support for the phrase ""Prednisolone related to Inflammation."" 

        Here's why: 

        Hydrocortisone and Prednisolone are both corticosteroids, but they have different specific uses and mechanisms of action. Hydrocortisone is primarily used for its glucocorticoid effect, which includes anti-inflammatory and immunosuppressive actions. It is often used in conditions like Addison's disease, which is a disorder of the adrenal glands that results in decreased production of hormones such as cortisol.

        Prednisolone, on the other hand, is also used for its anti-inflammatory effects but is often used in different clinical contexts. It is more potent than hydrocortisone and has a longer half-life, making it useful for conditions requiring prolonged suppression of inflammation.

        The statement ""Continuous subcutaneous hydrocortisone infusion in Addison'"
10118116,Prednisolone related to Prednisone,260,The current findings underline the relevance of cortisol and DHEA assessments and the need for further scrutiny of their interplay to foster our understanding of the biological basis of stress regulation in BPD.,False,"'Does the phrase ""Prednisolone related to Prednisone"" receive at least indirect support from the statement: ""The current findings underline the relevance of cortisol and DHEA assessments and the need for further scrutiny of their interplay to foster our understanding of the biological basis of stress regulation in BPD.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to Prednisone."" The statement discusses cortisol and DHEA assessments in relation to stress regulation in Borderline Personality Disorder (BPD). Prednisolone and Prednisone are both synthetic glucocorticoids used in medical treatments but they are not mentioned nor implied in the given statement about cortisol and DHEA in BPD patients."
9924521,Prednisolone related to colitis,261,"This hypoxia-specific increase in surface beta-adrenoreceptors was significantly enhanced in the cortisol-treated erythrocytes, showing that cortisol had a significant impact on erythrocyte beta-adrenoreceptor dynamics in addition to the direct influence of hypoxia.",False,"'Does the phrase ""Prednisolone related to colitis"" receive at least indirect support from the statement: ""This hypoxia-specific increase in surface beta-adrenoreceptors was significantly enhanced in the cortisol-treated erythrocytes, showing that cortisol had a significant impact on erythrocyte beta-adrenoreceptor dynamics in addition to the direct influence of hypoxia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to colitis."" 

        The statement discusses the effect of cortisol on erythrocyte beta-adrenoreceptor dynamics under hypoxic conditions. Prednisolone is a synthetic glucocorticoid often used in clinical settings as an anti-inflammatory agent, similar to cortisol (hydrocortisone). However, there is no mention of colitis or even gut inflammation in the statement provided.

        Colitis is inflammation of the inner lining of the colon, which can have various causes such as infections, autoimmune conditions, or side effects of certain medications like nonsteroidal anti-inflammatory drugs (NSAIDs) but not corticosteroids like cortisol or prednisolone. In fact, corticosteroids like prednisolone are often used in treating inflammatory bowel diseases like ulcerative colitis due to their potent anti-inflammatory effects.

        Therefore, while prednisolone may be related to colitis in some contexts"
9437304,Prednisolone related to systemic lupus erythematosus,262,"Congenital adrenal hyperplasia (CAH) due to deficiency of 21-hydroxylase is a disorder of the adrenal cortex characterised by cortisol deficiency, with or without aldosterone deficiency, and androgen excess.",False,"'Does the phrase ""Prednisolone related to systemic lupus erythematosus"" receive at least indirect support from the statement: ""Congenital adrenal hyperplasia (CAH) due to deficiency of 21-hydroxylase is a disorder of the adrenal cortex characterised by cortisol deficiency, with or without aldosterone deficiency, and androgen excess.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to systemic lupus erythematosus"". 

         The statement discusses congenital adrenal hyperplasia (CAH), which is caused by a deficiency of 21-hydroxylase, leading to cortisol deficiency and sometimes aldosterone deficiency, along with androgen excess. Prednisolone is a synthetic glucocorticoid often used in treating various conditions such as CAH due to its ability to mimic cortisol's effects in the body.

         Systemic lupus erythematosus (SLE) is an autoimmune disease in which prednisolone might be used as an immunosuppressive agent to manage inflammation and immune system overactivity. However, there is no connection between CAH, as described in the statement, and SLE that would suggest prednisolone as a treatment for SLE is related to its use in CAH.

         In summary, while prednisolone may be used in treating both CAH and SLE, these conditions are unrelated; thus"
9282196,Prednisolone related to IgA glomerulonephritis,263,"Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment.",False,"'Does the phrase ""Prednisolone related to IgA glomerulonephritis"" receive at least indirect support from the statement: ""Changes of smoking behavior and serum adrenocorticotropic hormone, cortisol, prolactin, and endogenous opioids levels in nicotine dependence after naltrexone treatment.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to IgA glomerulonephritis"". The statement discusses changes in smoking behavior and certain hormone levels after naltrexone treatment, which is unrelated to Prednisolone or IgA glomerulonephritis. IgA glomerulonephritis is an autoimmune disease characterized by inflammation of the glomeruli in the kidneys due to IgA immune complex deposition; Prednisolone is a synthetic glucocorticoid used in treating various inflammatory diseases including IgA glomerulonephritis by reducing inflammation in the kidneys. The connection between these two concepts is not evident in the provided statement."
9222009,Prednisolone related to hypereosinophilic syndrome,264,We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications.,False,"'Does the phrase ""Prednisolone related to hypereosinophilic syndrome"" receive at least indirect support from the statement: ""We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to hypereosinophilic syndrome"". 

        The statement discusses hydrocortisone infusion in severe community-acquired pneumonia, its potential effects on systemic inflammation, and its impact on the resolution of pneumonia and sepsis-related complications. Hydrocortisone is a type of corticosteroid, similar to prednisolone, but they are not identical. 

        Furthermore, hypereosinophilic syndrome is a condition characterized by an elevated eosinophil count in the blood (greater than 1500 eosinophils per microliter), which can lead to tissue damage if left untreated. The statement does not mention or imply any connection between corticosteroid use (hydrocortisone) and hypereosinophilic syndrome. Therefore, it does not offer indirect support for the phrase ""Prednisolone related to hypereosinophilic syndrome""."
9216084,Prednisolone related to non-Hodgkin lymphoma,265,A prospective study was performed to investigate the combination of the aromatase inhibitor aminoglutethimide and hydrocortisone in androgen-independent prostate cancer with changes in prostate-specific antigen (PSA) level as main determinant for response.,False,"'Does the phrase ""Prednisolone related to non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""A prospective study was performed to investigate the combination of the aromatase inhibitor aminoglutethimide and hydrocortisone in androgen-independent prostate cancer with changes in prostate-specific antigen (PSA) level as main determinant for response.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to non-Hodgkin lymphoma."" The prospective study mentioned in the statement investigates the combination of aromatase inhibitor aminoglutethimide and hydrocortisone in androgen-independent prostate cancer. Prednisolone is not mentioned in the study, nor is there any connection made between hydrocortisone or any other drug in the study and non-Hodgkin lymphoma. Therefore, there is no basis for inferring any relationship between Prednisolone and non-Hodgkin lymphoma based on this statement alone."
9208405,Prednisolone related to Duchenne muscular dystrophy,266,"To investigate the time courses of the effects of the exogenous glucocorticoid agonists dexamethasone (DEX) and hydrocortisone (HYD) and a glucocorticoid antagonist (RU-38486), and to characterize the local and systemic responses in experimental AP.",False,"'Does the phrase ""Prednisolone related to Duchenne muscular dystrophy"" receive at least indirect support from the statement: ""To investigate the time courses of the effects of the exogenous glucocorticoid agonists dexamethasone (DEX) and hydrocortisone (HYD) and a glucocorticoid antagonist (RU-38486), and to characterize the local and systemic responses in experimental AP.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to Duchenne muscular dystrophy."" The statement discusses an investigation into the effects of certain glucocorticoid agonists (dexamethasone and hydrocortisone) and an antagonist (RU-38486) in experimental animals (AP). Prednisolone is not mentioned in this statement; therefore, there is no connection established between Prednisolone and Duchenne muscular dystrophy in this context.

         However, it is important to note that Prednisolone is indeed a type of glucocorticoid used in treating Duchenne muscular dystrophy due to its anti-inflammatory properties that can help manage symptoms of the disease, such as muscle weakness. Nonetheless, based on the information provided in the statement alone, no support can be found for the connection between Prednisolone and Duchenne muscular dystrophy."
8405261,Prednisolone related to asthma,267,[The adrenal cortex and hydrocortisone metabolism in experimental myocardial infarct].,False,"'Does the phrase ""Prednisolone related to asthma"" receive at least indirect support from the statement: ""[The adrenal cortex and hydrocortisone metabolism in experimental myocardial infarct].""?","No, the phrase ""Prednisolone related to asthma"" does not receive direct or indirect support from the statement: ""[The adrenal cortex and hydrocortisone metabolism in experimental myocardial infarct].""

        

        Prednisolone is a synthetic glucocorticoid used in various clinical settings for its potent anti-inflammatory effects. It is often used off-label for managing asthma symptoms due to its ability to reduce airway inflammation and hyperresponsiveness [1]. However, there is no mention of Prednisolone or its connection to asthma in the provided statement.

        

        The statement focuses on the adrenal cortex and hydrocortisone metabolism in an experimental setting related to myocardial infarction (heart attack). The adrenal cortex is responsible for releasing corticosteroids like cortisol (hydrocortisone) in response to stress [2]. While Prednisolone is a synthetic glucocorticoid similar to cortisol in structure and function, there is no explicit or implicit connection between Prednisol"
7844202,Prednisolone related to chronic obstructive pulmonary disease,268,[Intraarticular hydrocortisone (cortril) in arthritis and osteoarthritis].,False,"'Does the phrase ""Prednisolone related to chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""[Intraarticular hydrocortisone (cortril) in arthritis and osteoarthritis].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to chronic obstructive pulmonary disease."" The statement discusses intraarticular hydrocortisone (cortril) used in arthritis and osteoarthritis but does not mention prednisolone nor chronic obstructive pulmonary disease (COPD). Prednisolone is a synthetic glucocorticoid commonly used in various inflammatory conditions (e.g., asthma, allergies) while COPD is a chronic lung disease characterized by persistent respiratory symptoms (e.g., breathlessness, cough). The lack of connection between hydrocortisone in arthritis/osteoarthritis does not imply any relationship between prednisolone and COPD."
7323744,Prednisolone related to pemphigus,269,[Use of cortisone and hydrocortisone in eye diseases].,False,"'Does the phrase ""Prednisolone related to pemphigus"" receive at least indirect support from the statement: ""[Use of cortisone and hydrocortisone in eye diseases].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to pemphigus."" The statement mentions cortisone and hydrocortisone, which are related to prednisolone as they all belong to the class of corticosteroids, but it does not specifically mention prednisolone or its use in pemphigus, a group of autoimmune blistering disorders. Therefore, there is no clear connection that can be inferred from the given statement."
7262473,Prednisolone related to rheumatoid arthritis,270,[Topical use of hydrocortisone in otitis externa].,False,"'Does the phrase ""Prednisolone related to rheumatoid arthritis"" receive at least indirect support from the statement: ""[Topical use of hydrocortisone in otitis externa].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone related to rheumatoid arthritis."" The statement refers specifically to the topical use of hydrocortisone in otitis externa, which is an inflammation of the ear canal. Prednisolone is a different glucocorticoid medication often used systemically (orally or injected) for various conditions including rheumatoid arthritis, but it is not mentioned in the provided statement. Therefore, there is no connection made between Prednisolone and rheumatoid arthritis in this context."
7206314,Prednisolone related to pulmonary tuberculosis,271,The use of hydrocortisone in ulcerative colitis:  preliminary observations.,False,"'Does the phrase ""Prednisolone related to pulmonary tuberculosis"" receive at least indirect support from the statement: ""The use of hydrocortisone in ulcerative colitis:  preliminary observations.""?","No, the statement ""The use of hydrocortisone in ulcerative colitis: preliminary observations"" does not provide indirect support for the phrase ""Prednisolone related to pulmonary tuberculosis."" 

        The statement discusses the use of hydrocortisone in ulcerative colitis, which is a type of inflammatory bowel disease. Hydrocortisone is a type of corticosteroid, similar to prednisolone, but they are not identical drugs and have different pharmacological properties. 

        Moreover, the statement does not mention pulmonary tuberculosis at all. Therefore, even if prednisolone was mentioned instead of hydrocortisone, there would still be no connection made to pulmonary tuberculosis in the statement. 

        In order for there to be indirect support for ""Prednisolone related to pulmonary tuberculosis,"" there would need to be some mention of prednisolone use in relation to pulmonary tuberculosis, even if it was not the primary focus of the study. However, in this statement, there is no such mention."
8856354,Prednisolone related to Prednisone,272,It can therefore be concluded that ointments containing either only E. coli BCS or a combination of BCS and hydrocortisone provide significant relief in perianal eczema as well as in early stages of hemorrhoidal disease.,False,"'Does the phrase ""Prednisolone related to Prednisone"" receive at least indirect support from the statement: ""It can therefore be concluded that ointments containing either only E. coli BCS or a combination of BCS and hydrocortisone provide significant relief in perianal eczema as well as in early stages of hemorrhoidal disease.""?","No, the phrase ""Prednisolone related to Prednisone"" does not receive indirect support from the statement provided. The statement discusses the effectiveness of ointments containing Escherichia coli BCS (BCS) alone or in combination with hydrocortisone in treating perianal eczema and early stages of hemorrhoidal disease, but it does not mention Prednisolone or Prednisone at all.

        Prednisolone and Prednisone are synthetic glucocorticoids that share structural similarities but have different pharmacokinetic properties; they can be used interchangeably in some clinical situations due to their similar mechanisms of action. However, there is no mention of these medications in the given statement, so it cannot provide indirect support for any relationship between them.

        To further clarify, Prednisolone is more soluble in water than Prednisone; thus, Prednisolone is often preferred in situations where rapid absorption is desired (e.g., intravenous administration). Prednisone, on the other hand, is more lipid-soluble than Prednisolone; therefore, it is more suitable for oral administration because"
26879702,Prednisolone has part acute lymphoblastic leukemia,273,The effect on cortisol supports the above conclusion and is consistent with HPA axis perturbation in opioid dependence as reported in other studies and extends these observations to stable methadone-maintained patients.,False,"'Does the phrase ""Prednisolone has part acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""The effect on cortisol supports the above conclusion and is consistent with HPA axis perturbation in opioid dependence as reported in other studies and extends these observations to stable methadone-maintained patients.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone has part acute lymphoblastic leukemia."" 

         The statement discusses the effects of cortisol and its relation to opioid dependence, specifically in methadone-maintained patients. It does not mention Prednisolone nor acute lymphoblastic leukemia at all. Therefore, it does not offer any form of support for the stated phrase. 

         Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory and immunosuppressive effects. Acute lymphoblastic leukemia (ALL) is a type of cancer of the blood and bone marrow that affects white blood cells. While both Prednisolone and leukemia can involve the immune system and hematopoietic cells, there is no direct connection between them based on the provided statement. 

         It is essential to critically evaluate each claim based on the evidence specifically presented for that claim, rather than drawing connections that may not exist based on unrelated information."
26670577,Prednisolone has part plasma cell myeloma,274,Several randomized controlled trials have evaluated the efficacy of a replacement therapy with hydrocortisone in severe sepsis.,False,"'Does the phrase ""Prednisolone has part plasma cell myeloma"" receive at least indirect support from the statement: ""Several randomized controlled trials have evaluated the efficacy of a replacement therapy with hydrocortisone in severe sepsis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone has part plasma cell myeloma."" 

         The statement discusses randomized controlled trials that have evaluated the efficacy of hydrocortisone replacement therapy in severe sepsis. This information is not related to Prednisolone or its potential involvement in plasma cell myeloma. Prednisolone is a synthetic glucocorticoid used in various medical conditions for its anti-inflammatory and immunosuppressive effects while plasma cell myeloma is a type of cancer that originates from malignant plasma cells in bone marrow. Therefore, there is no connection between Prednisolone and plasma cell myeloma in this context."
18935086,Prednisolone coexists with Prednisone,275,[Diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis].,False,"'Does the phrase ""Prednisolone coexists with Prednisone"" receive at least indirect support from the statement: ""[Diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone coexists with Prednisone."" The title you provided refers to a study on diurnal variations in blood glucose and plasma cortisol in juvenile diabetes mellitus without ketoacidosis. Prednisolone and Prednisone are both glucocorticoids used in treating various conditions, including diabetes, but the title does not mention nor imply their coexistence in any way.

        The title focuses on diurnal variations in blood glucose and cortisol levels in juvenile diabetes mellitus without ketoacidosis. While both Prednisolone and Prednisone could impact these levels given their glucocorticoid properties, their coexistence is not suggested by the title alone or supported by any implicit relationship between them in the context of diabetes management.

        In conclusion, there is no indirect support for ""Prednisolone coexists with Prednisone"" in relation to the given statement as it does not mention nor imply their coexistence in any way."
9296680,Prednisolone derives from Prednisone,276,"OBJECTIVES: Elderly women with proximal femur fracture show abnormal persistence of increased cortisol concentrations, which could contribute to the high morbidity associated with this injury.",False,"'Does the phrase ""Prednisolone derives from Prednisone"" receive at least indirect support from the statement: ""OBJECTIVES: Elderly women with proximal femur fracture show abnormal persistence of increased cortisol concentrations, which could contribute to the high morbidity associated with this injury.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone derives from Prednisone."" 

        The statement discusses increased cortisol concentrations in elderly women with proximal femur fractures and their potential contribution to morbidity. Neither Prednisolone nor Prednisone is mentioned in this context. 

        Prednisolone is a synthetic glucocorticoid, which is structurally similar to cortisol (a steroid hormone). Prednisone is also a synthetic glucocorticoid but is metabolized in the liver into Prednisolone after absorption in order for it to be active in the body. Therefore, Prednisolone can be considered a metabolite of Prednisone. However, there is no mention of either drug in relation to cortisol in the provided statement.

        To establish support for ""Prednisolone derives from Prednisone,"" there would need to be specific evidence linking these two compounds in terms of their synthesis, metabolism, or therapeutic use in medical treatment."
26415442,Prednisolone derives from Prednisone,277,"From the compendium presented above, the following statements become evident: 1) Inappropriately low secretion of cortisol in relation to inflammation is a typical feature of the inflammatory disease in patients with RA.",False,"'Does the phrase ""Prednisolone derives from Prednisone"" receive at least indirect support from the statement: ""From the compendium presented above, the following statements become evident: 1) Inappropriately low secretion of cortisol in relation to inflammation is a typical feature of the inflammatory disease in patients with RA.""?","No, the statement does not provide indirect support for ""Prednisolone derives from Prednisone."" The statement refers to a characteristic of rheumatoid arthritis (RA) patients but does not establish any relationship between Prednisolone and Prednisone.

        Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory effects and is metabolically equivalent to Prednisone but has better tissue distribution because it does not require hepatic activation like Prednisone does. They share structural similarities but are different drugs. Prednisolone is not derived from Prednisone; instead, Prednisone is converted into Prednisolone in the body through metabolic processes.

        Therefore, even though both drugs have therapeutic applications in treating inflammatory diseases like RA, one does not derive from another in terms of chemical synthesis or formulation."
14808035,Prednisolone physically interacts with Prednisone,278,Hydrocortisone infusion in septic shock differentially regulated the cytokine responses.,False,"'Does the phrase ""Prednisolone physically interacts with Prednisone"" receive at least indirect support from the statement: ""Hydrocortisone infusion in septic shock differentially regulated the cytokine responses.""?","No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone physically interacts with Prednisone."" 

        The statement discusses Hydrocortisone infusion in septic shock and its effect on cytokine responses. Hydrocortisone, Prednisolone, and Prednisone are all corticosteroids, but they are not identical compounds. They have different chemical structures and pharmacological properties. 

        Even if there were evidence of an interaction between Hydrocortisone and either Prednisolone or Prednisone, it would not necessarily imply an interaction between Prednisolone and Prednisone themselves. 

        Therefore, without additional evidence specifically pertaining to Prednisolone and Prednisone, it is not possible to conclude that there is any physical interaction between these two compounds based on the provided statement."
9296682,Prednisolone physically interacts with Prednisone,279,"BACKGROUND: There is substantial evidence of dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders.",False,"'Does the phrase ""Prednisolone physically interacts with Prednisone"" receive at least indirect support from the statement: ""BACKGROUND: There is substantial evidence of dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone physically interacts with Prednisone."" 

         The background statement discusses dysregulation of cortisol secretion, hippocampal abnormalities, and memory deficits in schizophrenia and other psychotic disorders. While both Prednisolone and Prednisone are corticosteroids that can influence cortisol secretion, the statement does not mention or imply any direct or indirect interaction between these two substances. 

         Prednisolone and Prednisone are structurally similar and metabolically related, but they do not physically interact in a way that one could alter the other's chemical structure or function in vivo or in vitro. They can compete for binding sites (such as glucocorticoid receptors), but that is not explicitly stated in the background information provided. 

         In conclusion, while both Prednisolone and Prednisone have similar mechanisms of action related to cortisol regulation, there is no evidence in the given statement suggesting they physically interact in any way that would support the initial phrase."
27055840,Prednisolone causes glaucoma,280,(2) One of the mechanisms of therapeutic effect of cortisol in asthma might be its inhibitory effect on CA uptake.,False,"'Does the phrase ""Prednisolone causes glaucoma"" receive at least indirect support from the statement: ""(2) One of the mechanisms of therapeutic effect of cortisol in asthma might be its inhibitory effect on CA uptake.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes glaucoma."" Prednisolone is a synthetic glucocorticoid, similar to cortisol, often used in treating inflammatory diseases such as asthma. The mechanism mentioned in the statement refers to cortisol's inhibitory effect on cyclooxygenase (COX) activity, which is involved in inflammation regulation.

         Glaucoma is an optic neuropathy characterized by increased intraocular pressure (IOP) leading to optic nerve damage and vision loss. The relationship between corticosteroids (including Prednisolone) and glaucoma is complex. While topical corticosteroids can increase IOP in some individuals predisposed to glaucoma, it does not necessarily mean that Prednisolone causes glaucoma in all cases.

         Therefore, without further evidence linking Prednisolone use specifically to glaucoma development, one cannot infer that the mentioned mechanism provides indirect support for that claim."
26677891,Prednisolone causes uveitis,281,"OBJECTIVE: To compare cortisol levels, diurnal cycles of cortisol, and reactivity of cortisol to psychological stress in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment, and to examine the effect on results of accounting for differences among the groups in psychological stress and other lifestyle and psychosocial variables.",False,"'Does the phrase ""Prednisolone causes uveitis"" receive at least indirect support from the statement: ""OBJECTIVE: To compare cortisol levels, diurnal cycles of cortisol, and reactivity of cortisol to psychological stress in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment, and to examine the effect on results of accounting for differences among the groups in psychological stress and other lifestyle and psychosocial variables.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes uveitis."" The objective of the study mentioned is focused on comparing cortisol levels, diurnal cycles of cortisol, and reactivity of cortisol to psychological stress in fibromyalgia (FM) and rheumatoid arthritis (RA) patients in their natural environment while accounting for differences among these groups in psychological stress and other lifestyle and psychosocial variables.

         Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory properties in treating various conditions such as rheumatoid arthritis; however, it is not mentioned in the study objective provided. Uveitis is an inflammation of the uvea—the middle layer of the eye—which can have various causes including infections, injuries, autoimmune diseases, and sometimes medications like corticosteroids (including prednisolone). However, without any direct mention of prednisolone in relation to uveitis in the given statement, it does not provide indirect support for that specific claim."
25953223,Prednisolone causes kidney disorder,282,"OBJECTIVES: Recent data suggest that higher plasma cortisol may be associated with hypertension and insulin resistance in otherwise healthy men, as it is in Cushing's syndrome.",False,"'Does the phrase ""Prednisolone causes kidney disorder"" receive at least indirect support from the statement: ""OBJECTIVES: Recent data suggest that higher plasma cortisol may be associated with hypertension and insulin resistance in otherwise healthy men, as it is in Cushing's syndrome.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes kidney disorder."" The objective provided focuses on the potential associations between higher plasma cortisol levels and hypertension as well as insulin resistance in healthy men, which is comparable to Cushing's syndrome. Although Prednisolone is a glucocorticoid that can increase cortisol levels in the body, the objective does not mention any connection to kidney disorders. Therefore, without additional context or evidence linking Prednisolone use to kidney issues, one cannot infer that Prednisolone causes kidney disorder based solely on this objective statement."
21556285,Prednisolone causes allergic disease,283,"These findings demonstrate 2 types of adrenal insufficiency with different clinical pictures: Type 1 is characterized by cortisol deficiency with hypoglycaemia, low corticoid levels and a low cortisol secretion rate; Type 2 shows aldosterone deficiency with prominent salt loss.",False,"'Does the phrase ""Prednisolone causes allergic disease"" receive at least indirect support from the statement: ""These findings demonstrate 2 types of adrenal insufficiency with different clinical pictures: Type 1 is characterized by cortisol deficiency with hypoglycaemia, low corticoid levels and a low cortisol secretion rate; Type 2 shows aldosterone deficiency with prominent salt loss.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes allergic disease."" The statement discusses two types of adrenal insufficiency and their associated characteristics but does not mention Prednisolone or allergic disease. Prednisolone is a synthetic glucocorticoid hormone used in various medical treatments, including allergic reactions; however, no connection is drawn between Prednisolone and allergic disease in this statement."
21293782,Prednisolone causes adrenocortical insufficiency,284,"November, a period of reproductive quiescence in the southern hemisphere, with new antler growth and rapid weight gain, is associated with higher mean plasma cortisol concentrations and a greater responsiveness to exogenous ACTH.",False,"'Does the phrase ""Prednisolone causes adrenocortical insufficiency"" receive at least indirect support from the statement: ""November, a period of reproductive quiescence in the southern hemisphere, with new antler growth and rapid weight gain, is associated with higher mean plasma cortisol concentrations and a greater responsiveness to exogenous ACTH.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes adrenocortical insufficiency."" 

        Prednisolone is a synthetic glucocorticoid often used in clinical settings for its anti-inflammatory effects. Adrenocortical insufficiency refers to the inadequate production of corticosteroids by the adrenal glands, which can be caused by prolonged exposure to exogenous glucocorticoids like Prednisolone—a phenomenon known as iatrogenic Cushing's syndrome.

        The provided statement discusses higher mean plasma cortisol concentrations and greater responsiveness to exogenous ACTH during November in the southern hemisphere. Cortisol is one of the primary stress hormones produced by the adrenal glands in response to ACTH stimulation from the pituitary gland; thus, an increase in cortisol levels could indicate heightened stress or activation of the hypothalamic-pituitary-adrenal (HPA) axis rather than adrenocortical insufficiency.

        Furthermore, there is no mention of Prednisolone"
20789636,Prednisolone causes ulcerative colitis,285,Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.,False,"'Does the phrase ""Prednisolone causes ulcerative colitis"" receive at least indirect support from the statement: ""Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes ulcerative colitis."" 

        Prednisolone is a synthetic glucocorticoid hormone similar to cortisol, which is primarily used for its anti-inflammatory effects in various medical conditions such as asthma, rheumatoid arthritis, inflammatory bowel diseases (including ulcerative colitis), and certain skin disorders. The statement in question discusses cortisol metabolism in human obesity without mentioning prednisolone or ulcerative colitis; hence it does not offer any indirect support for the claim in question.

        However, it is important to note that long-term use of glucocorticoids like prednisolone has been associated with side effects such as increased risk of infections, osteoporosis, hyperglycemia, mood changes, and gastrointestinal issues (including peptic ulcers). Nonetheless, these side effects result from chronic exposure and improper usage of such medications rather than being causative agents for ulcerative colitis.

        In conclusion, while prednis"
17230021,Prednisolone causes Headache,286,The hypothalamic-pituitary-adrenal (HPA) axis is one of the key physiological systems that counterbalances this systemic inflammation through changes in adrenocorticotrophic hormone (ACTH) and cortisol.,False,"'Does the phrase ""Prednisolone causes Headache"" receive at least indirect support from the statement: ""The hypothalamic-pituitary-adrenal (HPA) axis is one of the key physiological systems that counterbalances this systemic inflammation through changes in adrenocorticotrophic hormone (ACTH) and cortisol.""?","No, the statement does not provide direct or indirect support for the claim that Prednisolone causes headaches. The statement discusses the hypothalamic-pituitary-adrenal (HPA) axis's role in counteracting systemic inflammation through changes in adrenocorticotrophic hormone (ACTH) and cortisol levels. Prednisolone is indeed a synthetic glucocorticoid that acts on the HPA axis by mimicking cortisol's effects on target cells; however, it does not necessarily imply that Prednisolone causes headaches as a side effect. While headaches can be one of many potential side effects of Prednisolone, additional evidence would be required to establish a direct causal relationship between Prednisolone use and headaches specifically."
16304261,Prednisolone causes nephrotic syndrome,287,"The 5 dpf hypoxic exposure also elicited transient increases in whole body cortisol and in crf, uts1, and hsd20b2 expression, key regulators of the endocrine stress response.",False,"'Does the phrase ""Prednisolone causes nephrotic syndrome"" receive at least indirect support from the statement: ""The 5 dpf hypoxic exposure also elicited transient increases in whole body cortisol and in crf, uts1, and hsd20b2 expression, key regulators of the endocrine stress response.""?","No, the statement does not provide direct or indirect support for the claim that Prednisolone causes nephrotic syndrome. The statement discusses the effects of hypoxic exposure on zebrafish development at 5 days post-fertilization (dpf), including increased whole-body cortisol levels and upregulated expression of certain corticotropin-release factor (crf), urotensin-I (uts1), and 20β-hydroxysteroid dehydrogenase (hsd20b2) genes involved in the endocrine stress response. However, there is no mention of Prednisolone in the statement nor any connection made between hypoxic exposure, cortisol regulation, or these gene expressions in relation to nephrotic syndrome development."
15365269,Prednisolone causes infertility disorder,288,"At multiple regression analyses, HOMA-IR on admission in the IR group significantly correlated with thyroid-stimulating hormone, glucagon, and cortisol.",False,"'Does the phrase ""Prednisolone causes infertility disorder"" receive at least indirect support from the statement: ""At multiple regression analyses, HOMA-IR on admission in the IR group significantly correlated with thyroid-stimulating hormone, glucagon, and cortisol.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes infertility disorder."" The provided statement discusses correlations between HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) on admission in an insulin resistance (IR) group with thyroid-stimulating hormone, glucagon, and cortisol levels. While Prednisolone is a type of corticosteroid that can influence cortisol levels, there is no mention of Prednisolone in the statement, nor is there any direct or indirect link established between cortisol levels and infertility disorder. Therefore, it is not possible to infer that Prednisolone causes infertility disorder based on this information alone. However, it is essential to consider further evidence in order to draw more definitive conclusions about any potential relationships between Prednisolone use, cortisol levels, and infertility disorder."
14373522,Prednisolone causes exfoliative dermatitis,289,"The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).",False,"'Does the phrase ""Prednisolone causes exfoliative dermatitis"" receive at least indirect support from the statement: ""The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes exfoliative dermatitis."" 

         The statement discusses the suppression of anti-inflammatory effects of cortisol in states of excessive stress leading to hypercatabolic diseases such as AIDS, sepsis, toxic shock syndrome, and protein calorie malnutrition (NAIDS). Prednisolone is a synthetic glucocorticoid drug that acts similarly to cortisol in suppressing inflammation; however, it is not explicitly mentioned in this statement as causing exfoliative dermatitis.

         Exfoliative dermatitis is characterized by inflammation of the skin leading to scaling and shedding of large areas of skin; it can be caused by various factors like medications (including corticosteroids), infections, cancer, autoimmune disorders, and genetic conditions. Although Prednisolone can cause skin issues such as thinning of the skin, acne, and increased vulnerability to infections due to its immunosuppressive nature, it does not necessarily mean that it causes exfoliative dermatitis specifically.

         Therefore, without"
10735861,Prednisolone causes contact dermatitis,290,"The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).",False,"'Does the phrase ""Prednisolone causes contact dermatitis"" receive at least indirect support from the statement: ""The suppression of the anti-inflammatory effects of cortisol as a result of states of excessive stress leads to hypercatabolic diseases such as AIDS, sepsis and toxic shock syndrome and protein calorie malnutrition (NAIDS).""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes contact dermatitis."" 

         Prednisolone is a synthetic glucocorticoid hormone that is often used in medical treatments for its anti-inflammatory effects. The statement provided discusses the suppression of anti-inflammatory effects of cortisol due to excessive stress leading to certain diseases (NAIDS). While both cortisol and prednisolone have anti-inflammatory effects, they are distinct entities; cortisol is a natural hormone produced in the human body while prednisolone is a synthetic drug.

         Contact dermatitis is an inflammatory reaction of the skin resulting from exposure to an allergen or irritant. Although glucocorticoids like prednisolone can be used in treating contact dermatitis due to their anti-inflammatory properties, they can also cause adverse reactions such as skin thinning and increased susceptibility to infections when used over prolonged periods. However, these potential adverse effects do not directly imply that prednisolone causes contact dermatitis as an allergic reaction; it"
10545904,Prednisolone causes pulmonary tuberculosis,291,"We report the case of a 41-year-old nonatopic women with a previous history of eczematous reaction due to hydrocortisone who suffered worsening of her perennial rhinitis in association with perinasal dermatitis from the use of budesonide in nasal spray form, and stomatitis and pharyngitis due to budesonide in a bronchial inhaler.",False,"'Does the phrase ""Prednisolone causes pulmonary tuberculosis"" receive at least indirect support from the statement: ""We report the case of a 41-year-old nonatopic women with a previous history of eczematous reaction due to hydrocortisone who suffered worsening of her perennial rhinitis in association with perinasal dermatitis from the use of budesonide in nasal spray form, and stomatitis and pharyngitis due to budesonide in a bronchial inhaler.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes pulmonary tuberculosis."" The case report describes an individual who experienced adverse effects from using budesonide, a different corticosteroid than prednisolone. The patient had a history of eczematous reaction due to hydrocortisone but developed new symptoms after using budesonide in nasal spray form and bronchial inhaler form. There is no mention of prednisolone in the statement, nor any connection made between prednisolone use and pulmonary tuberculosis.

        To provide indirect support for the claim that ""Prednisolone causes pulmonary tuberculosis,"" there would need to be some evidence suggesting an association between prednisolone use and an increased risk of pulmonary tuberculosis development. However, in this statement, there is no such evidence presented."
10519611,Prednisolone causes colitis,292,"In this perspective paper, we focus on the neuro-endocrine interactions that occur between progesterone, allopregnanolone, and cortisol during pregnancy, and propose that they align with our previously proposed model of FM pathogenesis based on GABAergic ""weakening"" in a thalamocortical neural loop system.",False,"'Does the phrase ""Prednisolone causes colitis"" receive at least indirect support from the statement: ""In this perspective paper, we focus on the neuro-endocrine interactions that occur between progesterone, allopregnanolone, and cortisol during pregnancy, and propose that they align with our previously proposed model of FM pathogenesis based on GABAergic ""weakening"" in a thalamocortical neural loop system.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes colitis."" The focus of the perspective paper is on neuro-endocrine interactions during pregnancy involving progesterone, allopregnanolone, and cortisol, along with their proposed relationship to fibromyalgia (FM) pathogenesis based on GABAergic weakening in a thalamocortical neural loop system. Prednisolone is a synthetic glucocorticoid used primarily for its potent anti-inflammatory properties and is unrelated to the hormones discussed in the paper. Therefore, there is no connection between the statement and Prednisolone causing colitis."
9464043,Prednisolone causes cataract,293,The present study reported a case of hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to allergic reaction.,False,"'Does the phrase ""Prednisolone causes cataract"" receive at least indirect support from the statement: ""The present study reported a case of hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to allergic reaction.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes cataract"". The study mentioned in the statement investigates hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction due to an allergic reaction. Hydrocortisone and prednisolone belong to the same class of medications (glucocorticoids), but they are different drugs that can have different side effects profiles. The study does not mention cataracts or any ocular side effects related to hydrocortisone use; therefore, it does not provide evidence for prednisolone causing cataracts either.

        To provide indirect support for ""Prednisolone causes cataract,"" there should be some connection between prednisolone use and cataract development in the statement. However, in this case, no such connection is present. It is essential to base conclusions on solid evidence that directly supports the claim in question.

        In conclusion, while prednisolone may cause cataracts as a side effect (as supported by other studies), the statement provided does not offer any indirect support for such an assertion due to its lack of relevance"
8757881,Prednisolone causes systemic lupus erythematosus,294,Fetal adrenocorticotropic hormone and cortisol increased to peak values within 2.8 hours of induced hypoxia but by 7.2 hours had begun to fall to values that were not significantly different from those at 1.4 hours.,False,"'Does the phrase ""Prednisolone causes systemic lupus erythematosus"" receive at least indirect support from the statement: ""Fetal adrenocorticotropic hormone and cortisol increased to peak values within 2.8 hours of induced hypoxia but by 7.2 hours had begun to fall to values that were not significantly different from those at 1.4 hours.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone causes systemic lupus erythematosus"". The statement discusses fetal adrenocorticotropic hormone (ACTH) and cortisol levels in response to hypoxia, which is not directly related to Prednisolone or systemic lupus erythematosus (SLE). Prednisolone is a synthetic glucocorticoid often used in treating inflammatory diseases due to its immunosuppressive properties, while SLE is an autoimmune disease characterized by the production of autoantibodies leading to inflammation and tissue damage in multiple organs. Although glucocorticoids like Prednisolone can have various side effects, including increased susceptibility to infections, they do not cause SLE.

        While it is true that excessive glucocorticoid levels can lead to Cushing's syndrome – characterized by redistribution of body fat, muscle weakness, mood changes, and other symptoms – it is distinct from SLE in both etiology and presentation. Therefore, without any direct link between Prednisolone use"
27658451,Prednisolone affects uveitis,295,Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.,False,"'Does the phrase ""Prednisolone affects uveitis"" receive at least indirect support from the statement: ""Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects uveitis."" The connection between congenital adrenal hyperplasia (CAH), elevated androgen levels in utero due to endogenous cortisol deficiency, and prednisolone (a synthetic glucocorticoid used in treating inflammatory disorders) is tenuous at best without further information linking these concepts together.

        Prednisolone is known for its anti-inflammatory properties and could potentially be used in treating uveitis (inflammation of the uvea), but that is not explicitly stated in either statement provided. The statement about congenital adrenal hyperplasia (CAH) describes how affected individuals have elevated androgen levels due to cortisol deficiency but doesn't mention uveitis or any connection between uveitis and CAH or prednisolone.

        Thus, while prednisolone might affect uveitis in certain contexts (such as when used as an anti-inflammatory treatment), there is no clear basis for inferring that from the given statement about congenital adrenal"
27410586,Prednisolone affects castration-resistant prostate carcinoma,296,The results of our study confirm that thymol has strong ameliorative effect against hydrocortisone-induced oxidative stress injury in hepatic tissues.,False,"'Does the phrase ""Prednisolone affects castration-resistant prostate carcinoma"" receive at least indirect support from the statement: ""The results of our study confirm that thymol has strong ameliorative effect against hydrocortisone-induced oxidative stress injury in hepatic tissues.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects castration-resistant prostate carcinoma"". 

         The statement discusses the ameliorative effect of thymol on hydrocortisone-induced oxidative stress injury in hepatic tissues. Prednisolone is a synthetic glucocorticoid often used in clinical settings for its anti-inflammatory and immunosuppressive effects, distinct from hydrocortisone, another glucocorticoid. 

         While both prednisolone and hydrocortisone belong to the glucocorticoid class of steroid hormones, they have different clinical applications and effects on various tissues. The study does not mention prednisolone, castration-resistant prostate carcinoma, or any related disease models; therefore, it does not provide any indirect support for the stated phrase.

         It is essential to maintain specificity when interpreting scientific statements, as extrapolations without proper evidence can lead to misinterpretations or inaccuracies in understanding biological phenomena and potential clinical applications."
27323391,Prednisolone affects focal segmental glomerulosclerosis,297,The effects of 8-bromo-cyclic AMP and cyclic AMP agonists (cholera toxin plus hydrocortisone and prostaglandin E2 plus 3-isobutyl-1-methylxanthine) on the cytotoxic activity of T cells generated during murine influenza virus infection have been examined.,False,"'Does the phrase ""Prednisolone affects focal segmental glomerulosclerosis"" receive at least indirect support from the statement: ""The effects of 8-bromo-cyclic AMP and cyclic AMP agonists (cholera toxin plus hydrocortisone and prostaglandin E2 plus 3-isobutyl-1-methylxanthine) on the cytotoxic activity of T cells generated during murine influenza virus infection have been examined.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects focal segmental glomerulosclerosis."" The statement discusses the effects of certain agents on T cell cytotoxic activity during murine influenza virus infection in mice. Prednisolone is a corticosteroid used primarily for its anti-inflammatory and immunosuppressive effects in various conditions, such as asthma, allergies, and autoimmune diseases. Focal segmental glomerulosclerosis is a kidney disease characterized by scarring in specific areas of the kidney filtration units (glomeruli). Although both prednisolone and glomerulosclerosis involve the immune system, the statement provided does not offer any connection between prednisolone and focal segmental glomerulosclerosis."
27042309,Prednisolone affects pulmonary eosinophilia,298,Open oral provocation with 100 or 250 mg hydrocortisone in patients with hydrocortisone contact hypersensitivity elicited cutaneous reactions at sites of previous allergic dermatitis caused by hydrocortisone in two patients and at sites of earlier allergic patch test reactions caused by hydrocortisone in the other two patients.,False,"'Does the phrase ""Prednisolone affects pulmonary eosinophilia"" receive at least indirect support from the statement: ""Open oral provocation with 100 or 250 mg hydrocortisone in patients with hydrocortisone contact hypersensitivity elicited cutaneous reactions at sites of previous allergic dermatitis caused by hydrocortisone in two patients and at sites of earlier allergic patch test reactions caused by hydrocortisone in the other two patients.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects pulmonary eosinophilia."" 

        The statement discusses the effects of hydrocortisone on patients with hydrocortisone contact hypersensitivity, specifically in relation to cutaneous reactions at sites of previous allergic dermatitis or patch test reactions caused by hydrocortisone. This has no explicit or implicit connection to prednisolone or its effects on pulmonary eosinophilia. 

        Prednisolone is a synthetic glucocorticoid often used in clinical settings for its anti-inflammatory effects, which could potentially impact various cell types, including eosinophils. However, the statement provided does not offer any insights into this specific drug or its effects on eosinophils in the lungs or any other organ system. 

        Therefore, it is crucial to evaluate each claim within its own context and not draw broad conclusions based on tenuous connections between disparate pieces of information."
25790510,Prednisolone affects allergic disease,299,"Although initial studies in transgenic mice and humans are encouraging, more data are required to conclusively prove the hypothesis that the adipose-tissue-specific overexpression of HSD1 and the resultant increase in tissue-specific cortisol concentrations result in human obesity, insulin resistance, high blood pressure, and metabolic syndrome.",False,"'Does the phrase ""Prednisolone affects allergic disease"" receive at least indirect support from the statement: ""Although initial studies in transgenic mice and humans are encouraging, more data are required to conclusively prove the hypothesis that the adipose-tissue-specific overexpression of HSD1 and the resultant increase in tissue-specific cortisol concentrations result in human obesity, insulin resistance, high blood pressure, and metabolic syndrome.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects allergic disease."" The statement discusses research regarding adipose-tissue-specific overexpression of HSD1 (11β-hydroxysteroid dehydrogenase type 1) and its impact on obesity, insulin resistance, high blood pressure, and metabolic syndrome in humans and transgenic mice. While Prednisolone is a glucocorticoid that can modulate HSD1 activity, it is not explicitly mentioned in the statement in relation to allergic disease. Therefore, there is no implicit support for the connection between Prednisolone use and allergic disease in this context."
25165576,Prednisolone affects glomerulonephritis,300,"CONCLUSION: Although hydrocortisone has anti-inflammatory properties, it seems to provoke inflammation in the round window membrane after topical instillation.",False,"'Does the phrase ""Prednisolone affects glomerulonephritis"" receive at least indirect support from the statement: ""CONCLUSION: Although hydrocortisone has anti-inflammatory properties, it seems to provoke inflammation in the round window membrane after topical instillation.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects glomerulonephritis."" The conclusion in the statement refers specifically to hydrocortisone's effect on the round window membrane after topical instillation, not prednisolone or its effect on glomerulonephritis. Glomerulonephritis is a condition of the kidney, unrelated to the round window membrane in the ear where hydrocortisone was instilled in the study referenced. Prednisolone is a synthetic glucocorticoid like hydrocortisone but belongs to a different chemical class (prednisolone is a C1,1-β-hydroxylated derivative of prednisone) and may have different pharmacological properties and effects on various tissues compared to hydrocortisone. Therefore, inferences about prednisolone based on hydrocortisone studies should be made cautiously if at all."
24270725,Prednisolone affects dermatomyositis,301,"Type 2 glucocorticoid receptors (GRs), which are occupied by cortisol in humans in times of stress, are thought to be responsible for the glucocorticoid-induced memory impairment.",False,"'Does the phrase ""Prednisolone affects dermatomyositis"" receive at least indirect support from the statement: ""Type 2 glucocorticoid receptors (GRs), which are occupied by cortisol in humans in times of stress, are thought to be responsible for the glucocorticoid-induced memory impairment.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects dermatomyositis."" The statement discusses type 2 glucocorticoid receptors (GRs) and their potential role in glucocorticoid-induced memory impairment. Prednisolone is a synthetic glucocorticoid used in various medical conditions, including dermatomyositis, but the statement does not make any connection between GRs, prednisolone, and dermatomyositis. Therefore, it is essential to evaluate each claim based on its specific context and evidence rather than making inferences without direct backing."
22922261,Prednisolone affects allergic bronchopulmonary aspergillosis,302,"Firstly, the GH-mediated increase in cortisol metabolism (mediated via reduced E to F conversion) may precipitate adrenal insufficiency in hypopituitary patients with partial adrenocorticotropic hormone deficiency commencing GH therapy.",False,"'Does the phrase ""Prednisolone affects allergic bronchopulmonary aspergillosis"" receive at least indirect support from the statement: ""Firstly, the GH-mediated increase in cortisol metabolism (mediated via reduced E to F conversion) may precipitate adrenal insufficiency in hypopituitary patients with partial adrenocorticotropic hormone deficiency commencing GH therapy.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects allergic bronchopulmonary aspergillosis."" The statement discusses the effects of growth hormone (GH) therapy on cortisol metabolism in hypopituitary patients with partial adrenocorticotropic hormone deficiency, specifically addressing adrenal insufficiency as a potential risk. Prednisolone is not mentioned in this statement, nor is there any connection made between GH therapy, cortisol metabolism, and allergic bronchopulmonary aspergillosis. Prednisolone is a corticosteroid medication commonly used for treating various conditions such as allergies, asthma, and autoimmune disorders; however, its direct impact on allergic bronchopulmonary aspergillosis is not addressed in the provided statement."
19824794,Prednisolone affects colitis,303,"From this study it is inferred that the group III steroid betamethasone dipropionate alone heals experimentally induced external otitis more rapidly than hydrocortisone with oxytetracycline, with or without polymyxin B.",False,"'Does the phrase ""Prednisolone affects colitis"" receive at least indirect support from the statement: ""From this study it is inferred that the group III steroid betamethasone dipropionate alone heals experimentally induced external otitis more rapidly than hydrocortisone with oxytetracycline, with or without polymyxin B.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects colitis."" The study referenced in the statement investigates the effects of different steroids on external otitis, not colitis. Prednisolone is not mentioned in the study at all, so there is no basis for inferring any effect of prednisolone on colitis from this statement. Colitis refers to inflammation of the colon, whereas otitis is inflammation of the ear. These two conditions affect different parts of the body and would require separate studies to determine any potential effects of various treatments."
19409335,Prednisolone affects sarcoidosis,304,"In conclusion, the reciprocal expression of CYP17 and the transcriptional repressors COUP-TF and DAX-1 indicates that these orphan receptors have a pathophysiologic role in the excessive hormone production in cortisol- and deoxycorticosterone-producing adrenocortical tumors.",False,"'Does the phrase ""Prednisolone affects sarcoidosis"" receive at least indirect support from the statement: ""In conclusion, the reciprocal expression of CYP17 and the transcriptional repressors COUP-TF and DAX-1 indicates that these orphan receptors have a pathophysiologic role in the excessive hormone production in cortisol- and deoxycorticosterone-producing adrenocortical tumors.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects sarcoidosis."" The conclusion in the provided statement discusses the roles of CYP17, COUP-TF, and DAX-1 in cortisol- and deoxycorticosterone-producing adrenocortical tumors, but it does not mention sarcoidosis or Prednisolone. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions such as asthma, rheumatoid arthritis, and inflammatory bowel disease; it is not specifically indicated for sarcoidosis treatment unless there is concomitant inflammation. Sarcoidosis is a multisystem granulomatous disorder of unknown etiology characterized by noncaseating granulomas in involved organs; its pathophysiology is distinct from adrenocortical tumors. Therefore, further evidence would be needed to establish any connection between Prednisolone and sarcoidosis."
18736907,Prednisolone affects asthma,305,"The administration of hydrocortisone before tumor inoculation resulted in increased tumor take, reduced mean survival time of mice, and concentration of tumor metastasis in a specific organ (i.e., lung metastasis for Ehrlich hypotetraploid clone 1 tumor, and liver metastasis for Ehrlich hypotetraploid stock and Ehrlich hyperdiploid stock tumors).",False,"'Does the phrase ""Prednisolone affects asthma"" receive at least indirect support from the statement: ""The administration of hydrocortisone before tumor inoculation resulted in increased tumor take, reduced mean survival time of mice, and concentration of tumor metastasis in a specific organ (i.e., lung metastasis for Ehrlich hypotetraploid clone 1 tumor, and liver metastasis for Ehrlich hypotetraploid stock and Ehrlich hyperdiploid stock tumors).""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects asthma."" The statement discusses the effects of hydrocortisone on tumor growth and metastasis in mice, which is not related to asthma in humans or animals. Prednisolone is a synthetic glucocorticoid similar to hydrocortisone but is not explicitly mentioned in the provided statement. Therefore, there is no connection between the two pieces of information in terms of their subject matter or implications."
17668631,Prednisolone affects Prednisone,306,"Cortisol counteracts the insulin activation of glycogen synthase in muscle, the insulin inhibition of hepatic glucose production and the insulin inhibition of lipolysis in adipose tissue, leading to the well-established systemic insulin resistance caused by excess cortisol.",True,"'Does the phrase ""Prednisolone affects Prednisone"" receive at least indirect support from the statement: ""Cortisol counteracts the insulin activation of glycogen synthase in muscle, the insulin inhibition of hepatic glucose production and the insulin inhibition of lipolysis in adipose tissue, leading to the well-established systemic insulin resistance caused by excess cortisol.""?","Yes, there is indirect support for the statement ""Prednisolone affects Prednisone"" from the provided statement about cortisol's effects on insulin resistance. This is because both Prednisolone and Prednisone belong to a class of drugs called glucocorticoids that have similar mechanisms of action in the body. 

        Glucocorticoids like cortisol, Prednisolone, and Prednisone can lead to insulin resistance by counteracting insulin activation of glycogen synthase in muscle, inhibiting hepatic glucose production, and inhibiting lipolysis in adipose tissue (as mentioned in the provided statement). Prednisolone and Prednisone specifically can bind to glucocorticoid receptors in cells leading to changes in gene expression that result in these metabolic effects.

        Therefore, if Prednisolone has these effects on insulin resistance due to its glucocorticoid activity, then it is reasonable to infer that Prednisone would have similar effects given that it is also a glucocorticoid drug. This inference is supported by studies showing that both Prednisol"
15888410,Prednisolone affects rheumatoid arthritis,307,"The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.",False,"'Does the phrase ""Prednisolone affects rheumatoid arthritis"" receive at least indirect support from the statement: ""The amount of N-acetyl D-glucosamine in the zymogen granule membrane was not altered by caerulein acute pancreatitis induced under continuous hydrocortisone treatment, but it was decreased by the administration of L-364,718 over 7 days after pancreatitis induction.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects rheumatoid arthritis"". The statement discusses the effects of caerulein acute pancreatitis induced under continuous hydrocortisone treatment on N-acetyl D-glucosamine in the zymogen granule membrane in rats. Hydrocortisone is a type of corticosteroid like prednisolone, but they have different mechanisms of action and uses in medicine. The study does not mention prednisolone nor rheumatoid arthritis; therefore, it does not provide any evidence that prednisolone affects rheumatoid arthritis.

        The misconception might arise because both hydrocortisone and prednisolone belong to the same class of medications (corticosteroids). However, without specific evidence linking prednisolone to rheumatoid arthritis in the given statement, it cannot be used as indirect support for that claim.

        Rheumatoid arthritis is an autoimmune disorder primarily treated using disease-modifying antirhe"
13564625,Prednisolone affects asthma,308,False elevation of plasma cortisol in congenital adrenal hyperplasia.,False,"'Does the phrase ""Prednisolone affects asthma"" receive at least indirect support from the statement: ""False elevation of plasma cortisol in congenital adrenal hyperplasia.""?","No, the statement ""False elevation of plasma cortisol in congenital adrenal hyperplasia"" does not provide indirect support for the phrase ""Prednisolone affects asthma."" 

        Prednisolone is a synthetic glucocorticoid hormone that acts similarly to cortisol in the human body. It is often used as an anti-inflammatory agent in treating various conditions such as asthma, rheumatoid arthritis, and inflammatory bowel disease [1]. 

        Congenital adrenal hyperplasia (CAH) is an inherited disorder of cortisol biosynthesis characterized by impaired cortisol production [2]. In some forms of CAH, there can be an overproduction of 17-hydroxyprogesterone, which is converted outside of the adrenal gland into cortisol precursors that can then be metabolized into androgens [3]. This results in false elevation of plasma cortisol levels due to these precursors being measured as cortisol [2].

        Although both prednisolone and CA"
13234063,Prednisolone affects pericarditis,309,Further studies evaluating the mechanism of action and long term effects of hydrocortisone in cardiac arrest need to be conducted.,False,"'Does the phrase ""Prednisolone affects pericarditis"" receive at least indirect support from the statement: ""Further studies evaluating the mechanism of action and long term effects of hydrocortisone in cardiac arrest need to be conducted.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects pericarditis."" The statement discusses further studies on hydrocortisone in cardiac arrest patients without mentioning prednisolone or pericarditis at all. Prednisolone is a glucocorticoid used for various inflammatory conditions; however, its specific effects on pericarditis have not been addressed in this statement.

        The two concepts - hydrocortisone in cardiac arrest patients and prednisolone in pericarditis - remain unconnected in terms of evidence provided in the statement. To establish indirect support for prednisolone affecting pericarditis from the given statement would require explicit or implicit connections between hydrocortisone, cardiac arrest patients, and pericarditis that do not exist in the provided context.

        To further clarify the relationship between glucocorticoids (including prednisolone) and pericarditis, it would be essential to examine studies specifically investigating their use in treating pericarditis and their potential impact on its progression and resolution."
13029310,Prednisolone affects chronic obstructive pulmonary disease,310,"In acute MI, there were elevated plasma levels of cortisol depending on the MI severity with a small repeated peak of its increase on day 14 and its subsequent decrease, except deaths.",False,"'Does the phrase ""Prednisolone affects chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""In acute MI, there were elevated plasma levels of cortisol depending on the MI severity with a small repeated peak of its increase on day 14 and its subsequent decrease, except deaths.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects chronic obstructive pulmonary disease"" (COPD). The statement discusses the relationship between acute myocardial infarction (MI) and cortisol levels, which is not directly related to Prednisolone or COPD. Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory effects, while COPD is a chronic lung disease characterized by obstruction of lung airflow that interferes with normal breathing. Although both Prednisolone and cortisol (a natural glucocorticoid) have similar effects on inflammation, they are not identical substances, and one does not necessarily influence the other in a predictable manner in different disease contexts (MI vs COPD). A direct link or shared biological mechanism between MI-related cortisol changes and Prednisolone's impact on COPD needs further substantiation through specific studies or evidence connecting these entities."
12949384,Prednisolone affects hypereosinophilic syndrome,311,"Aldosterone levels, like cortisol, have been shown to be increased in sepsis and hemorrhagic shock.",False,"'Does the phrase ""Prednisolone affects hypereosinophilic syndrome"" receive at least indirect support from the statement: ""Aldosterone levels, like cortisol, have been shown to be increased in sepsis and hemorrhagic shock.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects hypereosinophilic syndrome"". 

         The statement discusses increased aldosterone levels in sepsis and hemorrhagic shock, which is not directly related to prednisolone or hypereosinophilic syndrome. Prednisolone is a synthetic glucocorticoid used in various clinical settings for its anti-inflammatory effects, while hypereosinophilic syndrome is a group of disorders characterized by persistent eosinophilia (high levels of eosinophils) that can lead to organ damage.

         Although prednisolone has been used off-label in treating hypereosinophilic syndrome due to its anti-inflammatory properties, there is no evidence in the statement provided that connects aldosterone levels in sepsis and hemorrhagic shock to prednisolone's impact on hypereosinophilic syndrome.

         To establish indirect support for ""Prednisolone affects hypereosinophilic syndrome"", one would need evidence linking prednisolone usage, e"
12057849,Prednisolone affects Crohn disease,312,"In this review, we summarize the effects of circadian melatonin, TSH, and cortisol on OA, focusing on how different levels of these hormones affect OA pathogenesis and recovery with respect to the circadian clock.",False,"'Does the phrase ""Prednisolone affects Crohn disease"" receive at least indirect support from the statement: ""In this review, we summarize the effects of circadian melatonin, TSH, and cortisol on OA, focusing on how different levels of these hormones affect OA pathogenesis and recovery with respect to the circadian clock.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects Crohn disease."" The review focuses on the effects of circadian melatonin, TSH (thyroid-stimulating hormone), and cortisol on osteoarthritis (OA), not Crohn disease. Although cortisol is mentioned, it is in relation to its circadian rhythm rather than its therapeutic use as prednisolone in treating Crohn disease. Therefore, no inferences can be made about prednisolone's effect on Crohn disease based on this statement alone."
11166436,Prednisolone affects Headache,313,"There may be a subset of patients unable to elicit an appropriate immunosuppressive response to stress through upregulation of cortisol, with resultant exacerbation of their psoriasis.",False,"'Does the phrase ""Prednisolone affects Headache"" receive at least indirect support from the statement: ""There may be a subset of patients unable to elicit an appropriate immunosuppressive response to stress through upregulation of cortisol, with resultant exacerbation of their psoriasis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects Headache."" The statement discusses a potential relationship between stress-induced cortisol upregulation and psoriasis severity in certain patients, but it does not mention prednisolone or headaches. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects, which may help manage psoriasis symptoms but does not have a direct impact on headaches. Therefore, there is no clear connection between the two statements in question."
11074135,Prednisolone affects lymphoma,314,"In addition to local effect, topical hydrocortisone therapy of childhood dermatitis is accompanied by a systemic effect that may be pronounced in the acute phase of disease.",False,"'Does the phrase ""Prednisolone affects lymphoma"" receive at least indirect support from the statement: ""In addition to local effect, topical hydrocortisone therapy of childhood dermatitis is accompanied by a systemic effect that may be pronounced in the acute phase of disease.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects lymphoma."" The statement discusses the systemic effects of topical hydrocortisone therapy in childhood dermatitis, but it does not mention Prednisolone nor lymphoma. Prednisolone is a synthetic glucocorticoid often used in systemic therapy for various conditions including lymphoma, but the statement does not provide any information about its effects on lymphoma. Therefore, it cannot be used as evidence to support the claim that Prednisolone affects lymphoma."
10651502,Prednisolone affects kidney disorder,315,"They answered the Fibromyalgia Impact Questionnaire (FIQ), Perceived Stress Questionnaire (PSQ) and McGill Pain Questionnaire (MPQ-Br), and collected saliva to evaluate CC before and after the end of each month.",False,"'Does the phrase ""Prednisolone affects kidney disorder"" receive at least indirect support from the statement: ""They answered the Fibromyalgia Impact Questionnaire (FIQ), Perceived Stress Questionnaire (PSQ) and McGill Pain Questionnaire (MPQ-Br), and collected saliva to evaluate CC before and after the end of each month.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects kidney disorder."" The provided statement discusses participants answering questionnaires (FIQ, PSQ, MPQ-Br) and collecting saliva samples to evaluate cortisol concentration (CC) before and after each month. However, it does not mention Prednisolone use nor any kidney-related disorders. To establish a connection between Prednisolone usage and kidney disorders based on this information would require additional context and evidence linking these variables together."
10649036,Prednisolone affects chorioretinitis,316,"BACKGROUND: The hypothalamic-pituitary-adrenal stress axis plays a crucial role in community-acquired pneumonia (CAP), with high cortisol being associated with disease severity and corticosteroid treatment resulting in earlier time to recovery.",True,"'Does the phrase ""Prednisolone affects chorioretinitis"" receive at least indirect support from the statement: ""BACKGROUND: The hypothalamic-pituitary-adrenal stress axis plays a crucial role in community-acquired pneumonia (CAP), with high cortisol being associated with disease severity and corticosteroid treatment resulting in earlier time to recovery.""?","Yes, there is indirect support for the statement that prednisolone affects chorioretinitis based on the provided background information about community-acquired pneumonia (CAP). 

         The background statement suggests that corticosteroid treatment (which includes prednisolone) leads to earlier recovery in CAP patients who have higher cortisol levels associated with disease severity. 

         Although chorioretinitis is not explicitly mentioned in the background statement, prednisolone is known for its anti-inflammatory effects due to its ability to inhibit phospholipase A2, which is involved in inflammatory processes (Calabrese et al., 2000). Chorioretinitis is an inflammatory condition affecting layers of the eye (choroid and retina). Therefore, it is plausible that prednisolone may have some effect on chorioretinitis due to its anti-inflammatory properties.

         However, it is essential to acknowledge that direct evidence of prednisolone's effect on chorioretinitis is not present in the background statement. Further investigation would be required for more definitive conclusions about"
10555139,Prednisolone affects peptic ulcer disease,317,"The incidence of AF was compared among patients who received hydrocortisone, and the effect of low-dose hydrocortisone on AF was estimated using the inverse probability treatment weighting method based on propensity scores.",False,"'Does the phrase ""Prednisolone affects peptic ulcer disease"" receive at least indirect support from the statement: ""The incidence of AF was compared among patients who received hydrocortisone, and the effect of low-dose hydrocortisone on AF was estimated using the inverse probability treatment weighting method based on propensity scores.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone affects peptic ulcer disease."" The statement discusses a study comparing the incidence of atrial fibrillation (AF) between patients who received hydrocortisone, estimating the effect of low-dose hydrocortisone on AF using propensity scores. Prednisolone is not mentioned in the statement; therefore, it does not contribute any evidence regarding prednisolone's impact on peptic ulcer disease."
10183156,Prednisolone affects ulcerative colitis,318,"INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.",False,"'Does the phrase ""Prednisolone affects ulcerative colitis"" receive at least indirect support from the statement: ""INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects ulcerative colitis."" The introduction mentions intrathecal administration of methotrexate, cytarabine, and hydrocortisone for treating central nervous system involvement in leukemias and lymphomas. Prednisolone is not mentioned in the statement; moreover, ulcerative colitis is not related to leukemias or lymphomas. Therefore, there is no connection between the two statements that would provide indirect support for ""Prednisolone affects ulcerative colitis."""
9735520,Prednisolone affects Inflammation,319,"INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.",True,"'Does the phrase ""Prednisolone affects Inflammation"" receive at least indirect support from the statement: ""INTRODUCTION: Intrathecal administration of methotrexate, cytarabine, and hydrocortisone is commonly used to treat and prevent central nervous system involvement in leukemias and lymphomas.""?","Yes, there is indirect support for the statement ""Prednisolone affects inflammation"" from the provided introduction. Prednisolone is a type of glucocorticoid, which is a class of steroid hormones known for their anti-inflammatory effects. The statement mentions hydrocortisone as one of the intrathecally administered drugs for treating leukemias and lymphomas, which is also a glucocorticoid like prednisolone.

         Glucocorticoids like prednisolone and hydrocortisone act on various cells within the immune system, reducing the production of chemicals that cause inflammation in response to infection or tissue damage. The use of hydrocortisone in treating central nervous system involvement in leukemias and lymphomas suggests that glucocorticoids play an essential role in managing inflammation associated with these conditions.

         Therefore, while prednisolone is not explicitly mentioned in the statement, its classification as a glucocorticoid that shares anti-inflammatory properties with hydrocortisone provides indirect support for the claim that prednisolone affects"
9361682,Prednisolone affects osteoarthritis,320,"CONCLUSIONS: Early PN did not affect plasma concentrations of ACTH and (free) cortisol, but increased the incidence of septic shock, which statistically explained why more patients on early PN received corticosteroids.",False,"'Does the phrase ""Prednisolone affects osteoarthritis"" receive at least indirect support from the statement: ""CONCLUSIONS: Early PN did not affect plasma concentrations of ACTH and (free) cortisol, but increased the incidence of septic shock, which statistically explained why more patients on early PN received corticosteroids.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects osteoarthritis."" The conclusion in the statement is about early parenteral nutrition (PN) affecting plasma concentrations of adrenocorticotropic hormone (ACTH) and cortisol, as well as its impact on septic shock incidence leading to more corticosteroid usage in patients on early PN. There is no mention of prednisolone or osteoarthritis in the provided statement. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in various conditions; it is not typically associated with osteoarthritis management."
8533593,Prednisolone affects neoplasm,321,"Sixteen reacted to tixocortol pivalate and also to other corticosteroids, particularly to hydrocortisone, which could explain exacerbations of eczema in these cases.",False,"'Does the phrase ""Prednisolone affects neoplasm"" receive at least indirect support from the statement: ""Sixteen reacted to tixocortol pivalate and also to other corticosteroids, particularly to hydrocortisone, which could explain exacerbations of eczema in these cases.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects neoplasm."" 

        The statement discusses patients who reacted to tixocortol pivalate and other corticosteroids, specifically mentioning hydrocortisone. It then suggests that these reactions could explain exacerbations of eczema in these cases. Prednisolone is a corticosteroid, but it is not specifically mentioned in the statement. 

        Furthermore, while prednisolone does have immunosuppressive effects, which could potentially influence neoplasm growth, the statement does not provide any information linking prednisolone to neoplasm. Therefore, without specific evidence linking prednisolone to neoplasm, it is not accurate to infer that prednisolone affects neoplasm based on this statement alone."
7800426,Prednisolone affects acute lymphoblastic leukemia,322,"Finally, transient pre-treatment of healthy humans with cortisol induces a bi-phasic response during a later, delayed systemic inflammatory response: an intermediate cortisol concentration augments inflammation while a high cortisol concentration is neither pro- nor anti-inflammatory.",False,"'Does the phrase ""Prednisolone affects acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Finally, transient pre-treatment of healthy humans with cortisol induces a bi-phasic response during a later, delayed systemic inflammatory response: an intermediate cortisol concentration augments inflammation while a high cortisol concentration is neither pro- nor anti-inflammatory.""?","No, the statement does not provide direct support for the claim that prednisolone affects acute lymphoblastic leukemia (ALL). The statement discusses the effects of cortisol on inflammation in healthy humans, while the claim pertains to prednisolone's effect on ALL, which is a specific type of cancer.

        Although both cortisol and prednisolone are glucocorticoids and share some biological activities, they have distinct pharmacological profiles and clinical uses. Prednisolone is often used in cancer treatment due to its immunosuppressive properties, but its specific effects on ALL may not be directly inferred from cortisol's influence on inflammation in healthy individuals.

        Nonetheless, understanding how cortisol affects inflammation could potentially provide insights into glucocorticoid pharmacology that might be relevant for prednisolone use in cancer treatment. However, further investigation and evidence specifically addressing prednisolone's effects on ALL would be required for stronger support of that claim."
7395227,Prednisolone affects systemic lupus erythematosus,323,"Adrenaline induces the early posthypoglycaemic insulin resistance, whereas cortisol and growth hormone are important for the insulin resistance that is observed later following hypoglycaemia.",False,"'Does the phrase ""Prednisolone affects systemic lupus erythematosus"" receive at least indirect support from the statement: ""Adrenaline induces the early posthypoglycaemic insulin resistance, whereas cortisol and growth hormone are important for the insulin resistance that is observed later following hypoglycaemia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone affects systemic lupus erythematosus"". 

         The statement discusses the roles of adrenaline, cortisol, and growth hormone in insulin resistance following hypoglycaemia. Prednisolone is a synthetic glucocorticoid often used in the treatment of systemic lupus erythematosus (SLE), but it is not mentioned nor implied in the statement. 

         While cortisol is mentioned in the statement and is also a glucocorticoid like prednisolone, the statement does not make any connection between cortisol and SLE. Cortisol has immunosuppressive effects, which can be helpful in managing SLE, but the statement does not provide any evidence or implications regarding prednisolone's effect on SLE. 

         Therefore, without additional information linking prednisolone and SLE, the statement does not offer indirect support for the phrase ""Prednisolone affects systemic lupus erythematosus""."
21722189,Prednisolone affects Prednisone,324,"RESULTS: Within 24 hours following TBI, the concentrations of total cortisol, ACTH and gastrin increased proportionally to the severity of injury, especially significant in the experimental group (P less than 0.05).",False,"'Does the phrase ""Prednisolone affects Prednisone"" receive at least indirect support from the statement: ""RESULTS: Within 24 hours following TBI, the concentrations of total cortisol, ACTH and gastrin increased proportionally to the severity of injury, especially significant in the experimental group (P less than 0.05).""?","No, the statement does not provide any direct or indirect support for the phrase ""Prednisolone affects Prednisone."" The statement discusses the results of an experiment involving traumatic brain injury (TBI) and changes in concentrations of total cortisol, ACTH (adrenocorticotropic hormone), and gastrin in response to injury severity. However, it does not mention Prednisolone or Prednisone at all.

        

        Prednisolone and Prednisone are both synthetic corticosteroids used in medical treatments for various conditions such as inflammation, allergies, and autoimmune disorders. While they have similar therapeutic effects due to their structural similarity, they have different pharmacokinetic properties; Prednisone is converted into Prednisolone in the body after absorption.

        

        Therefore, although both drugs may interact within the body due to their shared mechanism of action as glucocorticoids, evidence of one affecting the other would require specific experimental investigation into their interaction, which is not provided in the given statement.

        

        In summary, without any direct mention of Prednisolone"
9655099,Prednisolone has input Prednisone,325,NEW OR UNIQUE INFORMATION PROVIDED: This case is the first published report of hydrocortisone-responsive hypotension and transient CIRCI associated with naturally occurring septic shock in a dog.,False,"'Does the phrase ""Prednisolone has input Prednisone"" receive at least indirect support from the statement: ""NEW OR UNIQUE INFORMATION PROVIDED: This case is the first published report of hydrocortisone-responsive hypotension and transient CIRCI associated with naturally occurring septic shock in a dog.""?","No, the phrase ""Prednisolone has input Prednisone"" does not receive at least indirect support from the statement provided. 

        The statement discusses a case report of hydrocortisone-responsive hypotension and transient Critical Illness-Related Corticosteroid Insufficiency (CIRCI) associated with naturally occurring septic shock in a dog. It does not provide any information about Prednisolone or its relationship to Prednisone.

        Prednisolone and Prednisone are both corticosteroids used in veterinary medicine, but they have different pharmacokinetic profiles. Prednisone is a prodrug that is metabolized into Prednisolone in the liver. Therefore, while they are related, one cannot infer from the statement that Prednisolone has any direct input in Prednisone's function or vice versa. 

        It is crucial in scientific interpretation to stick closely to the evidence provided and not draw conclusions that go beyond the scope of the information given. This helps maintain the integrity of scientific discourse and prevents misinformation."
27206106,Prednisolone disrupts uveitis,326,Several types of the congenital adrenal hyperplasias are associated with decreased cortisol production and excessive adrenal sex steroid secretion.,False,"'Does the phrase ""Prednisolone disrupts uveitis"" receive at least indirect support from the statement: ""Several types of the congenital adrenal hyperplasias are associated with decreased cortisol production and excessive adrenal sex steroid secretion.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone disrupts uveitis."" 

        Prednisolone is a synthetic glucocorticoid often used in medical treatments for its anti-inflammatory effects. Uveitis is an inflammation of the uvea, the middle layer of the eye. While it is plausible that Prednisolone could be used as a treatment for uveitis due to its anti-inflammatory properties, the statement provided does not mention Prednisolone, uveitis, or any direct link between cortisol production, adrenal sex steroid secretion, and uveitis disruption.

        The statement discusses congenital adrenal hyperplasias (CAH), which are genetic disorders affecting cortisol production and adrenal sex steroid secretion due to enzyme deficiencies in cortisol synthesis pathways. However, there is no clear connection between these disorders and Prednisolone's impact on uveitis.

        To establish indirect support at best, additional information would be needed that associates CAH-related conditions ("
26515767,Prednisolone disrupts neoplasm,327,[Use of cryo-apheresis in the treatment of patients with cortisol-dependent bronchial asthma].,False,"'Does the phrase ""Prednisolone disrupts neoplasm"" receive at least indirect support from the statement: ""[Use of cryo-apheresis in the treatment of patients with cortisol-dependent bronchial asthma].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts neoplasm."" 

         The statement discusses the use of cryo-apheresis in treating patients with cortisol-dependent bronchial asthma, which is unrelated to Prednisolone disrupting neoplasm (abnormal tissue growth indicative of cancer). Cryo-apheresis is a medical procedure that removes blood from a patient, cools it for separation of plasma, then reinfuses the patient's blood back into their system after adding replacement plasma or cryoprecipitate. It is commonly used for various conditions such as hyperviscosity syndrome or leukocytosis (high white blood cell count) due to leukemia or severe infections.

         Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects in treating several conditions such as asthma, rheumatoid arthritis, severe allergies, and some skin disorders. While glucocorticoids like Prednisolone can impact cell growth and proliferation, there is no direct link established in this statement between Pred"
26379811,Prednisolone disrupts contact dermatitis,328,Hypotension after recruitment was reduced by HC (0 vs. 30%).,False,"'Does the phrase ""Prednisolone disrupts contact dermatitis"" receive at least indirect support from the statement: ""Hypotension after recruitment was reduced by HC (0 vs. 30%).""?","No, the statement ""Hypotension after recruitment was reduced by HC (0 vs. 30%)"" does not provide indirect support for the phrase ""Prednisolone disrupts contact dermatitis"". 

        The statement in question pertains to the effect of HC (presumably Hydrocortisone) on hypotension after recruitment, which is not related to Prednisolone or contact dermatitis. Prednisolone is a synthetic glucocorticoid often used in dermatology for its anti-inflammatory effects, but its impact on contact dermatitis is not addressed in this statement. Therefore, no inferences can be made about Prednisolone's effect on contact dermatitis based on this information alone."
25763558,Prednisolone disrupts pneumonia,329,Fetal plasma cortisol concentrations were increased ( P < 0.05) during all levels of hypoxia.,False,"'Does the phrase ""Prednisolone disrupts pneumonia"" receive at least indirect support from the statement: ""Fetal plasma cortisol concentrations were increased ( P < 0.05) during all levels of hypoxia.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone disrupts pneumonia."" 

         Prednisolone is a synthetic glucocorticoid often used in clinical settings to reduce inflammation. The statement given discusses an increase in fetal plasma cortisol concentrations during hypoxia, which is relevant because cortisol is a natural glucocorticoid hormone in humans and other animals. However, this does not establish a connection between Prednisolone and disruption of pneumonia.

         Pneumonia is an infection of the lungs that can be influenced by many factors, including immune response and inflammation. While Prednisolone could potentially impact pneumonia due to its anti-inflammatory properties, the statement provided does not offer any evidence or implications regarding Prednisolone's effect on pneumonia. 

         Therefore, without additional information linking Prednisolone, its effects on inflammation or immune response, and pneumonia, it is not possible to infer that Prednisolone disrupts pneumonia based on the given statement."
25233555,Prednisolone disrupts allergic disease,330,"INTRA-CELL CORTISOL: Attention is also focused on the potential implication of cortisol in the genesis of metabolic syndrome, because cortisol is a potent antagonist of the effect of insulin and its presence in excess enhances visceral obesity and insulin resistance.",False,"'Does the phrase ""Prednisolone disrupts allergic disease"" receive at least indirect support from the statement: ""INTRA-CELL CORTISOL: Attention is also focused on the potential implication of cortisol in the genesis of metabolic syndrome, because cortisol is a potent antagonist of the effect of insulin and its presence in excess enhances visceral obesity and insulin resistance.""?","No, the statement does not provide direct or indirect support for the phrase ""Prednisolone disrupts allergic disease"". The provided statement discusses cortisol's potential role in metabolic syndrome, focusing on its antagonistic effect on insulin and its contribution to visceral obesity and insulin resistance. Prednisolone is a synthetic glucocorticoid often prescribed for its anti-inflammatory effects in various conditions, including allergic diseases; however, it is not directly linked to cortisol's antagonistic effect on insulin in this context.

        
        Prednisolone's primary mechanism of action involves binding to glucocorticoid receptors in cells, thereby suppressing inflammation through various pathways that do not necessarily involve cortisol's impact on insulin sensitivity in metabolic syndrome. Although prednisolone can increase cortisol levels due to its interaction with the hypothalamic-pituitary-adrenal (HPA) axis, that specific aspect is not addressed in the statement provided, making it an indirect link at best.

        
        Therefore, further evidence would be required to"
14331279,Prednisolone disrupts hypereosinophilic syndrome,331,The effect of hydrocortisone on standardized skin-surface trauma.,False,"'Does the phrase ""Prednisolone disrupts hypereosinophilic syndrome"" receive at least indirect support from the statement: ""The effect of hydrocortisone on standardized skin-surface trauma.""?","No, the statement ""The effect of hydrocortisone on standardized skin-surface trauma"" does not provide indirect support for the phrase ""Prednisolone disrupts hypereosinophilic syndrome."" 

        Hydrocortisone and Prednisolone are both corticosteroids used in treating various conditions, but they have different chemical structures and pharmacological properties that may lead to different therapeutic effects in specific contexts. Hypereosinophilic syndrome (HES) is characterized by an overproduction of eosinophils (a type of white blood cell) that can infiltrate various tissues and cause damage. Prednisolone has been used in treating HES due to its anti-inflammatory properties that can help reduce eosinophil levels.

        On the other hand, hydrocortisone has been studied in relation to its effect on standardized skin-surface trauma; however, this does not inherently imply any effect on eosinophilic syndrome since skin-surface trauma is unrelated to eosinophil levels or function in the body.

        While both hydrocortisone"
10594561,Prednisolone disrupts asthma,332,The action of hydrocortisone in synovial inflammation.,False,"'Does the phrase ""Prednisolone disrupts asthma"" receive at least indirect support from the statement: ""The action of hydrocortisone in synovial inflammation.""?","No, the statement ""The action of hydrocortisone in synovial inflammation"" does not provide indirect support for the phrase ""Prednisolone disrupts asthma."" 

        Here's why: 

        Although both prednisolone and hydrocortisone are glucocorticoids, they have different specific indications and uses in clinical settings due to their unique pharmacokinetic and pharmacodynamic properties. Hydrocortisone is primarily used for its anti-inflammatory effects in conditions such as synovial inflammation (inflammation of the synovial membrane in joints), while prednisolone is often used in the treatment of various allergic and inflammatory conditions such as asthma due to its potent glucocorticoid activity.

        The statement ""The action of hydrocortisone in synovial inflammation"" implies that hydrocortisone has anti-inflammatory effects in joint-related inflammation but does not provide any information about prednisolone's effects on asthma pathophysiology. Therefore, it does not offer"
8854473,Prednisolone disrupts Inflammation,333,"The effects of stressful life events, coping, and cortisol on HIV infection.",True,"'Does the phrase ""Prednisolone disrupts Inflammation"" receive at least indirect support from the statement: ""The effects of stressful life events, coping, and cortisol on HIV infection.""?","Yes, there is indirect support for the phrase ""Prednisolone disrupts Inflammation"" from the statement ""The effects of stressful life events, coping, and cortisol on HIV infection."" 

        Prednisolone is a synthetic glucocorticoid drug that is commonly used to reduce inflammation because it mimics the function of cortisol, a natural hormone produced by the adrenal gland in response to stress. Cortisol has a wide range of effects on various body systems, one of which is its anti-inflammatory effect. Prednisolone, therefore, can be said to disrupt inflammation by suppressing the immune system's response, which is often overactive in inflammatory conditions.

        The statement ""The effects of stressful life events, coping, and cortisol on HIV infection"" implies that cortisol has an impact on HIV infection, which is mediated through stressful life events and coping mechanisms. While this statement does not explicitly mention Prednisolone, it does suggest that cortisol can influence inflammation and immune function in HIV infection. Given that Prednisolone acts similarly"
27646185,Prednisolone prevents allergic disease,334,"Immunologic and hemodynamic effects of ""low-dose"" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.",False,"'Does the phrase ""Prednisolone prevents allergic disease"" receive at least indirect support from the statement: ""Immunologic and hemodynamic effects of ""low-dose"" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents allergic disease."" The study focuses on immunologic and hemodynamic effects of ""low-dose"" hydrocortisone in septic shock, which is not related to allergic disease or prednisolone use in preventing such conditions. Prednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory properties in various medical conditions including allergic reactions; however, its specific efficacy in preventing allergic disease is not discussed in the given study."
26227245,Prednisolone prevents synovitis,335,"To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus.",False,"'Does the phrase ""Prednisolone prevents synovitis"" receive at least indirect support from the statement: ""To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus.""?","No, the phrase ""Prednisolone prevents synovitis"" does not receive indirect support from the statement ""To prolong the anti-tumor effect some mice were also given cyclophosphamide, hydrocortisone, or a second injection of virus."" The statement does not provide any information about Prednisolone or its effects on synovitis. Hydrocortisone is a type of steroid like Prednisolone, but it is not necessarily indicative of Prednisolone's effects on synovitis. Therefore, more specific information is needed to provide indirect support for the initial claim."
19453072,Prednisolone prevents hypereosinophilic syndrome,336,"In conclusion, HRT in postmenopausal asthmatic women has a favorable influence on the course of asthma, reduces daily use of glucocorticosteroids and frequency of asthma exacerbations and normalizes serum concentrations of estradiol, cortisol and DHEAS, which were decreased before HRT.",False,"'Does the phrase ""Prednisolone prevents hypereosinophilic syndrome"" receive at least indirect support from the statement: ""In conclusion, HRT in postmenopausal asthmatic women has a favorable influence on the course of asthma, reduces daily use of glucocorticosteroids and frequency of asthma exacerbations and normalizes serum concentrations of estradiol, cortisol and DHEAS, which were decreased before HRT.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents hypereosinophilic syndrome"". The statement discusses hormone replacement therapy (HRT) in postmenopausal asthmatic women, its influence on asthma course, reduction of glucocorticosteroid use, frequency of asthma exacerbations, and normalization of serum concentrations of estradiol, cortisol, and DHEAS. There is no mention of Prednisolone or hypereosinophilic syndrome in the statement. Prednisolone is a synthetic glucocorticoid used for its anti-inflammatory effects in various conditions, while hypereosinophilic syndrome is a disorder characterized by an increased number of eosinophils in the blood and tissues, which can lead to inflammation and damage in various organs. The two concepts are unrelated in this context."
16706850,Prednisolone prevents neoplasm,337,"However, after adjusting for the effect of obesity by multiple regression, higher plasma cortisol was independently associated with higher diastolic blood pressure in men (r = 0.21, P = 0.04) but not in women, and higher fasting serum triglyceride levels in women (r = 0.28, P < 0. 001) but not in men.",False,"'Does the phrase ""Prednisolone prevents neoplasm"" receive at least indirect support from the statement: ""However, after adjusting for the effect of obesity by multiple regression, higher plasma cortisol was independently associated with higher diastolic blood pressure in men (r = 0.21, P = 0.04) but not in women, and higher fasting serum triglyceride levels in women (r = 0.28, P < 0. 001) but not in men.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents neoplasm."" 

        The statement discusses the association of higher plasma cortisol levels with diastolic blood pressure in men and fasting serum triglyceride levels in women. It does not mention prednisolone or neoplasm (a type of abnormal tissue growth that can lead to cancer) at all. Prednisolone is a synthetic glucocorticoid hormone used for its anti-inflammatory effects and is sometimes used in cancer treatment, but this statement does not provide any information about its potential preventative effects against neoplasm. Therefore, it does not offer indirect support for the claim that prednisolone prevents neoplasm."
15809068,Prednisolone prevents colitis,338,"ii) Reduction of cortisone to cortisol in the liver may increase insulin resistance in type 2 diabetes mellitus, and inhibition of the enzyme may lead to a decrease in gluconeogenesis.",False,"'Does the phrase ""Prednisolone prevents colitis"" receive at least indirect support from the statement: ""ii) Reduction of cortisone to cortisol in the liver may increase insulin resistance in type 2 diabetes mellitus, and inhibition of the enzyme may lead to a decrease in gluconeogenesis.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents colitis."" The provided statement discusses the relationship between cortisone reduction, cortisol increase, insulin resistance in type 2 diabetes mellitus, and inhibition of enzymes leading to decreased gluconeogenesis. While prednisolone is a synthetic glucocorticoid that can act similarly to cortisol in the body, there is no direct link established between these concepts and colitis prevention. Prednisolone is sometimes used as a treatment for colitis due to its anti-inflammatory properties, but the statement does not provide any evidence or reasoning for its preventative effects against colitis."
11858005,Prednisolone prevents asthma,339,"Pretreatment of rats with hydrocortisone or protamin-Zn-insulin within 4 days altered in subsequent acute hypoxia (3 hrs, ""height"" 10 000 m) the isoenzyme spectrum of LDH in lungs, liver tissue and kidney cortex.",False,"'Does the phrase ""Prednisolone prevents asthma"" receive at least indirect support from the statement: ""Pretreatment of rats with hydrocortisone or protamin-Zn-insulin within 4 days altered in subsequent acute hypoxia (3 hrs, ""height"" 10 000 m) the isoenzyme spectrum of LDH in lungs, liver tissue and kidney cortex.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents asthma."" The statement discusses the effects of pretreatment of rats with hydrocortisone or protamin-Zn-insulin on the isoenzyme spectrum of LDH in lungs, liver tissue, and kidney cortex under acute hypoxia conditions. Prednisolone is neither mentioned nor implied in this statement. Furthermore, asthma is a complex chronic respiratory disease characterized by airway inflammation, bronchoconstriction, and hyperresponsiveness, which is not explicitly addressed in the provided statement."
10983909,Prednisolone prevents leprosy,340,Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years.,False,"'Does the phrase ""Prednisolone prevents leprosy"" receive at least indirect support from the statement: ""Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone prevents leprosy."" The initial statement is about cortisol increases being related to memory impairments in elderly humans over five years. Prednisolone is a synthetic glucocorticoid often used as an anti-inflammatory and immunosuppressant drug. While it is true that glucocorticoids like prednisolone can affect cortisol levels (since they mimic cortisol action), no direct link is established between prednisolone use and leprosy prevention in either statement.

        To further elaborate on why there is no indirect support for ""Prednisolone prevents leprosy,"" let us consider some aspects of leprosy and prednisolone use in treating it. Leprosy is an infectious disease caused by Mycobacterium leprae, which primarily affects the skin, peripheral nerves, mucosa of upper respiratory tract, and eyes. Prednisolone is sometimes used in treating leprosy due to its immunosuppressive properties; however, it is not used as a preventive measure against leprosy but rather"
10240036,Prednisolone prevents Inflammation,341,It was suggested that the progressive shift from type 1 to type 2 cytokine production characteristic of HIV infection could be at least partially provoked by the increase in the production of cortisol and the reduction of DHEA.,True,"'Does the phrase ""Prednisolone prevents Inflammation"" receive at least indirect support from the statement: ""It was suggested that the progressive shift from type 1 to type 2 cytokine production characteristic of HIV infection could be at least partially provoked by the increase in the production of cortisol and the reduction of DHEA.""?","Yes, there is indirect support for the claim that Prednisolone prevents inflammation based on the provided statement. Prednisolone is a synthetic glucocorticoid hormone similar to cortisol in function; it reduces inflammation by mimicking the action of hormones that the body naturally produces in response to stress such as cortisol. The statement suggests that an increase in cortisol production during HIV infection may contribute to a shift from type 1 (pro-inflammatory) to type 2 (anti-inflammatory) cytokine production. Consequently, administering exogenous glucocorticoids like Prednisolone could help counteract inflammation by further increasing cortisol-like activity in the body during HIV infection.

         However, it is crucial to note that while Prednisolone may help manage inflammation in HIV patients, its long-term use may have detrimental side effects such as immunosuppression, which could negatively impact patients’ ability to fight off opportunistic infections associated with HIV. Therefore, careful consideration should be given when prescribing Prednisolone for inflammation in HIV patients, taking into"
18452194,Prednisolone exacerbates ulcerative colitis,342,CONCLUSIONS: This study suggests that 24 h urinary free cortisol could be considered as a potential index of adrenal cortisol production in patients with liver cirrhosis and it potentially detects patients with a high mortality risk.,False,"'Does the phrase ""Prednisolone exacerbates ulcerative colitis"" receive at least indirect support from the statement: ""CONCLUSIONS: This study suggests that 24 h urinary free cortisol could be considered as a potential index of adrenal cortisol production in patients with liver cirrhosis and it potentially detects patients with a high mortality risk.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone exacerbates ulcerative colitis."" The conclusion is about using 24-hour urinary free cortisol as a potential index of adrenal cortisol production in patients with liver cirrhosis, which could potentially detect patients with a high mortality risk. Prednisolone is a synthetic glucocorticoid, structurally related to cortisol, but there is no mention of its impact on ulcerative colitis in this conclusion. Ulcerative colitis is also not mentioned in the conclusion at all. Therefore, it is not possible to infer any relationship between Prednisolone and ulcerative colitis exacerbation based on this statement alone."
25753407,Prednisolone predisposes neoplasm,343,Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that leads to the partial or complete deficiency of cortisol and aldosterone production from the adrenal glands.,False,"'Does the phrase ""Prednisolone predisposes neoplasm"" receive at least indirect support from the statement: ""Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder that leads to the partial or complete deficiency of cortisol and aldosterone production from the adrenal glands.""?","No, the statement does not provide indirect support for the phrase ""Prednisolone predisposes neoplasm."" 

        The statement discusses congenital adrenal hyperplasia (CAH), an autosomal recessive disorder that affects cortisol and aldosterone production in the adrenal glands due to genetic mutations. Prednisolone is a synthetic glucocorticoid often used in treating various conditions such as inflammation, allergies, and autoimmune disorders by mimicking cortisol's effects in the body.

        While both CAH and Prednisolone have connections to cortisol production, there is no mention of neoplasm (abnormal tissue growth that can lead to cancer) in either statement. Therefore, no indirect support can be inferred from the statement provided concerning Prednisolone predisposing neoplasm.

        However, it is essential to note that long-term glucocorticoid use like Prednisolone has potential side effects such as increased risk of infections, osteoporosis, diabetes, and adrenal suppression; there is no conclusive evidence linking Prednisol"
16546227,Prednisolone predisposes pneumonia,344,[Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].,False,"'Does the phrase ""Prednisolone predisposes pneumonia"" receive at least indirect support from the statement: ""[Reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion)].""?","No, the statement does not provide indirect support for the phrase ""Prednisolone predisposes pneumonia."" The statement discusses the reaction of autogenous cortisol production in patients with extensive psoriasis vulgaris or atopic dermatitis following external administration of a 0.25% prednicarbate salve (W/O emulsion). Prednisolone is not mentioned in this statement, nor is there any connection made between cortisol production, prednisolone, and pneumonia. Prednicarbate is a different glucocorticoid than prednisolone and is not typically associated with an increased risk of pneumonia in patients using it topically as described in the statement."
27027571,Hydrocortisone related to HIV infectious disease,345,"OBJECTIVE: Corticosteroid-binding globulin (CBG), the cortisol transport protein, is cleaved from high-affinity (haCBG) to low-affinity (laCBG) CBG at sites of inflammation releasing bioavailable, anti-inflammatory cortisol.",False,"'Does the phrase ""Hydrocortisone related to HIV infectious disease"" receive at least indirect support from the statement: ""OBJECTIVE: Corticosteroid-binding globulin (CBG), the cortisol transport protein, is cleaved from high-affinity (haCBG) to low-affinity (laCBG) CBG at sites of inflammation releasing bioavailable, anti-inflammatory cortisol.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to HIV infectious disease."" 

        
        The statement discusses the cleavage of corticosteroid-binding globulin (CBG) at sites of inflammation, releasing bioavailable cortisol which is an anti-inflammatory hormone. Hydrocortisone is a synthetic form of cortisol used as a medication for various conditions such as inflammation, allergies, adrenal insufficiency, and autoimmune diseases among others. 

        
        Although hydrocortisone has immunosuppressive effects which could theoretically impact immune responses in HIV infection, there is no explicit mention of HIV or any infectious disease in the statement provided. Therefore, it would be inappropriate to infer any connection between hydrocortisone and HIV infectious disease based solely on this information."
25927636,Hydrocortisone related to cardiac arrest,346,The propensity to develop type 1 diabetes or type 2 diabetes/metabolic syndrome depends on the propensity to release of cortisol which correlates with race.,False,"'Does the phrase ""Hydrocortisone related to cardiac arrest"" receive at least indirect support from the statement: ""The propensity to develop type 1 diabetes or type 2 diabetes/metabolic syndrome depends on the propensity to release of cortisol which correlates with race.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to cardiac arrest."" 

        The statement discusses the relationship between race and the propensity to release cortisol, which in turn influences the development of type 1 diabetes or type 2 diabetes/metabolic syndrome. Cortisol is a hormone that the body produces in response to stress; hydrocortisone is a synthetic form of cortisol often used in medications such as corticosteroids.

        While both cortisol and hydrocortisone have similar effects on the body (including increasing blood sugar levels), they are not identical in their actions or consequences. Moreover, the statement does not mention anything about hydrocortisone use, cardiac arrest risk, or even cardiovascular health in general.

        Therefore, without additional information linking hydrocortisone use, cortisol release, race, and cardiac arrest risk, it is not possible to infer any relationship between these factors based on the provided statement alone."
25797574,Hydrocortisone related to lymphoma,347,"CIRCI is characterized by an inadequate production of cortisol in relation to an increased demand during periods of severe stress, particularly in critical illnesses such as sepsis or septic shock.",True,"'Does the phrase ""Hydrocortisone related to lymphoma"" receive at least indirect support from the statement: ""CIRCI is characterized by an inadequate production of cortisol in relation to an increased demand during periods of severe stress, particularly in critical illnesses such as sepsis or septic shock.""?","Yes, indirectly it does. The statement suggests that there is a relationship between cortisol levels and severe stress conditions such as sepsis or septic shock (CIRCI). Hydrocortisone is a synthetic form of cortisol, a hormone that the body produces in response to stress. Therefore, if lymphoma is a condition that causes severe stress leading to increased demand for cortisol, then it could be inferred that hydrocortisone might be related to lymphoma. However, this is a very indirect inference and would need much more direct evidence to confirm any causal relationship. It's also important to note that correlation does not imply causation."
25131277,Hydrocortisone related to Crohn disease,348,Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production.,False,"'Does the phrase ""Hydrocortisone related to Crohn disease"" receive at least indirect support from the statement: ""Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production.""?","No, the statement ""Synacthen test diagnosed Addison's disease with a clear deficiency of cortisol production"" does not provide indirect support for the phrase ""Hydrocortisone related to Crohn disease.""

        The Synacthen test is used for diagnosing adrenal insufficiency by measuring the body's ability to produce cortisol in response to synthetic ACTH (Synacthen). Addison's disease is characterized by deficient cortisol production due to damage in the adrenal glands.

        Hydrocortisone is a synthetic form of cortisol used primarily for treating adrenal insufficiency (including Addison's disease), inflammatory conditions (such as arthritis), allergic reactions, and certain types of cancer.

        Crohn's disease is an inflammatory bowel disease that can affect any part of the gastrointestinal tract from mouth to anus. Although corticosteroids like hydrocortisone can be used in treating Crohn's disease symptoms (such as inflammation), it does not establish any direct relationship between hydrocortisone and"
19793698,Hydrocortisone related to alcohol abuse,349,"Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.",False,"'Does the phrase ""Hydrocortisone related to alcohol abuse"" receive at least indirect support from the statement: ""Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to alcohol abuse."" The statement discusses enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression in relation to visceral fat and insulin resistance in men, following weight loss. Hydrocortisone is a synthetic form of cortisol, but the statement does not make any connection between cortisol/hydrocortisone and alcohol abuse. Therefore, it is not appropriate to infer any relationship between hydrocortisone and alcohol abuse based on this statement alone."
19531872,Hydrocortisone related to atrial fibrillation,350,"Obesity is also related to dysregulation of cortisol production by the pre-receptor enzyme, 11beta-hydroxysteroid dehydrogenase, and we speculate that this may have a role in the pathogenesis of obesity and raised ICP seen in IIH.",False,"'Does the phrase ""Hydrocortisone related to atrial fibrillation"" receive at least indirect support from the statement: ""Obesity is also related to dysregulation of cortisol production by the pre-receptor enzyme, 11beta-hydroxysteroid dehydrogenase, and we speculate that this may have a role in the pathogenesis of obesity and raised ICP seen in IIH.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to atrial fibrillation."" The statement discusses obesity's relationship with cortisol production dysregulation through the enzyme 11beta-hydroxysteroid dehydrogenase and its potential impact on intracranial pressure in IIH (Idiopathic Intracranial Hypertension). Hydrocortisone is a synthetic form of cortisol, but there is no mention of atrial fibrillation in the provided context. Therefore, it is not possible to draw any connections between hydrocortisone use and atrial fibrillation based on this statement alone."
18705900,Hydrocortisone related to phobic disorder,351,"This is an extremely rare case of bilateral adrenal tumors, in which the left adrenocortical tumor produced and secreted cortisol or both cortisol and aldosterone and the right one produced and secreted both aldosterone and cortisol, as confirmed by clinical findings and pathological studies using immunohistochemical analysis.",False,"'Does the phrase ""Hydrocortisone related to phobic disorder"" receive at least indirect support from the statement: ""This is an extremely rare case of bilateral adrenal tumors, in which the left adrenocortical tumor produced and secreted cortisol or both cortisol and aldosterone and the right one produced and secreted both aldosterone and cortisol, as confirmed by clinical findings and pathological studies using immunohistochemical analysis.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to phobic disorder"". The statement discusses an extremely rare case of bilateral adrenal tumors that produce and secrete cortisol and aldosterone. While hydrocortisone is a synthetic form of cortisol, there is no mention of any connection between these tumors, their secretions, and phobic disorders in the statement provided. Therefore, it is not possible to infer any relationship between hydrocortisone and phobic disorder based on this information alone."
15155784,Hydrocortisone related to psoriasis,352,"We conclude that the clinical picture of late-onset adrenal insufficiency in preterm infants is not a result of an absolute deficiency of cortisol production, but may be a result of a limited ability to synthesize sufficient cortisol for the degree of clinical stress.",False,"'Does the phrase ""Hydrocortisone related to psoriasis"" receive at least indirect support from the statement: ""We conclude that the clinical picture of late-onset adrenal insufficiency in preterm infants is not a result of an absolute deficiency of cortisol production, but may be a result of a limited ability to synthesize sufficient cortisol for the degree of clinical stress.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to psoriasis"". The conclusion in the statement is about late-onset adrenal insufficiency in preterm infants, which is related to cortisol production but not hydrocortisone use. Psoriasis is an autoimmune skin condition that is not mentioned in the statement. Therefore, there is no connection between hydrocortisone (a synthetic form of cortisol) and psoriasis in this context."
14891361,"Hydrocortisone related to dermatitis, atopic",353,"Ironically, despite our understanding of the various stressors that promote chronic adult-onset asthma, most of which are known to elevate cortisol production via the hypothalamic-pituitary-adrenal (HPA) axis, inhaled and systemic corticosteroids are the mainstay for the treatment of chronic asthma.",True,"'Does the phrase ""Hydrocortisone related to dermatitis, atopic"" receive at least indirect support from the statement: ""Ironically, despite our understanding of the various stressors that promote chronic adult-onset asthma, most of which are known to elevate cortisol production via the hypothalamic-pituitary-adrenal (HPA) axis, inhaled and systemic corticosteroids are the mainstay for the treatment of chronic asthma.""?","Yes, indirect support can be inferred from the statement provided for the phrase ""Hydrocortisone related to dermatitis, atopic."" Hydrocortisone is a type of corticosteroid that is often used in treating various conditions related to inflammation and allergies, such as atopic dermatitis (eczema).

        The statement highlights that corticosteroids like hydrocortisone are used as a primary treatment for chronic adult-onset asthma despite stressors promoting chronic asthma being known to elevate cortisol production via the HPA axis. This suggests that administering corticosteroids like hydrocortisone could help counteract the effects of increased cortisol levels in some instances.

        However, it is essential to acknowledge that atopic dermatitis is not asthma; they are separate conditions that can coexist in some individuals but have different underlying causes and mechanisms. Therefore, while hydrocortisone may be beneficial in managing atopic dermatitis in patients with chronic asthma, it may not necessarily impact asthma symptoms directly due to its relationship with cortisol production via the HPA"
14483328,Hydrocortisone related to bronchopulmonary dysplasia,354,Glucocorticoid insufficiency is common during sepsis and may result from insufficient production of cortisol or peripheral tissues resistance.,True,"'Does the phrase ""Hydrocortisone related to bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""Glucocorticoid insufficiency is common during sepsis and may result from insufficient production of cortisol or peripheral tissues resistance.""?","Yes, indirectly it does. Hydrocortisone is a type of glucocorticoid, which is a class of steroid hormones that includes cortisol. Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants often associated with premature birth and respiratory distress syndrome. 

        The statement provided suggests that glucocorticoid insufficiency, which can be due to decreased cortisol production or peripheral tissue resistance, is common during sepsis. Hydrocortisone is often used in clinical settings to treat conditions associated with glucocorticoid insufficiency. 

        Therefore, while the statement does not explicitly mention bronchopulmonary dysplasia, it does suggest a link between glucocorticoid insufficiency and conditions that may require hydrocortisone treatment. This could indirectly support the association between hydrocortisone and bronchopulmonary dysplasia, as both are related to glucocorticoid insufficiency. However, it's important to note that this is an indirect association and further research would be needed to confirm"
14450267,Hydrocortisone related to adrenal cortex neoplasm,355,"This likely represents an adaptive response to LTH, to prevent excessive cortisol production that would restrict fetal growth and potentially induce preterm delivery.",False,"'Does the phrase ""Hydrocortisone related to adrenal cortex neoplasm"" receive at least indirect support from the statement: ""This likely represents an adaptive response to LTH, to prevent excessive cortisol production that would restrict fetal growth and potentially induce preterm delivery.""?","No, the phrase ""Hydrocortisone related to adrenal cortex neoplasm"" does not receive indirect support from the statement provided. 

        The statement discusses an adaptive response related to hydrocortisone (cortisol), but it does not establish a connection between hydrocortisone and adrenal cortex neoplasm (a tumor of the adrenal gland). An adrenal cortex neoplasm would be a pathological condition involving uncontrolled cell growth in the adrenal gland, potentially leading to overproduction of hormones like cortisol. 

        In contrast, the statement suggests that lowering cortisol levels through an adaptive response might be beneficial in preventing excessive cortisol production that could negatively impact fetal growth and preterm delivery risk. This statement does not imply that hydrocortisone is related to an adrenal cortex neoplasm but rather focuses on its physiological function in fetal development under specific conditions (LTH). 

        Therefore, without further evidence linking hydrocortisone levels directly with adrenal cortex neoplasm, it is not reasonable to infer"
14387016,Hydrocortisone related to cirrhosis of liver,356,"The reduction in local cortisol production which diminishes the endogenous anti-inflammatory effects, also allows for the progression of both vascular and pulmonary inflammation.",False,"'Does the phrase ""Hydrocortisone related to cirrhosis of liver"" receive at least indirect support from the statement: ""The reduction in local cortisol production which diminishes the endogenous anti-inflammatory effects, also allows for the progression of both vascular and pulmonary inflammation.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to cirrhosis of liver."" The statement discusses the reduction in local cortisol production and its implications on vascular and pulmonary inflammation. Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. Although it has anti-inflammatory effects, the statement does not mention any connection between hydrocortisone use and cirrhosis of the liver. Therefore, it is not possible to make any inferences about hydrocortisone's relationship to liver cirrhosis based on the provided statement alone."
14360687,Hydrocortisone related to dermatitis,357,"CONCLUSIONS: Patients with newly diagnosed, untreated PC yielded significantly higher cortisol and lower estradiol serum concentrations than controls.",False,"'Does the phrase ""Hydrocortisone related to dermatitis"" receive at least indirect support from the statement: ""CONCLUSIONS: Patients with newly diagnosed, untreated PC yielded significantly higher cortisol and lower estradiol serum concentrations than controls.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to dermatitis."" The conclusion is about cortisol serum concentrations in patients with prostate cancer (PC) compared to controls, not about hydrocortisone or dermatitis. Hydrocortisone is a synthetic form of cortisol, but no information is given about its use or relation to dermatitis in this statement. Therefore, it is not possible to make any conclusions about hydrocortisone's relationship to dermatitis based on this information alone."
13844584,Hydrocortisone related to acute myeloid leukemia,358,"The tumour secreted excessive cortisol and dehydroepiandrosterone-sulphate (DHEA-S), and had invaded the right hepatic lobe and vena cava.",False,"'Does the phrase ""Hydrocortisone related to acute myeloid leukemia"" receive at least indirect support from the statement: ""The tumour secreted excessive cortisol and dehydroepiandrosterone-sulphate (DHEA-S), and had invaded the right hepatic lobe and vena cava.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to acute myeloid leukemia."" 

         The statement suggests that a tumor is producing cortisol and DHEA-S (dehydroepiandrosterone-sulphate), which are steroid hormones produced by the adrenal gland. Hydrocortisone is a synthetic form of cortisol often used in medications. While it is true that acute myeloid leukemia (AML) cells can produce steroid hormones, the statement does not indicate that hydrocortisone is involved in this particular case. Therefore, it does not provide support for the claimed relationship between hydrocortisone and AML."
13213365,Hydrocortisone related to chronic primary adrenal insufficiency,359,Replacement doses of hydrocortisone were administered throughout treatment to counteract potential adrenal insufficiency secondary to the ketoconazole.,True,"'Does the phrase ""Hydrocortisone related to chronic primary adrenal insufficiency"" receive at least indirect support from the statement: ""Replacement doses of hydrocortisone were administered throughout treatment to counteract potential adrenal insufficiency secondary to the ketoconazole.""?","Yes, indirect support can be inferred from the statement. The provided statement indicates that hydrocortisone was administered throughout treatment to counteract potential adrenal insufficiency secondary to ketoconazole use. This suggests a relationship between hydrocortisone and adrenal insufficiency, which aligns with the concept of hydrocortisone being related to chronic primary adrenal insufficiency. However, it is important to note that this relationship is not explicitly stated as primary adrenal insufficiency in the original statement; rather, it refers to adrenal insufficiency that is secondary to ketoconazole use. Nonetheless, it does provide some level of indirect support for the initial phrase based on the broader context of adrenal insufficiency."
12756660,Hydrocortisone related to borderline personality disorder,360,Amplication by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias.,False,"'Does the phrase ""Hydrocortisone related to borderline personality disorder"" receive at least indirect support from the statement: ""Amplication by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias.""?","No, the statement ""Amplification by hydrocortisone of the induction of cytotoxic response in vitro to syngeneic murine leukemias"" does not provide indirect support for the connection between hydrocortisone and borderline personality disorder (BPD). The statement is about hydrocortisone amplifying cytotoxic responses in vitro (in a laboratory setting) against syngeneic murine leukemias (mouse leukemias). This is related to immunology and cancer treatment rather than psychiatry or personality disorders like BPD.

         The two subjects - hydrocortisone and borderline personality disorder - may be connected in some broader contexts (e.g., hydrocortisone being used as a medication in psychiatric care), but the provided statement does not contain any information linking hydrocortisone to BPD specifically. Therefore, it does not indirectly support the claimed connection between hydrocortisone and borderline personality disorder based on this statement alone."
12576998,Hydrocortisone related to Hypoxemia,361,The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further.,False,"'Does the phrase ""Hydrocortisone related to Hypoxemia"" receive at least indirect support from the statement: ""The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further.""?","No, the statement ""The results demonstrated that the intrarectal dose of indomethacin and hydrocortisone inhibited the development of tumors from microscopic carcinoma lesions in the large bowel and growing further"" does not provide indirect support for the phrase ""Hydrocortisone related to Hypoxemia"". 

        The statement discusses the effect of indomethacin and hydrocortisone on tumor development in the large bowel, which is unrelated to hypoxemia, a condition characterized by low oxygen levels in the blood. Hypoxemia is not mentioned nor implied in the statement. Therefore, it does not offer any support for a relationship between hydrocortisone and hypoxemia."
11888652,Hydrocortisone related to congenital adrenal hyperplasia,362,"Growth of ovarian, lung, breast, and kidney carcinomas was increased by 136%, 126%, 78% and 69%, respectively, whereas melanomas, sarcomas, and colon tumors were inhibited by hydrocortisone.",False,"'Does the phrase ""Hydrocortisone related to congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""Growth of ovarian, lung, breast, and kidney carcinomas was increased by 136%, 126%, 78% and 69%, respectively, whereas melanomas, sarcomas, and colon tumors were inhibited by hydrocortisone.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to congenital adrenal hyperplasia"". 

        The statement presents data on the effects of hydrocortisone on various types of carcinomas and tumors. However, congenital adrenal hyperplasia (CAH) is a genetic disorder that affects the adrenal glands' production of certain hormones, most commonly cortisol and aldosterone. Hydrocortisone is a synthetic form of cortisol, a hormone that the adrenal gland produces naturally. 

        While hydrocortisone is used in treating CAH to replace deficient cortisol, the statement does not provide any information about hydrocortisone's relationship to CAH. It only discusses hydrocortisone's effects on various carcinomas and tumors, which is unrelated to CAH. Therefore, it does not provide indirect support for the phrase ""Hydrocortisone related to congenital adrenal hyperplasia""."
11866289,Hydrocortisone related to nicotine dependence,363,Insufficient cortisol limits the ability of the sick newborn to handle stress and inhibit pulmonary inflammation.,False,"'Does the phrase ""Hydrocortisone related to nicotine dependence"" receive at least indirect support from the statement: ""Insufficient cortisol limits the ability of the sick newborn to handle stress and inhibit pulmonary inflammation.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to nicotine dependence."" 

        The statement discusses the role of cortisol, a hormone that the body produces in response to stress, in newborns. It suggests that insufficient cortisol levels can limit a newborn's ability to manage stress and inhibit pulmonary inflammation. 

        Hydrocortisone is a synthetic form of cortisol often used in medical treatments to reduce inflammation. While both cortisol and hydrocortisone have similar effects in the body, nicotine dependence is not mentioned or implied in the statement. Nicotine dependence is a complex process involving multiple factors, including genetic predisposition, environmental influences, and addiction behavior, which are not addressed in the statement. 

        Therefore, without additional context or evidence linking hydrocortisone to nicotine dependence, it is inappropriate to infer such a connection based on the provided statement alone."
11530989,Hydrocortisone related to pneumonia,364,"BACKGROUND: Hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity, which converts cortisone (inactive) to cortisol, is downregulated in obesity.",False,"'Does the phrase ""Hydrocortisone related to pneumonia"" receive at least indirect support from the statement: ""BACKGROUND: Hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity, which converts cortisone (inactive) to cortisol, is downregulated in obesity.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to pneumonia."" The statement discusses hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) activity in obesity, which is responsible for converting cortisone (inactive) to cortisol (active). However, it does not mention hydrocortisone (a synthetic form of cortisol) nor does it provide any connection between these steroid hormones and pneumonia."
11442939,Hydrocortisone related to prostate cancer,365,"High-dose hydrocortisone treatment given in the first few hours after a traumatic experience was associated with significant favorable changes in the trajectory of exposure to trauma, as expressed by the reduced risk of the development of PTSD post-trauma.",False,"'Does the phrase ""Hydrocortisone related to prostate cancer"" receive at least indirect support from the statement: ""High-dose hydrocortisone treatment given in the first few hours after a traumatic experience was associated with significant favorable changes in the trajectory of exposure to trauma, as expressed by the reduced risk of the development of PTSD post-trauma.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to prostate cancer."" The statement discusses the association between high-dose hydrocortisone treatment and reduced risk of post-traumatic stress disorder (PTSD) development after a traumatic experience. This is unrelated to prostate cancer. Therefore, it does not offer any relevant information or implications regarding hydrocortisone's potential relationship with prostate cancer."
11089023,Hydrocortisone related to pancreatitis,366,"Under normal conditions, stress induces increased cortisol secretion that counteracts inflammatory reactions.",True,"'Does the phrase ""Hydrocortisone related to pancreatitis"" receive at least indirect support from the statement: ""Under normal conditions, stress induces increased cortisol secretion that counteracts inflammatory reactions.""?","Yes, indirectly it does support the statement ""Hydrocortisone related to pancreatitis"". This is because hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. The statement suggests that cortisol has an anti-inflammatory effect, which is true - one of cortisol's primary functions is to reduce inflammation in the body. 

        However, like all medications, hydrocortisone can have side effects, one of which can be pancreatitis, particularly at high doses or in patients with certain risk factors. Therefore, while the statement about cortisol's anti-inflammatory effects is correct, it doesn't tell the whole story about hydrocortisone use, which can indeed be related to pancreatitis under certain conditions. 

        It's important to note that correlation does not imply causation, and while there may be a relationship between hydrocortisone use and pancreatitis, it doesn't necessarily mean that the hydrocortisone is the direct cause of the pancreatitis. Other factors, such as the patient"
10649902,Hydrocortisone related to myocardial infarction,367,Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values.,False,"'Does the phrase ""Hydrocortisone related to myocardial infarction"" receive at least indirect support from the statement: ""Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values.""?","No, the statement ""Hydrocortisone (HC) reduced the macrophage content of four murine tumors to less than half of control values"" does not provide indirect support for the claim that ""Hydrocortisone is related to myocardial infarction."" The first statement refers to an observed effect of hydrocortisone on macrophage content in tumors in mice while the second statement relates to potential implications of hydrocortisone in myocardial infarction in humans (or other animals).

        The two statements involve different biological contexts (cancer vs cardiovascular disease), different species (mice vs humans/other animals), different endpoints (macrophage content in tumors vs myocardial infarction), and different directions of effect (reduction in macrophage content vs potential increase in myocardial infarction risk).

        While hydrocortisone has been associated with both anti-inflammatory effects (which could potentially reduce tumor growth by reducing macrophage content) and pro-inflammatory effects (which could potentially contribute to cardiovascular disease by increasing inflammation),"
10522181,Hydrocortisone related to osteoarthritis,368,"Further, because infant formula contains only trace amounts of glucocorticoids, these findings suggest that cortisol in milk is a novel biological pathway through which breastfeeding may protect against later obesity.",False,"'Does the phrase ""Hydrocortisone related to osteoarthritis"" receive at least indirect support from the statement: ""Further, because infant formula contains only trace amounts of glucocorticoids, these findings suggest that cortisol in milk is a novel biological pathway through which breastfeeding may protect against later obesity.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to osteoarthritis"". The statement discusses the potential protective effect of breastfeeding against later obesity through cortisol in milk, which is a type of glucocorticoid. However, it does not mention hydrocortisone specifically nor does it discuss osteoarthritis. Hydrocortisone is one of several types of glucocorticoids, but the statement does not provide any information that would suggest a relationship between hydrocortisone and osteoarthritis."
10521296,Hydrocortisone related to eye disorder,369,"Conclusions and Relevance: Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days.",False,"'Does the phrase ""Hydrocortisone related to eye disorder"" receive at least indirect support from the statement: ""Conclusions and Relevance: Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to eye disorder"". The conclusion is about the use of hydrocortisone in adults with severe sepsis not in septic shock and its effect on reducing the risk of septic shock within 14 days. It does not mention nor imply any relation between hydrocortisone and eye disorders."
10518203,Hydrocortisone related to otitis externa,370,These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature.,False,"'Does the phrase ""Hydrocortisone related to otitis externa"" receive at least indirect support from the statement: ""These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature.""?","No, the statement ""These findings suggest that HC may protect against hyperoxic injury in the developing pulmonary vasculature"" does not provide indirect support for the phrase ""Hydrocortisone related to otitis externa."" 

        The statement in question discusses the potential protective effects of hydrocortisone (HC) against hyperoxic injury in the developing pulmonary vasculature. This is an entirely different context from otitis externa, which is an inflammation or infection of the outer ear canal. 

        The two statements discuss different aspects of hydrocortisone's potential effects, one in pulmonary vasculature and the other in the ear canal, without any overlap or connection between these two distinct areas of the body. Therefore, there is no implicit or explicit support for a relationship between hydrocortisone and otitis externa from the given statement."
10484611,Hydrocortisone related to ulcerative colitis,371,OBJECTIVE: Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency.,False,"'Does the phrase ""Hydrocortisone related to ulcerative colitis"" receive at least indirect support from the statement: ""OBJECTIVE: Cortisol clearance is reduced in sepsis and may contribute to the development of impaired adrenocortical function that is thought to contribute to the pathophysiology of critical illness-related corticosteroid insufficiency.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to ulcerative colitis."" The statement discusses cortisol clearance in sepsis and its potential contribution to impaired adrenocortical function in critical illness-related corticosteroid insufficiency. Hydrocortisone is a synthetic form of cortisol (a hormone naturally produced in the human body), but there is no mention of ulcerative colitis in the statement provided. Ulcerative colitis is a chronic inflammatory bowel disease, which may be treated using hydrocortisone as a therapeutic agent; however, that connection is not implied in the statement provided. To establish a connection between hydrocortisone and ulcerative colitis, additional information would be required that explicitly links these two concepts together."
9718673,Hydrocortisone related to atopic eczema,372,Hydrocortisone therapy was started to prevent adrenal insufficiency before laboratory findings for ACTH (adrenocorticotropic hormone) and cortisol levels.,False,"'Does the phrase ""Hydrocortisone related to atopic eczema"" receive at least indirect support from the statement: ""Hydrocortisone therapy was started to prevent adrenal insufficiency before laboratory findings for ACTH (adrenocorticotropic hormone) and cortisol levels.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to atopic eczema."" The statement indicates that hydrocortisone therapy was initiated as a preventative measure for adrenal insufficiency based on laboratory results for ACTH (adrenocorticotropic hormone) and cortisol levels. The reason for initiating hydrocortisone therapy in this case is unrelated to atopic eczema. Therefore, there is no implicit or explicit connection between hydrocortisone use and atopic eczema in the provided statement."
9492934,Hydrocortisone related to opiate dependence,373,CONCLUSION: We conclude that intravenous stress doses of hydrocortisone lead to a reduction of systemic inflammation and to a potential improvement in the early outcome of patients undergoing off-pump CABG.,False,"'Does the phrase ""Hydrocortisone related to opiate dependence"" receive at least indirect support from the statement: ""CONCLUSION: We conclude that intravenous stress doses of hydrocortisone lead to a reduction of systemic inflammation and to a potential improvement in the early outcome of patients undergoing off-pump CABG.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to opiate dependence."" The conclusion presented in the statement is about the effects of intravenous stress doses of hydrocortisone on systemic inflammation and early outcomes in patients undergoing off-pump coronary artery bypass grafting (CABG). It does not mention or imply any relationship between hydrocortisone and opiate dependence."
9238280,Hydrocortisone related to Sepsis,374,"CONCLUSION: In intubated trauma patients, the use of an intravenous stress-dose of hydrocortisone, compared with placebo, resulted in a decreased risk of hospital-acquired pneumonia.",False,"'Does the phrase ""Hydrocortisone related to Sepsis"" receive at least indirect support from the statement: ""CONCLUSION: In intubated trauma patients, the use of an intravenous stress-dose of hydrocortisone, compared with placebo, resulted in a decreased risk of hospital-acquired pneumonia.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to Sepsis."" The conclusion in the statement indicates that hydrocortisone use in intubated trauma patients led to a decreased risk of hospital-acquired pneumonia compared to placebo. However, it does not mention or imply any connection between hydrocortisone and sepsis. Sepsis is a systemic inflammatory response syndrome due to infection, while hydrocortisone is primarily used as an anti-inflammatory and immunosuppressive agent in certain clinical situations, such as preventing adrenal insufficiency in septic shock patients. Although both sepsis and hydrocortisone use can be related in some contexts, this particular conclusion does not establish such a connection."
9235597,Hydrocortisone related to type 1 diabetes mellitus,375,"Early hydrocortisone (HC) treatment may decrease the incidence of bronchopulmonary dysplasia; however, the long-term effects are still under evaluation.",False,"'Does the phrase ""Hydrocortisone related to type 1 diabetes mellitus"" receive at least indirect support from the statement: ""Early hydrocortisone (HC) treatment may decrease the incidence of bronchopulmonary dysplasia; however, the long-term effects are still under evaluation.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to type 1 diabetes mellitus."" 

        The statement discusses the use of hydrocortisone (HC) in relation to bronchopulmonary dysplasia, a chronic lung disease in premature infants. It does not mention or imply any connection between hydrocortisone and type 1 diabetes mellitus. Type 1 diabetes mellitus is an autoimmune disease where the body does not produce insulin, while hydrocortisone is a steroid hormone often used in treating various conditions due to its anti-inflammatory and immunosuppressive properties. Although hydrocortisone can have metabolic side effects that might theoretically impact diabetes risk, there is no direct evidence in the statement provided to suggest such a link. 

        Therefore, it is crucial to evaluate scientific claims based on direct evidence pertaining to the specific claim in question. Extrapolating unrelated information may lead to misinterpretations or misunderstandings of the actual implications of the research."
8977987,Hydrocortisone related to injury,376,CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.,True,"'Does the phrase ""Hydrocortisone related to injury"" receive at least indirect support from the statement: ""CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.""?","Yes, there is indirect support for the phrase ""Hydrocortisone related to injury"" from the statement ""CONCLUSION: Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery."" This is because hydrocortisone is being administered as an intervention to prevent atrial fibrillation (AF), which can be considered an injury in the context of cardiac surgery due to its potential negative impacts on patient outcomes. The statement implies that hydrocortisone has a protective effect against AF occurrence after cardiac surgery, suggesting that it may be beneficial in mitigating injury related to this procedure. However, it is essential to consider that direct evidence connecting hydrocortisone specifically to injury reduction is not explicitly provided in the statement; therefore, the support is indirect in nature."
8778414,Hydrocortisone related to Inflammation,377,"Assuming a single dose of hydrocortisone improves sensitivity of peripheral tissues to insulin, it may be an interesting candidate for use in reducing insulin resistance in peripheral tissues of horses with several disease states.",True,"'Does the phrase ""Hydrocortisone related to Inflammation"" receive at least indirect support from the statement: ""Assuming a single dose of hydrocortisone improves sensitivity of peripheral tissues to insulin, it may be an interesting candidate for use in reducing insulin resistance in peripheral tissues of horses with several disease states.""?","Yes, there is indirect support for the phrase ""Hydrocortisone related to Inflammation"" from the statement provided. 

        The statement suggests that hydrocortisone could improve sensitivity of peripheral tissues to insulin, which may help reduce insulin resistance in horses with various disease states. This is relevant because insulin resistance is often associated with chronic low-grade inflammation in horses as well as in humans. 

        Hydrocortisone is a glucocorticoid hormone known for its potent anti-inflammatory effects due to its ability to suppress cytokine production and immune cell activity. Thus, by improving insulin sensitivity in peripheral tissues, hydrocortisone might indirectly help reduce inflammation in horses with certain disease states.

        However, it is essential to acknowledge that hydrocortisone also has immunosuppressive properties that could potentially exacerbate existing infections in horses suffering from inflammatory conditions. Therefore, further studies would be required to evaluate hydrocortisone's overall impact on inflammation in horses and any potential risks associated with its administration in horses with"
8763179,Hydrocortisone related to toxic shock syndrome,378,Plasma cortisol and glucagon concentrations were not increased markedly except in a case complicated other systemic bacterial infection.,False,"'Does the phrase ""Hydrocortisone related to toxic shock syndrome"" receive at least indirect support from the statement: ""Plasma cortisol and glucagon concentrations were not increased markedly except in a case complicated other systemic bacterial infection.""?","No, the phrase ""Hydrocortisone related to toxic shock syndrome"" does not receive indirect support from the statement provided. The statement discusses plasma cortisol concentrations in relation to bacterial infection but does not mention hydrocortisone or toxic shock syndrome directly. Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress; it is not typically associated with toxic shock syndrome (TSS). TSS is primarily caused by certain types of bacteria producing exotoxins that trigger an overwhelming immune response leading to shock-like symptoms, not by cortisol or its synthetic forms like hydrocortisone. Therefore, there is no indirect support for any relationship between hydrocortisone and TSS based on the statement given."
8625521,Hydrocortisone related to dissociative amnesia,379,"In view of the stimulatory effects of insulin and cortisol on adipogenesis, long-term stimulation of 11betaHSD reductase activity by insulin could aggravate visceral obesity.",False,"'Does the phrase ""Hydrocortisone related to dissociative amnesia"" receive at least indirect support from the statement: ""In view of the stimulatory effects of insulin and cortisol on adipogenesis, long-term stimulation of 11betaHSD reductase activity by insulin could aggravate visceral obesity.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to dissociative amnesia."" The statement discusses the relationship between insulin, cortisol (which is related to hydrocortisone), and adipogenesis (the formation of fat cells), but it does not mention or imply any connection to dissociative amnesia. Dissociative amnesia is a condition related to memory loss, not obesity or adipogenesis. Therefore, while there may be a connection between hydrocortisone (a synthetic form of cortisol) and adipogenesis as suggested by the statement, there is no connection established between hydrocortisone and dissociative amnesia in this context."
8615164,Hydrocortisone related to asthma,380,"For this purpose, this review article contends that plasma cortisol is linked to a greater risk of AF.",False,"'Does the phrase ""Hydrocortisone related to asthma"" receive at least indirect support from the statement: ""For this purpose, this review article contends that plasma cortisol is linked to a greater risk of AF.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to asthma"". The review article discusses plasma cortisol's link to an increased risk of atrial fibrillation (AF), not asthma. Hydrocortisone is a synthetic glucocorticoid hormone that mimics the actions of cortisol in the body; however, cortisol is not exclusively produced in response to asthma attacks but is part of the body's general stress response. Therefore, it is crucial to consider the context of any statement when interpreting its relevance to specific scientific questions."
8570630,Hydrocortisone related to fibromyalgia,381,"After multivariate analysis, duration of HC stress dose administration was associated with increased risk of mortality (OR 1.11, 95% CI 1.02-1.2, p = 0.021), and total duration of HC treatment was associated with increased risk of sepsis (OR 1.04, 95% CI 1.005-1.075, p = 0.026).",False,"'Does the phrase ""Hydrocortisone related to fibromyalgia"" receive at least indirect support from the statement: ""After multivariate analysis, duration of HC stress dose administration was associated with increased risk of mortality (OR 1.11, 95% CI 1.02-1.2, p = 0.021), and total duration of HC treatment was associated with increased risk of sepsis (OR 1.04, 95% CI 1.005-1.075, p = 0.026).""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone related to fibromyalgia"". The statement discusses the association of hydrocortisone (HC) stress dose administration duration with increased risk of mortality, and total duration of HC treatment associated with increased risk of sepsis in a general context. However, it does not mention or imply any connection between hydrocortisone and fibromyalgia."
8017438,Hydrocortisone related to Insulin resistance,382,"Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01).",False,"'Does the phrase ""Hydrocortisone related to Insulin resistance"" receive at least indirect support from the statement: ""Plasma leptin and ghrelin levels in endotoxin-treated dogs were correlated with serum nitric oxide (r = .955 and r = .890; p < .001), procalcitonin (r = .825 and r = .716; p < .001), cortisol (r = .823 and r = .786; p < .001), and hepatorenal injury markers (r = .580 to .745 and r = .393 to .574; p < .05 to .01).""?","No, the statement does not provide direct support for the phrase ""Hydrocortisone related to Insulin resistance"". The statement discusses correlations between various factors in endotoxin-treated dogs, including cortisol (which is related to hydrocortisone), but it does not mention insulin resistance or provide any information about how hydrocortisone might be related to insulin resistance. 

        However, it is important to note that cortisol is a glucocorticoid hormone like hydrocortisone, and both can influence metabolic processes including insulin sensitivity. Prolonged exposure to high levels of these hormones can lead to insulin resistance in some individuals. But this statement does not provide direct evidence for that relationship. 

        Therefore, while there is indirect theoretical support for a relationship between hydrocortisone and insulin resistance based on our general understanding of these hormones, this specific statement does not provide direct evidence for that relationship."
7919367,Hydrocortisone related to adrenocortical insufficiency,383,Contribution of cortisol deficiency to septic shock.,True,"'Does the phrase ""Hydrocortisone related to adrenocortical insufficiency"" receive at least indirect support from the statement: ""Contribution of cortisol deficiency to septic shock.""?","Yes, indirectly it does. The statement ""Contribution of cortisol deficiency to septic shock"" implies that there is a relationship between cortisol levels and adrenocortical insufficiency (a condition characterized by insufficient production of cortisol), as hydrocortisone is a synthetic form of cortisol. Therefore, if cortisol deficiency contributes to septic shock, then managing adrenocortical insufficiency with hydrocortisone could be beneficial in preventing or treating septic shock symptoms. However, it is important to note that further investigation would be required to establish a direct causal relationship between hydrocortisone use and adrenocortical insufficiency prevention/treatment in septic shock cases specifically."
7573954,Hydrocortisone related to neoplasm,384,The objective of this study was to demonstrate the effect of stress doses of hydrocortisone during the initial phase of human septic shock on the serum values of the neurospecific protein S-100B in comparison to the inflammation markers interleukin (IL)-8 in serum and polymorphonuclear (PMN) elastase in plasma.,False,"'Does the phrase ""Hydrocortisone related to neoplasm"" receive at least indirect support from the statement: ""The objective of this study was to demonstrate the effect of stress doses of hydrocortisone during the initial phase of human septic shock on the serum values of the neurospecific protein S-100B in comparison to the inflammation markers interleukin (IL)-8 in serum and polymorphonuclear (PMN) elastase in plasma.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone related to neoplasm"". The objective of the study as stated is focused on examining the impact of stress doses of hydrocortisone on serum values of certain proteins and inflammation markers in human septic shock patients. There is no mention of neoplasm (abnormal tissue growth that may become cancerous) in the statement. Therefore, it does not provide any relevant information or evidence regarding a relationship between hydrocortisone and neoplasm."
7182905,Hydrocortisone related to obesity disorder,385,"The synergism between insulin and cortisol in stimulating energy deposition, associated with a decreased effect of corticotropin-releasing factor in stimulating energy expenditure, is likely to contribute to the development of obesity.",True,"'Does the phrase ""Hydrocortisone related to obesity disorder"" receive at least indirect support from the statement: ""The synergism between insulin and cortisol in stimulating energy deposition, associated with a decreased effect of corticotropin-releasing factor in stimulating energy expenditure, is likely to contribute to the development of obesity.""?","Yes, the statement does provide indirect support for the connection between hydrocortisone (a type of cortisol) and obesity disorder. The statement suggests that cortisol, in conjunction with insulin, plays a significant role in stimulating energy deposition while decreasing the effect of corticotropin-releasing factor in stimulating energy expenditure. This imbalance can contribute to obesity development.

         Hydrocortisone is a glucocorticoid hormone that shares many functions with cortisol; they can be used interchangeably in some contexts. Obesity has been linked to excessive glucocorticoid exposure, such as that caused by Cushing syndrome (a condition characterized by high levels of cortisol). Thus, it is plausible that exposure to hydrocortisone could also contribute to obesity development due to its similarity in function to cortisol.

         However, it is essential to acknowledge that further investigation is necessary for establishing direct causality between hydrocortisone exposure and obesity disorder since numerous factors influence obesity development, including genetics, lifestyle choices, mental health conditions, and other environmental"
24445107,Hydrocortisone related to Inflammation,386,Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study.,True,"'Does the phrase ""Hydrocortisone related to Inflammation"" receive at least indirect support from the statement: ""Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study.""?","Yes, there is indirect support for the phrase ""Hydrocortisone related to Inflammation"" from the statement ""Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study."" 

        The key connection lies in understanding that hydrocortisone is a type of cortisol hormone naturally produced in the human body by the adrenal glands. Cortisol is known for its involvement in the body's response to stress, regulating metabolism, and reducing inflammation.

        The Rancho Bernardo Study indicates that higher basal cortisol levels predict verbal memory loss in postmenopausal women. Although this study does not explicitly mention hydrocortisone, it still provides indirect evidence for a relationship between cortisol (including hydrocortisone) and inflammation since elevated cortisol levels can be linked to chronic inflammation.

        Chronic inflammation is associated with various health issues, including impaired cognitive function and memory loss. Therefore, it is plausible that hydrocortisone could influence inflammation based on the Ran"
24030854,Hydrocortisone related to Hypoxemia,387,"A growing body of evidence now suggests that endogenous cortisol, which is produced in significant quantities by the body in a diurnal rhythm, is an important regulator of allergic disease expression and allergic inflammatory responses: lung function varies along with plasma cortisol levels; the number of circulating inflammatory cells varies with plasma cortisol levels; and low levels of endogenous cortisol may be associated with risk for asthma.",True,"'Does the phrase ""Hydrocortisone related to Hypoxemia"" receive at least indirect support from the statement: ""A growing body of evidence now suggests that endogenous cortisol, which is produced in significant quantities by the body in a diurnal rhythm, is an important regulator of allergic disease expression and allergic inflammatory responses: lung function varies along with plasma cortisol levels; the number of circulating inflammatory cells varies with plasma cortisol levels; and low levels of endogenous cortisol may be associated with risk for asthma.""?","Yes, there is indirect support for the statement ""Hydrocortisone related to Hypoxemia"" from the provided evidence. Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. The statement suggests that endogenous cortisol plays a significant role in regulating allergic disease expression and inflammatory responses, particularly in lung function and circulating inflammatory cells.

         Hypoxemia is a condition characterized by low levels of oxygen in the blood. Cortisol, including synthetic forms like hydrocortisone, has anti-inflammatory effects that could potentially impact lung function and inflammatory cell counts, both of which could be relevant to hypoxemia. However, it is important to note that while there is indirect support for a relationship between hydrocortisone and hypoxemia based on these mechanisms, direct evidence of such a relationship is not provided in the statement.

         Therefore, while it is plausible that hydrocortisone could be related to hypoxemia through its effects on lung function and inflammatory cells, further research would be needed to"
12533519,Hydrocortisone related to Insulin resistance,388,"In conclusion, the data presented here suggest that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia.",True,"'Does the phrase ""Hydrocortisone related to Insulin resistance"" receive at least indirect support from the statement: ""In conclusion, the data presented here suggest that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia.""?","Yes, there is indirect support for the phrase ""Hydrocortisone related to Insulin resistance"" from the statement provided. Hydrocortisone is a synthetic form of cortisol, a hormone that the body naturally produces in response to stress. The statement suggests that cortisol can contribute to insulin resistance in ponies with hyperlipoproteinaemia. Given that hydrocortisone is a synthetic form of cortisol, it stands to reason that hydrocortisone could also contribute to insulin resistance under similar circumstances. However, it is important to note that direct experimental evidence is not provided in the statement; therefore, any connection made between hydrocortisone and insulin resistance remains indirect at this point."
27747116,Hydrocortisone causes toxic shock syndrome,389,"OBJECTIVE: To investigate the relationship of cortisol concentrations during the first week of life to patent ductus arteriosus (PDA), markers of lung inflammation, and respiratory outcome in very low birth weight infants.",False,"'Does the phrase ""Hydrocortisone causes toxic shock syndrome"" receive at least indirect support from the statement: ""OBJECTIVE: To investigate the relationship of cortisol concentrations during the first week of life to patent ductus arteriosus (PDA), markers of lung inflammation, and respiratory outcome in very low birth weight infants.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes toxic shock syndrome."" The objective of the study is to investigate the relationship between cortisol concentrations during the first week of life (note that it does not specify hydrocortisone administration), PDA, markers of lung inflammation, and respiratory outcome in very low birth weight infants. Toxic shock syndrome is an acute illness characterized by fever, shock, and organ failure caused by certain types of bacteria that produce exotoxins; it is not explicitly linked to hydrocortisone use in the study objective provided."
27747115,Hydrocortisone causes Sepsis,390,Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease.,False,"'Does the phrase ""Hydrocortisone causes Sepsis"" receive at least indirect support from the statement: ""Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease.""?","No, the statement ""Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease"" does not provide indirect support for the claim that ""Hydrocortisone causes Sepsis"". The study referenced in the title is investigating two different treatments for Crohn's disease, neither of which is Hydrocortisone. The connection between these two pieces of information is tenuous at best, as there is no mention of Hydrocortisone in the study title or its implications for sepsis. Sepsis is a serious condition that can be caused by various factors, including infections; however, it is not caused by Hydrocortisone itself. Hydrocortisone is a medication used primarily for its anti-inflammatory effects in various conditions such as allergies, skin disorders, and autoimmune diseases."
27073884,Hydrocortisone causes atopic eczema,391,Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies.,False,"'Does the phrase ""Hydrocortisone causes atopic eczema"" receive at least indirect support from the statement: ""Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies.""?","No, the statement ""Pharmacokinetics of high dose methylprednisolone and use in hematological malignancies"" does not provide any direct or indirect support for the claim that ""Hydrocortisone causes atopic eczema.""

        The statement is about pharmacokinetics (the process of how a drug is absorbed, distributed, metabolized, and excreted) of high dose methylprednisolone (a type of corticosteroid) in hematological malignancies (blood cancers). It does not mention hydrocortisone at all, nor does it discuss any relationship between corticosteroids and atopic eczema.

        Atopic eczema is a chronic inflammatory skin condition that can be exacerbated by various factors including stress, changes in temperature or humidity, and certain types of medications including corticosteroids like hydrocortisone. However, saying that hydrocortisone causes atopic eczema is not accurate because while it may exacerbate existing symptoms in some individuals, it does not cause the condition itself.

        Therefore, without any reference made to"
25383174,Hydrocortisone causes fibromyalgia,392,"Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.",False,"'Does the phrase ""Hydrocortisone causes fibromyalgia"" receive at least indirect support from the statement: ""Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes fibromyalgia."" The statement discusses Methylprednisolone, which is a different type of corticosteroid than Hydrocortisone, being used in advanced chronic lymphocytic leukaemia patients. There is no mention of fibromyalgia in the statement, nor any connection made between corticosteroids (including Hydrocortisone) and fibromyalgia development."
25205462,Hydrocortisone causes hypotensive disorder,393,The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.,False,"'Does the phrase ""Hydrocortisone causes hypotensive disorder"" receive at least indirect support from the statement: ""The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes hypotensive disorder."" The statement discusses the effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis, which is unrelated to hydrocortisone or hypotensive disorder. Hydrocortisone is a different type of corticosteroid medication than methylprednisolone; therefore, any potential effects on blood pressure would need separate evaluation."
20591759,Hydrocortisone causes Hypoxemia,394,The effect of methylprednisolone (MP) on the cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue was investigated.,False,"'Does the phrase ""Hydrocortisone causes Hypoxemia"" receive at least indirect support from the statement: ""The effect of methylprednisolone (MP) on the cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue was investigated.""?","No, the statement does not provide any indirect support for the claim that ""Hydrocortisone causes Hypoxemia."" The statement discusses an investigation into the effect of methylprednisolone (MP) on cell kinetic response to cyclophosphamide (CP) and Adriamycin (ADR) in C3H/HeJ spontaneous mammary tumors and hematopoietic tissue. Hydrocortisone is not mentioned in this statement, nor is hypoxemia, which is a condition characterized by low levels of oxygen in the blood. Therefore, it is not possible to draw any conclusions about hydrocortisone causing hypoxemia based on this statement alone."
18446972,Hydrocortisone causes congenital adrenal hyperplasia,395,High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis.,False,"'Does the phrase ""Hydrocortisone causes congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis.""?","No, the statement ""High-dose intravenous methyl-prednisolone in chronic polymyositis/dermatomyositis"" does not provide indirect support for the claim that ""Hydrocortisone causes congenital adrenal hyperplasia."" 

         The two statements discuss different corticosteroids (methyl-prednisolone vs hydrocortisone) and different medical conditions (polymyositis/dermatomyositis vs congenital adrenal hyperplasia). Methyl-prednisolone is not hydrocortisone, and polymyositis/dermatomyositis is not congenital adrenal hyperplasia.

         Congenital adrenal hyperplasia (CAH) is primarily caused by genetic defects in enzymes involved in cortisol synthesis in the adrenal glands, not by exposure to exogenous corticosteroids such as hydrocortisone (or methyl-prednisolone) during pregnancy (Speiser et al., 2018).

         In conclusion, there is no indirect support for the claim that hydro"
18240145,Hydrocortisone causes injury,396,Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.,False,"'Does the phrase ""Hydrocortisone causes injury"" receive at least indirect support from the statement: ""Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.""?","No, the statement ""Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing"" does not provide indirect support for the phrase ""Hydrocortisone causes injury."" The statement is about a comparative study between Intratympanic Gentamicin and Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing. Hydrocortisone is not mentioned in this statement, hence it does not offer any support for the claim that Hydrocortisone causes injury."
17359303,Hydrocortisone causes influenza,397,"High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.",False,"'Does the phrase ""Hydrocortisone causes influenza"" receive at least indirect support from the statement: ""High-dose methylprednisolone, vincristine, MTX, and ara-C (SOMA) as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology: preliminary results of an ongoing phase II study.""?","No, the statement does not provide any indirect support for the claim that ""Hydrocortisone causes influenza."" The statement is about high-dose methylprednisolone, vincristine, MTX, and ara-C as initial bulk reducing therapy in non-Hodgkin's lymphoma of unfavorable histology in an ongoing phase II study. Hydrocortisone is not mentioned in this statement, nor is there any connection made between these treatments and influenza."
13585273,"Hydrocortisone causes dermatitis, atopic",398,A Prospective Study Comparing the Efficacy of Local Injection of Platelet-Rich Plasma (PRP) vs Methylprednisolone in Plantar Fasciitis.,False,"'Does the phrase ""Hydrocortisone causes dermatitis, atopic"" receive at least indirect support from the statement: ""A Prospective Study Comparing the Efficacy of Local Injection of Platelet-Rich Plasma (PRP) vs Methylprednisolone in Plantar Fasciitis.""?","No, the statement ""A Prospective Study Comparing the Efficacy of Local Injection of Platelet-Rich Plasma (PRP) vs Methylprednisolone in Plantar Fasciitis"" does not provide indirect support for the phrase ""Hydrocortisone causes dermatitis, atopic"". 

        The study in question compares the efficacy of two treatments for plantar fasciitis, one of which involves the use of methylprednisolone. Hydrocortisone is a different type of corticosteroid than methylprednisolone, and while both can have side effects including dermatitis, the study does not make any direct or indirect connections between hydrocortisone and dermatitis. 

        Furthermore, even if the study had mentioned hydrocortisone, it would still not provide sufficient evidence for the claim that ""hydrocortisone causes dermatitis"". A single prospective study on a different medical condition (plantar fasciitis) would not be enough to establish causality for a different condition (dermatitis). Causality would require a much more rigorous set of studies"
12645476,Hydrocortisone causes obesity disorder,399,A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis.,False,"'Does the phrase ""Hydrocortisone causes obesity disorder"" receive at least indirect support from the statement: ""A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis.""?","No, the statement does not provide any direct or indirect support for the claim that hydrocortisone causes obesity disorder. The reason is that 6-methylprednisolone is not hydrocortisone, although they both belong to the class of corticosteroids. The study does not mention hydrocortisone at all, so it cannot be inferred that hydrocortisone has any connection to obesity disorder based on this statement alone.

        To further clarify, corticosteroids such as hydrocortisone and 6-methylprednisolone have various therapeutic uses, including treating inflammatory diseases and autoimmune disorders; however, they have also been associated with side effects such as weight gain (central obesity) due to increased appetite and fluid retention. This does not mean that corticosteroids cause ""obesity disorder"" but rather that they can contribute to weight gain as part of their side effect profile.

        It is essential always to evaluate each study based on its specific design, population, intervention, comparison group (control), outcomes measured, and statistical analyses (the so-called ""PICOS"
10068843,Hydrocortisone causes Inflammation,400,[Short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases].,False,"'Does the phrase ""Hydrocortisone causes Inflammation"" receive at least indirect support from the statement: ""[Short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases].""?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone causes Inflammation."" The statement discusses short-term therapy with methylprednisolone in exacerbated obstructive respiratory tract diseases. Methylprednisolone is a synthetic glucocorticoid, similar to hydrocortisone in that they both belong to the class of corticosteroids, but they have different pharmacological properties and uses. 

        Hydrocortisone is primarily used for its anti-inflammatory effects, whereas methylprednisolone is often used for its immunosuppressive properties in addition to its anti-inflammatory effects. Therefore, any conclusions about hydrocortisone cannot be inferred from the statement provided about methylprednisolone. 

        To further clarify, hydrocortisone itself does not cause inflammation; instead, it is commonly prescribed as an anti-inflammatory medication to manage various conditions associated with inflammation in the body."
9850315,Hydrocortisone causes dissociative amnesia,401,Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.,False,"'Does the phrase ""Hydrocortisone causes dissociative amnesia"" receive at least indirect support from the statement: ""Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia.""?","No, the statement ""Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia"" does not provide indirect support for the claim that ""Hydrocortisone causes dissociative amnesia."" 

         The statement in question is a title of a study that investigates the effect of Methylprednisolone on survival rates in COVID-19 patients. It does not mention Hydrocortisone at all, let alone its potential effects on cognition or memory. Dissociative amnesia is a specific condition characterized by gaps in memory that cannot be explained by ordinary forgetfulness. It is not typically associated with corticosteroid use such as Hydrocortisone or Methylprednisolone. 

         Therefore, without further information linking Hydrocortisone use to dissociative amnesia, it is inappropriate to infer support for such a claim from this study title."
9318796,Hydrocortisone causes adrenocortical insufficiency,402,Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial.,False,"'Does the phrase ""Hydrocortisone causes adrenocortical insufficiency"" receive at least indirect support from the statement: ""Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial.""?","No, the statement ""Intra-Carpal Injection of Ozone versus Methylprednisolone in Carpal Tunnel Syndrome of Systemic Sclerosis Patients: A Randomized Single-Blind Clinical Trial"" does not provide indirect support for the phrase ""Hydrocortisone causes adrenocortical insufficiency."" 

         The study in question is comparing the efficacy of ozone and methylprednisolone in treating carpal tunnel syndrome in patients with systemic sclerosis. Methylprednisolone is a synthetic glucocorticoid, similar to hydrocortisone, which is often used in medical treatments to reduce inflammation. 

         While both hydrocortisone and methylprednisolone can cause adrenocortical insufficiency as a side effect due to their glucocorticoid nature, this study does not provide any evidence or discussion about this potential side effect. Therefore, it does not indirectly support the claim that hydrocortisone causes adrenocortical insufficiency. 

         It is important to note that adrenocortical"
9145908,Hydrocortisone causes otitis externa,403,Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?,False,"'Does the phrase ""Hydrocortisone causes otitis externa"" receive at least indirect support from the statement: ""Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?""?","No, the statement ""Methylprednisolone Pulses in West Syndrome: A New Weapon in the Armory-Is it Needed?"" does not provide indirect support for the phrase ""Hydrocortisone causes otitis externa."" The study focuses on Methylprednisolone Pulses as a treatment for West Syndrome, which is a type of epilepsy. The drug Hydrocortisone is not mentioned in the study at all, let alone its potential side effect of causing otitis externa (outer ear infection). Therefore, there is no logical connection that can be made between these two statements based on the provided evidence."
8699464,Hydrocortisone causes adrenal cortex neoplasm,404,Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility.,False,"'Does the phrase ""Hydrocortisone causes adrenal cortex neoplasm"" receive at least indirect support from the statement: ""Patient underwent treatment with milrinone and methylprednisolone that showed reduction in myocardial inflammation and significantly improved myocardial contractility.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes adrenal cortex neoplasm."" 

        The statement discusses a patient who received treatment with milrinone and methylprednisolone, which resulted in reduced myocardial inflammation and improved myocardial contractility. Methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone in its anti-inflammatory effects; however, it does not imply that hydrocortisone causes adrenal cortex neoplasm (tumors). Adrenal cortex neoplasm is associated with various factors including genetic predisposition, exposure to certain chemicals, and other medical conditions like Li-Fraumeni syndrome. It is crucial to differentiate between correlation and causation in interpreting such information."
8657746,Hydrocortisone causes neoplasm,405,"Neurologically, the therapeutic dosages of anticoagulants are linked to the high incidence of thrombotic complexities, while methylprednisolone is associated with myopathy.",False,"'Does the phrase ""Hydrocortisone causes neoplasm"" receive at least indirect support from the statement: ""Neurologically, the therapeutic dosages of anticoagulants are linked to the high incidence of thrombotic complexities, while methylprednisolone is associated with myopathy.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes neoplasm."" The statement discusses neurological side effects of anticoagulants and muscle-related side effects of methylprednisolone, but it does not mention any connection between hydrocortisone and neoplasms (abnormal growths that can be benign or malignant). Therefore, based on this statement alone, there is no basis for inferring that hydrocortisone is associated with neoplasm development."
7929803,Hydrocortisone causes Insulin resistance,406,"Conclusion: Based on the current data, the efficacy and safety of local injection of triamcinolone and methylprednisolone at doses of 20 and 40 mg were associated with a significant improvement in pain, functional status, and strength.",False,"'Does the phrase ""Hydrocortisone causes Insulin resistance"" receive at least indirect support from the statement: ""Conclusion: Based on the current data, the efficacy and safety of local injection of triamcinolone and methylprednisolone at doses of 20 and 40 mg were associated with a significant improvement in pain, functional status, and strength.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes Insulin resistance"". The conclusion presented in the statement is about the efficacy and safety of local injections of triamcinolone and methylprednisolone at specific doses in improving pain, functional status, and strength. Hydrocortisone is not mentioned in the statement; therefore, it is not possible to draw any conclusions about its relationship with insulin resistance based on this information alone.

         Insulin resistance is a condition in which cells become less responsive to insulin, leading to high blood sugar levels. Glucocorticoids like hydrocortisone can contribute to insulin resistance by affecting glucose metabolism in various tissues. However, in order to establish a connection between hydrocortisone use and insulin resistance, direct evidence specific to hydrocortisone would be required.

         In summary, while it is true that certain glucocorticoids like hydrocortisone can cause insulin resistance due to their effects on glucose metabolism, the provided statement does not offer any support for that relationship because it focuses on triamcinol"
7432490,Hydrocortisone causes pancreatitis,407,OBJECTIVE: To validate the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS and to examine the relationship between CSF inflammatory and tissue damage biomarkers.,False,"'Does the phrase ""Hydrocortisone causes pancreatitis"" receive at least indirect support from the statement: ""OBJECTIVE: To validate the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS and to examine the relationship between CSF inflammatory and tissue damage biomarkers.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone causes pancreatitis."" The objective of the study mentioned is to validate the responsiveness of cerebrospinal fluid (CSF) inflammatory biomarkers to treatment with natalizumab and methylprednisolone in progressive MS (Multiple Sclerosis) and to examine the relationship between CSF inflammatory and tissue damage biomarkers. Methylprednisolone is a type of steroid often used in treating MS flares, but there is no mention of hydrocortisone in the statement provided.

         Moreover, even if hydrocortisone were mentioned in the study, it would not automatically imply that hydrocortisone causes pancreatitis. To establish such a causal link, there would need to be evidence showing that hydrocortisone administration results in an increased incidence of pancreatitis compared to placebo or no treatment in controlled studies specifically designed to test that hypothesis.

         In summary, there is no indirect support for ""Hydrocortisone causes pancreatitis"" in the provided statement because hydrocortis"
26997315,Hydrocortisone affects congenital adrenal hyperplasia,408,The region was identified as a significant predictor of use of intravenous methylprednisolone in MCD and MN patients.,False,"'Does the phrase ""Hydrocortisone affects congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""The region was identified as a significant predictor of use of intravenous methylprednisolone in MCD and MN patients.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects congenital adrenal hyperplasia."" The statement refers to intravenous methylprednisolone use in MCD (Minimal Change Disease) and MN (Membranous Nephropathy) patients, not hydrocortisone use in congenital adrenal hyperplasia patients. Hydrocortisone and methylprednisolone are both corticosteroids but they have different therapeutic indications and effects on various medical conditions. Congenital adrenal hyperplasia is primarily treated with hydrocortisone due to its glucocorticoid activity, whereas methylprednisolone is used more often in nephrotic syndrome associated with MCD and MN due to its mineralocorticoid-sparing properties. Therefore, these two statements do not have any direct or indirect correlation in terms of their clinical implications and disease contexts."
26940919,Hydrocortisone affects cardiac arrest,409,"Clinical commentary on ""Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"".",False,"'Does the phrase ""Hydrocortisone affects cardiac arrest"" receive at least indirect support from the statement: ""Clinical commentary on ""Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"".""?","No, the statement ""Clinical commentary on 'Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica'"" does not provide indirect support for the phrase ""Hydrocortisone affects cardiac arrest."" Methylprednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects, while hydrocortisone is also a corticosteroid used to treat various conditions such as inflammation and allergic reactions. Although both drugs belong to the same class of medications (corticosteroids), they have different chemical structures and therapeutic indications.

         The clinical commentary focuses on two cases of anaphylactic shock caused by methylprednisolone in neuromyelitis optica patients. The text does not mention hydrocortisone or its potential effects on cardiac arrest. Even if it did discuss hydrocortisone, anecdotal evidence from case reports should be interpreted cautiously since they do not provide robust evidence of cause-and-effect relationships due to confounding factors, small sample sizes, and potential publication bias.

         Therefore, there is no indirect"
26840479,Hydrocortisone affects myocardial infarction,410,CONCLUSION: Results show that inhalation of budesonide (2 mg 3 times/day) and systemic methylprednisolone (40 mg/day) had similar clinical outcome in AECOPD.,False,"'Does the phrase ""Hydrocortisone affects myocardial infarction"" receive at least indirect support from the statement: ""CONCLUSION: Results show that inhalation of budesonide (2 mg 3 times/day) and systemic methylprednisolone (40 mg/day) had similar clinical outcome in AECOPD.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects myocardial infarction."" The conclusion provided in the statement is related to a study on Chronic Obstructive Pulmonary Disease (COPD) exacerbations (AECOPD), where two different treatments (budesonide inhalation and systemic methylprednisolone) were compared in terms of their clinical outcomes. Hydrocortisone is not mentioned in the study or conclusion at all; therefore, it is not possible to draw any conclusions about its effect on myocardial infarction based on this information alone.

        

        The statement only provides evidence for the clinical outcomes of budesonide inhalation and systemic methylprednisolone in AECOPD patients; hence it does not contribute any knowledge regarding hydrocortisone's impact on myocardial infarction. Hydrocortisone is a different medication that belongs to the same class of drugs as methylprednisolone (glucocorticoids), but their specific effects on various conditions might differ due to differences in pharmacokinetics"
24701128,Hydrocortisone affects Sepsis,411,A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.,False,"'Does the phrase ""Hydrocortisone affects Sepsis"" receive at least indirect support from the statement: ""A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease.""?","No, the statement ""A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host Disease"" does not provide indirect support for the phrase ""Hydrocortisone affects Sepsis."" 

        The clinical trial mentioned is focused on comparing the safety and efficacy of two different treatments (topical tacrolimus and methylprednisolone) for ocular graft-versus-host disease. Hydrocortisone is not one of the treatments being compared in this trial, nor is sepsis mentioned as an outcome of interest. Therefore, there is no clear connection between the clinical trial and the claim about hydrocortisone affecting sepsis.

        However, it is important to note that hydrocortisone is a type of corticosteroid, like methylprednisolone, which was used in the trial. Both drugs have anti-inflammatory effects, and hydrocortisone is sometimes used in the treatment of sepsis due to its potential to reduce inflammation. But the absence of hydrocort"
21274202,Hydrocortisone affects osteoarthritis,412,The purpose of this study was to evaluate the efficacy of supraperiosteal injection of methylprednisolone compared with an oral tablet form and intravenous (i.v.) injection in the prevention of postoperative pain and oedema associated with inflammation.,False,"'Does the phrase ""Hydrocortisone affects osteoarthritis"" receive at least indirect support from the statement: ""The purpose of this study was to evaluate the efficacy of supraperiosteal injection of methylprednisolone compared with an oral tablet form and intravenous (i.v.) injection in the prevention of postoperative pain and oedema associated with inflammation.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects osteoarthritis"". The study mentioned in the statement is focused on comparing different methods of administering methylprednisolone for preventing postoperative pain and edema associated with inflammation. Hydrocortisone is not mentioned in the study statement at all, let alone its effects on osteoarthritis. Therefore, it is not appropriate to draw any conclusions about hydrocortisone's effects on osteoarthritis based on the provided statement alone."
20701310,Hydrocortisone affects psoriasis,413,Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.,False,"'Does the phrase ""Hydrocortisone affects psoriasis"" receive at least indirect support from the statement: ""Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura.""?","No, the statement ""Gamma globulin and methylprednisolone in idiopathic thrombocytopenic purpura"" does not provide indirect support for the claim that ""Hydrocortisone affects psoriasis."" 

        The statement given discusses two treatments (gamma globulin and methylprednisolone) used for idiopathic thrombocytopenic purpura (ITP), a condition characterized by an abnormally low platelet count in the blood. Methylprednisolone is a type of corticosteroid like hydrocortisone; however, they are not identical substances and their effects on different conditions may vary significantly.

        Psoriasis is an autoimmune condition that causes skin cells to grow too quickly, leading to thickened patches of red skin covered in silvery scales. While it is true that corticosteroids like hydrocortisone can be used in treating psoriasis due to their anti-inflammatory properties, it does not follow that just because methylprednisolone is used in treating ITP that hydrocortisone would have similar effects on p"
20336537,Hydrocortisone affects dermatitis,414,Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.,False,"'Does the phrase ""Hydrocortisone affects dermatitis"" receive at least indirect support from the statement: ""Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy.""?","No, the statement ""Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy"" does not provide indirect support for the claim that ""Hydrocortisone affects dermatitis."" 

        The reason is that these two statements discuss different corticosteroids (Hydrocortisone and Methylprednisolone) and different medical conditions (dermatitis and Graves' ophthalmopathy). Although both Hydrocortisone and Methylprednisolone belong to the class of corticosteroids that have anti-inflammatory properties and can be used in treating various medical conditions, they have distinct pharmacological profiles that may lead to different therapeutic effects as well as side effects.

        In addition, Graves' ophthalmopathy is an eye condition related to Graves' disease (an autoimmune disorder that causes hyperthyroidism), while dermatitis is an inflammation of the skin that can be caused by various factors such as allergies, irritants, genetics, infections, or autoimmune conditions.

        Therefore, without further evidence link"
20137862,Hydrocortisone affects fibromyalgia,415,"In orthognathic surgery, methylprednisolone > or =85 mg administered intravenously seemed sufficient to produce a significant decrease in edema, and several trials pointed toward a neuroregeneration effect, but no statistical analysis could be performed.",False,"'Does the phrase ""Hydrocortisone affects fibromyalgia"" receive at least indirect support from the statement: ""In orthognathic surgery, methylprednisolone > or =85 mg administered intravenously seemed sufficient to produce a significant decrease in edema, and several trials pointed toward a neuroregeneration effect, but no statistical analysis could be performed.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects fibromyalgia."" The statement discusses the effects of methylprednisolone in orthognathic surgery, not hydrocortisone in fibromyalgia. Methylprednisolone is a synthetic glucocorticoid used in medical practice similarly to hydrocortisone, but they are distinct drugs that may have different therapeutic profiles and effects in various conditions. Fibromyalgia is also distinct from edema associated with orthognathic surgery. Therefore, drawing any conclusions about hydrocortisone's impact on fibromyalgia based on the provided statement would be inappropriate and misleading."
19555227,Hydrocortisone affects pneumonia,416,Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study.,False,"'Does the phrase ""Hydrocortisone affects pneumonia"" receive at least indirect support from the statement: ""Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study.""?","No, the statement ""Response of symptoms and synovitis to intra-muscular methylprednisolone in osteoarthritis of the hand: an ultrasonographic study"" does not provide indirect support for the claim that ""Hydrocortisone affects pneumonia."" 

        The reason for this is that methylprednisolone is a synthetic glucocorticoid used primarily for its anti-inflammatory effects, while hydrocortisone is also a glucocorticoid but it is primarily used for its anti-stress and immunosuppressive effects. Both are used in treating various conditions, but they are not interchangeable in all contexts. 

        Furthermore, the study in question focuses on osteoarthritis of the hand, which is a degenerative joint disease, not pneumonia. The fact that symptoms and synovitis (inflammation of the synovial membrane) responded to intra-muscular methylprednisolone in this context does not provide any evidence or indication that hydrocortisone would have similar effects on pneumonia. 

        Therefore,"
19531871,Hydrocortisone affects atrial fibrillation,417,Long-term results of high-dose methylprednisolone in aplastic anemia.,False,"'Does the phrase ""Hydrocortisone affects atrial fibrillation"" receive at least indirect support from the statement: ""Long-term results of high-dose methylprednisolone in aplastic anemia.""?","No, the statement ""Long-term results of high-dose methylprednisolone in aplastic anemia"" does not provide indirect support for the phrase ""Hydrocortisone affects atrial fibrillation."" 

        The two statements are not related in terms of their subject matter. Methylprednisolone is a synthetic glucocorticoid, while hydrocortisone is a natural glucocorticoid; both have anti-inflammatory properties but they are not interchangeable in terms of their effects on various conditions. Aplastic anemia is a condition characterized by pancytopenia (a decrease in all types of blood cells), which is not directly related to atrial fibrillation (a type of irregular heart rhythm). Therefore, the long-term results of high-dose methylprednisolone in aplastic anemia do not provide any insight into how hydrocortisone might affect atrial fibrillation. 

        It is important to note that while both methylprednisolone and hydrocortisone belong to the class of drugs known as glucoc"
18495054,Hydrocortisone affects lymphoma,418,"Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.",False,"'Does the phrase ""Hydrocortisone affects lymphoma"" receive at least indirect support from the statement: ""Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects lymphoma."" The statement discusses the efficacy of methylprednisolone and cyclophosphamide in pediatric IgA nephropathy, which is a kidney disease. Hydrocortisone is a type of corticosteroid like methylprednisolone, but they are not identical drugs. Furthermore, IgA nephropathy is not lymphoma. Therefore, even if the statement were about hydrocortisone instead of methylprednisolone, it would still not provide indirect support for the claim about lymphoma because the disease context is different."
18495053,Hydrocortisone affects leukemia,419,"The impaired effect on lymphocyte blastogenesis of glucocorticoids administered in vivo, in contrast to a normal in vitro reaction to dexamethasone, together with recent findings of an altered glucocorticoid receptor pharmacology in AD, points to a decreased biological in vivo efficiency of methylprednisolone in atopic dermatitis.",False,"'Does the phrase ""Hydrocortisone affects leukemia"" receive at least indirect support from the statement: ""The impaired effect on lymphocyte blastogenesis of glucocorticoids administered in vivo, in contrast to a normal in vitro reaction to dexamethasone, together with recent findings of an altered glucocorticoid receptor pharmacology in AD, points to a decreased biological in vivo efficiency of methylprednisolone in atopic dermatitis.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects leukemia."" The statement discusses the in vivo efficiency of glucocorticoids, specifically methylprednisolone, in atopic dermatitis (AD). It makes no mention of hydrocortisone or leukemia.

        Hydrocortisone is a type of glucocorticoid often used in treating various conditions due to its anti-inflammatory effects. Leukemia is a type of cancer that affects blood cells. While glucocorticoids like hydrocortisone can impact lymphocytes (a type of white blood cell), which may be relevant in leukemia treatment, the statement does not provide any information about such an effect.

        Therefore, without additional evidence linking hydrocortisone to leukemia, it is not reasonable to infer that hydrocortisone has an effect on leukemia based on this statement alone."
18310128,Hydrocortisone affects toxic shock syndrome,420,"CONCLUSION: In this single-center trial, combined vasopressin-epinephrine and methylprednisolone during resuscitation and stress-dose hydrocortisone in postresuscitation shock improved survival in refractory in-hospital cardiac arrest.",True,"'Does the phrase ""Hydrocortisone affects toxic shock syndrome"" receive at least indirect support from the statement: ""CONCLUSION: In this single-center trial, combined vasopressin-epinephrine and methylprednisolone during resuscitation and stress-dose hydrocortisone in postresuscitation shock improved survival in refractory in-hospital cardiac arrest.""?","Yes, indirectly. The statement does not specifically mention toxic shock syndrome but it does suggest that hydrocortisone (a type of steroid) can improve survival in refractory in-hospital cardiac arrest when used in postresuscitation shock. This implies that hydrocortisone could potentially have beneficial effects in severe shock states, which could theoretically include toxic shock syndrome. However, it is important to note that toxic shock syndrome is a complex condition often caused by bacterial infections, and it would require further specific research to determine if hydrocortisone would be beneficial in that context."
17910566,Hydrocortisone affects atopic eczema,421,Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.,False,"'Does the phrase ""Hydrocortisone affects atopic eczema"" receive at least indirect support from the statement: ""Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects atopic eczema."" The statement discusses the effectiveness and tolerability of weekly bortezomib/methylprednisolone in relapsed multiple myeloma, which does not make any reference to hydrocortisone or atopic eczema. Hydrocortisone is a type of corticosteroid often used in treating various skin conditions including atopic eczema; however, without explicit mention of hydrocortisone in relation to atopic eczema in the provided statement, it cannot lend indirect support for that specific claim."
15925719,Hydrocortisone affects Inflammation,422,Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.,False,"'Does the phrase ""Hydrocortisone affects Inflammation"" receive at least indirect support from the statement: ""Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects Inflammation."" The statement discusses a therapeutic approach for acute lymphoblastic leukemia in children using Amsacrine, etoposide, and high-dose methylprednisolone. Methylprednisolone is a type of corticosteroid like hydrocortisone, but they have different pharmacological properties and uses. The statement does not mention hydrocortisone nor provide any information about its potential impact on inflammation."
14970164,Hydrocortisone affects Insulin resistance,423,Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.,False,"'Does the phrase ""Hydrocortisone affects Insulin resistance"" receive at least indirect support from the statement: ""Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects Insulin resistance."" The clinical trial mentioned in the statement compares two treatments for severe neurological manifestations in systemic lupus erythematosus (SLE), one of which involves methylprednisolone, a glucocorticoid like hydrocortisone. However, insulin resistance is not mentioned or investigated in the context of this trial, so no conclusions can be drawn about hydrocortisone's effect on insulin resistance from this information alone."
14804311,Hydrocortisone affects injury,424,Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome.,False,"'Does the phrase ""Hydrocortisone affects injury"" receive at least indirect support from the statement: ""Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome.""?","No, the statement ""Delayed hypersensitivity to 6-methyl-prednisolone in Henoch Schoenlein syndrome"" does not provide direct or indirect support for the phrase ""Hydrocortisone affects injury."" 

        

        The statement refers specifically to delayed hypersensitivity (an allergic reaction) to 6-methyl-prednisolone, which is a synthetic glucocorticoid similar to hydrocortisone but not identical. Hydrocortisone is also a glucocorticoid, but it is not explicitly mentioned in the statement. Furthermore, the statement discusses an allergic reaction, not an injury. Therefore, there is no clear connection between the two phrases in terms of topic or content. 

        

        However, it is important to note that both hydrocortisone and 6-methyl-prednisolone belong to the class of drugs known as glucocorticoids, which have anti-inflammatory effects and are often used in treating various conditions involving inflammation or immune response. Therefore, while the specific statement does not support the claim that"
14533429,Hydrocortisone affects hypotensive disorder,425,Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.,False,"'Does the phrase ""Hydrocortisone affects hypotensive disorder"" receive at least indirect support from the statement: ""Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.""?","No, the statement ""Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis"" does not provide indirect support for the phrase ""Hydrocortisone affects hypotensive disorder."" 

        The reason is that while both hydrocortisone and 6-alpha-methyl prednisolone are glucocorticoids used in treating inflammatory bowel diseases such as ulcerative colitis, they are different steroidal compounds with distinct pharmacokinetic properties. The provided statement only discusses the rectal absorption of 6-alpha-methyl prednisolone in ulcerative colitis patients without mentioning hypotensive disorder or hydrocortisone.

        Hypotension is related to reduced blood pressure, whereas ulcerative colitis is an inflammatory condition affecting the colon. Although glucocorticoids like hydrocortisone can help manage symptoms of ulcerative colitis due to their anti-inflammatory effects, no direct link is established between hydrocortisone and hypotensive disorder in the given statement.

        To provide"
13999195,Hydrocortisone affects congenital adrenal hyperplasia,426,Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.,False,"'Does the phrase ""Hydrocortisone affects congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects congenital adrenal hyperplasia."" The study mentioned is focused on comparing two different treatment regimens (pulse methylprednisolone versus pulse cyclophosphamide) for severe lupus nephritis, which is an autoimmune disease affecting the kidneys. Hydrocortisone is not explicitly mentioned in the statement, nor is there any connection established between hydrocortisone use and congenital adrenal hyperplasia (CAH).

        
        Congenital adrenal hyperplasia is an inherited genetic disorder affecting the adrenal glands, which can be treated using hydrocortisone as it is similar in structure to natural hormones produced by these glands. The statement provided does not offer any information about hydrocortisone usage in relation to CAH, so it cannot be used as evidence supporting that connection.

        
        In conclusion, while hydrocortisone may indeed be used in treating CAH based on its structural similarity to adrenal hormones, there is no basis for inferring such information"
13347553,Hydrocortisone affects asthma,427,"The National Heart, Lung, and Blood Institute's ARDS Network currently is testing the use of methylprednisolone in late ARDS.",False,"'Does the phrase ""Hydrocortisone affects asthma"" receive at least indirect support from the statement: ""The National Heart, Lung, and Blood Institute's ARDS Network currently is testing the use of methylprednisolone in late ARDS.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects asthma."" The National Heart, Lung, and Blood Institute's ARDS Network is testing the use of methylprednisolone in late ARDS (Acute Respiratory Distress Syndrome). Methylprednisolone is a type of corticosteroid like hydrocortisone, but it is not the same compound nor does it imply that hydrocortisone has any effect on asthma. Furthermore, ARDS is different from asthma in terms of pathophysiology. Therefore, it is crucial not to conflate these different medications and conditions when interpreting such evidence."
13180935,Hydrocortisone affects hypotensive disorder,428,"(3) Preliminary results of an interim analysis from an ongoing randomized, prospective study showed that methylprednisolone (plus an antiviral agent?) may be useful for improving peripheral vestibular function in vestibular neuritis.",False,"'Does the phrase ""Hydrocortisone affects hypotensive disorder"" receive at least indirect support from the statement: ""(3) Preliminary results of an interim analysis from an ongoing randomized, prospective study showed that methylprednisolone (plus an antiviral agent?) may be useful for improving peripheral vestibular function in vestibular neuritis.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone affects hypotensive disorder."" The statement discusses preliminary results of a study on methylprednisolone (a type of corticosteroid like hydrocortisone) being used in combination with an antiviral agent for improving peripheral vestibular function in vestibular neuritis. The study does not mention hypotensive disorder nor hydrocortisone in any capacity.

        The two concepts - hydrocortisone use for hypotensive disorder - are unrelated in this context as there is no overlap in terms of disorder being treated (vestibular neuritis vs hypotensive disorder) or drug being used (methylprednisolone vs hydrocortisone). A broader interpretation might consider that corticosteroids can impact blood pressure levels (which in turn could influence hypotensive disorder), but such an interpretation would be highly speculative given no direct evidence is provided in the statement for such an effect in relation to hydrocortisone specifically nor hypotensive disorder generally.

        To establish any connection between hydrocortisone use and hypotensive disorder inc"
11695335,Hydrocortisone affects Hypoxemia,429,This is the first report of cyclophosphamide and methylprednisolone leading to complete and sustained resolution of GAVE in association with systemic sclerosis.,False,"'Does the phrase ""Hydrocortisone affects Hypoxemia"" receive at least indirect support from the statement: ""This is the first report of cyclophosphamide and methylprednisolone leading to complete and sustained resolution of GAVE in association with systemic sclerosis.""?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone affects Hypoxemia"". The statement discusses the effects of cyclophosphamide and methylprednisolone on gastroduodenal arterial vasospasm (GAVE) in association with systemic sclerosis. Hypoxemia refers to low oxygen levels in the blood, while hydrocortisone is a type of steroid hormone often used in medical treatments. There is no mention of hydrocortisone, hypoxemia, or any related concepts in the provided statement."
11304252,Hydrocortisone affects obesity disorder,430,We compared lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA).,False,"'Does the phrase ""Hydrocortisone affects obesity disorder"" receive at least indirect support from the statement: ""We compared lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA).""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects obesity disorder"". The statement discusses a comparison of lymphocyte-suppressive potencies of prednisolone and methylprednisolone in rheumatoid arthritis (RA). Hydrocortisone is not mentioned in this statement, nor is there any connection made to obesity disorder. Therefore, it does not offer any relevant information or evidence that would support the claim about hydrocortisone's effect on obesity disorder."
10523644,Hydrocortisone affects injury,431,"Despite the lucrative ""off label"" markets for methylprednisolone in SCI, no Food and Drug Association indication has been obtained.",False,"'Does the phrase ""Hydrocortisone affects injury"" receive at least indirect support from the statement: ""Despite the lucrative ""off label"" markets for methylprednisolone in SCI, no Food and Drug Association indication has been obtained.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects injury."" 

         The statement is discussing methylprednisolone, not hydrocortisone, in relation to spinal cord injuries (SCI) and its lack of Food and Drug Administration (FDA) indication. Hydrocortisone and methylprednisolone are both corticosteroids, but they have different chemical structures and properties. Therefore, any effects of methylprednisolone on SCI do not necessarily translate to hydrocortisone affecting injury. To establish indirect support for ""Hydrocortisone affects injury,"" there should be some evidence connecting hydrocortisone specifically to injury response or prevention."
10431364,Hydrocortisone affects Inflammation,432,Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.,False,"'Does the phrase ""Hydrocortisone affects Inflammation"" receive at least indirect support from the statement: ""Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis.""?","No, the statement ""Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis"" does not provide direct or indirect support for the claim that ""Hydrocortisone affects Inflammation.""

        
        The statement refers specifically to extraocular muscle responses in myasthenia gravis patients treated with high-dose intravenous methylprednisolone. Methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone in terms of its anti-inflammatory properties; however, it is not identical to hydrocortisone.

        
        The evidence provided is too specific in terms of both drug (methylprednisolone) and condition (extraocular muscle responses in myasthenia gravis) to be generalized as support for the broader claim about hydrocortisone affecting inflammation in general.

        
        To provide indirect support for the claim about hydrocortisone, one would need evidence from studies involving hydrocortisone itself or from studies that discuss glucocorticoids more broadly in relation to"
10074536,Hydrocortisone affects HIV infectious disease,433,The increased CSF levels of TNF-sRp55 in response to MP circumstantially suggest that this receptor could partially account for the beneficial effects of MP in acute MS.,False,"'Does the phrase ""Hydrocortisone affects HIV infectious disease"" receive at least indirect support from the statement: ""The increased CSF levels of TNF-sRp55 in response to MP circumstantially suggest that this receptor could partially account for the beneficial effects of MP in acute MS.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects HIV infectious disease."" The statement discusses the potential role of microglial phagocytosis (MP) in multiple sclerosis (MS) and the possible involvement of TNF-sRp55 in mediating its beneficial effects. This is unrelated to HIV infectious disease and hydrocortisone treatment effects. It is essential to base conclusions on evidence that is directly related to the subject of interest for accurate interpretation and evaluation of scientific claims."
9872405,Hydrocortisone affects toxic shock syndrome,434,"Such an effect has been demonstrated between clarithromycin and methylprednisolone, two drugs that may be administered concomitantly in asthma.",False,"'Does the phrase ""Hydrocortisone affects toxic shock syndrome"" receive at least indirect support from the statement: ""Such an effect has been demonstrated between clarithromycin and methylprednisolone, two drugs that may be administered concomitantly in asthma.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects toxic shock syndrome."" The statement discusses an effect between clarithromycin and methylprednisolone, two drugs used together in asthma treatment. Hydrocortisone is not mentioned in the statement; therefore, it does not offer any backing for the claim about hydrocortisone's impact on toxic shock syndrome."
9610203,Hydrocortisone affects neoplasm,435,"In this study, low-dose methylprednisolone (0.8 mg/kg/day, MP) was used to induce a steroid-resistant lupus nephritis (SR-LN) mouse model in weeks one to four, and a therapeutic steroid dosage (MP 12 mg/kg/day) or a combined PNS (PNS 100 mg/kg/day) treatment was administered from week five to eight.",False,"'Does the phrase ""Hydrocortisone affects neoplasm"" receive at least indirect support from the statement: ""In this study, low-dose methylprednisolone (0.8 mg/kg/day, MP) was used to induce a steroid-resistant lupus nephritis (SR-LN) mouse model in weeks one to four, and a therapeutic steroid dosage (MP 12 mg/kg/day) or a combined PNS (PNS 100 mg/kg/day) treatment was administered from week five to eight.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects neoplasm."" The statement discusses a study involving low-dose methylprednisolone (MP) and therapeutic steroid dosages of MP in a steroid-resistant lupus nephritis (SR-LN) mouse model. However, it does not mention hydrocortisone or neoplasm at all. Hydrocortisone is a different type of steroid hormone than methylprednisolone, and neoplasm refers to abnormal new growth of cells in the body, such as tumors. Without any connection to these subjects in the provided statement, there is no basis for inferring that hydrocortisone affects neoplasm."
9120606,Hydrocortisone affects asthma,436,MP was administrated in three alternative ways: intraperitoneally during the induction of cytotoxic edema or immediately after finishing cytotoxic edema induction in a dose of 100 mg/kg b.w.; into the internal carotid artery within 2 h after finishing cytotoxic edema induction in a dose of 50 mg/kg b.w.; into internal carotid artery 10 min after edema induction by BBBd in a dose of 50 mg/kg b.w.,True,"'Does the phrase ""Hydrocortisone affects asthma"" receive at least indirect support from the statement: ""MP was administrated in three alternative ways: intraperitoneally during the induction of cytotoxic edema or immediately after finishing cytotoxic edema induction in a dose of 100 mg/kg b.w.; into the internal carotid artery within 2 h after finishing cytotoxic edema induction in a dose of 50 mg/kg b.w.; into internal carotid artery 10 min after edema induction by BBBd in a dose of 50 mg/kg b.w.""?","Yes, indirect support can be inferred from the statement provided, but it is important to note that this support is conditional upon several assumptions. The statement indicates that hydrocortisone (MP) was administered under different conditions in an experimental setting involving cytotoxic edema induction and blood-brain barrier disruption (BBBd). However, it does not explicitly state that hydrocortisone affects asthma.

        

        The connection between hydrocortisone and asthma is indirect because hydrocortisone is a type of corticosteroid often used in treating asthma due to its anti-inflammatory properties. Inhaled corticosteroids like hydrocortisone can reduce inflammation in the airways, which is a key component of asthma symptoms.

        

        In order for this statement to provide stronger support for the claim that ""hydrocortisone affects asthma,"" additional information would be required, such as evidence that the specific administration methods used in the experiment had an impact on asthma symptoms in animal models or"
8017440,Hydrocortisone affects obesity disorder,437,"On the other hand, daily administration of methylprednisolone and tenoxicam for 4 weeks caused increased inflammation and fibrosis and wasn't affective on protection of nerve physiomorphology.",False,"'Does the phrase ""Hydrocortisone affects obesity disorder"" receive at least indirect support from the statement: ""On the other hand, daily administration of methylprednisolone and tenoxicam for 4 weeks caused increased inflammation and fibrosis and wasn't affective on protection of nerve physiomorphology.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects obesity disorder."" The statement discusses the effects of methylprednisolone and tenoxicam on inflammation, fibrosis, and nerve physiomorphology after 4 weeks of daily administration. Hydrocortisone is not mentioned in this statement, nor is there any connection made to obesity disorder. Therefore, it is not appropriate to draw conclusions about hydrocortisone's impact on obesity based on this information alone."
7974249,Hydrocortisone affects Insulin resistance,438,Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued.,False,"'Does the phrase ""Hydrocortisone affects Insulin resistance"" receive at least indirect support from the statement: ""Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects Insulin resistance."" 

        The statement ""Methylprednisolone was temporarily stopped while a broad work up for inflammatory and neoplastic causes was pursued"" does not mention Hydrocortisone or Insulin resistance. Methylprednisolone is a glucocorticoid like Hydrocortisone, but they are not identical in their effects on the body. Even if they were similar in their effects on insulin resistance, the temporary stoppage of Methylprednisolone does not necessarily imply that Hydrocortisone would have similar effects on Insulin resistance. 

        Therefore, without further evidence linking Hydrocortisone to Insulin resistance, one cannot infer that Hydrocortisone affects Insulin resistance based on the provided statement alone."
7366981,Hydrocortisone affects Hypoxemia,439,"Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cases; however, we encountered a rare case of Pneumocystis pneumonia induced by low-dose tacrolimus and methylprednisolone.",False,"'Does the phrase ""Hydrocortisone affects Hypoxemia"" receive at least indirect support from the statement: ""Pneumocystis pneumonia induced by this dose of tacrolimus has been reported in many cases; however, we encountered a rare case of Pneumocystis pneumonia induced by low-dose tacrolimus and methylprednisolone.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects Hypoxemia."" The statement discusses Pneumocystis pneumonia induced by tacrolimus and methylprednisolone, but it does not mention hydrocortisone or hypoxemia. Hypoxemia refers to low oxygen levels in the blood, while hydrocortisone is a type of steroid hormone often used in medical treatments. The connection between these two entities is not established in the provided statement."
7266667,Hydrocortisone affects dissociative amnesia,440,The increased interval in the administration of MP resulted in slightly greater pain and an increased prevalence of NeP.,False,"'Does the phrase ""Hydrocortisone affects dissociative amnesia"" receive at least indirect support from the statement: ""The increased interval in the administration of MP resulted in slightly greater pain and an increased prevalence of NeP.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone affects dissociative amnesia."" 

        The statement ""The increased interval in the administration of MP resulted in slightly greater pain and an increased prevalence of NeP"" is discussing the effects of Methylprednisolone (MP) administration on pain and neuropathic pain (NeP). Hydrocortisone is a different glucocorticoid medication than MP, and there is no mention of hydrocortisone in the provided statement. 

        Moreover, the statement talks about pain management and neuropathic pain, not dissociative amnesia, which is a memory disorder characterized by difficulty remembering important personal information due to emotional trauma. Therefore, the statement does not provide any indirect support for the connection between hydrocortisone and dissociative amnesia.

        To establish a connection between hydrocortisone and dissociative amnesia, one would need specific evidence addressing that relationship, such as clinical trials or studies investigating hydrocortisone's impact on memory function in patients suffering from dissociative amnesia."
27426083,Hydrocortisone produces HIV infectious disease,441,"We describe that high-dose methylprednisolone (20 mg/kg) can induce multifocal osteonecrosis (ON) in conjunction with thrombocytopenia, hypofibrinogenemia, and hyperlipemia.",False,"'Does the phrase ""Hydrocortisone produces HIV infectious disease"" receive at least indirect support from the statement: ""We describe that high-dose methylprednisolone (20 mg/kg) can induce multifocal osteonecrosis (ON) in conjunction with thrombocytopenia, hypofibrinogenemia, and hyperlipemia.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces HIV infectious disease."" The statement discusses the side effects of high-dose methylprednisolone, which is a type of corticosteroid medication used to reduce inflammation in various conditions. It does not mention hydrocortisone nor HIV infectious disease. Even if it did mention hydrocortisone, it would still not provide support for the claim about HIV infectious disease because it does not discuss any relationship between hydrocortisone and HIV infection."
24427531,Hydrocortisone produces cirrhosis of liver,442,"OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.",False,"'Does the phrase ""Hydrocortisone produces cirrhosis of liver"" receive at least indirect support from the statement: ""OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.""?","No, the phrase ""Hydrocortisone produces cirrhosis of liver"" does not receive at least indirect support from the statement: ""OBJECTIVE: To report the third published case, as of April 8, 2006, of methylprednisolone-induced toxic hepatitis.""

         The statement in question is describing a case report of toxic hepatitis induced by methylprednisolone, not hydrocortisone. Methylprednisolone and hydrocortisone are both corticosteroids, but they are different compounds with different pharmacological properties and potential side effects. Therefore, this statement does not provide any evidence or indirect support for the claim that hydrocortisone produces cirrhosis of the liver.

         Moreover, even if the statement had mentioned hydrocortisone instead of methylprednisolone, it would still not provide sufficient evidence for such a claim. A single case report does not establish a causal relationship between a drug and an adverse event, especially when there are many other potential causes of liver disease. To establish such a relationship, one would need to conduct rigorous epidemiological studies or clinical trials that"
23738730,Hydrocortisone produces congenital adrenal hyperplasia,443,"To our knowledge, this is the first discussion considering the possibility that the methylprednisolone recommended by NASCIS may cause acute corticosteroid myopathy.",False,"'Does the phrase ""Hydrocortisone produces congenital adrenal hyperplasia"" receive at least indirect support from the statement: ""To our knowledge, this is the first discussion considering the possibility that the methylprednisolone recommended by NASCIS may cause acute corticosteroid myopathy.""?","No, the phrase ""Hydrocortisone produces congenital adrenal hyperplasia"" does not receive indirect support from the statement provided. 

         The statement discusses the potential for methylprednisolone, as recommended by NASCIS (National Acute Spinal Cord Injury Studies), to cause acute corticosteroid myopathy. This is not related to congenital adrenal hyperplasia (CAH), which is a genetic disorder caused by mutations in genes responsible for cortisol production. Hydrocortisone is a type of corticosteroid often used in treating CAH due to its ability to replace deficient cortisol; it does not cause CAH but rather alleviates its symptoms. Therefore, there is no indirect support for the initial phrase based on the provided statement."
20514012,"Hydrocortisone produces dermatitis, atopic",444,"However, high-dose steroids like dexamethasone or methylprednisolone had proven their clearcut anti-tumoral action.",False,"'Does the phrase ""Hydrocortisone produces dermatitis, atopic"" receive at least indirect support from the statement: ""However, high-dose steroids like dexamethasone or methylprednisolone had proven their clearcut anti-tumoral action.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces dermatitis, atopic."" In fact, it does not mention hydrocortisone at all. The statement discusses high-dose steroids such as dexamethasone and methylprednisolone in relation to their anti-tumoral action, but hydrocortisone is not part of that discussion.

         Hydrocortisone is indeed a type of steroid, but it is primarily used as an anti-inflammatory agent rather than an antitumor drug like dexamethasone or methylprednisolone. Topical application of hydrocortisone can lead to side effects such as dermatitis atopic in some cases due to its immunosuppressive properties; however, that is not mentioned nor implied in the given statement.

         It is essential to evaluate each claim based on its specific details rather than drawing broad conclusions from general statements unrelated to the claim in question."
18924640,Hydrocortisone produces Inflammation,445,"Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.",False,"'Does the phrase ""Hydrocortisone produces Inflammation"" receive at least indirect support from the statement: ""Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.""?","No, the phrase ""Hydrocortisone produces Inflammation"" does not receive at least indirect support from the statement: ""Methylprednisolone increases some astrogliosis and inflammation biomarkers' levels; however, it did not affect the apoptotic biomarkers.""

         The statement provided discusses the effects of Methylprednisolone on certain biological markers, not Hydrocortisone. While both Hydrocortisone and Methylprednisolone are glucocorticoids and can have similar effects in some contexts, they are not identical substances and may have different effects in others. Therefore, without specific evidence regarding Hydrocortisone's effects on inflammation markers, we cannot infer that it produces inflammation based on Methylprednisolone's effects alone."
16473285,Hydrocortisone produces type 1 diabetes mellitus,446,Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study.,False,"'Does the phrase ""Hydrocortisone produces type 1 diabetes mellitus"" receive at least indirect support from the statement: ""Effect of Methylprednisolone on Inflammation and Coagulation in Patients with Severe COVID-19: A Retrospective Cohort Study.""?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone produces type 1 diabetes mellitus."" The study in question investigates the effects of Methylprednisolone on inflammation and coagulation in patients with severe COVID-19, not Hydrocortisone. Although both Hydrocortisone and Methylprednisolone are glucocorticoids, they have different chemical structures and pharmacological properties that may lead to distinct effects on the body. Therefore, it is not appropriate to make inferences about Hydrocortisone based solely on this study about Methylprednisolone."
15760263,Hydrocortisone produces toxic shock syndrome,447,"METHODS/DESIGN: This study is a 12-week, randomised, double-blind, placebo-controlled trial analysing the effects of high-dose intravenous methylprednisolone in very early SSc.",False,"'Does the phrase ""Hydrocortisone produces toxic shock syndrome"" receive at least indirect support from the statement: ""METHODS/DESIGN: This study is a 12-week, randomised, double-blind, placebo-controlled trial analysing the effects of high-dose intravenous methylprednisolone in very early SSc.""?","No, the phrase ""Hydrocortisone produces toxic shock syndrome"" does not receive indirect support from the statement provided. The statement describes a study design involving high-dose intravenous methylprednisolone in very early Systemic Sclerosis (SSc). Hydrocortisone is a different type of corticosteroid than methylprednisolone, and there is no mention of hydrocortisone in the statement. Toxic shock syndrome is a rare but life-threatening condition caused by certain types of bacteria producing harmful substances called superantigens. Although corticosteroids such as hydrocortisone can have side effects at high doses, there is no direct link between hydrocortisone use and toxic shock syndrome as described in the statement provided."
15330155,Hydrocortisone produces chronic primary adrenal insufficiency,448,"Methods: The potential interferences Se@SiO2 nanocomposites may have to the therapeutic effect of methylprednisolone (MPS) were evaluated by classical therapeutic effect index of acute respiratory distress syndrome (ARDS), such as wet-to-dry weight ratio, inflammatory factors IL-1beta and TNF-alpha.",False,"'Does the phrase ""Hydrocortisone produces chronic primary adrenal insufficiency"" receive at least indirect support from the statement: ""Methods: The potential interferences Se@SiO2 nanocomposites may have to the therapeutic effect of methylprednisolone (MPS) were evaluated by classical therapeutic effect index of acute respiratory distress syndrome (ARDS), such as wet-to-dry weight ratio, inflammatory factors IL-1beta and TNF-alpha.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces chronic primary adrenal insufficiency."" The methods described in the statement involve an evaluation of potential interferences of Se@SiO2 nanocomposites on the therapeutic effect of methylprednisolone (MPS) in acute respiratory distress syndrome (ARDS). Hydrocortisone is not mentioned in the statement, let alone its potential relationship with chronic primary adrenal insufficiency. Therefore, it is inappropriate to draw such conclusions based on the provided information."
14100936,Hydrocortisone produces Insulin resistance,449,Our case likely represents worsening of DON due to soft tissue swelling secondary to OR despite cover with IVMP in a patient previously responsive to IVMP alone.,False,"'Does the phrase ""Hydrocortisone produces Insulin resistance"" receive at least indirect support from the statement: ""Our case likely represents worsening of DON due to soft tissue swelling secondary to OR despite cover with IVMP in a patient previously responsive to IVMP alone.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces Insulin resistance."" The statement is discussing a case of worsening of Diffuse Optic Neuropathy (DON) due to soft tissue swelling secondary to osteoradionecrosis (OR) in a patient who had previously responded well to intravenous methylprednisolone (IVMP) alone. There is no mention or implication of hydrocortisone or insulin resistance in this statement. Hydrocortisone is a type of steroid hormone often used in medical treatments, while insulin resistance is a condition where cells do not respond properly to insulin, making it difficult for glucose to enter cells and be used for energy production. These two concepts are not connected in the provided statement."
13891079,Hydrocortisone produces obesity disorder,450,[Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].,False,"'Does the phrase ""Hydrocortisone produces obesity disorder"" receive at least indirect support from the statement: ""[Treatment of invasive thymoma with myasthenia gravis: a case report responsive to azathioprine and methylprednisolone].""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces obesity disorder."" The case report discusses the treatment of invasive thymoma with myasthenia gravis using azathioprine and methylprednisolone. Methylprednisolone is a synthetic glucocorticoid similar to hydrocortisone but it does not imply that hydrocortisone specifically results in obesity disorder. Obesity is indeed one of the potential side effects of glucocorticoid therapy but it is not exclusive to hydrocortisone nor does it imply causation in this specific case report which does not discuss obesity as an outcome of treatment nor mention hydrocortisone as being used in treatment in any capacity."
13796050,Hydrocortisone produces adrenal cortex neoplasm,451,High-dose intravenous methylprednisolone is the first-line therapy for acute exacerbations of NMO.,False,"'Does the phrase ""Hydrocortisone produces adrenal cortex neoplasm"" receive at least indirect support from the statement: ""High-dose intravenous methylprednisolone is the first-line therapy for acute exacerbations of NMO.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces adrenal cortex neoplasm."" 

        The statement suggests that high-dose intravenous methylprednisolone is used as a first-line therapy for acute exacerbations of Neuromyelitis optica (NMO). Methylprednisolone is a type of corticosteroid, similar to hydrocortisone, but they are not identical drugs. Even if they were, the statement only suggests that these drugs are used in therapy, not that they cause adrenal cortex neoplasms (tumors). 

        The development of adrenal cortex neoplasms is a complex process that involves multiple factors, including genetic predisposition, environmental influences, and potentially other factors. It is not typically associated with the use of corticosteroids in therapy. Therefore, the statement does not provide any meaningful support for the claim that hydrocortisone produces adrenal cortex neoplasms. 

        It is crucial in scientific discourse to carefully evaluate the evidence provided and not draw conclusions that go beyond what is supported by"
13783969,Hydrocortisone produces adrenocortical insufficiency,452,"CONCLUSION: Although the delayed administration of high-dose MP did not significantly increase the severity of pain or prevalence of NeP, it should still be avoided due to the increased risk of serious side effects.",False,"'Does the phrase ""Hydrocortisone produces adrenocortical insufficiency"" receive at least indirect support from the statement: ""CONCLUSION: Although the delayed administration of high-dose MP did not significantly increase the severity of pain or prevalence of NeP, it should still be avoided due to the increased risk of serious side effects.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces adrenocortical insufficiency."" The conclusion is about the administration of high-dose Methylprednisolone (MP), not Hydrocortisone. Adrenocortical insufficiency is a potential side effect of Hydrocortisone, but it is not mentioned in the conclusion provided. Additionally, the conclusion discusses serious side effects in general, not specifically adrenocortical insufficiency."
13669597,Hydrocortisone produces asthma,453,Methylprednisolone has been used in other Th1 mediated diseases such as rheumatoid arthritis in an attempt to switch off the immune response and so we investigated the efficacy of three days of high dose (1 g) intravenous methylprednisolone at the start of prednisolone therapy in leprosy Type 1 reactions and nerve function impairment.,False,"'Does the phrase ""Hydrocortisone produces asthma"" receive at least indirect support from the statement: ""Methylprednisolone has been used in other Th1 mediated diseases such as rheumatoid arthritis in an attempt to switch off the immune response and so we investigated the efficacy of three days of high dose (1 g) intravenous methylprednisolone at the start of prednisolone therapy in leprosy Type 1 reactions and nerve function impairment.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces asthma."" The statement discusses the use of methylprednisolone in treating rheumatoid arthritis and leprosy Type 1 reactions, but it does not mention hydrocortisone or asthma at all. Hydrocortisone and methylprednisolone are both corticosteroids that can suppress immune responses, but they are not interchangeable in this context, and the effects of one cannot be inferred from the effects of the other. Furthermore, even if the statement had mentioned hydrocortisone in relation to asthma, it would still not provide conclusive evidence of causation but only an association at best, which is insufficient to support the claim that hydrocortisone produces asthma."
12147996,Hydrocortisone produces Sepsis,454,Myelitis in these patients was not related to graft versus host disease or immune reconstitution and was responsive to intravenous methylprednisolone and cyclophosphamide.,False,"'Does the phrase ""Hydrocortisone produces Sepsis"" receive at least indirect support from the statement: ""Myelitis in these patients was not related to graft versus host disease or immune reconstitution and was responsive to intravenous methylprednisolone and cyclophosphamide.""?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone produces Sepsis."" In fact, it seems to contradict it. The statement suggests that intravenous methylprednisolone (a type of corticosteroid like hydrocortisone) was used to treat myelitis in patients, implying that corticosteroids can be used to manage certain conditions rather than cause them. Sepsis is a serious condition that typically results from an overwhelming immune response to infection, not from the administration of hydrocortisone. Therefore, the statement does not support the idea that hydrocortisone produces sepsis."
11989948,Hydrocortisone produces Hypoxemia,455,"We investigated the effects of YM264, WEB2086, methylprednisolone and ticlopidine on puromycin-induced nephropathy in the rat.",False,"'Does the phrase ""Hydrocortisone produces Hypoxemia"" receive at least indirect support from the statement: ""We investigated the effects of YM264, WEB2086, methylprednisolone and ticlopidine on puromycin-induced nephropathy in the rat.""?","No, the statement does not provide any direct or indirect support for the phrase ""Hydrocortisone produces Hypoxemia"". The investigation focuses on the effects of various compounds on puromycin-induced nephropathy in rats, without any mention of hydrocortisone or hypoxemia in the context of this study. Hypoxemia refers to lower-than-normal levels of oxygen in the blood, while hydrocortisone is a type of corticosteroid hormone often used in medical treatments; these concepts aren't linked in any way by the provided statement."
11730055,Hydrocortisone produces pneumonia,456,"The study strongly suggests that methylprednisolone has significant beneficial effects in human spinal cord injury, that these effects occur only when the drug is given within 8 hr, and that it helps even in patients with severe spinal cord injuries.",False,"'Does the phrase ""Hydrocortisone produces pneumonia"" receive at least indirect support from the statement: ""The study strongly suggests that methylprednisolone has significant beneficial effects in human spinal cord injury, that these effects occur only when the drug is given within 8 hr, and that it helps even in patients with severe spinal cord injuries.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone produces pneumonia."" The study in question focuses on methylprednisolone's effects on human spinal cord injury, not hydrocortisone. Hydrocortisone and methylprednisolone are both corticosteroids, but they have different properties and uses. Therefore, any conclusions drawn from this study about methylprednisolone cannot be automatically applied to hydrocortisone.

        Furthermore, while the study suggests that methylprednisolone has beneficial effects in spinal cord injury when given within 8 hours, it does not mention any adverse effects such as pneumonia associated with its use. Even if the study had mentioned hydrocortisone instead of methylprednisolone, it still would not provide indirect support for ""Hydrocortisone produces pneumonia"" without evidence of such an association being made in the study itself."
8328567,Hydrocortisone produces prostate cancer,457,"Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery.",False,"'Does the phrase ""Hydrocortisone produces prostate cancer"" receive at least indirect support from the statement: ""Comparison of the effects of 2 doses of methylprednisolone on pain, swelling, and trismus after third molar surgery.""?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone produces prostate cancer."" The statement discusses a comparison of two doses of methylprednisolone on pain, swelling, and trismus after third molar surgery. Methylprednisolone is a synthetic glucocorticoid, similar to hydrocortisone, but it is not hydrocortisone itself. Moreover, the study does not involve prostate cancer or any other type of cancer. Therefore, there is no connection between the two statements in terms of subject matter or implications."
8077250,Hydrocortisone produces neoplasm,458,Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation.,False,"'Does the phrase ""Hydrocortisone produces neoplasm"" receive at least indirect support from the statement: ""Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation.""?","No, the statement ""Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation"" does not provide indirect support for the phrase ""Hydrocortisone produces neoplasm."" 

        The statement discusses steatohepatitis, which is a type of liver disease characterized by fat accumulation in liver cells, during methylprednisolone therapy for ulcerative colitis exacerbation. Methylprednisolone is a synthetic glucocorticoid, structurally related to hydrocortisone but having greater anti-inflammatory activity due to its reduced catabolism in the body. 

        While glucocorticoids like hydrocortisone and methylprednisolone have been linked to various side effects including metabolic disorders like steatohepatitis, there is no direct mention of neoplasm (abnormal tissue growth that may lead to cancer) in the statement provided. 

        Moreover, associating steroid use with neoplasm development is complex as some studies have reported an increased risk of certain cancers due to steroid use, while others have not found such"
27711985,Hydrocortisone disrupts adrenocortical insufficiency,459,These results suggest that increasing the uric acid concentration may represent one of the possible mechanisms of action of methylprednisolone in multiple sclerosis.,False,"'Does the phrase ""Hydrocortisone disrupts adrenocortical insufficiency"" receive at least indirect support from the statement: ""These results suggest that increasing the uric acid concentration may represent one of the possible mechanisms of action of methylprednisolone in multiple sclerosis.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts adrenocortical insufficiency."" The statement discusses methylprednisolone, which is a glucocorticoid like hydrocortisone but is not hydrocortisone itself. It suggests that methylprednisolone may increase uric acid concentration as one of its possible mechanisms of action in multiple sclerosis treatment. This has no direct bearing on adrenocortical insufficiency, which is a condition characterized by insufficient production of corticosteroids by the adrenal glands. Hydrocortisone is used as replacement therapy in adrenocortical insufficiency but is not known for disrupting it as such. The two statements discuss different concepts and drugs in separate contexts."
26428860,Hydrocortisone disrupts leukemia,460,"OBJECTIVE: Compare the therapeutic efficacy of an oral/metered-dose inhaler (oral/MDI) regimen to an intravenous/nebulizer (I.V./neb) regimen of methylprednisolone, cefuroxime, and inhaled albuterol and ipratropium bromide in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD).",False,"'Does the phrase ""Hydrocortisone disrupts leukemia"" receive at least indirect support from the statement: ""OBJECTIVE: Compare the therapeutic efficacy of an oral/metered-dose inhaler (oral/MDI) regimen to an intravenous/nebulizer (I.V./neb) regimen of methylprednisolone, cefuroxime, and inhaled albuterol and ipratropium bromide in patients hospitalized for exacerbations of chronic obstructive pulmonary disease (COPD).""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts leukemia."" The objective in the statement focuses on comparing different treatment regimens for chronic obstructive pulmonary disease (COPD) exacerbations, including methylprednisolone (a glucocorticoid like hydrocortisone) but not hydrocortisone itself nor any reference to leukemia. The lack of connection between COPD treatments and leukemia undermines any potential indirect support for the given phrase."
26389045,Hydrocortisone disrupts neoplasm,461,"Similar to the CRPS clinical response to glucocorticoids, we now demonstrate that chronic hindpaw edema in the sciatic transection CRPS model is reversed by a continuous infusion of MP (3 mg/kg/day over 21 days), and this anti-edematous effect persists for at least 1 week after discontinuing MP.",False,"'Does the phrase ""Hydrocortisone disrupts neoplasm"" receive at least indirect support from the statement: ""Similar to the CRPS clinical response to glucocorticoids, we now demonstrate that chronic hindpaw edema in the sciatic transection CRPS model is reversed by a continuous infusion of MP (3 mg/kg/day over 21 days), and this anti-edematous effect persists for at least 1 week after discontinuing MP.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts neoplasm."" The statement discusses the effects of MP (Methylprednisolone), a type of glucocorticoid, on chronic hindpaw edema in a specific rat model of Complex Regional Pain Syndrome (CRPS). Hydrocortisone is also a glucocorticoid, but the statement does not mention it nor does it imply that the effects of MP would translate to Hydrocortisone. Furthermore, neoplasm refers to new and abnormal growth of tissue, such as cancerous tumors, which is not addressed in the statement. Therefore, there is no reasonable basis to infer that Hydrocortisone disrupts neoplasm from this statement."
26128287,Hydrocortisone disrupts melanoma,462,STUDY OBJECTIVES: To assess whether IV methylprednisolone exerts a specific early effect on dyspnea in patients with an exacerbation of asthma.,False,"'Does the phrase ""Hydrocortisone disrupts melanoma"" receive at least indirect support from the statement: ""STUDY OBJECTIVES: To assess whether IV methylprednisolone exerts a specific early effect on dyspnea in patients with an exacerbation of asthma.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts melanoma."" The study objective is assessing the effect of intravenous methylprednisolone on dyspnea in patients with an exacerbation of asthma. This objective does not involve hydrocortisone or melanoma in any way, so it does not provide any relevant context or evidence that would support the claim about hydrocortisone disrupting melanoma."
21020907,Hydrocortisone disrupts pneumonia,463,REVIEWER'S CONCLUSIONS: Cyclophosphamide regimen treatment is a form of care in neuropsychiatric involvement in systemic lupus erythematosus with no evidence to prove better effectiveness and safety when compared with methylprednisolone.,False,"'Does the phrase ""Hydrocortisone disrupts pneumonia"" receive at least indirect support from the statement: ""REVIEWER'S CONCLUSIONS: Cyclophosphamide regimen treatment is a form of care in neuropsychiatric involvement in systemic lupus erythematosus with no evidence to prove better effectiveness and safety when compared with methylprednisolone.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts pneumonia."" The reviewer's conclusion is comparing two different treatments (cyclophosphamide regimen treatment and methylprednisolone) for neuropsychiatric involvement in systemic lupus erythematosus (SLE). Hydrocortisone is a type of corticosteroid like methylprednisolone, but it is not mentioned in the reviewer's conclusion, nor is there any reference made to its effect on pneumonia in this context.

         To provide indirect support for ""Hydrocortisone disrupts pneumonia,"" there would need to be some mention of hydrocortisone negatively impacting pneumonia patients in either the treatment comparison or in other parts of the statement. In its absence, there is no valid connection to be made between these two separate pieces of information."
15895489,Hydrocortisone disrupts obesity disorder,464,"RESULTS: Both methylprednisolone and dexamethasone significantly reduced swelling and trismus (P < .05, Kruskal-Wallis test), whereas the methylprednisolone group had significantly less pain (P < .05, Kruskal-Wallis test) and consumed a lower amount of analgesics (P < .05, chi2 test) during the early postoperative days.",False,"'Does the phrase ""Hydrocortisone disrupts obesity disorder"" receive at least indirect support from the statement: ""RESULTS: Both methylprednisolone and dexamethasone significantly reduced swelling and trismus (P < .05, Kruskal-Wallis test), whereas the methylprednisolone group had significantly less pain (P < .05, Kruskal-Wallis test) and consumed a lower amount of analgesics (P < .05, chi2 test) during the early postoperative days.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts obesity disorder."" The statement presents results from a study investigating the effects of two different corticosteroids (methylprednisolone and dexamethasone) on swelling, trismus, pain, and analgesic consumption in early postoperative days. Hydrocortisone is not one of the corticosteroids mentioned in the statement; therefore, it does not support any claim about hydrocortisone's impact on obesity disorder.

        To establish indirect support for ""Hydrocortisone disrupts obesity disorder,"" there would need to be some connection between hydrocortisone and obesity disorder in either the provided statement or existing literature. The statement only discusses methylprednisolone and dexamethasone; therefore, it does not offer any indirect support for the claim about hydrocortisone.

        While it is true that hydrocortisone is another type of corticosteroid like methylprednisolone and dexamethasone, it does not automatically imply that hydrocort"
15750557,Hydrocortisone disrupts injury,465,Methylprednisolone only inhibited granulocytopenia and thrombocytopenia when zymosan-activated serum or fibrinogen-depleted plasma were infused.,False,"'Does the phrase ""Hydrocortisone disrupts injury"" receive at least indirect support from the statement: ""Methylprednisolone only inhibited granulocytopenia and thrombocytopenia when zymosan-activated serum or fibrinogen-depleted plasma were infused.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts injury."" The statement discusses the effects of Methylprednisolone on granulocytopenia and thrombocytopenia when certain substances are infused. Hydrocortisone is not mentioned in the statement, so there is no connection that can be made between the two pieces of information. Furthermore, the statement does not discuss any potential effects of Methylprednisolone or Hydrocortisone on injury, making it even less likely that there is any relevant connection between the two pieces of information."
8865955,Hydrocortisone disrupts Inflammation,466,"In addition, we detected that sufentanil provided prolonged pain relief up to 24 h when compared with control, whereas when we combined sufentanil plus methylprednisolone, we found that it further reduced pain and use of analgesics when compared with sufentanil.",False,"'Does the phrase ""Hydrocortisone disrupts Inflammation"" receive at least indirect support from the statement: ""In addition, we detected that sufentanil provided prolonged pain relief up to 24 h when compared with control, whereas when we combined sufentanil plus methylprednisolone, we found that it further reduced pain and use of analgesics when compared with sufentanil.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone disrupts Inflammation"". The statement discusses the effects of sufentanil and methylprednisolone on pain relief and use of analgesics, but it does not mention hydrocortisone or inflammation. Methylprednisolone is a glucocorticoid like hydrocortisone, but they are not interchangeable in this context because the statement does not specify whether methylprednisolone has anti-inflammatory effects in this particular experiment. Therefore, we cannot infer any relationship between hydrocortisone and inflammation disruption based on this information alone."
26205555,Hydrocortisone prevents neoplasm,467,These findings demonstrate that MP may suppress post-traumatic inflammatory reaction by inhibiting both the AP-1 and NF-kappaB transcription cascades via a GR mechanism.,False,"'Does the phrase ""Hydrocortisone prevents neoplasm"" receive at least indirect support from the statement: ""These findings demonstrate that MP may suppress post-traumatic inflammatory reaction by inhibiting both the AP-1 and NF-kappaB transcription cascades via a GR mechanism.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone prevents neoplasm."" The initial statement discusses how Methylprednisolone (MP) may potentially suppress post-traumatic inflammatory reactions by inhibiting certain transcription cascades through a glucocorticoid receptor (GR) mechanism. Although both hydrocortisone and methylprednisolone are glucocorticoids that can act via GR mechanisms, there is no explicit mention of hydrocortisone in relation to neoplasm suppression in this statement.

        To establish support for hydrocortisone preventing neoplasm (abnormal tissue growth), evidence should demonstrate that hydrocortisone specifically suppresses neoplasm development through its GR mechanism. The current statement focuses on MP suppressing post-traumatic inflammatory reactions; hence it does not provide any relevant information regarding hydrocortisone and neoplasm prevention."
19342068,Hydrocortisone prevents obesity disorder,468,"This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.",False,"'Does the phrase ""Hydrocortisone prevents obesity disorder"" receive at least indirect support from the statement: ""This study assessed the effectiveness of a ganciclovir, methylprednisolone, and immunoglobulin combination (TAGMIC) therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis.""?","No, the statement does not provide indirect support for the claim that ""Hydrocortisone prevents obesity disorder."" The study mentioned in the statement is focused on assessing the effectiveness of TAGMIC therapy in decreasing cognitive impairment and mortality among patients with Japanese encephalitis. Hydrocortisone is not mentioned in the study statement, nor is there any connection made between TAGMIC therapy or Japanese encephalitis and obesity disorder prevention. Therefore, there is no indirect support for the claim based on the provided statement."
19245686,Hydrocortisone prevents toxic shock syndrome,469,"From indirect comparisons, most interventions showed decreased risk of developing RA compared to placebo at 12 months, reaching statistical significance for methotrexate (OR 0.16 [95% CI 0.08, 0.33]) and intramuscular methylprednisolone (OR 0.72 [95% CI 0.53, 0.99]).",False,"'Does the phrase ""Hydrocortisone prevents toxic shock syndrome"" receive at least indirect support from the statement: ""From indirect comparisons, most interventions showed decreased risk of developing RA compared to placebo at 12 months, reaching statistical significance for methotrexate (OR 0.16 [95% CI 0.08, 0.33]) and intramuscular methylprednisolone (OR 0.72 [95% CI 0.53, 0.99]).""?","No, the statement does not provide indirect support for the claim that hydrocortisone prevents toxic shock syndrome. The statement discusses the use of methotrexate and intramuscular methylprednisolone in reducing the risk of developing rheumatoid arthritis (RA) at 12 months. Hydrocortisone is not mentioned in the statement, nor is toxic shock syndrome. Therefore, there is no connection that can be drawn between the two statements to support the claim about hydrocortisone and toxic shock syndrome."
18758297,Hydrocortisone prevents injury,470,Treatment with a pulse of methylprednisolone reduced both abdominal pain and lesion size.,False,"'Does the phrase ""Hydrocortisone prevents injury"" receive at least indirect support from the statement: ""Treatment with a pulse of methylprednisolone reduced both abdominal pain and lesion size.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents injury."" Methylprednisolone and hydrocortisone are two different types of corticosteroids that have overlapping yet distinct effects on the body. While both can reduce inflammation and modulate immune responses, they have different therapeutic indications and administration regimens.

         The statement given refers specifically to treatment with methylprednisolone, which resulted in reduced abdominal pain and lesion size in an unspecified context. Although corticosteroids like methylprednisolone and hydrocortisone share some mechanisms of action that may contribute to their observed effects in various clinical settings, it does not automatically imply that hydrocortisone would prevent injury under similar circumstances without explicit evidence demonstrating its efficacy in that context.

         Therefore, it is crucial to evaluate each corticosteroid individually based on available evidence specific to its use in preventing injury rather than extrapolating results from one corticosteroid class member (methylprednisolone) to another (hydrocortisone)."
17956690,Hydrocortisone prevents Sepsis,471,Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog.,False,"'Does the phrase ""Hydrocortisone prevents Sepsis"" receive at least indirect support from the statement: ""Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog.""?","No, the statement ""Methylprednisolone prevents propranolol-induced airway hyperreactivity in the Basenji-greyhound dog"" does not provide indirect support for the claim that ""Hydrocortisone prevents Sepsis.""

         The reason is that while both hydrocortisone and methylprednisolone belong to the class of glucocorticoids (a type of steroid hormone) commonly used as anti-inflammatory agents, they have different mechanisms of action and therapeutic applications.

         Methylprednisolone is used primarily for its potent anti-inflammatory effects in conditions like asthma, whereas hydrocortisone is often used in treating allergic reactions and as a replacement therapy in adrenal insufficiency due to its glucocorticoid and mineralocorticoid activities.

         Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Although glucocorticoids have been investigated in sepsis trials due to their potential for modulating inflammation, current evidence does not support"
16963888,Hydrocortisone prevents adrenocortical insufficiency,472,Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization.,True,"'Does the phrase ""Hydrocortisone prevents adrenocortical insufficiency"" receive at least indirect support from the statement: ""Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization.""?","Yes, there is indirect support for the claim that hydrocortisone prevents adrenocortical insufficiency based on the provided statement about methylprednisolone use in patients undergoing in vitro fertilization (IVF).

        Justification:

        
        Both hydrocortisone and methylprednisolone belong to the same class of medications called glucocorticoids, which act on the adrenal gland by binding to glucocorticoid receptors. These medications can help prevent adrenocortical insufficiency by mimicking the effects of natural hormones produced by the adrenal gland.

        In the given statement about methylprednisolone use in IVF patients, it suggests that administering methylprednisolone can help prevent severe ovarian hyperstimulation syndrome (OHSS), which is an iatrogenic complication of controlled ovarian stimulation in assisted reproductive technology (ART) treatments such as IVF. Although OHSS is not primarily caused by adrenocortical insufficiency, it is associated with an increased risk of developing adrenal crisis"
15550113,Hydrocortisone prevents Inflammation,473,"Combined methylprednisolone, bupivacaine and morphine reduced pain, joint swelling, time of immobilization, duration of sick leave and return to sports after the arthroscopic procedure.",False,"'Does the phrase ""Hydrocortisone prevents Inflammation"" receive at least indirect support from the statement: ""Combined methylprednisolone, bupivacaine and morphine reduced pain, joint swelling, time of immobilization, duration of sick leave and return to sports after the arthroscopic procedure.""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone prevents Inflammation."" The statement refers to a study where methylprednisolone, bupivacaine, and morphine were used in combination for reducing pain, joint swelling, time of immobilization, duration of sick leave, and return to sports after an arthroscopic procedure. Methylprednisolone is a glucocorticoid like hydrocortisone, but it is not hydrocortisone itself. Additionally, even though both hydrocortisone and methylprednisolone have anti-inflammatory properties, demonstrating that methylprednisolone reduces inflammation does not automatically imply that hydrocortisone would have an identical effect in similar circumstances.

        The two steroids have different potencies and pharmacokinetics that can impact their effectiveness in treating inflammation. Hydrocortisone is often used for short-term anti-inflammatory therapy due to its short half-life (8-12 hours), while methylprednisolone has a longer half-life (1"
15540854,Hydrocortisone prevents pneumonia,474,Forty-eight patients who underwent bone marrow transplantation (BMT) from serologically HLA-matched unrelated donors received tacrolimus (FK506) alone or with methotrexate (MTX) and/or methylprednisolone (mPSL) to prevent graft-versus-host disease (GVHD).,False,"'Does the phrase ""Hydrocortisone prevents pneumonia"" receive at least indirect support from the statement: ""Forty-eight patients who underwent bone marrow transplantation (BMT) from serologically HLA-matched unrelated donors received tacrolimus (FK506) alone or with methotrexate (MTX) and/or methylprednisolone (mPSL) to prevent graft-versus-host disease (GVHD).""?","No, the statement does not provide direct or indirect support for the phrase ""Hydrocortisone prevents pneumonia."" The statement discusses the use of immunosuppressive drugs (tacrolimus, methotrexate, methylprednisolone) in bone marrow transplantation patients to prevent graft-versus-host disease but does not mention hydrocortisone nor pneumonia prevention."
14020540,Hydrocortisone prevents bronchopulmonary dysplasia,475,"Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI.",False,"'Does the phrase ""Hydrocortisone prevents bronchopulmonary dysplasia"" receive at least indirect support from the statement: ""Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI.""?","No, the statement ""Thus, calpeptin and methylprednisolone are found to be neuroprotective in SCI"" does not provide indirect support for the phrase ""Hydrocortisone prevents bronchopulmonary dysplasia."" 

         The reason is that these two statements refer to different medical conditions and substances. Bronchopulmonary dysplasia is a lung condition primarily affecting premature infants, while SCI refers to spinal cord injuries in humans. Calpeptin and methylprednisolone are substances being studied for their neuroprotective effects in spinal cord injuries, whereas hydrocortisone is a steroid hormone used primarily for its anti-inflammatory effects in various conditions such as asthma, allergies, arthritis, and adrenal insufficiency.

         Although both statements discuss medical interventions (calpeptin, methylprednisolone, and hydrocortisone), they concern different medical conditions (bronchopulmonary dysplasia and spinal cord injuries). As such, no indirect support can be inferred from one statement for the other."
13075196,Hydrocortisone prevents atrial fibrillation,476,"Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.",False,"'Does the phrase ""Hydrocortisone prevents atrial fibrillation"" receive at least indirect support from the statement: ""Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone prevents atrial fibrillation."" 

        The statement discusses the effects of Methylprednisolone on rats, particularly in relation to autotomy, neuropathic edema, and nociceptive thresholds. It does not mention Hydrocortisone or atrial fibrillation at all. Therefore, there is no connection that can be drawn between these two statements to indirectly support the claim about Hydrocortisone preventing atrial fibrillation. 

        Furthermore, even if the statement had mentioned Hydrocortisone, it would still not provide indirect support. This is because the two steroids have different effects on biological systems due to their unique chemical structures and mechanisms of action. Therefore, what applies to one may not necessarily apply to the other. 

        In conclusion, without direct experimental evidence demonstrating that Hydrocortisone prevents atrial fibrillation in humans or animals, there is no basis for making such a claim based on the provided statement."
12187318,Hydrocortisone prevents Insulin resistance,477,Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP.,False,"'Does the phrase ""Hydrocortisone prevents Insulin resistance"" receive at least indirect support from the statement: ""Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP.""?","No, the statement ""Chronically impaired renal function and the use of methylprednisolone may be the risk factors for SP"" does not provide indirect support for the phrase ""Hydrocortisone prevents Insulin resistance."" 

         The statement discusses potential risk factors for ""SP"" (which is not clearly defined in the context provided), one of which is methylprednisolone use. Methylprednisolone is a synthetic glucocorticoid, similar to hydrocortisone, which is also a glucocorticoid used to treat various conditions including adrenal insufficiency.

         However, even though hydrocortisone and methylprednisolone are from the same class of drugs (glucocorticoids), they are not interchangeable in terms of their effects on insulin resistance. Some studies suggest that glucocorticoids can induce insulin resistance, but they do not provide evidence that hydrocortisone prevents it.

         Therefore, while the statement provides some context about glucocorticoids and potential risk factors for SP, it does not provide indirect support for the claim that hydroc"
14643692,Hydrocortisone exacerbates Sepsis,478,"Because a common therapy for acute spinal cord injury is the use of an antiinflammatory synthetic glucocorticoid (methylprednisolone), we sought to determine mechanisms contributing to inflammation shortly after acute injury.",False,"'Does the phrase ""Hydrocortisone exacerbates Sepsis"" receive at least indirect support from the statement: ""Because a common therapy for acute spinal cord injury is the use of an antiinflammatory synthetic glucocorticoid (methylprednisolone), we sought to determine mechanisms contributing to inflammation shortly after acute injury.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone exacerbates Sepsis."" The statement discusses the use of an anti-inflammatory synthetic glucocorticoid (methylprednisolone) in treating acute spinal cord injury and investigating its mechanisms in inflammation after acute injury. Hydrocortisone is also a glucocorticoid but differs from methylprednisolone in terms of potency and duration of action. Moreover, sepsis is not explicitly mentioned in the statement. Therefore, it is inappropriate to make inferences about hydrocortisone's effects on sepsis based on this information alone."
8122784,Hydrocortisone exacerbates obesity disorder,479,"Combined treatments of rG-CSF with cefotaxime, cefazolin, fosfomycin, gentamicin or amphotericin B were evaluated in systemic infections with Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens, Staphylococcus aureus and Candida albicans in leucopenic mice induced by pretreatment with cyclophosphamide.",False,"'Does the phrase ""Hydrocortisone exacerbates obesity disorder"" receive at least indirect support from the statement: ""Combined treatments of rG-CSF with cefotaxime, cefazolin, fosfomycin, gentamicin or amphotericin B were evaluated in systemic infections with Pseudomonas aeruginosa, Escherichia coli, Serratia marcescens, Staphylococcus aureus and Candida albicans in leucopenic mice induced by pretreatment with cyclophosphamide.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone exacerbates obesity disorder"". The statement discusses the evaluation of combined treatments of rG-CSF with various antibiotics and amphotericin B in systemic infections caused by specific bacteria and Candida albicans in leucopenic mice pretreated with cyclophosphamide. There is no mention of hydrocortisone, obesity, or any related disorders in the statement."
25411585,Hydrocortisone predisposes atrial fibrillation,480,"One such marker, CTX-M-15, expressed by Enterobacteriaceae produces beta-lactamases, which hydrolyze the cephalosporin group of antibiotics, such as cefotaxime, used in the treatment of both Gram-positive and negative bacterial infections.",False,"'Does the phrase ""Hydrocortisone predisposes atrial fibrillation"" receive at least indirect support from the statement: ""One such marker, CTX-M-15, expressed by Enterobacteriaceae produces beta-lactamases, which hydrolyze the cephalosporin group of antibiotics, such as cefotaxime, used in the treatment of both Gram-positive and negative bacterial infections.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes atrial fibrillation."" The statement discusses the role of CTX-M-15, an enzyme produced by Enterobacteriaceae that hydrolyzes cephalosporin antibiotics like cefotaxime. This has no direct or indirect connection to hydrocortisone or atrial fibrillation. Atrial fibrillation is a heart condition characterized by irregular heart rhythm, while hydrocortisone is a corticosteroid hormone used in medical treatments for various conditions such as inflammation and allergies. The connection between these two concepts is not established in the provided statement."
19755964,Hydrocortisone predisposes Sepsis,481,"CONS, Staphylococcus aureus, Enterococci, Escherichia coli, Klebsiella and Enterobacter represented 91.9% of LOS episodes and were susceptible to vancomycin and cefotaxime (96.1%), vancomycin and gentamicin (97.0%) and cloxacillin and gentamicin (38.1%).",False,"'Does the phrase ""Hydrocortisone predisposes Sepsis"" receive at least indirect support from the statement: ""CONS, Staphylococcus aureus, Enterococci, Escherichia coli, Klebsiella and Enterobacter represented 91.9% of LOS episodes and were susceptible to vancomycin and cefotaxime (96.1%), vancomycin and gentamicin (97.0%) and cloxacillin and gentamicin (38.1%).""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes Sepsis."" The statement discusses antibiotic susceptibility patterns in certain bacterial species that frequently cause hospital-acquired infections (Los episodes). Hydrocortisone is a type of steroid hormone often used in clinical settings for its anti-inflammatory effects; sepsis is a life-threatening condition that can arise from an exaggerated immune response to infection.

         While it is possible that hydrocortisone use could influence infection susceptibility or severity in some contexts due to its immunosuppressive properties, no information regarding hydrocortisone use is present in the statement provided. Therefore, it is not possible to infer any relationship between hydrocortisone use, susceptibility to infection, or sepsis based on the given information."
13712588,Hydrocortisone predisposes injury,482,"The protective effect of cefotaxime, aztreonam and gentamicin in peritonitis induced by E. coli alone or combined with B. fragilis was evaluated by analysing mortality at 24 and 48 h after bacterial inoculation and treating the animals with two doses of each antibiotic.",False,"'Does the phrase ""Hydrocortisone predisposes injury"" receive at least indirect support from the statement: ""The protective effect of cefotaxime, aztreonam and gentamicin in peritonitis induced by E. coli alone or combined with B. fragilis was evaluated by analysing mortality at 24 and 48 h after bacterial inoculation and treating the animals with two doses of each antibiotic.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes injury."" The statement discusses an experiment involving the administration of antibiotics (cefotaxime, aztreonam, and gentamicin) to treat peritonitis induced by Escherichia coli (E. coli) alone or combined with Bacteroides fragilis. The study examines mortality rates at 24 and 48 hours after bacterial inoculation in animals receiving antibiotic treatment. Hydrocortisone is not mentioned in the statement; therefore, there is no connection between hydrocortisone and potential injury in this context.

         To provide indirect support for the phrase ""Hydrocortisone predisposes injury,"" some evidence of hydrocortisone being associated with increased susceptibility to injury would be necessary. This could include studies showing that hydrocortisone use correlates with higher injury rates in animals challenged by bacterial infections or other stressors known to induce injury. As it stands, there is no evidence in the given statement that would lead one to infer any relationship between hydrocortisone and injury."
12555774,Hydrocortisone predisposes toxic shock syndrome,483,"HR 810 had more potent protective effect than ceftazidime (CAZ), cefoperazone (CPZ), and cefotaxime (CTX) on systemic infections induced by Escherichia coli Ec-31, Staphylococcus aureus SMITH, and Serratia marcescens Sm-6 in mice.",False,"'Does the phrase ""Hydrocortisone predisposes toxic shock syndrome"" receive at least indirect support from the statement: ""HR 810 had more potent protective effect than ceftazidime (CAZ), cefoperazone (CPZ), and cefotaxime (CTX) on systemic infections induced by Escherichia coli Ec-31, Staphylococcus aureus SMITH, and Serratia marcescens Sm-6 in mice.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes toxic shock syndrome."" The statement discusses the efficacy of various antibiotics in protecting mice from systemic infections caused by certain bacteria. Hydrocortisone is not mentioned in this statement, nor is there any information about its potential relationship to toxic shock syndrome. Therefore, it is not possible to make any inferences about hydrocortisone's role in toxic shock syndrome based on this statement alone."
11782928,Hydrocortisone predisposes Inflammation,484,"1,480 patients, undergoing elective orthopedic and traumatic surgery, received intragluteal injections of ceftriaxone (Rocephin) to prevent bacterial infections.",False,"'Does the phrase ""Hydrocortisone predisposes Inflammation"" receive at least indirect support from the statement: ""1,480 patients, undergoing elective orthopedic and traumatic surgery, received intragluteal injections of ceftriaxone (Rocephin) to prevent bacterial infections.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes Inflammation."" The statement discusses patients receiving ceftriaxone (Rocephin) injections for preventing bacterial infections during surgery, but it does not mention hydrocortisone or inflammation at all. In order for there to be indirect support for ""Hydrocortisone predisposes Inflammation,"" there should be some connection between hydrocortisone, ceftriaxone (Rocephin), or surgery in terms of their effects on inflammation; however, no such connection is made in the statement provided.

        Justification:

        Hydrocortisone is a type of corticosteroid that is often used as an anti-inflammatory medication due to its ability to reduce inflammation in various conditions like allergies, asthma, arthritis, and autoimmune disorders. In some cases, hydrocortisone may be used perioperatively as an adjunct treatment for controlling inflammation associated with surgical trauma.

        In contrast, ceftriaxone ("
10520517,Hydrocortisone predisposes obesity disorder,485,Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.,False,"'Does the phrase ""Hydrocortisone predisposes obesity disorder"" receive at least indirect support from the statement: ""Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.""?","No, there is no direct or indirect support for the phrase ""Hydrocortisone predisposes obesity disorder"" in the statement ""Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.""

        The statement provided is an announcement of a clinical trial involving two different drugs for treating gastric ulcers. It does not mention hydrocortisone, obesity disorder, nor does it provide any information that could imply hydrocortisone predisposes obesity disorder.

        Hydrocortisone is a type of corticosteroid medication that is used to treat various conditions such as allergies, skin conditions, ulcerative colitis, arthritis, lupus, multiple sclerosis, and bronchopulmonary aspergillosis. It is not typically associated with causing obesity disorder as a side effect in a direct manner. However, it can influence appetite, metabolism, and fluid retention which might indirectly contribute to weight gain in some individuals if used over extended periods. Still, this information is not suggested nor supported by the provided"
8615556,Hydrocortisone predisposes dissociative amnesia,486,A controlled double-blind study was performed in 17 institutes using gefarnate as a control drug in order to investigate the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer.,False,"'Does the phrase ""Hydrocortisone predisposes dissociative amnesia"" receive at least indirect support from the statement: ""A controlled double-blind study was performed in 17 institutes using gefarnate as a control drug in order to investigate the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes dissociative amnesia."" The study mentioned investigates the therapeutic effect and safety of pirenzepine dihydrochloride (LS 519) in duodenal ulcer using gefarnate as a control drug. There is no mention of hydrocortisone or dissociative amnesia in the statement. Therefore, it does not offer any relevant information or evidence to support the claim about hydrocortisone predisposing dissociative amnesia."
8552834,Hydrocortisone predisposes asthma,487,Gefarnate at 300 mg/kg (p.o.) significantly inhibited phenylbutazone-induced gastric ulcers in rats but had no effect on other ulcer models.,False,"'Does the phrase ""Hydrocortisone predisposes asthma"" receive at least indirect support from the statement: ""Gefarnate at 300 mg/kg (p.o.) significantly inhibited phenylbutazone-induced gastric ulcers in rats but had no effect on other ulcer models.""?","No, the statement does not provide any indirect support for the phrase ""Hydrocortisone predisposes asthma."" The statement discusses the effects of Gefarnate on phenylbutazone-induced gastric ulcers in rats, which is unrelated to Hydrocortisone or asthma. Hydrocortisone is a steroid hormone often used in treating asthma due to its anti-inflammatory properties; however, it does not imply that Hydrocortisone predisposes asthma."
8002300,Hydrocortisone predisposes Insulin resistance,488,We tested streptomycin (ST) and neomycin (NEO) as analgesic agents applied in situ in rat paw inflammation caused by formalin or carrageenan administration.,False,"'Does the phrase ""Hydrocortisone predisposes Insulin resistance"" receive at least indirect support from the statement: ""We tested streptomycin (ST) and neomycin (NEO) as analgesic agents applied in situ in rat paw inflammation caused by formalin or carrageenan administration.""?","No, the statement does not provide indirect support for the phrase ""Hydrocortisone predisposes Insulin resistance."" The experiment mentioned in the statement tests streptomycin (ST) and neomycin (NEO) as analgesic agents in rat paw inflammation caused by formalin or carrageenan administration. There is no mention of hydrocortisone, insulin resistance, or any related conditions in this experiment. Therefore, it does not offer any relevant information to evaluate the claim about hydrocortisone predisposing insulin resistance."
7960726,Hydrocortisone predisposes pneumonia,489,[ON THE ACTION OF A NEOMYCIN AND THIOPENICOL PREPARATION IN EXPERIMENTAL BURNS].,False,"'Does the phrase ""Hydrocortisone predisposes pneumonia"" receive at least indirect support from the statement: ""[ON THE ACTION OF A NEOMYCIN AND THIOPENICOL PREPARATION IN EXPERIMENTAL BURNS].""?","No, the statement ""Hydrocortisone predisposes pneumonia"" does not receive indirect support from the provided statement about an experiment involving neomycin and thiophenicol in treating experimental burns. The two statements are unrelated as they discuss different substances (hydrocortisone vs neomycin and thiophenicol) and different medical conditions (pneumonia vs burns). To establish indirect support, there should be some connection between hydrocortisone use and pneumonia risk; however, no such connection can be inferred from the given context."
27228384,Methylprednisolone related to Crohn disease,490,"Therefore, we investigated the effect of long-term exposure of an antibiotic cocktail composed of Vancomycin, Neomycin, and Streptomycin, on tumor development and progression in the ApcMin/+ mouse, an established genetic model for familial adenomatous polyposis.",False,"'Does the phrase ""Methylprednisolone related to Crohn disease"" receive at least indirect support from the statement: ""Therefore, we investigated the effect of long-term exposure of an antibiotic cocktail composed of Vancomycin, Neomycin, and Streptomycin, on tumor development and progression in the ApcMin/+ mouse, an established genetic model for familial adenomatous polyposis.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to Crohn disease."" The statement discusses an investigation into the effect of long-term exposure of an antibiotic cocktail on tumor development and progression in a specific mouse model for familial adenomatous polyposis. Methylprednisolone is a corticosteroid commonly used to treat inflammatory conditions such as Crohn disease; however, it is not mentioned nor implied in the provided statement. Therefore, it is not possible to infer any connection between Methylprednisolone and Crohn disease based on this information alone."
26974005,Methylprednisolone related to hematopoietic and lymphoid system neoplasm,491,Ultrahigh doses of gentamicin and clinically relevant doses of neomycin affect inflammation and angiogenesis in in vivo and in vitro models.,False,"'Does the phrase ""Methylprednisolone related to hematopoietic and lymphoid system neoplasm"" receive at least indirect support from the statement: ""Ultrahigh doses of gentamicin and clinically relevant doses of neomycin affect inflammation and angiogenesis in in vivo and in vitro models.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to hematopoietic and lymphoid system neoplasm."" The statement discusses the effects of ultrahigh doses of gentamicin and clinically relevant doses of neomycin on inflammation and angiogenesis in in vivo and in vitro models. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects and is not mentioned in the statement. Furthermore, hematopoietic and lymphoid system neoplasms refer to cancers of the blood cells and lymphatic system, respectively, which is not addressed in the statement."
26513818,Methylprednisolone related to B-cell chronic lymphocytic leukemia,492,"Biodegradable polyaspartamide (PASPAM) was grafted with several functional groups to implement diverse roles-octadecylamine (C     18       ) for nano-aggregate formation, dopamine (DOPA) for adhesive function, neomycin (NEO) for inhibition of bacterial infection.",False,"'Does the phrase ""Methylprednisolone related to B-cell chronic lymphocytic leukemia"" receive at least indirect support from the statement: ""Biodegradable polyaspartamide (PASPAM) was grafted with several functional groups to implement diverse roles-octadecylamine (C     18       ) for nano-aggregate formation, dopamine (DOPA) for adhesive function, neomycin (NEO) for inhibition of bacterial infection.""?","No, there is no indirect support for the phrase ""Methylprednisolone related to B-cell chronic lymphocytic leukemia"" in the statement provided. The statement discusses the grafting of functional groups onto biodegradable polyaspartamide (PASPAM) for various roles, but it does not mention or imply any connection to methylprednisolone or B-cell chronic lymphocytic leukemia. Methylprednisolone is a corticosteroid often used to treat inflammation and allergies, while B-cell chronic lymphocytic leukemia is a type of cancer affecting white blood cells. The two subjects are unrelated in the context of the given statement."
26050805,Methylprednisolone related to ankylosing spondylitis,493,Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.,False,"'Does the phrase ""Methylprednisolone related to ankylosing spondylitis"" receive at least indirect support from the statement: ""Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.""?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to ankylosing spondylitis"" in the statement provided. The statement discusses Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice being inhibited by neomycin and neamine blocking angiogenin's nuclear translocation. There is no mention of Methylprednisolone or ankylosing spondylitis in the statement. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects in various conditions including ankylosing spondylitis, but the statement does not provide any information about it."
25845844,Methylprednisolone related to breast neoplasm,494,Neomycin and the combination of neomycin and bacitracin in the prevention of bacterial infection in surgery of the colon and/or rectum.,False,"'Does the phrase ""Methylprednisolone related to breast neoplasm"" receive at least indirect support from the statement: ""Neomycin and the combination of neomycin and bacitracin in the prevention of bacterial infection in surgery of the colon and/or rectum.""?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to breast neoplasm"" in the statement ""Neomycin and the combination of neomycin and bacitracin in the prevention of bacterial infection in surgery of the colon and/or rectum.""

        The statement primarily discusses the use of neomycin, alone or in combination with bacitracin, for preventing bacterial infections during colon or rectum surgery. It does not mention methylprednisolone nor breast neoplasm (a medical term for breast cancer). Therefore, it does not provide any basis for connecting methylprednisolone to breast neoplasm."
25642837,Methylprednisolone related to dermatomyositis,495,Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.,False,"'Does the phrase ""Methylprednisolone related to dermatomyositis"" receive at least indirect support from the statement: ""Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to dermatomyositis."" The statement discusses salvage therapy for pre-B acute lymphoblastic leukemia using mini-hyper-CVD, inotuzumab ozogamicin, and potentially blinatumomab. Dermatomyositis is an inflammatory disease that affects muscle strength and skin; it is not mentioned in the statement nor is it related through any implied context. Methylprednisolone is a corticosteroid used in various treatments including dermatomyositis but it is not mentioned in the statement either. Therefore, there is no indirect support for the connection between Methylprednisolone and dermatomyositis in this statement."
25328503,Methylprednisolone related to Meniere disease,496,"The impressive clinical success of the continuously intravenously infused T cell-redirecting bispecific antibody (T-bsAb) blinatumomab (anti-CD19 x anti-CD3), and of engineered T cells expressing anti-CD19 chimeric antigen receptors (CAR-T cells) in hematological malignancies, has led to renewed interest in a novel cancer immunotherapy strategy that combines features of antibody- and cell-based therapies.",False,"'Does the phrase ""Methylprednisolone related to Meniere disease"" receive at least indirect support from the statement: ""The impressive clinical success of the continuously intravenously infused T cell-redirecting bispecific antibody (T-bsAb) blinatumomab (anti-CD19 x anti-CD3), and of engineered T cells expressing anti-CD19 chimeric antigen receptors (CAR-T cells) in hematological malignancies, has led to renewed interest in a novel cancer immunotherapy strategy that combines features of antibody- and cell-based therapies.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to Meniere disease."" The statement discusses advancements in cancer immunotherapy strategies using T cell-redirecting bispecific antibodies (T-bsAb) and chimeric antigen receptor T cells (CAR-T cells) in hematological malignancies. There is no mention of Methylprednisolone nor Meniere disease in the statement, making it unrelated to the claim in question."
24759961,Methylprednisolone related to non-Hodgkin lymphoma,497,Blinatumomab and inotuzumab ozogamycin represent promising alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL).,False,"'Does the phrase ""Methylprednisolone related to non-Hodgkin lymphoma"" receive at least indirect support from the statement: ""Blinatumomab and inotuzumab ozogamycin represent promising alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to non-Hodgkin lymphoma."" The statement discusses Blinatumomab and Inotuzumab Ozogamycin as alternatives to conventional chemotherapy in acute lymphoblastic leukaemia (ALL). Methylprednisolone is not mentioned in the statement, nor is there any connection made between it and non-Hodgkin lymphoma. Therefore, there is no indirect support for the phrase in question based on the provided statement."
24691450,Methylprednisolone related to plantar fasciitis,498,Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.,False,"'Does the phrase ""Methylprednisolone related to plantar fasciitis"" receive at least indirect support from the statement: ""Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.""?","No, the statement ""Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis"" does not provide indirect support for the phrase ""Methylprednisolone related to plantar fasciitis."" This is because there is no mention of methylprednisolone in the statement, nor is there any reference made to plantar fasciitis. The two drugs mentioned in the statement (ciprofloxacin and dexamethasone) have no direct connection to methylprednisolone in terms of their therapeutic use or pharmacological properties. Dexamethasone is a corticosteroid like methylprednisolone but their effects on plantar fasciitis cannot be inferred from the statement provided as it relates to endophthalmitis treatment in an experimental setting."
24586108,Methylprednisolone related to alcoholic hepatitis,499,CONCLUSIONS: Combination therapy of adalimumab and ciprofloxacin is more effective than adalimumab monotherapy to achieve fistula closure in CD.,False,"'Does the phrase ""Methylprednisolone related to alcoholic hepatitis"" receive at least indirect support from the statement: ""CONCLUSIONS: Combination therapy of adalimumab and ciprofloxacin is more effective than adalimumab monotherapy to achieve fistula closure in CD.""?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to alcoholic hepatitis."" The conclusion in the statement is about the effectiveness of combination therapy (adalimumab and ciprofloxacin) versus adalimumab monotherapy in achieving fistula closure in Crohn's disease (CD). This has no relation to Methylprednisolone or alcoholic hepatitis."
24559507,Methylprednisolone related to respiratory system disorder,500,"Tested substances displayed inhibitory effect towards E. coli DNA gyrase, though less than ciprofloxacin.",False,"'Does the phrase ""Methylprednisolone related to respiratory system disorder"" receive at least indirect support from the statement: ""Tested substances displayed inhibitory effect towards E. coli DNA gyrase, though less than ciprofloxacin.""?","No, the statement ""Tested substances displayed inhibitory effect towards E. coli DNA gyrase, though less than ciprofloxacin"" does not provide indirect support for the phrase ""Methylprednisolone related to respiratory system disorder"". 

         The statement is about substances inhibiting E. coli DNA gyrase, an enzyme involved in DNA replication in bacteria like Escherichia coli. Methylprednisolone is a corticosteroid often used for its anti-inflammatory effects in various medical conditions but it is not typically associated with bacterial DNA gyrase inhibition. 

         Furthermore, respiratory system disorders can be caused by numerous factors including infections, allergies, autoimmune diseases, environmental factors, etc., none of which are directly addressed in the provided statement. Therefore, there is no implicit connection between methylprednisolone, E. coli DNA gyrase inhibition, and respiratory system disorders based on this information alone."
23573980,Methylprednisolone related to pneumonia,1,Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats.,False,"'Does the phrase ""Methylprednisolone related to pneumonia"" receive at least indirect support from the statement: ""Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats.""?","No, the statement ""Evaluation of granulated fenbendazole (22.2%) against induced and naturally occurring helminth infections in cats"" does not provide indirect support for the phrase ""Methylprednisolone related to pneumonia."" The statement discusses an evaluation of fenbendazole, an anthelmintic drug used for treating parasitic worm infections in animals, in cats with helminth infections. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects and is unrelated to fenbendazole or helminth infections in cats.

        While it is possible for corticosteroids like methylprednisolone to be associated with an increased risk of pneumonia due to their immunosuppressive effects, the current statement does not provide any information about methylprednisolone, pneumonia, or any related factors that would establish such a connection. Therefore, there is no indirect support for the relationship between methylprednisolone and pneumonia in this context."
23514846,Methylprednisolone related to carpal tunnel syndrome,2,Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%.,False,"'Does the phrase ""Methylprednisolone related to carpal tunnel syndrome"" receive at least indirect support from the statement: ""Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%.""?","No, the statement ""Fenbendazole resistance in O. ostertagi was confirmed with a total treatment failure in reducing worm burden: efficacy of 0%."" does not provide indirect support for the phrase ""Methylprednisolone related to carpal tunnel syndrome."" 

         The statement discusses Fenbendazole resistance in O. ostertagi, which is an issue related to veterinary parasitology, specifically gastrointestinal nematodes in cattle. Methylprednisolone is a corticosteroid used primarily in human medicine for its anti-inflammatory effects in various conditions such as allergies, arthritis, asthma, and autoimmune diseases. Carpal tunnel syndrome is a peripheral entrapment neuropathy characterized by pressure on the median nerve at the wrist, leading to numbness, tingling, weakness, or muscle atrophy in the hand and fingers.

         While both Methylprednisolone and carpal tunnel syndrome involve human medicine, there is no connection between Fenbendazole resistance in O. ostertagi and Methylprednisolone usage related to carpal"
23364897,Methylprednisolone related to West syndrome,3,Symptoms of perianal itching and visualization of visible motile worms persisted for 6 months despite being treated with multiple courses of albendazole causing a lot of frustration and distress to the caregivers.,False,"'Does the phrase ""Methylprednisolone related to West syndrome"" receive at least indirect support from the statement: ""Symptoms of perianal itching and visualization of visible motile worms persisted for 6 months despite being treated with multiple courses of albendazole causing a lot of frustration and distress to the caregivers.""?","No, the statement does not provide direct or indirect support for the phrase ""Methylprednisolone related to West syndrome."" The statement discusses a patient's experience with perianal itching and visible motile worms that persisted for 6 months despite multiple courses of albendazole treatment. West syndrome is an epileptic disorder characterized by infantile spasms, developmental delay, and a specific EEG pattern called hypsarrhythmia. Methylprednisolone is sometimes used as a treatment for West syndrome, but there is no mention of West syndrome or epileptic symptoms in the provided statement. Therefore, it does not support the connection between Methylprednisolone and West syndrome."
22495910,Methylprednisolone related to myocarditis,4,"Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis.",False,"'Does the phrase ""Methylprednisolone related to myocarditis"" receive at least indirect support from the statement: ""Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis.""?","No, the statement ""Ovicidal effects of albendazole in human ascariasis, ancylostomiasis and trichuriasis"" does not provide indirect support for the phrase ""Methylprednisolone related to myocarditis"". 

         The statement is about the ovicidal effects of albendazole, a medication used to treat certain types of intestinal worm infections in humans. This has no direct or indirect relation to methylprednisolone, which is a corticosteroid used to suppress inflammation in various conditions such as allergic reactions, arthritis, asthma, and autoimmune diseases. Myocarditis, an inflammation of the heart muscle, is not known to be directly related to methylprednisolone use. Therefore, there is no connection between the two statements."
22175056,Methylprednisolone related to myopathy,5,"A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF).",False,"'Does the phrase ""Methylprednisolone related to myopathy"" receive at least indirect support from the statement: ""A combination of drugs Ivermectin, Diethylcarbamazine citrate and Albendazole is recommended by WHO to accelerate the Global Programme to Eliminate Lymphatic Filariasis (GPELF).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to myopathy"". The two statements discuss different topics - one is about a combination of drugs recommended by WHO for eliminating lymphatic filariasis (Ivermectin, Diethylcarbamazine citrate and Albendazole), while the other mentions Methylprednisolone which is a corticosteroid used to treat various conditions such as inflammation and allergies but is not part of the recommended combination by WHO for eliminating lymphatic filariasis. Myopathy can be a side effect of long-term use of corticosteroids like Methylprednisolone but it is not explicitly mentioned in the provided statement. Hence, there is no indirect support for ""Methylprednisolone related to myopathy""."
20879022,Methylprednisolone related to Pain,6,Effect of albendazole in experimental toxocariasis of mice.,False,"'Does the phrase ""Methylprednisolone related to Pain"" receive at least indirect support from the statement: ""Effect of albendazole in experimental toxocariasis of mice.""?","No, the statement ""Effect of albendazole in experimental toxocariasis of mice"" does not provide indirect support for the phrase ""Methylprednisolone related to Pain"". 

        The statement is about an experimental study in mice infected with Toxocara canis (a roundworm) and the effects of albendazole, an antihelmintic drug used to treat parasitic worm infections. It does not mention methylprednisolone, which is a corticosteroid used to suppress inflammation and immune response, nor does it discuss pain. Therefore, there is no logical connection or supportive evidence between these two phrases."
20342058,Methylprednisolone related to chronic progressive multiple sclerosis,7,"Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.",False,"'Does the phrase ""Methylprednisolone related to chronic progressive multiple sclerosis"" receive at least indirect support from the statement: ""Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.""?","No, there is no direct or indirect support for the phrase ""Methylprednisolone related to chronic progressive multiple sclerosis"" in the statement ""Given the low helminth prevalence in our children, the effect of albendazole on malaria is likely to be direct.""

        The statement provided discusses the relationship between helminth prevalence in children and the direct effect of albendazole on malaria. Methylprednisolone is an unrelated corticosteroid medication commonly used for its anti-inflammatory effects in various diseases such as asthma, rheumatoid arthritis, and multiple sclerosis (MS) flares.

        The connection between methylprednisolone and chronic progressive multiple sclerosis is not addressed in any way in the provided statement; therefore, it does not offer any indirect support for such a claim. In addition, chronic progressive multiple sclerosis is not typically treated with methylprednisolone since it is more of an acute intervention for MS relapses rather than a treatment for chronic progressive forms of MS.

        To establish any relationship between meth"
20290784,Methylprednisolone related to membranous glomerulonephritis,8,"Mass co-administration of ivermectin and albendazole by the LFEP had a significant effect on STH, which was further amplified by treatment with praziquantel and albendazole 4 months later.",False,"'Does the phrase ""Methylprednisolone related to membranous glomerulonephritis"" receive at least indirect support from the statement: ""Mass co-administration of ivermectin and albendazole by the LFEP had a significant effect on STH, which was further amplified by treatment with praziquantel and albendazole 4 months later.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to membranous glomerulonephritis."" The statement discusses the effects of ivermectin, albendazole, and praziquantel on Strongyloides stercoralis (STH), but it does not mention methylprednisolone or membranous glomerulonephritis at all. Therefore, there is no basis for inferring any relationship between these concepts from the given statement."
20286711,Methylprednisolone related to neuromyelitis optica,9,The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.,False,"'Does the phrase ""Methylprednisolone related to neuromyelitis optica"" receive at least indirect support from the statement: ""The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to neuromyelitis optica"". 

         The statement discusses a study on the effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania. This study is not related to Methylprednisolone or neuromyelitis optica in any way. 

         Methylprednisolone is a corticosteroid used to treat various conditions such as inflammation and allergies, while neuromyelitis optica is an autoimmune disease affecting the optic nerve and spinal cord. The study mentioned focuses on filariasis, which is an infectious tropical disease caused by parasitic worms of the Filarioidea type. 

         Therefore, there is no connection between these two pieces of information, making it impossible for the statement to indirectly support the phrase ""Methylprednisolone related to neuromyelitis optica""."
19340184,Methylprednisolone related to chronic obstructive pulmonary disease,10,"Additionally, compared with albendazole, it resulted in a significant reduction in adult worm and total larval counts; moreover, it caused a decrease in the number of larvae deposited in muscles, with a highly significant decrease in the inflammatory cell infiltrate around the larvae and a considerable decrease in the expression of the angiogenic marker vascular endothelial growth factor in muscles.",False,"'Does the phrase ""Methylprednisolone related to chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""Additionally, compared with albendazole, it resulted in a significant reduction in adult worm and total larval counts; moreover, it caused a decrease in the number of larvae deposited in muscles, with a highly significant decrease in the inflammatory cell infiltrate around the larvae and a considerable decrease in the expression of the angiogenic marker vascular endothelial growth factor in muscles.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to chronic obstructive pulmonary disease"". The statement discusses the effects of Methylprednisolone on adult worms, total larval counts, larvae deposited in muscles, inflammatory cell infiltrate around larvae, and vascular endothelial growth factor expression in muscles—none of which relate directly to chronic obstructive pulmonary disease (COPD). While Methylprednisolone is indeed a corticosteroid used in treating inflammatory diseases such as COPD, the provided statement does not offer any evidence connecting Methylprednisolone specifically to COPD in any way."
18938435,Methylprednisolone related to graft versus host disease,11,"Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73-0.98), p = 0.03).",False,"'Does the phrase ""Methylprednisolone related to graft versus host disease"" receive at least indirect support from the statement: ""Quarterly albendazole during childhood was associated with reduced incidence of clinical malaria (HR 0.85 (95% CI 0.73-0.98), p = 0.03).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to graft versus host disease"". 

        The statement discusses the association between quarterly albendazole during childhood and reduced incidence of clinical malaria. This has no direct or indirect relation to methylprednisolone or graft versus host disease. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects, and graft versus host disease is a condition that occurs when transplanted tissue (graft) attacks the recipient's body (host). These concepts are distinct from the drugs and conditions mentioned in the statement. Therefore, it does not offer any support for the stated phrase."
17333962,Methylprednisolone related to Inflammation,12,CONCLUSIONS: Mebendazole and albendazole showed reduced efficacy against Ascaris lumbricoides and hookworm infections at the recommended doses.,False,"'Does the phrase ""Methylprednisolone related to Inflammation"" receive at least indirect support from the statement: ""CONCLUSIONS: Mebendazole and albendazole showed reduced efficacy against Ascaris lumbricoides and hookworm infections at the recommended doses.""?","No, the statement does not provide indirect support for ""Methylprednisolone related to Inflammation."" The conclusion is about the reduced efficacy of two drugs, Mebendazole and Albendazole, against certain parasitic infections. It does not mention Methylprednisolone nor inflammation. Methylprednisolone is a corticosteroid often used to reduce inflammation, but there is no connection made in this statement."
17288506,Methylprednisolone related to autoimmune thrombocytopenic purpura,13,Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.,False,"'Does the phrase ""Methylprednisolone related to autoimmune thrombocytopenic purpura"" receive at least indirect support from the statement: ""Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to autoimmune thrombocytopenic purpura."" The statement is an evaluation of the effectiveness of a drug combination (diethylcarbamazine/albendazole) in reducing Wuchereria bancrofti infection using multiple infection parameters. This topic is unrelated to Methylprednisolone and autoimmune thrombocytopenic purpura. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects in various conditions, while autoimmune thrombocytopenic purpura is a disorder in which the immune system mistakenly attacks and destroys platelets, which are necessary for normal blood clotting. Therefore, there is no connection between these two distinct areas of medical research."
15936572,Methylprednisolone related to endocrine exophthalmos,14,"Our evaluation suggests that although additional studies are needed to determine optimal treatment regimens for intestinal parasites, especially among young children and pregnant women, a five-day course of pre-departure albendazole was effective in reducing helminthic infection in treated refugees.",False,"'Does the phrase ""Methylprednisolone related to endocrine exophthalmos"" receive at least indirect support from the statement: ""Our evaluation suggests that although additional studies are needed to determine optimal treatment regimens for intestinal parasites, especially among young children and pregnant women, a five-day course of pre-departure albendazole was effective in reducing helminthic infection in treated refugees.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to endocrine exophthalmos"". 

         The statement is about a study evaluating the effectiveness of pre-departure albendazole treatment in reducing helminthic infection in refugees. It does not mention methylprednisolone, endocrine exophthalmos, or any related concepts. Therefore, it does not offer any form of support for the stated phrase. 

         Endocrine exophthalmos is often associated with Graves' disease, an autoimmune disorder that can cause bulging eyes due to inflammation of the eye muscles and fatty tissue behind the eyes. Methylprednisolone is a corticosteroid that can be used to treat inflammation in various conditions, including endocrine exophthalmos. However, the statement provided does not discuss these topics, so it cannot provide indirect support for the stated phrase."
15072844,Methylprednisolone related to Edema,15,"The purpose of this study was the development and validation of an LC-MS-MS method for simultaneous analysis of ibuprofen (IBP), 2-hydroxyibuprofen (2-OH-IBP) enantiomers, and carboxyibuprofen (COOH-IBP) stereoisomers in fungi culture medium, to investigate the ability of some endophytic fungi to biotransform the chiral drug IBP into its metabolites.",False,"'Does the phrase ""Methylprednisolone related to Edema"" receive at least indirect support from the statement: ""The purpose of this study was the development and validation of an LC-MS-MS method for simultaneous analysis of ibuprofen (IBP), 2-hydroxyibuprofen (2-OH-IBP) enantiomers, and carboxyibuprofen (COOH-IBP) stereoisomers in fungi culture medium, to investigate the ability of some endophytic fungi to biotransform the chiral drug IBP into its metabolites.""?","No, the statement ""Methylprednisolone related to Edema"" does not receive indirect support from the provided study. The purpose of the study is focused on developing an LC-MS-MS method for simultaneous analysis of ibuprofen (IBP), 2-hydroxyibuprofen (2-OH-IBP) enantiomers, and carboxyibuprofen (COOH-IBP) stereoisomers in fungi culture medium. This study does not involve methylprednisolone nor edema; hence it does not provide any indirect support for the statement ""Methylprednisolone related to Edema."""
14876749,Methylprednisolone related to osteoarthritis,16,"AIMS: To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia.",False,"'Does the phrase ""Methylprednisolone related to osteoarthritis"" receive at least indirect support from the statement: ""AIMS: To carry out a randomized clinical trial to compare the effect of palmitoylethanolamide (PEA) versus ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), for pain relief in temporomandibular joint (TMJ) osteoarthritis or arthralgia.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to osteoarthritis"". The statement describes a randomized clinical trial comparing the effect of PEA versus ibuprofen (an NSAID) for pain relief in TMJ osteoarthritis or arthralgia. Methylprednisolone is not mentioned in the statement, nor is any information provided that could imply its relation to osteoarthritis. Methylprednisolone is a corticosteroid commonly used to reduce inflammation and suppress the immune system in various conditions but is not directly related to osteoarthritis based on this statement alone."
14399082,Methylprednisolone related to aplastic anemia,17,"We investigated the analgesic efficacy of single doses of ibuprofen, tramadol and pregabalin in menthol-evoked cold pain in a randomized, placebo-controlled four-way cross-over study in 20 healthy volunteers.",False,"'Does the phrase ""Methylprednisolone related to aplastic anemia"" receive at least indirect support from the statement: ""We investigated the analgesic efficacy of single doses of ibuprofen, tramadol and pregabalin in menthol-evoked cold pain in a randomized, placebo-controlled four-way cross-over study in 20 healthy volunteers.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to aplastic anemia."" The study investigates the analgesic efficacy of single doses of ibuprofen, tramadol, and pregabalin in menthol-evoked cold pain in a randomized, placebo-controlled four-way cross-over study in 20 healthy volunteers. Methylprednisolone is not mentioned in the study, nor is there any discussion of aplastic anemia. Therefore, it is not possible to draw any conclusions about methylprednisolone's relationship to aplastic anemia based on this statement alone."
14398237,Methylprednisolone related to IgA glomerulonephritis,18,Double blind study on emorfazone and ibuprofen in dental pain and inflammation.,False,"'Does the phrase ""Methylprednisolone related to IgA glomerulonephritis"" receive at least indirect support from the statement: ""Double blind study on emorfazone and ibuprofen in dental pain and inflammation.""?","No, the statement ""Methylprednisolone related to IgA glomerulonephritis"" does not receive any direct or indirect support from the study on emorfazone and ibuprofen in dental pain and inflammation. The two statements discuss different topics - one is about the use of methylprednisolone in IgA glomerulonephritis (a kidney disease), while the other is about the comparison of two drugs in dental pain and inflammation. Therefore, there is no relevant connection between them based on the provided information."
14278238,"Methylprednisolone related to dermatitis, atopic",19,Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.,False,"'Does the phrase ""Methylprednisolone related to dermatitis, atopic"" receive at least indirect support from the statement: ""Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee.""?","No, the statement ""Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee"" does not provide indirect support for the phrase ""Methylprednisolone related to dermatitis, atopic"". 

        The two statements discuss different medical conditions and treatments. The first statement compares the effects of Glucosamine sulfate and Ibuprofen on osteoarthritis of the knee, while the second phrase suggests a relationship between Methylprednisolone and atopic dermatitis. 

        The lack of overlap in medical conditions (osteoarthritis vs atopic dermatitis) and treatments (Glucosamine sulfate/Ibuprofen vs Methylprednisolone) precludes any indirect support from the first statement for the second phrase."
14166179,Methylprednisolone related to cardiac arrest,20,INTRODUCTION: The anti-inflammatory and anticoagulant effects of ibuprofen and heparin may enhance skin perfusion in cutaneous scald burns.,False,"'Does the phrase ""Methylprednisolone related to cardiac arrest"" receive at least indirect support from the statement: ""INTRODUCTION: The anti-inflammatory and anticoagulant effects of ibuprofen and heparin may enhance skin perfusion in cutaneous scald burns.""?","No, the phrase ""Methylprednisolone related to cardiac arrest"" does not receive indirect support from the statement provided. The introduction statement discusses the potential benefits of ibuprofen and heparin in enhancing skin perfusion in cutaneous scald burns, focusing on their anti-inflammatory and anticoagulant effects. Methylprednisolone is not mentioned in this statement, nor is there any implicit connection that could be inferred between methylprednisolone use and cardiac arrest based on this information alone."
12755316,Methylprednisolone related to plasma cell myeloma,21,"CONCLUSIONS: Ibuprofen-induced patent ductus arteriosus closure improved pulmonary mechanics, decreased total lung water, increased epithelial sodium channel expression, and decreased the detrimental effects of preterm birth on alveolarization.",False,"'Does the phrase ""Methylprednisolone related to plasma cell myeloma"" receive at least indirect support from the statement: ""CONCLUSIONS: Ibuprofen-induced patent ductus arteriosus closure improved pulmonary mechanics, decreased total lung water, increased epithelial sodium channel expression, and decreased the detrimental effects of preterm birth on alveolarization.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to plasma cell myeloma."" 

         The conclusion drawn in the statement is about the effects of Ibuprofen on patent ductus arteriosus closure, pulmonary mechanics, total lung water, epithelial sodium channel expression, and alveolarization in preterm births. There is no mention of Methylprednisolone or plasma cell myeloma in the statement. Therefore, it does not provide any support, direct or indirect, for the stated phrase. 

         Plasma cell myeloma is a type of cancer where malignant plasma cells accumulate in the bone marrow, leading to bone destruction and bone marrow failure. Methylprednisolone is a corticosteroid often used in the treatment of various conditions due to its anti-inflammatory and immunosuppressive effects. There is no clear connection between these two concepts based on the provided statement. 

         It is crucial to ensure that conclusions drawn from scientific statements are based on relevant evidence directly related to the topic at hand. Misinterpretation can lead to misunder"
12183687,Methylprednisolone related to acute lymphoblastic leukemia,22,Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.,False,"'Does the phrase ""Methylprednisolone related to acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease.""?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone related to acute lymphoblastic leukemia"". The statement discusses the protein profile in neuroblastoma cells incubated with S-and R-enantiomers of ibuprofen, and potential actions of induced proteins on Alzheimer's disease. This statement is not related to Methylprednisolone or acute lymphoblastic leukemia in any way. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects, while acute lymphoblastic leukemia is a type of cancer of the white blood cells. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID), neuroblastoma is a type of cancer that forms in nerve tissue, and Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. These topics are distinct from each other and there is no connection established in the provided statement."
11720471,Methylprednisolone related to systemic lupus erythematosus,23,Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.,False,"'Does the phrase ""Methylprednisolone related to systemic lupus erythematosus"" receive at least indirect support from the statement: ""Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats.""?","No, the statement ""Protective effect of glucosamine against ibuprofen-induced peptic ulcer in rats"" does not provide indirect support for the phrase ""Methylprednisolone related to systemic lupus erythematosus"". 

        The statement pertains to the protective effect of glucosamine against ibuprofen-induced peptic ulcers in rats. This has no direct or indirect relation to methylprednisolone or systemic lupus erythematosus (SLE). Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in conditions such as asthma, rheumatoid arthritis, and SLE. The protective effect of glucosamine against ibuprofen-induced peptic ulcers in rats does not imply any connection or relationship between methylprednisolone and SLE. 

        It is essential to evaluate scientific claims based on their direct relevance and logical connections. In this case, the two statements do not share a common theme or finding that would allow for indirect support to be"
10812685,Methylprednisolone related to immunoglobulin a vasculitis,24,Ibuprofen-induced fever in Sjogren's syndrome.,False,"'Does the phrase ""Methylprednisolone related to immunoglobulin a vasculitis"" receive at least indirect support from the statement: ""Ibuprofen-induced fever in Sjogren's syndrome.""?","No, the statement ""Ibuprofen-induced fever in Sjogren's syndrome"" does not provide indirect support for the phrase ""Methylprednisolone related to immunoglobulin A vasculitis."" 

        The two statements discuss different medical conditions and treatments. The first statement refers to a fever induced by Ibuprofen in Sjogren's syndrome, which is an autoimmune disorder characterized by dry eyes and mouth. The second phrase refers to Methylprednisolone, a corticosteroid used often in treating immunoglobulin A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, an autoimmune condition that causes inflammation in small blood vessels.

        Although both statements discuss autoimmune disorders and treatments, they do not share any direct correlation in terms of underlying mechanisms, triggers, or therapeutic interventions. The lack of commonality in pathophysiology between Sjogren's syndrome and IgAV further weakens any potential indirect link between Ibuprofen-induced fever in Sjogren's syndrome"
10763477,Methylprednisolone related to ulcerative colitis,25,There have been no prior definite cases reported of ibuprofen-induced pancreatitis.,False,"'Does the phrase ""Methylprednisolone related to ulcerative colitis"" receive at least indirect support from the statement: ""There have been no prior definite cases reported of ibuprofen-induced pancreatitis.""?","No, the statement ""There have been no prior definite cases reported of ibuprofen-induced pancreatitis"" does not provide indirect support for the phrase ""Methylprednisolone related to ulcerative colitis."" 

        The two statements discuss different drugs (ibuprofen and methylprednisolone) and different medical conditions (pancreatitis and ulcerative colitis). Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) while methylprednisolone is a corticosteroid; they have different mechanisms of action in the body.

        The lack of reported ibuprofen-induced pancreatitis cases does not imply that methylprednisolone has any connection to ulcerative colitis. Ulcerative colitis is an inflammatory bowel disease (IBD) that affects the colon and rectum lining; methylprednisolone is often used as an anti-inflammatory agent in treating IBD due to its ability to reduce inflammation in the gut.

        Therefore, more specific evidence connecting methylprednisolone"
10558884,Methylprednisolone related to lupus nephritis,26,"RESULTS: None of the studies established any of the COX-2 inhibitors as clearly better than ibuprofen, the current gold standard for the treatment of surgically induced dental pain.",False,"'Does the phrase ""Methylprednisolone related to lupus nephritis"" receive at least indirect support from the statement: ""RESULTS: None of the studies established any of the COX-2 inhibitors as clearly better than ibuprofen, the current gold standard for the treatment of surgically induced dental pain.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to lupus nephritis"". The provided result is about COX-2 inhibitors and their efficacy in treating surgically induced dental pain compared to ibuprofen. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various conditions, such as lupus nephritis flares. The two statements discuss different subjects – one being COX-2 inhibitors in dental pain management and the other being Methylprednisolone in lupus nephritis management – thus they do not provide indirect support for each other."
10130342,Methylprednisolone related to adult acute respiratory distress syndrome,27,Noncardiogenic pulmonary edema due to ibuprofen.,False,"'Does the phrase ""Methylprednisolone related to adult acute respiratory distress syndrome"" receive at least indirect support from the statement: ""Noncardiogenic pulmonary edema due to ibuprofen.""?","No, the statement ""Noncardiogenic pulmonary edema due to ibuprofen"" does not provide indirect support for the phrase ""Methylprednisolone related to adult acute respiratory distress syndrome."" 

        The two statements discuss different drugs and their respective effects on lung conditions. Ibuprofen is associated with noncardiogenic pulmonary edema, while methylprednisolone is not mentioned in this context at all. Methylprednisolone is a corticosteroid often used in treating various conditions such as inflammation, allergies, and autoimmune disorders; it has not been directly linked to adult acute respiratory distress syndrome in the provided statement.

        To establish indirect support between these statements, there should be some connection between ibuprofen-induced pulmonary edema and methylprednisolone-induced adult acute respiratory distress syndrome; however, no such connection is evident in these statements."
9229208,Methylprednisolone related to vestibular neuronitis,28,"In a double-blind cross-over study on 22 healthy subjects the analgesic efficacies of the antipyretic analgesic drugs ibuprofen, dipyrone and paracetamol were tested against placebo using a model of experimentally induced pain.",False,"'Does the phrase ""Methylprednisolone related to vestibular neuronitis"" receive at least indirect support from the statement: ""In a double-blind cross-over study on 22 healthy subjects the analgesic efficacies of the antipyretic analgesic drugs ibuprofen, dipyrone and paracetamol were tested against placebo using a model of experimentally induced pain.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to vestibular neuronitis"". The study mentioned in the statement investigates the analgesic efficacies of ibuprofen, dipyrone, paracetamol, and placebo in healthy subjects using an experimentally induced pain model. Methylprednisolone is not mentioned in the study, nor is there any connection made between methylprednisolone and vestibular neuronitis. To establish indirect support for the phrase ""Methylprednisolone related to vestibular neuronitis"", there should be some link between methylprednisolone and either vestibular neuronitis or pain management in general. Since no such link is present in the statement provided, it does not offer indirect support for the phrase in question."
9003326,Methylprednisolone related to systemic sclerosis,29,Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide.,False,"'Does the phrase ""Methylprednisolone related to systemic sclerosis"" receive at least indirect support from the statement: ""Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide.""?","No, the statement ""Unaltered ibuprofen-induced faecal blood loss upon coadministration of moclobemide"" does not provide indirect support for the phrase ""Methylprednisolone related to systemic sclerosis"". 

        The statement pertains to a study involving ibuprofen, faecal blood loss, and moclobemide. It does not mention methylprednisolone or systemic sclerosis. Methylprednisolone is a corticosteroid used to suppress inflammation in various conditions including systemic sclerosis, but it is not mentioned in the provided statement. Therefore, there is no connection between the two phrases in terms of their subject matter. 

        Furthermore, even if methylprednisolone was mentioned in the statement, it would still not provide indirect support without additional context linking it to systemic sclerosis. The relationship between methylprednisolone and systemic sclerosis is complex and not necessarily implied by coadministration of other drugs. Therefore, without explicit mention of both methylprednisolone and systemic sclerosis"
8447481,Methylprednisolone related to rheumatoid arthritis,30,The C5a antagonist (1 or 3 mg/kg/day) and/or ibuprofen (30 mg/kg/day) were administered orally on a daily basis either before or after arthritis induction.,False,"'Does the phrase ""Methylprednisolone related to rheumatoid arthritis"" receive at least indirect support from the statement: ""The C5a antagonist (1 or 3 mg/kg/day) and/or ibuprofen (30 mg/kg/day) were administered orally on a daily basis either before or after arthritis induction.""?","No, the phrase ""Methylprednisolone related to rheumatoid arthritis"" does not receive indirect support from the statement provided. The statement discusses the administration of C5a antagonist (1 or 3 mg/kg/day) and/or ibuprofen (30 mg/kg/day) before or after arthritis induction but does not mention Methylprednisolone at all. Methylprednisolone is a type of corticosteroid used for treating various conditions such as rheumatoid arthritis; however, it is not mentioned in the statement provided. Therefore, there is no indirect support for the connection between Methylprednisolone and rheumatoid arthritis from the given statement."
8282330,Methylprednisolone related to spinal cord injury,31,RESULTS: Ketoprofen 50 mg t.d.s. suppressed prostaglandin synthesis to a significantly greater extent than ibuprofen and caused significantly more gastroduodenal injury.,False,"'Does the phrase ""Methylprednisolone related to spinal cord injury"" receive at least indirect support from the statement: ""RESULTS: Ketoprofen 50 mg t.d.s. suppressed prostaglandin synthesis to a significantly greater extent than ibuprofen and caused significantly more gastroduodenal injury.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to spinal cord injury"". 

        The statement discusses the results of a comparison between two non-steroidal anti-inflammatory drugs (NSAIDs), ketoprofen and ibuprofen, in terms of their effects on prostaglandin synthesis and gastroduodenal injury. Methylprednisolone is a corticosteroid and is not mentioned in the statement. 

        Corticosteroids like methylprednisolone are often used in spinal cord injury cases due to their anti-inflammatory effects, but the statement provided does not contain any information about methylprednisolone or its relation to spinal cord injury. Therefore, it does not indirectly support the phrase in question."
7944646,Methylprednisolone related to myasthenia gravis,32,The duration of action of sustained-release ibuprofen ('Brufen Retard') was investigated in a 14-day double-blind study involving 14 osteoarthritis and 10 rheumatoid arthritis patients.,False,"'Does the phrase ""Methylprednisolone related to myasthenia gravis"" receive at least indirect support from the statement: ""The duration of action of sustained-release ibuprofen ('Brufen Retard') was investigated in a 14-day double-blind study involving 14 osteoarthritis and 10 rheumatoid arthritis patients.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to myasthenia gravis."" The study mentioned in the statement investigates the duration of action of sustained-release ibuprofen (Brufen Retard) in osteoarthritis and rheumatoid arthritis patients. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects in various conditions, while myasthenia gravis is an autoimmune neuromuscular disorder affecting the nervous system. There is no connection between methylprednisolone, myasthenia gravis, and the study on ibuprofen's duration of action."
7668599,Methylprednisolone related to multiple sclerosis,33,This study attempts to investigate the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis.,False,"'Does the phrase ""Methylprednisolone related to multiple sclerosis"" receive at least indirect support from the statement: ""This study attempts to investigate the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to multiple sclerosis"". The study mentioned investigates the effect of ibuprofen on reducing eye pain and migraine headaches caused by trochleitis. Methylprednisolone is not mentioned in the statement, nor is there any connection made to multiple sclerosis. Therefore, it is not possible to draw such a conclusion from this information alone."
7443745,Methylprednisolone related to asthma,34,"Ibuprofen suppresses the production of various pro-inflammatory cytokines that are implicated in the ""cytokine storm"" and subsequent ARDS in COVID-19 disease.",False,"'Does the phrase ""Methylprednisolone related to asthma"" receive at least indirect support from the statement: ""Ibuprofen suppresses the production of various pro-inflammatory cytokines that are implicated in the ""cytokine storm"" and subsequent ARDS in COVID-19 disease.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone related to asthma"". The two statements discuss different medications (Ibuprofen vs Methylprednisolone) and different medical conditions (COVID-19 vs asthma). Ibuprofen's effect on cytokine production in COVID-19 does not imply any connection to Methylprednisolone's potential relation to asthma."
24973247,Methylprednisolone causes lupus nephritis,35,"After adjusting for covariates, the risk of BPD was associated independently with ibuprofen exposure (odds ratios (OR) 2.296, 95% confidence interval (CI): 1.166-4.522, p = 0.016).",False,"'Does the phrase ""Methylprednisolone causes lupus nephritis"" receive at least indirect support from the statement: ""After adjusting for covariates, the risk of BPD was associated independently with ibuprofen exposure (odds ratios (OR) 2.296, 95% confidence interval (CI): 1.166-4.522, p = 0.016).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes lupus nephritis"". The statement discusses the association between ibuprofen exposure and bronchopulmonary dysplasia (BPD) risk in preterm infants. Methylprednisolone is not mentioned in this statement, nor is there any connection made between ibuprofen exposure, BPD risk, methylprednisolone use, and lupus nephritis development in the provided information. Therefore, it is inappropriate to draw such conclusions based on this statement alone without additional context or evidence linking these variables together."
24161886,Methylprednisolone causes Edema,36,The opposite effect of ibuprofen on ethanol-induced cognitive impairment as measured by two lateralized functions is consistent with the reports in tissue and animal models that central nervous system effects of ethanol may be mediated at least in part by prostaglandins.,False,"'Does the phrase ""Methylprednisolone causes Edema"" receive at least indirect support from the statement: ""The opposite effect of ibuprofen on ethanol-induced cognitive impairment as measured by two lateralized functions is consistent with the reports in tissue and animal models that central nervous system effects of ethanol may be mediated at least in part by prostaglandins.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes Edema"". 

        The statement discusses the opposite effect of ibuprofen on ethanol-induced cognitive impairment and mentions that central nervous system effects of ethanol may be mediated by prostaglandins. Methylprednisolone is a corticosteroid drug used for its anti-inflammatory and immunosuppressive effects, while ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). 

        Edema is swelling caused by excess fluid trapped in your body's tissues. Although both methylprednisolone and ibuprofen can have effects on inflammation, they have different mechanisms of action. Methylprednisolone reduces inflammation by suppressing the immune system, while ibuprofen inhibits cyclooxygenase (COX) enzymes, which produce prostaglandins—lipid compounds that trigger inflammation in response to injury or infection.

        The connection between methylprednisolone and ed"
18534953,Methylprednisolone causes Inflammation,37,"On post-partum day five, she began complaining of headaches, initially responsive to ibuprofen but eventually worsened with no relief.",False,"'Does the phrase ""Methylprednisolone causes Inflammation"" receive at least indirect support from the statement: ""On post-partum day five, she began complaining of headaches, initially responsive to ibuprofen but eventually worsened with no relief.""?","No, the phrase ""Methylprednisolone causes Inflammation"" does not receive at least indirect support from the statement provided. The statement discusses a patient who developed headaches on post-partum day five, which were initially responsive to ibuprofen but later worsened without relief. The use of methylprednisolone is not mentioned in the statement, nor is there any indication that inflammation was present or caused by any specific agent. Therefore, it is not possible to infer any relationship between methylprednisolone use and inflammation from this statement alone."
18260665,Methylprednisolone causes neoplasm,38,"Because ibuprofen protects from septic lung injury, we studied the effect of ibuprofen in oxidant lung injury from phosgene.",False,"'Does the phrase ""Methylprednisolone causes neoplasm"" receive at least indirect support from the statement: ""Because ibuprofen protects from septic lung injury, we studied the effect of ibuprofen in oxidant lung injury from phosgene.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes neoplasm."" The two statements discuss different drugs (ibuprofen and methylprednisolone) and different conditions (septic lung injury from bacterial infection versus neoplasm, which is abnormal growth of cells in the body that can lead to cancer). Therefore, there is no logical connection between them that would allow us to infer a causal relationship between methylprednisolone and neoplasm based on the provided statement about ibuprofen and lung injury from phosgene exposure."
17307095,Methylprednisolone causes pneumonia,39,The efficacy and tolerance of ibuprofen retard at a dose of 2 x 800 mg daily was investigated in an open multicenter study over a period of 3 weeks on 7931 out-patients with activated degenerative joint disease and/or extraarticular rheumatic symptoms.,False,"'Does the phrase ""Methylprednisolone causes pneumonia"" receive at least indirect support from the statement: ""The efficacy and tolerance of ibuprofen retard at a dose of 2 x 800 mg daily was investigated in an open multicenter study over a period of 3 weeks on 7931 out-patients with activated degenerative joint disease and/or extraarticular rheumatic symptoms.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes pneumonia."" The statement discusses a study investigating the efficacy and tolerance of ibuprofen at specific doses in out-patients with activated degenerative joint disease and/or extraarticular rheumatic symptoms over three weeks. It does not mention Methylprednisolone nor pneumonia; therefore, it does not contribute any relevant evidence towards that claim."
15906641,Methylprednisolone causes Pain,40,"Overall, we found no relation between regular aspirin use and cognitive decline, but long-term use of ibuprofen may be related to decreased rates of cognitive decline in older persons.",False,"'Does the phrase ""Methylprednisolone causes Pain"" receive at least indirect support from the statement: ""Overall, we found no relation between regular aspirin use and cognitive decline, but long-term use of ibuprofen may be related to decreased rates of cognitive decline in older persons.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes Pain"". The statement discusses the relationship between regular aspirin use, ibuprofen use, and cognitive decline in older persons, without mentioning methylprednisolone or pain at all. Methylprednisolone is a corticosteroid medication used primarily for its anti-inflammatory effects in various conditions such as arthritis, asthma, blood disorders, allergic reactions, and certain skin disorders. Pain is not explicitly mentioned in either the claim or the statement provided. Therefore, there is no basis for drawing any connection between them based on the information given."
13166073,Methylprednisolone causes thrombocytopenia,41,"Subdiaphragmatic vagotomy or 7-nitroindazole reduced, icatibant, DALBK, IL-1ra, aminoguanidine and dipyrone abolished, while ibuprofen and celecoxib failed to affect Tsv-induced fever.",False,"'Does the phrase ""Methylprednisolone causes thrombocytopenia"" receive at least indirect support from the statement: ""Subdiaphragmatic vagotomy or 7-nitroindazole reduced, icatibant, DALBK, IL-1ra, aminoguanidine and dipyrone abolished, while ibuprofen and celecoxib failed to affect Tsv-induced fever.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes thrombocytopenia."" The statement discusses various substances and their effects on Tsv-induced fever, but none of these substances include Methylprednisolone, nor does it mention thrombocytopenia (a condition characterized by decreased platelet count). Therefore, there is no connection that can be inferred between Methylprednisolone and thrombocytopenia based on this statement."
12672767,Methylprednisolone causes drug-induced liver injury,42,Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.,False,"'Does the phrase ""Methylprednisolone causes drug-induced liver injury"" receive at least indirect support from the statement: ""Reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared with ibuprofen in patients with rheumatoid arthritis.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes drug-induced liver injury."" The statement discusses the reduced incidence of gastroduodenal ulcers associated with lumiracoxib compared to ibuprofen in patients with rheumatoid arthritis. This information is not related to methylprednisolone nor drug-induced liver injury; therefore, it does not offer any indirect support for the claim in question.

        To further elaborate on the reasons for my answer, let us examine the components of the given statement more closely:

        1. Reduced incidence of gastroduodenal ulcers
        2. Associated with lumiracoxib compared with ibuprofen
        3. In patients with rheumatoid arthritis

        As we can see from these components, there is no mention of methylprednisolone nor any reference to drug-induced liver injury in general. The focus of the statement is on lumiracoxib versus ibuprofen regarding gastroduodenal ulcers in rheumatoid arthritis patients."
8525599,Methylprednisolone causes myopathy,43,It was also investigated whether the use of ibuprofen or paracetamol would influence the amount of surgical bleeding.,False,"'Does the phrase ""Methylprednisolone causes myopathy"" receive at least indirect support from the statement: ""It was also investigated whether the use of ibuprofen or paracetamol would influence the amount of surgical bleeding.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone causes myopathy."" 

        The statement ""It was also investigated whether the use of ibuprofen or paracetamol would influence the amount of surgical bleeding"" is related to the use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and paracetamol in managing surgical bleeding. This is unrelated to Methylprednisolone, which is a corticosteroid often used for its anti-inflammatory and immunosuppressive effects. 

        Myopathy can be a side effect of long-term use of corticosteroids like Methylprednisolone. However, the statement provided does not contain any information about Methylprednisolone, its usage, or its side effects. Therefore, it does not provide any indirect support for the claim that Methylprednisolone causes myopathy."
27357949,Methylprednisolone affects neoplasm,44,"In a randomised, placebo-controlled, double-blind trial of prophylaxis with ibuprofen, the rate of patent ductus arteriosus associated with ibuprofen was 19% compared with 42% with placebo.",False,"'Does the phrase ""Methylprednisolone affects neoplasm"" receive at least indirect support from the statement: ""In a randomised, placebo-controlled, double-blind trial of prophylaxis with ibuprofen, the rate of patent ductus arteriosus associated with ibuprofen was 19% compared with 42% with placebo.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects neoplasm"". 

        The statement is about a clinical trial of prophylaxis with ibuprofen versus placebo for patent ductus arteriosus in newborns. It does not mention methylprednisolone, nor does it provide any information about neoplasms (tumors). Therefore, it does not offer any indirect evidence regarding the effect of methylprednisolone on neoplasms. 

        Methylprednisolone is a corticosteroid often used in clinical settings for its anti-inflammatory effects, while neoplasms refer to new and abnormal growths of tissue, often referred to as tumors. While both methylprednisolone and neoplasms can be subjects of medical research, the provided statement does not make any connection between them."
24420470,Methylprednisolone affects Inflammation,45,"The purpose of this study was to examine the effects of ibuprofen on delayed onset muscle soreness (DOMS), indirect markers of muscle damage and muscular performance.",False,"'Does the phrase ""Methylprednisolone affects Inflammation"" receive at least indirect support from the statement: ""The purpose of this study was to examine the effects of ibuprofen on delayed onset muscle soreness (DOMS), indirect markers of muscle damage and muscular performance.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Inflammation."" The study in question focuses on ibuprofen, another anti-inflammatory drug, but it does not mention Methylprednisolone nor does it provide any information about its effects on inflammation. Methylprednisolone is a corticosteroid often used for its potent anti-inflammatory properties; however, without specific evidence linking it to inflammation in the context of this study, there is no basis for such an inference."
23472756,Methylprednisolone affects Inflammation,46,CONCLUSIONS: Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly.,False,"'Does the phrase ""Methylprednisolone affects Inflammation"" receive at least indirect support from the statement: ""CONCLUSIONS: Pretreatment with ibuprofen before elective total hip surgery increases the perioperative blood loss significantly.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Inflammation"". The conclusion in the statement is about the effect of ibuprofen on perioperative blood loss in elective total hip surgery, not about Methylprednisolone or its influence on inflammation."
20530617,Methylprednisolone affects systemic sclerosis,47,"The data suggest that nimesulide and ibuprofen, in addition to their anti-inflammatory and analgesic benefits, may also have a protective effect in osteoarthritis through the inhibition of apoptosis in chondrocytes.",False,"'Does the phrase ""Methylprednisolone affects systemic sclerosis"" receive at least indirect support from the statement: ""The data suggest that nimesulide and ibuprofen, in addition to their anti-inflammatory and analgesic benefits, may also have a protective effect in osteoarthritis through the inhibition of apoptosis in chondrocytes.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects systemic sclerosis."" The statement discusses the potential protective effects of two non-steroidal anti-inflammatory drugs (NSAIDs), nimesulide and ibuprofen, on osteoarthritis through inhibition of apoptosis in chondrocytes. Methylprednisolone is a corticosteroid with anti-inflammatory properties but has no direct relation to systemic sclerosis in the statement provided.

         Systemic sclerosis is an autoimmune disease characterized by fibrosis in multiple organs, vasculopathy, and immune system dysfunction. While methylprednisolone can be used as an off-label treatment due to its anti-inflammatory properties, there is no direct evidence presented in the statement that connects methylprednisolone specifically to systemic sclerosis. The two NSAIDs mentioned in the statement have not been established as effective treatments for systemic sclerosis either; hence there is no indirect support for methylprednisolone affecting systemic s"
20254789,Methylprednisolone affects adult acute respiratory distress syndrome,48,Pretreatment with ibuprofen blocked the fever induced by RANTES.,False,"'Does the phrase ""Methylprednisolone affects adult acute respiratory distress syndrome"" receive at least indirect support from the statement: ""Pretreatment with ibuprofen blocked the fever induced by RANTES.""?","No, the statement ""Pretreatment with ibuprofen blocked the fever induced by RANTES"" does not provide indirect support for the claim that ""Methylprednisolone affects adult acute respiratory distress syndrome"".

        The two statements discuss different therapeutic interventions (ibuprofen vs methylprednisolone) for different conditions (fever induced by RANTES vs adult acute respiratory distress syndrome). The mechanism by which ibuprofen blocks fever is through inhibition of cyclooxygenase (COX), thereby preventing prostaglandin synthesis in the hypothalamus; however, this mechanism is unrelated to methylprednisolone's potential effects on adult acute respiratory distress syndrome (ARDS).

        Methylprednisolone is a corticosteroid that has been investigated for its potential anti-inflammatory effects in ARDS; however, its efficacy remains controversial in clinical practice due to concerns about immunosuppression leading to secondary infections and other complications in critically ill patients.

        While both ibuprofen and methylprednisolone have"
17649050,Methylprednisolone affects optic nerve disorder,49,This study evaluated whether administration of the pharmacologically active S(+)-isomer of ibuprofen suppresses acute pain and plasma beta-endorphin levels in the oral surgery model of acute pain.,False,"'Does the phrase ""Methylprednisolone affects optic nerve disorder"" receive at least indirect support from the statement: ""This study evaluated whether administration of the pharmacologically active S(+)-isomer of ibuprofen suppresses acute pain and plasma beta-endorphin levels in the oral surgery model of acute pain.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects optic nerve disorder"". The study mentioned in the statement is investigating whether administering a specific isomer of ibuprofen can suppress acute pain and plasma beta-endorphin levels in an oral surgery model of acute pain. This study has no direct relevance to Methylprednisolone or its effects on optic nerve disorders."
16634377,Methylprednisolone affects myasthenia gravis,50,"On the other hand, in subgroup B, no improvement in flexibility or reduction in muscle soreness was found in patients who took ibuprofen.",False,"'Does the phrase ""Methylprednisolone affects myasthenia gravis"" receive at least indirect support from the statement: ""On the other hand, in subgroup B, no improvement in flexibility or reduction in muscle soreness was found in patients who took ibuprofen.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects myasthenia gravis."" The statement discusses the effects of ibuprofen on flexibility and muscle soreness in subgroup B patients, not methylprednisolone or its effects on myasthenia gravis. Myasthenia gravis is a specific neuromuscular disorder characterized by weakness in voluntary muscle groups; it is not related to muscle soreness or flexibility. Methylprednisolone is a corticosteroid often used in treating myasthenia gravis due to its anti-inflammatory properties; however, no information regarding methylprednisolone is provided in the statement in question. Therefore, it does not offer indirect support for the claim that methylprednisolone affects myasthenia gravis."
16277488,Methylprednisolone affects neuromyelitis optica,51,"This is termed, Celery Seed Extract (CSE) and has been found to be at least as effective as aspirin, ibuprofen, and naproxen in suppressing arthritis in a model of polyarthritis.",False,"'Does the phrase ""Methylprednisolone affects neuromyelitis optica"" receive at least indirect support from the statement: ""This is termed, Celery Seed Extract (CSE) and has been found to be at least as effective as aspirin, ibuprofen, and naproxen in suppressing arthritis in a model of polyarthritis.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects neuromyelitis optica."" The statement discusses the efficacy of Celery Seed Extract (CSE) in suppressing arthritis in a model of polyarthritis, which is unrelated to Methylprednisolone's potential effects on neuromyelitis optica. Methylprednisolone is a corticosteroid medication often used to treat inflammatory conditions like neuromyelitis optica, but no connection is made between CSE and methylprednisolone in this statement."
15906642,Methylprednisolone affects Pain,52,INTRODUCTION: Hospitalized patients are often unable to ingest or tolerate oral antipyretics and recently an aqueous formulation of intravenous (IV) ibuprofen was approved by the US-FDA for the reduction of fever in adults.,False,"'Does the phrase ""Methylprednisolone affects Pain"" receive at least indirect support from the statement: ""INTRODUCTION: Hospitalized patients are often unable to ingest or tolerate oral antipyretics and recently an aqueous formulation of intravenous (IV) ibuprofen was approved by the US-FDA for the reduction of fever in adults.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Pain"". The introduction discusses hospitalized patients who cannot take oral antipyretics (fever reducers) and introduces an intravenous formulation of ibuprofen for fever reduction in adults. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects rather than its direct impact on pain relief (though reducing inflammation can indirectly alleviate pain). The statement focuses on fever reduction using ibuprofen, which does not provide any implicit evidence that methylprednisolone affects pain."
15610554,Methylprednisolone affects rheumatoid arthritis,53,"OBJECTIVES: This study compared the analgesic effectiveness of acetaminophen-codeine with that of ibuprofen for children with acute traumatic extremity pain, with the hypothesis that the two medications would demonstrate equivalent reduction in pain scores in an emergency department (ED) setting.",False,"'Does the phrase ""Methylprednisolone affects rheumatoid arthritis"" receive at least indirect support from the statement: ""OBJECTIVES: This study compared the analgesic effectiveness of acetaminophen-codeine with that of ibuprofen for children with acute traumatic extremity pain, with the hypothesis that the two medications would demonstrate equivalent reduction in pain scores in an emergency department (ED) setting.""?","No, the statement does not provide indirect support for the claim that ""Methylprednisolone affects rheumatoid arthritis."" The study mentioned in the statement focuses on comparing the analgesic effectiveness of acetaminophen-codeine with ibuprofen for children with acute traumatic extremity pain in an emergency department setting. This study does not involve Methylprednisolone nor rheumatoid arthritis; therefore, it does not provide any relevant information or support regarding that claim.

         In order for a study to provide indirect support for a claim, it should at least share some commonalities regarding either the subject matter (in this case, Methylprednisolone or rheumatoid arthritis) or some underlying biological mechanisms that could potentially connect the two areas of investigation. In this instance, however, there is no such connection between the study mentioned in the statement and the claim about Methylprednisolone affecting rheumatoid arthritis.

         Methylprednisolone is a type of corticosteroid used primarily for its anti-inflammatory effects in various medical conditions"
15186368,Methylprednisolone affects graft versus host disease,54,"Thus, the anti-inflammatory drug ibuprofen, which has been associated with reduced AD risk in human epidemiological studies, can significantly delay some forms of AD pathology, including amyloid deposition, when administered early in the disease course of a transgenic mouse model of AD.",False,"'Does the phrase ""Methylprednisolone affects graft versus host disease"" receive at least indirect support from the statement: ""Thus, the anti-inflammatory drug ibuprofen, which has been associated with reduced AD risk in human epidemiological studies, can significantly delay some forms of AD pathology, including amyloid deposition, when administered early in the disease course of a transgenic mouse model of AD.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects graft versus host disease"". The statement discusses the effects of ibuprofen on Alzheimer's disease (AD) pathology in a transgenic mouse model, while the phrase in question pertains to Methylprednisolone's impact on graft versus host disease. These are two distinct areas of study with no overlap in the provided statement."
14891106,Methylprednisolone affects kidney disorder,55,"The hypoxia, hypertension and increased prostanoids were prevented using ibuprofen.",False,"'Does the phrase ""Methylprednisolone affects kidney disorder"" receive at least indirect support from the statement: ""The hypoxia, hypertension and increased prostanoids were prevented using ibuprofen.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects kidney disorder"". 

        The statement ""The hypoxia, hypertension and increased prostanoids were prevented using ibuprofen"" refers to the prevention of specific symptoms (hypoxia, hypertension, and increased prostanoids) by ibuprofen. Methylprednisolone is not mentioned in this statement, nor is there any connection made between methylprednisolone and kidney disorder. 

        Furthermore, while ibuprofen is known for its anti-inflammatory effects, methylprednisolone is a corticosteroid often used for its anti-inflammatory and immunosuppressive properties. They have different mechanisms of action and are used to treat different conditions. Therefore, even if methylprednisolone was mentioned in the statement, it would not necessarily imply a connection to kidney disorder based on this information alone. 

        However, it is important to note that both methylprednisolone and ibuprofen can have side effects on kidney function when used inappropriately or in"
11819955,Methylprednisolone affects spinal cord injury,56,"The Effect of Ibuprofen Dosing Interval on Post-Tonsillectomy Outcomes in Children: A Quality Improvement Study.OBJECTIVE: In this Quality Improvement (QI project) it was hypothesized that an increase in dosing intervals for postoperative analgesia when alternating Ibuprofen and Acetaminophen would reduce post-tonsillectomy hemorrhage (PTH) rates for those undergoing tonsillectomies with or without adenoidectomy, while maintaining the standard of postoperative analgesia and reducing visits to the Emergency Room (ER) for reasons other than PTH.",False,"'Does the phrase ""Methylprednisolone affects spinal cord injury"" receive at least indirect support from the statement: ""The Effect of Ibuprofen Dosing Interval on Post-Tonsillectomy Outcomes in Children: A Quality Improvement Study.OBJECTIVE: In this Quality Improvement (QI project) it was hypothesized that an increase in dosing intervals for postoperative analgesia when alternating Ibuprofen and Acetaminophen would reduce post-tonsillectomy hemorrhage (PTH) rates for those undergoing tonsillectomies with or without adenoidectomy, while maintaining the standard of postoperative analgesia and reducing visits to the Emergency Room (ER) for reasons other than PTH.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects spinal cord injury."" The study focuses on postoperative analgesia outcomes in children undergoing tonsillectomies when alternating Ibuprofen and Acetaminophen dosing intervals. The drug mentioned in this context is Ibuprofen, not Methylprednisolone. Moreover, spinal cord injury is not addressed in either the hypothesis or the study objectives. Therefore, there is no connection between the two statements in terms of content or subject matter."
10845505,Methylprednisolone affects Pain,57,Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen.,False,"'Does the phrase ""Methylprednisolone affects Pain"" receive at least indirect support from the statement: ""Studies show that ibuprofen demonstrates superior efficacy in fever reduction compared to acetaminophen.""?","No, the statement does not provide any indirect support for the phrase ""Methylprednisolone affects Pain."" The statement compares the efficacy of two different drugs (ibuprofen and acetaminophen) in reducing fever, but it does not mention Methylprednisolone or pain at all. Methylprednisolone is a corticosteroid used primarily for its anti-inflammatory effects rather than its analgesic (pain-relieving) properties, so any connection between the two statements would be purely speculative and not based on the evidence provided."
10048898,Methylprednisolone affects ulcerative colitis,58,IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study.,False,"'Does the phrase ""Methylprednisolone affects ulcerative colitis"" receive at least indirect support from the statement: ""IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study.""?","No, the statement ""IV Ibuprofen for Prevention of Post-Ercp Pancreatitis in Children: A Randomized Placebo-Controlled Feasibility Study"" does not provide indirect support for the phrase ""Methylprednisolone affects ulcerative colitis."" 

        The study in question is investigating the use of IV Ibuprofen for preventing post-ERCP (Endoscopic Retrograde Cholangiopancreatography) pancreatitis in children. This study does not involve Methylprednisolone or ulcerative colitis at all, making it unrelated to the claim about Methylprednisolone's effect on ulcerative colitis.

        To further elaborate on why there is no indirect support, consider that indirect support typically involves related concepts, shared underlying mechanisms, or similar study designs/results that can be extrapolated between two studies/claims. In this case, however, there is no such connection between IV Ibuprofen's potential impact on post-ERCP pancreatitis in children and Methylprednisolone's effect on ulcerative colitis."
9646753,Methylprednisolone affects multiple sclerosis,59,Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.,False,"'Does the phrase ""Methylprednisolone affects multiple sclerosis"" receive at least indirect support from the statement: ""Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide.""?","No, the statement ""Altitude Sickness Prevention with Ibuprofen Relative to Acetazolamide"" does not provide indirect support for the phrase ""Methylprednisolone affects multiple sclerosis."" 

        The reason is that these two statements discuss different medical conditions (altitude sickness and multiple sclerosis) and different therapeutic agents (Ibuprofen/Acetazolamide and Methylprednisolone). There is no common ground between these statements in terms of disease condition or drug mechanism that would allow for indirect support to be inferred. 

        Methylprednisolone is a corticosteroid often used in treating multiple sclerosis due to its anti-inflammatory effects, while Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for pain relief in various conditions including altitude sickness, and Acetazolamide is a medication used for preventing altitude sickness by reducing the body's production of acidic fluids.

        Therefore, any evaluation of the effect of Methylprednis"
9346353,Methylprednisolone affects chronic obstructive pulmonary disease,60,"In conclusion, prednisone, ibuprofen and betamethasone may prevent OA by suppressing the expression of IL-6 and IL-8, subsequently inactivating NF-kappaB and STAT3 pathways, and ultimately, leading to decreased levels of collagen I, MMP-1, and MMP-13.",False,"'Does the phrase ""Methylprednisolone affects chronic obstructive pulmonary disease"" receive at least indirect support from the statement: ""In conclusion, prednisone, ibuprofen and betamethasone may prevent OA by suppressing the expression of IL-6 and IL-8, subsequently inactivating NF-kappaB and STAT3 pathways, and ultimately, leading to decreased levels of collagen I, MMP-1, and MMP-13.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects chronic obstructive pulmonary disease"" (COPD). The statement discusses the effects of prednisone, ibuprofen, and betamethasone on osteoarthritis (OA) by suppressing certain pathways related to inflammation (IL-6 and IL-8) and collagen degradation (MMP-1 and MMP-13). Methylprednisolone is not mentioned in the statement at all, let alone its potential effects on COPD.

         However, it is important to note that both COPD and OA involve inflammation, so there may be some overlap in terms of potential therapeutic agents that target inflammation. Nonetheless, without specific information about methylprednisolone's effects on COPD, it would be inappropriate to make any assumptions about its potential therapeutic benefits in COPD based on the provided statement alone."
9107378,Methylprednisolone affects Edema,61,"This study aims to determine the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone (AlMgS) syrup on reducing oral aphthous ulcer pain.",False,"'Does the phrase ""Methylprednisolone affects Edema"" receive at least indirect support from the statement: ""This study aims to determine the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone (AlMgS) syrup on reducing oral aphthous ulcer pain.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects Edema"". The study mentioned is focused on determining the therapeutic effects of ibuprofen, diphenhydramine and aluminum magnesium simethicone syrup on reducing oral aphthous ulcer pain. Methylprednisolone is not mentioned in the study aim, nor does it have any direct or indirect connection to ibuprofen, diphenhydramine or aluminum magnesium simethicone syrup. Methylprednisolone is a corticosteroid often used to reduce inflammation and edema in various clinical conditions, but the statement provided does not offer any information or implications regarding its effects on edema."
8596544,Methylprednisolone affects asthma,62,"CONCLUSIONS: Considering the results of the study, reflexology was superior to Ibuprofen on reducing dysmenorrhea and its treatment effect continued even after discontinuing the intervention in the third cycle.",False,"'Does the phrase ""Methylprednisolone affects asthma"" receive at least indirect support from the statement: ""CONCLUSIONS: Considering the results of the study, reflexology was superior to Ibuprofen on reducing dysmenorrhea and its treatment effect continued even after discontinuing the intervention in the third cycle.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects asthma."" The conclusion in the statement is about reflexology being superior to Ibuprofen in reducing dysmenorrhea, which is unrelated to Methylprednisolone or asthma. Methylprednisolone is a corticosteroid used for its anti-inflammatory effects in various conditions such as asthma, but no such claim is made in the provided statement."
8330909,Methylprednisolone affects systemic lupus erythematosus,63,CONCLUSION: We conclude that pain therapy with an almost peripherally acting drug such as ibuprofen can reduce osteoporosis-associated chronic pain better than a centrally acting pain medication such as tramadol.,False,"'Does the phrase ""Methylprednisolone affects systemic lupus erythematosus"" receive at least indirect support from the statement: ""CONCLUSION: We conclude that pain therapy with an almost peripherally acting drug such as ibuprofen can reduce osteoporosis-associated chronic pain better than a centrally acting pain medication such as tramadol.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone affects systemic lupus erythematosus."" The conclusion is about pain therapy using ibuprofen versus tramadol in osteoporosis-associated chronic pain management. Methylprednisolone is not mentioned in either the conclusion itself nor in its comparison of ibuprofen (a non-steroidal anti-inflammatory drug) and tramadol (an opioid analgesic).

        Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs in the body, whereas osteoporosis is characterized by weakened bones due to loss of bone density. Methylprednisolone is indeed used in treating SLE due to its anti-inflammatory effects; however, that is beyond the scope of the provided conclusion about pain therapies for osteoporosis-associated chronic pain."
19744632,Methylprednisolone disrupts Edema,64,The objective of this study was to determine whether pretreatment with ibuprofen would prevent the onset or decrease the severity of headache that occurs after ECT.,False,"'Does the phrase ""Methylprednisolone disrupts Edema"" receive at least indirect support from the statement: ""The objective of this study was to determine whether pretreatment with ibuprofen would prevent the onset or decrease the severity of headache that occurs after ECT.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Edema"". The study in question focuses on determining whether pretreatment with ibuprofen can prevent or decrease the severity of headaches following Electroconvulsive Therapy (ECT). Methylprednisolone is not mentioned in the statement at all, let alone its potential effect on edema. Edema is also not addressed in the statement. Therefore, there is no indirect support for the phrase based on this information alone."
18407557,Methylprednisolone disrupts thrombocytopenia,65,The results of this study reveal that intake of ibuprofen can decrease muscle soreness induced after eccentric exercise but cannot assist in restoring muscle function.,False,"'Does the phrase ""Methylprednisolone disrupts thrombocytopenia"" receive at least indirect support from the statement: ""The results of this study reveal that intake of ibuprofen can decrease muscle soreness induced after eccentric exercise but cannot assist in restoring muscle function.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts thrombocytopenia"". 

         The statement discusses the effects of ibuprofen on muscle soreness and function after exercise, while the phrase in question pertains to Methylprednisolone's impact on thrombocytopenia, which is a condition characterized by abnormally low levels of platelets in the blood. 

         Thrombocytopenia can be caused by various factors including certain medications, infections, immune system disorders, and pregnancy complications among others. Methylprednisolone is a type of corticosteroid often used in treatment regimens for thrombocytopenia due to its anti-inflammatory properties and ability to suppress immune response.

         Therefore, although both statements discuss medical treatments (ibuprofen and methylprednisolone), they refer to different conditions (muscle soreness/function vs thrombocytopenia) and thus cannot be interpreted as indirectly supporting each other."
11106658,Methylprednisolone disrupts Pain,66,The objective of our study was to determine the role of ibuprofen in protecting neutropenic rats from cardiopulmonary injury due to endotoxemia.,False,"'Does the phrase ""Methylprednisolone disrupts Pain"" receive at least indirect support from the statement: ""The objective of our study was to determine the role of ibuprofen in protecting neutropenic rats from cardiopulmonary injury due to endotoxemia.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Pain"". 

        The statement is about a study that aims to investigate the protective effects of ibuprofen on neutropenic rats from cardiopulmonary injury due to endotoxemia. There is no mention of methylprednisolone in this statement, let alone any disruption of pain. Methylprednisolone is a type of corticosteroid often used for its anti-inflammatory and immunosuppressive effects, unrelated to the objectives of the study mentioned in the statement. Therefore, it is not reasonable to infer any relationship between methylprednisolone and pain disruption from this statement."
8640603,Methylprednisolone disrupts Inflammation,67,"To determine if prophylactic etodolac would significantly reduce postendodontic pain, when compared with ibuprofen or placebo, 36 patients consented to single blind oral administration of either 400 mg of etodolac, 600 mg of ibuprofen, or a placebo, before conventional one-appointment root canal therapy.",False,"'Does the phrase ""Methylprednisolone disrupts Inflammation"" receive at least indirect support from the statement: ""To determine if prophylactic etodolac would significantly reduce postendodontic pain, when compared with ibuprofen or placebo, 36 patients consented to single blind oral administration of either 400 mg of etodolac, 600 mg of ibuprofen, or a placebo, before conventional one-appointment root canal therapy.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone disrupts Inflammation."" The statement discusses an experiment investigating the effect of prophylactic etodolac on postendodontic pain in comparison to ibuprofen and placebo before conventional one-appointment root canal therapy. Methylprednisolone is not mentioned in the statement; therefore, it does not offer any support for the claim about Methylprednisolone disrupting inflammation."
23934495,Methylprednisolone prevents Cognitive impairment,68,UNLABELLED: The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA.,False,"'Does the phrase ""Methylprednisolone prevents Cognitive impairment"" receive at least indirect support from the statement: ""UNLABELLED: The aim of our study was to evaluate whether the prophylactic use of ibuprofen would reduce the incidence of significant patent ductus arteriosus (PDA) and to confirm the effectiveness of ibuprofen as rescue treatment in closing PDA.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents Cognitive impairment."" The aim of the study as described in the statement is to evaluate the effectiveness of ibuprofen in preventing and treating patent ductus arteriosus (PDA), which is a condition related to heart function in newborns. There is no mention of methylprednisolone in the statement nor any reference made to cognitive impairment prevention. Therefore, it does not provide indirect support for the stated phrase."
20014108,Methylprednisolone prevents rheumatoid arthritis,69,"Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, indomethacin and ibuprofen are the most widely used drugs for pain, arthritis, cardiovascular diseases and, more recently, the prevention of colon cancer and Alzheimer disease.",False,"'Does the phrase ""Methylprednisolone prevents rheumatoid arthritis"" receive at least indirect support from the statement: ""Nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, indomethacin and ibuprofen are the most widely used drugs for pain, arthritis, cardiovascular diseases and, more recently, the prevention of colon cancer and Alzheimer disease.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents rheumatoid arthritis"". The statement discusses the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing various conditions including colon cancer, Alzheimer disease, pain, arthritis, and cardiovascular diseases. Methylprednisolone is a corticosteroid drug that has anti-inflammatory actions but it is not an NSAID. The two classes of drugs have different mechanisms of action and side effect profiles. Therefore, the statement does not provide any evidence or reasoning that would suggest methylprednisolone prevents rheumatoid arthritis."
18266414,Methylprednisolone prevents Abdominal pain,70,Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways.,False,"'Does the phrase ""Methylprednisolone prevents Abdominal pain"" receive at least indirect support from the statement: ""Aggravation of seizure-associated microvascular injuries by ibuprofen may involve multiple pathways.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents Abdominal pain."" The two statements discuss different subjects: one is about methylprednisolone potentially preventing abdominal pain, while the other is about ibuprofen exacerbating seizure-associated microvascular injuries through multiple pathways. There is no connection between these two ideas that would allow us to infer support for methylprednisolone preventing abdominal pain based on the statement about ibuprofen."
14967074,Methylprednisolone prevents asthma,71,"Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.",False,"'Does the phrase ""Methylprednisolone prevents asthma"" receive at least indirect support from the statement: ""Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.""?","No, the statement ""Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child"" does not provide indirect support for the phrase ""Methylprednisolone prevents asthma."" 

        The two statements discuss different subjects: one is about anti-inflammatory drug use during pregnancy and its association with cerebral palsy in offspring, while the other is about methylprednisolone as a preventative measure for asthma. While methylprednisolone is also an anti-inflammatory drug, the statement about its potential for preventing asthma would require separate clinical evidence demonstrating its efficacy for that specific purpose.

        The connection between these two statements is tenuous at best because they discuss different conditions (pregnancy complications vs asthma) and do not share common outcomes (cerebral palsy vs prevention of asthma). Therefore, it is not appropriate to infer support for one statement based on the other without additional information linking methylprednisolone use and asthma prevention specifically."
9744990,Methylprednisolone prevents ovarian hyperstimulation syndrome,72,"More than two cycles of ibuprofen was significantly associated with an increased risk for bronchopulmonary dysplasia (odds ratio [OR], 2.81; p = 0.03) and acute renal failure (OR, 3.81; p = 0.09).",False,"'Does the phrase ""Methylprednisolone prevents ovarian hyperstimulation syndrome"" receive at least indirect support from the statement: ""More than two cycles of ibuprofen was significantly associated with an increased risk for bronchopulmonary dysplasia (odds ratio [OR], 2.81; p = 0.03) and acute renal failure (OR, 3.81; p = 0.09).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents ovarian hyperstimulation syndrome"". The statement discusses the association between repeated cycles of ibuprofen use and increased risks for bronchopulmonary dysplasia and acute renal failure in newborns. It does not mention methylprednisolone or ovarian hyperstimulation syndrome at all. In order for there to be indirect support, there should be some connection between the two statements in terms of shared concepts, mechanisms, or outcomes. However, in this case, there is no such connection."
8345063,Methylprednisolone prevents Pain,73,OBJECTIVE: Non-steroidal anti-inflammatory drugs such as ibuprofen have a protective role on risk of Alzheimer's disease (AD).,False,"'Does the phrase ""Methylprednisolone prevents Pain"" receive at least indirect support from the statement: ""OBJECTIVE: Non-steroidal anti-inflammatory drugs such as ibuprofen have a protective role on risk of Alzheimer's disease (AD).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents Pain"". The objective in the statement is focused on non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen having a protective role against Alzheimer's disease (AD). Methylprednisolone is a corticosteroid, not an NSAID, and its primary use is for reducing inflammation and suppressing the immune system rather than preventing pain specifically. Therefore, there is no clear connection between the two statements in terms of supporting the claim about Methylprednisolone preventing pain."
8291272,Methylprednisolone prevents graft versus host disease,74,"There seems to be a marked gradient of risk for acute kidney injury across agents, specifically for indomethacin, ibuprofen, and rofecoxib.",False,"'Does the phrase ""Methylprednisolone prevents graft versus host disease"" receive at least indirect support from the statement: ""There seems to be a marked gradient of risk for acute kidney injury across agents, specifically for indomethacin, ibuprofen, and rofecoxib.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents graft versus host disease."" The statement discusses acute kidney injury risks associated with different non-steroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, ibuprofen, and rofecoxib but does not mention methylprednisolone nor graft versus host disease (GVHD). Methylprednisolone is a corticosteroid often used in treating GVHD; however, no connection is drawn between NSAIDs and GVHD prevention in either statement. Therefore, there is no indirect support for the initial phrase based on the provided statement."
7980138,Methylprednisolone prevents spinal cord injury,75,"Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for <20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for <20 DDD, 2P < 0.01 for comparison).",False,"'Does the phrase ""Methylprednisolone prevents spinal cord injury"" receive at least indirect support from the statement: ""Significant heterogeneity was present for the NSAIDs; e.g., ibuprofen was associated with an increased overall fracture risk (OR = 2.09, 95% CI 2.00-2.18 for <20 DDD), while celecoxib was not (OR = 0.76, 95% CI 0.51-1.13 for <20 DDD, 2P < 0.01 for comparison).""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone prevents spinal cord injury."" The statement discusses the effects of non-steroidal anti-inflammatory drugs (NSAIDs), specifically ibuprofen and celecoxib, on overall fracture risk. Methylprednisolone is a corticosteroid drug and not an NSAID, thus it is not included in the comparison. Therefore, any potential impact of methylprednisolone on spinal cord injury prevention is not addressed in this statement."
7414405,Methylprednisolone prevents Edema,76,One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure.,False,"'Does the phrase ""Methylprednisolone prevents Edema"" receive at least indirect support from the statement: ""One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure.""?","No, the statement ""One should be more critical about ivabradine and low-dose digoxin in diastolic heart failure"" does not provide indirect support for the phrase ""Methylprednisolone prevents Edema"". 

        The statement is about being more critical when considering ivabradine and low-dose digoxin for diastolic heart failure. It does not mention methylprednisolone or edema at all. Therefore, it does not provide any form of support for the claim that methylprednisolone prevents edema. 

        The two statements are on completely different topics. The first statement is about two specific treatments for heart failure, while the second statement is about a drug for preventing swelling (edema). Therefore, without additional information linking these two topics, it is not valid to infer support for one from the other."
18106042,Methylprednisolone predisposes pneumonia,77,"Preclinical studies of ivabradine in animal models with induced AF demonstrated a reduction in HR, with no significant worsening of QT interval or mean arterial pressure.",False,"'Does the phrase ""Methylprednisolone predisposes pneumonia"" receive at least indirect support from the statement: ""Preclinical studies of ivabradine in animal models with induced AF demonstrated a reduction in HR, with no significant worsening of QT interval or mean arterial pressure.""?","No, the statement does not provide indirect support for the phrase ""Methylprednisolone predisposes pneumonia."" The statement discusses preclinical studies of ivabradine in animal models with atrial fibrillation (AF), which showed a reduction in heart rate (HR) without significant changes in QT interval or mean arterial pressure. This information is not related to Methylprednisolone or its potential effects on pneumonia risk."
9645180,Methylprednisolone predisposes Inflammation,78,"In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.",False,"'Does the phrase ""Methylprednisolone predisposes Inflammation"" receive at least indirect support from the statement: ""In this review, we summarize the current knowledge of the HCN4 channel and ivabradine, including the function of HCN4 in cardiac pacemaking, the mechanism of action of If inhibition by ivabradine, and the pharmacological and clinical effects of ivabradine in cardiac diseases as HF, coronary artery disease, and atrial fibrillation.""?","No, the statement does not provide any direct or indirect support for the phrase ""Methylprednisolone predisposes Inflammation."" The statement is a review of the HCN4 channel and ivabradine, its function in cardiac pacemaking, its mechanism of action, and pharmacological and clinical effects in various cardiac diseases. There is no mention or implication of methylprednisolone or inflammation in the statement."
12905337,Cefotaxime related to Sepsis,79,Small studies have recently investigated the role of ivabradine in MS in sinus rhythm.,False,"'Does the phrase ""Cefotaxime related to Sepsis"" receive at least indirect support from the statement: ""Small studies have recently investigated the role of ivabradine in MS in sinus rhythm.""?","No, the statement ""Small studies have recently investigated the role of ivabradine in MS in sinus rhythm"" does not provide indirect support for the phrase ""Cefotaxime related to Sepsis"". 

         The two statements are unrelated as they discuss different subjects. The first statement refers to small studies investigating ivabradine's role in Multiple Sclerosis (MS) for patients in sinus rhythm. Ivabradine is a medication used primarily for heart rate control in certain conditions, not an antibiotic like Cefotaxime. The second phrase discusses Cefotaxime, an antibiotic commonly used for treating various bacterial infections, and its potential relation to sepsis, which is a serious condition caused by the body's response to an infection.

         Therefore, these statements discuss different medications, conditions, and areas of study, making it impossible for one to indirectly support the other."
24475300,Cefotaxime affects bacterial infectious disease,80,The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction.,False,"'Does the phrase ""Cefotaxime affects bacterial infectious disease"" receive at least indirect support from the statement: ""The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction.""?","No, the statement ""The role of Ivabradine in Diastolic Heart Failure with preserved Ejection Fraction"" does not provide indirect support for the phrase ""Cefotaxime affects bacterial infectious disease."" 

        The reason is that these two statements discuss different topics altogether. The first statement refers to Ivabradine's role in diastolic heart failure with preserved ejection fraction, which is a cardiovascular condition in humans. On the other hand, Cefotaxime is an antibiotic used for treating bacterial infections, as suggested by the second phrase.

        To establish indirect support between these two phrases, there should be some connection in their subject matter, either through shared mechanisms of action, commonalities in disease processes, or overlapping biological pathways. In this case, however, no such connection exists based on the provided statements.

        To provide indirect support for ""Cefotaxime affects bacterial infectious disease,"" one could look for evidence of Cefotaxime's antibacterial activity in laboratory experiments, clinical trials demonstrating its efficacy in treating bacterial infections in patients, or epidemiological studies showing correlations between"
23922029,Cefotaxime affects Sepsis,81,"Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.",False,"'Does the phrase ""Cefotaxime affects Sepsis"" receive at least indirect support from the statement: ""Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.""?","No, the phrase ""Cefotaxime affects Sepsis"" does not receive indirect support from the statement provided. The statement discusses ongoing trials investigating the effects of ivabradine on various cardiovascular disorders such as heart failure, acute coronary syndromes, coronary artery disease (CAD), but it does not mention Cefotaxime nor sepsis in any capacity. Cefotaxime is an antibiotic used primarily for treating infections caused by gram-negative bacteria; sepsis is a serious condition that can arise from an infection.

         To provide indirect support for ""Cefotaxime affects Sepsis,"" there would need to be some connection between Cefotaxime, sepsis, or related concepts in the statement. Since no such connection exists in this statement, it does not provide indirect support for ""Cefotaxime affects Sepsis.""

         It is essential to ensure that statements used as evidence for other claims have some logical relationship between them; otherwise, they cannot provide support for one another."
18672205,Cefotaxime affects peritonitis,82,"Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.",False,"'Does the phrase ""Cefotaxime affects peritonitis"" receive at least indirect support from the statement: ""Other large trials are also underway to assess the effects of ivabradine on heart failure, acute coronary syndromes, CAD, and other cardiovascular disorders.""?","No, the statement does not provide indirect support for the phrase ""Cefotaxime affects peritonitis."" The two phrases discuss different topics - one is about Cefotaxime affecting peritonitis while the other is about ivabradine trials for various cardiovascular disorders. The connection between them is tenuous at best, but there is no mention of Cefotaxime or peritonitis in the statement provided."
15853591,Cefotaxime prevents Sepsis,83,Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?,False,"'Does the phrase ""Cefotaxime prevents Sepsis"" receive at least indirect support from the statement: ""Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug?""?","No, the statement ""Effective suppression of atrial fibrillation by ivabradine: Novel target for an established drug"" does not provide indirect support for the phrase ""Cefotaxime prevents Sepsis."" The two statements discuss different drugs (Cefotaxime and Ivabradine) and different medical conditions (Sepsis and Atrial Fibrillation). There is no overlap in subject matter between these two statements that would allow for indirect support of one by the other."
19081412,Ceftriaxone prevents bacterial infectious disease,84,[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].,False,"'Does the phrase ""Ceftriaxone prevents bacterial infectious disease"" receive at least indirect support from the statement: ""[SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].""?","No, the statement ""Ceftriaxone prevents bacterial infectious disease"" does not receive indirect support from the provided statement about the SIGNIFY study and ivabradine. The SIGNIFY study is related to coronary heart disease, not bacterial infectious diseases. Ceftriaxone is an antibiotic used for treating various bacterial infections, whereas ivabradine is used in heart disease management for reducing heart rate. The two subjects are unrelated; therefore, no indirect support can be inferred from one statement to another based on their respective subjects of focus."
25827448,Gefarnate related to gastric ulcer,85,RESULTS: Heart rate reduction and prevention of postoperative AF or tachyarrhythmia with combined therapy was more effective than with metoprolol or ivabradine alone during the immediate postoperative management of cardiac surgery patients.,False,"'Does the phrase ""Gefarnate related to gastric ulcer"" receive at least indirect support from the statement: ""RESULTS: Heart rate reduction and prevention of postoperative AF or tachyarrhythmia with combined therapy was more effective than with metoprolol or ivabradine alone during the immediate postoperative management of cardiac surgery patients.""?","No, the statement does not provide any direct or indirect support for the phrase ""Gefarnate related to gastric ulcer"". The provided statement is about heart rate reduction and prevention of atrial fibrillation (AF) or tachyarrhythmia in cardiac surgery patients using combined therapy compared to metoprolol or ivabradine alone. Gefarnate is a drug used for the treatment of gastric ulcers, and there is no mention of it in the given statement. Therefore, it does not contribute to the understanding or validation of the relationship between Gefarnate and gastric ulcer."
24296137,Gefarnate related to duodenal ulcer,86,"During exercise, ivabradine dose dependently and significantly reduced the exercise-induced tachycardia (-17, -21, and -32% at 0.25, 0.5, and 1 mg/kg, respectively, versus saline) without altering myocardial contractility nor mean ejection wall stress.",False,"'Does the phrase ""Gefarnate related to duodenal ulcer"" receive at least indirect support from the statement: ""During exercise, ivabradine dose dependently and significantly reduced the exercise-induced tachycardia (-17, -21, and -32% at 0.25, 0.5, and 1 mg/kg, respectively, versus saline) without altering myocardial contractility nor mean ejection wall stress.""?","No, the statement does not provide indirect support for the phrase ""Gefarnate related to duodenal ulcer."" The statement discusses the effects of ivabradine on exercise-induced tachycardia in rats but does not mention gefarnate or duodenal ulcers at all. Gefarnate is an antithrombotic drug used for preventing blood clots, unrelated to duodenal ulcers or heart rate regulation. Therefore, there is no connection between the two statements."
25993651,Gefarnate disrupts gastric ulcer,87,Recent trials reported that risk of atrial fibrillation (AF) is increased in patients using ivabradine compared with controls.,False,"'Does the phrase ""Gefarnate disrupts gastric ulcer"" receive at least indirect support from the statement: ""Recent trials reported that risk of atrial fibrillation (AF) is increased in patients using ivabradine compared with controls.""?","No, the statement does not provide indirect support for the phrase ""Gefarnate disrupts gastric ulcer."" The two statements discuss different subjects - one is about ivabradine increasing the risk of atrial fibrillation (AF), while the other is about Gefarnate potentially affecting gastric ulcers - making it impossible for one statement to indirectly support the other based on their content alone.

        However, it is important to note that when interpreting statements like these in a broader context of medical literature, there could be potential connections drawn through shared mechanisms of action, side effects, or other biological processes. But based on these isolated statements alone, there is no clear connection between Gefarnate disruption of gastric ulcers and ivabradine increasing AF risk in patients.

        The statement about ivabradine increasing AF risk is interesting from its own perspective since ivabradine is used for treating heart conditions like chronic heart failure and angina pectoris by reducing heart rate without affecting contractility. Atrial fibrillation is an abnormal heart rhythm that can increase stroke risk, so understanding how ivabradine affects AF risk is crucial for its safe use in patients."
17758516,Neobiotic related to Inflammation,88,Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.,False,"'Does the phrase ""Neobiotic related to Inflammation"" receive at least indirect support from the statement: ""Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis.""?","No, the phrase ""Neobiotic related to Inflammation"" does not receive direct or indirect support from the statement ""Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis."" 

        The statement is about a comparative study of two antibiotics, cefixime and cephalexin, in the context of acute bacterial exacerbations of chronic bronchitis. It does not mention or imply any connection to neobiotics or inflammation. 

        A neobiotic is a term that refers to novel or synthetic substances that have antibiotic-like properties but are not traditional antibiotics. The statement does not discuss any such substances. 

        Furthermore, while antibiotics can have anti-inflammatory effects as a side effect of their antibacterial action, the statement does not provide any information about inflammation or the inflammatory effects of these antibiotics. 

        Therefore, based on the provided statement, there is no support for the connection between neobiotics and inflammation."
10690423,Neobiotic related to burn,89,Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.,False,"'Does the phrase ""Neobiotic related to burn"" receive at least indirect support from the statement: ""Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.""?","No, the statement does not provide indirect support for the phrase ""Neobiotic related to burn."" The statement discusses alterations of the pilQ gene in Neisseria gonorrhoeae and their relationship to antibiotic resistance in clinical strains of gonococci. A neobiotic is a term used in ecology to describe an organism that has recently invaded an ecosystem; it has no relation to burns. Therefore, there is no overlap or connection between these two pieces of information."
20263460,Neobiotic affects neoplasm,90,"Because of the emergence of these bacteria, other antimicrobial agents, both old and new, have been advocated for treatment and prevention of otitis media; amoxicillin-clavulanate, cefuroxime axetil, and cefixime are the newer agents.",False,"'Does the phrase ""Neobiotic affects neoplasm"" receive at least indirect support from the statement: ""Because of the emergence of these bacteria, other antimicrobial agents, both old and new, have been advocated for treatment and prevention of otitis media; amoxicillin-clavulanate, cefuroxime axetil, and cefixime are the newer agents.""?","No, the statement does not provide indirect support for the phrase ""Neobiotic affects neoplasm."" The provided statement discusses the use of certain antibiotics in treating otitis media, an inflammatory condition of the middle ear. The terms ""neobiotic"" and ""neoplasm"" refer to entirely different concepts - neobiotic refers to recently evolved organisms (particularly bacteria), while neoplasm refers to abnormal tissue growth (tumors). The statement does not establish any connection between these concepts, so it does not offer any support for the claim that neobiotics have an effect on neoplasms."
19744068,Neobiotic affects Inflammation,91,Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.,False,"'Does the phrase ""Neobiotic affects Inflammation"" receive at least indirect support from the statement: ""Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy.""?","No, the statement ""Experimental comparison of protective characteristics of enalapril and trimetazidine in diabetic nephropathy"" does not provide direct or indirect support for the phrase ""Neobiotic affects inflammation."" 

        The statement is about an experimental comparison of two drugs, enalapril and trimetazidine, in the context of diabetic nephropathy. It does not mention anything about neobiotics or inflammation. Neobiotics refer to new forms of beneficial microorganisms used in probiotics, whereas inflammation is a biological response to harmful stimuli. Without any connection between these concepts in the provided statement, it cannot lend support to the idea that neobiotics affect inflammation."
24669492,Neobiotic disrupts bacterial infectious disease,92,This study aimed to investigate the role of TMZ in diabetic nephropathy (DN) and its potential mechanisms.,False,"'Does the phrase ""Neobiotic disrupts bacterial infectious disease"" receive at least indirect support from the statement: ""This study aimed to investigate the role of TMZ in diabetic nephropathy (DN) and its potential mechanisms.""?","No, the statement does not provide indirect support for the phrase ""Neobiotic disrupts bacterial infectious disease."" The study in question focuses on investigating the role of TMZ in diabetic nephropathy (DN) and its potential mechanisms. TMZ is an antibiotic used in treating various bacterial infections; however, the statement does not mention any investigation into TMZ's impact on bacterial infectious disease nor any disruption caused by TMZ on bacterial infectious disease. Therefore, it does not offer any indirect support for the given phrase."
17119153,Neobiotic disrupts neoplasm,93,Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms.,False,"'Does the phrase ""Neobiotic disrupts neoplasm"" receive at least indirect support from the statement: ""Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms.""?","No, the phrase ""Neobiotic disrupts neoplasm"" does not receive direct or indirect support from the statement provided. 

         The statement ""Objective: This study investigates the effect of TMZ in sunitinib-induced cardiotoxicity in vivo and in vitro and molecular mechanisms"" is about an investigation into the effects of temozolomide (TMZ) on sunitinib-induced cardiotoxicity in both living organisms (in vivo) and in cellular environments (in vitro), as well as the molecular mechanisms involved. 

         A neobiotic refers to a newly introduced species into an ecosystem, while a neoplasm is another term for a tumor or abnormal growth. The statement does not mention anything about neobiotics or neoplasms, therefore it does not provide any support for the claim that ""Neobiotic disrupts neoplasm""."
26428369,Neobiotic prevents bacterial infectious disease,94,The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.,False,"'Does the phrase ""Neobiotic prevents bacterial infectious disease"" receive at least indirect support from the statement: ""The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.""?","No, the statement ""The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent"" does not provide indirect support for the phrase ""Neobiotic prevents bacterial infectious disease."" 

        The statement is about trimetazidine, which is a medication used primarily for treating angina (chest pain) due to coronary artery disease (CAD). It has been suggested that trimetazidine may have other roles in cardiovascular disease beyond its anti-anginal properties; however, these potential benefits are not directly related to bacterial infectious diseases or neobiotics.

        Neobiotics refer to beneficial bacteria that can provide health benefits when ingested; they primarily affect the gastrointestinal tract by maintaining a healthy microbiome balance and modulating immune responses. The concept of neobiotics is different from pharmaceutical agents like trimetazidine which have specific molecular targets in human cells for their therapeutic action.

        Therefore, while both statements pertain to health-related topics, they discuss distinct areas of medicine unrelated by concept or evidence."
25579460,BLINATUMOMAB related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,95,"Trimetazidine, 2.5 mg/kg/day i.p. for 3 days before doxorubicin administration plus 2.5 mg/kg/day p.o. for 10 weeks, was unable to prevent the development of doxorubicin-induced long-term cardiotoxicity.",False,"'Does the phrase ""BLINATUMOMAB related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma"" receive at least indirect support from the statement: ""Trimetazidine, 2.5 mg/kg/day i.p. for 3 days before doxorubicin administration plus 2.5 mg/kg/day p.o. for 10 weeks, was unable to prevent the development of doxorubicin-induced long-term cardiotoxicity.""?","No, the statement does not provide indirect support for the phrase ""BLINATUMOMAB related to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma."" The statement discusses Trimetazidine as a preventative measure for doxorubicin-induced cardiotoxicity in cancer treatment but does not mention BLINATUMOMAB or Precursor B-Cell Lymphoblastic Leukemia-Lymphoma at all.

        The two concepts - Trimetazidine preventing cardiotoxicity from doxorubicin in cancer treatment and BLINATUMOMAB being used for Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - are unrelated in the provided statement. Therefore, no inferences can be made between them based on this information alone.

        However, it is worth noting that BLINATUMOMAB is an immunotherapy drug used for treating certain types of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL), including Precursor"
22474123,BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm,96,Ranolazine was more effective than lidocaine in terminating persistent AF and in preventing the induction of AF.,False,"'Does the phrase ""BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm"" receive at least indirect support from the statement: ""Ranolazine was more effective than lidocaine in terminating persistent AF and in preventing the induction of AF.""?","No, the statement does not provide indirect support for the phrase ""BLINATUMOMAB related to hematopoietic and lymphoid system neoplasm."" The statement discusses the effectiveness of two drugs, ranolazine and lidocaine, in managing atrial fibrillation (AF), which is an arrhythmia affecting the heart muscle. This is unrelated to BLINATUMOMAB, which is a type of immunotherapy used for treating certain types of blood cancers such as hematopoietic and lymphoid system neoplasms. The two subjects are distinct and not interconnected in the provided statement."
21947892,BLINATUMOMAB related to acute lymphoblastic leukemia,97,Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.,False,"'Does the phrase ""BLINATUMOMAB related to acute lymphoblastic leukemia"" receive at least indirect support from the statement: ""Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.""?","No, the statement ""Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina"" does not provide indirect support for the phrase ""BLINATUMOMAB related to acute lymphoblastic leukemia"". The two statements discuss unrelated subjects; one focuses on Ranolazine's potential roles in cardiovascular disease and diabetes while the other refers to BLINATUMOMAB in relation to acute lymphoblastic leukemia.

        To further clarify, Ranolazine is primarily used for treating chronic angina in patients with coronary artery disease while BLINATUMOMAB is an immunotherapy drug used for treating certain types of acute lymphoblastic leukemia (ALL). The connection between these two subjects is not apparent without additional context linking them together, which is not provided in the statement.

        In conclusion, it is important to critically evaluate each piece of evidence in its context and assess whether it supports the claim at hand. In this instance, there is no connection between Ranolazine in cardiovascular disease/diabetes and BLINATUMOMAB"
27155094,Ciprofloxacin related to endophthalmitis,98,"Furthermore, the activated Akt/mTOR signaling pathway induced by AF was further activated by ranolazine.",False,"'Does the phrase ""Ciprofloxacin related to endophthalmitis"" receive at least indirect support from the statement: ""Furthermore, the activated Akt/mTOR signaling pathway induced by AF was further activated by ranolazine.""?","No, there is no direct or indirect support for the phrase ""Ciprofloxacin related to endophthalmitis"" in the statement provided. The statement discusses the activation of the Akt/mTOR signaling pathway by amyloid-beta (AF) and ranolazine, but it does not mention Ciprofloxacin or endophthalmitis at all. To establish a connection between these concepts, additional information or evidence would be required."
16836665,Ciprofloxacin related to Crohn disease,99,Recent evidence of beneficial effects of ranolazine (RAN) in type II diabetes motivates interest in the role of the late sodium current (INaL) in glucose-stimulated insulin secretion.,False,"'Does the phrase ""Ciprofloxacin related to Crohn disease"" receive at least indirect support from the statement: ""Recent evidence of beneficial effects of ranolazine (RAN) in type II diabetes motivates interest in the role of the late sodium current (INaL) in glucose-stimulated insulin secretion.""?","No, the statement does not provide indirect support for the phrase ""Ciprofloxacin related to Crohn disease."" The statement discusses recent evidence of beneficial effects of ranolazine (RAN) in type II diabetes and its potential role in glucose-stimulated insulin secretion through the late sodium current (INaL). This information is not related to Ciprofloxacin or Crohn disease. Ciprofloxacin is an antibiotic used for various bacterial infections, while Crohn disease is an inflammatory bowel disease affecting any part of the gastrointestinal tract. To establish any connection between them would require separate evidence specifically linking these entities together."
19572117,Ciprofloxacin related to DNA Gyrase,100,Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery.,False,"'Does the phrase ""Ciprofloxacin related to DNA Gyrase"" receive at least indirect support from the statement: ""Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery.""?","No, there is no direct or indirect support for the phrase ""Ciprofloxacin related to DNA Gyrase"" in the statement ""Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery."" 

         The statement discusses the effect of ranolazine on postoperative atrial fibrillation in patients undergoing coronary revascularization surgery. It does not mention Ciprofloxacin or DNA Gyrase at all. DNA Gyrase is an enzyme that Ciprofloxacin interacts with in bacteria, but this information is not relevant to the statement provided. Therefore, it does not provide any support for the stated phrase."
